{
  "@context": {
    "bemo": "https://w3id.org/bemo/",
    "bfo": "http://purl.obolibrary.org/obo/BFO_",
    "brick": "https://brickschema.org/schema/Brick#",
    "csvw": "http://www.w3.org/ns/csvw#",
    "dc": "http://purl.org/dc/elements/1.1/",
    "dcam": "http://purl.org/dc/dcam/",
    "dcat": "http://www.w3.org/ns/dcat#",
    "dcmitype": "http://purl.org/dc/dcmitype/",
    "dcterms": "http://purl.org/dc/terms/",
    "doap": "http://usefulinc.com/ns/doap#",
    "foaf": "http://xmlns.com/foaf/0.1/",
    "geo": "http://www.opengis.net/ont/geosparql#",
    "iao": "http://purl.obolibrary.org/obo/IAO_",
    "obo": "http://purl.obolibrary.org/obo/",
    "oboInOwl": "http://www.geneontology.org/formats/oboInOwl#",
    "odrl": "http://www.w3.org/ns/odrl/2/",
    "org": "http://www.w3.org/ns/org#",
    "owl": "http://www.w3.org/2002/07/owl#",
    "prof": "http://www.w3.org/ns/dx/prof/",
    "prov": "http://www.w3.org/ns/prov#",
    "qb": "http://purl.org/linked-data/cube#",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "schema": "https://schema.org/",
    "sh": "http://www.w3.org/ns/shacl#",
    "skos": "http://www.w3.org/2004/02/skos/core#",
    "sosa": "http://www.w3.org/ns/sosa/",
    "ssn": "http://www.w3.org/ns/ssn/",
    "time": "http://www.w3.org/2006/time#",
    "vann": "http://purl.org/vocab/vann/",
    "void": "http://rdfs.org/ns/void#",
    "wgs": "https://www.w3.org/2003/01/geo/wgs84_pos#",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/403",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 403,
      "bemo:BEMO_3100023": "0977ae8d7278730723c8d024585a95d1125aa9fe6da897fe977a079b172ddb48",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All experimental, computational, clinical, and omics studies\", \"Category\": \"Reproducibility and Replication\", \"Closely Related Metrics\": \"Experimental Reproducibility; Intralaboratory Repeatability; Method Reproducibility\", \"Common Misinterpretations\": \"Treating interlaboratory reproducibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Interlaboratory Reproducibility\", \"References or Origin\": \"https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines\", \"Related Frameworks\": \"PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0\", \"Scientific Definition\": \"The degree to which interlaboratory reproducibility yields concordant results under the specified repeated-analysis or repeated-measurement conditions.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses interlaboratory reproducibility using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in interlaboratory reproducibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 403"
    },
    {
      "@id": "bemo:BEMO_2000100",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000100",
      "bemo:BEMO_3100022": 107,
      "bemo:BEMO_3100023": "63bedc3fc09ef48160a8d522d76618e50e47197d3d502ae109f1015d0fbcb67e",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses negative-control validation using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in negative-control validation can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating negative-control validation as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized and observational etiologic studies, natural experiments, target-trial emulations"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000100"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000091"
        },
        {
          "@id": "bemo:BEMO_2000092"
        },
        {
          "@id": "bemo:BEMO_2000098"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of negative-control validation."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/107"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000100",
      "rdfs:label": {
        "@language": "en",
        "@value": "Negative-Control Validation"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb142"
        },
        {
          "@id": "bemo:BEMO_1100004"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb142",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000100"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000420",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000420"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/427"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Null-Result Interpretability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000188",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000188"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/195"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Technical Artifact Exclusion"
      }
    },
    {
      "@id": "bemo:BEMO_2000138",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000138",
      "bemo:BEMO_3100022": 145,
      "bemo:BEMO_3100023": "2f165758b70b1e482bfb8517e1a69a7d4e05ba84cd41dc36c2f346f991371034",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses verification bias risk using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in verification bias risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating verification bias risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "QUADAS-2; STARD; TRIPOD; REMARK"
      },
      "bemo:BEMO_3200011": "https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000138"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000118"
        },
        {
          "@id": "bemo:BEMO_2000119"
        },
        {
          "@id": "bemo:BEMO_2000121"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The probability or degree that verification bias introduces systematic distortion into a biomedical estimate or conclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/145"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000138",
      "rdfs:label": {
        "@language": "en",
        "@value": "Verification Bias Risk"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb177"
        },
        {
          "@id": "bemo:BEMO_1100005"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb177",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000138"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000072",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000072"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/79"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Microbial Contamination"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000120",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000120"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/127"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Incremental Diagnostic Value"
      }
    },
    {
      "@id": "bemo:BEMO_2000422",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000422",
      "bemo:BEMO_3100022": 429,
      "bemo:BEMO_3100023": "c3caaa14ecea68f7075a25ef235cdae89d1a9b9b86ed2b5a30dab5cb5b8bf20d",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses participant flow completeness using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in participant flow completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating participant flow completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Study report / dataset / evidence package"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All biomedical study reports and data releases"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000422"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000414"
        },
        {
          "@id": "bemo:BEMO_2000429"
        },
        {
          "@id": "bemo:BEMO_2000431"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which all scientifically necessary components of participant flow are present, documented, and evaluable."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/429"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000422",
      "rdfs:label": {
        "@language": "en",
        "@value": "Participant Flow Completeness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb431"
        },
        {
          "@id": "bemo:BEMO_1100016"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb431",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000422"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/291",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 291,
      "bemo:BEMO_3100023": "543dc6e95f52dce066f892ad8d141154500ea9d0cf35d11564c84cc551f70c3b",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Repeatability; Reproducibility of Measurement; Analytical Sensitivity\", \"Common Misinterpretations\": \"Treating intermediate precision as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Intermediate Precision\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"The closeness of repeated estimates or measurements and the narrowness of uncertainty around intermediate.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses intermediate precision using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in intermediate precision can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 291"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000391",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000391"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/398"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Data Provenance Completeness"
      }
    },
    {
      "@id": "bemo:BEMO_2000119",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000119",
      "bemo:BEMO_3100022": 126,
      "bemo:BEMO_3100023": "00ceeb2a9486ba76c68ad0f07ad3fe11fadf573e3b3b3fb37898281142b34a91",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses incorporation bias risk using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in incorporation bias risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating incorporation bias risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "QUADAS-2; STARD; TRIPOD; REMARK"
      },
      "bemo:BEMO_3200011": "https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000119"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000118"
        },
        {
          "@id": "bemo:BEMO_2000126"
        },
        {
          "@id": "bemo:BEMO_2000135"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The probability or degree that incorporation bias introduces systematic distortion into a biomedical estimate or conclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/126"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000119",
      "rdfs:label": {
        "@language": "en",
        "@value": "Incorporation Bias Risk"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb158"
        },
        {
          "@id": "bemo:BEMO_1100005"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb158",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000119"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000193",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000193",
      "bemo:BEMO_3100022": 200,
      "bemo:BEMO_3100023": "84e49bfba34c254503c96b181528bf2beab33e58bfa3d6d711b6afaa740ea566",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses context sensitivity using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in context sensitivity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating context sensitivity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Clinical, epidemiologic, diagnostic, translational, and population studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; QUADAS-2; CONSORT; STROBE"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000193"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000191"
        },
        {
          "@id": "bemo:BEMO_2000196"
        },
        {
          "@id": "bemo:BEMO_2000204"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of context sensitivity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/200"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000193",
      "rdfs:label": {
        "@language": "en",
        "@value": "Context Sensitivity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb226"
        },
        {
          "@id": "bemo:BEMO_1100008"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb226",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000193"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/49",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 49,
      "bemo:BEMO_3100023": "e147bf4116de09d3c1bd6b5fb8081223589d31f54f697b6e869790830619757d",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Biomarker development, qualification, endpoint and surrogate validation studies\", \"Category\": \"Biomarker and Endpoint Validation\", \"Closely Related Metrics\": \"Outcome Relevance; Endpoint Responsiveness; Minimal Clinically Important Difference Validity\", \"Common Misinterpretations\": \"Treating endpoint reliability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Endpoint Reliability\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"FDA Biomarker; BEST; EMA E16; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of endpoint reliability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses endpoint reliability using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in endpoint reliability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 49"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000117",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000117"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/124"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Diagnostic Specificity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/358",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 358,
      "bemo:BEMO_3100023": "1725f0845040d88689ff2869cde10ea44454b5cfaa1c303d02071f7ff5ccb751",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies\", \"Category\": \"Pharmacology and Toxicology\", \"Closely Related Metrics\": \"Carcinogenicity Evidence Strength; Developmental Toxicity Evidence Strength; Immunotoxicity Evidence Strength\", \"Common Misinterpretations\": \"Treating reproductive toxicity evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Reproductive Toxicity Evidence Strength\", \"References or Origin\": \"https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline\", \"Related Frameworks\": \"OECD; OHAT; FDA Biomarker; EMA E16\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting reproductive toxicity evidence.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses reproductive toxicity evidence strength using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in reproductive toxicity evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 358"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/418",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 418,
      "bemo:BEMO_3100023": "6d08df9b94938aa4356ba3bbe963ef6fed2e0e499e09e30936b635d55a24d3c8",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All biomedical study reports and data releases\", \"Category\": \"Research Transparency and Reporting Completeness\", \"Closely Related Metrics\": \"Null-Result Interpretability; Reproducibility Information Completeness\", \"Common Misinterpretations\": \"Treating deviations-from-protocol transparency as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Study report / dataset / evidence package\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Deviations-from-Protocol Transparency\", \"References or Origin\": \"https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/\", \"Related Frameworks\": \"EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of deviations-from-protocol transparency.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses deviations-from-protocol transparency using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in deviations-from-protocol transparency can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 418"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000178",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000178"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/185"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Housing and Husbandry Control"
      }
    },
    {
      "@id": "bemo:BEMO_2000192",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000192",
      "bemo:BEMO_3100022": 199,
      "bemo:BEMO_3100023": "607cceee390b7cb8ce577becf5db87c7c9a4643da6c8fbe5bd44948e1b9e3853",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses comparator applicability using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in comparator applicability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating comparator applicability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Clinical, epidemiologic, diagnostic, translational, and population studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; QUADAS-2; CONSORT; STROBE"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000192"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000200"
        },
        {
          "@id": "bemo:BEMO_2000201"
        },
        {
          "@id": "bemo:BEMO_2000207"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of comparator applicability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/199"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000192",
      "rdfs:label": {
        "@language": "en",
        "@value": "Comparator Applicability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb225"
        },
        {
          "@id": "bemo:BEMO_1100008"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb225",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000192"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000253",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000253",
      "bemo:BEMO_3100022": 260,
      "bemo:BEMO_3100023": "e9483af6db486496b6f4b0c18d333bb38a6c500a6b80dd23beefe82c05de4acc",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses read quality using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in read quality can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Read- and variant-level quality-control summaries; replicate concordance; orthogonal confirmation; benchmarking against reference materials."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating read quality as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAME; MINSEQE; STROBE-ME; GA4GH; HCA"
      },
      "bemo:BEMO_3200011": "https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000253"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000245"
        },
        {
          "@id": "bemo:BEMO_2000249"
        },
        {
          "@id": "bemo:BEMO_2000250"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of read quality."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/260"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000253",
      "rdfs:label": {
        "@language": "en",
        "@value": "Read Quality"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb278"
        },
        {
          "@id": "bemo:BEMO_1100010"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb278",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000253"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/468",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 468,
      "bemo:BEMO_3100023": "de4287424d92a6f5a119531d8abefacf3d79beff40059540425ff1afc5f1021d",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Type I Error Control; Multiplicity Control; Model Specification Adequacy\", \"Common Misinterpretations\": \"Treating type ii error risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Type II Error Risk\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"The probability or degree that type ii error introduces systematic distortion into a biomedical estimate or conclusion.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses type ii error risk using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in type ii error risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 468"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000254",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000254"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/261"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Reference Bias"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/235",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 235,
      "bemo:BEMO_3100023": "eba377fe2c190b6390cd804f64874ad58540debe287184cfa259e70d97d1fcc8",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mendelian disease, cancer genetics, association, segregation, and functional studies\", \"Category\": \"Genetics and Variant Evidence\", \"Closely Related Metrics\": \"Founder-Effect Assessment; Locus Heterogeneity Assessment; Genotype–Phenotype Concordance\", \"Common Misinterpretations\": \"Treating phenocopy risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Phenocopy Risk\", \"References or Origin\": \"https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/\", \"Related Frameworks\": \"ClinGen; ACMG AMP; STREGA; Gene Ontology\", \"Scientific Definition\": \"The probability or degree that phenocopy introduces systematic distortion into a biomedical estimate or conclusion.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses phenocopy risk using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in phenocopy risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 235"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/369",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 369,
      "bemo:BEMO_3100023": "5024c9034e231e8bc296cf1d9092cc063fe94890f4856d8bf70ac077514b55f9",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies\", \"Category\": \"Proteomics and Metabolomics\", \"Closely Related Metrics\": \"Internal Standard Performance; Derivatization Efficiency; Metabolic Feature Reproducibility\", \"Common Misinterpretations\": \"Treating extraction recovery as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Extraction Recovery\", \"References or Origin\": \"https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/\", \"Related Frameworks\": \"MIAPE; HUPO PSI; Metabolomics Standards\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of extraction recovery.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Replicate dilution series; blank and spiked samples; reference materials; method-comparison studies; predefined CLSI/ISO acceptance criteria.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses extraction recovery using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in extraction recovery can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 369"
    },
    {
      "@id": "bemo:BEMO_2000424",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000424",
      "bemo:BEMO_3100022": 431,
      "bemo:BEMO_3100023": "3d4a65e6d3c66bcaca4ff40b6df33feaedf2f77c58697c32f80c96a00d211e95",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses processed-data availability using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in processed-data availability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating processed-data availability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Study report / dataset / evidence package"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All biomedical study reports and data releases"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000424"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000419"
        },
        {
          "@id": "bemo:BEMO_2000427"
        },
        {
          "@id": "bemo:BEMO_2000428"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of processed-data availability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/431"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000424",
      "rdfs:label": {
        "@language": "en",
        "@value": "Processed-Data Availability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb433"
        },
        {
          "@id": "bemo:BEMO_1100016"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb433",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000424"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_3100021",
      "@type": "owl:DatatypeProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Calibration requirement for the output."
      },
      "oboInOwl:id": "BEMO:3100021",
      "rdfs:label": {
        "@language": "en",
        "@value": "calibration requirement"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000488",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000488"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/495"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Temporal Precedence"
      }
    },
    {
      "@id": "bemo:BEMO_2000171",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000171",
      "bemo:BEMO_3100022": 178,
      "bemo:BEMO_3100023": "74976e4cf57f53c444f4721c04fc26fb7298cad4ac743db45feeb9a0be34587a",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses biological replicate adequacy using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in biological replicate adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating biological replicate adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "In vitro, ex vivo, organoid, animal, and preclinical experiments"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ARRIVE 2.0; SYRCLE; OECD"
      },
      "bemo:BEMO_3200011": "https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000171"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000176"
        },
        {
          "@id": "bemo:BEMO_2000185"
        },
        {
          "@id": "bemo:BEMO_2000189"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which biological replicate is sufficient and fit for the stated biomedical inference."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/178"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000171",
      "rdfs:label": {
        "@language": "en",
        "@value": "Biological Replicate Adequacy"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb31"
        },
        {
          "@id": "bemo:BEMO_1100007"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb31",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000171"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/283",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 283,
      "bemo:BEMO_3100023": "0d8876821c8ce33e4a6f72fcdd334c759d21fb2784bd7f9f779179758d7849c8",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Method Comparison Agreement; Sample Stability; Reagent Lot Consistency\", \"Common Misinterpretations\": \"Treating commutability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Commutability\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of commutability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses commutability using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in commutability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 283"
    },
    {
      "@id": "bemo:BEMO_1100017",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Category of biomedical evidence metrics concerned with statistical validity and inference."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:1100017",
      "rdfs:label": {
        "@language": "en",
        "@value": "Statistical Validity and Inference metric"
      },
      "rdfs:subClassOf": {
        "@id": "bemo:BEMO_1000002"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/189",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 189,
      "bemo:BEMO_3100023": "86d52a57d493edc61e94352ed7d2d8f4feaaa492b37b0afb047315bb8706c00e",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"In vitro, ex vivo, organoid, animal, and preclinical experiments\", \"Category\": \"Experimental Biology and Animal Research\", \"Closely Related Metrics\": \"Vehicle-Control Validity; Technical Artifact Exclusion\", \"Common Misinterpretations\": \"Treating orthogonal validation as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Orthogonal Validation\", \"References or Origin\": \"https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"ARRIVE 2.0; SYRCLE; OECD\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of orthogonal validation.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses orthogonal validation using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in orthogonal validation can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 189"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/379",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 379,
      "bemo:BEMO_3100023": "770bd2fa8c1eedf14831e8e8caca6d53a1ad4a7b7272433891be0eac41a4e30c",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies\", \"Category\": \"Proteomics and Metabolomics\", \"Closely Related Metrics\": \"Dynamic Range Coverage; Ion Suppression Assessment; Retention-Time Stability\", \"Common Misinterpretations\": \"Treating missing-value burden as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Missing-Value Burden\", \"References or Origin\": \"https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/\", \"Related Frameworks\": \"MIAPE; HUPO PSI; Metabolomics Standards\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of missing-value burden.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses missing-value burden using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in missing-value burden can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 379"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000015",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000015"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/22"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Molecular-Phenotypic Concordance"
      }
    },
    {
      "@id": "bemo:BEMO_2000137",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000137",
      "bemo:BEMO_3100022": 144,
      "bemo:BEMO_3100023": "5232bfe9f1dc1ddd88662ddb65a550d0d1fc5338bb4a530ed1072ed6078116bf",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses time-dependent discrimination using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in time-dependent discrimination can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating time-dependent discrimination as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "QUADAS-2; STARD; TRIPOD; REMARK"
      },
      "bemo:BEMO_3200011": "https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000137"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000114"
        },
        {
          "@id": "bemo:BEMO_2000132"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of time-dependent discrimination."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/144"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000137",
      "rdfs:label": {
        "@language": "en",
        "@value": "Time-Dependent Discrimination"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb176"
        },
        {
          "@id": "bemo:BEMO_1100005"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb176",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000137"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000350",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000350",
      "bemo:BEMO_3100022": 357,
      "bemo:BEMO_3100023": "5025e34702ce03c8ed7e7aa3ed95dd9bde6bac1786183651ce608b34ffcc6a28",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses receptor occupancy evidence using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in receptor occupancy evidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating receptor occupancy evidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "OECD; OHAT; FDA Biomarker; EMA E16"
      },
      "bemo:BEMO_3200011": "https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000350"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000335"
        },
        {
          "@id": "bemo:BEMO_2000349"
        },
        {
          "@id": "bemo:BEMO_2000353"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of receptor occupancy evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/357"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000350",
      "rdfs:label": {
        "@language": "en",
        "@value": "Receptor Occupancy Evidence"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb365"
        },
        {
          "@id": "bemo:BEMO_1100013"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb365",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000350"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000174",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000174"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/181"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Exclusion-Criteria Prespecification"
      }
    },
    {
      "@id": "bemo:BEMO_2000316",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000316",
      "bemo:BEMO_3100022": 323,
      "bemo:BEMO_3100023": "79eaf0a8e6c6fc3012d48e379c545c17d89aecf6de033d40ae6399ec89441a3b",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses network node confidence using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in network node confidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating network node confidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Dataset / model / pathway / network / evidence body"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Integrated omics, networks, pathways, mechanistic and dynamic systems models"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "Gene Ontology; Reactome; UniProt; GA4GH"
      },
      "bemo:BEMO_3200011": "https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000316"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000314"
        },
        {
          "@id": "bemo:BEMO_2000315"
        },
        {
          "@id": "bemo:BEMO_2000322"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The justified degree of certainty assigned to network node given the quantity, quality, consistency, and limitations of supporting evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/323"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000316",
      "rdfs:label": {
        "@language": "en",
        "@value": "Network Node Confidence"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb334"
        },
        {
          "@id": "bemo:BEMO_1100012"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb334",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000316"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000111",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000111"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/118"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Calibration Slope"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000142",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000142"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/149"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Evidence Coherence"
      }
    },
    {
      "@id": "bemo:BEMO_2000318",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000318",
      "bemo:BEMO_3100022": 325,
      "bemo:BEMO_3100023": "b8714924720c209e415f9bf2c9aaf707f6bf0edbbbf6ca8da11d2546f9da563d",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses ontology annotation completeness using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in ontology annotation completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating ontology annotation completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Dataset / model / pathway / network / evidence body"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Integrated omics, networks, pathways, mechanistic and dynamic systems models"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "Gene Ontology; Reactome; UniProt; GA4GH"
      },
      "bemo:BEMO_3200011": "https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000318"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000313"
        },
        {
          "@id": "bemo:BEMO_2000319"
        },
        {
          "@id": "bemo:BEMO_2000326"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which all scientifically necessary components of ontology annotation are present, documented, and evaluable."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/325"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000318",
      "rdfs:label": {
        "@language": "en",
        "@value": "Ontology Annotation Completeness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb336"
        },
        {
          "@id": "bemo:BEMO_1100012"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb336",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000318"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_1000001",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Metrics assessing the completeness, certainty, consistency, precision, and synthesis of biomedical evidence."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:1000001",
      "rdfs:label": {
        "@language": "en",
        "@value": "Evidence Synthesis and Certainty metric"
      },
      "rdfs:subClassOf": {
        "@id": "bemo:BEMO_0000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/416",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 416,
      "bemo:BEMO_3100023": "e951e1891736a22e6ef317b85f2f1f3032c69473b10d7ac72b1ed8342656df25",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All biomedical study reports and data releases\", \"Category\": \"Research Transparency and Reporting Completeness\", \"Closely Related Metrics\": \"Funding-Source Transparency; Data-Sharing Transparency; Code-Sharing Transparency\", \"Common Misinterpretations\": \"Treating conflict-of-interest transparency as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Study report / dataset / evidence package\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Conflict-of-Interest Transparency\", \"References or Origin\": \"https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/\", \"Related Frameworks\": \"EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of conflict-of-interest transparency.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses conflict-of-interest transparency using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in conflict-of-interest transparency can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 416"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/11",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 11,
      "bemo:BEMO_3100023": "6f883b8ebe7aa3d7407688c8b2390b245a894c21f5c21ffef99fe634674c5fd3",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Molecular, cellular, animal, translational, pharmacologic, and human studies\", \"Category\": \"Biological Plausibility and Mechanism\", \"Closely Related Metrics\": \"Temporal Biological Concordance; Phenotypic Concordance; Molecular-Phenotypic Concordance\", \"Common Misinterpretations\": \"Treating cross-species biological concordance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Cross-Species Biological Concordance\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"GRADE; FDA Biomarker; ClinGen; OHAT; OECD\", \"Scientific Definition\": \"The degree of agreement in cross-species biological across measurements, studies, methods, populations, or biological levels.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses cross-species biological concordance using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in cross-species biological concordance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 11"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000442",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000442"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/449"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Fragility Index"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000220",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000220"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/227"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Functional Variant Evidence"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000265",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000265"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/272"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Transcript Quantification Reliability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000148",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000148"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/155"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Evidence Directness"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000393",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000393"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/400"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Experimental Reproducibility"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000395",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000395"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/402"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Inferential Reproducibility"
      }
    },
    {
      "@id": "bemo:BEMO_2000239",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000239",
      "bemo:BEMO_3100022": 246,
      "bemo:BEMO_3100023": "0751d3491af658db1257b3b04a366a751c7fd0fdfb5e615ebbae3dab6970c7c9",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses batch-effect control using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in batch-effect control can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating batch-effect control as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAME; MINSEQE; STROBE-ME; GA4GH; HCA"
      },
      "bemo:BEMO_3200011": "https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000239"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000248"
        },
        {
          "@id": "bemo:BEMO_2000252"
        },
        {
          "@id": "bemo:BEMO_2000255"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of batch-effect control."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/246"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000239",
      "rdfs:label": {
        "@language": "en",
        "@value": "Batch-Effect Control"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb266"
        },
        {
          "@id": "bemo:BEMO_1100010"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb266",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000239"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/79",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 79,
      "bemo:BEMO_3100023": "a7e7bf9a47cefd808a5ba122413c735b8b095ffc84592451f9857f4fe080e389",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All studies using human or animal biospecimens\", \"Category\": \"Biospecimen and Preanalytical Quality\", \"Closely Related Metrics\": \"Protein Integrity; Chain-of-Custody Integrity; Matched-Sample Integrity\", \"Common Misinterpretations\": \"Treating microbial contamination as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Microbial Contamination\", \"References or Origin\": \"https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"BRISQ; ISO 15189; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of microbial contamination.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses microbial contamination using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in microbial contamination can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 79"
    },
    {
      "@id": "bemo:BEMO_2000250",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000250",
      "bemo:BEMO_3100022": 257,
      "bemo:BEMO_3100023": "aef9eeffa971170a3db3642e806206bdf35806d1d8cc427e16ad9106f7e0207c",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses mapping quality using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in mapping quality can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Read- and variant-level quality-control summaries; replicate concordance; orthogonal confirmation; benchmarking against reference materials."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating mapping quality as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAME; MINSEQE; STROBE-ME; GA4GH; HCA"
      },
      "bemo:BEMO_3200011": "https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000250"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000245"
        },
        {
          "@id": "bemo:BEMO_2000246"
        },
        {
          "@id": "bemo:BEMO_2000253"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of mapping quality."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/257"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000250",
      "rdfs:label": {
        "@language": "en",
        "@value": "Mapping Quality"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb275"
        },
        {
          "@id": "bemo:BEMO_1100010"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb275",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000250"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000338",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000338"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/345"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Genotoxicity Evidence Strength"
      }
    },
    {
      "@id": "bemo:BEMO_3200017",
      "@type": "owl:AnnotationProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "License status of the record or ontology."
      },
      "oboInOwl:id": "BEMO:3200017",
      "rdfs:label": {
        "@language": "en",
        "@value": "license status"
      }
    },
    {
      "@id": "bemo:BEMO_2000035",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000035",
      "bemo:BEMO_3100022": 42,
      "bemo:BEMO_3100023": "5bd558ed006f260bde44545e9ab38951fc6c2e450b4d3cb07f929d1fcb479f4e",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses construct validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in construct validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating construct validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Biomarker development, qualification, endpoint and surrogate validation studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; BEST; EMA E16; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000035"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000036"
        },
        {
          "@id": "bemo:BEMO_2000039"
        },
        {
          "@id": "bemo:BEMO_2000051"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which construct supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/42"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000035",
      "rdfs:label": {
        "@language": "en",
        "@value": "Construct Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb84"
        },
        {
          "@id": "bemo:BEMO_1100002"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb84",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000035"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/415",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 415,
      "bemo:BEMO_3100023": "a4617b71362b91773383e09e14a13eab2a1f342da234aa0f9bf7cc4400a6ff10",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All biomedical study reports and data releases\", \"Category\": \"Research Transparency and Reporting Completeness\", \"Closely Related Metrics\": \"Intervention Description Completeness; Eligibility Criteria Completeness; Recruitment Reporting Completeness\", \"Common Misinterpretations\": \"Treating comparator description completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Study report / dataset / evidence package\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Comparator Description Completeness\", \"References or Origin\": \"https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/\", \"Related Frameworks\": \"EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS\", \"Scientific Definition\": \"The extent to which all scientifically necessary components of comparator description are present, documented, and evaluable.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses comparator description completeness using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in comparator description completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 415"
    },
    {
      "@id": "bemo:BEMO_2000186",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000186",
      "bemo:BEMO_3100022": 193,
      "bemo:BEMO_3100023": "67d1bc84f2c2d0324ee734ed3d2df1c72cd4820b21290b5a8b136d75863a4866",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses sex as a biological variable adequacy using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in sex as a biological variable adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating sex as a biological variable adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "In vitro, ex vivo, organoid, animal, and preclinical experiments"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ARRIVE 2.0; SYRCLE; OECD"
      },
      "bemo:BEMO_3200011": "https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000186"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000166"
        },
        {
          "@id": "bemo:BEMO_2000177"
        },
        {
          "@id": "bemo:BEMO_2000187"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which sex as a biological variable is sufficient and fit for the stated biomedical inference."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/193"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000186",
      "rdfs:label": {
        "@language": "en",
        "@value": "Sex as a Biological Variable Adequacy"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb220"
        },
        {
          "@id": "bemo:BEMO_1100007"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb220",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000186"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000463",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000463",
      "bemo:BEMO_3100022": 470,
      "bemo:BEMO_3100023": "9a20a1494ccbc46d7bc0acd4d260241ebc29edd15b77d8ccc525c9f0dba8e8de",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses adherence integrity using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in adherence integrity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating adherence integrity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000463"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000476"
        },
        {
          "@id": "bemo:BEMO_2000477"
        },
        {
          "@id": "bemo:BEMO_2000479"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of adherence integrity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/470"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000463",
      "rdfs:label": {
        "@language": "en",
        "@value": "Adherence Integrity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb466"
        },
        {
          "@id": "bemo:BEMO_1100018"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb466",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000463"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000214",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000214",
      "bemo:BEMO_3100022": 221,
      "bemo:BEMO_3100023": "965b0273f9a305e64b50437dcad85ab39818fad51d561d0ac4da1daaf7d204f2",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses co-segregation likelihood using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in co-segregation likelihood can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "ClinGen/ACMG evidence scoring; pedigree analysis; population databases; case-control data; functional assays; expert-panel review."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating co-segregation likelihood as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mendelian disease, cancer genetics, association, segregation, and functional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ClinGen; ACMG AMP; STREGA; Gene Ontology"
      },
      "bemo:BEMO_3200011": "https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000214"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000218"
        },
        {
          "@id": "bemo:BEMO_2000227"
        },
        {
          "@id": "bemo:BEMO_2000231"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of co-segregation likelihood."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/221"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000214",
      "rdfs:label": {
        "@language": "en",
        "@value": "Co-segregation Likelihood"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb244"
        },
        {
          "@id": "bemo:BEMO_1100009"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb244",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000214"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/22",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 22,
      "bemo:BEMO_3100023": "81a78e88eaa62f6e2bb0ae947aba28fe819150032abcf9264f9205803cc7dfd1",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Molecular, cellular, animal, translational, pharmacologic, and human studies\", \"Category\": \"Biological Plausibility and Mechanism\", \"Closely Related Metrics\": \"Phenotypic Concordance; Perturbational Validation; Loss-of-Function Validation\", \"Common Misinterpretations\": \"Treating molecular-phenotypic concordance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Molecular-Phenotypic Concordance\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"GRADE; FDA Biomarker; ClinGen; OHAT; OECD\", \"Scientific Definition\": \"The degree of agreement in molecular-phenotypic across measurements, studies, methods, populations, or biological levels.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses molecular-phenotypic concordance using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in molecular-phenotypic concordance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 22"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000165",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000165"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/172"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Study Heterogeneity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000129",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000129"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/136"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Prognostic Added Value"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000359",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Developing; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000359"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/366"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Cross-Omics Concordance"
      }
    },
    {
      "@id": "bemo:BEMO_2000361",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000361",
      "bemo:BEMO_3100022": 368,
      "bemo:BEMO_3100023": "57e4c77ea2a48565f0758aadf8529c7db52bab9beb67f6e9c8366f0f3232e753",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses dynamic range coverage using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in dynamic range coverage can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating dynamic range coverage as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAPE; HUPO PSI; Metabolomics Standards"
      },
      "bemo:BEMO_3200011": "https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000361"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000366"
        },
        {
          "@id": "bemo:BEMO_2000372"
        },
        {
          "@id": "bemo:BEMO_2000381"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The proportion and representativeness of the relevant dynamic range captured by the evidence or measurement process."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/368"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000361",
      "rdfs:label": {
        "@language": "en",
        "@value": "Dynamic Range Coverage"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb375"
        },
        {
          "@id": "bemo:BEMO_1100014"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb375",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000361"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/368",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 368,
      "bemo:BEMO_3100023": "57e4c77ea2a48565f0758aadf8529c7db52bab9beb67f6e9c8366f0f3232e753",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies\", \"Category\": \"Proteomics and Metabolomics\", \"Closely Related Metrics\": \"Quantification Accuracy; Missing-Value Burden; Ion Suppression Assessment\", \"Common Misinterpretations\": \"Treating dynamic range coverage as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Dynamic Range Coverage\", \"References or Origin\": \"https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/\", \"Related Frameworks\": \"MIAPE; HUPO PSI; Metabolomics Standards\", \"Scientific Definition\": \"The proportion and representativeness of the relevant dynamic range captured by the evidence or measurement process.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses dynamic range coverage using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in dynamic range coverage can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 368"
    },
    {
      "@id": "bemo:BEMO_3100028",
      "@type": "owl:DatatypeProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Version of the executed protocol."
      },
      "oboInOwl:id": "BEMO:3100028",
      "rdfs:label": {
        "@language": "en",
        "@value": "computation protocol version"
      }
    },
    {
      "@id": "bemo:BEMO_2000294",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000294",
      "bemo:BEMO_3100022": 301,
      "bemo:BEMO_3100023": "66143063e8139ffa9de4cc6fb03a0eb1778bd92be05c901387fc7af071b0e433",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses reagent lot consistency using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in reagent lot consistency can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating reagent lot consistency as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000294"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000282"
        },
        {
          "@id": "bemo:BEMO_2000291"
        },
        {
          "@id": "bemo:BEMO_2000300"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree of agreement in reagent lot across measurements, studies, methods, populations, or biological levels."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/301"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000294",
      "rdfs:label": {
        "@language": "en",
        "@value": "Reagent Lot Consistency"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb315"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb315",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000294"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/324",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 324,
      "bemo:BEMO_3100023": "0b4f2bdfa3ccc3b3abdb67b1f3be15b6d8479743942152580ad3f1929db67d5f",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Integrated omics, networks, pathways, mechanistic and dynamic systems models\", \"Category\": \"Multi-omics and Systems Biology\", \"Closely Related Metrics\": \"Latent-Factor Stability; Network Edge Confidence; Network Node Confidence\", \"Common Misinterpretations\": \"Treating network reconstruction robustness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Dataset / model / pathway / network / evidence body\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Network Reconstruction Robustness\", \"References or Origin\": \"https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/\", \"Related Frameworks\": \"Gene Ontology; Reactome; UniProt; GA4GH\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of network reconstruction robustness.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses network reconstruction robustness using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in network reconstruction robustness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 324"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000458",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000458"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/465"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Residual Diagnostics Adequacy"
      }
    },
    {
      "@id": "bemo:BEMO_3100008",
      "@type": "owl:DatatypeProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Expected output datatype."
      },
      "oboInOwl:id": "BEMO:3100008",
      "rdfs:label": {
        "@language": "en",
        "@value": "output datatype"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/436",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 436,
      "bemo:BEMO_3100023": "d9e587b4cd42324cc1668fb835e848ce02fea72bac0af2f37bcc6e0a40cbc327",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All biomedical study reports and data releases\", \"Category\": \"Research Transparency and Reporting Completeness\", \"Closely Related Metrics\": \"Eligibility Criteria Completeness; Participant Flow Completeness; Harms Reporting Completeness\", \"Common Misinterpretations\": \"Treating recruitment reporting completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Study report / dataset / evidence package\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Recruitment Reporting Completeness\", \"References or Origin\": \"https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/\", \"Related Frameworks\": \"EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS\", \"Scientific Definition\": \"The extent to which all scientifically necessary components of recruitment reporting are present, documented, and evaluable.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses recruitment reporting completeness using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in recruitment reporting completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 436"
    },
    {
      "@id": "bemo:BEMO_3000016",
      "@type": "owl:ObjectProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Represents a curated computational dependency between metrics."
      },
      "oboInOwl:id": "BEMO:3000016",
      "rdfs:label": {
        "@language": "en",
        "@value": "depends on metric"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000160",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000160"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/167"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Overall Evidence Certainty"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/71",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 71,
      "bemo:BEMO_3100023": "c748a49d52923f74e8e31a0f69a4e91ee50970289d8b43c903a638e0573cc828",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All studies using human or animal biospecimens\", \"Category\": \"Biospecimen and Preanalytical Quality\", \"Closely Related Metrics\": \"Biospecimen Provenance Completeness; Warm Ischemia Control; Cold Ischemia Control\", \"Common Misinterpretations\": \"Treating collection procedure consistency as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Collection Procedure Consistency\", \"References or Origin\": \"https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"BRISQ; ISO 15189; REMARK\", \"Scientific Definition\": \"The degree of agreement in collection procedure across measurements, studies, methods, populations, or biological levels.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses collection procedure consistency using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in collection procedure consistency can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 71"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000112",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000112"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/119"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Calibration-in-the-Large"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/217",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 217,
      "bemo:BEMO_3100023": "ef0b46b07942a1780f9e2e890b09b7edc3579f016762848aa46c4d956da3075d",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Clinical, epidemiologic, diagnostic, translational, and population studies\", \"Category\": \"External Validity and Applicability\", \"Closely Related Metrics\": \"Sampling Frame Adequacy; Generalizability; Setting Applicability\", \"Common Misinterpretations\": \"Treating transportability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Transportability\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/\", \"Related Frameworks\": \"GRADE; QUADAS-2; CONSORT; STROBE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of transportability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses transportability using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in transportability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 217"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000467",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000467"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/474"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Blinding Integrity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000322",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000322"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/329"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Pathway Enrichment Consistency"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000469",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000469"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/476"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Cluster Recruitment Bias Risk"
      }
    },
    {
      "@id": "bemo:BEMO_2000263",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000263",
      "bemo:BEMO_3100022": 270,
      "bemo:BEMO_3100023": "e61d8e9d42dcb8b644bc33652bdf4f396f77ace1c2d848fb684d0c722e5a1598",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses spatial transcriptomic registration accuracy using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in spatial transcriptomic registration accuracy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating spatial transcriptomic registration accuracy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAME; MINSEQE; STROBE-ME; GA4GH; HCA"
      },
      "bemo:BEMO_3200011": "https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000263"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000241"
        },
        {
          "@id": "bemo:BEMO_2000243"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The closeness of spatial transcriptomic registration to the accepted reference or true value."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/270"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000263",
      "rdfs:label": {
        "@language": "en",
        "@value": "Spatial Transcriptomic Registration Accuracy"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb287"
        },
        {
          "@id": "bemo:BEMO_1100010"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb287",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000263"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000373",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000373",
      "bemo:BEMO_3100022": 380,
      "bemo:BEMO_3100023": "1a891a794290e0f5eee9ca88b64bc6b46d5840f63c8709e0e546399158fbb914",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses pathway enrichment robustness using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in pathway enrichment robustness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating pathway enrichment robustness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAPE; HUPO PSI; Metabolomics Standards"
      },
      "bemo:BEMO_3200011": "https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000373"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000359"
        },
        {
          "@id": "bemo:BEMO_2000369"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of pathway enrichment robustness."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/380"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000373",
      "rdfs:label": {
        "@language": "en",
        "@value": "Pathway Enrichment Robustness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb387"
        },
        {
          "@id": "bemo:BEMO_1100014"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb387",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000373"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000070",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000070"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/77"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Lipemia Burden"
      }
    },
    {
      "@id": "https://w3id.org/bemo/alignment/ECO",
      "@type": "prov:Entity",
      "dcterms:source": {
        "@id": "obo:eco.owl"
      }
    },
    {
      "@id": "bemo:BEMO_2000078",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000078",
      "bemo:BEMO_3100022": 85,
      "bemo:BEMO_3100023": "98ac509f170b3163d862e8e08cc16dad8b915df5508f4e7394a8627d881f7350",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses rna integrity using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in rna integrity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating rna integrity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All studies using human or animal biospecimens"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "BRISQ; ISO 15189; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000078"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000065"
        },
        {
          "@id": "bemo:BEMO_2000069"
        },
        {
          "@id": "bemo:BEMO_2000077"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of rna integrity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/85"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000078",
      "rdfs:label": {
        "@language": "en",
        "@value": "RNA Integrity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb123"
        },
        {
          "@id": "bemo:BEMO_1100003"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb123",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000078"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_3200004",
      "@type": "owl:AnnotationProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Preserves the source measurement criteria."
      },
      "oboInOwl:id": "BEMO:3200004",
      "rdfs:label": {
        "@language": "en",
        "@value": "measurement criteria"
      }
    },
    {
      "@id": "bemo:BEMO_2000064",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000064",
      "bemo:BEMO_3100022": 71,
      "bemo:BEMO_3100023": "c748a49d52923f74e8e31a0f69a4e91ee50970289d8b43c903a638e0573cc828",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses collection procedure consistency using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in collection procedure consistency can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating collection procedure consistency as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All studies using human or animal biospecimens"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "BRISQ; ISO 15189; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000064"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000060"
        },
        {
          "@id": "bemo:BEMO_2000063"
        },
        {
          "@id": "bemo:BEMO_2000083"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree of agreement in collection procedure across measurements, studies, methods, populations, or biological levels."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/71"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000064",
      "rdfs:label": {
        "@language": "en",
        "@value": "Collection Procedure Consistency"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb110"
        },
        {
          "@id": "bemo:BEMO_1100003"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb110",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000064"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000307",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Developing; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000307"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/314"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Emergent-Property Reproducibility"
      }
    },
    {
      "@id": "bemo:BEMO_2000458",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000458",
      "bemo:BEMO_3100022": 465,
      "bemo:BEMO_3100023": "1193234e513641f836d7ad506af2e69fb2fcba17a604fff5710f7b53f487ad89",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses residual diagnostics adequacy using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in residual diagnostics adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating residual diagnostics adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000458"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000438"
        },
        {
          "@id": "bemo:BEMO_2000449"
        },
        {
          "@id": "bemo:BEMO_2000462"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which residual diagnostics is sufficient and fit for the stated biomedical inference."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/465"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000458",
      "rdfs:label": {
        "@language": "en",
        "@value": "Residual Diagnostics Adequacy"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb461"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb461",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000458"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/472",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 472,
      "bemo:BEMO_3100023": "0783cbbb1a7caf7ef448d6830ae564e73010beb87e2e08710ddb494b6b76ccb3",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies\", \"Category\": \"Study Design and Internal Validity\", \"Closely Related Metrics\": \"Detection Bias Risk; Selective Outcome Reporting Risk; Protocol Deviation Risk\", \"Common Misinterpretations\": \"Treating attrition bias risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Attrition Bias Risk\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools\", \"Related Frameworks\": \"CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI\", \"Scientific Definition\": \"The probability or degree that attrition bias introduces systematic distortion into a biomedical estimate or conclusion.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses attrition bias risk using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in attrition bias risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 472"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000045",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000045"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/52"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Individual-Level Surrogacy"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000074",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000074"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/81"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Pathology Confirmation"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000189",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000189"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/196"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Technical Replicate Adequacy"
      }
    },
    {
      "@id": "https://w3id.org/bemo/ontology/bemo",
      "@type": "owl:Ontology",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO Foundry compatibility.",
      "dcterms:created": {
        "@type": "xsd:date",
        "@value": "2026-08-02"
      },
      "dcterms:creator": "BEMO Project",
      "dcterms:description": {
        "@language": "en",
        "@value": "A provisional, computable ontology of pure biomedical evidence research metrics. Each source metric is represented as an OWL class and linked to a versioned computation specification."
      },
      "dcterms:modified": {
        "@type": "xsd:date",
        "@value": "2026-08-02"
      },
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "dcterms:title": {
        "@language": "en",
        "@value": "Biomedical Evidence Metrics Ontology (BEMO)"
      },
      "owl:imports": [
        {
          "@id": "obo:bfo.owl"
        },
        {
          "@id": "obo:eco.owl"
        },
        {
          "@id": "obo:iao.owl"
        },
        {
          "@id": "obo:obi.owl"
        },
        {
          "@id": "obo:ro.owl"
        },
        {
          "@id": "http://www.w3.org/ns/prov-o"
        }
      ],
      "owl:versionIRI": {
        "@id": "https://w3id.org/bemo/releases/2026-08-02/bemo.owl"
      },
      "owl:versionInfo": "0.1.0",
      "rdfs:comment": {
        "@language": "en",
        "@value": "DRAFT. This namespace is provisional, the ontology has not been reviewed or accepted by the OBO Foundry, and the final open license requires owner approval."
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/491",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 491,
      "bemo:BEMO_3100023": "ae404e8a9df9a665347ede4db7ae7370bdc6c77c15da3474e23c516ad81dd25e",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies\", \"Category\": \"Study Design and Internal Validity\", \"Closely Related Metrics\": \"Study Design Appropriateness; Outcome Ascertainment Validity; Follow-up Completeness\", \"Common Misinterpretations\": \"Treating protocol fidelity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Protocol Fidelity\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools\", \"Related Frameworks\": \"CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of protocol fidelity.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses protocol fidelity using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in protocol fidelity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 491"
    },
    {
      "@id": "bemo:BEMO_2000349",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000349",
      "bemo:BEMO_3100022": 356,
      "bemo:BEMO_3100023": "2199b92ac6c23ce1866fa6fdae782c65a478ec51834e2f0193f79d608ea4c3e7",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses potency reproducibility using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in potency reproducibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating potency reproducibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "OECD; OHAT; FDA Biomarker; EMA E16"
      },
      "bemo:BEMO_3200011": "https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000349"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000336"
        },
        {
          "@id": "bemo:BEMO_2000353"
        },
        {
          "@id": "bemo:BEMO_2000355"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which potency reproducibility yields concordant results under the specified repeated-analysis or repeated-measurement conditions."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/356"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000349",
      "rdfs:label": {
        "@language": "en",
        "@value": "Potency Reproducibility"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb364"
        },
        {
          "@id": "bemo:BEMO_1100013"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb364",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000349"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000345",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000345",
      "bemo:BEMO_3100022": 352,
      "bemo:BEMO_3100023": "277a918d22b52db9e79eabf5451f64320f342f326be1cc2382f16c69ec72f0a9",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses organ-specific toxicity evidence using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in organ-specific toxicity evidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating organ-specific toxicity evidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "OECD; OHAT; FDA Biomarker; EMA E16"
      },
      "bemo:BEMO_3200011": "https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000345"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000329"
        },
        {
          "@id": "bemo:BEMO_2000332"
        },
        {
          "@id": "bemo:BEMO_2000338"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of organ-specific toxicity evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/352"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000345",
      "rdfs:label": {
        "@language": "en",
        "@value": "Organ-Specific Toxicity Evidence"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb361"
        },
        {
          "@id": "bemo:BEMO_1100013"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb361",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000345"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000329",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000329",
      "bemo:BEMO_3100022": 336,
      "bemo:BEMO_3100023": "8935703e7b30761e4213b86ddafc1aecae0696f4523a201860d9e64493990a74",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses adverse outcome pathway support using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in adverse outcome pathway support can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating adverse outcome pathway support as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "OECD; OHAT; FDA Biomarker; EMA E16"
      },
      "bemo:BEMO_3200011": "https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000329"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000338"
        },
        {
          "@id": "bemo:BEMO_2000345"
        },
        {
          "@id": "bemo:BEMO_2000358"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting adverse outcome pathway."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/336"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000329",
      "rdfs:label": {
        "@language": "en",
        "@value": "Adverse Outcome Pathway Support"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb347"
        },
        {
          "@id": "bemo:BEMO_1100013"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb347",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000329"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000382",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000382"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/389"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Quantification Precision"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000448",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000448"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/455"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Missing-Data Sensitivity"
      }
    },
    {
      "@id": "bemo:BEMO_2000147",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000147",
      "bemo:BEMO_3100022": 154,
      "bemo:BEMO_3100023": "a64cee9a2114ea7d5580ea8d59eaef0691fce1d63dd3e4fd9f3d63e0dac86a3d",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses evidence coverage using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in evidence coverage can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating evidence coverage as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Systematic reviews, meta-analyses, evidence profiles, guidelines"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; PRISMA; AMSTAR 2; RoB"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000147"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000143"
        },
        {
          "@id": "bemo:BEMO_2000149"
        },
        {
          "@id": "bemo:BEMO_2000152"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The proportion and representativeness of the relevant evidence captured by the evidence or measurement process."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/154"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000147",
      "rdfs:label": {
        "@language": "en",
        "@value": "Evidence Coverage"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb186"
        },
        {
          "@id": "bemo:BEMO_1100006"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb186",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000147"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_4000001",
      "@type": [
        "owl:NamedIndividual",
        "bemo:BEMO_0000400"
      ],
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Controlled BEMO ScaleType value: ContextDependentMixedScale."
      },
      "oboInOwl:id": "BEMO:4000001",
      "rdfs:label": {
        "@language": "en",
        "@value": "Context Dependent Mixed Scale"
      },
      "skos:notation": "ContextDependentMixedScale"
    },
    {
      "@id": "bemo:BEMO_3000003",
      "@type": "owl:ObjectProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Connects a metric assessment to the evidence object assessed."
      },
      "oboInOwl:id": "BEMO:3000003",
      "rdfs:domain": {
        "@id": "bemo:BEMO_0000200"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "assesses evidence object"
      },
      "rdfs:range": {
        "@id": "bemo:BEMO_0000201"
      }
    },
    {
      "@id": "bemo:BEMO_2000391",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000391",
      "bemo:BEMO_3100022": 398,
      "bemo:BEMO_3100023": "da25c768c2ee710f0cf6b50b686a1880c8166dd651b4f062c14e952fc1bdf622",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses data provenance completeness using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in data provenance completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating data provenance completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All experimental, computational, clinical, and omics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0"
      },
      "bemo:BEMO_3200011": "https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000391"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000398"
        },
        {
          "@id": "bemo:BEMO_2000401"
        },
        {
          "@id": "bemo:BEMO_2000403"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which all scientifically necessary components of data provenance are present, documented, and evaluable."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/398"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000391",
      "rdfs:label": {
        "@language": "en",
        "@value": "Data Provenance Completeness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb403"
        },
        {
          "@id": "bemo:BEMO_1100015"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb403",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000391"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000118",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000118",
      "bemo:BEMO_3100022": 125,
      "bemo:BEMO_3100023": "2805e0d0838d99254f4675a5517e72c35cb3e1cb875fbc214edb03376568c858",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses differential verification bias risk using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in differential verification bias risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating differential verification bias risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "QUADAS-2; STARD; TRIPOD; REMARK"
      },
      "bemo:BEMO_3200011": "https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000118"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000119"
        },
        {
          "@id": "bemo:BEMO_2000126"
        },
        {
          "@id": "bemo:BEMO_2000138"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The probability or degree that differential verification bias introduces systematic distortion into a biomedical estimate or conclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/125"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000118",
      "rdfs:label": {
        "@language": "en",
        "@value": "Differential Verification Bias Risk"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb157"
        },
        {
          "@id": "bemo:BEMO_1100005"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb157",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000118"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000269",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000269",
      "bemo:BEMO_3100022": 276,
      "bemo:BEMO_3100023": "7c4987f5f8c3c9cca41bb28896f2392e5c664fc505d3f5db2c63ad7c10e1d04d",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses analytical precision using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in analytical precision can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating analytical precision as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000269"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000284"
        },
        {
          "@id": "bemo:BEMO_2000297"
        },
        {
          "@id": "bemo:BEMO_2000302"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The closeness of repeated estimates or measurements and the narrowness of uncertainty around analytical."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/276"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000269",
      "rdfs:label": {
        "@language": "en",
        "@value": "Analytical Precision"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb292"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb292",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000269"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_0000103",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "An information content entity specifying evidence levels, study types, domains, and contexts to which a metric applies."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:0000103",
      "rdfs:label": {
        "@language": "en",
        "@value": "metric applicability profile"
      },
      "rdfs:subClassOf": {
        "@id": "obo:IAO_0000030"
      }
    },
    {
      "@id": "bemo:BEMO_2000159",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000159",
      "bemo:BEMO_3100022": 166,
      "bemo:BEMO_3100023": "40900cc3965adf1a4a61ca1880158e0ed27ede5d1a6163f63eb4f6d38b99a3b8",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses multiplicity-adjusted credibility using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in multiplicity-adjusted credibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating multiplicity-adjusted credibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Systematic reviews, meta-analyses, evidence profiles, guidelines"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; PRISMA; AMSTAR 2; RoB"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000159"
      },
      "bemo:BEMO_3200013": {
        "@id": "bemo:BEMO_2000157"
      },
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of multiplicity-adjusted credibility."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/166"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000159",
      "rdfs:label": {
        "@language": "en",
        "@value": "Multiplicity-Adjusted Credibility"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb30"
        },
        {
          "@id": "bemo:BEMO_1100006"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb30",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000159"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000479",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000479"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/486"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Intervention Classification Validity"
      }
    },
    {
      "@id": "bemo:BEMO_3200016",
      "@type": "owl:AnnotationProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Term lifecycle status."
      },
      "oboInOwl:id": "BEMO:3200016",
      "rdfs:label": {
        "@language": "en",
        "@value": "lifecycle status"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000118",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000118"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/125"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Differential Verification Bias Risk"
      }
    },
    {
      "@id": "bemo:BEMO_2000262",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000262",
      "bemo:BEMO_3100022": 269,
      "bemo:BEMO_3100023": "faf5bedb35b3c8e6f9b571b29c9788bb087192d600f7d5646da266201f76f5dd",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses single-cell viability using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in single-cell viability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating single-cell viability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAME; MINSEQE; STROBE-ME; GA4GH; HCA"
      },
      "bemo:BEMO_3200011": "https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000262"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000241"
        },
        {
          "@id": "bemo:BEMO_2000259"
        },
        {
          "@id": "bemo:BEMO_2000261"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of single-cell viability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/269"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000262",
      "rdfs:label": {
        "@language": "en",
        "@value": "Single-Cell Viability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb286"
        },
        {
          "@id": "bemo:BEMO_1100010"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb286",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000262"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/233",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 233,
      "bemo:BEMO_3100023": "de2f4749e64a7014070a28c9c8587efaf4dbb9b3583c2ab6e78cd6826c00de34",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mendelian disease, cancer genetics, association, segregation, and functional studies\", \"Category\": \"Genetics and Variant Evidence\", \"Closely Related Metrics\": \"Hotspot/Functional-Domain Evidence; Splicing Evidence Strength; RNA Evidence Strength\", \"Common Misinterpretations\": \"Treating null-variant quality as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Null-Variant Quality\", \"References or Origin\": \"https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/\", \"Related Frameworks\": \"ClinGen; ACMG AMP; STREGA; Gene Ontology\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of null-variant quality.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"ClinGen/ACMG evidence scoring; pedigree analysis; population databases; case-control data; functional assays; expert-panel review.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses null-variant quality using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in null-variant quality can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 233"
    },
    {
      "@id": "bemo:BEMO_1100004",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Category of biomedical evidence metrics concerned with causal inference."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:1100004",
      "rdfs:label": {
        "@language": "en",
        "@value": "Causal Inference metric"
      },
      "rdfs:subClassOf": {
        "@id": "bemo:BEMO_1000002"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/154",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 154,
      "bemo:BEMO_3100023": "a64cee9a2114ea7d5580ea8d59eaef0691fce1d63dd3e4fd9f3d63e0dac86a3d",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Systematic reviews, meta-analyses, evidence profiles, guidelines\", \"Category\": \"Evidence Certainty and Synthesis\", \"Closely Related Metrics\": \"Evidence Completeness; Evidence Freshness; Evidence Robustness\", \"Common Misinterpretations\": \"Treating evidence coverage as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Evidence Coverage\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/\", \"Related Frameworks\": \"GRADE; PRISMA; AMSTAR 2; RoB\", \"Scientific Definition\": \"The proportion and representativeness of the relevant evidence captured by the evidence or measurement process.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses evidence coverage using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in evidence coverage can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 154"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/129",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 129,
      "bemo:BEMO_3100023": "6dc29889e79017542636c8b841aff4c0f5947b19dec51307e00a9c51cdc593cc",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies\", \"Category\": \"Diagnostic and Prognostic Evidence\", \"Closely Related Metrics\": \"Positive Likelihood Ratio; Diagnostic Odds Ratio; Area Under the Receiver Operating Characteristic Curve\", \"Common Misinterpretations\": \"Treating negative likelihood ratio as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment.\", \"Metric\": \"Negative Likelihood Ratio\", \"References or Origin\": \"https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"QUADAS-2; STARD; TRIPOD; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of negative likelihood ratio.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Two-by-two tables; binomial confidence intervals; hierarchical diagnostic meta-analysis; threshold and prevalence analyses.\", \"Units or Scale (if applicable)\": \"Ratio scale; null typically 1\", \"What It Measures\": \"Assesses negative likelihood ratio using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in negative likelihood ratio can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 129"
    },
    {
      "@id": "bemo:BEMO_0000403",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A controlled concept describing whether a formula is defined, generic, method-specific, or context-specific."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:0000403",
      "rdfs:label": {
        "@language": "en",
        "@value": "formula status"
      },
      "rdfs:subClassOf": {
        "@id": "skos:Concept"
      }
    },
    {
      "@id": "bemo:BEMO_2000429",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000429",
      "bemo:BEMO_3100022": 436,
      "bemo:BEMO_3100023": "d9e587b4cd42324cc1668fb835e848ce02fea72bac0af2f37bcc6e0a40cbc327",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses recruitment reporting completeness using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in recruitment reporting completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating recruitment reporting completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Study report / dataset / evidence package"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All biomedical study reports and data releases"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000429"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000412"
        },
        {
          "@id": "bemo:BEMO_2000414"
        },
        {
          "@id": "bemo:BEMO_2000422"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which all scientifically necessary components of recruitment reporting are present, documented, and evaluable."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/436"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000429",
      "rdfs:label": {
        "@language": "en",
        "@value": "Recruitment Reporting Completeness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb436"
        },
        {
          "@id": "bemo:BEMO_1100016"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb436",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000429"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000295",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000295",
      "bemo:BEMO_3100022": 302,
      "bemo:BEMO_3100023": "5e396bd1803ce209b22910e5705b5bf0dc26bd235bba5ac5c904b2514e3f7ea8",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses recovery using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in recovery can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Replicate dilution series; blank and spiked samples; reference materials; method-comparison studies; predefined CLSI/ISO acceptance criteria."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating recovery as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000295"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000279"
        },
        {
          "@id": "bemo:BEMO_2000280"
        },
        {
          "@id": "bemo:BEMO_2000288"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of recovery."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/302"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000295",
      "rdfs:label": {
        "@language": "en",
        "@value": "Recovery"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb316"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb316",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000295"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/14",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 14,
      "bemo:BEMO_3100023": "61aaa3d7ba71760f01fcbbb79304031b61f416940944ef459f48b6d07dc0628d",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Molecular, cellular, animal, translational, pharmacologic, and human studies\", \"Category\": \"Biological Plausibility and Mechanism\", \"Closely Related Metrics\": \"Biological Gradient; Network Context Support; Systems-Level Emergence Support\", \"Common Misinterpretations\": \"Treating homeostatic compensation assessment as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Homeostatic Compensation Assessment\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"GRADE; FDA Biomarker; ClinGen; OHAT; OECD\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of homeostatic compensation assessment.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses homeostatic compensation assessment using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in homeostatic compensation assessment can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 14"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/302",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 302,
      "bemo:BEMO_3100023": "5e396bd1803ce209b22910e5705b5bf0dc26bd235bba5ac5c904b2514e3f7ea8",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Dynamic Range; Dilution Integrity; Matrix Effect\", \"Common Misinterpretations\": \"Treating recovery as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Recovery\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of recovery.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Replicate dilution series; blank and spiked samples; reference materials; method-comparison studies; predefined CLSI/ISO acceptance criteria.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses recovery using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in recovery can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 302"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/44",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 44,
      "bemo:BEMO_3100023": "170c4bee423f9901b11abd5c6c7203f1253da40dbd46a33c459bac07471058e8",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Biomarker development, qualification, endpoint and surrogate validation studies\", \"Category\": \"Biomarker and Endpoint Validation\", \"Closely Related Metrics\": \"Biomarker Clinical Relevance; Biomarker Qualification Strength; Biomarker Reliability\", \"Common Misinterpretations\": \"Treating context-of-use validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Context-of-Use Validity\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"FDA Biomarker; BEST; EMA E16; REMARK\", \"Scientific Definition\": \"The degree to which context-of-use supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses context-of-use validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in context-of-use validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 44"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000437",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000437"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/444"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Discrimination of Statistical Predictions"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/326",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 326,
      "bemo:BEMO_3100023": "98cc3b5d977b0d0bd7a309c477d2653f05eeb7554078021a2d0b2bf21036d891",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Integrated omics, networks, pathways, mechanistic and dynamic systems models\", \"Category\": \"Multi-omics and Systems Biology\", \"Closely Related Metrics\": \"Ontology Annotation Completeness; Model–Experiment Concordance; Parameter Identifiability\", \"Common Misinterpretations\": \"Treating ontology evidence-code strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Dataset / model / pathway / network / evidence body\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Ontology Evidence-Code Strength\", \"References or Origin\": \"https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/\", \"Related Frameworks\": \"Gene Ontology; Reactome; UniProt; GA4GH\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting ontology evidence-code.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses ontology evidence-code strength using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in ontology evidence-code strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 326"
    },
    {
      "@id": "bemo:BEMO_0000002",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A high-level organizational class grouping biomedical evidence metrics by scientific function."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:0000002",
      "rdfs:label": {
        "@language": "en",
        "@value": "metric pillar"
      },
      "rdfs:subClassOf": {
        "@id": "obo:IAO_0000030"
      }
    },
    {
      "@id": "bemo:BEMO_2000125",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000125",
      "bemo:BEMO_3100022": 132,
      "bemo:BEMO_3100023": "79f6b607e0d7504f46e1d3842fa8966ae929db7058236a6b4ed553277ad444b5",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses partial area under the receiver operating characteristic curve using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in partial area under the receiver operating characteristic curve can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating partial area under the receiver operating characteristic curve as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "QUADAS-2; STARD; TRIPOD; REMARK"
      },
      "bemo:BEMO_3200011": "https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000125"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000110"
        },
        {
          "@id": "bemo:BEMO_2000134"
        },
        {
          "@id": "bemo:BEMO_2000136"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of partial area under the receiver operating characteristic curve."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/132"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000125",
      "rdfs:label": {
        "@language": "en",
        "@value": "Partial Area Under the Receiver Operating Characteristic Curve"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb164"
        },
        {
          "@id": "bemo:BEMO_1100005"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb164",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000125"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/332",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 332,
      "bemo:BEMO_3100023": "cb110edeb57b36960477192ea5d1484823905d046fc0f22c33bc8eb340c3c4c3",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Integrated omics, networks, pathways, mechanistic and dynamic systems models\", \"Category\": \"Multi-omics and Systems Biology\", \"Closely Related Metrics\": \"Structural Identifiability; Dynamical Stability; Steady-State Validity\", \"Common Misinterpretations\": \"Treating practical identifiability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Dataset / model / pathway / network / evidence body\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Practical Identifiability\", \"References or Origin\": \"https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/\", \"Related Frameworks\": \"Gene Ontology; Reactome; UniProt; GA4GH\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of practical identifiability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses practical identifiability using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in practical identifiability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 332"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000122",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000005"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000009"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator; the null value is typically 1 where scientifically applicable"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator != 0\"],\"null_value\":1}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "confidence_level; stratum",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Ratio scale; null typically 1",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100012": "1",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Not generally required unless converted to a probability or score."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000122"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/129"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Negative Likelihood Ratio"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000065",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000065"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/72"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for DNA Integrity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/469",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 469,
      "bemo:BEMO_3100023": "43a84aea1ea6cc79814a3121476a165954a222aece0c751b1ff5414b40efbe28",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Distributional Assumption Adequacy; Missing-Data Mechanism Plausibility; Missing-Data Sensitivity\", \"Common Misinterpretations\": \"Treating variance estimation validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Variance Estimation Validity\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"The degree to which variance estimation supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses variance estimation validity using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in variance estimation validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 469"
    },
    {
      "@id": "bemo:BEMO_2000034",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000034",
      "bemo:BEMO_3100022": 41,
      "bemo:BEMO_3100023": "628005d99d3e18a7b100ce400c64fc5218e46beeaa2cfec80dbac2445270cead",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses clinical validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in clinical validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating clinical validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Biomarker development, qualification, endpoint and surrogate validation studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; BEST; EMA E16; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000034"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000028"
        },
        {
          "@id": "bemo:BEMO_2000033"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which clinical supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/41"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000034",
      "rdfs:label": {
        "@language": "en",
        "@value": "Clinical Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb2"
        },
        {
          "@id": "bemo:BEMO_1100002"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb2",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000034"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000106",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000106"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/113"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Selection-on-Survival Bias Risk"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/191",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 191,
      "bemo:BEMO_3100023": "5cc94b6085b9c596d4f74c18712e9f8177db4335ab703b2218b9c3a63209c113",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"In vitro, ex vivo, organoid, animal, and preclinical experiments\", \"Category\": \"Experimental Biology and Animal Research\", \"Closely Related Metrics\": \"Sample Size Justification; Blinding in Experimental Assessment; Animal Model Face Validity\", \"Common Misinterpretations\": \"Treating randomization in experimental allocation as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Randomization in Experimental Allocation\", \"References or Origin\": \"https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"ARRIVE 2.0; SYRCLE; OECD\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of randomization in experimental allocation.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses randomization in experimental allocation using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in randomization in experimental allocation can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 191"
    },
    {
      "@id": "bemo:BEMO_1100005",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Category of biomedical evidence metrics concerned with diagnostic and prognostic evidence."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:1100005",
      "rdfs:label": {
        "@language": "en",
        "@value": "Diagnostic and Prognostic Evidence metric"
      },
      "rdfs:subClassOf": {
        "@id": "bemo:BEMO_1000005"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000312",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000312"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/319"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Latent-Factor Stability"
      }
    },
    {
      "@id": "bemo:BEMO_3100011",
      "@type": "owl:DatatypeProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Maximum allowed or expected numeric value."
      },
      "oboInOwl:id": "BEMO:3100011",
      "rdfs:label": {
        "@language": "en",
        "@value": "maximum value"
      }
    },
    {
      "@id": "bemo:BEMO_2000063",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000063",
      "bemo:BEMO_3100022": 70,
      "bemo:BEMO_3100023": "450f9e94b009036abe7a13fe3055116e7c4959857a7291ed7e337a746d7bf722",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses cold ischemia control using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in cold ischemia control can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating cold ischemia control as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All studies using human or animal biospecimens"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "BRISQ; ISO 15189; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000063"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000066"
        },
        {
          "@id": "bemo:BEMO_2000080"
        },
        {
          "@id": "bemo:BEMO_2000083"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of cold ischemia control."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/70"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000063",
      "rdfs:label": {
        "@language": "en",
        "@value": "Cold Ischemia Control"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb109"
        },
        {
          "@id": "bemo:BEMO_1100003"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb109",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000063"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/473",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 473,
      "bemo:BEMO_3100023": "93fad13257c869638e96dc16ab4687d4b955a0d40d8d10736f49f12cebec65eb",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies\", \"Category\": \"Study Design and Internal Validity\", \"Closely Related Metrics\": \"Allocation Concealment; Blinding Integrity; Performance Bias Risk\", \"Common Misinterpretations\": \"Treating baseline comparability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Baseline Comparability\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools\", \"Related Frameworks\": \"CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of baseline comparability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses baseline comparability using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in baseline comparability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 473"
    },
    {
      "@id": "bemo:BEMO_2000155",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000155",
      "bemo:BEMO_3100022": 162,
      "bemo:BEMO_3100023": "516f7f59fc37d19455d99f12f79cf9f0baf5cd671807c3364f013a016d7ec68a",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses evidence sufficiency using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in evidence sufficiency can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating evidence sufficiency as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Systematic reviews, meta-analyses, evidence profiles, guidelines"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; PRISMA; AMSTAR 2; RoB"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000155"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000143"
        },
        {
          "@id": "bemo:BEMO_2000145"
        },
        {
          "@id": "bemo:BEMO_2000147"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of evidence sufficiency."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/162"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000155",
      "rdfs:label": {
        "@language": "en",
        "@value": "Evidence Sufficiency"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb193"
        },
        {
          "@id": "bemo:BEMO_1100006"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb193",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000155"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000402",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000402"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/409"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Random-Seed Stability"
      }
    },
    {
      "@id": "bemo:BEMO_2000440",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000440",
      "bemo:BEMO_3100022": 447,
      "bemo:BEMO_3100023": "226b21fe561d36c12bfde0bcc47bb1ad6cb02760533a4b768747d6a0ab92184b",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses equivalence margin validity using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in equivalence margin validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating equivalence margin validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000440"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000452"
        },
        {
          "@id": "bemo:BEMO_2000457"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which equivalence margin supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/447"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000440",
      "rdfs:label": {
        "@language": "en",
        "@value": "Equivalence Margin Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb445"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb445",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000440"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_4000006",
      "@type": [
        "owl:NamedIndividual",
        "bemo:BEMO_0000400"
      ],
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Controlled BEMO ScaleType value: RiskScale."
      },
      "oboInOwl:id": "BEMO:4000006",
      "rdfs:label": {
        "@language": "en",
        "@value": "Risk Scale"
      },
      "skos:notation": "RiskScale"
    },
    {
      "@id": "bemo:BEMO_2000015",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000015",
      "bemo:BEMO_3100022": 22,
      "bemo:BEMO_3100023": "81a78e88eaa62f6e2bb0ae947aba28fe819150032abcf9264f9205803cc7dfd1",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses molecular-phenotypic concordance using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in molecular-phenotypic concordance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating molecular-phenotypic concordance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Molecular, cellular, animal, translational, pharmacologic, and human studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; FDA Biomarker; ClinGen; OHAT; OECD"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000015"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000008"
        },
        {
          "@id": "bemo:BEMO_2000020"
        },
        {
          "@id": "bemo:BEMO_2000021"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree of agreement in molecular-phenotypic across measurements, studies, methods, populations, or biological levels."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/22"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000015",
      "rdfs:label": {
        "@language": "en",
        "@value": "Molecular-Phenotypic Concordance"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb67"
        },
        {
          "@id": "bemo:BEMO_1100001"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb67",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000015"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/81",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 81,
      "bemo:BEMO_3100023": "e470a75855d7bb24a7f3957922ccdf78961ef4c923b6f754c0006ebb46c0367e",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All studies using human or animal biospecimens\", \"Category\": \"Biospecimen and Preanalytical Quality\", \"Closely Related Metrics\": \"Anatomical Site Fidelity; Tumor Purity; Cellularity Adequacy\", \"Common Misinterpretations\": \"Treating pathology confirmation as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Pathology Confirmation\", \"References or Origin\": \"https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"BRISQ; ISO 15189; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of pathology confirmation.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses pathology confirmation using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in pathology confirmation can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 81"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000109",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000109"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/116"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Unmeasured Confounding Sensitivity"
      }
    },
    {
      "@id": "bemo:BEMO_0000401",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A controlled concept describing the general computational approach used by a metric."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:0000401",
      "rdfs:label": {
        "@language": "en",
        "@value": "computation mode"
      },
      "rdfs:subClassOf": {
        "@id": "skos:Concept"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000073",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000073"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/80"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Necrosis Burden"
      }
    },
    {
      "@id": "bemo:BEMO_2000322",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000322",
      "bemo:BEMO_3100022": 329,
      "bemo:BEMO_3100023": "d7e323b8eddcaff29fe662695a2fa9bae2a0f04120cfdf422fa3e2d1cd3b117e",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses pathway enrichment consistency using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in pathway enrichment consistency can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating pathway enrichment consistency as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Dataset / model / pathway / network / evidence body"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Integrated omics, networks, pathways, mechanistic and dynamic systems models"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "Gene Ontology; Reactome; UniProt; GA4GH"
      },
      "bemo:BEMO_3200011": "https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000322"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000310"
        },
        {
          "@id": "bemo:BEMO_2000314"
        },
        {
          "@id": "bemo:BEMO_2000323"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree of agreement in pathway enrichment across measurements, studies, methods, populations, or biological levels."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/329"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000322",
      "rdfs:label": {
        "@language": "en",
        "@value": "Pathway Enrichment Consistency"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb340"
        },
        {
          "@id": "bemo:BEMO_1100012"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb340",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000322"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000114",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000114"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/121"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Competing-Risk Model Validity"
      }
    },
    {
      "@id": "bemo:BEMO_2000120",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000120",
      "bemo:BEMO_3100022": 127,
      "bemo:BEMO_3100023": "8c0d8dc6983b3100a525f45a2c3c327af7d21cf2d155dc05a19b99e0d7f43578",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses incremental diagnostic value using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in incremental diagnostic value can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating incremental diagnostic value as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "QUADAS-2; STARD; TRIPOD; REMARK"
      },
      "bemo:BEMO_3200011": "https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000120"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000113"
        },
        {
          "@id": "bemo:BEMO_2000131"
        },
        {
          "@id": "bemo:BEMO_2000133"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of incremental diagnostic value."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/127"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000120",
      "rdfs:label": {
        "@language": "en",
        "@value": "Incremental Diagnostic Value"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb159"
        },
        {
          "@id": "bemo:BEMO_1100005"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb159",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000120"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_1000005",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Metrics assessing generalizability, diagnostic or prognostic evidence, biomarkers, endpoints, and clinical applicability."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:1000005",
      "rdfs:label": {
        "@language": "en",
        "@value": "External Validity, Biomarkers, and Clinical Evidence metric"
      },
      "rdfs:subClassOf": {
        "@id": "bemo:BEMO_0000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/82",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 82,
      "bemo:BEMO_3100023": "de3923232eba7ea0cab4f8eddc6a1539eac9f06416d7c31e6d2ce8fbf8492ba5",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All studies using human or animal biospecimens\", \"Category\": \"Biospecimen and Preanalytical Quality\", \"Closely Related Metrics\": \"Fixation Adequacy; Storage Temperature Control; Freeze–Thaw Burden\", \"Common Misinterpretations\": \"Treating preservation adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Preservation Adequacy\", \"References or Origin\": \"https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"BRISQ; ISO 15189; REMARK\", \"Scientific Definition\": \"The extent to which preservation is sufficient and fit for the stated biomedical inference.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses preservation adequacy using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in preservation adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 82"
    },
    {
      "@id": "bemo:BEMO_2000201",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000201",
      "bemo:BEMO_3100022": 208,
      "bemo:BEMO_3100023": "5c0db0a0257f7b171655d97624fdf4764d1fabad77716300abc92c2debe71f7d",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses outcome applicability using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in outcome applicability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating outcome applicability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Clinical, epidemiologic, diagnostic, translational, and population studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; QUADAS-2; CONSORT; STROBE"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000201"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000192"
        },
        {
          "@id": "bemo:BEMO_2000207"
        },
        {
          "@id": "bemo:BEMO_2000208"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of outcome applicability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/208"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000201",
      "rdfs:label": {
        "@language": "en",
        "@value": "Outcome Applicability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb233"
        },
        {
          "@id": "bemo:BEMO_1100008"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb233",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000201"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/471",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 471,
      "bemo:BEMO_3100023": "3367e7e58461dcb460260b263a504d906f8c26af8608d0cf2767790d3843a2e7",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies\", \"Category\": \"Study Design and Internal Validity\", \"Closely Related Metrics\": \"Randomization Integrity; Baseline Comparability; Blinding Integrity\", \"Common Misinterpretations\": \"Treating allocation concealment as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Allocation Concealment\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools\", \"Related Frameworks\": \"CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of allocation concealment.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses allocation concealment using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in allocation concealment can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 471"
    },
    {
      "@id": "bemo:BEMO_2000062",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000062",
      "bemo:BEMO_3100022": 69,
      "bemo:BEMO_3100023": "38ecb99023f4b12b1bfca7d66221917ae384546ef170c868cd32fb2eb70f3f40",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses chain-of-custody integrity using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in chain-of-custody integrity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating chain-of-custody integrity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All studies using human or animal biospecimens"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "BRISQ; ISO 15189; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000062"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000071"
        },
        {
          "@id": "bemo:BEMO_2000072"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of chain-of-custody integrity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/69"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000062",
      "rdfs:label": {
        "@language": "en",
        "@value": "Chain-of-Custody Integrity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb108"
        },
        {
          "@id": "bemo:BEMO_1100003"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb108",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000062"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000275",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000275"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/282"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Carryover"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000049",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000049"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/56"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Outcome Relevance"
      }
    },
    {
      "@id": "bemo:BEMO_2000362",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000362",
      "bemo:BEMO_3100022": 369,
      "bemo:BEMO_3100023": "5024c9034e231e8bc296cf1d9092cc063fe94890f4856d8bf70ac077514b55f9",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses extraction recovery using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in extraction recovery can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Replicate dilution series; blank and spiked samples; reference materials; method-comparison studies; predefined CLSI/ISO acceptance criteria."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating extraction recovery as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAPE; HUPO PSI; Metabolomics Standards"
      },
      "bemo:BEMO_3200011": "https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000362"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000360"
        },
        {
          "@id": "bemo:BEMO_2000365"
        },
        {
          "@id": "bemo:BEMO_2000369"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of extraction recovery."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/369"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000362",
      "rdfs:label": {
        "@language": "en",
        "@value": "Extraction Recovery"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb376"
        },
        {
          "@id": "bemo:BEMO_1100014"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb376",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000362"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/alignment/BFO",
      "@type": "prov:Entity",
      "dcterms:source": {
        "@id": "obo:bfo.owl"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/407",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 407,
      "bemo:BEMO_3100023": "80472d064c943a6566bee4bd605245ecac370ebde0eb5ae577d7687482d47cc8",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All experimental, computational, clinical, and omics studies\", \"Category\": \"Reproducibility and Replication\", \"Closely Related Metrics\": \"Researcher-Degrees-of-Freedom Sensitivity; Specification-Curve Robustness\", \"Common Misinterpretations\": \"Treating multiverse analysis robustness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Specialized / infrequent\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Developing\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Multiverse Analysis Robustness\", \"References or Origin\": \"https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines\", \"Related Frameworks\": \"PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of multiverse analysis robustness.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses multiverse analysis robustness using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in multiverse analysis robustness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 407"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000041",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000041"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/48"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Discriminant Validity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000348",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000348"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/355"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Pharmacological Target Validity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/47",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 47,
      "bemo:BEMO_3100023": "b87f6768315d9d24a6505cd78867a8b0dc9310fbd10aa04b46856994c12562e5",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Biomarker development, qualification, endpoint and surrogate validation studies\", \"Category\": \"Biomarker and Endpoint Validation\", \"Closely Related Metrics\": \"Prognostic Biomarker Validity; Pharmacodynamic Biomarker Validity; Monitoring Biomarker Validity\", \"Common Misinterpretations\": \"Treating diagnostic biomarker validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Diagnostic Biomarker Validity\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"FDA Biomarker; BEST; EMA E16; REMARK\", \"Scientific Definition\": \"The degree to which diagnostic biomarker supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses diagnostic biomarker validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in diagnostic biomarker validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 47"
    },
    {
      "@id": "bemo:BEMO_2000051",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000051",
      "bemo:BEMO_3100022": 58,
      "bemo:BEMO_3100023": "c5c7cbb5b7738940f61731df207186f05f8ae71ecab7ca3c5588c823af8d00eb",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses predictive biomarker validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in predictive biomarker validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating predictive biomarker validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Biomarker development, qualification, endpoint and surrogate validation studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; BEST; EMA E16; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000051"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000036"
        },
        {
          "@id": "bemo:BEMO_2000040"
        },
        {
          "@id": "bemo:BEMO_2000052"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which predictive biomarker supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/58"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000051",
      "rdfs:label": {
        "@language": "en",
        "@value": "Predictive Biomarker Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb99"
        },
        {
          "@id": "bemo:BEMO_1100002"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb99",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000051"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/455",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 455,
      "bemo:BEMO_3100023": "6708217d617153345c000ff0b34cc96bd34facf9514e5d1a84b3e56623ffb545",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Missing-Data Mechanism Plausibility; Imputation Validity; Outlier Influence Robustness\", \"Common Misinterpretations\": \"Treating missing-data sensitivity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment.\", \"Metric\": \"Missing-Data Sensitivity\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of missing-data sensitivity.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses missing-data sensitivity using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in missing-data sensitivity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 455"
    },
    {
      "@id": "bemo:BEMO_2000225",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000225",
      "bemo:BEMO_3100022": 232,
      "bemo:BEMO_3100023": "a389d5411c414282451fe5495bf2c1c444f06ae12cd17457edf93df2953dc32e",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses loss-of-function mechanism validity using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in loss-of-function mechanism validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating loss-of-function mechanism validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mendelian disease, cancer genetics, association, segregation, and functional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ClinGen; ACMG AMP; STREGA; Gene Ontology"
      },
      "bemo:BEMO_3200011": "https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000225"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000223"
        },
        {
          "@id": "bemo:BEMO_2000226"
        },
        {
          "@id": "bemo:BEMO_2000236"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which loss-of-function mechanism supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/232"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000225",
      "rdfs:label": {
        "@language": "en",
        "@value": "Loss-of-Function Mechanism Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb253"
        },
        {
          "@id": "bemo:BEMO_1100009"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb253",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000225"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/245",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 245,
      "bemo:BEMO_3100023": "64b27913521868b5a9491d569eb82729fee0c3cb2133bfc9132e110785fa8847",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies\", \"Category\": \"Genomics and Transcriptomics\", \"Closely Related Metrics\": \"Transcript Quantification Reliability; Single-Cell Doublet Burden; Single-Cell Ambient RNA Burden\", \"Common Misinterpretations\": \"Treating alternative splicing validation as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Alternative Splicing Validation\", \"References or Origin\": \"https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/\", \"Related Frameworks\": \"MIAME; MINSEQE; STROBE-ME; GA4GH; HCA\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of alternative splicing validation.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses alternative splicing validation using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in alternative splicing validation can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 245"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000386",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000386"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/393"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Analytical Reproducibility"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/460",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 460,
      "bemo:BEMO_3100023": "aec401720de6539460ff9d49f62284a772b28790802eda1b3dc7c5fc2d67af3f",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Influential Observation Sensitivity; Interaction Assessment Adequacy; Overadjustment Bias Risk\", \"Common Misinterpretations\": \"Treating nonlinearity assessment as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Nonlinearity Assessment\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of nonlinearity assessment.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Replicate dilution series; blank and spiked samples; reference materials; method-comparison studies; predefined CLSI/ISO acceptance criteria.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses nonlinearity assessment using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in nonlinearity assessment can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 460"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/203",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 203,
      "bemo:BEMO_3100023": "04e73707dc619457f6718e0be03029ef6e99208f68cbcad30d9f5bb20b2cd94b",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Clinical, epidemiologic, diagnostic, translational, and population studies\", \"Category\": \"External Validity and Applicability\", \"Closely Related Metrics\": \"Context Sensitivity; Real-World Evidence Alignment\", \"Common Misinterpretations\": \"Treating ecological validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Ecological Validity\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/\", \"Related Frameworks\": \"GRADE; QUADAS-2; CONSORT; STROBE\", \"Scientific Definition\": \"The degree to which ecological supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses ecological validity using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in ecological validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 203"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/441",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 441,
      "bemo:BEMO_3100023": "7e04bf59de003d9389f3d5e5a39c09dbec7b25b54fdd665e24d339ccf148fb17",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Decision-Curve Net Benefit; Fragility Index; Bayes Factor Evidence\", \"Common Misinterpretations\": \"Treating clinical relevance of effect as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Clinical Relevance of Effect\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of clinical relevance of effect.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses clinical relevance of effect using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in clinical relevance of effect can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 441"
    },
    {
      "@id": "bemo:BEMO_2000040",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000040",
      "bemo:BEMO_3100022": 47,
      "bemo:BEMO_3100023": "b87f6768315d9d24a6505cd78867a8b0dc9310fbd10aa04b46856994c12562e5",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses diagnostic biomarker validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in diagnostic biomarker validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating diagnostic biomarker validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Biomarker development, qualification, endpoint and surrogate validation studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; BEST; EMA E16; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000040"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000048"
        },
        {
          "@id": "bemo:BEMO_2000050"
        },
        {
          "@id": "bemo:BEMO_2000052"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which diagnostic biomarker supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/47"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000040",
      "rdfs:label": {
        "@language": "en",
        "@value": "Diagnostic Biomarker Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb89"
        },
        {
          "@id": "bemo:BEMO_1100002"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb89",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000040"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000367",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000367",
      "bemo:BEMO_3100022": 374,
      "bemo:BEMO_3100023": "beec5d62727ea3baba10451d532801205b190af60b03027284c15989d51ba1e4",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses isotope pattern fidelity using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in isotope pattern fidelity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating isotope pattern fidelity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAPE; HUPO PSI; Metabolomics Standards"
      },
      "bemo:BEMO_3200011": "https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000367"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000364"
        },
        {
          "@id": "bemo:BEMO_2000368"
        },
        {
          "@id": "bemo:BEMO_2000376"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of isotope pattern fidelity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/374"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000367",
      "rdfs:label": {
        "@language": "en",
        "@value": "Isotope Pattern Fidelity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb381"
        },
        {
          "@id": "bemo:BEMO_1100014"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb381",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000367"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/384",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 384,
      "bemo:BEMO_3100023": "86cf8ad175ebd274f625e908935f946750c2c41a33f40e7a8dc33224d8db7d28",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies\", \"Category\": \"Proteomics and Metabolomics\", \"Closely Related Metrics\": \"Peptide Identification Confidence; False Discovery Rate Control; Peptide-Spectrum Match Quality\", \"Common Misinterpretations\": \"Treating protein identification confidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Protein Identification Confidence\", \"References or Origin\": \"https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/\", \"Related Frameworks\": \"MIAPE; HUPO PSI; Metabolomics Standards\", \"Scientific Definition\": \"The justified degree of certainty assigned to protein identification given the quantity, quality, consistency, and limitations of supporting evidence.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Target-decoy analysis; spectral scoring; reference standards; replicate injections; retention-time and mass-error monitoring; orthogonal confirmation.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses protein identification confidence using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in protein identification confidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 384"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/109",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 109,
      "bemo:BEMO_3100023": "be2ac5c0345d954f0ccc1ce41f05b792425f3fb9c158083a6db1928102b69608",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized and observational etiologic studies, natural experiments, target-trial emulations\", \"Category\": \"Causal Inference\", \"Closely Related Metrics\": \"Exchangeability Plausibility; Consistency Assumption Plausibility; No-Interference Plausibility\", \"Common Misinterpretations\": \"Treating positivity adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Positivity Adequacy\", \"References or Origin\": \"https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9\", \"Scientific Definition\": \"The extent to which positivity is sufficient and fit for the stated biomedical inference.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Directed acyclic graphs; design emulation; balance diagnostics; negative controls; quantitative bias analysis; sensitivity and falsification analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses positivity adequacy using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in positivity adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 109"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/274",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 274,
      "bemo:BEMO_3100023": "35d988975cf78a06cb70788f89a4196551552de36a3cf47e57d2d96fc8cf41fd",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Analytical Validity; Trueness; Analytical Precision\", \"Common Misinterpretations\": \"Treating accuracy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Accuracy\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"The closeness of accuracy to the accepted reference or true value.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses accuracy using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in accuracy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 274"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000411",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000411"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/418"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Deviations-from-Protocol Transparency"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/331",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 331,
      "bemo:BEMO_3100023": "5cc466b3de703eb697570667c57a9230690c56d69b5cf6ec528e42740ec621e9",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Integrated omics, networks, pathways, mechanistic and dynamic systems models\", \"Category\": \"Multi-omics and Systems Biology\", \"Closely Related Metrics\": \"Flux-Balance Consistency; Emergent-Property Reproducibility\", \"Common Misinterpretations\": \"Treating perturbation prediction accuracy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Dataset / model / pathway / network / evidence body\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Perturbation Prediction Accuracy\", \"References or Origin\": \"https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/\", \"Related Frameworks\": \"Gene Ontology; Reactome; UniProt; GA4GH\", \"Scientific Definition\": \"The closeness of perturbation prediction to the accepted reference or true value.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses perturbation prediction accuracy using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in perturbation prediction accuracy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 331"
    },
    {
      "@id": "bemo:BEMO_2000011",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000011",
      "bemo:BEMO_3100022": 18,
      "bemo:BEMO_3100023": "70dc43fe10f07fb6cf3546a825ad424f5db2e21cc1b19a9f92b47d758bf660bd",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses mechanistic completeness using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in mechanistic completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating mechanistic completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Molecular, cellular, animal, translational, pharmacologic, and human studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; FDA Biomarker; ClinGen; OHAT; OECD"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000011"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000010"
        },
        {
          "@id": "bemo:BEMO_2000012"
        },
        {
          "@id": "bemo:BEMO_2000013"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which all scientifically necessary components of mechanistic are present, documented, and evaluable."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/18"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000011",
      "rdfs:label": {
        "@language": "en",
        "@value": "Mechanistic Completeness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb64"
        },
        {
          "@id": "bemo:BEMO_1100001"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb64",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000011"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/168",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 168,
      "bemo:BEMO_3100023": "0acc1464b5d065a6f38744191dff4d933036cf918aeac3f16274b9cdb9dd1059",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Systematic reviews, meta-analyses, evidence profiles, guidelines\", \"Category\": \"Evidence Certainty and Synthesis\", \"Closely Related Metrics\": \"Between-Study Variance; Cumulative Evidence Stability; Information Size Adequacy\", \"Common Misinterpretations\": \"Treating prediction interval adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Prediction Interval Adequacy\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/\", \"Related Frameworks\": \"GRADE; PRISMA; AMSTAR 2; RoB\", \"Scientific Definition\": \"The extent to which prediction interval is sufficient and fit for the stated biomedical inference.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses prediction interval adequacy using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in prediction interval adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 168"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/135",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 135,
      "bemo:BEMO_3100023": "89034784369de0142956f172eb3ca87ccad9b4cc69ac8a45b8a92adf9cc1731f",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies\", \"Category\": \"Diagnostic and Prognostic Evidence\", \"Closely Related Metrics\": \"Diagnostic Specificity; Negative Predictive Value; Positive Likelihood Ratio\", \"Common Misinterpretations\": \"Treating positive predictive value as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment.\", \"Metric\": \"Positive Predictive Value\", \"References or Origin\": \"https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"QUADAS-2; STARD; TRIPOD; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of positive predictive value.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Two-by-two tables; binomial confidence intervals; hierarchical diagnostic meta-analysis; threshold and prevalence analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses positive predictive value using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in positive predictive value can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 135"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000444",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000444"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/451"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Influential Observation Sensitivity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000266",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000266"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/273"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Variant Call Quality"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000043",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000043"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/50"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Endpoint Responsiveness"
      }
    },
    {
      "@id": "bemo:BEMO_2000187",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000187",
      "bemo:BEMO_3100022": 194,
      "bemo:BEMO_3100023": "93f7de14ca784e8a47e3c6ab351c1e75c21a4c3e26305cfe63e0d4fef2122575",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses species appropriateness using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in species appropriateness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating species appropriateness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "In vitro, ex vivo, organoid, animal, and preclinical experiments"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ARRIVE 2.0; SYRCLE; OECD"
      },
      "bemo:BEMO_3200011": "https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000187"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000166"
        },
        {
          "@id": "bemo:BEMO_2000169"
        },
        {
          "@id": "bemo:BEMO_2000186"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which species is sufficient and fit for the stated biomedical inference."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/194"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000187",
      "rdfs:label": {
        "@language": "en",
        "@value": "Species Appropriateness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb221"
        },
        {
          "@id": "bemo:BEMO_1100007"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb221",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000187"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000193",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000193"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/200"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Context Sensitivity"
      }
    },
    {
      "@id": "bemo:BEMO_2000085",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000085",
      "bemo:BEMO_3100022": 92,
      "bemo:BEMO_3100023": "d81e7f98cb339c656ef93d3243144295a2c872dc2bcb50f64863414984f27993",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses causal contrast clarity using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in causal contrast clarity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Directed acyclic graphs; design emulation; balance diagnostics; negative controls; quantitative bias analysis; sensitivity and falsification analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating causal contrast clarity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized and observational etiologic studies, natural experiments, target-trial emulations"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000085"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000090"
        },
        {
          "@id": "bemo:BEMO_2000098"
        },
        {
          "@id": "bemo:BEMO_2000107"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of causal contrast clarity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/92"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000085",
      "rdfs:label": {
        "@language": "en",
        "@value": "Causal Contrast Clarity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb130"
        },
        {
          "@id": "bemo:BEMO_1100004"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb130",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000085"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/355",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 355,
      "bemo:BEMO_3100023": "2cff4752043ea892788f37639d922b1a249d83c13dfedf581ad1a4ad12ab95b8",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies\", \"Category\": \"Pharmacology and Toxicology\", \"Closely Related Metrics\": \"Exposure–Response Relationship; Pharmacokinetic Adequacy\", \"Common Misinterpretations\": \"Treating pharmacological target validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Pharmacological Target Validity\", \"References or Origin\": \"https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline\", \"Related Frameworks\": \"OECD; OHAT; FDA Biomarker; EMA E16\", \"Scientific Definition\": \"The degree to which pharmacological target supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses pharmacological target validity using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in pharmacological target validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 355"
    },
    {
      "@id": "bemo:BEMO_2000117",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000117",
      "bemo:BEMO_3100022": 124,
      "bemo:BEMO_3100023": "14be8f0b88f11902e6b1562a38b9cb710840858fc59f748048f96b74c8f6c2b2",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses diagnostic specificity using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in diagnostic specificity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Two-by-two tables; binomial confidence intervals; hierarchical diagnostic meta-analysis; threshold and prevalence analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating diagnostic specificity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "QUADAS-2; STARD; TRIPOD; REMARK"
      },
      "bemo:BEMO_3200011": "https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000117"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000116"
        },
        {
          "@id": "bemo:BEMO_2000123"
        },
        {
          "@id": "bemo:BEMO_2000128"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of diagnostic specificity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/124"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000117",
      "rdfs:label": {
        "@language": "en",
        "@value": "Diagnostic Specificity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb28"
        },
        {
          "@id": "bemo:BEMO_1100005"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb28",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000117"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000215",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000215",
      "bemo:BEMO_3100022": 222,
      "bemo:BEMO_3100023": "1f84faa3d8c87f3b1ed44b62077d2c489782ab72b149d6009c127395a0070a10",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses computational variant evidence using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in computational variant evidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "ClinGen/ACMG evidence scoring; pedigree analysis; population databases; case-control data; functional assays; expert-panel review."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating computational variant evidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mendelian disease, cancer genetics, association, segregation, and functional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ClinGen; ACMG AMP; STREGA; Gene Ontology"
      },
      "bemo:BEMO_3200011": "https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000215"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000220"
        },
        {
          "@id": "bemo:BEMO_2000229"
        },
        {
          "@id": "bemo:BEMO_2000236"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of computational variant evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/222"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000215",
      "rdfs:label": {
        "@language": "en",
        "@value": "Computational Variant Evidence"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb245"
        },
        {
          "@id": "bemo:BEMO_1100009"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb245",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000215"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_1000006",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Metrics assessing biological plausibility, mechanistic evidence, experimental biology, and model-system evidence."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:1000006",
      "rdfs:label": {
        "@language": "en",
        "@value": "Biological Mechanism and Experimental Evidence metric"
      },
      "rdfs:subClassOf": {
        "@id": "bemo:BEMO_0000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000329",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000329"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/336"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Adverse Outcome Pathway Support"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000133",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000133"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/140"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Reclassification Improvement"
      }
    },
    {
      "@id": "bemo:BEMO_2000271",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000271",
      "bemo:BEMO_3100022": 278,
      "bemo:BEMO_3100023": "f6458dae6787eecc6dbfe775e26236c89d02f80c2f92e3575c7f9ddfa0e84b0e",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses analytical specificity using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in analytical specificity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating analytical specificity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000271"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000270"
        },
        {
          "@id": "bemo:BEMO_2000285"
        },
        {
          "@id": "bemo:BEMO_2000286"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of analytical specificity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/278"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000271",
      "rdfs:label": {
        "@language": "en",
        "@value": "Analytical Specificity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb294"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb294",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000271"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000297",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000297",
      "bemo:BEMO_3100022": 304,
      "bemo:BEMO_3100023": "289ee6101d32dc64bb4644380815480f0d1de4b3d0512c355bf6d1bb8e30c7f2",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses repeatability using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in repeatability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating repeatability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000297"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000269"
        },
        {
          "@id": "bemo:BEMO_2000284"
        },
        {
          "@id": "bemo:BEMO_2000299"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which repeatability yields concordant results under the specified repeated-analysis or repeated-measurement conditions."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/304"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000297",
      "rdfs:label": {
        "@language": "en",
        "@value": "Repeatability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb318"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb318",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000297"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000327",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000327",
      "bemo:BEMO_3100022": 334,
      "bemo:BEMO_3100023": "3a349724361b2712b35c94baaaa135ce8e313533d3edafc463242f1cddef411b",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses steady-state validity using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in steady-state validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating steady-state validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Dataset / model / pathway / network / evidence body"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Integrated omics, networks, pathways, mechanistic and dynamic systems models"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "Gene Ontology; Reactome; UniProt; GA4GH"
      },
      "bemo:BEMO_3200011": "https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000327"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000306"
        },
        {
          "@id": "bemo:BEMO_2000309"
        },
        {
          "@id": "bemo:BEMO_2000324"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which steady-state supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/334"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000327",
      "rdfs:label": {
        "@language": "en",
        "@value": "Steady-State Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb345"
        },
        {
          "@id": "bemo:BEMO_1100012"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb345",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000327"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/360",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 360,
      "bemo:BEMO_3100023": "2957579a3d734fc808c8a89eb160fb182b5f5a0f68ba40c4eecc1921dea93153",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies\", \"Category\": \"Pharmacology and Toxicology\", \"Closely Related Metrics\": \"Receptor Occupancy Evidence; Potency Reproducibility; Efficacy Reproducibility\", \"Common Misinterpretations\": \"Treating selectivity profile as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Selectivity Profile\", \"References or Origin\": \"https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline\", \"Related Frameworks\": \"OECD; OHAT; FDA Biomarker; EMA E16\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of selectivity profile.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses selectivity profile using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in selectivity profile can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 360"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000436",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000436"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/443"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Decision-Curve Net Benefit"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/354",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 354,
      "bemo:BEMO_3100023": "2b02efdd0f6a774096cee910d90b575b8f28f136a8ee594876642fb213f66330",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies\", \"Category\": \"Pharmacology and Toxicology\", \"Closely Related Metrics\": \"Exposure–Response Relationship; Pharmacodynamic Adequacy; Bioavailability\", \"Common Misinterpretations\": \"Treating pharmacokinetic adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Pharmacokinetic Adequacy\", \"References or Origin\": \"https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline\", \"Related Frameworks\": \"OECD; OHAT; FDA Biomarker; EMA E16\", \"Scientific Definition\": \"The extent to which pharmacokinetic is sufficient and fit for the stated biomedical inference.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses pharmacokinetic adequacy using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in pharmacokinetic adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 354"
    },
    {
      "@id": "bemo:BEMO_2000008",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000008",
      "bemo:BEMO_3100022": 15,
      "bemo:BEMO_3100023": "7b09e166eefa32f832c89264de2b3521f93b540fbc674d78fc625fd792779d09",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses loss-of-function validation using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in loss-of-function validation can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating loss-of-function validation as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Molecular, cellular, animal, translational, pharmacologic, and human studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; FDA Biomarker; ClinGen; OHAT; OECD"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000008"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000006"
        },
        {
          "@id": "bemo:BEMO_2000020"
        },
        {
          "@id": "bemo:BEMO_2000022"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of loss-of-function validation."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/15"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000008",
      "rdfs:label": {
        "@language": "en",
        "@value": "Loss-of-Function Validation"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb61"
        },
        {
          "@id": "bemo:BEMO_1100001"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb61",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000008"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000333",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000333",
      "bemo:BEMO_3100022": 340,
      "bemo:BEMO_3100023": "f5636ed02b8746eb48d98671b027c695a8940399bff60ebeae8ca955d99bae6a",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses developmental toxicity evidence strength using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in developmental toxicity evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating developmental toxicity evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "OECD; OHAT; FDA Biomarker; EMA E16"
      },
      "bemo:BEMO_3200011": "https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000333"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000340"
        },
        {
          "@id": "bemo:BEMO_2000351"
        },
        {
          "@id": "bemo:BEMO_2000357"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting developmental toxicity evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/340"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000333",
      "rdfs:label": {
        "@language": "en",
        "@value": "Developmental Toxicity Evidence Strength"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb351"
        },
        {
          "@id": "bemo:BEMO_1100013"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb351",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000333"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/174",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 174,
      "bemo:BEMO_3100023": "f8c928bcc279a4856d6377104c402fb4a00d102300c3c3fa14181f174b53f974",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"In vitro, ex vivo, organoid, animal, and preclinical experiments\", \"Category\": \"Experimental Biology and Animal Research\", \"Closely Related Metrics\": \"Animal Model Face Validity; Animal Model Predictive Validity; Species Appropriateness\", \"Common Misinterpretations\": \"Treating animal model construct validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Animal Model Construct Validity\", \"References or Origin\": \"https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"ARRIVE 2.0; SYRCLE; OECD\", \"Scientific Definition\": \"The degree to which animal model construct supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses animal model construct validity using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in animal model construct validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 174"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000252",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000252"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/259"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Population Stratification Control"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/443",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 443,
      "bemo:BEMO_3100023": "7e96f3c494e389efab04f0ca564863ebd840cadeaf424446d3f94ddb483ed76c",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Discrimination of Statistical Predictions; Clinical Relevance of Effect; Fragility Index\", \"Common Misinterpretations\": \"Treating decision-curve net benefit as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Decision-Curve Net Benefit\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of decision-curve net benefit.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses decision-curve net benefit using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in decision-curve net benefit can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 443"
    },
    {
      "@id": "bemo:BEMO_2000423",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000423",
      "bemo:BEMO_3100022": 430,
      "bemo:BEMO_3100023": "fe370510831c4feb18d187a9f8348ee0b93ff3174da9ddceea906467255bbd60",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses prespecified analysis adherence using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in prespecified analysis adherence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating prespecified analysis adherence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Study report / dataset / evidence package"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All biomedical study reports and data releases"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000423"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000415"
        },
        {
          "@id": "bemo:BEMO_2000421"
        },
        {
          "@id": "bemo:BEMO_2000425"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of prespecified analysis adherence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/430"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000423",
      "rdfs:label": {
        "@language": "en",
        "@value": "Prespecified Analysis Adherence"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb432"
        },
        {
          "@id": "bemo:BEMO_1100016"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb432",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000423"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000056",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000056",
      "bemo:BEMO_3100022": 63,
      "bemo:BEMO_3100023": "596927f557190db71a0b686158bde6134cafa9cdb9c1876784270d91a80452f5",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses susceptibility/risk biomarker validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in susceptibility/risk biomarker validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating susceptibility/risk biomarker validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Biomarker development, qualification, endpoint and surrogate validation studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; BEST; EMA E16; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000056"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000053"
        },
        {
          "@id": "bemo:BEMO_2000054"
        },
        {
          "@id": "bemo:BEMO_2000055"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The probability or degree that susceptibility/risk biomarker validity introduces systematic distortion into a biomedical estimate or conclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/63"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000056",
      "rdfs:label": {
        "@language": "en",
        "@value": "Susceptibility/Risk Biomarker Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb104"
        },
        {
          "@id": "bemo:BEMO_1100002"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb104",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000056"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/103",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 103,
      "bemo:BEMO_3100023": "280760fd65dbda26ef711b182bed36c1b7e3679af41be52e50dfca26f92b3400",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized and observational etiologic studies, natural experiments, target-trial emulations\", \"Category\": \"Causal Inference\", \"Closely Related Metrics\": \"Assumption Sensitivity\", \"Common Misinterpretations\": \"Treating falsification test support as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Falsification Test Support\", \"References or Origin\": \"https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting falsification test.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses falsification test support using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in falsification test support can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 103"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000175",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000175"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/182"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Experimental Batch Randomization"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/377",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 377,
      "bemo:BEMO_3100023": "883e5fdd2ff9e198b3ddcbafc3e6478eed144bbcc7f46c67f19ec93850e8ec4c",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies\", \"Category\": \"Proteomics and Metabolomics\", \"Closely Related Metrics\": \"Metabolite Identification Confidence; Spectral Library Match Quality; Internal Standard Performance\", \"Common Misinterpretations\": \"Treating metabolite annotation level as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Metabolite Annotation Level\", \"References or Origin\": \"https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/\", \"Related Frameworks\": \"MIAPE; HUPO PSI; Metabolomics Standards\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of metabolite annotation level.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Target-decoy analysis; spectral scoring; reference standards; replicate injections; retention-time and mass-error monitoring; orthogonal confirmation.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses metabolite annotation level using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in metabolite annotation level can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 377"
    },
    {
      "@id": "bemo:BEMO_2000019",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000019",
      "bemo:BEMO_3100022": 26,
      "bemo:BEMO_3100023": "a1a0e0a377d9f949a45a0ad0a040b0443e29f24bfe701f3b015420b52cd21ab2",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses pathway-level support using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in pathway-level support can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating pathway-level support as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Molecular, cellular, animal, translational, pharmacologic, and human studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; FDA Biomarker; ClinGen; OHAT; OECD"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000019"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000003"
        },
        {
          "@id": "bemo:BEMO_2000009"
        },
        {
          "@id": "bemo:BEMO_2000027"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting pathway-level."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/26"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000019",
      "rdfs:label": {
        "@language": "en",
        "@value": "Pathway-Level Support"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb71"
        },
        {
          "@id": "bemo:BEMO_1100001"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb71",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000019"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/486",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 486,
      "bemo:BEMO_3100023": "283a3544a9dd5cb1a16190c929c82c6db2608db0f4c24860780498cb89bc0ac5",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies\", \"Category\": \"Study Design and Internal Validity\", \"Closely Related Metrics\": \"Exposure Classification Validity; Comparator Validity; Control Group Appropriateness\", \"Common Misinterpretations\": \"Treating intervention classification validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Intervention Classification Validity\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools\", \"Related Frameworks\": \"CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI\", \"Scientific Definition\": \"The degree to which intervention classification supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses intervention classification validity using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in intervention classification validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 486"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000373",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000373"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/380"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Pathway Enrichment Robustness"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/35",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 35,
      "bemo:BEMO_3100023": "70bbbca5f05350dbfed193659c18ff0eef66a6552528618a931911c0bbfe7878",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Biomarker development, qualification, endpoint and surrogate validation studies\", \"Category\": \"Biomarker and Endpoint Validation\", \"Closely Related Metrics\": \"Biomarker-Outcome Association Strength; Context-of-Use Validity; Biomarker Qualification Strength\", \"Common Misinterpretations\": \"Treating biomarker clinical relevance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Biomarker Clinical Relevance\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"FDA Biomarker; BEST; EMA E16; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of biomarker clinical relevance.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses biomarker clinical relevance using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in biomarker clinical relevance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 35"
    },
    {
      "@id": "bemo:BEMO_2000116",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000116",
      "bemo:BEMO_3100022": 123,
      "bemo:BEMO_3100023": "4ea75714eea731a1e4644a00db0476f8628bf028934f92bd9e4029ee31ddf173",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses diagnostic sensitivity using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in diagnostic sensitivity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Two-by-two tables; binomial confidence intervals; hierarchical diagnostic meta-analysis; threshold and prevalence analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating diagnostic sensitivity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "QUADAS-2; STARD; TRIPOD; REMARK"
      },
      "bemo:BEMO_3200011": "https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000116"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000117"
        },
        {
          "@id": "bemo:BEMO_2000128"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of diagnostic sensitivity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/123"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000116",
      "rdfs:label": {
        "@language": "en",
        "@value": "Diagnostic Sensitivity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb5"
        },
        {
          "@id": "bemo:BEMO_1100005"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb5",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000116"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/261",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 261,
      "bemo:BEMO_3100023": "7f170b7ac0b632bb15937074f6f54297bd1374274ba7dd6a71c308a1270c144b",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies\", \"Category\": \"Genomics and Transcriptomics\", \"Closely Related Metrics\": \"Strand Bias; Call-Rate Completeness; Hardy–Weinberg Equilibrium Compatibility\", \"Common Misinterpretations\": \"Treating reference bias as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Reference Bias\", \"References or Origin\": \"https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/\", \"Related Frameworks\": \"MIAME; MINSEQE; STROBE-ME; GA4GH; HCA\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of reference bias.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses reference bias using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in reference bias can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 261"
    },
    {
      "@id": "bemo:BEMO_2000388",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000388",
      "bemo:BEMO_3100022": 395,
      "bemo:BEMO_3100023": "c15f070192e578e50deb91384b3e8099e5c4b1a0c28cc84d1ac6a3163d36cd17",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses computational reproducibility using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in computational reproducibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating computational reproducibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All experimental, computational, clinical, and omics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0"
      },
      "bemo:BEMO_3200011": "https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000388"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000386"
        },
        {
          "@id": "bemo:BEMO_2000393"
        },
        {
          "@id": "bemo:BEMO_2000396"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which computational reproducibility yields concordant results under the specified repeated-analysis or repeated-measurement conditions."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/395"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000388",
      "rdfs:label": {
        "@language": "en",
        "@value": "Computational Reproducibility"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb400"
        },
        {
          "@id": "bemo:BEMO_1100015"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb400",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000388"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000349",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000349"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/356"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Potency Reproducibility"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000345",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000345"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/352"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Organ-Specific Toxicity Evidence"
      }
    },
    {
      "@id": "bemo:BEMO_2000444",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000444",
      "bemo:BEMO_3100022": 451,
      "bemo:BEMO_3100023": "0202d30b443e9ba2dd8ad4597c8e7b9fcc240af0f60b19db4a115b1d2866e858",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses influential observation sensitivity using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in influential observation sensitivity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating influential observation sensitivity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000444"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000445"
        },
        {
          "@id": "bemo:BEMO_2000453"
        },
        {
          "@id": "bemo:BEMO_2000454"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of influential observation sensitivity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/451"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000444",
      "rdfs:label": {
        "@language": "en",
        "@value": "Influential Observation Sensitivity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb448"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb448",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000444"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000445",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000445",
      "bemo:BEMO_3100022": 452,
      "bemo:BEMO_3100023": "7942499ba472159741e9410722d92887d17131b3d661f12b98b8ec8f2d490791",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses interaction assessment adequacy using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in interaction assessment adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating interaction assessment adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000445"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000446"
        },
        {
          "@id": "bemo:BEMO_2000453"
        },
        {
          "@id": "bemo:BEMO_2000455"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which interaction assessment is sufficient and fit for the stated biomedical inference."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/452"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000445",
      "rdfs:label": {
        "@language": "en",
        "@value": "Interaction Assessment Adequacy"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb449"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb449",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000445"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/237",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 237,
      "bemo:BEMO_3100023": "da2b6bc79f60e4e8121c9a5cd9a562fbe0d255feef3ecb78f1de13bffe50a0f4",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mendelian disease, cancer genetics, association, segregation, and functional studies\", \"Category\": \"Genetics and Variant Evidence\", \"Closely Related Metrics\": \"Variant Pathogenicity Evidence Strength; Segregation Evidence Strength; De Novo Evidence Strength\", \"Common Misinterpretations\": \"Treating population frequency compatibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Population Frequency Compatibility\", \"References or Origin\": \"https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/\", \"Related Frameworks\": \"ClinGen; ACMG AMP; STREGA; Gene Ontology\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of population frequency compatibility.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses population frequency compatibility using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in population frequency compatibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 237"
    },
    {
      "@id": "bemo:BEMO_2000242",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000242",
      "bemo:BEMO_3100022": 249,
      "bemo:BEMO_3100023": "fc0cd98bc92235d469bf2bc025f0d327d8170dfb4df97b973710a8d887eff3f4",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses contamination burden using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in contamination burden can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating contamination burden as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAME; MINSEQE; STROBE-ME; GA4GH; HCA"
      },
      "bemo:BEMO_3200011": "https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000242"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000249"
        },
        {
          "@id": "bemo:BEMO_2000256"
        },
        {
          "@id": "bemo:BEMO_2000258"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of contamination burden."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/249"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000242",
      "rdfs:label": {
        "@language": "en",
        "@value": "Contamination Burden"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb269"
        },
        {
          "@id": "bemo:BEMO_1100010"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb269",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000242"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000131",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000131"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/138"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Prognostic Discrimination"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/88",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 88,
      "bemo:BEMO_3100023": "81f1c97831f3ffbcc8b4e89c16604f987d3fa2baac750496d710981c68a60598",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All studies using human or animal biospecimens\", \"Category\": \"Biospecimen and Preanalytical Quality\", \"Closely Related Metrics\": \"Freeze–Thaw Burden; Processing Delay Control; Anatomical Site Fidelity\", \"Common Misinterpretations\": \"Treating transport condition integrity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Transport Condition Integrity\", \"References or Origin\": \"https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"BRISQ; ISO 15189; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of transport condition integrity.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses transport condition integrity using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in transport condition integrity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 88"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/383",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 383,
      "bemo:BEMO_3100023": "6761ab89a934b85357a2d58a5e53503065037a8cd658104babdb5536291a3653",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies\", \"Category\": \"Proteomics and Metabolomics\", \"Closely Related Metrics\": \"Fragmentation Spectrum Quality; Proteoform Identification Confidence; Metabolite Identification Confidence\", \"Common Misinterpretations\": \"Treating post-translational modification localization confidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Post-Translational Modification Localization Confidence\", \"References or Origin\": \"https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/\", \"Related Frameworks\": \"MIAPE; HUPO PSI; Metabolomics Standards\", \"Scientific Definition\": \"The justified degree of certainty assigned to post-translational modification localization given the quantity, quality, consistency, and limitations of supporting evidence.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses post-translational modification localization confidence using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in post-translational modification localization confidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 383"
    },
    {
      "@id": "bemo:BEMO_2000452",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000452",
      "bemo:BEMO_3100022": 459,
      "bemo:BEMO_3100023": "5c494db875d0f3ad6860a3bba83e6ac01d9f571b40aa89617a37a42c1c489cab",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses noninferiority margin validity using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in noninferiority margin validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating noninferiority margin validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000452"
      },
      "bemo:BEMO_3200013": {
        "@id": "bemo:BEMO_2000440"
      },
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which noninferiority margin supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/459"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000452",
      "rdfs:label": {
        "@language": "en",
        "@value": "Noninferiority Margin Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb52"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb52",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000452"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/456",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 456,
      "bemo:BEMO_3100023": "bf6f70bdb1883a9c1ba70dc7d37eb1885dd46ed70094a2b12bd2cc41e0f53bad",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Model Specification Adequacy; Residual Diagnostics Adequacy; Distributional Assumption Adequacy\", \"Common Misinterpretations\": \"Treating model fit as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Model Fit\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of model fit.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses model fit using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in model fit can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 456"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/458",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 458,
      "bemo:BEMO_3100023": "282fd29ea793d9f6346d4b34598e7ca30406dad2a72b3f3167d354ca92803ec0",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Type II Error Risk; Model Specification Adequacy; Model Fit\", \"Common Misinterpretations\": \"Treating multiplicity control as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Multiplicity Control\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of multiplicity control.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses multiplicity control using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in multiplicity control can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 458"
    },
    {
      "@id": "bemo:BEMO_4000019",
      "@type": [
        "owl:NamedIndividual",
        "bemo:BEMO_0000403"
      ],
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Controlled BEMO FormulaStatus value: GenericTemplateDefined."
      },
      "oboInOwl:id": "BEMO:4000019",
      "rdfs:label": {
        "@language": "en",
        "@value": "Generic Template Defined"
      },
      "skos:notation": "GenericTemplateDefined"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000323",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000323"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/330"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Pathway Topology Support"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/161",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 161,
      "bemo:BEMO_3100023": "d0050ec2d0692a0a792ec941fce4c076cf8613142effd9ef06a03cab99fa82fe",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Systematic reviews, meta-analyses, evidence profiles, guidelines\", \"Category\": \"Evidence Certainty and Synthesis\", \"Closely Related Metrics\": \"Evidence Quality; Evidence Confidence; Evidence Stability\", \"Common Misinterpretations\": \"Treating evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Evidence Strength\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/\", \"Related Frameworks\": \"GRADE; PRISMA; AMSTAR 2; RoB\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting evidence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses evidence strength using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 161"
    },
    {
      "@id": "bemo:BEMO_2000302",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000302",
      "bemo:BEMO_3100022": 309,
      "bemo:BEMO_3100023": "9094cf98fb975c34384185560acacc946dab62ebd8f1815100dcaac099d9df1b",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses trueness using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in trueness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating trueness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000302"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000267"
        },
        {
          "@id": "bemo:BEMO_2000269"
        },
        {
          "@id": "bemo:BEMO_2000297"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of trueness."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/309"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000302",
      "rdfs:label": {
        "@language": "en",
        "@value": "Trueness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb323"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb323",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000302"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000181",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000181",
      "bemo:BEMO_3100022": 188,
      "bemo:BEMO_3100023": "0095c2122f8f2e2a2aa6070b8c33f6576321db691574400350300c93ce956830",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses negative-control performance using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in negative-control performance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating negative-control performance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "In vitro, ex vivo, organoid, animal, and preclinical experiments"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ARRIVE 2.0; SYRCLE; OECD"
      },
      "bemo:BEMO_3200011": "https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000181"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000182"
        },
        {
          "@id": "bemo:BEMO_2000183"
        },
        {
          "@id": "bemo:BEMO_2000190"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of negative-control performance."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/188"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000181",
      "rdfs:label": {
        "@language": "en",
        "@value": "Negative-Control Performance"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb215"
        },
        {
          "@id": "bemo:BEMO_1100007"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb215",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000181"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000059",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000059",
      "bemo:BEMO_3100022": 66,
      "bemo:BEMO_3100023": "b89a21b15f8ca110af0a2e2a28ae4ce7939819f7d62769c459c1cd5dc9b712cc",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses biospecimen integrity using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in biospecimen integrity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating biospecimen integrity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All studies using human or animal biospecimens"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "BRISQ; ISO 15189; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000059"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000060"
        },
        {
          "@id": "bemo:BEMO_2000064"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of biospecimen integrity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/66"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000059",
      "rdfs:label": {
        "@language": "en",
        "@value": "Biospecimen Integrity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb3"
        },
        {
          "@id": "bemo:BEMO_1100003"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb3",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000059"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_3100016",
      "@type": "owl:DatatypeProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Whether uncertainty reporting is mandatory."
      },
      "oboInOwl:id": "BEMO:3100016",
      "rdfs:label": {
        "@language": "en",
        "@value": "uncertainty required"
      },
      "rdfs:range": {
        "@id": "xsd:boolean"
      }
    },
    {
      "@id": "bemo:BEMO_2000013",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000013",
      "bemo:BEMO_3100022": 20,
      "bemo:BEMO_3100023": "29074cf2dac765628d0a639b922f2e3313846aa414af9c4ef760ea93c86819ca",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses mechanistic specificity using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in mechanistic specificity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating mechanistic specificity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Molecular, cellular, animal, translational, pharmacologic, and human studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; FDA Biomarker; ClinGen; OHAT; OECD"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000013"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000009"
        },
        {
          "@id": "bemo:BEMO_2000010"
        },
        {
          "@id": "bemo:BEMO_2000019"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of mechanistic specificity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/20"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000013",
      "rdfs:label": {
        "@language": "en",
        "@value": "Mechanistic Specificity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb66"
        },
        {
          "@id": "bemo:BEMO_1100001"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb66",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000013"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_3000017",
      "@type": "owl:ObjectProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Represents a curated derivation relation between metrics."
      },
      "oboInOwl:id": "BEMO:3000017",
      "rdfs:label": {
        "@language": "en",
        "@value": "derived from metric"
      }
    },
    {
      "@id": "bemo:BEMO_2000007",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000007",
      "bemo:BEMO_3100022": 14,
      "bemo:BEMO_3100023": "61aaa3d7ba71760f01fcbbb79304031b61f416940944ef459f48b6d07dc0628d",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses homeostatic compensation assessment using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in homeostatic compensation assessment can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating homeostatic compensation assessment as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Molecular, cellular, animal, translational, pharmacologic, and human studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; FDA Biomarker; ClinGen; OHAT; OECD"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000007"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000001"
        },
        {
          "@id": "bemo:BEMO_2000016"
        },
        {
          "@id": "bemo:BEMO_2000024"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of homeostatic compensation assessment."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/14"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000007",
      "rdfs:label": {
        "@language": "en",
        "@value": "Homeostatic Compensation Assessment"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb60"
        },
        {
          "@id": "bemo:BEMO_1100001"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb60",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000007"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_4000016",
      "@type": [
        "owl:NamedIndividual",
        "bemo:BEMO_0000402"
      ],
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Controlled BEMO ComputationReadinessStatus value: RubricRequired."
      },
      "oboInOwl:id": "BEMO:4000016",
      "rdfs:label": {
        "@language": "en",
        "@value": "Rubric Required"
      },
      "skos:notation": "RubricRequired"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/330",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 330,
      "bemo:BEMO_3100023": "f408d8b817c9e3179698dad395d8e94ea187b92ae192e0ab52e026106d82f40a",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Integrated omics, networks, pathways, mechanistic and dynamic systems models\", \"Category\": \"Multi-omics and Systems Biology\", \"Closely Related Metrics\": \"Pathway Enrichment Consistency; Knowledge-Graph Evidence Completeness; Knowledge-Graph Provenance Quality\", \"Common Misinterpretations\": \"Treating pathway topology support as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Dataset / model / pathway / network / evidence body\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Pathway Topology Support\", \"References or Origin\": \"https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/\", \"Related Frameworks\": \"Gene Ontology; Reactome; UniProt; GA4GH\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting pathway topology.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses pathway topology support using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in pathway topology support can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 330"
    },
    {
      "@id": "bemo:BEMO_2000331",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000331",
      "bemo:BEMO_3100022": 338,
      "bemo:BEMO_3100023": "1dbec5a00f53d17cad5a3a88dd4dfde9ceab9bbbe33a898c76c7086698d1a0a2",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses bioavailability using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in bioavailability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating bioavailability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "OECD; OHAT; FDA Biomarker; EMA E16"
      },
      "bemo:BEMO_3200011": "https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000331"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000334"
        },
        {
          "@id": "bemo:BEMO_2000346"
        },
        {
          "@id": "bemo:BEMO_2000356"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of bioavailability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/338"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000331",
      "rdfs:label": {
        "@language": "en",
        "@value": "Bioavailability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb349"
        },
        {
          "@id": "bemo:BEMO_1100013"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb349",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000331"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000336",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000336",
      "bemo:BEMO_3100022": 343,
      "bemo:BEMO_3100023": "e3d46320b779b7100a656dae6dcb02f7b9eae6762c1680f48b9313843cb64c84",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses efficacy reproducibility using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in efficacy reproducibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating efficacy reproducibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "OECD; OHAT; FDA Biomarker; EMA E16"
      },
      "bemo:BEMO_3200011": "https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000336"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000349"
        },
        {
          "@id": "bemo:BEMO_2000352"
        },
        {
          "@id": "bemo:BEMO_2000355"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which efficacy reproducibility yields concordant results under the specified repeated-analysis or repeated-measurement conditions."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/343"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000336",
      "rdfs:label": {
        "@language": "en",
        "@value": "Efficacy Reproducibility"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb354"
        },
        {
          "@id": "bemo:BEMO_1100013"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb354",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000336"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000005",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000005"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/12"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Epistasis Support"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/265",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 265,
      "bemo:BEMO_3100023": "897b2797d8e6449a88906be71f955c7726607e3b28833aef8661c12a890476a4",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies\", \"Category\": \"Genomics and Transcriptomics\", \"Closely Related Metrics\": \"Sample Identity Concordance; Variant Call Quality; Genotype Quality\", \"Common Misinterpretations\": \"Treating sex concordance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Sex Concordance\", \"References or Origin\": \"https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/\", \"Related Frameworks\": \"MIAME; MINSEQE; STROBE-ME; GA4GH; HCA\", \"Scientific Definition\": \"The degree of agreement in sex across measurements, studies, methods, populations, or biological levels.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses sex concordance using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in sex concordance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 265"
    },
    {
      "@id": "bemo:BEMO_2000108",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000108",
      "bemo:BEMO_3100022": 115,
      "bemo:BEMO_3100023": "f46690f0cea7611ea5bb0e9a0e5c1b90d25ecad9c8f28f3083cc2a71b53ce7f0",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses time-varying confounding control using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in time-varying confounding control can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Directed acyclic graphs; design emulation; balance diagnostics; negative controls; quantitative bias analysis; sensitivity and falsification analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating time-varying confounding control as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized and observational etiologic studies, natural experiments, target-trial emulations"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000108"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000087"
        },
        {
          "@id": "bemo:BEMO_2000097"
        },
        {
          "@id": "bemo:BEMO_2000105"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of time-varying confounding control."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/115"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000108",
      "rdfs:label": {
        "@language": "en",
        "@value": "Time-Varying Confounding Control"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb150"
        },
        {
          "@id": "bemo:BEMO_1100004"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb150",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000108"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_3100005",
      "@type": "owl:DatatypeProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Serialized machine-readable computation expression."
      },
      "oboInOwl:id": "BEMO:3100005",
      "rdfs:label": {
        "@language": "en",
        "@value": "machine formula expression"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/12",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 12,
      "bemo:BEMO_3100023": "cd57f610728234561644257a8387987f0aa8934688593c5fbd817b3779032054",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Molecular, cellular, animal, translational, pharmacologic, and human studies\", \"Category\": \"Biological Plausibility and Mechanism\", \"Closely Related Metrics\": \"Rescue Experiment Support; Target Engagement Evidence; On-Target Specificity\", \"Common Misinterpretations\": \"Treating epistasis support as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Epistasis Support\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"GRADE; FDA Biomarker; ClinGen; OHAT; OECD\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting epistasis.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses epistasis support using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in epistasis support can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 12"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000405",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000405"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/412"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Result Reproducibility"
      }
    },
    {
      "@id": "bemo:BEMO_2000218",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000218",
      "bemo:BEMO_3100022": 225,
      "bemo:BEMO_3100023": "d100842d4d2c367ecd1122df00784975aa0a773a92bbb5c68a8ff23fbbd4dfc4",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses expressivity consistency using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in expressivity consistency can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating expressivity consistency as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mendelian disease, cancer genetics, association, segregation, and functional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ClinGen; ACMG AMP; STREGA; Gene Ontology"
      },
      "bemo:BEMO_3200011": "https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000218"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000219"
        },
        {
          "@id": "bemo:BEMO_2000227"
        },
        {
          "@id": "bemo:BEMO_2000228"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree of agreement in expressivity across measurements, studies, methods, populations, or biological levels."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/225"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000218",
      "rdfs:label": {
        "@language": "en",
        "@value": "Expressivity Consistency"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb247"
        },
        {
          "@id": "bemo:BEMO_1100009"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb247",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000218"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_3200013",
      "@type": "owl:AnnotationProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Source-declared closely related metric."
      },
      "oboInOwl:id": "BEMO:3200013",
      "rdfs:label": {
        "@language": "en",
        "@value": "closely related metric"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000366",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000366"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/373"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Ion Suppression Assessment"
      }
    },
    {
      "@id": "bemo:BEMO_2000087",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000087",
      "bemo:BEMO_3100022": 94,
      "bemo:BEMO_3100023": "0d0ee23715a02b538d00c3772dc0b2a1a64aba9fb6a21ecd62845d74c88b63ca",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses collider bias risk using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in collider bias risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating collider bias risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized and observational etiologic studies, natural experiments, target-trial emulations"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000087"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000094"
        },
        {
          "@id": "bemo:BEMO_2000097"
        },
        {
          "@id": "bemo:BEMO_2000108"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The probability or degree that collider bias introduces systematic distortion into a biomedical estimate or conclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/94"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000087",
      "rdfs:label": {
        "@language": "en",
        "@value": "Collider Bias Risk"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb131"
        },
        {
          "@id": "bemo:BEMO_1100004"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb131",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000087"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000441",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000441"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/448"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Estimate Precision"
      }
    },
    {
      "@id": "bemo:BEMO_2000291",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000291",
      "bemo:BEMO_3100022": 298,
      "bemo:BEMO_3100023": "ae9e50b8f8857543ecb1eb315c23fc88dd3a028cfd40ee4377e1039431544ca0",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses operator variability using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in operator variability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating operator variability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000291"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000273"
        },
        {
          "@id": "bemo:BEMO_2000282"
        },
        {
          "@id": "bemo:BEMO_2000301"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of operator variability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/298"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000291",
      "rdfs:label": {
        "@language": "en",
        "@value": "Operator Variability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb313"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb313",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000291"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000334",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000003"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000012"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000013"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000020"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a validated analyte- and method-specific measurement procedure with calibration and quality control."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"unitRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "specimen_or_material; measurement_procedure; calibration_reference; quality_control_results; unit",
      "bemo:BEMO_3100007": "replicate_measurements; environmental_conditions; instrument_version",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Method- and analyte-specific physical units",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000334"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/341"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Dose Proportionality"
      }
    },
    {
      "@id": "bemo:BEMO_3100001",
      "@type": "owl:DatatypeProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Stable OBO-style CURIE assigned to a metric."
      },
      "oboInOwl:id": "BEMO:3100001",
      "rdfs:label": {
        "@language": "en",
        "@value": "metric identifier"
      },
      "rdfs:range": {
        "@id": "xsd:string"
      }
    },
    {
      "@id": "bemo:BEMO_3000018",
      "@type": "owl:ObjectProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Connects a composite metric to a component metric."
      },
      "oboInOwl:id": "BEMO:3000018",
      "rdfs:label": {
        "@language": "en",
        "@value": "composite of metric"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/220",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 220,
      "bemo:BEMO_3100023": "e9e681d8a3c5b4ca82348a6cd8fe70f3f48bd8351d482c3aa492a6712873c3db",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mendelian disease, cancer genetics, association, segregation, and functional studies\", \"Category\": \"Genetics and Variant Evidence\", \"Closely Related Metrics\": \"Allelic Evidence Strength; Case-Control Evidence Strength; Functional Variant Evidence\", \"Common Misinterpretations\": \"Treating case-level evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Case-Level Evidence Strength\", \"References or Origin\": \"https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/\", \"Related Frameworks\": \"ClinGen; ACMG AMP; STREGA; Gene Ontology\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting case-level evidence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses case-level evidence strength using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in case-level evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 220"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000141",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000141"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/148"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Cumulative Evidence Stability"
      }
    },
    {
      "@id": "bemo:BEMO_2000026",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000026",
      "bemo:BEMO_3100022": 33,
      "bemo:BEMO_3100023": "57d68c3c49543e85a4a6ee1a26a1705e9e0e05df169673d5a8f0a00632bfa39b",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses temporal biological concordance using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in temporal biological concordance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating temporal biological concordance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Molecular, cellular, animal, translational, pharmacologic, and human studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; FDA Biomarker; ClinGen; OHAT; OECD"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000026"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000004"
        },
        {
          "@id": "bemo:BEMO_2000021"
        },
        {
          "@id": "bemo:BEMO_2000023"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree of agreement in temporal biological across measurements, studies, methods, populations, or biological levels."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/33"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000026",
      "rdfs:label": {
        "@language": "en",
        "@value": "Temporal Biological Concordance"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb77"
        },
        {
          "@id": "bemo:BEMO_1100001"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb77",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000026"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000121",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000121",
      "bemo:BEMO_3100022": 128,
      "bemo:BEMO_3100023": "3bc623a30f8cb3956f6d71196888c1021137e72c87604513c9fc1e352f98bb4c",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses index-test blinding using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in index-test blinding can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating index-test blinding as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "QUADAS-2; STARD; TRIPOD; REMARK"
      },
      "bemo:BEMO_3200011": "https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000121"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000118"
        },
        {
          "@id": "bemo:BEMO_2000134"
        },
        {
          "@id": "bemo:BEMO_2000138"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of index-test blinding."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/128"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000121",
      "rdfs:label": {
        "@language": "en",
        "@value": "Index-Test Blinding"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb160"
        },
        {
          "@id": "bemo:BEMO_1100005"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb160",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000121"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_4000022",
      "@type": [
        "owl:NamedIndividual",
        "bemo:BEMO_0000404"
      ],
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Controlled BEMO Directionality value: LowerIsBetter."
      },
      "oboInOwl:id": "BEMO:4000022",
      "rdfs:label": {
        "@language": "en",
        "@value": "Lower Is Better"
      },
      "skos:notation": "LowerIsBetter"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/432",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 432,
      "bemo:BEMO_3100023": "32ae2352b0f17339d30893a08c10c681c7fa3992e6b60a3343dae6e95aa8dda5",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All biomedical study reports and data releases\", \"Category\": \"Research Transparency and Reporting Completeness\", \"Closely Related Metrics\": \"Protocol Availability; Prespecified Analysis Adherence; Outcome Definition Completeness\", \"Common Misinterpretations\": \"Treating prospective registration as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Study report / dataset / evidence package\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Prospective Registration\", \"References or Origin\": \"https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/\", \"Related Frameworks\": \"EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of prospective registration.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses prospective registration using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in prospective registration can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 432"
    },
    {
      "@id": "bemo:BEMO_2000303",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000303",
      "bemo:BEMO_3100022": 310,
      "bemo:BEMO_3100023": "89f675805a18a02e8214d03853d6a7cdcea2d29079ee839babae7605cea7a581",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses cross-layer directional concordance using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in cross-layer directional concordance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating cross-layer directional concordance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Dataset / model / pathway / network / evidence body"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Integrated omics, networks, pathways, mechanistic and dynamic systems models"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "Gene Ontology; Reactome; UniProt; GA4GH"
      },
      "bemo:BEMO_3200011": "https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000303"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000305"
        },
        {
          "@id": "bemo:BEMO_2000312"
        },
        {
          "@id": "bemo:BEMO_2000317"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree of agreement in cross-layer directional across measurements, studies, methods, populations, or biological levels."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/310"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000303",
      "rdfs:label": {
        "@language": "en",
        "@value": "Cross-Layer Directional Concordance"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb324"
        },
        {
          "@id": "bemo:BEMO_1100012"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb324",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000303"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/422",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 422,
      "bemo:BEMO_3100023": "52ff9263e3651129913da102dae69c16126528e71dde3bf30595ca84301723b5",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All biomedical study reports and data releases\", \"Category\": \"Research Transparency and Reporting Completeness\", \"Closely Related Metrics\": \"Outcome Definition Completeness; Comparator Description Completeness; Eligibility Criteria Completeness\", \"Common Misinterpretations\": \"Treating intervention description completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Study report / dataset / evidence package\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Intervention Description Completeness\", \"References or Origin\": \"https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/\", \"Related Frameworks\": \"EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS\", \"Scientific Definition\": \"The extent to which all scientifically necessary components of intervention description are present, documented, and evaluable.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses intervention description completeness using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in intervention description completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 422"
    },
    {
      "@id": "bemo:BEMO_3000011",
      "@type": "owl:ObjectProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Connects a computation specification to interpretation directionality."
      },
      "oboInOwl:id": "BEMO:3000011",
      "rdfs:label": {
        "@language": "en",
        "@value": "has directionality"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000215",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000215"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/222"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Computational Variant Evidence"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/351",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 351,
      "bemo:BEMO_3100023": "f5f71661574e809d9eb1b7625ffde603665b4c0d25ddbb968f6b8d1a88c38a42",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies\", \"Category\": \"Pharmacology and Toxicology\", \"Closely Related Metrics\": \"Safety Margin Evidence; Lowest-Observed-Adverse-Effect Level Robustness; Benchmark Dose Reliability\", \"Common Misinterpretations\": \"Treating no-observed-adverse-effect level robustness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"No-Observed-Adverse-Effect Level Robustness\", \"References or Origin\": \"https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline\", \"Related Frameworks\": \"OECD; OHAT; FDA Biomarker; EMA E16\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of no-observed-adverse-effect level robustness.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses no-observed-adverse-effect level robustness using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in no-observed-adverse-effect level robustness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 351"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/447",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 447,
      "bemo:BEMO_3100023": "226b21fe561d36c12bfde0bcc47bb1ad6cb02760533a4b768747d6a0ab92184b",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Prior Sensitivity; Noninferiority Margin Validity\", \"Common Misinterpretations\": \"Treating equivalence margin validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Equivalence Margin Validity\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"The degree to which equivalence margin supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses equivalence margin validity using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in equivalence margin validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 447"
    },
    {
      "@id": "bemo:BEMO_2000488",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000488",
      "bemo:BEMO_3100022": 495,
      "bemo:BEMO_3100023": "ec85a4abfc9e480fea03dfff5177f17a293899d488f06a679715de258c8591b9",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses temporal precedence using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in temporal precedence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating temporal precedence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000488"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000473"
        },
        {
          "@id": "bemo:BEMO_2000484"
        },
        {
          "@id": "bemo:BEMO_2000487"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of temporal precedence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/495"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000488",
      "rdfs:label": {
        "@language": "en",
        "@value": "Temporal Precedence"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb488"
        },
        {
          "@id": "bemo:BEMO_1100018"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb488",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000488"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000344",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000344"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/351"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for No-Observed-Adverse-Effect Level Robustness"
      }
    },
    {
      "@id": "bemo:BEMO_4000015",
      "@type": [
        "owl:NamedIndividual",
        "bemo:BEMO_0000402"
      ],
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Controlled BEMO ComputationReadinessStatus value: RubricOrModelRequired."
      },
      "oboInOwl:id": "BEMO:4000015",
      "rdfs:label": {
        "@language": "en",
        "@value": "Rubric Or Model Required"
      },
      "skos:notation": "RubricOrModelRequired"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/271",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 271,
      "bemo:BEMO_3100023": "6ac08afc8cf99d9cd5ee94bc247ff32edf260fc542fd5e27409d9c3b702afd66",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies\", \"Category\": \"Genomics and Transcriptomics\", \"Closely Related Metrics\": \"Allelic Balance; Reference Bias; Call-Rate Completeness\", \"Common Misinterpretations\": \"Treating strand bias as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Strand Bias\", \"References or Origin\": \"https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/\", \"Related Frameworks\": \"MIAME; MINSEQE; STROBE-ME; GA4GH; HCA\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of strand bias.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Read- and variant-level quality-control summaries; replicate concordance; orthogonal confirmation; benchmarking against reference materials.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses strand bias using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in strand bias can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 271"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000434",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000434"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/441"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Clinical Relevance of Effect"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/234",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 234,
      "bemo:BEMO_3100023": "83c8ddff797d0831554af5cae66094d559ff9fcf3cefc498edc05f2c18b6ee97",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mendelian disease, cancer genetics, association, segregation, and functional studies\", \"Category\": \"Genetics and Variant Evidence\", \"Closely Related Metrics\": \"Co-segregation Likelihood; Expressivity Consistency; Founder-Effect Assessment\", \"Common Misinterpretations\": \"Treating penetrance evidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Penetrance Evidence\", \"References or Origin\": \"https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/\", \"Related Frameworks\": \"ClinGen; ACMG AMP; STREGA; Gene Ontology\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of penetrance evidence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"ClinGen/ACMG evidence scoring; pedigree analysis; population databases; case-control data; functional assays; expert-panel review.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses penetrance evidence using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in penetrance evidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 234"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000315",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000315"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/322"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Network Edge Confidence"
      }
    },
    {
      "@id": "bemo:BEMO_2000069",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000069",
      "bemo:BEMO_3100022": 76,
      "bemo:BEMO_3100023": "d0f3346c9caa8abb9b49bded0ab6e26e5f13d5a8fb5a20971f64067dd82054ea",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses icterus interference using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in icterus interference can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Replicate dilution series; blank and spiked samples; reference materials; method-comparison studies; predefined CLSI/ISO acceptance criteria."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating icterus interference as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All studies using human or animal biospecimens"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "BRISQ; ISO 15189; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000069"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000065"
        },
        {
          "@id": "bemo:BEMO_2000070"
        },
        {
          "@id": "bemo:BEMO_2000078"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of icterus interference."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/76"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000069",
      "rdfs:label": {
        "@language": "en",
        "@value": "Icterus Interference"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb115"
        },
        {
          "@id": "bemo:BEMO_1100003"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb115",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000069"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000074",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000074",
      "bemo:BEMO_3100022": 81,
      "bemo:BEMO_3100023": "e470a75855d7bb24a7f3957922ccdf78961ef4c923b6f754c0006ebb46c0367e",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses pathology confirmation using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in pathology confirmation can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating pathology confirmation as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All studies using human or animal biospecimens"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "BRISQ; ISO 15189; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000074"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000058"
        },
        {
          "@id": "bemo:BEMO_2000061"
        },
        {
          "@id": "bemo:BEMO_2000082"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of pathology confirmation."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/81"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000074",
      "rdfs:label": {
        "@language": "en",
        "@value": "Pathology Confirmation"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb119"
        },
        {
          "@id": "bemo:BEMO_1100003"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb119",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000074"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000278",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000278",
      "bemo:BEMO_3100022": 285,
      "bemo:BEMO_3100023": "f74e484a95fd67b9bd73e0f0c112bc85ddaf01e7476f82b9c24c9382fe2bfe48",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses cutoff validity using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in cutoff validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating cutoff validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000278"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000289"
        },
        {
          "@id": "bemo:BEMO_2000290"
        },
        {
          "@id": "bemo:BEMO_2000296"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which cutoff supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/285"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000278",
      "rdfs:label": {
        "@language": "en",
        "@value": "Cutoff Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb300"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb300",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000278"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000181",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000181"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/188"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Negative-Control Performance"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/199",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 199,
      "bemo:BEMO_3100023": "607cceee390b7cb8ce577becf5db87c7c9a4643da6c8fbe5bd44948e1b9e3853",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Clinical, epidemiologic, diagnostic, translational, and population studies\", \"Category\": \"External Validity and Applicability\", \"Closely Related Metrics\": \"Intervention Applicability; Outcome Applicability; Spectrum Representativeness\", \"Common Misinterpretations\": \"Treating comparator applicability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Comparator Applicability\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/\", \"Related Frameworks\": \"GRADE; QUADAS-2; CONSORT; STROBE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of comparator applicability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses comparator applicability using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in comparator applicability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 199"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000419",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000419"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/426"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Negative-Result Reporting"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/185",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 185,
      "bemo:BEMO_3100023": "d4c26e56573de7f55de0caafd1e2880580fe66b8b4d599787ebf0b2bb3808344",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"In vitro, ex vivo, organoid, animal, and preclinical experiments\", \"Category\": \"Experimental Biology and Animal Research\", \"Closely Related Metrics\": \"Genetic Background Control; Environmental Standardization; Intervention Fidelity in Animal Studies\", \"Common Misinterpretations\": \"Treating housing and husbandry control as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Housing and Husbandry Control\", \"References or Origin\": \"https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"ARRIVE 2.0; SYRCLE; OECD\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of housing and husbandry control.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses housing and husbandry control using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in housing and husbandry control can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 185"
    },
    {
      "@id": "bemo:BEMO_4000012",
      "@type": [
        "owl:NamedIndividual",
        "bemo:BEMO_0000401"
      ],
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Controlled BEMO ComputationMode value: ValidatedMeasurementProcedure."
      },
      "oboInOwl:id": "BEMO:4000012",
      "rdfs:label": {
        "@language": "en",
        "@value": "Validated Measurement Procedure"
      },
      "skos:notation": "ValidatedMeasurementProcedure"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/197",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 197,
      "bemo:BEMO_3100023": "b1aee501d417f186bec79f011141586c66408c5b9c272dd6db3a4fa3a34f419d",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"In vitro, ex vivo, organoid, animal, and preclinical experiments\", \"Category\": \"Experimental Biology and Animal Research\", \"Closely Related Metrics\": \"Negative-Control Performance; Orthogonal Validation; Technical Artifact Exclusion\", \"Common Misinterpretations\": \"Treating vehicle-control validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Vehicle-Control Validity\", \"References or Origin\": \"https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"ARRIVE 2.0; SYRCLE; OECD\", \"Scientific Definition\": \"The degree to which vehicle-control supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses vehicle-control validity using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in vehicle-control validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 197"
    },
    {
      "@id": "bemo:BEMO_2000299",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000299",
      "bemo:BEMO_3100022": 306,
      "bemo:BEMO_3100023": "83e10528c5f3255388bb807d6bfc99c4e2c93d4f418421fcd184c242521982d5",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses reproducibility of measurement using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in reproducibility of measurement can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating reproducibility of measurement as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000299"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000270"
        },
        {
          "@id": "bemo:BEMO_2000271"
        },
        {
          "@id": "bemo:BEMO_2000284"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which reproducibility of measurement yields concordant results under the specified repeated-analysis or repeated-measurement conditions."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/306"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000299",
      "rdfs:label": {
        "@language": "en",
        "@value": "Reproducibility of Measurement"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb320"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb320",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000299"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000281",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000281",
      "bemo:BEMO_3100022": 288,
      "bemo:BEMO_3100023": "3d6a1547d736b7a958bf1c94a2df8cb5599400f10305a91c657ae1dce184650b",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses hook effect risk using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in hook effect risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating hook effect risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000281"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000274"
        },
        {
          "@id": "bemo:BEMO_2000275"
        },
        {
          "@id": "bemo:BEMO_2000296"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The probability or degree that hook effect introduces systematic distortion into a biomedical estimate or conclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/288"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000281",
      "rdfs:label": {
        "@language": "en",
        "@value": "Hook Effect Risk"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb303"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb303",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000281"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000242",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000242"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/249"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Contamination Burden"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000003",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000003"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/10"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Cell-Type Specificity"
      }
    },
    {
      "@id": "bemo:BEMO_2000144",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000144",
      "bemo:BEMO_3100022": 151,
      "bemo:BEMO_3100023": "a6abc5b380d07d44d4ec1e48b63cf0e3bf7299ab7264d6edcc898627f3bd0952",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses evidence confidence using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in evidence confidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating evidence confidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Systematic reviews, meta-analyses, evidence profiles, guidelines"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; PRISMA; AMSTAR 2; RoB"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000144"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000146"
        },
        {
          "@id": "bemo:BEMO_2000153"
        },
        {
          "@id": "bemo:BEMO_2000154"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The justified degree of certainty assigned to evidence given the quantity, quality, consistency, and limitations of supporting evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/151"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000144",
      "rdfs:label": {
        "@language": "en",
        "@value": "Evidence Confidence"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb183"
        },
        {
          "@id": "bemo:BEMO_1100006"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb183",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000144"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000218",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000218"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/225"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Expressivity Consistency"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000147",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000147"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/154"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Evidence Coverage"
      }
    },
    {
      "@id": "bemo:BEMO_2000286",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000286",
      "bemo:BEMO_3100022": 293,
      "bemo:BEMO_3100023": "e110a21f976b308d8a01ff42efac55157e3af426e1182c74cf700e2fb4ce3595",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses limit of quantification using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in limit of quantification can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Replicate dilution series; blank and spiked samples; reference materials; method-comparison studies; predefined CLSI/ISO acceptance criteria."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating limit of quantification as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000286"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000268"
        },
        {
          "@id": "bemo:BEMO_2000285"
        },
        {
          "@id": "bemo:BEMO_2000287"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of limit of quantification."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/293"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000286",
      "rdfs:label": {
        "@language": "en",
        "@value": "Limit of Quantification"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb308"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb308",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000286"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000017",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000017",
      "bemo:BEMO_3100022": 24,
      "bemo:BEMO_3100023": "688a2bdbd29ad4b59eca6350cf3462f2bc158ee3d70ef4de59f338b6e6c797a6",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses off-target liability evidence using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in off-target liability evidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating off-target liability evidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Molecular, cellular, animal, translational, pharmacologic, and human studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; FDA Biomarker; ClinGen; OHAT; OECD"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000017"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000001"
        },
        {
          "@id": "bemo:BEMO_2000007"
        },
        {
          "@id": "bemo:BEMO_2000018"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of off-target liability evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/24"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000017",
      "rdfs:label": {
        "@language": "en",
        "@value": "Off-Target Liability Evidence"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb69"
        },
        {
          "@id": "bemo:BEMO_1100001"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb69",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000017"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000103",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000103"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/110"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Quantitative Bias Analysis Robustness"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/136",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 136,
      "bemo:BEMO_3100023": "6a8e54c8d71bbaa2bc8361d6fc19eb1f50b8f4acd2b6d09e2b648f2337fa9298",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies\", \"Category\": \"Diagnostic and Prognostic Evidence\", \"Closely Related Metrics\": \"Observed-to-Expected Ratio; Prognostic Transportability; Time-Dependent Discrimination\", \"Common Misinterpretations\": \"Treating prognostic added value as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Prognostic Added Value\", \"References or Origin\": \"https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"QUADAS-2; STARD; TRIPOD; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of prognostic added value.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses prognostic added value using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in prognostic added value can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 136"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000273",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000273"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/280"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Batch-Effect Sensitivity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000481",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000481"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/488"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Performance Bias Risk"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/272",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 272,
      "bemo:BEMO_3100023": "45c762be688f8b3f57f3b563b58fc816d5802e731de9aee9acb732eea429ea1a",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies\", \"Category\": \"Genomics and Transcriptomics\", \"Closely Related Metrics\": \"Normalization Adequacy; Alternative Splicing Validation; Single-Cell Doublet Burden\", \"Common Misinterpretations\": \"Treating transcript quantification reliability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Transcript Quantification Reliability\", \"References or Origin\": \"https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/\", \"Related Frameworks\": \"MIAME; MINSEQE; STROBE-ME; GA4GH; HCA\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of transcript quantification reliability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses transcript quantification reliability using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in transcript quantification reliability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 272"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000335",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000335"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/342"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Drug–Drug Interaction Evidence"
      }
    },
    {
      "@id": "bemo:BEMO_2000351",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000351",
      "bemo:BEMO_3100022": 358,
      "bemo:BEMO_3100023": "1725f0845040d88689ff2869cde10ea44454b5cfaa1c303d02071f7ff5ccb751",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses reproductive toxicity evidence strength using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in reproductive toxicity evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating reproductive toxicity evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "OECD; OHAT; FDA Biomarker; EMA E16"
      },
      "bemo:BEMO_3200011": "https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000351"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000332"
        },
        {
          "@id": "bemo:BEMO_2000333"
        },
        {
          "@id": "bemo:BEMO_2000340"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting reproductive toxicity evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/358"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000351",
      "rdfs:label": {
        "@language": "en",
        "@value": "Reproductive Toxicity Evidence Strength"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb366"
        },
        {
          "@id": "bemo:BEMO_1100013"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb366",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000351"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000262",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000262"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/269"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Single-Cell Viability"
      }
    },
    {
      "@id": "bemo:BEMO_4000025",
      "@type": [
        "owl:NamedIndividual",
        "bemo:BEMO_0000402"
      ],
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Controlled BEMO LifecycleStatus value: Deprecated."
      },
      "oboInOwl:id": "BEMO:4000025",
      "rdfs:label": {
        "@language": "en",
        "@value": "Deprecated"
      },
      "skos:notation": "Deprecated"
    },
    {
      "@id": "bemo:BEMO_2000265",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000265",
      "bemo:BEMO_3100022": 272,
      "bemo:BEMO_3100023": "45c762be688f8b3f57f3b563b58fc816d5802e731de9aee9acb732eea429ea1a",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses transcript quantification reliability using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in transcript quantification reliability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating transcript quantification reliability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAME; MINSEQE; STROBE-ME; GA4GH; HCA"
      },
      "bemo:BEMO_3200011": "https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000265"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000238"
        },
        {
          "@id": "bemo:BEMO_2000251"
        },
        {
          "@id": "bemo:BEMO_2000260"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of transcript quantification reliability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/272"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000265",
      "rdfs:label": {
        "@language": "en",
        "@value": "Transcript Quantification Reliability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb289"
        },
        {
          "@id": "bemo:BEMO_1100010"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb289",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000265"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000457",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000457"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/464"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Prior Sensitivity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000007",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000007"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/14"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Homeostatic Compensation Assessment"
      }
    },
    {
      "@id": "bemo:BEMO_1100001",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Category of biomedical evidence metrics concerned with biological plausibility and mechanism."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:1100001",
      "rdfs:label": {
        "@language": "en",
        "@value": "Biological Plausibility and Mechanism metric"
      },
      "rdfs:subClassOf": {
        "@id": "bemo:BEMO_1000006"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000347",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000347"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/354"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Pharmacokinetic Adequacy"
      }
    },
    {
      "@id": "bemo:BEMO_2000455",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000455",
      "bemo:BEMO_3100022": 462,
      "bemo:BEMO_3100023": "20f394b3ef37b7c0b5d8426ebcce5fe9f9ef841bbb2622101174fbb411ab7957",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses overadjustment bias risk using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in overadjustment bias risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating overadjustment bias risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000455"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000433"
        },
        {
          "@id": "bemo:BEMO_2000445"
        },
        {
          "@id": "bemo:BEMO_2000446"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The probability or degree that overadjustment bias introduces systematic distortion into a biomedical estimate or conclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/462"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000455",
      "rdfs:label": {
        "@language": "en",
        "@value": "Overadjustment Bias Risk"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb458"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb458",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000455"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000198",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000198",
      "bemo:BEMO_3100022": 205,
      "bemo:BEMO_3100023": "27f8a61447192cbdeaaa7e84078183a3604b2e6ac6c0df13be6cfe9e4a09224a",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses generalizability using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in generalizability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating generalizability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Clinical, epidemiologic, diagnostic, translational, and population studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; QUADAS-2; CONSORT; STROBE"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000198"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000202"
        },
        {
          "@id": "bemo:BEMO_2000206"
        },
        {
          "@id": "bemo:BEMO_2000210"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of generalizability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/205"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000198",
      "rdfs:label": {
        "@language": "en",
        "@value": "Generalizability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb230"
        },
        {
          "@id": "bemo:BEMO_1100008"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb230",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000198"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000249",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000249"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/256"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Library Complexity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000116",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000116"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/123"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Diagnostic Sensitivity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/262",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 262,
      "bemo:BEMO_3100023": "c66c714b8c2b1fb9da08eabc61ab1b346b5733232f7901baf90ed1206b3491ba",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies\", \"Category\": \"Genomics and Transcriptomics\", \"Closely Related Metrics\": \"Population Stratification Control; Differential Expression Robustness; Normalization Adequacy\", \"Common Misinterpretations\": \"Treating relatedness control as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Relatedness Control\", \"References or Origin\": \"https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/\", \"Related Frameworks\": \"MIAME; MINSEQE; STROBE-ME; GA4GH; HCA\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of relatedness control.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses relatedness control using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in relatedness control can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 262"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/74",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 74,
      "bemo:BEMO_3100023": "40c5c886eacc67a9addeaa92c47d69bf9fbd4b1d2a0042a2efd3611fd5cebb4b",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All studies using human or animal biospecimens\", \"Category\": \"Biospecimen and Preanalytical Quality\", \"Closely Related Metrics\": \"Storage Temperature Control; Transport Condition Integrity; Processing Delay Control\", \"Common Misinterpretations\": \"Treating freeze–thaw burden as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Freeze–Thaw Burden\", \"References or Origin\": \"https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"BRISQ; ISO 15189; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of freeze–thaw burden.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses freeze–thaw burden using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in freeze–thaw burden can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 74"
    },
    {
      "@id": "bemo:BEMO_3100013",
      "@type": "owl:DatatypeProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Aggregation rule for multi-input or composite computations."
      },
      "oboInOwl:id": "BEMO:3100013",
      "rdfs:label": {
        "@language": "en",
        "@value": "aggregation rule"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000017",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000017"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/24"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Off-Target Liability Evidence"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000167",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000167"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/174"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Animal Model Construct Validity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/131",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 131,
      "bemo:BEMO_3100023": "cdf33871a90f7426da799fbf8148672bff9e925c7981ff58372c39511bd4050e",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies\", \"Category\": \"Diagnostic and Prognostic Evidence\", \"Closely Related Metrics\": \"Calibration-in-the-Large; Prognostic Added Value; Prognostic Transportability\", \"Common Misinterpretations\": \"Treating observed-to-expected ratio as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Observed-to-Expected Ratio\", \"References or Origin\": \"https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"QUADAS-2; STARD; TRIPOD; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of observed-to-expected ratio.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses observed-to-expected ratio using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in observed-to-expected ratio can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 131"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/163",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 163,
      "bemo:BEMO_3100023": "b9d887ba211f3aea4699afd087a0aa12fb8ca924209ee34ccda2bfd968c02a4a",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Systematic reviews, meta-analyses, evidence profiles, guidelines\", \"Category\": \"Evidence Certainty and Synthesis\", \"Closely Related Metrics\": \"Evidence Robustness; Counterevidence Strength; Missing Evidence Risk\", \"Common Misinterpretations\": \"Treating evidence triangulation strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Evidence Triangulation Strength\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/\", \"Related Frameworks\": \"GRADE; PRISMA; AMSTAR 2; RoB\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting evidence triangulation.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses evidence triangulation strength using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in evidence triangulation strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 163"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/430",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 430,
      "bemo:BEMO_3100023": "fe370510831c4feb18d187a9f8348ee0b93ff3174da9ddceea906467255bbd60",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All biomedical study reports and data releases\", \"Category\": \"Research Transparency and Reporting Completeness\", \"Closely Related Metrics\": \"Prospective Registration; Outcome Definition Completeness; Intervention Description Completeness\", \"Common Misinterpretations\": \"Treating prespecified analysis adherence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Study report / dataset / evidence package\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Prespecified Analysis Adherence\", \"References or Origin\": \"https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/\", \"Related Frameworks\": \"EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of prespecified analysis adherence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses prespecified analysis adherence using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in prespecified analysis adherence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 430"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000238",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000238"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/245"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Alternative Splicing Validation"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000006",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000006"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/13"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Gain-of-Function Validation"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000392",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000392"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/399"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Direct Replication Success"
      }
    },
    {
      "@id": "bemo:BEMO_2000276",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000276",
      "bemo:BEMO_3100022": 283,
      "bemo:BEMO_3100023": "0d8876821c8ce33e4a6f72fcdd334c759d21fb2784bd7f9f779179758d7849c8",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses commutability using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in commutability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating commutability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000276"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000290"
        },
        {
          "@id": "bemo:BEMO_2000294"
        },
        {
          "@id": "bemo:BEMO_2000300"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of commutability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/283"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000276",
      "rdfs:label": {
        "@language": "en",
        "@value": "Commutability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb298"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb298",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000276"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/227",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 227,
      "bemo:BEMO_3100023": "7a71bec12dfb580d6d32593ad450868d51a755f2a8b35e7eee350ad98d24c73e",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mendelian disease, cancer genetics, association, segregation, and functional studies\", \"Category\": \"Genetics and Variant Evidence\", \"Closely Related Metrics\": \"Case-Control Evidence Strength; Computational Variant Evidence; Phenotypic Specificity for Variant\", \"Common Misinterpretations\": \"Treating functional variant evidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Functional Variant Evidence\", \"References or Origin\": \"https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/\", \"Related Frameworks\": \"ClinGen; ACMG AMP; STREGA; Gene Ontology\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of functional variant evidence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"ClinGen/ACMG evidence scoring; pedigree analysis; population databases; case-control data; functional assays; expert-panel review.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses functional variant evidence using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in functional variant evidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 227"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/278",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 278,
      "bemo:BEMO_3100023": "f6458dae6787eecc6dbfe775e26236c89d02f80c2f92e3575c7f9ddfa0e84b0e",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Analytical Sensitivity; Limit of Detection; Limit of Quantification\", \"Common Misinterpretations\": \"Treating analytical specificity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment.\", \"Metric\": \"Analytical Specificity\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of analytical specificity.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses analytical specificity using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in analytical specificity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 278"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/23",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 23,
      "bemo:BEMO_3100023": "d14cae7a1ae4e812a18da95395619423ade3837794dc32beea80cb11af0003f0",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Molecular, cellular, animal, translational, pharmacologic, and human studies\", \"Category\": \"Biological Plausibility and Mechanism\", \"Closely Related Metrics\": \"Homeostatic Compensation Assessment; Systems-Level Emergence Support\", \"Common Misinterpretations\": \"Treating network context support as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Network Context Support\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"GRADE; FDA Biomarker; ClinGen; OHAT; OECD\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting network context.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses network context support using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in network context support can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 23"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000465",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000465"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/472"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Attrition Bias Risk"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000069",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000069"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/76"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Icterus Interference"
      }
    },
    {
      "@id": "bemo:BEMO_2000451",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000451",
      "bemo:BEMO_3100022": 458,
      "bemo:BEMO_3100023": "282fd29ea793d9f6346d4b34598e7ca30406dad2a72b3f3167d354ca92803ec0",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses multiplicity control using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in multiplicity control can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating multiplicity control as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000451"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000449"
        },
        {
          "@id": "bemo:BEMO_2000450"
        },
        {
          "@id": "bemo:BEMO_2000461"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of multiplicity control."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/458"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000451",
      "rdfs:label": {
        "@language": "en",
        "@value": "Multiplicity Control"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb455"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb455",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000451"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/228",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 228,
      "bemo:BEMO_3100023": "4501a0d637c0d3d7b3852d3be8f61115b2b1ac442582dd9a3ec88bd21dad9f7c",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mendelian disease, cancer genetics, association, segregation, and functional studies\", \"Category\": \"Genetics and Variant Evidence\", \"Closely Related Metrics\": \"Variant Pathogenicity Evidence Strength; Population Frequency Compatibility\", \"Common Misinterpretations\": \"Treating gene–disease validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Gene–Disease Validity\", \"References or Origin\": \"https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/\", \"Related Frameworks\": \"ClinGen; ACMG AMP; STREGA; Gene Ontology\", \"Scientific Definition\": \"The degree to which gene–disease supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"ClinGen/ACMG evidence scoring; pedigree analysis; population databases; case-control data; functional assays; expert-panel review.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses gene–disease validity using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in gene–disease validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 228"
    },
    {
      "@id": "bemo:BEMO_2000231",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000231",
      "bemo:BEMO_3100022": 238,
      "bemo:BEMO_3100023": "8e776a34bb92ed3d093c7eb03481f1c61ce724a0995235355586c28e53418e35",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses rna evidence strength using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in rna evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating rna evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mendelian disease, cancer genetics, association, segregation, and functional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ClinGen; ACMG AMP; STREGA; Gene Ontology"
      },
      "bemo:BEMO_3200011": "https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000231"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000214"
        },
        {
          "@id": "bemo:BEMO_2000227"
        },
        {
          "@id": "bemo:BEMO_2000233"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting rna evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/238"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000231",
      "rdfs:label": {
        "@language": "en",
        "@value": "RNA Evidence Strength"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb259"
        },
        {
          "@id": "bemo:BEMO_1100009"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb259",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000231"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/490",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 490,
      "bemo:BEMO_3100023": "7632dd2b67a9f407b6c186b3a54ef8714ff7082ed9c885957d4f06c0008e5f26",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies\", \"Category\": \"Study Design and Internal Validity\", \"Closely Related Metrics\": \"Selective Outcome Reporting Risk; Contamination Risk; Co-intervention Bias Risk\", \"Common Misinterpretations\": \"Treating protocol deviation risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Protocol Deviation Risk\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools\", \"Related Frameworks\": \"CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI\", \"Scientific Definition\": \"The probability or degree that protocol deviation introduces systematic distortion into a biomedical estimate or conclusion.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses protocol deviation risk using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in protocol deviation risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 490"
    },
    {
      "@id": "bemo:BEMO_3000012",
      "@type": "owl:ObjectProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Connects a computation specification or assessment to an uncertainty specification."
      },
      "oboInOwl:id": "BEMO:3000012",
      "rdfs:label": {
        "@language": "en",
        "@value": "has uncertainty specification"
      }
    },
    {
      "@id": "bemo:BEMO_2000371",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000371",
      "bemo:BEMO_3100022": 378,
      "bemo:BEMO_3100023": "dd08774f62d4c8036bc0f7c590a94eca58c7ca0613c38dec0e386cab59cc0dbd",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses metabolite identification confidence using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in metabolite identification confidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Target-decoy analysis; spectral scoring; reference standards; replicate injections; retention-time and mass-error monitoring; orthogonal confirmation."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating metabolite identification confidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAPE; HUPO PSI; Metabolomics Standards"
      },
      "bemo:BEMO_3200011": "https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000371"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000370"
        },
        {
          "@id": "bemo:BEMO_2000379"
        },
        {
          "@id": "bemo:BEMO_2000385"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The justified degree of certainty assigned to metabolite identification given the quantity, quality, consistency, and limitations of supporting evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/378"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000371",
      "rdfs:label": {
        "@language": "en",
        "@value": "Metabolite Identification Confidence"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb385"
        },
        {
          "@id": "bemo:BEMO_1100014"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb385",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000371"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000433",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000433",
      "bemo:BEMO_3100022": 440,
      "bemo:BEMO_3100023": "1d5cbda1b0dc5b30aa8339e6219d08168170bd684f74bf0679b26dd4ece9ead4",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses calibration of statistical predictions using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in calibration of statistical predictions can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating calibration of statistical predictions as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000433"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000436"
        },
        {
          "@id": "bemo:BEMO_2000437"
        },
        {
          "@id": "bemo:BEMO_2000446"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of calibration of statistical predictions."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/440"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000433",
      "rdfs:label": {
        "@language": "en",
        "@value": "Calibration of Statistical Predictions"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb439"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb439",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000433"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/348",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 348,
      "bemo:BEMO_3100023": "cd00c7765086fbbe65040e649de98f22bdf10298c91d8da0f6e7300a18f0ba9f",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies\", \"Category\": \"Pharmacology and Toxicology\", \"Closely Related Metrics\": \"No-Observed-Adverse-Effect Level Robustness; Benchmark Dose Reliability; Toxicological Mode-of-Action Support\", \"Common Misinterpretations\": \"Treating lowest-observed-adverse-effect level robustness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Lowest-Observed-Adverse-Effect Level Robustness\", \"References or Origin\": \"https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline\", \"Related Frameworks\": \"OECD; OHAT; FDA Biomarker; EMA E16\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of lowest-observed-adverse-effect level robustness.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses lowest-observed-adverse-effect level robustness using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in lowest-observed-adverse-effect level robustness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 348"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000088",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000088"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/95"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Confounding Risk"
      }
    },
    {
      "@id": "bemo:BEMO_2000319",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000319",
      "bemo:BEMO_3100022": 326,
      "bemo:BEMO_3100023": "98cc3b5d977b0d0bd7a309c477d2653f05eeb7554078021a2d0b2bf21036d891",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses ontology evidence-code strength using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in ontology evidence-code strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating ontology evidence-code strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Dataset / model / pathway / network / evidence body"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Integrated omics, networks, pathways, mechanistic and dynamic systems models"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "Gene Ontology; Reactome; UniProt; GA4GH"
      },
      "bemo:BEMO_3200011": "https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000319"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000313"
        },
        {
          "@id": "bemo:BEMO_2000318"
        },
        {
          "@id": "bemo:BEMO_2000320"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting ontology evidence-code."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/326"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000319",
      "rdfs:label": {
        "@language": "en",
        "@value": "Ontology Evidence-Code Strength"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb337"
        },
        {
          "@id": "bemo:BEMO_1100012"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb337",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000319"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000435",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000435",
      "bemo:BEMO_3100022": 442,
      "bemo:BEMO_3100023": "4b44e65362db0ef8f1ef0ae6eb87b631fd22642d5790f792ab6c3d6a9a693508",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses confidence interval compatibility using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in confidence interval compatibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating confidence interval compatibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000435"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000441"
        },
        {
          "@id": "bemo:BEMO_2000459"
        },
        {
          "@id": "bemo:BEMO_2000460"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The justified degree of certainty assigned to confidence interval compatibility given the quantity, quality, consistency, and limitations of supporting evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/442"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000435",
      "rdfs:label": {
        "@language": "en",
        "@value": "Confidence Interval Compatibility"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb441"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb441",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000435"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/495",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 495,
      "bemo:BEMO_3100023": "ec85a4abfc9e480fea03dfff5177f17a293899d488f06a679715de258c8591b9",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies\", \"Category\": \"Study Design and Internal Validity\", \"Closely Related Metrics\": \"Control Group Appropriateness; Study Design Appropriateness; Protocol Fidelity\", \"Common Misinterpretations\": \"Treating temporal precedence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Temporal Precedence\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools\", \"Related Frameworks\": \"CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of temporal precedence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses temporal precedence using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in temporal precedence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 495"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/299",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 299,
      "bemo:BEMO_3100023": "b1cf2cbf0a36602510f89d4d570874b9d2148d8bd132ef3b47e7be72655f9ff3",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Preanalytical Robustness\", \"Common Misinterpretations\": \"Treating postanalytical integrity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Postanalytical Integrity\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of postanalytical integrity.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses postanalytical integrity using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in postanalytical integrity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 299"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000289",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000289"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/296"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Measurement Uncertainty"
      }
    },
    {
      "@id": "bemo:BEMO_2000369",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000369",
      "bemo:BEMO_3100022": 376,
      "bemo:BEMO_3100023": "521bf8b7c1bbe892685e95c05cc7d63a05c4e26119e9951d705ff460b3bb99d1",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses metabolic feature reproducibility using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in metabolic feature reproducibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating metabolic feature reproducibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAPE; HUPO PSI; Metabolomics Standards"
      },
      "bemo:BEMO_3200011": "https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000369"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000359"
        },
        {
          "@id": "bemo:BEMO_2000360"
        },
        {
          "@id": "bemo:BEMO_2000373"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which metabolic feature reproducibility yields concordant results under the specified repeated-analysis or repeated-measurement conditions."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/376"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000369",
      "rdfs:label": {
        "@language": "en",
        "@value": "Metabolic Feature Reproducibility"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb383"
        },
        {
          "@id": "bemo:BEMO_1100014"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb383",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000369"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/337",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 337,
      "bemo:BEMO_3100023": "43d4a4ce7127bc52167a879f611c41413072f25e775dbe7c9446cf4028783b10",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies\", \"Category\": \"Pharmacology and Toxicology\", \"Closely Related Metrics\": \"Lowest-Observed-Adverse-Effect Level Robustness; Toxicological Mode-of-Action Support; Adverse Outcome Pathway Support\", \"Common Misinterpretations\": \"Treating benchmark dose reliability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Benchmark Dose Reliability\", \"References or Origin\": \"https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline\", \"Related Frameworks\": \"OECD; OHAT; FDA Biomarker; EMA E16\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of benchmark dose reliability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Method- and analyte-specific physical units\", \"What It Measures\": \"Assesses benchmark dose reliability using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in benchmark dose reliability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 337"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/24",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 24,
      "bemo:BEMO_3100023": "688a2bdbd29ad4b59eca6350cf3462f2bc158ee3d70ef4de59f338b6e6c797a6",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Molecular, cellular, animal, translational, pharmacologic, and human studies\", \"Category\": \"Biological Plausibility and Mechanism\", \"Closely Related Metrics\": \"On-Target Specificity; Biological Gradient; Homeostatic Compensation Assessment\", \"Common Misinterpretations\": \"Treating off-target liability evidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Off-Target Liability Evidence\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"GRADE; FDA Biomarker; ClinGen; OHAT; OECD\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of off-target liability evidence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses off-target liability evidence using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in off-target liability evidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 24"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000425",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000425"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/432"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Prospective Registration"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000247",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000247"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/254"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Genotype Quality"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000206",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000206"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/213"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Setting Applicability"
      }
    },
    {
      "@id": "bemo:BEMO_2000364",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000364",
      "bemo:BEMO_3100022": 371,
      "bemo:BEMO_3100023": "4295f539b87882bc52461f7bd190419d6afdf7864927b9a24efe1e5f65c9fcd7",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses fragmentation spectrum quality using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in fragmentation spectrum quality can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Target-decoy analysis; spectral scoring; reference standards; replicate injections; retention-time and mass-error monitoring; orthogonal confirmation."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating fragmentation spectrum quality as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAPE; HUPO PSI; Metabolomics Standards"
      },
      "bemo:BEMO_3200011": "https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000364"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000367"
        },
        {
          "@id": "bemo:BEMO_2000376"
        },
        {
          "@id": "bemo:BEMO_2000379"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of fragmentation spectrum quality."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/371"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000364",
      "rdfs:label": {
        "@language": "en",
        "@value": "Fragmentation Spectrum Quality"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb378"
        },
        {
          "@id": "bemo:BEMO_1100014"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb378",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000364"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000422",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000422"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/429"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Participant Flow Completeness"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/312",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 312,
      "bemo:BEMO_3100023": "5b9be25d7af680eef194d1d2e393dbdeaaf607f62c516cb41c75f5dfd1ba50b9",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Integrated omics, networks, pathways, mechanistic and dynamic systems models\", \"Category\": \"Multi-omics and Systems Biology\", \"Closely Related Metrics\": \"Cross-Omics Integration Coherence; Cross-Layer Directional Concordance; Latent-Factor Stability\", \"Common Misinterpretations\": \"Treating cross-omics replication as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Dataset / model / pathway / network / evidence body\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Developing\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Cross-Omics Replication\", \"References or Origin\": \"https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/\", \"Related Frameworks\": \"Gene Ontology; Reactome; UniProt; GA4GH\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of cross-omics replication.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses cross-omics replication using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in cross-omics replication can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 312"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000113",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000113"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/120"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Comparative Test Accuracy"
      }
    },
    {
      "@id": "bemo:BEMO_2000306",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000306",
      "bemo:BEMO_3100022": 313,
      "bemo:BEMO_3100023": "d58852cf510c70b8fcfa12f792791c36728adc16d59c5b9bb4b7a9b129c39f52",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses dynamical stability using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in dynamical stability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating dynamical stability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Dataset / model / pathway / network / evidence body"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Integrated omics, networks, pathways, mechanistic and dynamic systems models"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "Gene Ontology; Reactome; UniProt; GA4GH"
      },
      "bemo:BEMO_3200011": "https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000306"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000309"
        },
        {
          "@id": "bemo:BEMO_2000325"
        },
        {
          "@id": "bemo:BEMO_2000327"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of dynamical stability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/313"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000306",
      "rdfs:label": {
        "@language": "en",
        "@value": "Dynamical Stability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb325"
        },
        {
          "@id": "bemo:BEMO_1100012"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb325",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000306"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000363",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000363"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/370"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for False Discovery Rate Control"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/277",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 277,
      "bemo:BEMO_3100023": "193a9fb566dfa18750368d0657f7d1e8c3de7251eea014f0d99b1b3e73df3afa",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Reproducibility of Measurement; Analytical Specificity; Limit of Detection\", \"Common Misinterpretations\": \"Treating analytical sensitivity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment.\", \"Metric\": \"Analytical Sensitivity\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of analytical sensitivity.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses analytical sensitivity using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in analytical sensitivity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 277"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/286",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 286,
      "bemo:BEMO_3100023": "a31ef0b724223ebc3d1ad0dbe731b0b7823f6b347840ea43769f01a33866757b",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Recovery; Matrix Effect; Interference Susceptibility\", \"Common Misinterpretations\": \"Treating dilution integrity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Dilution Integrity\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of dilution integrity.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses dilution integrity using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in dilution integrity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 286"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000084",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000084"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/91"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Assumption Sensitivity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000408",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000408"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/415"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Comparator Description Completeness"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000200",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000200"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/207"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Intervention Applicability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000311",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Developing; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000311"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/318"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Knowledge-Graph Provenance Quality"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000183",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000183"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/190"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Positive-Control Performance"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/350",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 350,
      "bemo:BEMO_3100023": "241ffa4364ee9325fbb3832728344d8484375a1aca172f524b6f871b9dc07687",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies\", \"Category\": \"Pharmacology and Toxicology\", \"Closely Related Metrics\": \"Human-Relevance of Toxicological Evidence\", \"Common Misinterpretations\": \"Treating mixture interaction assessment as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Mixture Interaction Assessment\", \"References or Origin\": \"https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline\", \"Related Frameworks\": \"OECD; OHAT; FDA Biomarker; EMA E16\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of mixture interaction assessment.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses mixture interaction assessment using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in mixture interaction assessment can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 350"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000024",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000024"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/31"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Systems-Level Emergence Support"
      }
    },
    {
      "@id": "bemo:BEMO_2000252",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000252",
      "bemo:BEMO_3100022": 259,
      "bemo:BEMO_3100023": "c82d16c5b00c0127f5b02c510a48d677f57d7580cba4dcb68dce1141e1686c1d",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses population stratification control using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in population stratification control can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating population stratification control as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAME; MINSEQE; STROBE-ME; GA4GH; HCA"
      },
      "bemo:BEMO_3200011": "https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000252"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000239"
        },
        {
          "@id": "bemo:BEMO_2000244"
        },
        {
          "@id": "bemo:BEMO_2000255"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of population stratification control."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/259"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000252",
      "rdfs:label": {
        "@language": "en",
        "@value": "Population Stratification Control"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb277"
        },
        {
          "@id": "bemo:BEMO_1100010"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb277",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000252"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000107",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000107"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/114"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Target Trial Emulation Fidelity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/345",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 345,
      "bemo:BEMO_3100023": "e40592e267890e51ad35407c7dc2af7775fdac9174afe2f08486d28a5e2901b8",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies\", \"Category\": \"Pharmacology and Toxicology\", \"Closely Related Metrics\": \"Organ-Specific Toxicity Evidence; Carcinogenicity Evidence Strength; Reproductive Toxicity Evidence Strength\", \"Common Misinterpretations\": \"Treating genotoxicity evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Genotoxicity Evidence Strength\", \"References or Origin\": \"https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline\", \"Related Frameworks\": \"OECD; OHAT; FDA Biomarker; EMA E16\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting genotoxicity evidence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses genotoxicity evidence strength using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in genotoxicity evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 345"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000298",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000003"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000012"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000013"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000020"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a validated analyte- and method-specific measurement procedure with calibration and quality control."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"unitRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "specimen_or_material; measurement_procedure; calibration_reference; quality_control_results; unit",
      "bemo:BEMO_3100007": "replicate_measurements; environmental_conditions; instrument_version",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Method- and analyte-specific physical units",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000298"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/305"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Reportable Range"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/216",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 216,
      "bemo:BEMO_3100023": "dc35bc0fc74498ddd3acc1a47faf52ec96fba459b80f9800025d1a3d1e674317",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Clinical, epidemiologic, diagnostic, translational, and population studies\", \"Category\": \"External Validity and Applicability\", \"Closely Related Metrics\": \"Geographic Consistency; Demographic Generalizability; Disease-Severity Generalizability\", \"Common Misinterpretations\": \"Treating temporal generalizability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Temporal Generalizability\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/\", \"Related Frameworks\": \"GRADE; QUADAS-2; CONSORT; STROBE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of temporal generalizability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses temporal generalizability using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in temporal generalizability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 216"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000027",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000027"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/34"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Tissue Specificity"
      }
    },
    {
      "@id": "bemo:BEMO_2000340",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000340",
      "bemo:BEMO_3100022": 347,
      "bemo:BEMO_3100023": "577a4370c7a1dc270882fc655889fdc7a0b8ee20d5e6f81f1f733233db939fbd",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses immunotoxicity evidence strength using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in immunotoxicity evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating immunotoxicity evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "OECD; OHAT; FDA Biomarker; EMA E16"
      },
      "bemo:BEMO_3200011": "https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000340"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000333"
        },
        {
          "@id": "bemo:BEMO_2000354"
        },
        {
          "@id": "bemo:BEMO_2000357"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting immunotoxicity evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/347"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000340",
      "rdfs:label": {
        "@language": "en",
        "@value": "Immunotoxicity Evidence Strength"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb357"
        },
        {
          "@id": "bemo:BEMO_1100013"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb357",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000340"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000464",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000464",
      "bemo:BEMO_3100022": 471,
      "bemo:BEMO_3100023": "3367e7e58461dcb460260b263a504d906f8c26af8608d0cf2767790d3843a2e7",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses allocation concealment using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in allocation concealment can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating allocation concealment as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000464"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000466"
        },
        {
          "@id": "bemo:BEMO_2000467"
        },
        {
          "@id": "bemo:BEMO_2000485"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of allocation concealment."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/471"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000464",
      "rdfs:label": {
        "@language": "en",
        "@value": "Allocation Concealment"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb53"
        },
        {
          "@id": "bemo:BEMO_1100018"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb53",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000464"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000108",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000108"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/115"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Time-Varying Confounding Control"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000038",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000038"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/45"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Convergent Validity"
      }
    },
    {
      "@id": "bemo:BEMO_2000337",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000337",
      "bemo:BEMO_3100022": 344,
      "bemo:BEMO_3100023": "882d0346f9d5903a7e9b6a2b5ae992e9e24bd2be9c7e249168f2f9e157dc0354",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses exposure–response relationship using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in exposure–response relationship can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating exposure–response relationship as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "OECD; OHAT; FDA Biomarker; EMA E16"
      },
      "bemo:BEMO_3200011": "https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000337"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000346"
        },
        {
          "@id": "bemo:BEMO_2000347"
        },
        {
          "@id": "bemo:BEMO_2000348"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of exposure–response relationship."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/344"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000337",
      "rdfs:label": {
        "@language": "en",
        "@value": "Exposure–Response Relationship"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb43"
        },
        {
          "@id": "bemo:BEMO_1100013"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb43",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000337"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/64",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 64,
      "bemo:BEMO_3100023": "977d5f2b7e02b5e90f442ea4e8788e2fe539316cddda3ae61da29b0fa71c5325",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Biomarker development, qualification, endpoint and surrogate validation studies\", \"Category\": \"Biomarker and Endpoint Validation\", \"Closely Related Metrics\": \"Individual-Level Surrogacy; Endpoint Validity; Outcome Relevance\", \"Common Misinterpretations\": \"Treating trial-level surrogacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Trial-Level Surrogacy\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"FDA Biomarker; BEST; EMA E16; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of trial-level surrogacy.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses trial-level surrogacy using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in trial-level surrogacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 64"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/420",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 420,
      "bemo:BEMO_3100023": "35377c10ba740cabcf147ce4b6ab00e3a9c4087ca2ca810c337f7fe08223e6f9",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All biomedical study reports and data releases\", \"Category\": \"Research Transparency and Reporting Completeness\", \"Closely Related Metrics\": \"Missing-Data Reporting Completeness; Conflict-of-Interest Transparency; Data-Sharing Transparency\", \"Common Misinterpretations\": \"Treating funding-source transparency as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Study report / dataset / evidence package\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Funding-Source Transparency\", \"References or Origin\": \"https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/\", \"Related Frameworks\": \"EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of funding-source transparency.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses funding-source transparency using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in funding-source transparency can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 420"
    },
    {
      "@id": "bemo:BEMO_2000133",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000133",
      "bemo:BEMO_3100022": 140,
      "bemo:BEMO_3100023": "74d83029c18dff3247c8fb9baae1d6aba52c9b7328d218dd0210458cbd5ad7d5",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses reclassification improvement using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in reclassification improvement can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating reclassification improvement as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "QUADAS-2; STARD; TRIPOD; REMARK"
      },
      "bemo:BEMO_3200011": "https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000133"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000120"
        },
        {
          "@id": "bemo:BEMO_2000130"
        },
        {
          "@id": "bemo:BEMO_2000131"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of reclassification improvement."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/140"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000133",
      "rdfs:label": {
        "@language": "en",
        "@value": "Reclassification Improvement"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb172"
        },
        {
          "@id": "bemo:BEMO_1100005"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb172",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000133"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000131",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000131",
      "bemo:BEMO_3100022": 138,
      "bemo:BEMO_3100023": "b58deaf6b24f17f45025c2e10bd742dcb00a937cc0410366fbe092bfbfd13882",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses prognostic discrimination using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in prognostic discrimination can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating prognostic discrimination as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "QUADAS-2; STARD; TRIPOD; REMARK"
      },
      "bemo:BEMO_3200011": "https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000131"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000111"
        },
        {
          "@id": "bemo:BEMO_2000130"
        },
        {
          "@id": "bemo:BEMO_2000133"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of prognostic discrimination."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/138"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000131",
      "rdfs:label": {
        "@language": "en",
        "@value": "Prognostic Discrimination"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb170"
        },
        {
          "@id": "bemo:BEMO_1100005"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb170",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000131"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000204",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000204"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/211"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Real-World Evidence Alignment"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/43",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 43,
      "bemo:BEMO_3100023": "1ceb580fd3a672a7c14d44163bda2886dd03d14b99ce004f1db40aa485bb3e1b",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Biomarker development, qualification, endpoint and surrogate validation studies\", \"Category\": \"Biomarker and Endpoint Validation\", \"Closely Related Metrics\": \"Construct Validity; Predictive Biomarker Validity; Prognostic Biomarker Validity\", \"Common Misinterpretations\": \"Treating content validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Content Validity\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"FDA Biomarker; BEST; EMA E16; REMARK\", \"Scientific Definition\": \"The degree to which content supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses content validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in content validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 43"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000471",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000471"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/478"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Comparator Validity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/314",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 314,
      "bemo:BEMO_3100023": "e554ab3ba02f294f767076d372c3967762b850eccc356bf4d7c243480641cd98",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Integrated omics, networks, pathways, mechanistic and dynamic systems models\", \"Category\": \"Multi-omics and Systems Biology\", \"Closely Related Metrics\": \"Perturbation Prediction Accuracy\", \"Common Misinterpretations\": \"Treating emergent-property reproducibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Dataset / model / pathway / network / evidence body\", \"Frequency of Use\": \"Specialized / infrequent\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Developing\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Emergent-Property Reproducibility\", \"References or Origin\": \"https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/\", \"Related Frameworks\": \"Gene Ontology; Reactome; UniProt; GA4GH\", \"Scientific Definition\": \"The degree to which emergent-property reproducibility yields concordant results under the specified repeated-analysis or repeated-measurement conditions.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses emergent-property reproducibility using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in emergent-property reproducibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 314"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/94",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 94,
      "bemo:BEMO_3100023": "0d0ee23715a02b538d00c3772dc0b2a1a64aba9fb6a21ecd62845d74c88b63ca",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized and observational etiologic studies, natural experiments, target-trial emulations\", \"Category\": \"Causal Inference\", \"Closely Related Metrics\": \"Effect-Modification Credibility; Time-Varying Confounding Control; Immortal-Time Bias Risk\", \"Common Misinterpretations\": \"Treating collider bias risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Collider Bias Risk\", \"References or Origin\": \"https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9\", \"Scientific Definition\": \"The probability or degree that collider bias introduces systematic distortion into a biomedical estimate or conclusion.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses collider bias risk using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in collider bias risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 94"
    },
    {
      "@id": "bemo:BEMO_2000356",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000356",
      "bemo:BEMO_3100022": 363,
      "bemo:BEMO_3100023": "8bfcea065494f7118cb14f95a9459e3f35fa404437872877955c4fdff069147a",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses time–concentration profile adequacy using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in time–concentration profile adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating time–concentration profile adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "OECD; OHAT; FDA Biomarker; EMA E16"
      },
      "bemo:BEMO_3200011": "https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000356"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000334"
        },
        {
          "@id": "bemo:BEMO_2000335"
        },
        {
          "@id": "bemo:BEMO_2000342"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which time–concentration profile is sufficient and fit for the stated biomedical inference."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/363"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000356",
      "rdfs:label": {
        "@language": "en",
        "@value": "Time–Concentration Profile Adequacy"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb371"
        },
        {
          "@id": "bemo:BEMO_1100013"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb371",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000356"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/207",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 207,
      "bemo:BEMO_3100023": "d1cb3929ecc9b0976fba4823cb5a09ca13a634dd6efaa3ee43969eafe3250a95",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Clinical, epidemiologic, diagnostic, translational, and population studies\", \"Category\": \"External Validity and Applicability\", \"Closely Related Metrics\": \"Population Applicability; Comparator Applicability; Outcome Applicability\", \"Common Misinterpretations\": \"Treating intervention applicability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Intervention Applicability\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/\", \"Related Frameworks\": \"GRADE; QUADAS-2; CONSORT; STROBE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of intervention applicability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses intervention applicability using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in intervention applicability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 207"
    },
    {
      "@id": "bemo:BEMO_2000070",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000070",
      "bemo:BEMO_3100022": 77,
      "bemo:BEMO_3100023": "572ca1cf50802a5447be4c1286cdad2930a7ec08e97e7b9af663a3cb66e1d788",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses lipemia burden using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in lipemia burden can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating lipemia burden as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All studies using human or animal biospecimens"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "BRISQ; ISO 15189; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000070"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000068"
        },
        {
          "@id": "bemo:BEMO_2000069"
        },
        {
          "@id": "bemo:BEMO_2000078"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of lipemia burden."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/77"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000070",
      "rdfs:label": {
        "@language": "en",
        "@value": "Lipemia Burden"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb116"
        },
        {
          "@id": "bemo:BEMO_1100003"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb116",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000070"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_1100014",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Category of biomedical evidence metrics concerned with proteomics and metabolomics."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:1100014",
      "rdfs:label": {
        "@language": "en",
        "@value": "Proteomics and Metabolomics metric"
      },
      "rdfs:subClassOf": {
        "@id": "bemo:BEMO_1000007"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/30",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 30,
      "bemo:BEMO_3100023": "6c08ba26b1257f37b62212d7633a9e83166a0f74706ae3ffbb9de90cd98613f7",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Molecular, cellular, animal, translational, pharmacologic, and human studies\", \"Category\": \"Biological Plausibility and Mechanism\", \"Closely Related Metrics\": \"Tissue Specificity; Temporal Biological Concordance; Cross-Species Biological Concordance\", \"Common Misinterpretations\": \"Treating spatial biological concordance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Spatial Biological Concordance\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"GRADE; FDA Biomarker; ClinGen; OHAT; OECD\", \"Scientific Definition\": \"The degree of agreement in spatial biological across measurements, studies, methods, populations, or biological levels.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses spatial biological concordance using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in spatial biological concordance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 30"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000151",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000151"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/158"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Evidence Quality"
      }
    },
    {
      "@id": "bemo:BEMO_3000005",
      "@type": "owl:ObjectProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Connects a computation specification to an optional input specification."
      },
      "oboInOwl:id": "BEMO:3000005",
      "rdfs:label": {
        "@language": "en",
        "@value": "has optional input specification"
      }
    },
    {
      "@id": "bemo:BEMO_2000240",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000240",
      "bemo:BEMO_3100022": 247,
      "bemo:BEMO_3100023": "c69a25da4615faa5675944ca32d4c5ec30a0c44f5216034581329797d9a32abc",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses call-rate completeness using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in call-rate completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Read- and variant-level quality-control summaries; replicate concordance; orthogonal confirmation; benchmarking against reference materials."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating call-rate completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAME; MINSEQE; STROBE-ME; GA4GH; HCA"
      },
      "bemo:BEMO_3200011": "https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000240"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000239"
        },
        {
          "@id": "bemo:BEMO_2000248"
        },
        {
          "@id": "bemo:BEMO_2000254"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which all scientifically necessary components of call-rate are present, documented, and evaluable."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/247"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000240",
      "rdfs:label": {
        "@language": "en",
        "@value": "Call-Rate Completeness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb267"
        },
        {
          "@id": "bemo:BEMO_1100010"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb267",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000240"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000157",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000157",
      "bemo:BEMO_3100022": 164,
      "bemo:BEMO_3100023": "1349313eaf86ad90454f8dbf26aa9cb5389132fc9ac2e44b703024851df5136c",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses information size adequacy using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in information size adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating information size adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Systematic reviews, meta-analyses, evidence profiles, guidelines"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; PRISMA; AMSTAR 2; RoB"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000157"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000141"
        },
        {
          "@id": "bemo:BEMO_2000159"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which information size is sufficient and fit for the stated biomedical inference."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/164"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000157",
      "rdfs:label": {
        "@language": "en",
        "@value": "Information Size Adequacy"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb195"
        },
        {
          "@id": "bemo:BEMO_1100006"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb195",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000157"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000287",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000287",
      "bemo:BEMO_3100022": 294,
      "bemo:BEMO_3100023": "511e3fb111714ad52a916859d22dfd9a9aa36539d615e5b295fdf52500ac32e5",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses linearity using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in linearity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Replicate dilution series; blank and spiked samples; reference materials; method-comparison studies; predefined CLSI/ISO acceptance criteria."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating linearity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000287"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000268"
        },
        {
          "@id": "bemo:BEMO_2000286"
        },
        {
          "@id": "bemo:BEMO_2000298"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of linearity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/294"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000287",
      "rdfs:label": {
        "@language": "en",
        "@value": "Linearity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb309"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb309",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000287"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000466",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000466",
      "bemo:BEMO_3100022": 473,
      "bemo:BEMO_3100023": "93fad13257c869638e96dc16ab4687d4b955a0d40d8d10736f49f12cebec65eb",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses baseline comparability using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in baseline comparability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating baseline comparability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000466"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000464"
        },
        {
          "@id": "bemo:BEMO_2000467"
        },
        {
          "@id": "bemo:BEMO_2000481"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of baseline comparability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/473"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000466",
      "rdfs:label": {
        "@language": "en",
        "@value": "Baseline Comparability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb468"
        },
        {
          "@id": "bemo:BEMO_1100018"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb468",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000466"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/146",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 146,
      "bemo:BEMO_3100023": "167d33dabeef5837833710d7e97d42ff17e46ede74b98e0e88db46e921ff811e",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Systematic reviews, meta-analyses, evidence profiles, guidelines\", \"Category\": \"Evidence Certainty and Synthesis\", \"Closely Related Metrics\": \"Study Heterogeneity; Prediction Interval Adequacy; Cumulative Evidence Stability\", \"Common Misinterpretations\": \"Treating between-study variance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Between-Study Variance\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/\", \"Related Frameworks\": \"GRADE; PRISMA; AMSTAR 2; RoB\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of between-study variance.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Forest plots; heterogeneity statistics; tau-squared; prediction intervals; funnel plots; regression or selection models; sensitivity analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses between-study variance using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in between-study variance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 146"
    },
    {
      "@id": "bemo:BEMO_2000172",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000172",
      "bemo:BEMO_3100022": 179,
      "bemo:BEMO_3100023": "2a7451a420224db55e7f75f4a33818fc20cbc59d2bbc81f21fd652f7ea1a7931",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses blinding in experimental assessment using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in blinding in experimental assessment can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating blinding in experimental assessment as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "In vitro, ex vivo, organoid, animal, and preclinical experiments"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ARRIVE 2.0; SYRCLE; OECD"
      },
      "bemo:BEMO_3200011": "https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000172"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000167"
        },
        {
          "@id": "bemo:BEMO_2000168"
        },
        {
          "@id": "bemo:BEMO_2000184"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of blinding in experimental assessment."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/179"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000172",
      "rdfs:label": {
        "@language": "en",
        "@value": "Blinding in Experimental Assessment"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb207"
        },
        {
          "@id": "bemo:BEMO_1100007"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb207",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000172"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_4000010",
      "@type": [
        "owl:NamedIndividual",
        "bemo:BEMO_0000401"
      ],
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Controlled BEMO ComputationMode value: RiskAssessmentComputation."
      },
      "oboInOwl:id": "BEMO:4000010",
      "rdfs:label": {
        "@language": "en",
        "@value": "Risk Assessment Computation"
      },
      "skos:notation": "RiskAssessmentComputation"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000180",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000180"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/187"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Intervention Fidelity in Animal Studies"
      }
    },
    {
      "@id": "bemo:BEMO_2000166",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000166",
      "bemo:BEMO_3100022": 173,
      "bemo:BEMO_3100023": "6f50922de3489bf44a56c621fcc8933973821a524b4c3ba13cb746276b4a9bea",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses age appropriateness using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in age appropriateness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating age appropriateness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "In vitro, ex vivo, organoid, animal, and preclinical experiments"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ARRIVE 2.0; SYRCLE; OECD"
      },
      "bemo:BEMO_3200011": "https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000166"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000177"
        },
        {
          "@id": "bemo:BEMO_2000178"
        },
        {
          "@id": "bemo:BEMO_2000186"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which age is sufficient and fit for the stated biomedical inference."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/173"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000166",
      "rdfs:label": {
        "@language": "en",
        "@value": "Age Appropriateness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb202"
        },
        {
          "@id": "bemo:BEMO_1100007"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb202",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000166"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/13",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 13,
      "bemo:BEMO_3100023": "5c02cfac370a9d2c1514479546d6e291e60bffe1758412ceec02bbf8edaab2dc",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Molecular, cellular, animal, translational, pharmacologic, and human studies\", \"Category\": \"Biological Plausibility and Mechanism\", \"Closely Related Metrics\": \"Loss-of-Function Validation; Rescue Experiment Support; Epistasis Support\", \"Common Misinterpretations\": \"Treating gain-of-function validation as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Gain-of-Function Validation\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"GRADE; FDA Biomarker; ClinGen; OHAT; OECD\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of gain-of-function validation.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses gain-of-function validation using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in gain-of-function validation can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 13"
    },
    {
      "@id": "bemo:BEMO_1100015",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Category of biomedical evidence metrics concerned with reproducibility and replication."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:1100015",
      "rdfs:label": {
        "@language": "en",
        "@value": "Reproducibility and Replication metric"
      },
      "rdfs:subClassOf": {
        "@id": "bemo:BEMO_1000004"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/41",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 41,
      "bemo:BEMO_3100023": "628005d99d3e18a7b100ce400c64fc5218e46beeaa2cfec80dbac2445270cead",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Biomarker development, qualification, endpoint and surrogate validation studies\", \"Category\": \"Biomarker and Endpoint Validation\", \"Closely Related Metrics\": \"Biomarker-Outcome Association Strength; Biomarker Clinical Relevance\", \"Common Misinterpretations\": \"Treating clinical validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Clinical Validity\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"FDA Biomarker; BEST; EMA E16; REMARK\", \"Scientific Definition\": \"The degree to which clinical supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses clinical validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in clinical validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 41"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/322",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 322,
      "bemo:BEMO_3100023": "6118b228a2af4e149e82150fb026ef08cdd6d05b9748a0128d6e8c14f147784c",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Integrated omics, networks, pathways, mechanistic and dynamic systems models\", \"Category\": \"Multi-omics and Systems Biology\", \"Closely Related Metrics\": \"Network Reconstruction Robustness; Network Node Confidence; Module Stability\", \"Common Misinterpretations\": \"Treating network edge confidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Dataset / model / pathway / network / evidence body\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Network Edge Confidence\", \"References or Origin\": \"https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/\", \"Related Frameworks\": \"Gene Ontology; Reactome; UniProt; GA4GH\", \"Scientific Definition\": \"The justified degree of certainty assigned to network edge given the quantity, quality, consistency, and limitations of supporting evidence.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses network edge confidence using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in network edge confidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 322"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000428",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000428"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/435"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Raw-Data Availability"
      }
    },
    {
      "@id": "bemo:BEMO_2000032",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000032",
      "bemo:BEMO_3100022": 39,
      "bemo:BEMO_3100023": "80beed232e03f65da1843b394120d8baef7fb4428401374caac926260837e2b2",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses biomarker sensitivity to change using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in biomarker sensitivity to change can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating biomarker sensitivity to change as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Biomarker development, qualification, endpoint and surrogate validation studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; BEST; EMA E16; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000032"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000031"
        },
        {
          "@id": "bemo:BEMO_2000038"
        },
        {
          "@id": "bemo:BEMO_2000046"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of biomarker sensitivity to change."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/39"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000032",
      "rdfs:label": {
        "@language": "en",
        "@value": "Biomarker Sensitivity to Change"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb83"
        },
        {
          "@id": "bemo:BEMO_1100002"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb83",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000032"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/343",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 343,
      "bemo:BEMO_3100023": "e3d46320b779b7100a656dae6dcb02f7b9eae6762c1680f48b9313843cb64c84",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies\", \"Category\": \"Pharmacology and Toxicology\", \"Closely Related Metrics\": \"Potency Reproducibility; Therapeutic Window Evidence; Safety Margin Evidence\", \"Common Misinterpretations\": \"Treating efficacy reproducibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Efficacy Reproducibility\", \"References or Origin\": \"https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline\", \"Related Frameworks\": \"OECD; OHAT; FDA Biomarker; EMA E16\", \"Scientific Definition\": \"The degree to which efficacy reproducibility yields concordant results under the specified repeated-analysis or repeated-measurement conditions.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses efficacy reproducibility using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in efficacy reproducibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 343"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000014",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000014"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/21"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Mechanistic Support"
      }
    },
    {
      "@id": "bemo:BEMO_2000158",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000158",
      "bemo:BEMO_3100022": 165,
      "bemo:BEMO_3100023": "ffec67315125f9639a3601d51e352906c34b1c9847a274942f934888c1188977",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses missing evidence risk using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in missing evidence risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating missing evidence risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Systematic reviews, meta-analyses, evidence profiles, guidelines"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; PRISMA; AMSTAR 2; RoB"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000158"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000140"
        },
        {
          "@id": "bemo:BEMO_2000162"
        },
        {
          "@id": "bemo:BEMO_2000163"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The probability or degree that missing evidence introduces systematic distortion into a biomedical estimate or conclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/165"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000158",
      "rdfs:label": {
        "@language": "en",
        "@value": "Missing Evidence Risk"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb196"
        },
        {
          "@id": "bemo:BEMO_1100006"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb196",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000158"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/419",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 419,
      "bemo:BEMO_3100023": "02e23f40dd856c6f19f825d6191af4cb70f9ed2e604c47f5cbd7bf406e4d2381",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All biomedical study reports and data releases\", \"Category\": \"Research Transparency and Reporting Completeness\", \"Closely Related Metrics\": \"Comparator Description Completeness; Recruitment Reporting Completeness; Participant Flow Completeness\", \"Common Misinterpretations\": \"Treating eligibility criteria completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Study report / dataset / evidence package\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Eligibility Criteria Completeness\", \"References or Origin\": \"https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/\", \"Related Frameworks\": \"EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS\", \"Scientific Definition\": \"The extent to which all scientifically necessary components of eligibility criteria are present, documented, and evaluable.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses eligibility criteria completeness using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in eligibility criteria completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 419"
    },
    {
      "@id": "bemo:BEMO_2000275",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000275",
      "bemo:BEMO_3100022": 282,
      "bemo:BEMO_3100023": "0e987b7e93f5f6b586140ce3b08eb3d87acd863bc4cb825ee0d1e4b7b1bb3994",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses carryover using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in carryover can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Replicate dilution series; blank and spiked samples; reference materials; method-comparison studies; predefined CLSI/ISO acceptance criteria."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating carryover as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000275"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000274"
        },
        {
          "@id": "bemo:BEMO_2000277"
        },
        {
          "@id": "bemo:BEMO_2000281"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of carryover."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/282"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000275",
      "rdfs:label": {
        "@language": "en",
        "@value": "Carryover"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb297"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb297",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000275"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000412",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000412"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/419"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Eligibility Criteria Completeness"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000418",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000418"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/425"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Missing-Data Reporting Completeness"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/478",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 478,
      "bemo:BEMO_3100023": "de06a641ed9f64a7c11259e9a1d1346140c2469d57bbd106c6257d947909a5a3",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies\", \"Category\": \"Study Design and Internal Validity\", \"Closely Related Metrics\": \"Intervention Classification Validity; Control Group Appropriateness; Temporal Precedence\", \"Common Misinterpretations\": \"Treating comparator validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Comparator Validity\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools\", \"Related Frameworks\": \"CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI\", \"Scientific Definition\": \"The degree to which comparator supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses comparator validity using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in comparator validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 478"
    },
    {
      "@id": "bemo:BEMO_2000091",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000091",
      "bemo:BEMO_3100022": 98,
      "bemo:BEMO_3100023": "9e166f37b12b35c895b18fc7e56e04526e22004c0b70dee562c1cf80c5d17e69",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses dechallenge–rechallenge support using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in dechallenge–rechallenge support can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating dechallenge–rechallenge support as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized and observational etiologic studies, natural experiments, target-trial emulations"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000091"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000092"
        },
        {
          "@id": "bemo:BEMO_2000094"
        },
        {
          "@id": "bemo:BEMO_2000099"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting dechallenge–rechallenge."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/98"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000091",
      "rdfs:label": {
        "@language": "en",
        "@value": "Dechallenge–Rechallenge Support"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb134"
        },
        {
          "@id": "bemo:BEMO_1100004"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb134",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000091"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000160",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000160",
      "bemo:BEMO_3100022": 167,
      "bemo:BEMO_3100023": "31b48110148a1ebdd1379016bfff93898087ec61573fac3b850ccada3e1f7ae5",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses overall evidence certainty using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in overall evidence certainty can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating overall evidence certainty as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Systematic reviews, meta-analyses, evidence profiles, guidelines"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; PRISMA; AMSTAR 2; RoB"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000160"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000151"
        },
        {
          "@id": "bemo:BEMO_2000154"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of overall evidence certainty."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/167"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000160",
      "rdfs:label": {
        "@language": "en",
        "@value": "Overall Evidence Certainty"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb6"
        },
        {
          "@id": "bemo:BEMO_1100006"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb6",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000160"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/202",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 202,
      "bemo:BEMO_3100023": "867ff07055e7596b98039def11c9ce9ca056af7a3a11134bb8f46a0bd5adc97a",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Clinical, epidemiologic, diagnostic, translational, and population studies\", \"Category\": \"External Validity and Applicability\", \"Closely Related Metrics\": \"Demographic Generalizability; Care-Pathway Independence; Context Sensitivity\", \"Common Misinterpretations\": \"Treating disease-severity generalizability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Disease-Severity Generalizability\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/\", \"Related Frameworks\": \"GRADE; QUADAS-2; CONSORT; STROBE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of disease-severity generalizability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses disease-severity generalizability using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in disease-severity generalizability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 202"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000100",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000100"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/107"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Negative-Control Validation"
      }
    },
    {
      "@id": "bemo:BEMO_2000233",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000233",
      "bemo:BEMO_3100022": 240,
      "bemo:BEMO_3100023": "50c6384810a1443b5a98f42466fb8ab2489b57dad29ed2dab35ef7acec1960d2",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses splicing evidence strength using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in splicing evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating splicing evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mendelian disease, cancer genetics, association, segregation, and functional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ClinGen; ACMG AMP; STREGA; Gene Ontology"
      },
      "bemo:BEMO_3200011": "https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000233"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000214"
        },
        {
          "@id": "bemo:BEMO_2000226"
        },
        {
          "@id": "bemo:BEMO_2000231"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting splicing evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/240"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000233",
      "rdfs:label": {
        "@language": "en",
        "@value": "Splicing Evidence Strength"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb261"
        },
        {
          "@id": "bemo:BEMO_1100009"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb261",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000233"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000089",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000089",
      "bemo:BEMO_3100022": 96,
      "bemo:BEMO_3100023": "1bec3d5308662b9b5fad28978574efe7573d32766cf45ac34286863d2d2267a8",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses consistency assumption plausibility using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in consistency assumption plausibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating consistency assumption plausibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized and observational etiologic studies, natural experiments, target-trial emulations"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000089"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000090"
        },
        {
          "@id": "bemo:BEMO_2000101"
        },
        {
          "@id": "bemo:BEMO_2000102"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree of agreement in consistency assumption plausibility across measurements, studies, methods, populations, or biological levels."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/96"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000089",
      "rdfs:label": {
        "@language": "en",
        "@value": "Consistency Assumption Plausibility"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb132"
        },
        {
          "@id": "bemo:BEMO_1100004"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb132",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000089"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000454",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000454"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/461"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Outlier Influence Robustness"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/186",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 186,
      "bemo:BEMO_3100023": "efafe26c06dac15c0d485bfb264933c40fe9cf7ca97c5195ea92c9cfeb3f7a98",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"In vitro, ex vivo, organoid, animal, and preclinical experiments\", \"Category\": \"Experimental Biology and Animal Research\", \"Closely Related Metrics\": \"Intervention Fidelity in Animal Studies; Attrition Accounting in Animal Studies; Exclusion-Criteria Prespecification\", \"Common Misinterpretations\": \"Treating humane endpoint appropriateness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Humane Endpoint Appropriateness\", \"References or Origin\": \"https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"ARRIVE 2.0; SYRCLE; OECD\", \"Scientific Definition\": \"The extent to which humane endpoint is sufficient and fit for the stated biomedical inference.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses humane endpoint appropriateness using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in humane endpoint appropriateness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 186"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000035",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000035"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/42"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Construct Validity"
      }
    },
    {
      "@id": "bemo:BEMO_2000417",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000417",
      "bemo:BEMO_3100022": 424,
      "bemo:BEMO_3100023": "cfce2b3ca58f108e1dc5461ad1ef2f5a84b55171c75536d306bf4e1e2b3bc58d",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses metadata completeness using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in metadata completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating metadata completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Study report / dataset / evidence package"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All biomedical study reports and data releases"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000417"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000416"
        },
        {
          "@id": "bemo:BEMO_2000424"
        },
        {
          "@id": "bemo:BEMO_2000428"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which all scientifically necessary components of metadata are present, documented, and evaluable."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/424"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000417",
      "rdfs:label": {
        "@language": "en",
        "@value": "Metadata Completeness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb426"
        },
        {
          "@id": "bemo:BEMO_1100016"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb426",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000417"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/404",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 404,
      "bemo:BEMO_3100023": "44bfb4ae3b82bb963a97cc8f3dfed3bd610b7903405993c8f3031931f746d1ce",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All experimental, computational, clinical, and omics studies\", \"Category\": \"Reproducibility and Replication\", \"Closely Related Metrics\": \"Interlaboratory Reproducibility; Method Reproducibility; Result Reproducibility\", \"Common Misinterpretations\": \"Treating intralaboratory repeatability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Intralaboratory Repeatability\", \"References or Origin\": \"https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines\", \"Related Frameworks\": \"PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0\", \"Scientific Definition\": \"The degree to which intralaboratory repeatability yields concordant results under the specified repeated-analysis or repeated-measurement conditions.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses intralaboratory repeatability using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in intralaboratory repeatability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 404"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000277",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000277"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/284"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Cross-Reactivity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000085",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000085"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/92"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Causal Contrast Clarity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000237",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000237"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/244"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Allelic Balance"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000150",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000150"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/157"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Evidence Precision"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000371",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000371"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/378"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Metabolite Identification Confidence"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000264",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000264"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/271"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Strand Bias"
      }
    },
    {
      "@id": "bemo:BEMO_1100012",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Category of biomedical evidence metrics concerned with multi-omics and systems biology."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:1100012",
      "rdfs:label": {
        "@language": "en",
        "@value": "Multi-omics and Systems Biology metric"
      },
      "rdfs:subClassOf": {
        "@id": "bemo:BEMO_1000007"
      }
    },
    {
      "@id": "bemo:BEMO_2000151",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000151",
      "bemo:BEMO_3100022": 158,
      "bemo:BEMO_3100023": "f4e08b1965ce7d1832ff4c5191f1e7298781d9bec3cb9a96c09198d6faaa1339",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses evidence quality using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in evidence quality can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating evidence quality as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Systematic reviews, meta-analyses, evidence profiles, guidelines"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; PRISMA; AMSTAR 2; RoB"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000151"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000144"
        },
        {
          "@id": "bemo:BEMO_2000154"
        },
        {
          "@id": "bemo:BEMO_2000160"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of evidence quality."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/158"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000151",
      "rdfs:label": {
        "@language": "en",
        "@value": "Evidence Quality"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb29"
        },
        {
          "@id": "bemo:BEMO_1100006"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb29",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000151"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000397",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000397"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/404"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Intralaboratory Repeatability"
      }
    },
    {
      "@id": "bemo:BEMO_2000142",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000142",
      "bemo:BEMO_3100022": 149,
      "bemo:BEMO_3100023": "573628981de9da600edff4f13001018973ec4403d9ad58179a02f6958d0404dd",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses evidence coherence using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in evidence coherence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating evidence coherence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Systematic reviews, meta-analyses, evidence profiles, guidelines"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; PRISMA; AMSTAR 2; RoB"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000142"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000145"
        },
        {
          "@id": "bemo:BEMO_2000150"
        },
        {
          "@id": "bemo:BEMO_2000155"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of evidence coherence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/149"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000142",
      "rdfs:label": {
        "@language": "en",
        "@value": "Evidence Coherence"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb181"
        },
        {
          "@id": "bemo:BEMO_1100006"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb181",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000142"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_3200003",
      "@type": "owl:AnnotationProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Preserves the source rationale."
      },
      "oboInOwl:id": "BEMO:3200003",
      "rdfs:label": {
        "@language": "en",
        "@value": "why it matters"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000381",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000381"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/388"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Quantification Accuracy"
      }
    },
    {
      "@id": "bemo:BEMO_3100006",
      "@type": "owl:DatatypeProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Semicolon-delimited required input roles."
      },
      "oboInOwl:id": "BEMO:3100006",
      "rdfs:label": {
        "@language": "en",
        "@value": "required inputs text"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/405",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 405,
      "bemo:BEMO_3100023": "ad24de4b8dd0c9ae8c1a3d7d5fcdd166b9bd923967cbf8032882e26fce35feb2",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All experimental, computational, clinical, and omics studies\", \"Category\": \"Reproducibility and Replication\", \"Closely Related Metrics\": \"Protocol Reproducibility; Code Availability; Data Availability\", \"Common Misinterpretations\": \"Treating material availability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Material Availability\", \"References or Origin\": \"https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines\", \"Related Frameworks\": \"PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of material availability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses material availability using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in material availability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 405"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000279",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000279"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/286"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Dilution Integrity"
      }
    },
    {
      "@id": "bemo:BEMO_2000152",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000152",
      "bemo:BEMO_3100022": 159,
      "bemo:BEMO_3100023": "59315ce160586081fc3fd71f96646716829d26fde9e0a21aa0afec923b5083d6",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses evidence robustness using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in evidence robustness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating evidence robustness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Systematic reviews, meta-analyses, evidence profiles, guidelines"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; PRISMA; AMSTAR 2; RoB"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000152"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000140"
        },
        {
          "@id": "bemo:BEMO_2000149"
        },
        {
          "@id": "bemo:BEMO_2000156"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of evidence robustness."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/159"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000152",
      "rdfs:label": {
        "@language": "en",
        "@value": "Evidence Robustness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb190"
        },
        {
          "@id": "bemo:BEMO_1100006"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb190",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000152"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000424",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000424"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/431"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Processed-Data Availability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/431",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 431,
      "bemo:BEMO_3100023": "3d4a65e6d3c66bcaca4ff40b6df33feaedf2f77c58697c32f80c96a00d211e95",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All biomedical study reports and data releases\", \"Category\": \"Research Transparency and Reporting Completeness\", \"Closely Related Metrics\": \"Raw-Data Availability; Quality-Control Reporting Completeness; Negative-Result Reporting\", \"Common Misinterpretations\": \"Treating processed-data availability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Study report / dataset / evidence package\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Processed-Data Availability\", \"References or Origin\": \"https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/\", \"Related Frameworks\": \"EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of processed-data availability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses processed-data availability using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in processed-data availability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 431"
    },
    {
      "@id": "bemo:BEMO_2000112",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000112",
      "bemo:BEMO_3100022": 119,
      "bemo:BEMO_3100023": "4a117ceb82993be69cf387d42f6626e25d4ff682e98eb458d01d55a60ca6f29d",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses calibration-in-the-large using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in calibration-in-the-large can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating calibration-in-the-large as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "QUADAS-2; STARD; TRIPOD; REMARK"
      },
      "bemo:BEMO_3200011": "https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000112"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000111"
        },
        {
          "@id": "bemo:BEMO_2000124"
        },
        {
          "@id": "bemo:BEMO_2000129"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of calibration-in-the-large."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/119"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000112",
      "rdfs:label": {
        "@language": "en",
        "@value": "Calibration-in-the-Large"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb154"
        },
        {
          "@id": "bemo:BEMO_1100005"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb154",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000112"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000028",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000028"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/35"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Biomarker Clinical Relevance"
      }
    },
    {
      "@id": "bemo:BEMO_2000048",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000048",
      "bemo:BEMO_3100022": 55,
      "bemo:BEMO_3100023": "cc605972d7119b4dabf5e0bc927d29fa05979e706703654bb3ea93c2ebe95461",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses monitoring biomarker validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in monitoring biomarker validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating monitoring biomarker validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Biomarker development, qualification, endpoint and surrogate validation studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; BEST; EMA E16; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000048"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000050"
        },
        {
          "@id": "bemo:BEMO_2000054"
        },
        {
          "@id": "bemo:BEMO_2000056"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which monitoring biomarker supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/55"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000048",
      "rdfs:label": {
        "@language": "en",
        "@value": "Monitoring Biomarker Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb96"
        },
        {
          "@id": "bemo:BEMO_1100002"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb96",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000048"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000480",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000480",
      "bemo:BEMO_3100022": 487,
      "bemo:BEMO_3100023": "654f73aad6650cd58d63f5a49ae9e034bfcb22952cbf7a018f652c070e1ba6c1",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses outcome ascertainment validity using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in outcome ascertainment validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating outcome ascertainment validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000480"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000475"
        },
        {
          "@id": "bemo:BEMO_2000478"
        },
        {
          "@id": "bemo:BEMO_2000484"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which outcome ascertainment supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/487"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000480",
      "rdfs:label": {
        "@language": "en",
        "@value": "Outcome Ascertainment Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb481"
        },
        {
          "@id": "bemo:BEMO_1100018"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb481",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000480"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/37",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 37,
      "bemo:BEMO_3100023": "74c0c7f33ecc210cbe2fa1dd5ddc15c31273005f3e5caaa4afc370a3f6c94a4e",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Biomarker development, qualification, endpoint and surrogate validation studies\", \"Category\": \"Biomarker and Endpoint Validation\", \"Closely Related Metrics\": \"Biomarker Qualification Strength; Biomarker Responsiveness; Biomarker Sensitivity to Change\", \"Common Misinterpretations\": \"Treating biomarker reliability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Biomarker Reliability\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"FDA Biomarker; BEST; EMA E16; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of biomarker reliability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses biomarker reliability using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in biomarker reliability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 37"
    },
    {
      "@id": "bemo:BEMO_2000135",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000135",
      "bemo:BEMO_3100022": 142,
      "bemo:BEMO_3100023": "ffb2707e3bed89aca5f5c790dc5a9b0312e89c5a1dba27ebac908e4597a355bd",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses test-timing appropriateness using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in test-timing appropriateness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating test-timing appropriateness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "QUADAS-2; STARD; TRIPOD; REMARK"
      },
      "bemo:BEMO_3200011": "https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000135"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000113"
        },
        {
          "@id": "bemo:BEMO_2000120"
        },
        {
          "@id": "bemo:BEMO_2000126"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which test-timing is sufficient and fit for the stated biomedical inference."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/142"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000135",
      "rdfs:label": {
        "@language": "en",
        "@value": "Test-Timing Appropriateness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb174"
        },
        {
          "@id": "bemo:BEMO_1100005"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb174",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000135"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_1100011",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Category of biomedical evidence metrics concerned with measurement and assay analytical validity."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:1100011",
      "rdfs:label": {
        "@language": "en",
        "@value": "Measurement and Assay Analytical Validity metric"
      },
      "rdfs:subClassOf": {
        "@id": "bemo:BEMO_1000003"
      }
    },
    {
      "@id": "bemo:BEMO_2000202",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000202",
      "bemo:BEMO_3100022": 209,
      "bemo:BEMO_3100023": "9073b7f8b73fc788aa084d5c4ac174d69482c2a1439b22f86a39e465503328bc",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses population applicability using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in population applicability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating population applicability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Clinical, epidemiologic, diagnostic, translational, and population studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; QUADAS-2; CONSORT; STROBE"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000202"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000192"
        },
        {
          "@id": "bemo:BEMO_2000200"
        },
        {
          "@id": "bemo:BEMO_2000206"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of population applicability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/209"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000202",
      "rdfs:label": {
        "@language": "en",
        "@value": "Population Applicability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb234"
        },
        {
          "@id": "bemo:BEMO_1100008"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb234",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000202"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000343",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000343",
      "bemo:BEMO_3100022": 350,
      "bemo:BEMO_3100023": "241ffa4364ee9325fbb3832728344d8484375a1aca172f524b6f871b9dc07687",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses mixture interaction assessment using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in mixture interaction assessment can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating mixture interaction assessment as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "OECD; OHAT; FDA Biomarker; EMA E16"
      },
      "bemo:BEMO_3200011": "https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000343"
      },
      "bemo:BEMO_3200013": {
        "@id": "bemo:BEMO_2000339"
      },
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of mixture interaction assessment."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/350"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000343",
      "rdfs:label": {
        "@language": "en",
        "@value": "Mixture Interaction Assessment"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb44"
        },
        {
          "@id": "bemo:BEMO_1100013"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb44",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000343"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/108",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 108,
      "bemo:BEMO_3100023": "8aa9a1ba76fa5fd8217fff1b4352656d262602a1040dc8618b138b2e37a93d9a",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized and observational etiologic studies, natural experiments, target-trial emulations\", \"Category\": \"Causal Inference\", \"Closely Related Metrics\": \"Consistency Assumption Plausibility; Correct Temporal Ordering; Causal Contrast Clarity\", \"Common Misinterpretations\": \"Treating no-interference plausibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"No-Interference Plausibility\", \"References or Origin\": \"https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of no-interference plausibility.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Replicate dilution series; blank and spiked samples; reference materials; method-comparison studies; predefined CLSI/ISO acceptance criteria.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses no-interference plausibility using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in no-interference plausibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 108"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000202",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000202"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/209"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Population Applicability"
      }
    },
    {
      "@id": "bemo:BEMO_2000009",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000009",
      "bemo:BEMO_3100022": 16,
      "bemo:BEMO_3100023": "114851a566f6667271761fd50b701ab810f623c4ee0ecdabe88d5bbacc5941db",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses mechanistic causality strength using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in mechanistic causality strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Directed acyclic graphs; design emulation; balance diagnostics; negative controls; quantitative bias analysis; sensitivity and falsification analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating mechanistic causality strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Molecular, cellular, animal, translational, pharmacologic, and human studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; FDA Biomarker; ClinGen; OHAT; OECD"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000009"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000003"
        },
        {
          "@id": "bemo:BEMO_2000013"
        },
        {
          "@id": "bemo:BEMO_2000019"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting mechanistic causality."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/16"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000009",
      "rdfs:label": {
        "@language": "en",
        "@value": "Mechanistic Causality Strength"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb62"
        },
        {
          "@id": "bemo:BEMO_1100001"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb62",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000009"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000436",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000436",
      "bemo:BEMO_3100022": 443,
      "bemo:BEMO_3100023": "7e96f3c494e389efab04f0ca564863ebd840cadeaf424446d3f94ddb483ed76c",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses decision-curve net benefit using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in decision-curve net benefit can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating decision-curve net benefit as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000436"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000434"
        },
        {
          "@id": "bemo:BEMO_2000437"
        },
        {
          "@id": "bemo:BEMO_2000442"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of decision-curve net benefit."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/443"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000436",
      "rdfs:label": {
        "@language": "en",
        "@value": "Decision-Curve Net Benefit"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb442"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb442",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000436"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000486",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000486"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/493"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Selective Outcome Reporting Risk"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000435",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000435"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/442"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Confidence Interval Compatibility"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/426",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 426,
      "bemo:BEMO_3100023": "f6803e55dc7d7550d62e5bed1f8773c7da7d0266b37145da5354a96ceaf769c2",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All biomedical study reports and data releases\", \"Category\": \"Research Transparency and Reporting Completeness\", \"Closely Related Metrics\": \"Quality-Control Reporting Completeness; Null-Result Interpretability; Deviations-from-Protocol Transparency\", \"Common Misinterpretations\": \"Treating negative-result reporting as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Study report / dataset / evidence package\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Negative-Result Reporting\", \"References or Origin\": \"https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/\", \"Related Frameworks\": \"EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of negative-result reporting.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses negative-result reporting using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in negative-result reporting can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 426"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/488",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 488,
      "bemo:BEMO_3100023": "67d1ca80d7087e3cfba7c1c9f64d45d3f4094887ac27aef09ef61bfb6d49d732",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies\", \"Category\": \"Study Design and Internal Validity\", \"Closely Related Metrics\": \"Blinding Integrity; Detection Bias Risk; Attrition Bias Risk\", \"Common Misinterpretations\": \"Treating performance bias risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Performance Bias Risk\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools\", \"Related Frameworks\": \"CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI\", \"Scientific Definition\": \"The probability or degree that performance bias introduces systematic distortion into a biomedical estimate or conclusion.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses performance bias risk using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in performance bias risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 488"
    },
    {
      "@id": "bemo:BEMO_0000201",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "An entity or information artifact evaluated by a biomedical evidence metric, such as a claim, study, dataset, result, hypothesis, assay, or body of evidence."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:0000201",
      "rdfs:label": {
        "@language": "en",
        "@value": "evidence object"
      },
      "rdfs:subClassOf": {
        "@id": "obo:IAO_0000030"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000325",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000325"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/332"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Practical Identifiability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/91",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 91,
      "bemo:BEMO_3100023": "b75d62759fbd8f126f27997543f0f46dde1cb8c2484d156a08c9925c9476aa63",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized and observational etiologic studies, natural experiments, target-trial emulations\", \"Category\": \"Causal Inference\", \"Closely Related Metrics\": \"E-value Strength; Falsification Test Support\", \"Common Misinterpretations\": \"Treating assumption sensitivity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment.\", \"Metric\": \"Assumption Sensitivity\", \"References or Origin\": \"https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of assumption sensitivity.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses assumption sensitivity using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in assumption sensitivity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 91"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/385",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 385,
      "bemo:BEMO_3100023": "601ad0978c475da6065d2502b00169f5521ae97cb0543ad15ad88f49903cb27e",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies\", \"Category\": \"Proteomics and Metabolomics\", \"Closely Related Metrics\": \"Peptide-Spectrum Match Quality; Proteome Coverage; Sequence Coverage\", \"Common Misinterpretations\": \"Treating protein inference reliability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Protein Inference Reliability\", \"References or Origin\": \"https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/\", \"Related Frameworks\": \"MIAPE; HUPO PSI; Metabolomics Standards\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of protein inference reliability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Target-decoy analysis; spectral scoring; reference standards; replicate injections; retention-time and mass-error monitoring; orthogonal confirmation.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses protein inference reliability using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in protein inference reliability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 385"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000161",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000161"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/168"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Prediction Interval Adequacy"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000357",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000357"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/364"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Toxicokinetic Concordance"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/96",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 96,
      "bemo:BEMO_3100023": "1bec3d5308662b9b5fad28978574efe7573d32766cf45ac34286863d2d2267a8",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized and observational etiologic studies, natural experiments, target-trial emulations\", \"Category\": \"Causal Inference\", \"Closely Related Metrics\": \"Positivity Adequacy; No-Interference Plausibility; Correct Temporal Ordering\", \"Common Misinterpretations\": \"Treating consistency assumption plausibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Consistency Assumption Plausibility\", \"References or Origin\": \"https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9\", \"Scientific Definition\": \"The degree of agreement in consistency assumption plausibility across measurements, studies, methods, populations, or biological levels.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses consistency assumption plausibility using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in consistency assumption plausibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 96"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000061",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000061"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/68"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Cellularity Adequacy"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000271",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000271"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/278"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Analytical Specificity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/303",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 303,
      "bemo:BEMO_3100023": "3706e41c2a6c519ccdfb2643facf47ec1d2a45cc4b5b902e54040a5a53624b7e",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Calibration Traceability; Cutoff Validity; Measurement Uncertainty\", \"Common Misinterpretations\": \"Treating reference interval validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Reference Interval Validity\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"The degree to which reference interval supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses reference interval validity using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in reference interval validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 303"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/259",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 259,
      "bemo:BEMO_3100023": "c82d16c5b00c0127f5b02c510a48d677f57d7580cba4dcb68dce1141e1686c1d",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies\", \"Category\": \"Genomics and Transcriptomics\", \"Closely Related Metrics\": \"Batch-Effect Control; Relatedness Control; Differential Expression Robustness\", \"Common Misinterpretations\": \"Treating population stratification control as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Population Stratification Control\", \"References or Origin\": \"https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/\", \"Related Frameworks\": \"MIAME; MINSEQE; STROBE-ME; GA4GH; HCA\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of population stratification control.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses population stratification control using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in population stratification control can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 259"
    },
    {
      "@id": "bemo:BEMO_0000003",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A source-preserving organizational class grouping biomedical evidence metrics within a metric pillar."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:0000003",
      "rdfs:label": {
        "@language": "en",
        "@value": "metric category"
      },
      "rdfs:subClassOf": {
        "@id": "obo:IAO_0000030"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000144",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000144"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/151"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Evidence Confidence"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/166",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 166,
      "bemo:BEMO_3100023": "40900cc3965adf1a4a61ca1880158e0ed27ede5d1a6163f63eb4f6d38b99a3b8",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Systematic reviews, meta-analyses, evidence profiles, guidelines\", \"Category\": \"Evidence Certainty and Synthesis\", \"Closely Related Metrics\": \"Information Size Adequacy\", \"Common Misinterpretations\": \"Treating multiplicity-adjusted credibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Multiplicity-Adjusted Credibility\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/\", \"Related Frameworks\": \"GRADE; PRISMA; AMSTAR 2; RoB\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of multiplicity-adjusted credibility.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses multiplicity-adjusted credibility using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in multiplicity-adjusted credibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 166"
    },
    {
      "@id": "bemo:BEMO_3100007",
      "@type": "owl:DatatypeProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Semicolon-delimited optional input roles."
      },
      "oboInOwl:id": "BEMO:3100007",
      "rdfs:label": {
        "@language": "en",
        "@value": "optional inputs text"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000476",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000476"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/483"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Early Stopping Bias Risk"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/370",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 370,
      "bemo:BEMO_3100023": "4059adb92dbe8fea43e57c309bf3c42531450ae52d814c6f79932af37f2f97a2",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies\", \"Category\": \"Proteomics and Metabolomics\", \"Closely Related Metrics\": \"Protein Identification Confidence; Peptide-Spectrum Match Quality; Protein Inference Reliability\", \"Common Misinterpretations\": \"Treating false discovery rate control as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"False Discovery Rate Control\", \"References or Origin\": \"https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/\", \"Related Frameworks\": \"MIAPE; HUPO PSI; Metabolomics Standards\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of false discovery rate control.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses false discovery rate control using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in false discovery rate control can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 370"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/474",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 474,
      "bemo:BEMO_3100023": "4e84b980ded4e833e93013ba317d5857e2211ad9b612e4b77eb9308cf8244573",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies\", \"Category\": \"Study Design and Internal Validity\", \"Closely Related Metrics\": \"Baseline Comparability; Performance Bias Risk; Detection Bias Risk\", \"Common Misinterpretations\": \"Treating blinding integrity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Blinding Integrity\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools\", \"Related Frameworks\": \"CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of blinding integrity.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses blinding integrity using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in blinding integrity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 474"
    },
    {
      "@id": "bemo:BEMO_2000300",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000300",
      "bemo:BEMO_3100022": 307,
      "bemo:BEMO_3100023": "42f10127b0bb2f21e12bfaaba11ee2a6c8335cd39935669d6733741eadfc7015",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses sample stability using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in sample stability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating sample stability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000300"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000276"
        },
        {
          "@id": "bemo:BEMO_2000282"
        },
        {
          "@id": "bemo:BEMO_2000294"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of sample stability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/307"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000300",
      "rdfs:label": {
        "@language": "en",
        "@value": "Sample Stability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb321"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb321",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000300"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/347",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 347,
      "bemo:BEMO_3100023": "577a4370c7a1dc270882fc655889fdc7a0b8ee20d5e6f81f1f733233db939fbd",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies\", \"Category\": \"Pharmacology and Toxicology\", \"Closely Related Metrics\": \"Developmental Toxicity Evidence Strength; Toxicokinetic Concordance; Species Extrapolation Validity\", \"Common Misinterpretations\": \"Treating immunotoxicity evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Immunotoxicity Evidence Strength\", \"References or Origin\": \"https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline\", \"Related Frameworks\": \"OECD; OHAT; FDA Biomarker; EMA E16\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting immunotoxicity evidence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses immunotoxicity evidence strength using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in immunotoxicity evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 347"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/253",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 253,
      "bemo:BEMO_3100023": "c86e8ba8cbfb79ea4dbc1a9a4cd5da76837e35c7f45f5966b51b9734760bdf1f",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies\", \"Category\": \"Genomics and Transcriptomics\", \"Closely Related Metrics\": \"Sequencing Depth Adequacy; Mapping Quality; Read Quality\", \"Common Misinterpretations\": \"Treating genome coverage uniformity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Genome Coverage Uniformity\", \"References or Origin\": \"https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/\", \"Related Frameworks\": \"MIAME; MINSEQE; STROBE-ME; GA4GH; HCA\", \"Scientific Definition\": \"The proportion and representativeness of the relevant genome uniformity captured by the evidence or measurement process.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses genome coverage uniformity using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in genome coverage uniformity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 253"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000139",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000139"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/146"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Between-Study Variance"
      }
    },
    {
      "@id": "bemo:BEMO_2000080",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000080",
      "bemo:BEMO_3100022": 87,
      "bemo:BEMO_3100023": "49559a7ae628351af963a27a55893cf501098be34876ce35bdc2d4969fd4f94b",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses time-to-fixation adequacy using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in time-to-fixation adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating time-to-fixation adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All studies using human or animal biospecimens"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "BRISQ; ISO 15189; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000080"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000063"
        },
        {
          "@id": "bemo:BEMO_2000066"
        },
        {
          "@id": "bemo:BEMO_2000075"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which time-to-fixation is sufficient and fit for the stated biomedical inference."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/87"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000080",
      "rdfs:label": {
        "@language": "en",
        "@value": "Time-to-Fixation Adequacy"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb125"
        },
        {
          "@id": "bemo:BEMO_1100003"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb125",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000080"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000475",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000475"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/482"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Differential Follow-up Risk"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000239",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000239"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/246"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Batch-Effect Control"
      }
    },
    {
      "@id": "bemo:BEMO_2000415",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000415",
      "bemo:BEMO_3100022": 422,
      "bemo:BEMO_3100023": "52ff9263e3651129913da102dae69c16126528e71dde3bf30595ca84301723b5",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses intervention description completeness using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in intervention description completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating intervention description completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Study report / dataset / evidence package"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All biomedical study reports and data releases"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000415"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000408"
        },
        {
          "@id": "bemo:BEMO_2000412"
        },
        {
          "@id": "bemo:BEMO_2000421"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which all scientifically necessary components of intervention description are present, documented, and evaluable."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/422"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000415",
      "rdfs:label": {
        "@language": "en",
        "@value": "Intervention Description Completeness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb424"
        },
        {
          "@id": "bemo:BEMO_1100016"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb424",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000415"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000214",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000214"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/221"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Co-segregation Likelihood"
      }
    },
    {
      "@id": "bemo:BEMO_2000403",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000403",
      "bemo:BEMO_3100022": 410,
      "bemo:BEMO_3100023": "07f0b47b85e307e7887d3c938a89cbcad651d37d8bfa888ea4ce710d25410a29",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses reanalysis concordance using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in reanalysis concordance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating reanalysis concordance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All experimental, computational, clinical, and omics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0"
      },
      "bemo:BEMO_3200011": "https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000403"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000391"
        },
        {
          "@id": "bemo:BEMO_2000395"
        },
        {
          "@id": "bemo:BEMO_2000401"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree of agreement in reanalysis across measurements, studies, methods, populations, or biological levels."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/410"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000403",
      "rdfs:label": {
        "@language": "en",
        "@value": "Reanalysis Concordance"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb413"
        },
        {
          "@id": "bemo:BEMO_1100015"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb413",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000403"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000313",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000313"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/320"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Model–Experiment Concordance"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/387",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 387,
      "bemo:BEMO_3100023": "5fec1390446b523e8b6072b1babcb11902375d326650ad448b800e258e0a8401",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies\", \"Category\": \"Proteomics and Metabolomics\", \"Closely Related Metrics\": \"Protein Inference Reliability; Sequence Coverage; Quantification Precision\", \"Common Misinterpretations\": \"Treating proteome coverage as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Proteome Coverage\", \"References or Origin\": \"https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/\", \"Related Frameworks\": \"MIAPE; HUPO PSI; Metabolomics Standards\", \"Scientific Definition\": \"The proportion and representativeness of the relevant proteome captured by the evidence or measurement process.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses proteome coverage using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in proteome coverage can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 387"
    },
    {
      "@id": "bemo:BEMO_2000387",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000387",
      "bemo:BEMO_3100022": 394,
      "bemo:BEMO_3100023": "196f2dc58cfb1ea70e003d9904020fcfd1f4feec7308ace2e85d573eb71d3b5e",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses code availability using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in code availability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating code availability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All experimental, computational, clinical, and omics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0"
      },
      "bemo:BEMO_3200011": "https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000387"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000390"
        },
        {
          "@id": "bemo:BEMO_2000398"
        },
        {
          "@id": "bemo:BEMO_2000402"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of code availability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/394"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000387",
      "rdfs:label": {
        "@language": "en",
        "@value": "Code Availability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb399"
        },
        {
          "@id": "bemo:BEMO_1100015"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb399",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000387"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000102",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000102",
      "bemo:BEMO_3100022": 109,
      "bemo:BEMO_3100023": "be2ac5c0345d954f0ccc1ce41f05b792425f3fb9c158083a6db1928102b69608",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses positivity adequacy using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in positivity adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Directed acyclic graphs; design emulation; balance diagnostics; negative controls; quantitative bias analysis; sensitivity and falsification analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating positivity adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized and observational etiologic studies, natural experiments, target-trial emulations"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000102"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000089"
        },
        {
          "@id": "bemo:BEMO_2000095"
        },
        {
          "@id": "bemo:BEMO_2000101"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which positivity is sufficient and fit for the stated biomedical inference."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/109"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000102",
      "rdfs:label": {
        "@language": "en",
        "@value": "Positivity Adequacy"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb144"
        },
        {
          "@id": "bemo:BEMO_1100004"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb144",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000102"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/102",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 102,
      "bemo:BEMO_3100023": "7f4004986e0cd5fd0b8462346aec167d3be6e60fe67bb8a5838de7a005fd58d1",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized and observational etiologic studies, natural experiments, target-trial emulations\", \"Category\": \"Causal Inference\", \"Closely Related Metrics\": \"Unmeasured Confounding Sensitivity; Positivity Adequacy; Consistency Assumption Plausibility\", \"Common Misinterpretations\": \"Treating exchangeability plausibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Exchangeability Plausibility\", \"References or Origin\": \"https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of exchangeability plausibility.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Directed acyclic graphs; design emulation; balance diagnostics; negative controls; quantitative bias analysis; sensitivity and falsification analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses exchangeability plausibility using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in exchangeability plausibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 102"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/255",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 255,
      "bemo:BEMO_3100023": "158d6abc0d325612b86f33eeb0aa8e0dbdfd4460dc9c1934f90601f28ed25284",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies\", \"Category\": \"Genomics and Transcriptomics\", \"Closely Related Metrics\": \"Call-Rate Completeness; Batch-Effect Control; Population Stratification Control\", \"Common Misinterpretations\": \"Treating hardy–weinberg equilibrium compatibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Hardy–Weinberg Equilibrium Compatibility\", \"References or Origin\": \"https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/\", \"Related Frameworks\": \"MIAME; MINSEQE; STROBE-ME; GA4GH; HCA\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of hardy–weinberg equilibrium compatibility.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses hardy–weinberg equilibrium compatibility using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in hardy–weinberg equilibrium compatibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 255"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000358",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000358"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/365"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Toxicological Mode-of-Action Support"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000451",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000451"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/458"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Multiplicity Control"
      }
    },
    {
      "@id": "bemo:BEMO_2000217",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000217",
      "bemo:BEMO_3100022": 224,
      "bemo:BEMO_3100023": "e1a17a41d450c91691b405a890d0fa9af7ecd8fed12385f8124d85b912c16860",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses de novo evidence strength using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in de novo evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "ClinGen/ACMG evidence scoring; pedigree analysis; population databases; case-control data; functional assays; expert-panel review."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating de novo evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mendelian disease, cancer genetics, association, segregation, and functional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ClinGen; ACMG AMP; STREGA; Gene Ontology"
      },
      "bemo:BEMO_3200011": "https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000217"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000211"
        },
        {
          "@id": "bemo:BEMO_2000213"
        },
        {
          "@id": "bemo:BEMO_2000232"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting de novo evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/224"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000217",
      "rdfs:label": {
        "@language": "en",
        "@value": "De Novo Evidence Strength"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb246"
        },
        {
          "@id": "bemo:BEMO_1100009"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb246",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000217"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000002",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000002",
      "bemo:BEMO_3100022": 9,
      "bemo:BEMO_3100023": "6cbc5f525d668cebb0928b8428848a625103a7b6492d0a2a618adb116f200bd3",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses biological plausibility using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in biological plausibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating biological plausibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Molecular, cellular, animal, translational, pharmacologic, and human studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; FDA Biomarker; ClinGen; OHAT; OECD"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000002"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000012"
        },
        {
          "@id": "bemo:BEMO_2000014"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of biological plausibility."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/9"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000002",
      "rdfs:label": {
        "@language": "en",
        "@value": "Biological Plausibility"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb1"
        },
        {
          "@id": "bemo:BEMO_1100001"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb1",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000002"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000370",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000370",
      "bemo:BEMO_3100022": 377,
      "bemo:BEMO_3100023": "883e5fdd2ff9e198b3ddcbafc3e6478eed144bbcc7f46c67f19ec93850e8ec4c",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses metabolite annotation level using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in metabolite annotation level can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Target-decoy analysis; spectral scoring; reference standards; replicate injections; retention-time and mass-error monitoring; orthogonal confirmation."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating metabolite annotation level as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAPE; HUPO PSI; Metabolomics Standards"
      },
      "bemo:BEMO_3200011": "https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000370"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000365"
        },
        {
          "@id": "bemo:BEMO_2000371"
        },
        {
          "@id": "bemo:BEMO_2000385"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of metabolite annotation level."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/377"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000370",
      "rdfs:label": {
        "@language": "en",
        "@value": "Metabolite Annotation Level"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb384"
        },
        {
          "@id": "bemo:BEMO_1100014"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb384",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000370"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000417",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000417"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/424"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Metadata Completeness"
      }
    },
    {
      "@id": "bemo:BEMO_4000002",
      "@type": [
        "owl:NamedIndividual",
        "bemo:BEMO_0000400"
      ],
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Controlled BEMO ScaleType value: OrdinalOrNormalizedScoreScale."
      },
      "oboInOwl:id": "BEMO:4000002",
      "rdfs:label": {
        "@language": "en",
        "@value": "Ordinal Or Normalized Score Scale"
      },
      "skos:notation": "OrdinalOrNormalizedScoreScale"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/401",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 401,
      "bemo:BEMO_3100023": "3837461a84fca58515b90e02475b1cf195c845c2cf4704aa9d0c7c2b412d9406",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All experimental, computational, clinical, and omics studies\", \"Category\": \"Reproducibility and Replication\", \"Closely Related Metrics\": \"Direct Replication Success; Conceptual Replication Success\", \"Common Misinterpretations\": \"Treating independent replication strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Independent Replication Strength\", \"References or Origin\": \"https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines\", \"Related Frameworks\": \"PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting independent replication.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses independent replication strength using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in independent replication strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 401"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/179",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 179,
      "bemo:BEMO_3100023": "2a7451a420224db55e7f75f4a33818fc20cbc59d2bbc81f21fd652f7ea1a7931",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"In vitro, ex vivo, organoid, animal, and preclinical experiments\", \"Category\": \"Experimental Biology and Animal Research\", \"Closely Related Metrics\": \"Randomization in Experimental Allocation; Animal Model Face Validity; Animal Model Construct Validity\", \"Common Misinterpretations\": \"Treating blinding in experimental assessment as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Blinding in Experimental Assessment\", \"References or Origin\": \"https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"ARRIVE 2.0; SYRCLE; OECD\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of blinding in experimental assessment.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses blinding in experimental assessment using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in blinding in experimental assessment can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 179"
    },
    {
      "@id": "bemo:BEMO_3000004",
      "@type": "owl:ObjectProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Connects a computation specification to a required input specification."
      },
      "oboInOwl:id": "BEMO:3000004",
      "rdfs:label": {
        "@language": "en",
        "@value": "has required input specification"
      }
    },
    {
      "@id": "bemo:BEMO_2000483",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000483",
      "bemo:BEMO_3100022": 490,
      "bemo:BEMO_3100023": "7632dd2b67a9f407b6c186b3a54ef8714ff7082ed9c885957d4f06c0008e5f26",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses protocol deviation risk using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in protocol deviation risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating protocol deviation risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000483"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000470"
        },
        {
          "@id": "bemo:BEMO_2000472"
        },
        {
          "@id": "bemo:BEMO_2000486"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The probability or degree that protocol deviation introduces systematic distortion into a biomedical estimate or conclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/490"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000483",
      "rdfs:label": {
        "@language": "en",
        "@value": "Protocol Deviation Risk"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb484"
        },
        {
          "@id": "bemo:BEMO_1100018"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb484",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000483"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000367",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000367"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/374"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Isotope Pattern Fidelity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000225",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000225"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/232"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Loss-of-Function Mechanism Validity"
      }
    },
    {
      "@id": "bemo:BEMO_2000311",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000311",
      "bemo:BEMO_3100022": 318,
      "bemo:BEMO_3100023": "50aaf6749314a5ad4694891f48d60c74feaa99da022b5cc91c17f4221f0696a2",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses knowledge-graph provenance quality using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in knowledge-graph provenance quality can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating knowledge-graph provenance quality as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Dataset / model / pathway / network / evidence body"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Integrated omics, networks, pathways, mechanistic and dynamic systems models"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "Gene Ontology; Reactome; UniProt; GA4GH"
      },
      "bemo:BEMO_3200011": "https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000311"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000308"
        },
        {
          "@id": "bemo:BEMO_2000310"
        },
        {
          "@id": "bemo:BEMO_2000326"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Developing",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of knowledge-graph provenance quality."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/318"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000311",
      "rdfs:label": {
        "@language": "en",
        "@value": "Knowledge-Graph Provenance Quality"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb329"
        },
        {
          "@id": "bemo:BEMO_1100012"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb329",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000311"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/76",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 76,
      "bemo:BEMO_3100023": "d0f3346c9caa8abb9b49bded0ab6e26e5f13d5a8fb5a20971f64067dd82054ea",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All studies using human or animal biospecimens\", \"Category\": \"Biospecimen and Preanalytical Quality\", \"Closely Related Metrics\": \"Lipemia Burden; RNA Integrity; DNA Integrity\", \"Common Misinterpretations\": \"Treating icterus interference as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Icterus Interference\", \"References or Origin\": \"https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"BRISQ; ISO 15189; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of icterus interference.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Replicate dilution series; blank and spiked samples; reference materials; method-comparison studies; predefined CLSI/ISO acceptance criteria.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses icterus interference using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in icterus interference can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 76"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000431",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000431"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/438"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Statistical Methods Reporting Completeness"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000173",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000173"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/180"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Environmental Standardization"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000212",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000212"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/219"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Case-Control Evidence Strength"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000185",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000185"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/192"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Sample Size Justification"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000337",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000337"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/344"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Exposure–Response Relationship"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/105",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 105,
      "bemo:BEMO_3100023": "e7033f91a59f115f9fba748b04cab66664ac151f4c8d653ea61aa823a8c6cce4",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized and observational etiologic studies, natural experiments, target-trial emulations\", \"Category\": \"Causal Inference\", \"Closely Related Metrics\": \"Target Trial Emulation Fidelity; Negative-Control Validation; Dose–Response Support\", \"Common Misinterpretations\": \"Treating instrument validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Instrument Validity\", \"References or Origin\": \"https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9\", \"Scientific Definition\": \"The degree to which instrument supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses instrument validity using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in instrument validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 105"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000154",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000154"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/161"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Evidence Strength"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000040",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000040"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/47"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Diagnostic Biomarker Validity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/252",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 252,
      "bemo:BEMO_3100023": "c1d6b63aea87c65750f96b5e3a771c6866843a2e5ba7e8081dd07af03bc0e9c5",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies\", \"Category\": \"Genomics and Transcriptomics\", \"Closely Related Metrics\": \"Read Quality; Library Complexity; Contamination Burden\", \"Common Misinterpretations\": \"Treating duplicate read burden as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Duplicate Read Burden\", \"References or Origin\": \"https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/\", \"Related Frameworks\": \"MIAME; MINSEQE; STROBE-ME; GA4GH; HCA\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of duplicate read burden.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Read- and variant-level quality-control summaries; replicate concordance; orthogonal confirmation; benchmarking against reference materials.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses duplicate read burden using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in duplicate read burden can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 252"
    },
    {
      "@id": "bemo:BEMO_2000018",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000018",
      "bemo:BEMO_3100022": 25,
      "bemo:BEMO_3100023": "5b75004715c78ae57eb0dfbf1a6fe3b6212289ca6b06f39e35b36270d16b13e5",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses on-target specificity using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in on-target specificity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating on-target specificity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Molecular, cellular, animal, translational, pharmacologic, and human studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; FDA Biomarker; ClinGen; OHAT; OECD"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000018"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000001"
        },
        {
          "@id": "bemo:BEMO_2000017"
        },
        {
          "@id": "bemo:BEMO_2000025"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of on-target specificity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/25"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000018",
      "rdfs:label": {
        "@language": "en",
        "@value": "On-Target Specificity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb70"
        },
        {
          "@id": "bemo:BEMO_1100001"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb70",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000018"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000260",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000260"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/267"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Single-Cell Doublet Burden"
      }
    },
    {
      "@id": "bemo:BEMO_2000392",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000392",
      "bemo:BEMO_3100022": 399,
      "bemo:BEMO_3100023": "e6b0ec1b803bb2c7cb8becab175dbb88ab91c9d8ccd3f713a814c836846ea547",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses direct replication success using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in direct replication success can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating direct replication success as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All experimental, computational, clinical, and omics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0"
      },
      "bemo:BEMO_3200011": "https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000392"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000386"
        },
        {
          "@id": "bemo:BEMO_2000389"
        },
        {
          "@id": "bemo:BEMO_2000394"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of direct replication success."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/399"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000392",
      "rdfs:label": {
        "@language": "en",
        "@value": "Direct Replication Success"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb47"
        },
        {
          "@id": "bemo:BEMO_1100015"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb47",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000392"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000471",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000471",
      "bemo:BEMO_3100022": 478,
      "bemo:BEMO_3100023": "de06a641ed9f64a7c11259e9a1d1346140c2469d57bbd106c6257d947909a5a3",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses comparator validity using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in comparator validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating comparator validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000471"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000473"
        },
        {
          "@id": "bemo:BEMO_2000479"
        },
        {
          "@id": "bemo:BEMO_2000488"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which comparator supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/478"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000471",
      "rdfs:label": {
        "@language": "en",
        "@value": "Comparator Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb473"
        },
        {
          "@id": "bemo:BEMO_1100018"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb473",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000471"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/380",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 380,
      "bemo:BEMO_3100023": "1a891a794290e0f5eee9ca88b64bc6b46d5840f63c8709e0e546399158fbb914",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies\", \"Category\": \"Proteomics and Metabolomics\", \"Closely Related Metrics\": \"Metabolic Feature Reproducibility; Cross-Omics Concordance\", \"Common Misinterpretations\": \"Treating pathway enrichment robustness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Pathway Enrichment Robustness\", \"References or Origin\": \"https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/\", \"Related Frameworks\": \"MIAPE; HUPO PSI; Metabolomics Standards\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of pathway enrichment robustness.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses pathway enrichment robustness using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in pathway enrichment robustness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 380"
    },
    {
      "@id": "bemo:BEMO_2000418",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000418",
      "bemo:BEMO_3100022": 425,
      "bemo:BEMO_3100023": "810e02862dfc4630d6f7a0d7bd830ccd305d847e2d0153cfdb863b68f1c2ece8",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses missing-data reporting completeness using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in missing-data reporting completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating missing-data reporting completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Study report / dataset / evidence package"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All biomedical study reports and data releases"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000418"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000409"
        },
        {
          "@id": "bemo:BEMO_2000413"
        },
        {
          "@id": "bemo:BEMO_2000431"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which all scientifically necessary components of missing-data reporting are present, documented, and evaluable."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/425"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000418",
      "rdfs:label": {
        "@language": "en",
        "@value": "Missing-Data Reporting Completeness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb427"
        },
        {
          "@id": "bemo:BEMO_1100016"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb427",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000418"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000264",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000264",
      "bemo:BEMO_3100022": 271,
      "bemo:BEMO_3100023": "6ac08afc8cf99d9cd5ee94bc247ff32edf260fc542fd5e27409d9c3b702afd66",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses strand bias using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in strand bias can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Read- and variant-level quality-control summaries; replicate concordance; orthogonal confirmation; benchmarking against reference materials."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating strand bias as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAME; MINSEQE; STROBE-ME; GA4GH; HCA"
      },
      "bemo:BEMO_3200011": "https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000264"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000237"
        },
        {
          "@id": "bemo:BEMO_2000240"
        },
        {
          "@id": "bemo:BEMO_2000254"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of strand bias."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/271"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000264",
      "rdfs:label": {
        "@language": "en",
        "@value": "Strand Bias"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb288"
        },
        {
          "@id": "bemo:BEMO_1100010"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb288",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000264"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000129",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000129",
      "bemo:BEMO_3100022": 136,
      "bemo:BEMO_3100023": "6a8e54c8d71bbaa2bc8361d6fc19eb1f50b8f4acd2b6d09e2b648f2337fa9298",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses prognostic added value using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in prognostic added value can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating prognostic added value as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "QUADAS-2; STARD; TRIPOD; REMARK"
      },
      "bemo:BEMO_3200011": "https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000129"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000124"
        },
        {
          "@id": "bemo:BEMO_2000132"
        },
        {
          "@id": "bemo:BEMO_2000137"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of prognostic added value."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/136"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000129",
      "rdfs:label": {
        "@language": "en",
        "@value": "Prognostic Added Value"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb168"
        },
        {
          "@id": "bemo:BEMO_1100005"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb168",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000129"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000361",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000361"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/368"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Dynamic Range Coverage"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/212",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 212,
      "bemo:BEMO_3100023": "39b818e971de479787fde11a4523a1b0d31f5dcbc88f645b968cff60fa6bf381",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Clinical, epidemiologic, diagnostic, translational, and population studies\", \"Category\": \"External Validity and Applicability\", \"Closely Related Metrics\": \"Population Representativeness; Transportability; Generalizability\", \"Common Misinterpretations\": \"Treating sampling frame adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Sampling Frame Adequacy\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/\", \"Related Frameworks\": \"GRADE; QUADAS-2; CONSORT; STROBE\", \"Scientific Definition\": \"The extent to which sampling frame is sufficient and fit for the stated biomedical inference.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses sampling frame adequacy using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in sampling frame adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 212"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/381",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 381,
      "bemo:BEMO_3100023": "7f78eede8aa05781dde3f12d7ea8111e1c0b552f5b722c402b0de5323e65b0ea",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies\", \"Category\": \"Proteomics and Metabolomics\", \"Closely Related Metrics\": \"Protein Identification Confidence; False Discovery Rate Control\", \"Common Misinterpretations\": \"Treating peptide identification confidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Peptide Identification Confidence\", \"References or Origin\": \"https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/\", \"Related Frameworks\": \"MIAPE; HUPO PSI; Metabolomics Standards\", \"Scientific Definition\": \"The justified degree of certainty assigned to peptide identification given the quantity, quality, consistency, and limitations of supporting evidence.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Target-decoy analysis; spectral scoring; reference standards; replicate injections; retention-time and mass-error monitoring; orthogonal confirmation.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses peptide identification confidence using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in peptide identification confidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 381"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/77",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 77,
      "bemo:BEMO_3100023": "572ca1cf50802a5447be4c1286cdad2930a7ec08e97e7b9af663a3cb66e1d788",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All studies using human or animal biospecimens\", \"Category\": \"Biospecimen and Preanalytical Quality\", \"Closely Related Metrics\": \"Hemolysis Burden; Icterus Interference; RNA Integrity\", \"Common Misinterpretations\": \"Treating lipemia burden as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Lipemia Burden\", \"References or Origin\": \"https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"BRISQ; ISO 15189; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of lipemia burden.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses lipemia burden using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in lipemia burden can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 77"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000346",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000346"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/353"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Pharmacodynamic Adequacy"
      }
    },
    {
      "@id": "bemo:BEMO_3100027",
      "@type": "owl:DatatypeProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Time at which an assessment was generated."
      },
      "oboInOwl:id": "BEMO:3100027",
      "rdfs:label": {
        "@language": "en",
        "@value": "assessment timestamp"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000282",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000282"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/289"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Instrument Drift"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000083",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000083"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/90"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Warm Ischemia Control"
      }
    },
    {
      "@id": "bemo:BEMO_4000030",
      "@type": [
        "owl:NamedIndividual",
        "bemo:BEMO_0000402"
      ],
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Controlled BEMO ApprovalStatus value: Rejected."
      },
      "oboInOwl:id": "BEMO:4000030",
      "rdfs:label": {
        "@language": "en",
        "@value": "Rejected"
      },
      "skos:notation": "Rejected"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000086",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000086"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/93"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Causal Identifiability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/280",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 280,
      "bemo:BEMO_3100023": "7222c30713cc035f86bae406549aaf0d4751a919d50ae68b917efd9629244d28",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Site-to-Site Assay Portability; Preanalytical Robustness; Postanalytical Integrity\", \"Common Misinterpretations\": \"Treating batch-effect sensitivity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment.\", \"Metric\": \"Batch-Effect Sensitivity\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of batch-effect sensitivity.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses batch-effect sensitivity using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in batch-effect sensitivity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 280"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000068",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000068"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/75"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Hemolysis Burden"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000267",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000267"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/274"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Accuracy"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/190",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 190,
      "bemo:BEMO_3100023": "98f43a472c5bc9ced611ad7ff89ac485c18a5c20ba0a8428164700738b649f75",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"In vitro, ex vivo, organoid, animal, and preclinical experiments\", \"Category\": \"Experimental Biology and Animal Research\", \"Closely Related Metrics\": \"Experimental Batch Randomization; Negative-Control Performance; Vehicle-Control Validity\", \"Common Misinterpretations\": \"Treating positive-control performance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Positive-Control Performance\", \"References or Origin\": \"https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"ARRIVE 2.0; SYRCLE; OECD\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of positive-control performance.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses positive-control performance using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in positive-control performance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 190"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/311",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 311,
      "bemo:BEMO_3100023": "c10b406fc4ce6db5663280fc4b358cc062cc17f0ce7a593af68a762307815cdc",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Integrated omics, networks, pathways, mechanistic and dynamic systems models\", \"Category\": \"Multi-omics and Systems Biology\", \"Closely Related Metrics\": \"Cross-Omics Replication; Cross-Layer Directional Concordance\", \"Common Misinterpretations\": \"Treating cross-omics integration coherence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Dataset / model / pathway / network / evidence body\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Developing\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Cross-Omics Integration Coherence\", \"References or Origin\": \"https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/\", \"Related Frameworks\": \"Gene Ontology; Reactome; UniProt; GA4GH\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of cross-omics integration coherence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses cross-omics integration coherence using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in cross-omics integration coherence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 311"
    },
    {
      "@id": "bemo:BEMO_4000026",
      "@type": [
        "owl:NamedIndividual",
        "bemo:BEMO_0000402"
      ],
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Controlled BEMO LifecycleStatus value: Obsolete."
      },
      "oboInOwl:id": "BEMO:4000026",
      "rdfs:label": {
        "@language": "en",
        "@value": "Obsolete"
      },
      "skos:notation": "Obsolete"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000079",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000079"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/86"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Storage Temperature Control"
      }
    },
    {
      "@id": "bemo:BEMO_3100030",
      "@type": "owl:DatatypeProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Human-readable validation status."
      },
      "oboInOwl:id": "BEMO:3100030",
      "rdfs:label": {
        "@language": "en",
        "@value": "validation status text"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000285",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000003"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000012"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000013"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000020"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a validated analyte- and method-specific measurement procedure with calibration and quality control."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"unitRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "specimen_or_material; measurement_procedure; calibration_reference; quality_control_results; unit",
      "bemo:BEMO_3100007": "replicate_measurements; environmental_conditions; instrument_version",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Method- and analyte-specific physical units",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000285"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/292"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Limit of Detection"
      }
    },
    {
      "@id": "bemo:BEMO_2000209",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000209",
      "bemo:BEMO_3100022": 216,
      "bemo:BEMO_3100023": "dc35bc0fc74498ddd3acc1a47faf52ec96fba459b80f9800025d1a3d1e674317",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses temporal generalizability using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in temporal generalizability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating temporal generalizability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Clinical, epidemiologic, diagnostic, translational, and population studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; QUADAS-2; CONSORT; STROBE"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000209"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000194"
        },
        {
          "@id": "bemo:BEMO_2000195"
        },
        {
          "@id": "bemo:BEMO_2000199"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of temporal generalizability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/216"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000209",
      "rdfs:label": {
        "@language": "en",
        "@value": "Temporal Generalizability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb239"
        },
        {
          "@id": "bemo:BEMO_1100008"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb239",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000209"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000276",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000276"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/283"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Commutability"
      }
    },
    {
      "@id": "bemo:BEMO_1100009",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Category of biomedical evidence metrics concerned with genetics and variant evidence."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:1100009",
      "rdfs:label": {
        "@language": "en",
        "@value": "Genetics and Variant Evidence metric"
      },
      "rdfs:subClassOf": {
        "@id": "bemo:BEMO_1000007"
      }
    },
    {
      "@id": "bemo:BEMO_2000379",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000379",
      "bemo:BEMO_3100022": 386,
      "bemo:BEMO_3100023": "8df86e86625f432ba76b927808300a9cfa4a9b6844cae40ca0c6240f4f899eda",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses proteoform identification confidence using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in proteoform identification confidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating proteoform identification confidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAPE; HUPO PSI; Metabolomics Standards"
      },
      "bemo:BEMO_3200011": "https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000379"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000370"
        },
        {
          "@id": "bemo:BEMO_2000371"
        },
        {
          "@id": "bemo:BEMO_2000376"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The justified degree of certainty assigned to proteoform identification given the quantity, quality, consistency, and limitations of supporting evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/386"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000379",
      "rdfs:label": {
        "@language": "en",
        "@value": "Proteoform Identification Confidence"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb391"
        },
        {
          "@id": "bemo:BEMO_1100014"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb391",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000379"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000125",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000125"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/132"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Partial Area Under the Receiver Operating Characteristic Curve"
      }
    },
    {
      "@id": "bemo:BEMO_2000109",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000109",
      "bemo:BEMO_3100022": 116,
      "bemo:BEMO_3100023": "50677da95ed69c14f1f1ec5786cb5c4d590d6e339c1a13fdedfd18d811ffc8f4",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses unmeasured confounding sensitivity using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in unmeasured confounding sensitivity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Directed acyclic graphs; design emulation; balance diagnostics; negative controls; quantitative bias analysis; sensitivity and falsification analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating unmeasured confounding sensitivity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized and observational etiologic studies, natural experiments, target-trial emulations"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000109"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000095"
        },
        {
          "@id": "bemo:BEMO_2000102"
        },
        {
          "@id": "bemo:BEMO_2000104"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of unmeasured confounding sensitivity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/116"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000109",
      "rdfs:label": {
        "@language": "en",
        "@value": "Unmeasured Confounding Sensitivity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb151"
        },
        {
          "@id": "bemo:BEMO_1100004"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb151",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000109"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000047",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000047",
      "bemo:BEMO_3100022": 54,
      "bemo:BEMO_3100023": "604e83a95f413c6c8ddc8abe7ad03f24c441ede8e65d506baef0410866c23fa7",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses minimal clinically important difference validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in minimal clinically important difference validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating minimal clinically important difference validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Biomarker development, qualification, endpoint and surrogate validation studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; BEST; EMA E16; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000047"
      },
      "bemo:BEMO_3200013": {
        "@id": "bemo:BEMO_2000043"
      },
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which minimal clinically important difference supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/54"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000047",
      "rdfs:label": {
        "@language": "en",
        "@value": "Minimal Clinically Important Difference Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb22"
        },
        {
          "@id": "bemo:BEMO_1100002"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb22",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000047"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000114",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000114",
      "bemo:BEMO_3100022": 121,
      "bemo:BEMO_3100023": "6f322698057cc9561b413498181b8f2503720420a935d144d2173ae5298a3b2f",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses competing-risk model validity using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in competing-risk model validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating competing-risk model validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "QUADAS-2; STARD; TRIPOD; REMARK"
      },
      "bemo:BEMO_3200011": "https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000114"
      },
      "bemo:BEMO_3200013": {
        "@id": "bemo:BEMO_2000137"
      },
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The probability or degree that competing-risk model validity introduces systematic distortion into a biomedical estimate or conclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/121"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000114",
      "rdfs:label": {
        "@language": "en",
        "@value": "Competing-Risk Model Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb27"
        },
        {
          "@id": "bemo:BEMO_1100005"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb27",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000114"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/204",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 204,
      "bemo:BEMO_3100023": "291600cbcf719af0c4e82629e00cccabf1b55b19eff672c1fb6c5c7fe2ec4338",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Clinical, epidemiologic, diagnostic, translational, and population studies\", \"Category\": \"External Validity and Applicability\", \"Closely Related Metrics\": \"Population Representativeness; Sampling Frame Adequacy\", \"Common Misinterpretations\": \"Treating external validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"External Validity\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/\", \"Related Frameworks\": \"GRADE; QUADAS-2; CONSORT; STROBE\", \"Scientific Definition\": \"The degree to which external supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses external validity using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in external validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 204"
    },
    {
      "@id": "bemo:BEMO_2000430",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000430",
      "bemo:BEMO_3100022": 437,
      "bemo:BEMO_3100023": "3aaeec4ac26a2a3b26b615c686a2f19768e2153bd9e1e676bdcd1f2ba2812fc8",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses reproducibility information completeness using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in reproducibility information completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating reproducibility information completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Study report / dataset / evidence package"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All biomedical study reports and data releases"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000430"
      },
      "bemo:BEMO_3200013": {
        "@id": "bemo:BEMO_2000411"
      },
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which all scientifically necessary components of reproducibility information are present, documented, and evaluable."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/437"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000430",
      "rdfs:label": {
        "@language": "en",
        "@value": "Reproducibility Information Completeness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb50"
        },
        {
          "@id": "bemo:BEMO_1100016"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb50",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000430"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000269",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000269"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/276"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Analytical Precision"
      }
    },
    {
      "@id": "bemo:BEMO_4000017",
      "@type": [
        "owl:NamedIndividual",
        "bemo:BEMO_0000402"
      ],
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Controlled BEMO ComputationReadinessStatus value: TemplateComputable."
      },
      "oboInOwl:id": "BEMO:4000017",
      "rdfs:label": {
        "@language": "en",
        "@value": "Template Computable"
      },
      "skos:notation": "TemplateComputable"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000026",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000026"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/33"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Temporal Biological Concordance"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000303",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000303"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/310"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Cross-Layer Directional Concordance"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000375",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000375"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/382"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Peptide-Spectrum Match Quality"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/97",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 97,
      "bemo:BEMO_3100023": "b11d505f3985b03d1ab78fe50a79558d187aeacc3fabbc39b5dc3da61a0cfbe2",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized and observational etiologic studies, natural experiments, target-trial emulations\", \"Category\": \"Causal Inference\", \"Closely Related Metrics\": \"No-Interference Plausibility; Causal Contrast Clarity; Target Trial Emulation Fidelity\", \"Common Misinterpretations\": \"Treating correct temporal ordering as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Correct Temporal Ordering\", \"References or Origin\": \"https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of correct temporal ordering.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses correct temporal ordering using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in correct temporal ordering can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 97"
    },
    {
      "@id": "bemo:BEMO_2000076",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000076",
      "bemo:BEMO_3100022": 83,
      "bemo:BEMO_3100023": "575df935e8ca0edd1975c05772eaa99f38b63f196b0ee598cef40ebcb4554aaf",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses processing delay control using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in processing delay control can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating processing delay control as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All studies using human or animal biospecimens"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "BRISQ; ISO 15189; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000076"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000058"
        },
        {
          "@id": "bemo:BEMO_2000074"
        },
        {
          "@id": "bemo:BEMO_2000081"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of processing delay control."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/83"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000076",
      "rdfs:label": {
        "@language": "en",
        "@value": "Processing Delay Control"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb121"
        },
        {
          "@id": "bemo:BEMO_1100003"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb121",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000076"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_3100018",
      "@type": "owl:DatatypeProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Whether interval estimation is required."
      },
      "oboInOwl:id": "BEMO:3100018",
      "rdfs:label": {
        "@language": "en",
        "@value": "confidence interval required"
      },
      "rdfs:range": {
        "@id": "xsd:boolean"
      }
    },
    {
      "@id": "bemo:BEMO_2000481",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000481",
      "bemo:BEMO_3100022": 488,
      "bemo:BEMO_3100023": "67d1ca80d7087e3cfba7c1c9f64d45d3f4094887ac27aef09ef61bfb6d49d732",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses performance bias risk using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in performance bias risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating performance bias risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000481"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000465"
        },
        {
          "@id": "bemo:BEMO_2000467"
        },
        {
          "@id": "bemo:BEMO_2000474"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The probability or degree that performance bias introduces systematic distortion into a biomedical estimate or conclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/488"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000481",
      "rdfs:label": {
        "@language": "en",
        "@value": "Performance Bias Risk"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb482"
        },
        {
          "@id": "bemo:BEMO_1100018"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb482",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000481"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/281",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 281,
      "bemo:BEMO_3100023": "7d6efe540a48fdb6c1d86b381d867ad016fd03d3ba3039e34ba0dd8d59bcbf8d",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Hook Effect Risk; Reference Interval Validity; Cutoff Validity\", \"Common Misinterpretations\": \"Treating calibration traceability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Calibration Traceability\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of calibration traceability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses calibration traceability using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in calibration traceability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 281"
    },
    {
      "@id": "bemo:BEMO_2000107",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000107",
      "bemo:BEMO_3100022": 114,
      "bemo:BEMO_3100023": "7a907a8dc4fe2c40df0aa3c333c85c8e7231c1e33d26321171335bcd3464b6a6",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses target trial emulation fidelity using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in target trial emulation fidelity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating target trial emulation fidelity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized and observational etiologic studies, natural experiments, target-trial emulations"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000107"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000085"
        },
        {
          "@id": "bemo:BEMO_2000098"
        },
        {
          "@id": "bemo:BEMO_2000100"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of target trial emulation fidelity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/114"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000107",
      "rdfs:label": {
        "@language": "en",
        "@value": "Target Trial Emulation Fidelity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb149"
        },
        {
          "@id": "bemo:BEMO_1100004"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb149",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000107"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/270",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 270,
      "bemo:BEMO_3100023": "e61d8e9d42dcb8b644bc33652bdf4f396f77ace1c2d848fb684d0c722e5a1598",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies\", \"Category\": \"Genomics and Transcriptomics\", \"Closely Related Metrics\": \"Cell-Type Annotation Confidence; Cross-Platform Genomic Concordance\", \"Common Misinterpretations\": \"Treating spatial transcriptomic registration accuracy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Spatial Transcriptomic Registration Accuracy\", \"References or Origin\": \"https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/\", \"Related Frameworks\": \"MIAME; MINSEQE; STROBE-ME; GA4GH; HCA\", \"Scientific Definition\": \"The closeness of spatial transcriptomic registration to the accepted reference or true value.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses spatial transcriptomic registration accuracy using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in spatial transcriptomic registration accuracy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 270"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/382",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 382,
      "bemo:BEMO_3100023": "69f7898b8265a7daaa45bd90d4d5387c92da6521721d3c4901a5c208a63f0169",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies\", \"Category\": \"Proteomics and Metabolomics\", \"Closely Related Metrics\": \"False Discovery Rate Control; Protein Inference Reliability; Proteome Coverage\", \"Common Misinterpretations\": \"Treating peptide-spectrum match quality as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Peptide-Spectrum Match Quality\", \"References or Origin\": \"https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/\", \"Related Frameworks\": \"MIAPE; HUPO PSI; Metabolomics Standards\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of peptide-spectrum match quality.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Target-decoy analysis; spectral scoring; reference standards; replicate injections; retention-time and mass-error monitoring; orthogonal confirmation.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses peptide-spectrum match quality using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in peptide-spectrum match quality can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 382"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000176",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000176"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/183"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Experimental Unit Validity"
      }
    },
    {
      "@id": "bemo:BEMO_3000002",
      "@type": "owl:ObjectProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Connects a metric assessment to the metric used."
      },
      "oboInOwl:id": "BEMO:3000002",
      "rdfs:domain": {
        "@id": "bemo:BEMO_0000200"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "uses metric"
      },
      "rdfs:range": {
        "@id": "bemo:BEMO_0000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000179",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000179"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/186"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Humane Endpoint Appropriateness"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000306",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000306"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/313"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Dynamical Stability"
      }
    },
    {
      "@id": "bemo:BEMO_2000258",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000258",
      "bemo:BEMO_3100022": 265,
      "bemo:BEMO_3100023": "897b2797d8e6449a88906be71f955c7726607e3b28833aef8661c12a890476a4",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses sex concordance using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in sex concordance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating sex concordance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAME; MINSEQE; STROBE-ME; GA4GH; HCA"
      },
      "bemo:BEMO_3200011": "https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000258"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000247"
        },
        {
          "@id": "bemo:BEMO_2000256"
        },
        {
          "@id": "bemo:BEMO_2000266"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree of agreement in sex across measurements, studies, methods, populations, or biological levels."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/265"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000258",
      "rdfs:label": {
        "@language": "en",
        "@value": "Sex Concordance"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb282"
        },
        {
          "@id": "bemo:BEMO_1100010"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb282",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000258"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/67",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 67,
      "bemo:BEMO_3100023": "c859051c1fe5f3cb60cda0bb4dcf804459be135ee18bb1bb44d89345dea50253",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All studies using human or animal biospecimens\", \"Category\": \"Biospecimen and Preanalytical Quality\", \"Closely Related Metrics\": \"Biospecimen Integrity; Collection Procedure Consistency; Warm Ischemia Control\", \"Common Misinterpretations\": \"Treating biospecimen provenance completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Biospecimen Provenance Completeness\", \"References or Origin\": \"https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"BRISQ; ISO 15189; REMARK\", \"Scientific Definition\": \"The extent to which all scientifically necessary components of biospecimen provenance are present, documented, and evaluable.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses biospecimen provenance completeness using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in biospecimen provenance completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 67"
    },
    {
      "@id": "bemo:BEMO_2000339",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000339",
      "bemo:BEMO_3100022": 346,
      "bemo:BEMO_3100023": "32b4aadfeeab004a7a018b1fe09f04f0b2283eb92e7749123f8ac828db8cfce6",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses human-relevance of toxicological evidence using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in human-relevance of toxicological evidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating human-relevance of toxicological evidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "OECD; OHAT; FDA Biomarker; EMA E16"
      },
      "bemo:BEMO_3200011": "https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000339"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000343"
        },
        {
          "@id": "bemo:BEMO_2000354"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of human-relevance of toxicological evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/346"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000339",
      "rdfs:label": {
        "@language": "en",
        "@value": "Human-Relevance of Toxicological Evidence"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb356"
        },
        {
          "@id": "bemo:BEMO_1100013"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb356",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000339"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/122",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 122,
      "bemo:BEMO_3100023": "a903f03627bce43e756f3c1d10c27c552a53bce0346a40196ea1cd72afe63de0",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies\", \"Category\": \"Diagnostic and Prognostic Evidence\", \"Closely Related Metrics\": \"Negative Likelihood Ratio; Area Under the Receiver Operating Characteristic Curve; Partial Area Under the Receiver Operating Characteristic Curve\", \"Common Misinterpretations\": \"Treating diagnostic odds ratio as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Diagnostic Odds Ratio\", \"References or Origin\": \"https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"QUADAS-2; STARD; TRIPOD; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of diagnostic odds ratio.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Two-by-two tables; binomial confidence intervals; hierarchical diagnostic meta-analysis; threshold and prevalence analyses.\", \"Units or Scale (if applicable)\": \"Ratio scale; null typically 1\", \"What It Measures\": \"Assesses diagnostic odds ratio using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in diagnostic odds ratio can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 122"
    },
    {
      "@id": "bemo:BEMO_2000163",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000163",
      "bemo:BEMO_3100022": 170,
      "bemo:BEMO_3100023": "8c42609174eeba28064b2f75bd158a40f97b17f9cdaa32aed81219eddf87ef89",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses selective nonreporting risk using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in selective nonreporting risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating selective nonreporting risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Systematic reviews, meta-analyses, evidence profiles, guidelines"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; PRISMA; AMSTAR 2; RoB"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000163"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000162"
        },
        {
          "@id": "bemo:BEMO_2000164"
        },
        {
          "@id": "bemo:BEMO_2000165"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The probability or degree that selective nonreporting introduces systematic distortion into a biomedical estimate or conclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/170"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000163",
      "rdfs:label": {
        "@language": "en",
        "@value": "Selective Nonreporting Risk"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb199"
        },
        {
          "@id": "bemo:BEMO_1100006"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb199",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000163"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/440",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 440,
      "bemo:BEMO_3100023": "1d5cbda1b0dc5b30aa8339e6219d08168170bd684f74bf0679b26dd4ece9ead4",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Measurement Error Correction; Discrimination of Statistical Predictions; Decision-Curve Net Benefit\", \"Common Misinterpretations\": \"Treating calibration of statistical predictions as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Calibration of Statistical Predictions\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of calibration of statistical predictions.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses calibration of statistical predictions using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in calibration of statistical predictions can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 440"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/194",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 194,
      "bemo:BEMO_3100023": "93f7de14ca784e8a47e3c6ab351c1e75c21a4c3e26305cfe63e0d4fef2122575",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"In vitro, ex vivo, organoid, animal, and preclinical experiments\", \"Category\": \"Experimental Biology and Animal Research\", \"Closely Related Metrics\": \"Animal Model Predictive Validity; Sex as a Biological Variable Adequacy; Age Appropriateness\", \"Common Misinterpretations\": \"Treating species appropriateness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Species Appropriateness\", \"References or Origin\": \"https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"ARRIVE 2.0; SYRCLE; OECD\", \"Scientific Definition\": \"The extent to which species is sufficient and fit for the stated biomedical inference.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses species appropriateness using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in species appropriateness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 194"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/53",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 53,
      "bemo:BEMO_3100023": "8e195ef346deba393b7a3adaf4c77bfbd949dbf0f057cd9af26312568cb85421",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Biomarker development, qualification, endpoint and surrogate validation studies\", \"Category\": \"Biomarker and Endpoint Validation\", \"Closely Related Metrics\": \"Biomarker Sensitivity to Change; Convergent Validity; Discriminant Validity\", \"Common Misinterpretations\": \"Treating known-groups validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Known-Groups Validity\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"FDA Biomarker; BEST; EMA E16; REMARK\", \"Scientific Definition\": \"The degree to which known-groups supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses known-groups validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in known-groups validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 53"
    },
    {
      "@id": "bemo:BEMO_2000467",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000467",
      "bemo:BEMO_3100022": 474,
      "bemo:BEMO_3100023": "4e84b980ded4e833e93013ba317d5857e2211ad9b612e4b77eb9308cf8244573",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses blinding integrity using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in blinding integrity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating blinding integrity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000467"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000466"
        },
        {
          "@id": "bemo:BEMO_2000474"
        },
        {
          "@id": "bemo:BEMO_2000481"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of blinding integrity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/474"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000467",
      "rdfs:label": {
        "@language": "en",
        "@value": "Blinding Integrity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb469"
        },
        {
          "@id": "bemo:BEMO_1100018"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb469",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000467"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000217",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000217"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/224"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for De Novo Evidence Strength"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/106",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 106,
      "bemo:BEMO_3100023": "b7abd5f34cd2addb34f26d923a9c80b402d8914f57510a7f5fe8c4ed41659c58",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized and observational etiologic studies, natural experiments, target-trial emulations\", \"Category\": \"Causal Inference\", \"Closely Related Metrics\": \"Dechallenge–Rechallenge Support; Effect-Modification Credibility; Collider Bias Risk\", \"Common Misinterpretations\": \"Treating mediation evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Mediation Evidence Strength\", \"References or Origin\": \"https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting mediation evidence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses mediation evidence strength using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in mediation evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 106"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000350",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000350"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/357"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Receptor Occupancy Evidence"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/29",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 29,
      "bemo:BEMO_3100023": "9f3de30fb4252544b664477f26ad879c47cffd18e4a902652a07ca5b9fa59ec2",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Molecular, cellular, animal, translational, pharmacologic, and human studies\", \"Category\": \"Biological Plausibility and Mechanism\", \"Closely Related Metrics\": \"Gain-of-Function Validation; Epistasis Support; Target Engagement Evidence\", \"Common Misinterpretations\": \"Treating rescue experiment support as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Rescue Experiment Support\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"GRADE; FDA Biomarker; ClinGen; OHAT; OECD\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting rescue experiment.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses rescue experiment support using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in rescue experiment support can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 29"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000302",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000302"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/309"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Trueness"
      }
    },
    {
      "@id": "bemo:BEMO_2000399",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000399",
      "bemo:BEMO_3100022": 406,
      "bemo:BEMO_3100023": "b36c4ba0356ae6813b5bb255ebc6934635b0cbf83c44326cfea7019592803c5e",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses method reproducibility using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in method reproducibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating method reproducibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All experimental, computational, clinical, and omics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0"
      },
      "bemo:BEMO_3200011": "https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000399"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000395"
        },
        {
          "@id": "bemo:BEMO_2000397"
        },
        {
          "@id": "bemo:BEMO_2000405"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which method reproducibility yields concordant results under the specified repeated-analysis or repeated-measurement conditions."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/406"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000399",
      "rdfs:label": {
        "@language": "en",
        "@value": "Method Reproducibility"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb409"
        },
        {
          "@id": "bemo:BEMO_1100015"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb409",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000399"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000039",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000039"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/46"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Criterion Validity"
      }
    },
    {
      "@id": "bemo:BEMO_2000103",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000103",
      "bemo:BEMO_3100022": 110,
      "bemo:BEMO_3100023": "7ee1bd197cfd8211ed7ac785b0e49ec8e73324814e415213789e479477f73c74",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses quantitative bias analysis robustness using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in quantitative bias analysis robustness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating quantitative bias analysis robustness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized and observational etiologic studies, natural experiments, target-trial emulations"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000103"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000084"
        },
        {
          "@id": "bemo:BEMO_2000093"
        },
        {
          "@id": "bemo:BEMO_2000106"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of quantitative bias analysis robustness."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/110"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000103",
      "rdfs:label": {
        "@language": "en",
        "@value": "Quantitative Bias Analysis Robustness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb145"
        },
        {
          "@id": "bemo:BEMO_1100004"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb145",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000103"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000421",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000421"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/428"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Outcome Definition Completeness"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000464",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000464"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/471"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Allocation Concealment"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/319",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 319,
      "bemo:BEMO_3100023": "be1e726b2fd3735d5492ec8f375d473b36cbff860abc6d682d2065974c115c50",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Integrated omics, networks, pathways, mechanistic and dynamic systems models\", \"Category\": \"Multi-omics and Systems Biology\", \"Closely Related Metrics\": \"Cross-Layer Directional Concordance; Network Reconstruction Robustness; Network Edge Confidence\", \"Common Misinterpretations\": \"Treating latent-factor stability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Dataset / model / pathway / network / evidence body\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Latent-Factor Stability\", \"References or Origin\": \"https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/\", \"Related Frameworks\": \"Gene Ontology; Reactome; UniProt; GA4GH\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of latent-factor stability.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses latent-factor stability using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in latent-factor stability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 319"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/86",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 86,
      "bemo:BEMO_3100023": "b39a92acfa55bd840331823c88476d9d65ca0179f68f0f37ed8d7677a63d2193",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All studies using human or animal biospecimens\", \"Category\": \"Biospecimen and Preanalytical Quality\", \"Closely Related Metrics\": \"Preservation Adequacy; Freeze–Thaw Burden; Transport Condition Integrity\", \"Common Misinterpretations\": \"Treating storage temperature control as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Storage Temperature Control\", \"References or Origin\": \"https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"BRISQ; ISO 15189; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of storage temperature control.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses storage temperature control using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in storage temperature control can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 86"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000292",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000292"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/299"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Postanalytical Integrity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/341",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 341,
      "bemo:BEMO_3100023": "6d7bafb114f62ee059333139662f0dfa2a0fb0aaab829ac8fcdb03ed2fbd0708",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies\", \"Category\": \"Pharmacology and Toxicology\", \"Closely Related Metrics\": \"Bioavailability; Time–Concentration Profile Adequacy; Metabolite Coverage\", \"Common Misinterpretations\": \"Treating dose proportionality as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Dose Proportionality\", \"References or Origin\": \"https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline\", \"Related Frameworks\": \"OECD; OHAT; FDA Biomarker; EMA E16\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of dose proportionality.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Method- and analyte-specific physical units\", \"What It Measures\": \"Assesses dose proportionality using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in dose proportionality can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 341"
    },
    {
      "@id": "bemo:BEMO_1000008",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Metrics assessing pharmacologic activity, exposure, efficacy, selectivity, and toxicologic evidence."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:1000008",
      "rdfs:label": {
        "@language": "en",
        "@value": "Pharmacology and Toxicology metric"
      },
      "rdfs:subClassOf": {
        "@id": "bemo:BEMO_0000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000067",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000067"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/74"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Freeze–Thaw Burden"
      }
    },
    {
      "@id": "bemo:BEMO_2000381",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000381",
      "bemo:BEMO_3100022": 388,
      "bemo:BEMO_3100023": "5205abd1da59c18e5b7272ce8586c2ec2bee590ad36aa3289ce71f4aa4c17c0b",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses quantification accuracy using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in quantification accuracy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating quantification accuracy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAPE; HUPO PSI; Metabolomics Standards"
      },
      "bemo:BEMO_3200011": "https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000381"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000361"
        },
        {
          "@id": "bemo:BEMO_2000372"
        },
        {
          "@id": "bemo:BEMO_2000382"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The closeness of quantification to the accepted reference or true value."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/388"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000381",
      "rdfs:label": {
        "@language": "en",
        "@value": "Quantification Accuracy"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb393"
        },
        {
          "@id": "bemo:BEMO_1100014"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb393",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000381"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_4000018",
      "@type": [
        "owl:NamedIndividual",
        "bemo:BEMO_0000403"
      ],
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Controlled BEMO FormulaStatus value: ContextSpecificProtocolRequired."
      },
      "oboInOwl:id": "BEMO:4000018",
      "rdfs:label": {
        "@language": "en",
        "@value": "Context Specific Protocol Required"
      },
      "skos:notation": "ContextSpecificProtocolRequired"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000339",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000339"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/346"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Human-Relevance of Toxicological Evidence"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000207",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000207"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/214"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Spectrum Representativeness"
      }
    },
    {
      "@id": "bemo:BEMO_2000280",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000280",
      "bemo:BEMO_3100022": 287,
      "bemo:BEMO_3100023": "41309e5f36c397d08d76621c273137352b099c93484f2a2eca025bcf85ccffdc",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses dynamic range using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in dynamic range can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating dynamic range as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000280"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000279"
        },
        {
          "@id": "bemo:BEMO_2000295"
        },
        {
          "@id": "bemo:BEMO_2000298"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of dynamic range."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/287"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000280",
      "rdfs:label": {
        "@language": "en",
        "@value": "Dynamic Range"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb302"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb302",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000280"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000232",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000232"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/239"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Segregation Evidence Strength"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/196",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 196,
      "bemo:BEMO_3100023": "8f5bd5eed372632eafdff28f1c8035067d4634c207012fb089ff55a67d705176",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"In vitro, ex vivo, organoid, animal, and preclinical experiments\", \"Category\": \"Experimental Biology and Animal Research\", \"Closely Related Metrics\": \"Biological Replicate Adequacy; Sample Size Justification; Randomization in Experimental Allocation\", \"Common Misinterpretations\": \"Treating technical replicate adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Technical Replicate Adequacy\", \"References or Origin\": \"https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"ARRIVE 2.0; SYRCLE; OECD\", \"Scientific Definition\": \"The extent to which technical replicate is sufficient and fit for the stated biomedical inference.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses technical replicate adequacy using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in technical replicate adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 196"
    },
    {
      "@id": "bemo:BEMO_2000098",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000098",
      "bemo:BEMO_3100022": 105,
      "bemo:BEMO_3100023": "e7033f91a59f115f9fba748b04cab66664ac151f4c8d653ea61aa823a8c6cce4",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses instrument validity using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in instrument validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating instrument validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized and observational etiologic studies, natural experiments, target-trial emulations"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000098"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000092"
        },
        {
          "@id": "bemo:BEMO_2000100"
        },
        {
          "@id": "bemo:BEMO_2000107"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which instrument supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/105"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000098",
      "rdfs:label": {
        "@language": "en",
        "@value": "Instrument Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb140"
        },
        {
          "@id": "bemo:BEMO_1100004"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb140",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000098"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000031",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000031"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/38"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Biomarker Responsiveness"
      }
    },
    {
      "@id": "bemo:BEMO_1100008",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Category of biomedical evidence metrics concerned with external validity and applicability."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:1100008",
      "rdfs:label": {
        "@language": "en",
        "@value": "External Validity and Applicability metric"
      },
      "rdfs:subClassOf": {
        "@id": "bemo:BEMO_1000005"
      }
    },
    {
      "@id": "bemo:BEMO_2000406",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000406",
      "bemo:BEMO_3100022": 413,
      "bemo:BEMO_3100023": "290b2551a20c17c23c05ae84270ce7ac2c9d4a43b9817050cdbe8a353ce743ac",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses specification-curve robustness using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in specification-curve robustness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating specification-curve robustness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All experimental, computational, clinical, and omics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0"
      },
      "bemo:BEMO_3200011": "https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000406"
      },
      "bemo:BEMO_3200013": {
        "@id": "bemo:BEMO_2000400"
      },
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Specialized / infrequent",
      "bemo:BEMO_3200020": "Developing",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of specification-curve robustness."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/413"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000406",
      "rdfs:label": {
        "@language": "en",
        "@value": "Specification-Curve Robustness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb48"
        },
        {
          "@id": "bemo:BEMO_1100015"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb48",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000406"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000154",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000154",
      "bemo:BEMO_3100022": 161,
      "bemo:BEMO_3100023": "d0050ec2d0692a0a792ec941fce4c076cf8613142effd9ef06a03cab99fa82fe",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses evidence strength using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Systematic reviews, meta-analyses, evidence profiles, guidelines"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; PRISMA; AMSTAR 2; RoB"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000154"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000144"
        },
        {
          "@id": "bemo:BEMO_2000151"
        },
        {
          "@id": "bemo:BEMO_2000153"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/161"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000154",
      "rdfs:label": {
        "@language": "en",
        "@value": "Evidence Strength"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb192"
        },
        {
          "@id": "bemo:BEMO_1100006"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb192",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000154"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000258",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000258"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/265"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Sex Concordance"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000470",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000470"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/477"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Co-intervention Bias Risk"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/219",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 219,
      "bemo:BEMO_3100023": "a2868c878aff5e68e6f9aeb87fd5a98fd776f1ca106d2e9dbad34a8cc81ecfd8",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mendelian disease, cancer genetics, association, segregation, and functional studies\", \"Category\": \"Genetics and Variant Evidence\", \"Closely Related Metrics\": \"Case-Level Evidence Strength; Functional Variant Evidence; Computational Variant Evidence\", \"Common Misinterpretations\": \"Treating case-control evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Case-Control Evidence Strength\", \"References or Origin\": \"https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/\", \"Related Frameworks\": \"ClinGen; ACMG AMP; STREGA; Gene Ontology\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting case-control evidence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses case-control evidence strength using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in case-control evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 219"
    },
    {
      "@id": "bemo:BEMO_3100010",
      "@type": "owl:DatatypeProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Minimum allowed or expected numeric value."
      },
      "oboInOwl:id": "BEMO:3100010",
      "rdfs:label": {
        "@language": "en",
        "@value": "minimum value"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/226",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 226,
      "bemo:BEMO_3100023": "6530e53b02059e4bfd6465ae64ac385198a560d8a80df4ba701894a8c5cb0975",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mendelian disease, cancer genetics, association, segregation, and functional studies\", \"Category\": \"Genetics and Variant Evidence\", \"Closely Related Metrics\": \"Expressivity Consistency; Phenocopy Risk; Locus Heterogeneity Assessment\", \"Common Misinterpretations\": \"Treating founder-effect assessment as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Founder-Effect Assessment\", \"References or Origin\": \"https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/\", \"Related Frameworks\": \"ClinGen; ACMG AMP; STREGA; Gene Ontology\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of founder-effect assessment.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses founder-effect assessment using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in founder-effect assessment can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 226"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000365",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000365"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/372"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Internal Standard Performance"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/90",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 90,
      "bemo:BEMO_3100023": "293c5ebda3d3695852f06644549a5b920266b83358bf49b383b5d90078fcdde6",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All studies using human or animal biospecimens\", \"Category\": \"Biospecimen and Preanalytical Quality\", \"Closely Related Metrics\": \"Collection Procedure Consistency; Cold Ischemia Control; Time-to-Fixation Adequacy\", \"Common Misinterpretations\": \"Treating warm ischemia control as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Warm Ischemia Control\", \"References or Origin\": \"https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"BRISQ; ISO 15189; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of warm ischemia control.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses warm ischemia control using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in warm ischemia control can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 90"
    },
    {
      "@id": "bemo:BEMO_2000200",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000200",
      "bemo:BEMO_3100022": 207,
      "bemo:BEMO_3100023": "d1cb3929ecc9b0976fba4823cb5a09ca13a634dd6efaa3ee43969eafe3250a95",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses intervention applicability using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in intervention applicability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating intervention applicability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Clinical, epidemiologic, diagnostic, translational, and population studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; QUADAS-2; CONSORT; STROBE"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000200"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000192"
        },
        {
          "@id": "bemo:BEMO_2000201"
        },
        {
          "@id": "bemo:BEMO_2000202"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of intervention applicability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/207"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000200",
      "rdfs:label": {
        "@language": "en",
        "@value": "Intervention Applicability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb232"
        },
        {
          "@id": "bemo:BEMO_1100008"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb232",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000200"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000472",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000472",
      "bemo:BEMO_3100022": 479,
      "bemo:BEMO_3100023": "eed78db6e72161c41f0a51c8bc55e5d20b0d6675373ef1a7bf65b4c5b0dc75c0",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses contamination risk using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in contamination risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating contamination risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000472"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000468"
        },
        {
          "@id": "bemo:BEMO_2000470"
        },
        {
          "@id": "bemo:BEMO_2000483"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The probability or degree that contamination introduces systematic distortion into a biomedical estimate or conclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/479"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000472",
      "rdfs:label": {
        "@language": "en",
        "@value": "Contamination Risk"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb474"
        },
        {
          "@id": "bemo:BEMO_1100018"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb474",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000472"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/162",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 162,
      "bemo:BEMO_3100023": "516f7f59fc37d19455d99f12f79cf9f0baf5cd671807c3364f013a016d7ec68a",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Systematic reviews, meta-analyses, evidence profiles, guidelines\", \"Category\": \"Evidence Certainty and Synthesis\", \"Closely Related Metrics\": \"Evidence Consensus Strength; Evidence Completeness; Evidence Coverage\", \"Common Misinterpretations\": \"Treating evidence sufficiency as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Evidence Sufficiency\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/\", \"Related Frameworks\": \"GRADE; PRISMA; AMSTAR 2; RoB\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of evidence sufficiency.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses evidence sufficiency using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in evidence sufficiency can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 162"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/371",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 371,
      "bemo:BEMO_3100023": "4295f539b87882bc52461f7bd190419d6afdf7864927b9a24efe1e5f65c9fcd7",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies\", \"Category\": \"Proteomics and Metabolomics\", \"Closely Related Metrics\": \"Isotope Pattern Fidelity; Post-Translational Modification Localization Confidence; Proteoform Identification Confidence\", \"Common Misinterpretations\": \"Treating fragmentation spectrum quality as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Fragmentation Spectrum Quality\", \"References or Origin\": \"https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/\", \"Related Frameworks\": \"MIAPE; HUPO PSI; Metabolomics Standards\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of fragmentation spectrum quality.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Target-decoy analysis; spectral scoring; reference standards; replicate injections; retention-time and mass-error monitoring; orthogonal confirmation.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses fragmentation spectrum quality using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in fragmentation spectrum quality can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 371"
    },
    {
      "@id": "bemo:BEMO_2000401",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000401",
      "bemo:BEMO_3100022": 408,
      "bemo:BEMO_3100023": "caa28491bc96ceb6cd2e1c6685b9eb89f21391a6d4502473143986af13cc088b",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses protocol reproducibility using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in protocol reproducibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating protocol reproducibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All experimental, computational, clinical, and omics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0"
      },
      "bemo:BEMO_3200011": "https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000401"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000387"
        },
        {
          "@id": "bemo:BEMO_2000391"
        },
        {
          "@id": "bemo:BEMO_2000398"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which protocol reproducibility yields concordant results under the specified repeated-analysis or repeated-measurement conditions."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/408"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000401",
      "rdfs:label": {
        "@language": "en",
        "@value": "Protocol Reproducibility"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb411"
        },
        {
          "@id": "bemo:BEMO_1100015"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb411",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000401"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000182",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000182"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/189"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Orthogonal Validation"
      }
    },
    {
      "@id": "bemo:BEMO_2000106",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000106",
      "bemo:BEMO_3100022": 113,
      "bemo:BEMO_3100023": "ba5e2bde29a386ccb9cae3afe1f1c9476a350f65371bc1aebd58a3579e6e702c",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses selection-on-survival bias risk using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in selection-on-survival bias risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating selection-on-survival bias risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized and observational etiologic studies, natural experiments, target-trial emulations"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000106"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000093"
        },
        {
          "@id": "bemo:BEMO_2000103"
        },
        {
          "@id": "bemo:BEMO_2000105"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The probability or degree that selection-on-survival bias introduces systematic distortion into a biomedical estimate or conclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/113"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000106",
      "rdfs:label": {
        "@language": "en",
        "@value": "Selection-on-Survival Bias Risk"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb148"
        },
        {
          "@id": "bemo:BEMO_1100004"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb148",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000106"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000034",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000034"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/41"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Clinical Validity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/309",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 309,
      "bemo:BEMO_3100023": "9094cf98fb975c34384185560acacc946dab62ebd8f1815100dcaac099d9df1b",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Accuracy; Analytical Precision; Repeatability\", \"Common Misinterpretations\": \"Treating trueness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Trueness\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of trueness.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses trueness using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in trueness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 309"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000272",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000272"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/279"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Analytical Validity"
      }
    },
    {
      "@id": "bemo:BEMO_4000014",
      "@type": [
        "owl:NamedIndividual",
        "bemo:BEMO_0000402"
      ],
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Controlled BEMO ComputationReadinessStatus value: OperationalDefinitionRequired."
      },
      "oboInOwl:id": "BEMO:4000014",
      "rdfs:label": {
        "@language": "en",
        "@value": "Operational Definition Required"
      },
      "skos:notation": "OperationalDefinitionRequired"
    },
    {
      "@id": "bemo:BEMO_2000170",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000170",
      "bemo:BEMO_3100022": 177,
      "bemo:BEMO_3100023": "bfb6735bf1e0494f94802ec087edc274ccdaea50558f3ea043f6f21ae9210505",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses attrition accounting in animal studies using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in attrition accounting in animal studies can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating attrition accounting in animal studies as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "In vitro, ex vivo, organoid, animal, and preclinical experiments"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ARRIVE 2.0; SYRCLE; OECD"
      },
      "bemo:BEMO_3200011": "https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000170"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000174"
        },
        {
          "@id": "bemo:BEMO_2000175"
        },
        {
          "@id": "bemo:BEMO_2000179"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of attrition accounting in animal studies."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/177"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000170",
      "rdfs:label": {
        "@language": "en",
        "@value": "Attrition Accounting in Animal Studies"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb206"
        },
        {
          "@id": "bemo:BEMO_1100007"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb206",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000170"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/75",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 75,
      "bemo:BEMO_3100023": "1b0946c6b109834d9e6fa6dc5ae7dde1ce95bc65f999a58a3c5a88bc66c6a47c",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All studies using human or animal biospecimens\", \"Category\": \"Biospecimen and Preanalytical Quality\", \"Closely Related Metrics\": \"Necrosis Burden; Lipemia Burden; Icterus Interference\", \"Common Misinterpretations\": \"Treating hemolysis burden as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Hemolysis Burden\", \"References or Origin\": \"https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"BRISQ; ISO 15189; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of hemolysis burden.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses hemolysis burden using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in hemolysis burden can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 75"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/414",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 414,
      "bemo:BEMO_3100023": "d85d4b116984de9e36c9410fc248aae4b536153c50f4651cf7e48c6b558b49eb",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All biomedical study reports and data releases\", \"Category\": \"Research Transparency and Reporting Completeness\", \"Closely Related Metrics\": \"Data-Sharing Transparency; Materials-and-Reagents Reporting Completeness; Metadata Completeness\", \"Common Misinterpretations\": \"Treating code-sharing transparency as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Study report / dataset / evidence package\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Code-Sharing Transparency\", \"References or Origin\": \"https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/\", \"Related Frameworks\": \"EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of code-sharing transparency.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses code-sharing transparency using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in code-sharing transparency can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 414"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/329",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 329,
      "bemo:BEMO_3100023": "d7e323b8eddcaff29fe662695a2fa9bae2a0f04120cfdf422fa3e2d1cd3b117e",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Integrated omics, networks, pathways, mechanistic and dynamic systems models\", \"Category\": \"Multi-omics and Systems Biology\", \"Closely Related Metrics\": \"Module Stability; Pathway Topology Support; Knowledge-Graph Evidence Completeness\", \"Common Misinterpretations\": \"Treating pathway enrichment consistency as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Dataset / model / pathway / network / evidence body\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Pathway Enrichment Consistency\", \"References or Origin\": \"https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/\", \"Related Frameworks\": \"Gene Ontology; Reactome; UniProt; GA4GH\", \"Scientific Definition\": \"The degree of agreement in pathway enrichment across measurements, studies, methods, populations, or biological levels.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses pathway enrichment consistency using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in pathway enrichment consistency can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 329"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000071",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000071"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/78"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Matched-Sample Integrity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/89",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 89,
      "bemo:BEMO_3100023": "e7836bb1f6728d199c8634dbdbf560dae6243a3932920cc82164935a37c9180e",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All studies using human or animal biospecimens\", \"Category\": \"Biospecimen and Preanalytical Quality\", \"Closely Related Metrics\": \"Pathology Confirmation; Cellularity Adequacy; Necrosis Burden\", \"Common Misinterpretations\": \"Treating tumor purity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Tumor Purity\", \"References or Origin\": \"https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"BRISQ; ISO 15189; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of tumor purity.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses tumor purity using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in tumor purity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 89"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/412",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 412,
      "bemo:BEMO_3100023": "60121a2998efa943018d3ff7dd4130d4332ee279da0e8111b650ea175e9dacce",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All experimental, computational, clinical, and omics studies\", \"Category\": \"Reproducibility and Replication\", \"Closely Related Metrics\": \"Method Reproducibility; Inferential Reproducibility; Reanalysis Concordance\", \"Common Misinterpretations\": \"Treating result reproducibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Result Reproducibility\", \"References or Origin\": \"https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines\", \"Related Frameworks\": \"PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0\", \"Scientific Definition\": \"The degree to which result reproducibility yields concordant results under the specified repeated-analysis or repeated-measurement conditions.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses result reproducibility using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in result reproducibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 412"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000468",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000468"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/475"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Carryover Effect Risk"
      }
    },
    {
      "@id": "bemo:BEMO_2000050",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000050",
      "bemo:BEMO_3100022": 57,
      "bemo:BEMO_3100023": "4eb497c772907b7927e32ee929fba9a804b1c75888594041caa61dfab977440a",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses pharmacodynamic biomarker validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in pharmacodynamic biomarker validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating pharmacodynamic biomarker validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Biomarker development, qualification, endpoint and surrogate validation studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; BEST; EMA E16; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000050"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000040"
        },
        {
          "@id": "bemo:BEMO_2000048"
        },
        {
          "@id": "bemo:BEMO_2000054"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which pharmacodynamic biomarker supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/57"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000050",
      "rdfs:label": {
        "@language": "en",
        "@value": "Pharmacodynamic Biomarker Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb98"
        },
        {
          "@id": "bemo:BEMO_1100002"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb98",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000050"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/375",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 375,
      "bemo:BEMO_3100023": "ebb0e828e6a056d20bce6788aee10b743cfcc2fc175a82fd693585711880ff73",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies\", \"Category\": \"Proteomics and Metabolomics\", \"Closely Related Metrics\": \"Retention-Time Stability; Isotope Pattern Fidelity; Fragmentation Spectrum Quality\", \"Common Misinterpretations\": \"Treating mass accuracy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Mass Accuracy\", \"References or Origin\": \"https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/\", \"Related Frameworks\": \"MIAPE; HUPO PSI; Metabolomics Standards\", \"Scientific Definition\": \"The closeness of mass to the accepted reference or true value.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Target-decoy analysis; spectral scoring; reference standards; replicate injections; retention-time and mass-error monitoring; orthogonal confirmation.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses mass accuracy using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in mass accuracy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 375"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/139",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 139,
      "bemo:BEMO_3100023": "c2720768cdf2be8ed6a3b935c205e9cb522ea1c958d036e680eee5e7cba4038e",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies\", \"Category\": \"Diagnostic and Prognostic Evidence\", \"Closely Related Metrics\": \"Prognostic Added Value; Time-Dependent Discrimination; Competing-Risk Model Validity\", \"Common Misinterpretations\": \"Treating prognostic transportability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Prognostic Transportability\", \"References or Origin\": \"https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"QUADAS-2; STARD; TRIPOD; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of prognostic transportability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses prognostic transportability using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in prognostic transportability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 139"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000205",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000205"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/212"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Sampling Frame Adequacy"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000240",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000240"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/247"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Call-Rate Completeness"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/218",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 218,
      "bemo:BEMO_3100023": "2dd4a685750034c6175101f0128d889784cf621fed0cf93a74098e6b4879332b",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mendelian disease, cancer genetics, association, segregation, and functional studies\", \"Category\": \"Genetics and Variant Evidence\", \"Closely Related Metrics\": \"De Novo Evidence Strength; Case-Level Evidence Strength; Case-Control Evidence Strength\", \"Common Misinterpretations\": \"Treating allelic evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Allelic Evidence Strength\", \"References or Origin\": \"https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/\", \"Related Frameworks\": \"ClinGen; ACMG AMP; STREGA; Gene Ontology\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting allelic evidence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"ClinGen/ACMG evidence scoring; pedigree analysis; population databases; case-control data; functional assays; expert-panel review.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses allelic evidence strength using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in allelic evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 218"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/301",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 301,
      "bemo:BEMO_3100023": "66143063e8139ffa9de4cc6fb03a0eb1778bd92be05c901387fc7af071b0e433",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Sample Stability; Instrument Drift; Operator Variability\", \"Common Misinterpretations\": \"Treating reagent lot consistency as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Reagent Lot Consistency\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"The degree of agreement in reagent lot across measurements, studies, methods, populations, or biological levels.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses reagent lot consistency using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in reagent lot consistency can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 301"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/361",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 361,
      "bemo:BEMO_3100023": "f3eb077ab3d21773df18d06eb29c8a11272ed7cbfe8f22da0ffedd8a171bc393",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies\", \"Category\": \"Pharmacology and Toxicology\", \"Closely Related Metrics\": \"Toxicokinetic Concordance; Human-Relevance of Toxicological Evidence; Mixture Interaction Assessment\", \"Common Misinterpretations\": \"Treating species extrapolation validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Species Extrapolation Validity\", \"References or Origin\": \"https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline\", \"Related Frameworks\": \"OECD; OHAT; FDA Biomarker; EMA E16\", \"Scientific Definition\": \"The degree to which species extrapolation supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses species extrapolation validity using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in species extrapolation validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 361"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/113",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 113,
      "bemo:BEMO_3100023": "ba5e2bde29a386ccb9cae3afe1f1c9476a350f65371bc1aebd58a3579e6e702c",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized and observational etiologic studies, natural experiments, target-trial emulations\", \"Category\": \"Causal Inference\", \"Closely Related Metrics\": \"Reverse-Causation Risk; Quantitative Bias Analysis Robustness; E-value Strength\", \"Common Misinterpretations\": \"Treating selection-on-survival bias risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Selection-on-Survival Bias Risk\", \"References or Origin\": \"https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9\", \"Scientific Definition\": \"The probability or degree that selection-on-survival bias introduces systematic distortion into a biomedical estimate or conclusion.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses selection-on-survival bias risk using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in selection-on-survival bias risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 113"
    },
    {
      "@id": "bemo:BEMO_2000164",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000164",
      "bemo:BEMO_3100022": 171,
      "bemo:BEMO_3100023": "ec5ee159f748d5035209ae456b71092c6724bc73af9b720bf70afe3ffc41f242",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses small-study effects using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in small-study effects can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Forest plots; heterogeneity statistics; tau-squared; prediction intervals; funnel plots; regression or selection models; sensitivity analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating small-study effects as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Systematic reviews, meta-analyses, evidence profiles, guidelines"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; PRISMA; AMSTAR 2; RoB"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000164"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000139"
        },
        {
          "@id": "bemo:BEMO_2000163"
        },
        {
          "@id": "bemo:BEMO_2000165"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of small-study effects."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/171"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000164",
      "rdfs:label": {
        "@language": "en",
        "@value": "Small-Study Effects"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb200"
        },
        {
          "@id": "bemo:BEMO_1100006"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb200",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000164"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000296",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000296"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/303"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Reference Interval Validity"
      }
    },
    {
      "@id": "bemo:BEMO_2000248",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000248",
      "bemo:BEMO_3100022": 255,
      "bemo:BEMO_3100023": "158d6abc0d325612b86f33eeb0aa8e0dbdfd4460dc9c1934f90601f28ed25284",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses hardy–weinberg equilibrium compatibility using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in hardy–weinberg equilibrium compatibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating hardy–weinberg equilibrium compatibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAME; MINSEQE; STROBE-ME; GA4GH; HCA"
      },
      "bemo:BEMO_3200011": "https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000248"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000239"
        },
        {
          "@id": "bemo:BEMO_2000240"
        },
        {
          "@id": "bemo:BEMO_2000252"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of hardy–weinberg equilibrium compatibility."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/255"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000248",
      "rdfs:label": {
        "@language": "en",
        "@value": "Hardy–Weinberg Equilibrium Compatibility"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb273"
        },
        {
          "@id": "bemo:BEMO_1100010"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb273",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000248"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/339",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 339,
      "bemo:BEMO_3100023": "a171459b41fd9ad0436588a80669a48227118c77c3d87194654b56ab6dfa6ad7",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies\", \"Category\": \"Pharmacology and Toxicology\", \"Closely Related Metrics\": \"Genotoxicity Evidence Strength; Reproductive Toxicity Evidence Strength; Developmental Toxicity Evidence Strength\", \"Common Misinterpretations\": \"Treating carcinogenicity evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Carcinogenicity Evidence Strength\", \"References or Origin\": \"https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline\", \"Related Frameworks\": \"OECD; OHAT; FDA Biomarker; EMA E16\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting carcinogenicity evidence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses carcinogenicity evidence strength using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in carcinogenicity evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 339"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000093",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000005"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000009"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator; the null value is typically 1 where scientifically applicable"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator != 0\"],\"null_value\":1}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "confidence_level; stratum",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Ratio scale; null typically 1",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100012": "1",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Not generally required unless converted to a probability or score."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Developing; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000093"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/100"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for E-value Strength"
      }
    },
    {
      "@id": "bemo:BEMO_2000126",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000126",
      "bemo:BEMO_3100022": 133,
      "bemo:BEMO_3100023": "67544e05c38d184f5e9fa9830136b1408e7835e115b1fa9c54147ad65e14b99c",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses patient flow integrity using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in patient flow integrity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating patient flow integrity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "QUADAS-2; STARD; TRIPOD; REMARK"
      },
      "bemo:BEMO_3200011": "https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000126"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000113"
        },
        {
          "@id": "bemo:BEMO_2000119"
        },
        {
          "@id": "bemo:BEMO_2000135"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of patient flow integrity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/133"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000126",
      "rdfs:label": {
        "@language": "en",
        "@value": "Patient Flow Integrity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb165"
        },
        {
          "@id": "bemo:BEMO_1100005"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb165",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000126"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000149",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000149"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/156"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Evidence Freshness"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/336",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 336,
      "bemo:BEMO_3100023": "8935703e7b30761e4213b86ddafc1aecae0696f4523a201860d9e64493990a74",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies\", \"Category\": \"Pharmacology and Toxicology\", \"Closely Related Metrics\": \"Toxicological Mode-of-Action Support; Organ-Specific Toxicity Evidence; Genotoxicity Evidence Strength\", \"Common Misinterpretations\": \"Treating adverse outcome pathway support as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Adverse Outcome Pathway Support\", \"References or Origin\": \"https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline\", \"Related Frameworks\": \"OECD; OHAT; FDA Biomarker; EMA E16\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting adverse outcome pathway.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses adverse outcome pathway support using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in adverse outcome pathway support can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 336"
    },
    {
      "@id": "bemo:BEMO_2000113",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000113",
      "bemo:BEMO_3100022": 120,
      "bemo:BEMO_3100023": "01f4b65430acfaca391e550bb1550450d424a1dd47aebe4ed0f6dd9d60fe28ab",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses comparative test accuracy using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in comparative test accuracy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating comparative test accuracy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "QUADAS-2; STARD; TRIPOD; REMARK"
      },
      "bemo:BEMO_3200011": "https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000113"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000120"
        },
        {
          "@id": "bemo:BEMO_2000133"
        },
        {
          "@id": "bemo:BEMO_2000135"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The closeness of comparative test to the accepted reference or true value."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/120"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000113",
      "rdfs:label": {
        "@language": "en",
        "@value": "Comparative Test Accuracy"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb155"
        },
        {
          "@id": "bemo:BEMO_1100005"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb155",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000113"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000372",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000372",
      "bemo:BEMO_3100022": 379,
      "bemo:BEMO_3100023": "770bd2fa8c1eedf14831e8e8caca6d53a1ad4a7b7272433891be0eac41a4e30c",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses missing-value burden using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in missing-value burden can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating missing-value burden as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAPE; HUPO PSI; Metabolomics Standards"
      },
      "bemo:BEMO_3200011": "https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000372"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000361"
        },
        {
          "@id": "bemo:BEMO_2000366"
        },
        {
          "@id": "bemo:BEMO_2000383"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of missing-value burden."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/379"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000372",
      "rdfs:label": {
        "@language": "en",
        "@value": "Missing-Value Burden"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb386"
        },
        {
          "@id": "bemo:BEMO_1100014"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb386",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000372"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000190",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000190",
      "bemo:BEMO_3100022": 197,
      "bemo:BEMO_3100023": "b1aee501d417f186bec79f011141586c66408c5b9c272dd6db3a4fa3a34f419d",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses vehicle-control validity using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in vehicle-control validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating vehicle-control validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "In vitro, ex vivo, organoid, animal, and preclinical experiments"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ARRIVE 2.0; SYRCLE; OECD"
      },
      "bemo:BEMO_3200011": "https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000190"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000181"
        },
        {
          "@id": "bemo:BEMO_2000182"
        },
        {
          "@id": "bemo:BEMO_2000188"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which vehicle-control supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/197"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000190",
      "rdfs:label": {
        "@language": "en",
        "@value": "Vehicle-Control Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb223"
        },
        {
          "@id": "bemo:BEMO_1100007"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb223",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000190"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000174",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000174",
      "bemo:BEMO_3100022": 181,
      "bemo:BEMO_3100023": "9718ea523adf00e3cd776b8e22423abc28cf080bd659786c7568ddd524ab9208",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses exclusion-criteria prespecification using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in exclusion-criteria prespecification can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating exclusion-criteria prespecification as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "In vitro, ex vivo, organoid, animal, and preclinical experiments"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ARRIVE 2.0; SYRCLE; OECD"
      },
      "bemo:BEMO_3200011": "https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000174"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000170"
        },
        {
          "@id": "bemo:BEMO_2000175"
        },
        {
          "@id": "bemo:BEMO_2000183"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of exclusion-criteria prespecification."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/181"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000174",
      "rdfs:label": {
        "@language": "en",
        "@value": "Exclusion-Criteria Prespecification"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb209"
        },
        {
          "@id": "bemo:BEMO_1100007"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb209",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000174"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/92",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 92,
      "bemo:BEMO_3100023": "d81e7f98cb339c656ef93d3243144295a2c872dc2bcb50f64863414984f27993",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized and observational etiologic studies, natural experiments, target-trial emulations\", \"Category\": \"Causal Inference\", \"Closely Related Metrics\": \"Correct Temporal Ordering; Target Trial Emulation Fidelity; Instrument Validity\", \"Common Misinterpretations\": \"Treating causal contrast clarity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Causal Contrast Clarity\", \"References or Origin\": \"https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of causal contrast clarity.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Directed acyclic graphs; design emulation; balance diagnostics; negative controls; quantitative bias analysis; sensitivity and falsification analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses causal contrast clarity using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in causal contrast clarity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 92"
    },
    {
      "@id": "bemo:BEMO_2000314",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000314",
      "bemo:BEMO_3100022": 321,
      "bemo:BEMO_3100023": "191acd0c1abb112365dc2e82b9a1c639642c0798eb52983d078ac92e3f0fbeec",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses module stability using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in module stability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating module stability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Dataset / model / pathway / network / evidence body"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Integrated omics, networks, pathways, mechanistic and dynamic systems models"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "Gene Ontology; Reactome; UniProt; GA4GH"
      },
      "bemo:BEMO_3200011": "https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000314"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000316"
        },
        {
          "@id": "bemo:BEMO_2000322"
        },
        {
          "@id": "bemo:BEMO_2000323"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of module stability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/321"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000314",
      "rdfs:label": {
        "@language": "en",
        "@value": "Module Stability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb332"
        },
        {
          "@id": "bemo:BEMO_1100012"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb332",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000314"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/183",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 183,
      "bemo:BEMO_3100023": "3d08eaaab51eb4d1095b9fb5e884110ba36de86e61615acc1661c581f985a6b1",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"In vitro, ex vivo, organoid, animal, and preclinical experiments\", \"Category\": \"Experimental Biology and Animal Research\", \"Closely Related Metrics\": \"Biological Replicate Adequacy; Technical Replicate Adequacy\", \"Common Misinterpretations\": \"Treating experimental unit validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Experimental Unit Validity\", \"References or Origin\": \"https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"ARRIVE 2.0; SYRCLE; OECD\", \"Scientific Definition\": \"The degree to which experimental unit supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses experimental unit validity using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in experimental unit validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 183"
    },
    {
      "@id": "bemo:BEMO_2000024",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000024",
      "bemo:BEMO_3100022": 31,
      "bemo:BEMO_3100023": "07df8f6070c405006e36806e8ccb515126dc2c7269ea9cf3934662d28e9264c6",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses systems-level emergence support using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in systems-level emergence support can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating systems-level emergence support as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Molecular, cellular, animal, translational, pharmacologic, and human studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; FDA Biomarker; ClinGen; OHAT; OECD"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000024"
      },
      "bemo:BEMO_3200013": {
        "@id": "bemo:BEMO_2000016"
      },
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting systems-level emergence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/31"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000024",
      "rdfs:label": {
        "@language": "en",
        "@value": "Systems-Level Emergence Support"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb20"
        },
        {
          "@id": "bemo:BEMO_1100001"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb20",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000024"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000326",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000326",
      "bemo:BEMO_3100022": 333,
      "bemo:BEMO_3100023": "9009911ac3f6266273d49aa664b528314dd25468ab2969a5c3dfb8593502a99c",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses relation evidence strength using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in relation evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating relation evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Dataset / model / pathway / network / evidence body"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Integrated omics, networks, pathways, mechanistic and dynamic systems models"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "Gene Ontology; Reactome; UniProt; GA4GH"
      },
      "bemo:BEMO_3200011": "https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000326"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000308"
        },
        {
          "@id": "bemo:BEMO_2000318"
        },
        {
          "@id": "bemo:BEMO_2000319"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting relation evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/333"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000326",
      "rdfs:label": {
        "@language": "en",
        "@value": "Relation Evidence Strength"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb344"
        },
        {
          "@id": "bemo:BEMO_1100012"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb344",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000326"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000012",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000012"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/19"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Mechanistic Coverage"
      }
    },
    {
      "@id": "bemo:BEMO_2000393",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000393",
      "bemo:BEMO_3100022": 400,
      "bemo:BEMO_3100023": "6c9d1f649c85d73c0009300283cb79e817b0ca9b1d53444f1a4aa4b5a2e6d8ae",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses experimental reproducibility using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in experimental reproducibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating experimental reproducibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All experimental, computational, clinical, and omics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0"
      },
      "bemo:BEMO_3200011": "https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000393"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000388"
        },
        {
          "@id": "bemo:BEMO_2000396"
        },
        {
          "@id": "bemo:BEMO_2000397"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which experimental reproducibility yields concordant results under the specified repeated-analysis or repeated-measurement conditions."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/400"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000393",
      "rdfs:label": {
        "@language": "en",
        "@value": "Experimental Reproducibility"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb404"
        },
        {
          "@id": "bemo:BEMO_1100015"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb404",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000393"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000342",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000342"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/349"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Metabolite Coverage"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000316",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000316"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/323"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Network Node Confidence"
      }
    },
    {
      "@id": "bemo:BEMO_0000104",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "An information content entity documenting validation design, benchmark, results, scope, and status for a metric or computation profile."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:0000104",
      "rdfs:label": {
        "@language": "en",
        "@value": "metric validation record"
      },
      "rdfs:subClassOf": {
        "@id": "obo:IAO_0000030"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/293",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 293,
      "bemo:BEMO_3100023": "e110a21f976b308d8a01ff42efac55157e3af426e1182c74cf700e2fb4ce3595",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Limit of Detection; Linearity; Analytical Measurement Range\", \"Common Misinterpretations\": \"Treating limit of quantification as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Limit of Quantification\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of limit of quantification.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Replicate dilution series; blank and spiked samples; reference materials; method-comparison studies; predefined CLSI/ISO acceptance criteria.\", \"Units or Scale (if applicable)\": \"Method- and analyte-specific physical units\", \"What It Measures\": \"Assesses limit of quantification using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in limit of quantification can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 293"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/410",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 410,
      "bemo:BEMO_3100023": "07f0b47b85e307e7887d3c938a89cbcad651d37d8bfa888ea4ce710d25410a29",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All experimental, computational, clinical, and omics studies\", \"Category\": \"Reproducibility and Replication\", \"Closely Related Metrics\": \"Inferential Reproducibility; Data Provenance Completeness; Protocol Reproducibility\", \"Common Misinterpretations\": \"Treating reanalysis concordance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Reanalysis Concordance\", \"References or Origin\": \"https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines\", \"Related Frameworks\": \"PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0\", \"Scientific Definition\": \"The degree of agreement in reanalysis across measurements, studies, methods, populations, or biological levels.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses reanalysis concordance using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in reanalysis concordance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 410"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000121",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000121"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/128"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Index-Test Blinding"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000233",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000233"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/240"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Splicing Evidence Strength"
      }
    },
    {
      "@id": "bemo:BEMO_2000099",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000099",
      "bemo:BEMO_3100022": 106,
      "bemo:BEMO_3100023": "b7abd5f34cd2addb34f26d923a9c80b402d8914f57510a7f5fe8c4ed41659c58",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses mediation evidence strength using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in mediation evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating mediation evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized and observational etiologic studies, natural experiments, target-trial emulations"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000099"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000087"
        },
        {
          "@id": "bemo:BEMO_2000091"
        },
        {
          "@id": "bemo:BEMO_2000094"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting mediation evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/106"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000099",
      "rdfs:label": {
        "@language": "en",
        "@value": "Mediation Evidence Strength"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb141"
        },
        {
          "@id": "bemo:BEMO_1100004"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb141",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000099"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000427",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000427"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/434"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Quality-Control Reporting Completeness"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/425",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 425,
      "bemo:BEMO_3100023": "810e02862dfc4630d6f7a0d7bd830ccd305d847e2d0153cfdb863b68f1c2ece8",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All biomedical study reports and data releases\", \"Category\": \"Research Transparency and Reporting Completeness\", \"Closely Related Metrics\": \"Statistical Methods Reporting Completeness; Funding-Source Transparency; Conflict-of-Interest Transparency\", \"Common Misinterpretations\": \"Treating missing-data reporting completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Study report / dataset / evidence package\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Missing-Data Reporting Completeness\", \"References or Origin\": \"https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/\", \"Related Frameworks\": \"EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS\", \"Scientific Definition\": \"The extent to which all scientifically necessary components of missing-data reporting are present, documented, and evaluable.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses missing-data reporting completeness using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in missing-data reporting completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 425"
    },
    {
      "@id": "bemo:BEMO_2000156",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000156",
      "bemo:BEMO_3100022": 163,
      "bemo:BEMO_3100023": "b9d887ba211f3aea4699afd087a0aa12fb8ca924209ee34ccda2bfd968c02a4a",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses evidence triangulation strength using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in evidence triangulation strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating evidence triangulation strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Systematic reviews, meta-analyses, evidence profiles, guidelines"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; PRISMA; AMSTAR 2; RoB"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000156"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000140"
        },
        {
          "@id": "bemo:BEMO_2000152"
        },
        {
          "@id": "bemo:BEMO_2000158"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting evidence triangulation."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/163"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000156",
      "rdfs:label": {
        "@language": "en",
        "@value": "Evidence Triangulation Strength"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb194"
        },
        {
          "@id": "bemo:BEMO_1100006"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb194",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000156"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/32",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 32,
      "bemo:BEMO_3100023": "a51c69d24f2bf9ef711f1d3b54d2086032245754bf1992c1b5999a88e3ca185f",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Molecular, cellular, animal, translational, pharmacologic, and human studies\", \"Category\": \"Biological Plausibility and Mechanism\", \"Closely Related Metrics\": \"Epistasis Support; On-Target Specificity; Off-Target Liability Evidence\", \"Common Misinterpretations\": \"Treating target engagement evidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Target Engagement Evidence\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"GRADE; FDA Biomarker; ClinGen; OHAT; OECD\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of target engagement evidence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses target engagement evidence using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in target engagement evidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 32"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/269",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 269,
      "bemo:BEMO_3100023": "faf5bedb35b3c8e6f9b571b29c9788bb087192d600f7d5646da266201f76f5dd",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies\", \"Category\": \"Genomics and Transcriptomics\", \"Closely Related Metrics\": \"Single-Cell Ambient RNA Burden; Single-Cell Feature Detection Rate; Cell-Type Annotation Confidence\", \"Common Misinterpretations\": \"Treating single-cell viability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Single-Cell Viability\", \"References or Origin\": \"https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/\", \"Related Frameworks\": \"MIAME; MINSEQE; STROBE-ME; GA4GH; HCA\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of single-cell viability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses single-cell viability using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in single-cell viability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 269"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000332",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000332"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/339"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Carcinogenicity Evidence Strength"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/243",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 243,
      "bemo:BEMO_3100023": "e63350cbc225389693f86f1ceb6c24e47930b1a6b522574479bcaf1390376503",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mendelian disease, cancer genetics, association, segregation, and functional studies\", \"Category\": \"Genetics and Variant Evidence\", \"Closely Related Metrics\": \"Phenotypic Specificity for Variant; Loss-of-Function Mechanism Validity; Hotspot/Functional-Domain Evidence\", \"Common Misinterpretations\": \"Treating variant phase evidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Variant Phase Evidence\", \"References or Origin\": \"https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/\", \"Related Frameworks\": \"ClinGen; ACMG AMP; STREGA; Gene Ontology\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of variant phase evidence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"ClinGen/ACMG evidence scoring; pedigree analysis; population databases; case-control data; functional assays; expert-panel review.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses variant phase evidence using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in variant phase evidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 243"
    },
    {
      "@id": "bemo:BEMO_2000031",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000031",
      "bemo:BEMO_3100022": 38,
      "bemo:BEMO_3100023": "19a54854b5dfb7168eddad304da95ddbab2e1ad34992146fcedfd650dfe09548",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses biomarker responsiveness using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in biomarker responsiveness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating biomarker responsiveness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Biomarker development, qualification, endpoint and surrogate validation studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; BEST; EMA E16; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000031"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000030"
        },
        {
          "@id": "bemo:BEMO_2000032"
        },
        {
          "@id": "bemo:BEMO_2000046"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of biomarker responsiveness."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/38"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000031",
      "rdfs:label": {
        "@language": "en",
        "@value": "Biomarker Responsiveness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb82"
        },
        {
          "@id": "bemo:BEMO_1100002"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb82",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000031"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000135",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000135"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/142"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Test-Timing Appropriateness"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000058",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000058"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/65"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Anatomical Site Fidelity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000301",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000301"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/308"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Site-to-Site Assay Portability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/263",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 263,
      "bemo:BEMO_3100023": "cf22f061ff0a6f0403c89f061c9c86c0fdc0e5186e885958801878829549f2cd",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies\", \"Category\": \"Genomics and Transcriptomics\", \"Closely Related Metrics\": \"Contamination Burden; Sex Concordance; Variant Call Quality\", \"Common Misinterpretations\": \"Treating sample identity concordance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Sample Identity Concordance\", \"References or Origin\": \"https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/\", \"Related Frameworks\": \"MIAME; MINSEQE; STROBE-ME; GA4GH; HCA\", \"Scientific Definition\": \"The degree of agreement in sample identity across measurements, studies, methods, populations, or biological levels.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses sample identity concordance using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in sample identity concordance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 263"
    },
    {
      "@id": "bemo:BEMO_1000007",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Metrics assessing genetic, genomic, transcriptomic, proteomic, metabolomic, multi-omic, and systems-level evidence."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:1000007",
      "rdfs:label": {
        "@language": "en",
        "@value": "Genetics, Omics, and Systems Biology metric"
      },
      "rdfs:subClassOf": {
        "@id": "bemo:BEMO_0000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000376",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000376"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/383"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Post-Translational Modification Localization Confidence"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/424",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 424,
      "bemo:BEMO_3100023": "cfce2b3ca58f108e1dc5461ad1ef2f5a84b55171c75536d306bf4e1e2b3bc58d",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All biomedical study reports and data releases\", \"Category\": \"Research Transparency and Reporting Completeness\", \"Closely Related Metrics\": \"Materials-and-Reagents Reporting Completeness; Raw-Data Availability; Processed-Data Availability\", \"Common Misinterpretations\": \"Treating metadata completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Study report / dataset / evidence package\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Metadata Completeness\", \"References or Origin\": \"https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/\", \"Related Frameworks\": \"EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS\", \"Scientific Definition\": \"The extent to which all scientifically necessary components of metadata are present, documented, and evaluable.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses metadata completeness using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in metadata completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 424"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000324",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000324"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/331"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Perturbation Prediction Accuracy"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/206",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 206,
      "bemo:BEMO_3100023": "22cb03e816656f6f9ad7a2acb4c32a01ffbc6b40d04a48011cef0a52134d504e",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Clinical, epidemiologic, diagnostic, translational, and population studies\", \"Category\": \"External Validity and Applicability\", \"Closely Related Metrics\": \"Subgroup Consistency; Temporal Generalizability; Demographic Generalizability\", \"Common Misinterpretations\": \"Treating geographic consistency as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Geographic Consistency\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/\", \"Related Frameworks\": \"GRADE; QUADAS-2; CONSORT; STROBE\", \"Scientific Definition\": \"The degree of agreement in geographic across measurements, studies, methods, populations, or biological levels.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses geographic consistency using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in geographic consistency can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 206"
    },
    {
      "@id": "bemo:BEMO_2000359",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000359",
      "bemo:BEMO_3100022": 366,
      "bemo:BEMO_3100023": "447ad3207c1d5333015f6a5189727d810a3a517e4d6a4351f8dc28acbe93a5f0",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses cross-omics concordance using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in cross-omics concordance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating cross-omics concordance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAPE; HUPO PSI; Metabolomics Standards"
      },
      "bemo:BEMO_3200011": "https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000359"
      },
      "bemo:BEMO_3200013": {
        "@id": "bemo:BEMO_2000373"
      },
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Developing",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree of agreement in cross-omics across measurements, studies, methods, populations, or biological levels."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/366"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000359",
      "rdfs:label": {
        "@language": "en",
        "@value": "Cross-Omics Concordance"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb45"
        },
        {
          "@id": "bemo:BEMO_1100014"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb45",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000359"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000076",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000076"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/83"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Processing Delay Control"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000177",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000177"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/184"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Genetic Background Control"
      }
    },
    {
      "@id": "bemo:BEMO_2000360",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000360",
      "bemo:BEMO_3100022": 367,
      "bemo:BEMO_3100023": "d83b78fc8beda508a5c18da8dbb9e284c948a9741d4fb8d070f9f30bc9267827",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses derivatization efficiency using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in derivatization efficiency can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating derivatization efficiency as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAPE; HUPO PSI; Metabolomics Standards"
      },
      "bemo:BEMO_3200011": "https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000360"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000362"
        },
        {
          "@id": "bemo:BEMO_2000369"
        },
        {
          "@id": "bemo:BEMO_2000373"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of derivatization efficiency."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/367"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000360",
      "rdfs:label": {
        "@language": "en",
        "@value": "Derivatization Efficiency"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb374"
        },
        {
          "@id": "bemo:BEMO_1100014"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb374",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000360"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/130",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 130,
      "bemo:BEMO_3100023": "9f42e5362ad2e55445a028ec6d3cc9c062886d8c9272f983b0c1acec345502f7",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies\", \"Category\": \"Diagnostic and Prognostic Evidence\", \"Closely Related Metrics\": \"Positive Predictive Value; Positive Likelihood Ratio; Negative Likelihood Ratio\", \"Common Misinterpretations\": \"Treating negative predictive value as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment.\", \"Metric\": \"Negative Predictive Value\", \"References or Origin\": \"https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"QUADAS-2; STARD; TRIPOD; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of negative predictive value.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Two-by-two tables; binomial confidence intervals; hierarchical diagnostic meta-analysis; threshold and prevalence analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses negative predictive value using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in negative predictive value can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 130"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/46",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 46,
      "bemo:BEMO_3100023": "04af58cc2d88f851cf92e0d1960d29a74b3d8a5cf3525dda9579101a813732b2",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Biomarker development, qualification, endpoint and surrogate validation studies\", \"Category\": \"Biomarker and Endpoint Validation\", \"Closely Related Metrics\": \"Discriminant Validity; Construct Validity; Content Validity\", \"Common Misinterpretations\": \"Treating criterion validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Criterion Validity\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"FDA Biomarker; BEST; EMA E16; REMARK\", \"Scientific Definition\": \"The degree to which criterion supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses criterion validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in criterion validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 46"
    },
    {
      "@id": "bemo:BEMO_2000462",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000462",
      "bemo:BEMO_3100022": 469,
      "bemo:BEMO_3100023": "43a84aea1ea6cc79814a3121476a165954a222aece0c751b1ff5414b40efbe28",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses variance estimation validity using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in variance estimation validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating variance estimation validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000462"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000438"
        },
        {
          "@id": "bemo:BEMO_2000447"
        },
        {
          "@id": "bemo:BEMO_2000448"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which variance estimation supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/469"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000462",
      "rdfs:label": {
        "@language": "en",
        "@value": "Variance Estimation Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb465"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb465",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000462"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_1100003",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Category of biomedical evidence metrics concerned with biospecimen and preanalytical quality."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:1100003",
      "rdfs:label": {
        "@language": "en",
        "@value": "Biospecimen and Preanalytical Quality metric"
      },
      "rdfs:subClassOf": {
        "@id": "bemo:BEMO_1000003"
      }
    },
    {
      "@id": "bemo:BEMO_3100004",
      "@type": "owl:DatatypeProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Language used for a machine-readable formula."
      },
      "oboInOwl:id": "BEMO:3100004",
      "rdfs:label": {
        "@language": "en",
        "@value": "machine formula language"
      }
    },
    {
      "@id": "bemo:BEMO_2000256",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000256",
      "bemo:BEMO_3100022": 263,
      "bemo:BEMO_3100023": "cf22f061ff0a6f0403c89f061c9c86c0fdc0e5186e885958801878829549f2cd",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses sample identity concordance using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in sample identity concordance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating sample identity concordance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAME; MINSEQE; STROBE-ME; GA4GH; HCA"
      },
      "bemo:BEMO_3200011": "https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000256"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000242"
        },
        {
          "@id": "bemo:BEMO_2000258"
        },
        {
          "@id": "bemo:BEMO_2000266"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree of agreement in sample identity across measurements, studies, methods, populations, or biological levels."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/263"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000256",
      "rdfs:label": {
        "@language": "en",
        "@value": "Sample Identity Concordance"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb281"
        },
        {
          "@id": "bemo:BEMO_1100010"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb281",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000256"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_0000105",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "An information content entity documenting ownership, review, approval, lifecycle, version, and change history."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:0000105",
      "rdfs:label": {
        "@language": "en",
        "@value": "metric governance record"
      },
      "rdfs:subClassOf": {
        "@id": "obo:IAO_0000030"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/101",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 101,
      "bemo:BEMO_3100023": "f66521085db07e7bd17f7b93b07cf74e57b1c85461a2555c1146f672069098b2",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized and observational etiologic studies, natural experiments, target-trial emulations\", \"Category\": \"Causal Inference\", \"Closely Related Metrics\": \"Mediation Evidence Strength; Collider Bias Risk; Time-Varying Confounding Control\", \"Common Misinterpretations\": \"Treating effect-modification credibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Effect-Modification Credibility\", \"References or Origin\": \"https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of effect-modification credibility.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses effect-modification credibility using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in effect-modification credibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 101"
    },
    {
      "@id": "bemo:BEMO_2000431",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000431",
      "bemo:BEMO_3100022": 438,
      "bemo:BEMO_3100023": "d8af14618f3e80ecff3b617a35c54caa9b3c73184f234fcea88a9ee83c7090ff",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses statistical methods reporting completeness using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in statistical methods reporting completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating statistical methods reporting completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Study report / dataset / evidence package"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All biomedical study reports and data releases"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000431"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000413"
        },
        {
          "@id": "bemo:BEMO_2000414"
        },
        {
          "@id": "bemo:BEMO_2000418"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which all scientifically necessary components of statistical methods reporting are present, documented, and evaluable."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/438"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000431",
      "rdfs:label": {
        "@language": "en",
        "@value": "Statistical Methods Reporting Completeness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb437"
        },
        {
          "@id": "bemo:BEMO_1100016"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb437",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000431"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/95",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 95,
      "bemo:BEMO_3100023": "cebd58c93ed86b363870e131c5d23217522d15af0abb7eac8956ec81e8515565",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized and observational etiologic studies, natural experiments, target-trial emulations\", \"Category\": \"Causal Inference\", \"Closely Related Metrics\": \"Causal Identifiability; Residual Confounding Risk; Unmeasured Confounding Sensitivity\", \"Common Misinterpretations\": \"Treating confounding risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Confounding Risk\", \"References or Origin\": \"https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9\", \"Scientific Definition\": \"The probability or degree that confounding introduces systematic distortion into a biomedical estimate or conclusion.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Directed acyclic graphs; design emulation; balance diagnostics; negative controls; quantitative bias analysis; sensitivity and falsification analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses confounding risk using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in confounding risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 95"
    },
    {
      "@id": "bemo:BEMO_2000301",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000301",
      "bemo:BEMO_3100022": 308,
      "bemo:BEMO_3100023": "c0e7317023f6c1fc290d021e4b38163503a72ee411cc671fe6aae25ee84d1ee5",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses site-to-site assay portability using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in site-to-site assay portability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating site-to-site assay portability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000301"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000273"
        },
        {
          "@id": "bemo:BEMO_2000291"
        },
        {
          "@id": "bemo:BEMO_2000293"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of site-to-site assay portability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/308"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000301",
      "rdfs:label": {
        "@language": "en",
        "@value": "Site-to-Site Assay Portability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb322"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb322",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000301"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000376",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000376",
      "bemo:BEMO_3100022": 383,
      "bemo:BEMO_3100023": "6761ab89a934b85357a2d58a5e53503065037a8cd658104babdb5536291a3653",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses post-translational modification localization confidence using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in post-translational modification localization confidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating post-translational modification localization confidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAPE; HUPO PSI; Metabolomics Standards"
      },
      "bemo:BEMO_3200011": "https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000376"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000364"
        },
        {
          "@id": "bemo:BEMO_2000371"
        },
        {
          "@id": "bemo:BEMO_2000379"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The justified degree of certainty assigned to post-translational modification localization given the quantity, quality, consistency, and limitations of supporting evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/383"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000376",
      "rdfs:label": {
        "@language": "en",
        "@value": "Post-Translational Modification Localization Confidence"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb389"
        },
        {
          "@id": "bemo:BEMO_1100014"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb389",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000376"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/58",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 58,
      "bemo:BEMO_3100023": "c5c7cbb5b7738940f61731df207186f05f8ae71ecab7ca3c5588c823af8d00eb",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Biomarker development, qualification, endpoint and surrogate validation studies\", \"Category\": \"Biomarker and Endpoint Validation\", \"Closely Related Metrics\": \"Content Validity; Prognostic Biomarker Validity; Diagnostic Biomarker Validity\", \"Common Misinterpretations\": \"Treating predictive biomarker validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Predictive Biomarker Validity\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"FDA Biomarker; BEST; EMA E16; REMARK\", \"Scientific Definition\": \"The degree to which predictive biomarker supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses predictive biomarker validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in predictive biomarker validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 58"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/48",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 48,
      "bemo:BEMO_3100023": "c0e22c7d45b8b17a4c9f1de5c7c7bb4e085d98eb667da8d43e452ea31955900b",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Biomarker development, qualification, endpoint and surrogate validation studies\", \"Category\": \"Biomarker and Endpoint Validation\", \"Closely Related Metrics\": \"Convergent Validity; Criterion Validity; Construct Validity\", \"Common Misinterpretations\": \"Treating discriminant validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Discriminant Validity\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"FDA Biomarker; BEST; EMA E16; REMARK\", \"Scientific Definition\": \"The degree to which discriminant supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses discriminant validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in discriminant validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 48"
    },
    {
      "@id": "bemo:BEMO_2000402",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000402",
      "bemo:BEMO_3100022": 409,
      "bemo:BEMO_3100023": "c1a5a2e956afa3ff1606fb1893282ee7b8d5d3733fbd04798630fe0746f86074",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses random-seed stability using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in random-seed stability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating random-seed stability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All experimental, computational, clinical, and omics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0"
      },
      "bemo:BEMO_3200011": "https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000402"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000390"
        },
        {
          "@id": "bemo:BEMO_2000400"
        },
        {
          "@id": "bemo:BEMO_2000404"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of random-seed stability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/409"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000402",
      "rdfs:label": {
        "@language": "en",
        "@value": "Random-Seed Stability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb412"
        },
        {
          "@id": "bemo:BEMO_1100015"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb412",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000402"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/344",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 344,
      "bemo:BEMO_3100023": "882d0346f9d5903a7e9b6a2b5ae992e9e24bd2be9c7e249168f2f9e157dc0354",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies\", \"Category\": \"Pharmacology and Toxicology\", \"Closely Related Metrics\": \"Pharmacological Target Validity; Pharmacokinetic Adequacy; Pharmacodynamic Adequacy\", \"Common Misinterpretations\": \"Treating exposure–response relationship as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Exposure–Response Relationship\", \"References or Origin\": \"https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline\", \"Related Frameworks\": \"OECD; OHAT; FDA Biomarker; EMA E16\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of exposure–response relationship.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses exposure–response relationship using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in exposure–response relationship can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 344"
    },
    {
      "@id": "bemo:BEMO_2000312",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000312",
      "bemo:BEMO_3100022": 319,
      "bemo:BEMO_3100023": "be1e726b2fd3735d5492ec8f375d473b36cbff860abc6d682d2065974c115c50",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses latent-factor stability using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in latent-factor stability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating latent-factor stability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Dataset / model / pathway / network / evidence body"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Integrated omics, networks, pathways, mechanistic and dynamic systems models"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "Gene Ontology; Reactome; UniProt; GA4GH"
      },
      "bemo:BEMO_3200011": "https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000312"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000303"
        },
        {
          "@id": "bemo:BEMO_2000315"
        },
        {
          "@id": "bemo:BEMO_2000317"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of latent-factor stability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/319"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000312",
      "rdfs:label": {
        "@language": "en",
        "@value": "Latent-Factor Stability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb330"
        },
        {
          "@id": "bemo:BEMO_1100012"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb330",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000312"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000053",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000053"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/60"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Response Biomarker Validity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000192",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000192"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/199"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Comparator Applicability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/325",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 325,
      "bemo:BEMO_3100023": "b8714924720c209e415f9bf2c9aaf707f6bf0edbbbf6ca8da11d2546f9da563d",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Integrated omics, networks, pathways, mechanistic and dynamic systems models\", \"Category\": \"Multi-omics and Systems Biology\", \"Closely Related Metrics\": \"Relation Evidence Strength; Ontology Evidence-Code Strength; Model–Experiment Concordance\", \"Common Misinterpretations\": \"Treating ontology annotation completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Dataset / model / pathway / network / evidence body\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Ontology Annotation Completeness\", \"References or Origin\": \"https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/\", \"Related Frameworks\": \"Gene Ontology; Reactome; UniProt; GA4GH\", \"Scientific Definition\": \"The extent to which all scientifically necessary components of ontology annotation are present, documented, and evaluable.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses ontology annotation completeness using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in ontology annotation completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 325"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000450",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000450"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/457"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Model Specification Adequacy"
      }
    },
    {
      "@id": "bemo:BEMO_2000279",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000279",
      "bemo:BEMO_3100022": 286,
      "bemo:BEMO_3100023": "a31ef0b724223ebc3d1ad0dbe731b0b7823f6b347840ea43769f01a33866757b",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses dilution integrity using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in dilution integrity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating dilution integrity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000279"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000283"
        },
        {
          "@id": "bemo:BEMO_2000288"
        },
        {
          "@id": "bemo:BEMO_2000295"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of dilution integrity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/286"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000279",
      "rdfs:label": {
        "@language": "en",
        "@value": "Dilution Integrity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb301"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb301",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000279"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/157",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 157,
      "bemo:BEMO_3100023": "fed12d9ff25f08fc6db399dc5bed2e8d719fc0db8bcefb33987a3ef3db40f55c",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Systematic reviews, meta-analyses, evidence profiles, guidelines\", \"Category\": \"Evidence Certainty and Synthesis\", \"Closely Related Metrics\": \"Evidence Directness; Evidence Coherence; Evidence Consensus Strength\", \"Common Misinterpretations\": \"Treating evidence precision as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Evidence Precision\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/\", \"Related Frameworks\": \"GRADE; PRISMA; AMSTAR 2; RoB\", \"Scientific Definition\": \"The closeness of repeated estimates or measurements and the narrowness of uncertainty around evidence.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses evidence precision using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in evidence precision can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 157"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000485",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000485"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/492"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Randomization Integrity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000259",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000259"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/266"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Single-Cell Ambient RNA Burden"
      }
    },
    {
      "@id": "bemo:BEMO_1100013",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Category of biomedical evidence metrics concerned with pharmacology and toxicology."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:1100013",
      "rdfs:label": {
        "@language": "en",
        "@value": "Pharmacology and Toxicology metric"
      },
      "rdfs:subClassOf": {
        "@id": "bemo:BEMO_1000008"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/26",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 26,
      "bemo:BEMO_3100023": "a1a0e0a377d9f949a45a0ad0a040b0443e29f24bfe701f3b015420b52cd21ab2",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Molecular, cellular, animal, translational, pharmacologic, and human studies\", \"Category\": \"Biological Plausibility and Mechanism\", \"Closely Related Metrics\": \"Mechanistic Causality Strength; Cell-Type Specificity; Tissue Specificity\", \"Common Misinterpretations\": \"Treating pathway-level support as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Pathway-Level Support\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"GRADE; FDA Biomarker; ClinGen; OHAT; OECD\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting pathway-level.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses pathway-level support using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in pathway-level support can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 26"
    },
    {
      "@id": "bemo:BEMO_2000095",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000095",
      "bemo:BEMO_3100022": 102,
      "bemo:BEMO_3100023": "7f4004986e0cd5fd0b8462346aec167d3be6e60fe67bb8a5838de7a005fd58d1",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses exchangeability plausibility using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in exchangeability plausibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Directed acyclic graphs; design emulation; balance diagnostics; negative controls; quantitative bias analysis; sensitivity and falsification analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating exchangeability plausibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized and observational etiologic studies, natural experiments, target-trial emulations"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000095"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000089"
        },
        {
          "@id": "bemo:BEMO_2000102"
        },
        {
          "@id": "bemo:BEMO_2000109"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of exchangeability plausibility."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/102"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000095",
      "rdfs:label": {
        "@language": "en",
        "@value": "Exchangeability Plausibility"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb138"
        },
        {
          "@id": "bemo:BEMO_1100004"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb138",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000095"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/232",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 232,
      "bemo:BEMO_3100023": "a389d5411c414282451fe5495bf2c1c444f06ae12cd17457edf93df2953dc32e",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mendelian disease, cancer genetics, association, segregation, and functional studies\", \"Category\": \"Genetics and Variant Evidence\", \"Closely Related Metrics\": \"Variant Phase Evidence; Hotspot/Functional-Domain Evidence; Null-Variant Quality\", \"Common Misinterpretations\": \"Treating loss-of-function mechanism validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Loss-of-Function Mechanism Validity\", \"References or Origin\": \"https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/\", \"Related Frameworks\": \"ClinGen; ACMG AMP; STREGA; Gene Ontology\", \"Scientific Definition\": \"The degree to which loss-of-function mechanism supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses loss-of-function mechanism validity using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in loss-of-function mechanism validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 232"
    },
    {
      "@id": "bemo:BEMO_2000039",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000039",
      "bemo:BEMO_3100022": 46,
      "bemo:BEMO_3100023": "04af58cc2d88f851cf92e0d1960d29a74b3d8a5cf3525dda9579101a813732b2",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses criterion validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in criterion validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating criterion validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Biomarker development, qualification, endpoint and surrogate validation studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; BEST; EMA E16; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000039"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000035"
        },
        {
          "@id": "bemo:BEMO_2000036"
        },
        {
          "@id": "bemo:BEMO_2000041"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which criterion supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/46"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000039",
      "rdfs:label": {
        "@language": "en",
        "@value": "Criterion Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb88"
        },
        {
          "@id": "bemo:BEMO_1100002"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb88",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000039"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000282",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000282",
      "bemo:BEMO_3100022": 289,
      "bemo:BEMO_3100023": "39eec82dab659b7826d3bea8f3227e8afeb55e0f15214b02955200cb8a59a8ba",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses instrument drift using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in instrument drift can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating instrument drift as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000282"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000291"
        },
        {
          "@id": "bemo:BEMO_2000294"
        },
        {
          "@id": "bemo:BEMO_2000301"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of instrument drift."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/289"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000282",
      "rdfs:label": {
        "@language": "en",
        "@value": "Instrument Drift"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb304"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb304",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000282"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000208",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000208",
      "bemo:BEMO_3100022": 215,
      "bemo:BEMO_3100023": "26cabc1a909ce4ef7d5d54dc609f85f9fea3829985a8f8573b3da07a3e225f5b",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses subgroup consistency using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in subgroup consistency can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating subgroup consistency as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Clinical, epidemiologic, diagnostic, translational, and population studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; QUADAS-2; CONSORT; STROBE"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000208"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000199"
        },
        {
          "@id": "bemo:BEMO_2000207"
        },
        {
          "@id": "bemo:BEMO_2000209"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree of agreement in subgroup across measurements, studies, methods, populations, or biological levels."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/215"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000208",
      "rdfs:label": {
        "@language": "en",
        "@value": "Subgroup Consistency"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb238"
        },
        {
          "@id": "bemo:BEMO_1100008"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb238",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000208"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000235",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000235"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/242"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Variant Pathogenicity Evidence Strength"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000196",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000196"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/203"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Ecological Validity"
      }
    },
    {
      "@id": "bemo:BEMO_2000358",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000358",
      "bemo:BEMO_3100022": 365,
      "bemo:BEMO_3100023": "05b74bda1c6ce0d8b99d4d0ffdc239f28a207c0631f25d1605f8d1438c74148a",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses toxicological mode-of-action support using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in toxicological mode-of-action support can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating toxicological mode-of-action support as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "OECD; OHAT; FDA Biomarker; EMA E16"
      },
      "bemo:BEMO_3200011": "https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000358"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000329"
        },
        {
          "@id": "bemo:BEMO_2000330"
        },
        {
          "@id": "bemo:BEMO_2000345"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting toxicological mode-of-action."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/365"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000358",
      "rdfs:label": {
        "@language": "en",
        "@value": "Toxicological Mode-of-Action Support"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb373"
        },
        {
          "@id": "bemo:BEMO_1100013"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb373",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000358"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_1000004",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Metrics assessing reproducibility, independent replication, reporting completeness, and research transparency."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:1000004",
      "rdfs:label": {
        "@language": "en",
        "@value": "Reproducibility, Replication, and Research Transparency metric"
      },
      "rdfs:subClassOf": {
        "@id": "bemo:BEMO_0000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/145",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 145,
      "bemo:BEMO_3100023": "2f165758b70b1e482bfb8517e1a69a7d4e05ba84cd41dc36c2f346f991371034",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies\", \"Category\": \"Diagnostic and Prognostic Evidence\", \"Closely Related Metrics\": \"Index-Test Blinding; Differential Verification Bias Risk; Incorporation Bias Risk\", \"Common Misinterpretations\": \"Treating verification bias risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Verification Bias Risk\", \"References or Origin\": \"https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"QUADAS-2; STARD; TRIPOD; REMARK\", \"Scientific Definition\": \"The probability or degree that verification bias introduces systematic distortion into a biomedical estimate or conclusion.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses verification bias risk using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in verification bias risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 145"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/167",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 167,
      "bemo:BEMO_3100023": "31b48110148a1ebdd1379016bfff93898087ec61573fac3b850ccada3e1f7ae5",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Systematic reviews, meta-analyses, evidence profiles, guidelines\", \"Category\": \"Evidence Certainty and Synthesis\", \"Closely Related Metrics\": \"Evidence Quality; Evidence Strength\", \"Common Misinterpretations\": \"Treating overall evidence certainty as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Overall Evidence Certainty\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/\", \"Related Frameworks\": \"GRADE; PRISMA; AMSTAR 2; RoB\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of overall evidence certainty.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses overall evidence certainty using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in overall evidence certainty can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 167"
    },
    {
      "@id": "bemo:BEMO_3200020",
      "@type": "owl:AnnotationProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Source-provided maturity classification."
      },
      "oboInOwl:id": "BEMO:3200020",
      "rdfs:label": {
        "@language": "en",
        "@value": "maturity of metric"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000248",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000248"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/255"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Hardy–Weinberg Equilibrium Compatibility"
      }
    },
    {
      "@id": "bemo:BEMO_2000342",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000342",
      "bemo:BEMO_3100022": 349,
      "bemo:BEMO_3100023": "4bb05358971c228c81cd2238f505b14da043cabfc3f68e3d2dd07884c7f72bc5",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses metabolite coverage using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in metabolite coverage can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Target-decoy analysis; spectral scoring; reference standards; replicate injections; retention-time and mass-error monitoring; orthogonal confirmation."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating metabolite coverage as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "OECD; OHAT; FDA Biomarker; EMA E16"
      },
      "bemo:BEMO_3200011": "https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000342"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000335"
        },
        {
          "@id": "bemo:BEMO_2000350"
        },
        {
          "@id": "bemo:BEMO_2000356"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The proportion and representativeness of the relevant metabolite captured by the evidence or measurement process."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/349"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000342",
      "rdfs:label": {
        "@language": "en",
        "@value": "Metabolite Coverage"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb359"
        },
        {
          "@id": "bemo:BEMO_1100013"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb359",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000342"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/172",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 172,
      "bemo:BEMO_3100023": "93fce0e52f596e9f5e6b6636a82da697803846e686e6144faa894115a270196a",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Systematic reviews, meta-analyses, evidence profiles, guidelines\", \"Category\": \"Evidence Certainty and Synthesis\", \"Closely Related Metrics\": \"Small-Study Effects; Between-Study Variance; Prediction Interval Adequacy\", \"Common Misinterpretations\": \"Treating study heterogeneity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Study Heterogeneity\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/\", \"Related Frameworks\": \"GRADE; PRISMA; AMSTAR 2; RoB\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of study heterogeneity.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Forest plots; heterogeneity statistics; tau-squared; prediction intervals; funnel plots; regression or selection models; sensitivity analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses study heterogeneity using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in study heterogeneity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 172"
    },
    {
      "@id": "bemo:BEMO_2000330",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000330",
      "bemo:BEMO_3100022": 337,
      "bemo:BEMO_3100023": "43d4a4ce7127bc52167a879f611c41413072f25e775dbe7c9446cf4028783b10",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses benchmark dose reliability using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in benchmark dose reliability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating benchmark dose reliability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "OECD; OHAT; FDA Biomarker; EMA E16"
      },
      "bemo:BEMO_3200011": "https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000330"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000329"
        },
        {
          "@id": "bemo:BEMO_2000341"
        },
        {
          "@id": "bemo:BEMO_2000358"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of benchmark dose reliability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/337"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000330",
      "rdfs:label": {
        "@language": "en",
        "@value": "Benchmark Dose Reliability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb348"
        },
        {
          "@id": "bemo:BEMO_1100013"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb348",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000330"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/493",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 493,
      "bemo:BEMO_3100023": "bcdaa5f06df0a5ab7941c490a740787093ffc20f433c48125d9c2e174850f7fd",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies\", \"Category\": \"Study Design and Internal Validity\", \"Closely Related Metrics\": \"Attrition Bias Risk; Protocol Deviation Risk; Contamination Risk\", \"Common Misinterpretations\": \"Treating selective outcome reporting risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Selective Outcome Reporting Risk\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools\", \"Related Frameworks\": \"CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI\", \"Scientific Definition\": \"The probability or degree that selective outcome reporting introduces systematic distortion into a biomedical estimate or conclusion.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses selective outcome reporting risk using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in selective outcome reporting risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 493"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000294",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000294"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/301"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Reagent Lot Consistency"
      }
    },
    {
      "@id": "bemo:BEMO_2000081",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000081",
      "bemo:BEMO_3100022": 88,
      "bemo:BEMO_3100023": "81f1c97831f3ffbcc8b4e89c16604f987d3fa2baac750496d710981c68a60598",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses transport condition integrity using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in transport condition integrity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating transport condition integrity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All studies using human or animal biospecimens"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "BRISQ; ISO 15189; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000081"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000058"
        },
        {
          "@id": "bemo:BEMO_2000067"
        },
        {
          "@id": "bemo:BEMO_2000076"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of transport condition integrity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/88"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000081",
      "rdfs:label": {
        "@language": "en",
        "@value": "Transport Condition Integrity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb126"
        },
        {
          "@id": "bemo:BEMO_1100003"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb126",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000081"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000487",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000487",
      "bemo:BEMO_3100022": 494,
      "bemo:BEMO_3100023": "7f9fb8e0c1ccb555a18bd7b6b07b3173d661a6707fab17a21ee632e59503b393",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses study design appropriateness using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in study design appropriateness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating study design appropriateness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000487"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000480"
        },
        {
          "@id": "bemo:BEMO_2000484"
        },
        {
          "@id": "bemo:BEMO_2000488"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which study design is sufficient and fit for the stated biomedical inference."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/494"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000487",
      "rdfs:label": {
        "@language": "en",
        "@value": "Study Design Appropriateness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb487"
        },
        {
          "@id": "bemo:BEMO_1100018"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb487",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000487"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/362",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 362,
      "bemo:BEMO_3100023": "34f5d4730ddbb7e269fc6713d96c49c0fba2d2f738ddbfb47d339a6ed5f8cf6e",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies\", \"Category\": \"Pharmacology and Toxicology\", \"Closely Related Metrics\": \"Efficacy Reproducibility; Safety Margin Evidence; No-Observed-Adverse-Effect Level Robustness\", \"Common Misinterpretations\": \"Treating therapeutic window evidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Therapeutic Window Evidence\", \"References or Origin\": \"https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline\", \"Related Frameworks\": \"OECD; OHAT; FDA Biomarker; EMA E16\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of therapeutic window evidence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses therapeutic window evidence using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in therapeutic window evidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 362"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/386",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 386,
      "bemo:BEMO_3100023": "8df86e86625f432ba76b927808300a9cfa4a9b6844cae40ca0c6240f4f899eda",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies\", \"Category\": \"Proteomics and Metabolomics\", \"Closely Related Metrics\": \"Post-Translational Modification Localization Confidence; Metabolite Identification Confidence; Metabolite Annotation Level\", \"Common Misinterpretations\": \"Treating proteoform identification confidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Proteoform Identification Confidence\", \"References or Origin\": \"https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/\", \"Related Frameworks\": \"MIAPE; HUPO PSI; Metabolomics Standards\", \"Scientific Definition\": \"The justified degree of certainty assigned to proteoform identification given the quantity, quality, consistency, and limitations of supporting evidence.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses proteoform identification confidence using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in proteoform identification confidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 386"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/427",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 427,
      "bemo:BEMO_3100023": "0e7be34e4db71c86201d878decffa3c8da8ca62a1c8481dc3779d3c4caa454b1",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All biomedical study reports and data releases\", \"Category\": \"Research Transparency and Reporting Completeness\", \"Closely Related Metrics\": \"Negative-Result Reporting; Deviations-from-Protocol Transparency; Reproducibility Information Completeness\", \"Common Misinterpretations\": \"Treating null-result interpretability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Study report / dataset / evidence package\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Null-Result Interpretability\", \"References or Origin\": \"https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/\", \"Related Frameworks\": \"EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of null-result interpretability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses null-result interpretability using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in null-result interpretability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 427"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/123",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 123,
      "bemo:BEMO_3100023": "4ea75714eea731a1e4644a00db0476f8628bf028934f92bd9e4029ee31ddf173",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies\", \"Category\": \"Diagnostic and Prognostic Evidence\", \"Closely Related Metrics\": \"Diagnostic Specificity; Positive Predictive Value\", \"Common Misinterpretations\": \"Treating diagnostic sensitivity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment.\", \"Metric\": \"Diagnostic Sensitivity\", \"References or Origin\": \"https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"QUADAS-2; STARD; TRIPOD; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of diagnostic sensitivity.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Two-by-two tables; binomial confidence intervals; hierarchical diagnostic meta-analysis; threshold and prevalence analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses diagnostic sensitivity using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in diagnostic sensitivity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 123"
    },
    {
      "@id": "bemo:BEMO_2000054",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000054",
      "bemo:BEMO_3100022": 61,
      "bemo:BEMO_3100023": "a6b6c6cf8ada87a1112583df9bc78595f4f0975ec0e8bbfc01ca6f00c2c0adf1",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses safety biomarker validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in safety biomarker validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating safety biomarker validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Biomarker development, qualification, endpoint and surrogate validation studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; BEST; EMA E16; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000054"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000048"
        },
        {
          "@id": "bemo:BEMO_2000053"
        },
        {
          "@id": "bemo:BEMO_2000056"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which safety biomarker supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/61"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000054",
      "rdfs:label": {
        "@language": "en",
        "@value": "Safety Biomarker Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb102"
        },
        {
          "@id": "bemo:BEMO_1100002"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb102",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000054"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_4000008",
      "@type": [
        "owl:NamedIndividual",
        "bemo:BEMO_0000401"
      ],
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Controlled BEMO ComputationMode value: QuantitativeProportionComputation."
      },
      "oboInOwl:id": "BEMO:4000008",
      "rdfs:label": {
        "@language": "en",
        "@value": "Quantitative Proportion Computation"
      },
      "skos:notation": "QuantitativeProportionComputation"
    },
    {
      "@id": "bemo:BEMO_2000357",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000357",
      "bemo:BEMO_3100022": 364,
      "bemo:BEMO_3100023": "6cda2f6cb167ccc21d05523345b2fef382432ceed6ebbcbe84fa383cddc4562e",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses toxicokinetic concordance using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in toxicokinetic concordance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating toxicokinetic concordance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "OECD; OHAT; FDA Biomarker; EMA E16"
      },
      "bemo:BEMO_3200011": "https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000357"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000339"
        },
        {
          "@id": "bemo:BEMO_2000340"
        },
        {
          "@id": "bemo:BEMO_2000354"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree of agreement in toxicokinetic across measurements, studies, methods, populations, or biological levels."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/364"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000357",
      "rdfs:label": {
        "@language": "en",
        "@value": "Toxicokinetic Concordance"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb372"
        },
        {
          "@id": "bemo:BEMO_1100013"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb372",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000357"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000170",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000170"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/177"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Attrition Accounting in Animal Studies"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/187",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 187,
      "bemo:BEMO_3100023": "f4ebc6af400b7084f27d64f43d25beed78acdab6caf4a03c3179cab231054034",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"In vitro, ex vivo, organoid, animal, and preclinical experiments\", \"Category\": \"Experimental Biology and Animal Research\", \"Closely Related Metrics\": \"Environmental Standardization; Humane Endpoint Appropriateness; Attrition Accounting in Animal Studies\", \"Common Misinterpretations\": \"Treating intervention fidelity in animal studies as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Intervention Fidelity in Animal Studies\", \"References or Origin\": \"https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"ARRIVE 2.0; SYRCLE; OECD\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of intervention fidelity in animal studies.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses intervention fidelity in animal studies using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in intervention fidelity in animal studies can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 187"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000414",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000414"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/421"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Harms Reporting Completeness"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/413",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 413,
      "bemo:BEMO_3100023": "290b2551a20c17c23c05ae84270ce7ac2c9d4a43b9817050cdbe8a353ce743ac",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All experimental, computational, clinical, and omics studies\", \"Category\": \"Reproducibility and Replication\", \"Closely Related Metrics\": \"Multiverse Analysis Robustness\", \"Common Misinterpretations\": \"Treating specification-curve robustness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Specialized / infrequent\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Developing\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Specification-Curve Robustness\", \"References or Origin\": \"https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines\", \"Related Frameworks\": \"PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of specification-curve robustness.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses specification-curve robustness using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in specification-curve robustness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 413"
    },
    {
      "@id": "bemo:BEMO_2000065",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000065",
      "bemo:BEMO_3100022": 72,
      "bemo:BEMO_3100023": "494036e6478a34bfe608bc3b1267e04a777d16e96430109ab2ba9b01e99c6693",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses dna integrity using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in dna integrity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating dna integrity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All studies using human or animal biospecimens"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "BRISQ; ISO 15189; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000065"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000072"
        },
        {
          "@id": "bemo:BEMO_2000077"
        },
        {
          "@id": "bemo:BEMO_2000078"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of dna integrity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/72"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000065",
      "rdfs:label": {
        "@language": "en",
        "@value": "DNA Integrity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb111"
        },
        {
          "@id": "bemo:BEMO_1100003"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb111",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000065"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/165",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 165,
      "bemo:BEMO_3100023": "ffec67315125f9639a3601d51e352906c34b1c9847a274942f934888c1188977",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Systematic reviews, meta-analyses, evidence profiles, guidelines\", \"Category\": \"Evidence Certainty and Synthesis\", \"Closely Related Metrics\": \"Counterevidence Strength; Publication Bias Risk; Selective Nonreporting Risk\", \"Common Misinterpretations\": \"Treating missing evidence risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Missing Evidence Risk\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/\", \"Related Frameworks\": \"GRADE; PRISMA; AMSTAR 2; RoB\", \"Scientific Definition\": \"The probability or degree that missing evidence introduces systematic distortion into a biomedical estimate or conclusion.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses missing evidence risk using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in missing evidence risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 165"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/395",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 395,
      "bemo:BEMO_3100023": "c15f070192e578e50deb91384b3e8099e5c4b1a0c28cc84d1ac6a3163d36cd17",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All experimental, computational, clinical, and omics studies\", \"Category\": \"Reproducibility and Replication\", \"Closely Related Metrics\": \"Analytical Reproducibility; Experimental Reproducibility; Interlaboratory Reproducibility\", \"Common Misinterpretations\": \"Treating computational reproducibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Computational Reproducibility\", \"References or Origin\": \"https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines\", \"Related Frameworks\": \"PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0\", \"Scientific Definition\": \"The degree to which computational reproducibility yields concordant results under the specified repeated-analysis or repeated-measurement conditions.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses computational reproducibility using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in computational reproducibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 395"
    },
    {
      "@id": "bemo:BEMO_2000169",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000169",
      "bemo:BEMO_3100022": 176,
      "bemo:BEMO_3100023": "ae7f68af5b958c01b88066cf76664c77d333abaff4414b63760b817bf19359d0",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses animal model predictive validity using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in animal model predictive validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating animal model predictive validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "In vitro, ex vivo, organoid, animal, and preclinical experiments"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ARRIVE 2.0; SYRCLE; OECD"
      },
      "bemo:BEMO_3200011": "https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000169"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000167"
        },
        {
          "@id": "bemo:BEMO_2000186"
        },
        {
          "@id": "bemo:BEMO_2000187"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which animal model predictive supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/176"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000169",
      "rdfs:label": {
        "@language": "en",
        "@value": "Animal Model Predictive Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb205"
        },
        {
          "@id": "bemo:BEMO_1100007"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb205",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000169"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/134",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 134,
      "bemo:BEMO_3100023": "65ab6bc3c7bfa89dbab942e4977888e1ec5d3ea554c360ceffa76f4daab1fd7e",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies\", \"Category\": \"Diagnostic and Prognostic Evidence\", \"Closely Related Metrics\": \"Negative Predictive Value; Negative Likelihood Ratio; Diagnostic Odds Ratio\", \"Common Misinterpretations\": \"Treating positive likelihood ratio as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment.\", \"Metric\": \"Positive Likelihood Ratio\", \"References or Origin\": \"https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"QUADAS-2; STARD; TRIPOD; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of positive likelihood ratio.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Two-by-two tables; binomial confidence intervals; hierarchical diagnostic meta-analysis; threshold and prevalence analyses.\", \"Units or Scale (if applicable)\": \"Ratio scale; null typically 1\", \"What It Measures\": \"Assesses positive likelihood ratio using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in positive likelihood ratio can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 134"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000293",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000293"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/300"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Preanalytical Robustness"
      }
    },
    {
      "@id": "bemo:BEMO_2000105",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000105",
      "bemo:BEMO_3100022": 112,
      "bemo:BEMO_3100023": "17fc4b74f3434a4ae22f908b09530b9a1be33f82af499c89239235d78d7e1375",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses reverse-causation risk using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in reverse-causation risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating reverse-causation risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized and observational etiologic studies, natural experiments, target-trial emulations"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000105"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000097"
        },
        {
          "@id": "bemo:BEMO_2000103"
        },
        {
          "@id": "bemo:BEMO_2000106"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The probability or degree that reverse-causation introduces systematic distortion into a biomedical estimate or conclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/112"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000105",
      "rdfs:label": {
        "@language": "en",
        "@value": "Reverse-Causation Risk"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb147"
        },
        {
          "@id": "bemo:BEMO_1100004"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb147",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000105"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000456",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000456",
      "bemo:BEMO_3100022": 463,
      "bemo:BEMO_3100023": "8a96194c8b8e65d04df266b282704e480656791b819df12c8c4924c984b02272",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses posterior probability strength using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in posterior probability strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating posterior probability strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000456"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000432"
        },
        {
          "@id": "bemo:BEMO_2000440"
        },
        {
          "@id": "bemo:BEMO_2000457"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting posterior probability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/463"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000456",
      "rdfs:label": {
        "@language": "en",
        "@value": "Posterior Probability Strength"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb459"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb459",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000456"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/251",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 251,
      "bemo:BEMO_3100023": "e70802b2991914211c0dcd91213c02319dd673fc93963b9e2064b8bca944c528",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies\", \"Category\": \"Genomics and Transcriptomics\", \"Closely Related Metrics\": \"Relatedness Control; Normalization Adequacy; Transcript Quantification Reliability\", \"Common Misinterpretations\": \"Treating differential expression robustness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Differential Expression Robustness\", \"References or Origin\": \"https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/\", \"Related Frameworks\": \"MIAME; MINSEQE; STROBE-ME; GA4GH; HCA\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of differential expression robustness.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses differential expression robustness using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in differential expression robustness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 251"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000055",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000055"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/62"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Surrogate Endpoint Validity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000156",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000156"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/163"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Evidence Triangulation Strength"
      }
    },
    {
      "@id": "bemo:BEMO_0000400",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A controlled concept describing the scale used by a metric output."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:0000400",
      "rdfs:label": {
        "@language": "en",
        "@value": "scale type"
      },
      "rdfs:subClassOf": {
        "@id": "skos:Concept"
      }
    },
    {
      "@id": "bemo:BEMO_2000139",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000139",
      "bemo:BEMO_3100022": 146,
      "bemo:BEMO_3100023": "167d33dabeef5837833710d7e97d42ff17e46ede74b98e0e88db46e921ff811e",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses between-study variance using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in between-study variance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Forest plots; heterogeneity statistics; tau-squared; prediction intervals; funnel plots; regression or selection models; sensitivity analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating between-study variance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Systematic reviews, meta-analyses, evidence profiles, guidelines"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; PRISMA; AMSTAR 2; RoB"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000139"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000141"
        },
        {
          "@id": "bemo:BEMO_2000161"
        },
        {
          "@id": "bemo:BEMO_2000165"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of between-study variance."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/146"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000139",
      "rdfs:label": {
        "@language": "en",
        "@value": "Between-Study Variance"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb178"
        },
        {
          "@id": "bemo:BEMO_1100006"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb178",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000139"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/248",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 248,
      "bemo:BEMO_3100023": "f7aebc612affb172059739df32608fb7c4d69384f1ff8c565432595eea6b9937",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies\", \"Category\": \"Genomics and Transcriptomics\", \"Closely Related Metrics\": \"Single-Cell Feature Detection Rate; Spatial Transcriptomic Registration Accuracy; Cross-Platform Genomic Concordance\", \"Common Misinterpretations\": \"Treating cell-type annotation confidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Cell-Type Annotation Confidence\", \"References or Origin\": \"https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/\", \"Related Frameworks\": \"MIAME; MINSEQE; STROBE-ME; GA4GH; HCA\", \"Scientific Definition\": \"The justified degree of certainty assigned to cell-type annotation given the quantity, quality, consistency, and limitations of supporting evidence.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses cell-type annotation confidence using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in cell-type annotation confidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 248"
    },
    {
      "@id": "bemo:BEMO_2000374",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000374",
      "bemo:BEMO_3100022": 381,
      "bemo:BEMO_3100023": "7f78eede8aa05781dde3f12d7ea8111e1c0b552f5b722c402b0de5323e65b0ea",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses peptide identification confidence using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in peptide identification confidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Target-decoy analysis; spectral scoring; reference standards; replicate injections; retention-time and mass-error monitoring; orthogonal confirmation."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating peptide identification confidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAPE; HUPO PSI; Metabolomics Standards"
      },
      "bemo:BEMO_3200011": "https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000374"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000363"
        },
        {
          "@id": "bemo:BEMO_2000377"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The justified degree of certainty assigned to peptide identification given the quantity, quality, consistency, and limitations of supporting evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/381"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000374",
      "rdfs:label": {
        "@language": "en",
        "@value": "Peptide Identification Confidence"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb14"
        },
        {
          "@id": "bemo:BEMO_1100014"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb14",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000374"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000487",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000487"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/494"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Study Design Appropriateness"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/275",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 275,
      "bemo:BEMO_3100023": "40562e2bdf0f0c373312aa0a75941fd6a83f056ba5201b300a46242b3f5457df",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Linearity; Reportable Range; Dynamic Range\", \"Common Misinterpretations\": \"Treating analytical measurement range as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Analytical Measurement Range\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of analytical measurement range.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Method- and analyte-specific physical units\", \"What It Measures\": \"Assesses analytical measurement range using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in analytical measurement range can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 275"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000377",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000377"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/384"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Protein Identification Confidence"
      }
    },
    {
      "@id": "bemo:BEMO_3100014",
      "@type": "owl:DatatypeProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Normalization method and version."
      },
      "oboInOwl:id": "BEMO:3100014",
      "rdfs:label": {
        "@language": "en",
        "@value": "normalization method"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/188",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 188,
      "bemo:BEMO_3100023": "0095c2122f8f2e2a2aa6070b8c33f6576321db691574400350300c93ce956830",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"In vitro, ex vivo, organoid, animal, and preclinical experiments\", \"Category\": \"Experimental Biology and Animal Research\", \"Closely Related Metrics\": \"Positive-Control Performance; Vehicle-Control Validity; Orthogonal Validation\", \"Common Misinterpretations\": \"Treating negative-control performance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Negative-Control Performance\", \"References or Origin\": \"https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"ARRIVE 2.0; SYRCLE; OECD\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of negative-control performance.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses negative-control performance using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in negative-control performance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 188"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000318",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000318"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/325"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Ontology Annotation Completeness"
      }
    },
    {
      "@id": "bemo:BEMO_4000023",
      "@type": [
        "owl:NamedIndividual",
        "bemo:BEMO_0000402"
      ],
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Controlled BEMO LifecycleStatus value: Candidate."
      },
      "oboInOwl:id": "BEMO:4000023",
      "rdfs:label": {
        "@language": "en",
        "@value": "Candidate"
      },
      "skos:notation": "Candidate"
    },
    {
      "@id": "bemo:BEMO_3000020",
      "@type": "owl:ObjectProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Connects a metric assessment to the process that generated it."
      },
      "oboInOwl:id": "BEMO:3000020",
      "owl:equivalentProperty": {
        "@id": "prov:wasGeneratedBy"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "generated by computation process"
      },
      "skos:closeMatch": {
        "@id": "prov:wasGeneratedBy"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/117",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 117,
      "bemo:BEMO_3100023": "5c4feaae4c2a565042108ac4cb807678f9be09f3e84e62f596afd3338e3ceec6",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies\", \"Category\": \"Diagnostic and Prognostic Evidence\", \"Closely Related Metrics\": \"Diagnostic Odds Ratio; Partial Area Under the Receiver Operating Characteristic Curve; Threshold Validity\", \"Common Misinterpretations\": \"Treating area under the receiver operating characteristic curve as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Area Under the Receiver Operating Characteristic Curve\", \"References or Origin\": \"https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"QUADAS-2; STARD; TRIPOD; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of area under the receiver operating characteristic curve.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses area under the receiver operating characteristic curve using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in area under the receiver operating characteristic curve can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 117"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/349",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 349,
      "bemo:BEMO_3100023": "4bb05358971c228c81cd2238f505b14da043cabfc3f68e3d2dd07884c7f72bc5",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies\", \"Category\": \"Pharmacology and Toxicology\", \"Closely Related Metrics\": \"Time–Concentration Profile Adequacy; Drug–Drug Interaction Evidence; Receptor Occupancy Evidence\", \"Common Misinterpretations\": \"Treating metabolite coverage as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Metabolite Coverage\", \"References or Origin\": \"https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline\", \"Related Frameworks\": \"OECD; OHAT; FDA Biomarker; EMA E16\", \"Scientific Definition\": \"The proportion and representativeness of the relevant metabolite captured by the evidence or measurement process.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Target-decoy analysis; spectral scoring; reference standards; replicate injections; retention-time and mass-error monitoring; orthogonal confirmation.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses metabolite coverage using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in metabolite coverage can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 349"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/429",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 429,
      "bemo:BEMO_3100023": "c3caaa14ecea68f7075a25ef235cdae89d1a9b9b86ed2b5a30dab5cb5b8bf20d",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All biomedical study reports and data releases\", \"Category\": \"Research Transparency and Reporting Completeness\", \"Closely Related Metrics\": \"Recruitment Reporting Completeness; Harms Reporting Completeness; Statistical Methods Reporting Completeness\", \"Common Misinterpretations\": \"Treating participant flow completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Study report / dataset / evidence package\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Participant Flow Completeness\", \"References or Origin\": \"https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/\", \"Related Frameworks\": \"EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS\", \"Scientific Definition\": \"The extent to which all scientifically necessary components of participant flow are present, documented, and evaluable.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses participant flow completeness using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in participant flow completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 429"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000092",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000003"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000012"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000013"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000020"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a validated analyte- and method-specific measurement procedure with calibration and quality control."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"unitRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "specimen_or_material; measurement_procedure; calibration_reference; quality_control_results; unit",
      "bemo:BEMO_3100007": "replicate_measurements; environmental_conditions; instrument_version",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Method- and analyte-specific physical units",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000092"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/99"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Dose–Response Support"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/118",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 118,
      "bemo:BEMO_3100023": "44bfcfec74d2b98de3507998b5e63f6506912c93210fea4df7a678aed4417a75",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies\", \"Category\": \"Diagnostic and Prognostic Evidence\", \"Closely Related Metrics\": \"Prognostic Calibration; Calibration-in-the-Large; Observed-to-Expected Ratio\", \"Common Misinterpretations\": \"Treating calibration slope as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Calibration Slope\", \"References or Origin\": \"https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"QUADAS-2; STARD; TRIPOD; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of calibration slope.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses calibration slope using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in calibration slope can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 118"
    },
    {
      "@id": "bemo:BEMO_0000202",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "An information content entity asserting a biomedical proposition that may be evaluated using evidence metrics."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:0000202",
      "rdfs:label": {
        "@language": "en",
        "@value": "scientific claim"
      },
      "rdfs:subClassOf": {
        "@id": "obo:IAO_0000030"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000075",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000075"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/82"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Preservation Adequacy"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/388",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 388,
      "bemo:BEMO_3100023": "5205abd1da59c18e5b7272ce8586c2ec2bee590ad36aa3289ce71f4aa4c17c0b",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies\", \"Category\": \"Proteomics and Metabolomics\", \"Closely Related Metrics\": \"Quantification Precision; Dynamic Range Coverage; Missing-Value Burden\", \"Common Misinterpretations\": \"Treating quantification accuracy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Quantification Accuracy\", \"References or Origin\": \"https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/\", \"Related Frameworks\": \"MIAPE; HUPO PSI; Metabolomics Standards\", \"Scientific Definition\": \"The closeness of quantification to the accepted reference or true value.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses quantification accuracy using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in quantification accuracy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 388"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/61",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 61,
      "bemo:BEMO_3100023": "a6b6c6cf8ada87a1112583df9bc78595f4f0975ec0e8bbfc01ca6f00c2c0adf1",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Biomarker development, qualification, endpoint and surrogate validation studies\", \"Category\": \"Biomarker and Endpoint Validation\", \"Closely Related Metrics\": \"Monitoring Biomarker Validity; Susceptibility/Risk Biomarker Validity; Response Biomarker Validity\", \"Common Misinterpretations\": \"Treating safety biomarker validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Safety Biomarker Validity\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"FDA Biomarker; BEST; EMA E16; REMARK\", \"Scientific Definition\": \"The degree to which safety biomarker supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses safety biomarker validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in safety biomarker validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 61"
    },
    {
      "@id": "bemo:BEMO_2000249",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000249",
      "bemo:BEMO_3100022": 256,
      "bemo:BEMO_3100023": "fb650cc4b9fc46d550895b59d1656dada1a7ec625426686e0a708ba75b6fc5f0",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses library complexity using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in library complexity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating library complexity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAME; MINSEQE; STROBE-ME; GA4GH; HCA"
      },
      "bemo:BEMO_3200011": "https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000249"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000242"
        },
        {
          "@id": "bemo:BEMO_2000245"
        },
        {
          "@id": "bemo:BEMO_2000256"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of library complexity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/256"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000249",
      "rdfs:label": {
        "@language": "en",
        "@value": "Library Complexity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb274"
        },
        {
          "@id": "bemo:BEMO_1100010"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb274",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000249"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_3000007",
      "@type": "owl:ObjectProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Connects a computation specification to a controlled scale type."
      },
      "oboInOwl:id": "BEMO:3000007",
      "rdfs:label": {
        "@language": "en",
        "@value": "has scale type"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000280",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000003"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000012"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000013"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000020"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a validated analyte- and method-specific measurement procedure with calibration and quality control."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"unitRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "specimen_or_material; measurement_procedure; calibration_reference; quality_control_results; unit",
      "bemo:BEMO_3100007": "replicate_measurements; environmental_conditions; instrument_version",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Method- and analyte-specific physical units",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000280"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/287"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Dynamic Range"
      }
    },
    {
      "@id": "bemo:BEMO_2000447",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000447",
      "bemo:BEMO_3100022": 454,
      "bemo:BEMO_3100023": "399e0c1d410c7ca1c5cc767b5afb9291915d1ee3db3b4d7314b2092c6d4765e1",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses missing-data mechanism plausibility using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in missing-data mechanism plausibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating missing-data mechanism plausibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000447"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000443"
        },
        {
          "@id": "bemo:BEMO_2000448"
        },
        {
          "@id": "bemo:BEMO_2000462"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of missing-data mechanism plausibility."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/454"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000447",
      "rdfs:label": {
        "@language": "en",
        "@value": "Missing-Data Mechanism Plausibility"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb451"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb451",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000447"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000469",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000469",
      "bemo:BEMO_3100022": 476,
      "bemo:BEMO_3100023": "a9882065e899d9f8a8f701c6291666b702a9ad5b769971c1d3cb596c9e39b960",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses cluster recruitment bias risk using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in cluster recruitment bias risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating cluster recruitment bias risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000469"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000463"
        },
        {
          "@id": "bemo:BEMO_2000476"
        },
        {
          "@id": "bemo:BEMO_2000482"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The probability or degree that cluster recruitment bias introduces systematic distortion into a biomedical estimate or conclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/476"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000469",
      "rdfs:label": {
        "@language": "en",
        "@value": "Cluster Recruitment Bias Risk"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb471"
        },
        {
          "@id": "bemo:BEMO_1100018"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb471",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000469"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/482",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 482,
      "bemo:BEMO_3100023": "ccfe7e445aeb97f5f6fbabfec00706b7cd315705f68e05e908e47860b40d8ad4",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies\", \"Category\": \"Study Design and Internal Validity\", \"Closely Related Metrics\": \"Follow-up Completeness\", \"Common Misinterpretations\": \"Treating differential follow-up risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Differential Follow-up Risk\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools\", \"Related Frameworks\": \"CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI\", \"Scientific Definition\": \"The probability or degree that differential follow-up introduces systematic distortion into a biomedical estimate or conclusion.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses differential follow-up risk using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in differential follow-up risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 482"
    },
    {
      "@id": "bemo:BEMO_2000146",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000146",
      "bemo:BEMO_3100022": 153,
      "bemo:BEMO_3100023": "f74a279906eee7e4453803727494ade321b94fc1d6196fb1882daae7f1abcf75",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses evidence consistency using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in evidence consistency can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating evidence consistency as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Systematic reviews, meta-analyses, evidence profiles, guidelines"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; PRISMA; AMSTAR 2; RoB"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000146"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000148"
        },
        {
          "@id": "bemo:BEMO_2000150"
        },
        {
          "@id": "bemo:BEMO_2000153"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree of agreement in evidence across measurements, studies, methods, populations, or biological levels."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/153"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000146",
      "rdfs:label": {
        "@language": "en",
        "@value": "Evidence Consistency"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb185"
        },
        {
          "@id": "bemo:BEMO_1100006"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb185",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000146"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000221",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000221",
      "bemo:BEMO_3100022": 228,
      "bemo:BEMO_3100023": "4501a0d637c0d3d7b3852d3be8f61115b2b1ac442582dd9a3ec88bd21dad9f7c",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses gene–disease validity using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in gene–disease validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "ClinGen/ACMG evidence scoring; pedigree analysis; population databases; case-control data; functional assays; expert-panel review."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating gene–disease validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mendelian disease, cancer genetics, association, segregation, and functional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ClinGen; ACMG AMP; STREGA; Gene Ontology"
      },
      "bemo:BEMO_3200011": "https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000221"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000230"
        },
        {
          "@id": "bemo:BEMO_2000235"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which gene–disease supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/228"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000221",
      "rdfs:label": {
        "@language": "en",
        "@value": "Gene–Disease Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb9"
        },
        {
          "@id": "bemo:BEMO_1100009"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb9",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000221"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/367",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 367,
      "bemo:BEMO_3100023": "d83b78fc8beda508a5c18da8dbb9e284c948a9741d4fb8d070f9f30bc9267827",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies\", \"Category\": \"Proteomics and Metabolomics\", \"Closely Related Metrics\": \"Extraction Recovery; Metabolic Feature Reproducibility; Pathway Enrichment Robustness\", \"Common Misinterpretations\": \"Treating derivatization efficiency as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Derivatization Efficiency\", \"References or Origin\": \"https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/\", \"Related Frameworks\": \"MIAPE; HUPO PSI; Metabolomics Standards\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of derivatization efficiency.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses derivatization efficiency using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in derivatization efficiency can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 367"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000051",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000051"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/58"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Predictive Biomarker Validity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000461",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000461"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/468"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Type II Error Risk"
      }
    },
    {
      "@id": "bemo:BEMO_2000397",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000397",
      "bemo:BEMO_3100022": 404,
      "bemo:BEMO_3100023": "44bfb4ae3b82bb963a97cc8f3dfed3bd610b7903405993c8f3031931f746d1ce",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses intralaboratory repeatability using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in intralaboratory repeatability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating intralaboratory repeatability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All experimental, computational, clinical, and omics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0"
      },
      "bemo:BEMO_3200011": "https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000397"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000396"
        },
        {
          "@id": "bemo:BEMO_2000399"
        },
        {
          "@id": "bemo:BEMO_2000405"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which intralaboratory repeatability yields concordant results under the specified repeated-analysis or repeated-measurement conditions."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/404"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000397",
      "rdfs:label": {
        "@language": "en",
        "@value": "Intralaboratory Repeatability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb407"
        },
        {
          "@id": "bemo:BEMO_1100015"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb407",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000397"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/73",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 73,
      "bemo:BEMO_3100023": "c08e61688a36fec680e9073fc8888dbfd98852919e3f7ccf7c3180ed49d1e921",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All studies using human or animal biospecimens\", \"Category\": \"Biospecimen and Preanalytical Quality\", \"Closely Related Metrics\": \"Time-to-Fixation Adequacy; Preservation Adequacy; Storage Temperature Control\", \"Common Misinterpretations\": \"Treating fixation adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Fixation Adequacy\", \"References or Origin\": \"https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"BRISQ; ISO 15189; REMARK\", \"Scientific Definition\": \"The extent to which fixation is sufficient and fit for the stated biomedical inference.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses fixation adequacy using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in fixation adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 73"
    },
    {
      "@id": "bemo:BEMO_0000402",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A controlled concept describing how close a metric is to executable, validated computation."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:0000402",
      "rdfs:label": {
        "@language": "en",
        "@value": "computation readiness status"
      },
      "rdfs:subClassOf": {
        "@id": "skos:Concept"
      }
    },
    {
      "@id": "bemo:BEMO_3200002",
      "@type": "owl:AnnotationProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Preserves the source explanation of what a metric measures."
      },
      "oboInOwl:id": "BEMO:3200002",
      "rdfs:label": {
        "@language": "en",
        "@value": "what it measures"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/65",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 65,
      "bemo:BEMO_3100023": "8fa3b411fb892fff8cc31c078e25770eb74980a525cbc8e76d63bcb0f15bdaf8",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All studies using human or animal biospecimens\", \"Category\": \"Biospecimen and Preanalytical Quality\", \"Closely Related Metrics\": \"Processing Delay Control; Pathology Confirmation; Tumor Purity\", \"Common Misinterpretations\": \"Treating anatomical site fidelity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Anatomical Site Fidelity\", \"References or Origin\": \"https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"BRISQ; ISO 15189; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of anatomical site fidelity.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses anatomical site fidelity using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in anatomical site fidelity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 65"
    },
    {
      "@id": "bemo:BEMO_2000075",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000075",
      "bemo:BEMO_3100022": 82,
      "bemo:BEMO_3100023": "de3923232eba7ea0cab4f8eddc6a1539eac9f06416d7c31e6d2ce8fbf8492ba5",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses preservation adequacy using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in preservation adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating preservation adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All studies using human or animal biospecimens"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "BRISQ; ISO 15189; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000075"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000066"
        },
        {
          "@id": "bemo:BEMO_2000067"
        },
        {
          "@id": "bemo:BEMO_2000079"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which preservation is sufficient and fit for the stated biomedical inference."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/82"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000075",
      "rdfs:label": {
        "@language": "en",
        "@value": "Preservation Adequacy"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb120"
        },
        {
          "@id": "bemo:BEMO_1100003"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb120",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000075"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000230",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000230",
      "bemo:BEMO_3100022": 237,
      "bemo:BEMO_3100023": "da2b6bc79f60e4e8121c9a5cd9a562fbe0d255feef3ecb78f1de13bffe50a0f4",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses population frequency compatibility using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in population frequency compatibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating population frequency compatibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mendelian disease, cancer genetics, association, segregation, and functional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ClinGen; ACMG AMP; STREGA; Gene Ontology"
      },
      "bemo:BEMO_3200011": "https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000230"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000217"
        },
        {
          "@id": "bemo:BEMO_2000232"
        },
        {
          "@id": "bemo:BEMO_2000235"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of population frequency compatibility."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/237"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000230",
      "rdfs:label": {
        "@language": "en",
        "@value": "Population Frequency Compatibility"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb258"
        },
        {
          "@id": "bemo:BEMO_1100009"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb258",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000230"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_4000003",
      "@type": [
        "owl:NamedIndividual",
        "bemo:BEMO_0000400"
      ],
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Controlled BEMO ScaleType value: PhysicalMeasurementScale."
      },
      "oboInOwl:id": "BEMO:4000003",
      "rdfs:label": {
        "@language": "en",
        "@value": "Physical Measurement Scale"
      },
      "skos:notation": "PhysicalMeasurementScale"
    },
    {
      "@id": "bemo:BEMO_2000315",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000315",
      "bemo:BEMO_3100022": 322,
      "bemo:BEMO_3100023": "6118b228a2af4e149e82150fb026ef08cdd6d05b9748a0128d6e8c14f147784c",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses network edge confidence using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in network edge confidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating network edge confidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Dataset / model / pathway / network / evidence body"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Integrated omics, networks, pathways, mechanistic and dynamic systems models"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "Gene Ontology; Reactome; UniProt; GA4GH"
      },
      "bemo:BEMO_3200011": "https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000315"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000314"
        },
        {
          "@id": "bemo:BEMO_2000316"
        },
        {
          "@id": "bemo:BEMO_2000317"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The justified degree of certainty assigned to network edge given the quantity, quality, consistency, and limitations of supporting evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/322"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000315",
      "rdfs:label": {
        "@language": "en",
        "@value": "Network Edge Confidence"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb333"
        },
        {
          "@id": "bemo:BEMO_1100012"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb333",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000315"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/393",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 393,
      "bemo:BEMO_3100023": "8e400bbae5ea25bca3af45f9c956cb2ceeb52ded61247de3b92d5364736bab99",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All experimental, computational, clinical, and omics studies\", \"Category\": \"Reproducibility and Replication\", \"Closely Related Metrics\": \"Conceptual Replication Success; Computational Reproducibility; Experimental Reproducibility\", \"Common Misinterpretations\": \"Treating analytical reproducibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Analytical Reproducibility\", \"References or Origin\": \"https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines\", \"Related Frameworks\": \"PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0\", \"Scientific Definition\": \"The degree to which analytical reproducibility yields concordant results under the specified repeated-analysis or repeated-measurement conditions.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses analytical reproducibility using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in analytical reproducibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 393"
    },
    {
      "@id": "bemo:BEMO_2000260",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000260",
      "bemo:BEMO_3100022": 267,
      "bemo:BEMO_3100023": "47e6d4bd3f64b35d8abb9925b05e112fbb1356d383dc641a47f78f8e9bbeb676",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses single-cell doublet burden using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in single-cell doublet burden can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating single-cell doublet burden as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAME; MINSEQE; STROBE-ME; GA4GH; HCA"
      },
      "bemo:BEMO_3200011": "https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000260"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000238"
        },
        {
          "@id": "bemo:BEMO_2000259"
        },
        {
          "@id": "bemo:BEMO_2000262"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of single-cell doublet burden."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/267"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000260",
      "rdfs:label": {
        "@language": "en",
        "@value": "Single-Cell Doublet Burden"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb284"
        },
        {
          "@id": "bemo:BEMO_1100010"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb284",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000260"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000263",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000263"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/270"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Spatial Transcriptomic Registration Accuracy"
      }
    },
    {
      "@id": "bemo:BEMO_2000238",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000238",
      "bemo:BEMO_3100022": 245,
      "bemo:BEMO_3100023": "64b27913521868b5a9491d569eb82729fee0c3cb2133bfc9132e110785fa8847",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses alternative splicing validation using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in alternative splicing validation can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating alternative splicing validation as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAME; MINSEQE; STROBE-ME; GA4GH; HCA"
      },
      "bemo:BEMO_3200011": "https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000238"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000259"
        },
        {
          "@id": "bemo:BEMO_2000260"
        },
        {
          "@id": "bemo:BEMO_2000265"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of alternative splicing validation."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/245"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000238",
      "rdfs:label": {
        "@language": "en",
        "@value": "Alternative Splicing Validation"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb265"
        },
        {
          "@id": "bemo:BEMO_1100010"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb265",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000238"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_3100025",
      "@type": "owl:DatatypeProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Lexical representation of a metric assessment value."
      },
      "oboInOwl:id": "BEMO:3100025",
      "rdfs:label": {
        "@language": "en",
        "@value": "metric value lexical form"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000355",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000355"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/362"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Therapeutic Window Evidence"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/320",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 320,
      "bemo:BEMO_3100023": "433f97851837c60d123f8a332258d7d5b3872aa7c5564c19691b4c4c00871a8b",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Integrated omics, networks, pathways, mechanistic and dynamic systems models\", \"Category\": \"Multi-omics and Systems Biology\", \"Closely Related Metrics\": \"Ontology Evidence-Code Strength; Parameter Identifiability; Parameter Sensitivity\", \"Common Misinterpretations\": \"Treating model–experiment concordance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Dataset / model / pathway / network / evidence body\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Model–Experiment Concordance\", \"References or Origin\": \"https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/\", \"Related Frameworks\": \"Gene Ontology; Reactome; UniProt; GA4GH\", \"Scientific Definition\": \"The degree of agreement in model–experiment across measurements, studies, methods, populations, or biological levels.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses model–experiment concordance using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in model–experiment concordance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 320"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/376",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 376,
      "bemo:BEMO_3100023": "521bf8b7c1bbe892685e95c05cc7d63a05c4e26119e9951d705ff460b3bb99d1",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies\", \"Category\": \"Proteomics and Metabolomics\", \"Closely Related Metrics\": \"Derivatization Efficiency; Pathway Enrichment Robustness; Cross-Omics Concordance\", \"Common Misinterpretations\": \"Treating metabolic feature reproducibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Metabolic Feature Reproducibility\", \"References or Origin\": \"https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/\", \"Related Frameworks\": \"MIAPE; HUPO PSI; Metabolomics Standards\", \"Scientific Definition\": \"The degree to which metabolic feature reproducibility yields concordant results under the specified repeated-analysis or repeated-measurement conditions.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses metabolic feature reproducibility using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in metabolic feature reproducibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 376"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000023",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000023"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/30"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Spatial Biological Concordance"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/214",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 214,
      "bemo:BEMO_3100023": "771c727a328004aa438f83d20410cd3600ce67ac5affa57fc6e9aaee55cb7ed9",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Clinical, epidemiologic, diagnostic, translational, and population studies\", \"Category\": \"External Validity and Applicability\", \"Closely Related Metrics\": \"Outcome Applicability; Subgroup Consistency; Geographic Consistency\", \"Common Misinterpretations\": \"Treating spectrum representativeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Spectrum Representativeness\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/\", \"Related Frameworks\": \"GRADE; QUADAS-2; CONSORT; STROBE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of spectrum representativeness.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Target-decoy analysis; spectral scoring; reference standards; replicate injections; retention-time and mass-error monitoring; orthogonal confirmation.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses spectrum representativeness using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in spectrum representativeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 214"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000288",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000288"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/295"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Matrix Effect"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/466",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 466,
      "bemo:BEMO_3100023": "b5866270dc0b1ae7d14dc9e42f0ff6a1d28896f404d73ddeb44c5f7fdaf6b51a",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Confidence Interval Compatibility; Type I Error Control; Type II Error Risk\", \"Common Misinterpretations\": \"Treating statistical power as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Statistical Power\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of statistical power.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses statistical power using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in statistical power can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 466"
    },
    {
      "@id": "bemo:BEMO_2000277",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000277",
      "bemo:BEMO_3100022": 284,
      "bemo:BEMO_3100023": "1de0ffae2d83059ba1d111ea3bf309f20078d963ac7b7f912a42e8b4e10e5e32",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses cross-reactivity using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in cross-reactivity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating cross-reactivity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000277"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000275"
        },
        {
          "@id": "bemo:BEMO_2000281"
        },
        {
          "@id": "bemo:BEMO_2000283"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of cross-reactivity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/284"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000277",
      "rdfs:label": {
        "@language": "en",
        "@value": "Cross-Reactivity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb299"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb299",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000277"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/38",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 38,
      "bemo:BEMO_3100023": "19a54854b5dfb7168eddad304da95ddbab2e1ad34992146fcedfd650dfe09548",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Biomarker development, qualification, endpoint and surrogate validation studies\", \"Category\": \"Biomarker and Endpoint Validation\", \"Closely Related Metrics\": \"Biomarker Reliability; Biomarker Sensitivity to Change; Known-Groups Validity\", \"Common Misinterpretations\": \"Treating biomarker responsiveness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Biomarker Responsiveness\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"FDA Biomarker; BEST; EMA E16; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of biomarker responsiveness.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses biomarker responsiveness using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in biomarker responsiveness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 38"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000257",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000257"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/264"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Sequencing Depth Adequacy"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/258",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 258,
      "bemo:BEMO_3100023": "518f55960ed771c22a0c382ff436c097ae34f4481b35b5a64e7f2cf8493778a4",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies\", \"Category\": \"Genomics and Transcriptomics\", \"Closely Related Metrics\": \"Differential Expression Robustness; Transcript Quantification Reliability; Alternative Splicing Validation\", \"Common Misinterpretations\": \"Treating normalization adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Normalization Adequacy\", \"References or Origin\": \"https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/\", \"Related Frameworks\": \"MIAME; MINSEQE; STROBE-ME; GA4GH; HCA\", \"Scientific Definition\": \"The extent to which normalization is sufficient and fit for the stated biomedical inference.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses normalization adequacy using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in normalization adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 258"
    },
    {
      "@id": "bemo:BEMO_3200012",
      "@type": "owl:AnnotationProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Links a metric class to its profile using an annotation-safe IRI."
      },
      "oboInOwl:id": "BEMO:3200012",
      "rdfs:label": {
        "@language": "en",
        "@value": "computation profile IRI"
      }
    },
    {
      "@id": "bemo:BEMO_2000153",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000153",
      "bemo:BEMO_3100022": 160,
      "bemo:BEMO_3100023": "1f9ca5bc5be56489e2caf9d2f3eaaf37b12ae4271716853fb373d2db6aa8d657",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses evidence stability using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in evidence stability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating evidence stability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Systematic reviews, meta-analyses, evidence profiles, guidelines"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; PRISMA; AMSTAR 2; RoB"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000153"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000144"
        },
        {
          "@id": "bemo:BEMO_2000146"
        },
        {
          "@id": "bemo:BEMO_2000148"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of evidence stability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/160"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000153",
      "rdfs:label": {
        "@language": "en",
        "@value": "Evidence Stability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb191"
        },
        {
          "@id": "bemo:BEMO_1100006"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb191",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000153"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000090",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000090",
      "bemo:BEMO_3100022": 97,
      "bemo:BEMO_3100023": "b11d505f3985b03d1ab78fe50a79558d187aeacc3fabbc39b5dc3da61a0cfbe2",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses correct temporal ordering using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in correct temporal ordering can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating correct temporal ordering as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized and observational etiologic studies, natural experiments, target-trial emulations"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000090"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000085"
        },
        {
          "@id": "bemo:BEMO_2000101"
        },
        {
          "@id": "bemo:BEMO_2000107"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of correct temporal ordering."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/97"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000090",
      "rdfs:label": {
        "@language": "en",
        "@value": "Correct Temporal Ordering"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb133"
        },
        {
          "@id": "bemo:BEMO_1100004"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb133",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000090"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000235",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000235",
      "bemo:BEMO_3100022": 242,
      "bemo:BEMO_3100023": "ce239eedae0622eb1018ab2bfc52cd2d32ef0a5f6a874008c2d8838deb99bd4a",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses variant pathogenicity evidence strength using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in variant pathogenicity evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "ClinGen/ACMG evidence scoring; pedigree analysis; population databases; case-control data; functional assays; expert-panel review."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating variant pathogenicity evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mendelian disease, cancer genetics, association, segregation, and functional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ClinGen; ACMG AMP; STREGA; Gene Ontology"
      },
      "bemo:BEMO_3200011": "https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000235"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000221"
        },
        {
          "@id": "bemo:BEMO_2000230"
        },
        {
          "@id": "bemo:BEMO_2000232"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting variant pathogenicity evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/242"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000235",
      "rdfs:label": {
        "@language": "en",
        "@value": "Variant Pathogenicity Evidence Strength"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb36"
        },
        {
          "@id": "bemo:BEMO_1100009"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb36",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000235"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000472",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000472"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/479"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Contamination Risk"
      }
    },
    {
      "@id": "bemo:BEMO_2000104",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000104",
      "bemo:BEMO_3100022": 111,
      "bemo:BEMO_3100023": "fef3c7d8a6ff0d0d4088a08abb2cfe7420127e6170b4998b7b5ce06d44124e81",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses residual confounding risk using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in residual confounding risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Directed acyclic graphs; design emulation; balance diagnostics; negative controls; quantitative bias analysis; sensitivity and falsification analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating residual confounding risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized and observational etiologic studies, natural experiments, target-trial emulations"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000104"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000088"
        },
        {
          "@id": "bemo:BEMO_2000095"
        },
        {
          "@id": "bemo:BEMO_2000109"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The probability or degree that residual confounding introduces systematic distortion into a biomedical estimate or conclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/111"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000104",
      "rdfs:label": {
        "@language": "en",
        "@value": "Residual Confounding Risk"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb146"
        },
        {
          "@id": "bemo:BEMO_1100004"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb146",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000104"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000119",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000119"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/126"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Incorporation Bias Risk"
      }
    },
    {
      "@id": "bemo:BEMO_2000454",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000454",
      "bemo:BEMO_3100022": 461,
      "bemo:BEMO_3100023": "3a52b33f3faa79b95100ff084b9c7ca54158523c656fcaf5c298f073960428c9",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses outlier influence robustness using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in outlier influence robustness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating outlier influence robustness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000454"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000443"
        },
        {
          "@id": "bemo:BEMO_2000444"
        },
        {
          "@id": "bemo:BEMO_2000453"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of outlier influence robustness."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/461"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000454",
      "rdfs:label": {
        "@language": "en",
        "@value": "Outlier Influence Robustness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb457"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb457",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000454"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_4000021",
      "@type": [
        "owl:NamedIndividual",
        "bemo:BEMO_0000404"
      ],
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Controlled BEMO Directionality value: ContextDependentDirection."
      },
      "oboInOwl:id": "BEMO:4000021",
      "rdfs:label": {
        "@language": "en",
        "@value": "Context Dependent Direction"
      },
      "skos:notation": "ContextDependentDirection"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/213",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 213,
      "bemo:BEMO_3100023": "323f595d53815c626b380456c55c73f7ff5e2e10beb1e0ffc44edb8067c37e86",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Clinical, epidemiologic, diagnostic, translational, and population studies\", \"Category\": \"External Validity and Applicability\", \"Closely Related Metrics\": \"Generalizability; Population Applicability; Intervention Applicability\", \"Common Misinterpretations\": \"Treating setting applicability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Setting Applicability\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/\", \"Related Frameworks\": \"GRADE; QUADAS-2; CONSORT; STROBE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of setting applicability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses setting applicability using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in setting applicability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 213"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/51",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 51,
      "bemo:BEMO_3100023": "f79c486fa1f56b17619593da318c44a3704cbd1294be41ae30a2b38ceb9410d1",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Biomarker development, qualification, endpoint and surrogate validation studies\", \"Category\": \"Biomarker and Endpoint Validation\", \"Closely Related Metrics\": \"Trial-Level Surrogacy; Outcome Relevance; Endpoint Reliability\", \"Common Misinterpretations\": \"Treating endpoint validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Endpoint Validity\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"FDA Biomarker; BEST; EMA E16; REMARK\", \"Scientific Definition\": \"The degree to which endpoint supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses endpoint validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in endpoint validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 51"
    },
    {
      "@id": "bemo:BEMO_2000084",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000084",
      "bemo:BEMO_3100022": 91,
      "bemo:BEMO_3100023": "b75d62759fbd8f126f27997543f0f46dde1cb8c2484d156a08c9925c9476aa63",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses assumption sensitivity using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in assumption sensitivity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating assumption sensitivity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized and observational etiologic studies, natural experiments, target-trial emulations"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000084"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000093"
        },
        {
          "@id": "bemo:BEMO_2000096"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of assumption sensitivity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/91"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000084",
      "rdfs:label": {
        "@language": "en",
        "@value": "Assumption Sensitivity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb129"
        },
        {
          "@id": "bemo:BEMO_1100004"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb129",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000084"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000410",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000410",
      "bemo:BEMO_3100022": 417,
      "bemo:BEMO_3100023": "24a8774755f1b71359ef7a35f4a7813a446670f2da0ccc38d22836e1a84f1453",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses data-sharing transparency using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in data-sharing transparency can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating data-sharing transparency as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Study report / dataset / evidence package"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All biomedical study reports and data releases"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000410"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000407"
        },
        {
          "@id": "bemo:BEMO_2000409"
        },
        {
          "@id": "bemo:BEMO_2000416"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of data-sharing transparency."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/417"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000410",
      "rdfs:label": {
        "@language": "en",
        "@value": "Data-Sharing Transparency"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb419"
        },
        {
          "@id": "bemo:BEMO_1100016"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb419",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000410"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000463",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000463"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/470"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Adherence Integrity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/457",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 457,
      "bemo:BEMO_3100023": "c5d48404d8de034fc4aa45bb9f64638b1d861e61321423aa5f11d4f63cc6783b",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Multiplicity Control; Model Fit; Residual Diagnostics Adequacy\", \"Common Misinterpretations\": \"Treating model specification adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Model Specification Adequacy\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"The extent to which model specification is sufficient and fit for the stated biomedical inference.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses model specification adequacy using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in model specification adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 457"
    },
    {
      "@id": "bemo:BEMO_2000178",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000178",
      "bemo:BEMO_3100022": 185,
      "bemo:BEMO_3100023": "d4c26e56573de7f55de0caafd1e2880580fe66b8b4d599787ebf0b2bb3808344",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses housing and husbandry control using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in housing and husbandry control can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating housing and husbandry control as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "In vitro, ex vivo, organoid, animal, and preclinical experiments"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ARRIVE 2.0; SYRCLE; OECD"
      },
      "bemo:BEMO_3200011": "https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000178"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000173"
        },
        {
          "@id": "bemo:BEMO_2000177"
        },
        {
          "@id": "bemo:BEMO_2000180"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of housing and husbandry control."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/185"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000178",
      "rdfs:label": {
        "@language": "en",
        "@value": "Housing and Husbandry Control"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb212"
        },
        {
          "@id": "bemo:BEMO_1100007"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb212",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000178"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_3200010",
      "@type": "owl:AnnotationProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Preserves the source related frameworks."
      },
      "oboInOwl:id": "BEMO:3200010",
      "rdfs:label": {
        "@language": "en",
        "@value": "source frameworks"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/364",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 364,
      "bemo:BEMO_3100023": "6cda2f6cb167ccc21d05523345b2fef382432ceed6ebbcbe84fa383cddc4562e",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies\", \"Category\": \"Pharmacology and Toxicology\", \"Closely Related Metrics\": \"Immunotoxicity Evidence Strength; Species Extrapolation Validity; Human-Relevance of Toxicological Evidence\", \"Common Misinterpretations\": \"Treating toxicokinetic concordance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Toxicokinetic Concordance\", \"References or Origin\": \"https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline\", \"Related Frameworks\": \"OECD; OHAT; FDA Biomarker; EMA E16\", \"Scientific Definition\": \"The degree of agreement in toxicokinetic across measurements, studies, methods, populations, or biological levels.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses toxicokinetic concordance using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in toxicokinetic concordance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 364"
    },
    {
      "@id": "bemo:BEMO_2000088",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000088",
      "bemo:BEMO_3100022": 95,
      "bemo:BEMO_3100023": "cebd58c93ed86b363870e131c5d23217522d15af0abb7eac8956ec81e8515565",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses confounding risk using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in confounding risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Directed acyclic graphs; design emulation; balance diagnostics; negative controls; quantitative bias analysis; sensitivity and falsification analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating confounding risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized and observational etiologic studies, natural experiments, target-trial emulations"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000088"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000086"
        },
        {
          "@id": "bemo:BEMO_2000104"
        },
        {
          "@id": "bemo:BEMO_2000109"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The probability or degree that confounding introduces systematic distortion into a biomedical estimate or conclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/95"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000088",
      "rdfs:label": {
        "@language": "en",
        "@value": "Confounding Risk"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb25"
        },
        {
          "@id": "bemo:BEMO_1100004"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb25",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000088"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/390",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 390,
      "bemo:BEMO_3100023": "7ed489b83705dc957b891fd6483e7b54ca4c70547f903f7dfa9e53d0ca59fa58",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies\", \"Category\": \"Proteomics and Metabolomics\", \"Closely Related Metrics\": \"Ion Suppression Assessment; Mass Accuracy; Isotope Pattern Fidelity\", \"Common Misinterpretations\": \"Treating retention-time stability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Retention-Time Stability\", \"References or Origin\": \"https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/\", \"Related Frameworks\": \"MIAPE; HUPO PSI; Metabolomics Standards\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of retention-time stability.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Target-decoy analysis; spectral scoring; reference standards; replicate injections; retention-time and mass-error monitoring; orthogonal confirmation.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses retention-time stability using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in retention-time stability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 390"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000406",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Developing; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000406"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/413"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Specification-Curve Robustness"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/449",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 449,
      "bemo:BEMO_3100023": "045c39ed086cc31d598f1fe91547a90170ea8cc0b684f22d5338144e750a0843",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Clinical Relevance of Effect; Bayes Factor Evidence; Posterior Probability Strength\", \"Common Misinterpretations\": \"Treating fragility index as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Fragility Index\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of fragility index.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses fragility index using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in fragility index can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 449"
    },
    {
      "@id": "bemo:BEMO_2000404",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000404",
      "bemo:BEMO_3100022": 411,
      "bemo:BEMO_3100023": "c196ee0e5b3c49cffc78d559a15b400e1dec74f4854200e7fbd341eef60a59c4",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses researcher-degrees-of-freedom sensitivity using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in researcher-degrees-of-freedom sensitivity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating researcher-degrees-of-freedom sensitivity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All experimental, computational, clinical, and omics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0"
      },
      "bemo:BEMO_3200011": "https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000404"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000400"
        },
        {
          "@id": "bemo:BEMO_2000402"
        },
        {
          "@id": "bemo:BEMO_2000406"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of researcher-degrees-of-freedom sensitivity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/411"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000404",
      "rdfs:label": {
        "@language": "en",
        "@value": "Researcher-Degrees-of-Freedom Sensitivity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb414"
        },
        {
          "@id": "bemo:BEMO_1100015"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb414",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000404"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000186",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000186"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/193"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Sex as a Biological Variable Adequacy"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000056",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000056"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/63"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Susceptibility/Risk Biomarker Validity"
      }
    },
    {
      "@id": "bemo:BEMO_0000001",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "An information content entity that specifies a scientifically interpretable quantity, category, rubric, or assessment construct used to evaluate biomedical evidence."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:0000001",
      "rdfs:label": {
        "@language": "en",
        "@value": "biomedical evidence metric"
      },
      "rdfs:subClassOf": {
        "@id": "obo:IAO_0000030"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/435",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 435,
      "bemo:BEMO_3100023": "2fcf4f96e7ca202f61d3de161ead38ea506d30ac8f05b66ac8a84b27f3da645e",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All biomedical study reports and data releases\", \"Category\": \"Research Transparency and Reporting Completeness\", \"Closely Related Metrics\": \"Metadata Completeness; Processed-Data Availability; Quality-Control Reporting Completeness\", \"Common Misinterpretations\": \"Treating raw-data availability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Study report / dataset / evidence package\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Raw-Data Availability\", \"References or Origin\": \"https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/\", \"Related Frameworks\": \"EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of raw-data availability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses raw-data availability using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in raw-data availability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 435"
    },
    {
      "@id": "bemo:BEMO_2000414",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000414",
      "bemo:BEMO_3100022": 421,
      "bemo:BEMO_3100023": "15ffc51fd66113f5e5c480a7127c592104dbff4a2e6faafcfafb509cd725ea07",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses harms reporting completeness using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in harms reporting completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating harms reporting completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Study report / dataset / evidence package"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All biomedical study reports and data releases"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000414"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000418"
        },
        {
          "@id": "bemo:BEMO_2000422"
        },
        {
          "@id": "bemo:BEMO_2000431"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which all scientifically necessary components of harms reporting are present, documented, and evaluable."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/421"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000414",
      "rdfs:label": {
        "@language": "en",
        "@value": "Harms Reporting Completeness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb423"
        },
        {
          "@id": "bemo:BEMO_1100016"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb423",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000414"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000152",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000152"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/159"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Evidence Robustness"
      }
    },
    {
      "@id": "bemo:BEMO_2000220",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000220",
      "bemo:BEMO_3100022": 227,
      "bemo:BEMO_3100023": "7a71bec12dfb580d6d32593ad450868d51a755f2a8b35e7eee350ad98d24c73e",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses functional variant evidence using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in functional variant evidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "ClinGen/ACMG evidence scoring; pedigree analysis; population databases; case-control data; functional assays; expert-panel review."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating functional variant evidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mendelian disease, cancer genetics, association, segregation, and functional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ClinGen; ACMG AMP; STREGA; Gene Ontology"
      },
      "bemo:BEMO_3200011": "https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000220"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000212"
        },
        {
          "@id": "bemo:BEMO_2000215"
        },
        {
          "@id": "bemo:BEMO_2000229"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of functional variant evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/227"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000220",
      "rdfs:label": {
        "@language": "en",
        "@value": "Functional Variant Evidence"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb249"
        },
        {
          "@id": "bemo:BEMO_1100009"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb249",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000220"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000171",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000171"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/178"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Biological Replicate Adequacy"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/50",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 50,
      "bemo:BEMO_3100023": "3cb1f45a15a5daa5f6b98c2d745a57440f42e5840e757c82a744e9f010f76df0",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Biomarker development, qualification, endpoint and surrogate validation studies\", \"Category\": \"Biomarker and Endpoint Validation\", \"Closely Related Metrics\": \"Endpoint Reliability; Minimal Clinically Important Difference Validity\", \"Common Misinterpretations\": \"Treating endpoint responsiveness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Endpoint Responsiveness\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"FDA Biomarker; BEST; EMA E16; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of endpoint responsiveness.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses endpoint responsiveness using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in endpoint responsiveness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 50"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/244",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 244,
      "bemo:BEMO_3100023": "0857b2292263da43e4b892ac8b30335b2a7fd8730d0baae8269f0919f1da549b",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies\", \"Category\": \"Genomics and Transcriptomics\", \"Closely Related Metrics\": \"Genotype Quality; Strand Bias; Reference Bias\", \"Common Misinterpretations\": \"Treating allelic balance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Allelic Balance\", \"References or Origin\": \"https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/\", \"Related Frameworks\": \"MIAME; MINSEQE; STROBE-ME; GA4GH; HCA\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of allelic balance.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"ClinGen/ACMG evidence scoring; pedigree analysis; population databases; case-control data; functional assays; expert-panel review.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses allelic balance using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in allelic balance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 244"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/285",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 285,
      "bemo:BEMO_3100023": "f74e484a95fd67b9bd73e0f0c112bc85ddaf01e7476f82b9c24c9382fe2bfe48",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Reference Interval Validity; Measurement Uncertainty; Method Comparison Agreement\", \"Common Misinterpretations\": \"Treating cutoff validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Cutoff Validity\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"The degree to which cutoff supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses cutoff validity using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in cutoff validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 285"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/417",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 417,
      "bemo:BEMO_3100023": "24a8774755f1b71359ef7a35f4a7813a446670f2da0ccc38d22836e1a84f1453",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All biomedical study reports and data releases\", \"Category\": \"Research Transparency and Reporting Completeness\", \"Closely Related Metrics\": \"Conflict-of-Interest Transparency; Code-Sharing Transparency; Materials-and-Reagents Reporting Completeness\", \"Common Misinterpretations\": \"Treating data-sharing transparency as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Study report / dataset / evidence package\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Data-Sharing Transparency\", \"References or Origin\": \"https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/\", \"Related Frameworks\": \"EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of data-sharing transparency.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses data-sharing transparency using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in data-sharing transparency can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 417"
    },
    {
      "@id": "bemo:BEMO_2000203",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000203",
      "bemo:BEMO_3100022": 210,
      "bemo:BEMO_3100023": "efa730876069251ed2dde336a59f381b8c109c4ee429da0b68bf8bae61b0ba48",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses population representativeness using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in population representativeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating population representativeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Clinical, epidemiologic, diagnostic, translational, and population studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; QUADAS-2; CONSORT; STROBE"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000203"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000197"
        },
        {
          "@id": "bemo:BEMO_2000205"
        },
        {
          "@id": "bemo:BEMO_2000210"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of population representativeness."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/210"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000203",
      "rdfs:label": {
        "@language": "en",
        "@value": "Population Representativeness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb33"
        },
        {
          "@id": "bemo:BEMO_1100008"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb33",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000203"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000356",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000003"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000012"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000013"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000020"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a validated analyte- and method-specific measurement procedure with calibration and quality control."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"unitRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "specimen_or_material; measurement_procedure; calibration_reference; quality_control_results; unit",
      "bemo:BEMO_3100007": "replicate_measurements; environmental_conditions; instrument_version",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Method- and analyte-specific physical units",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000356"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/363"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Time–Concentration Profile Adequacy"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000374",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000374"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/381"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Peptide Identification Confidence"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000236",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000236"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/243"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Variant Phase Evidence"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000105",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000105"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/112"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Reverse-Causation Risk"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000360",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000360"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/367"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Derivatization Efficiency"
      }
    },
    {
      "@id": "bemo:BEMO_3000010",
      "@type": "owl:ObjectProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Connects a computation specification to formula availability status."
      },
      "oboInOwl:id": "BEMO:3000010",
      "rdfs:label": {
        "@language": "en",
        "@value": "has formula status"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/296",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 296,
      "bemo:BEMO_3100023": "02b8d5d020f47fcd1190b0fa52a15a86a5dd04748bbf2908e8c4e87ccdb4670f",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Cutoff Validity; Method Comparison Agreement; Commutability\", \"Common Misinterpretations\": \"Treating measurement uncertainty as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Measurement Uncertainty\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of measurement uncertainty.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses measurement uncertainty using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in measurement uncertainty can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 296"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/464",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 464,
      "bemo:BEMO_3100023": "ced026349740f092de03ee4146894b4367dab3b43793f3aa048eac1fd782cbda",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Posterior Probability Strength; Equivalence Margin Validity; Noninferiority Margin Validity\", \"Common Misinterpretations\": \"Treating prior sensitivity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment.\", \"Metric\": \"Prior Sensitivity\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of prior sensitivity.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses prior sensitivity using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in prior sensitivity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 464"
    },
    {
      "@id": "bemo:BEMO_2000058",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000058",
      "bemo:BEMO_3100022": 65,
      "bemo:BEMO_3100023": "8fa3b411fb892fff8cc31c078e25770eb74980a525cbc8e76d63bcb0f15bdaf8",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses anatomical site fidelity using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in anatomical site fidelity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating anatomical site fidelity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All studies using human or animal biospecimens"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "BRISQ; ISO 15189; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000058"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000074"
        },
        {
          "@id": "bemo:BEMO_2000076"
        },
        {
          "@id": "bemo:BEMO_2000082"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of anatomical site fidelity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/65"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000058",
      "rdfs:label": {
        "@language": "en",
        "@value": "Anatomical Site Fidelity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb106"
        },
        {
          "@id": "bemo:BEMO_1100003"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb106",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000058"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000223",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000223"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/230"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Hotspot/Functional-Domain Evidence"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000483",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000483"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/490"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Protocol Deviation Risk"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000008",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000008"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/15"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Loss-of-Function Validation"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000445",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000445"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/452"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Interaction Assessment Adequacy"
      }
    },
    {
      "@id": "bemo:BEMO_1100002",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Category of biomedical evidence metrics concerned with biomarker and endpoint validation."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:1100002",
      "rdfs:label": {
        "@language": "en",
        "@value": "Biomarker and Endpoint Validation metric"
      },
      "rdfs:subClassOf": {
        "@id": "bemo:BEMO_1000005"
      }
    },
    {
      "@id": "bemo:BEMO_3200005",
      "@type": "owl:AnnotationProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Preserves the source methods of assessment."
      },
      "oboInOwl:id": "BEMO:3200005",
      "rdfs:label": {
        "@language": "en",
        "@value": "methods of assessment"
      }
    },
    {
      "@id": "bemo:BEMO_2000094",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000094",
      "bemo:BEMO_3100022": 101,
      "bemo:BEMO_3100023": "f66521085db07e7bd17f7b93b07cf74e57b1c85461a2555c1146f672069098b2",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses effect-modification credibility using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in effect-modification credibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating effect-modification credibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized and observational etiologic studies, natural experiments, target-trial emulations"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000094"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000087"
        },
        {
          "@id": "bemo:BEMO_2000099"
        },
        {
          "@id": "bemo:BEMO_2000108"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of effect-modification credibility."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/101"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000094",
      "rdfs:label": {
        "@language": "en",
        "@value": "Effect-Modification Credibility"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb137"
        },
        {
          "@id": "bemo:BEMO_1100004"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb137",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000094"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/307",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 307,
      "bemo:BEMO_3100023": "42f10127b0bb2f21e12bfaaba11ee2a6c8335cd39935669d6733741eadfc7015",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Commutability; Reagent Lot Consistency; Instrument Drift\", \"Common Misinterpretations\": \"Treating sample stability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Sample Stability\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of sample stability.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses sample stability using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in sample stability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 307"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000438",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000438"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/445"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Distributional Assumption Adequacy"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/211",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 211,
      "bemo:BEMO_3100023": "2bcc973aa3f12efded260e2aef1541636262ee110856a34255ce0823d91dfb20",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Clinical, epidemiologic, diagnostic, translational, and population studies\", \"Category\": \"External Validity and Applicability\", \"Closely Related Metrics\": \"Ecological Validity\", \"Common Misinterpretations\": \"Treating real-world evidence alignment as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Real-World Evidence Alignment\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/\", \"Related Frameworks\": \"GRADE; QUADAS-2; CONSORT; STROBE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of real-world evidence alignment.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses real-world evidence alignment using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in real-world evidence alignment can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 211"
    },
    {
      "@id": "bemo:BEMO_2000386",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000386",
      "bemo:BEMO_3100022": 393,
      "bemo:BEMO_3100023": "8e400bbae5ea25bca3af45f9c956cb2ceeb52ded61247de3b92d5364736bab99",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses analytical reproducibility using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in analytical reproducibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating analytical reproducibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All experimental, computational, clinical, and omics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0"
      },
      "bemo:BEMO_3200011": "https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000386"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000388"
        },
        {
          "@id": "bemo:BEMO_2000389"
        },
        {
          "@id": "bemo:BEMO_2000393"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which analytical reproducibility yields concordant results under the specified repeated-analysis or repeated-measurement conditions."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/393"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000386",
      "rdfs:label": {
        "@language": "en",
        "@value": "Analytical Reproducibility"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb398"
        },
        {
          "@id": "bemo:BEMO_1100015"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb398",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000386"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000297",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000297"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/304"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Repeatability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/450",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 450,
      "bemo:BEMO_3100023": "451bb1f13aa8cd7feb728a231f72c948355ace1a73de7f1903381352517ceaf5",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Missing-Data Sensitivity; Outlier Influence Robustness; Influential Observation Sensitivity\", \"Common Misinterpretations\": \"Treating imputation validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Imputation Validity\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"The degree to which imputation supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses imputation validity using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in imputation validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 450"
    },
    {
      "@id": "bemo:BEMO_2000073",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000073",
      "bemo:BEMO_3100022": 80,
      "bemo:BEMO_3100023": "33466881e023e8dc75d5f189be9da266f95f3bf8283fa46f9f4cff10e5af6f95",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses necrosis burden using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in necrosis burden can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating necrosis burden as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All studies using human or animal biospecimens"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "BRISQ; ISO 15189; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000073"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000061"
        },
        {
          "@id": "bemo:BEMO_2000068"
        },
        {
          "@id": "bemo:BEMO_2000070"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of necrosis burden."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/80"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000073",
      "rdfs:label": {
        "@language": "en",
        "@value": "Necrosis Burden"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb118"
        },
        {
          "@id": "bemo:BEMO_1100003"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb118",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000073"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000432",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000432",
      "bemo:BEMO_3100022": 439,
      "bemo:BEMO_3100023": "ea8be0499c9c5441e47cac85f3e884bcc28099d593610c01dc6ad24ba5c3d0f3",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses bayes factor evidence using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in bayes factor evidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating bayes factor evidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000432"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000442"
        },
        {
          "@id": "bemo:BEMO_2000456"
        },
        {
          "@id": "bemo:BEMO_2000457"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of bayes factor evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/439"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000432",
      "rdfs:label": {
        "@language": "en",
        "@value": "Bayes Factor Evidence"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb438"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb438",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000432"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000394",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000394",
      "bemo:BEMO_3100022": 401,
      "bemo:BEMO_3100023": "3837461a84fca58515b90e02475b1cf195c845c2cf4704aa9d0c7c2b412d9406",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses independent replication strength using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in independent replication strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating independent replication strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All experimental, computational, clinical, and omics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0"
      },
      "bemo:BEMO_3200011": "https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000394"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000389"
        },
        {
          "@id": "bemo:BEMO_2000392"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting independent replication."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/401"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000394",
      "rdfs:label": {
        "@language": "en",
        "@value": "Independent Replication Strength"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb15"
        },
        {
          "@id": "bemo:BEMO_1100015"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb15",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000394"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000443",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000443",
      "bemo:BEMO_3100022": 450,
      "bemo:BEMO_3100023": "451bb1f13aa8cd7feb728a231f72c948355ace1a73de7f1903381352517ceaf5",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses imputation validity using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in imputation validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating imputation validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000443"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000444"
        },
        {
          "@id": "bemo:BEMO_2000448"
        },
        {
          "@id": "bemo:BEMO_2000454"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which imputation supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/450"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000443",
      "rdfs:label": {
        "@language": "en",
        "@value": "Imputation Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb447"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb447",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000443"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_0000101",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "An information content entity specifying a required or optional input role for a metric computation."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:0000101",
      "rdfs:label": {
        "@language": "en",
        "@value": "metric input specification"
      },
      "rdfs:subClassOf": {
        "@id": "obo:IAO_0000030"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/34",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 34,
      "bemo:BEMO_3100023": "e3cc6b49f3bcbfabd500e6222a7c3cc053aca55c824a6afddd04a9b448378651",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Molecular, cellular, animal, translational, pharmacologic, and human studies\", \"Category\": \"Biological Plausibility and Mechanism\", \"Closely Related Metrics\": \"Cell-Type Specificity; Spatial Biological Concordance; Temporal Biological Concordance\", \"Common Misinterpretations\": \"Treating tissue specificity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment.\", \"Metric\": \"Tissue Specificity\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"GRADE; FDA Biomarker; ClinGen; OHAT; OECD\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of tissue specificity.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses tissue specificity using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in tissue specificity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 34"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000140",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000140"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/147"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Counterevidence Strength"
      }
    },
    {
      "@id": "bemo:BEMO_2000082",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000082",
      "bemo:BEMO_3100022": 89,
      "bemo:BEMO_3100023": "e7836bb1f6728d199c8634dbdbf560dae6243a3932920cc82164935a37c9180e",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses tumor purity using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in tumor purity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating tumor purity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All studies using human or animal biospecimens"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "BRISQ; ISO 15189; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000082"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000061"
        },
        {
          "@id": "bemo:BEMO_2000073"
        },
        {
          "@id": "bemo:BEMO_2000074"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of tumor purity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/89"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000082",
      "rdfs:label": {
        "@language": "en",
        "@value": "Tumor Purity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb127"
        },
        {
          "@id": "bemo:BEMO_1100003"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb127",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000082"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/171",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 171,
      "bemo:BEMO_3100023": "ec5ee159f748d5035209ae456b71092c6724bc73af9b720bf70afe3ffc41f242",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Systematic reviews, meta-analyses, evidence profiles, guidelines\", \"Category\": \"Evidence Certainty and Synthesis\", \"Closely Related Metrics\": \"Selective Nonreporting Risk; Study Heterogeneity; Between-Study Variance\", \"Common Misinterpretations\": \"Treating small-study effects as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Small-Study Effects\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/\", \"Related Frameworks\": \"GRADE; PRISMA; AMSTAR 2; RoB\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of small-study effects.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Forest plots; heterogeneity statistics; tau-squared; prediction intervals; funnel plots; regression or selection models; sensitivity analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses small-study effects using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in small-study effects can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 171"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/433",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 433,
      "bemo:BEMO_3100023": "6e6dfc0138818017108063ab02fea9da669c25ffc36ec988048eb058c538f84a",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All biomedical study reports and data releases\", \"Category\": \"Research Transparency and Reporting Completeness\", \"Closely Related Metrics\": \"Prospective Registration; Prespecified Analysis Adherence\", \"Common Misinterpretations\": \"Treating protocol availability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Study report / dataset / evidence package\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Protocol Availability\", \"References or Origin\": \"https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/\", \"Related Frameworks\": \"EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of protocol availability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses protocol availability using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in protocol availability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 433"
    },
    {
      "@id": "bemo:BEMO_2000272",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000272",
      "bemo:BEMO_3100022": 279,
      "bemo:BEMO_3100023": "e4b1deae92fd2c549054f6f19f234dbf0b73ab8ff30ff5741db1c88b5618f6c3",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses analytical validity using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in analytical validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating analytical validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000272"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000267"
        },
        {
          "@id": "bemo:BEMO_2000302"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which analytical supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/279"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000272",
      "rdfs:label": {
        "@language": "en",
        "@value": "Analytical Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb11"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb11",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000272"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000243",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000243"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/250"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Cross-Platform Genomic Concordance"
      }
    },
    {
      "@id": "bemo:BEMO_3000009",
      "@type": "owl:ObjectProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Connects a computation specification to its readiness status."
      },
      "oboInOwl:id": "BEMO:3000009",
      "rdfs:label": {
        "@language": "en",
        "@value": "has computation readiness status"
      }
    },
    {
      "@id": "bemo:BEMO_2000296",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000296",
      "bemo:BEMO_3100022": 303,
      "bemo:BEMO_3100023": "3706e41c2a6c519ccdfb2643facf47ec1d2a45cc4b5b902e54040a5a53624b7e",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses reference interval validity using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in reference interval validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating reference interval validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000296"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000274"
        },
        {
          "@id": "bemo:BEMO_2000278"
        },
        {
          "@id": "bemo:BEMO_2000289"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which reference interval supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/303"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000296",
      "rdfs:label": {
        "@language": "en",
        "@value": "Reference Interval Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb317"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb317",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000296"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000134",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000134"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/141"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Reference Standard Validity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000184",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000184"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/191"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Randomization in Experimental Allocation"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000002",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000002"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/9"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Biological Plausibility"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000097",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000097"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/104"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Immortal-Time Bias Risk"
      }
    },
    {
      "@id": "bemo:BEMO_2000128",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000128",
      "bemo:BEMO_3100022": 135,
      "bemo:BEMO_3100023": "89034784369de0142956f172eb3ca87ccad9b4cc69ac8a45b8a92adf9cc1731f",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses positive predictive value using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in positive predictive value can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Two-by-two tables; binomial confidence intervals; hierarchical diagnostic meta-analysis; threshold and prevalence analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating positive predictive value as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "QUADAS-2; STARD; TRIPOD; REMARK"
      },
      "bemo:BEMO_3200011": "https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000128"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000117"
        },
        {
          "@id": "bemo:BEMO_2000123"
        },
        {
          "@id": "bemo:BEMO_2000127"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of positive predictive value."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/135"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000128",
      "rdfs:label": {
        "@language": "en",
        "@value": "Positive Predictive Value"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb167"
        },
        {
          "@id": "bemo:BEMO_1100005"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb167",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000128"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000354",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000354"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/361"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Species Extrapolation Validity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/317",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 317,
      "bemo:BEMO_3100023": "082de1cac908d5d8b791ddee2974743d0e0eae71997e72080a5d978e931f8b6c",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Integrated omics, networks, pathways, mechanistic and dynamic systems models\", \"Category\": \"Multi-omics and Systems Biology\", \"Closely Related Metrics\": \"Pathway Topology Support; Knowledge-Graph Provenance Quality; Entity Resolution Accuracy\", \"Common Misinterpretations\": \"Treating knowledge-graph evidence completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Dataset / model / pathway / network / evidence body\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Developing\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Knowledge-Graph Evidence Completeness\", \"References or Origin\": \"https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/\", \"Related Frameworks\": \"Gene Ontology; Reactome; UniProt; GA4GH\", \"Scientific Definition\": \"The extent to which all scientifically necessary components of knowledge-graph evidence are present, documented, and evaluable.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses knowledge-graph evidence completeness using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in knowledge-graph evidence completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 317"
    },
    {
      "@id": "bemo:BEMO_2000247",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000247",
      "bemo:BEMO_3100022": 254,
      "bemo:BEMO_3100023": "6b3ff41c46f655393bf02a8730b778b41b8fad3c6f62302d7543aef197484ea3",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses genotype quality using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in genotype quality can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Read- and variant-level quality-control summaries; replicate concordance; orthogonal confirmation; benchmarking against reference materials."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating genotype quality as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAME; MINSEQE; STROBE-ME; GA4GH; HCA"
      },
      "bemo:BEMO_3200011": "https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000247"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000237"
        },
        {
          "@id": "bemo:BEMO_2000264"
        },
        {
          "@id": "bemo:BEMO_2000266"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of genotype quality."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/254"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000247",
      "rdfs:label": {
        "@language": "en",
        "@value": "Genotype Quality"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb272"
        },
        {
          "@id": "bemo:BEMO_1100010"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb272",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000247"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/402",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 402,
      "bemo:BEMO_3100023": "b49eb32e7bf118727039f0240b17aee8970c665e4a359a2bcecc87341188ecf1",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All experimental, computational, clinical, and omics studies\", \"Category\": \"Reproducibility and Replication\", \"Closely Related Metrics\": \"Result Reproducibility; Reanalysis Concordance; Data Provenance Completeness\", \"Common Misinterpretations\": \"Treating inferential reproducibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Inferential Reproducibility\", \"References or Origin\": \"https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines\", \"Related Frameworks\": \"PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0\", \"Scientific Definition\": \"The degree to which inferential reproducibility yields concordant results under the specified repeated-analysis or repeated-measurement conditions.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses inferential reproducibility using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in inferential reproducibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 402"
    },
    {
      "@id": "bemo:BEMO_2000416",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000416",
      "bemo:BEMO_3100022": 423,
      "bemo:BEMO_3100023": "fc72795f141f7cb81bc8cc86190a0c7cf2a5f2f6065d3b22f9bc88dd2e13080e",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses materials-and-reagents reporting completeness using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in materials-and-reagents reporting completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating materials-and-reagents reporting completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Study report / dataset / evidence package"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All biomedical study reports and data releases"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000416"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000407"
        },
        {
          "@id": "bemo:BEMO_2000417"
        },
        {
          "@id": "bemo:BEMO_2000428"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which all scientifically necessary components of materials-and-reagents reporting are present, documented, and evaluable."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/423"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000416",
      "rdfs:label": {
        "@language": "en",
        "@value": "Materials-and-Reagents Reporting Completeness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb425"
        },
        {
          "@id": "bemo:BEMO_1100016"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb425",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000416"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000004",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000004",
      "bemo:BEMO_3100022": 11,
      "bemo:BEMO_3100023": "6f883b8ebe7aa3d7407688c8b2390b245a894c21f5c21ffef99fe634674c5fd3",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses cross-species biological concordance using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in cross-species biological concordance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating cross-species biological concordance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Molecular, cellular, animal, translational, pharmacologic, and human studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; FDA Biomarker; ClinGen; OHAT; OECD"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000004"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000015"
        },
        {
          "@id": "bemo:BEMO_2000021"
        },
        {
          "@id": "bemo:BEMO_2000026"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree of agreement in cross-species biological across measurements, studies, methods, populations, or biological levels."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/11"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000004",
      "rdfs:label": {
        "@language": "en",
        "@value": "Cross-Species Biological Concordance"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb57"
        },
        {
          "@id": "bemo:BEMO_1100001"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb57",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000004"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/121",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 121,
      "bemo:BEMO_3100023": "6f322698057cc9561b413498181b8f2503720420a935d144d2173ae5298a3b2f",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies\", \"Category\": \"Diagnostic and Prognostic Evidence\", \"Closely Related Metrics\": \"Time-Dependent Discrimination\", \"Common Misinterpretations\": \"Treating competing-risk model validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Competing-Risk Model Validity\", \"References or Origin\": \"https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"QUADAS-2; STARD; TRIPOD; REMARK\", \"Scientific Definition\": \"The probability or degree that competing-risk model validity introduces systematic distortion into a biomedical estimate or conclusion.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses competing-risk model validity using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in competing-risk model validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 121"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000320",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000320"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/327"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Parameter Identifiability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/448",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 448,
      "bemo:BEMO_3100023": "9458d6e4371d11a80963339d3a9a6c5dcc187a36080cf18d964ecb5827c41820",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Effect Magnitude; Confidence Interval Compatibility; Statistical Power\", \"Common Misinterpretations\": \"Treating estimate precision as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Estimate Precision\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"The closeness of repeated estimates or measurements and the narrowness of uncertainty around estimate.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses estimate precision using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in estimate precision can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 448"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/476",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 476,
      "bemo:BEMO_3100023": "a9882065e899d9f8a8f701c6291666b702a9ad5b769971c1d3cb596c9e39b960",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies\", \"Category\": \"Study Design and Internal Validity\", \"Closely Related Metrics\": \"Period Effect Risk; Early Stopping Bias Risk; Adherence Integrity\", \"Common Misinterpretations\": \"Treating cluster recruitment bias risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Cluster Recruitment Bias Risk\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools\", \"Related Frameworks\": \"CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI\", \"Scientific Definition\": \"The probability or degree that cluster recruitment bias introduces systematic distortion into a biomedical estimate or conclusion.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses cluster recruitment bias risk using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in cluster recruitment bias risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 476"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000336",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000336"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/343"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Efficacy Reproducibility"
      }
    },
    {
      "@id": "bemo:BEMO_2000243",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000243",
      "bemo:BEMO_3100022": 250,
      "bemo:BEMO_3100023": "91130249c6d3c5254de370a79251a5dce82ecc1afbe7b1276235f59ee93b7b5a",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses cross-platform genomic concordance using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in cross-platform genomic concordance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating cross-platform genomic concordance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAME; MINSEQE; STROBE-ME; GA4GH; HCA"
      },
      "bemo:BEMO_3200011": "https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000243"
      },
      "bemo:BEMO_3200013": {
        "@id": "bemo:BEMO_2000263"
      },
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree of agreement in cross-platform genomic across measurements, studies, methods, populations, or biological levels."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/250"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000243",
      "rdfs:label": {
        "@language": "en",
        "@value": "Cross-Platform Genomic Concordance"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb37"
        },
        {
          "@id": "bemo:BEMO_1100010"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb37",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000243"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000237",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000237",
      "bemo:BEMO_3100022": 244,
      "bemo:BEMO_3100023": "0857b2292263da43e4b892ac8b30335b2a7fd8730d0baae8269f0919f1da549b",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses allelic balance using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in allelic balance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "ClinGen/ACMG evidence scoring; pedigree analysis; population databases; case-control data; functional assays; expert-panel review."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating allelic balance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAME; MINSEQE; STROBE-ME; GA4GH; HCA"
      },
      "bemo:BEMO_3200011": "https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000237"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000247"
        },
        {
          "@id": "bemo:BEMO_2000254"
        },
        {
          "@id": "bemo:BEMO_2000264"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of allelic balance."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/244"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000237",
      "rdfs:label": {
        "@language": "en",
        "@value": "Allelic Balance"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb264"
        },
        {
          "@id": "bemo:BEMO_1100010"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb264",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000237"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000307",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000307",
      "bemo:BEMO_3100022": 314,
      "bemo:BEMO_3100023": "e554ab3ba02f294f767076d372c3967762b850eccc356bf4d7c243480641cd98",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses emergent-property reproducibility using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in emergent-property reproducibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating emergent-property reproducibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Dataset / model / pathway / network / evidence body"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Integrated omics, networks, pathways, mechanistic and dynamic systems models"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "Gene Ontology; Reactome; UniProt; GA4GH"
      },
      "bemo:BEMO_3200011": "https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000307"
      },
      "bemo:BEMO_3200013": {
        "@id": "bemo:BEMO_2000324"
      },
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Specialized / infrequent",
      "bemo:BEMO_3200020": "Developing",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which emergent-property reproducibility yields concordant results under the specified repeated-analysis or repeated-measurement conditions."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/314"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000307",
      "rdfs:label": {
        "@language": "en",
        "@value": "Emergent-Property Reproducibility"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb42"
        },
        {
          "@id": "bemo:BEMO_1100012"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb42",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000307"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/56",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 56,
      "bemo:BEMO_3100023": "1adca583ee04c245cdae3428bd050f3ed8796d29bf4b214b5880769da8977172",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Biomarker development, qualification, endpoint and surrogate validation studies\", \"Category\": \"Biomarker and Endpoint Validation\", \"Closely Related Metrics\": \"Endpoint Validity; Endpoint Reliability; Endpoint Responsiveness\", \"Common Misinterpretations\": \"Treating outcome relevance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Outcome Relevance\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"FDA Biomarker; BEST; EMA E16; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of outcome relevance.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses outcome relevance using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in outcome relevance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 56"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/99",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 99,
      "bemo:BEMO_3100023": "75f662d9e2ee059c317733c8704b2f0f1f234146f1b2920ed572ec892b5a2d41",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized and observational etiologic studies, natural experiments, target-trial emulations\", \"Category\": \"Causal Inference\", \"Closely Related Metrics\": \"Negative-Control Validation; Dechallenge–Rechallenge Support; Mediation Evidence Strength\", \"Common Misinterpretations\": \"Treating dose–response support as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Dose–Response Support\", \"References or Origin\": \"https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting dose–response.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Method- and analyte-specific physical units\", \"What It Measures\": \"Assesses dose–response support using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in dose–response support can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 99"
    },
    {
      "@id": "bemo:BEMO_2000363",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000363",
      "bemo:BEMO_3100022": 370,
      "bemo:BEMO_3100023": "4059adb92dbe8fea43e57c309bf3c42531450ae52d814c6f79932af37f2f97a2",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses false discovery rate control using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in false discovery rate control can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating false discovery rate control as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAPE; HUPO PSI; Metabolomics Standards"
      },
      "bemo:BEMO_3200011": "https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000363"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000375"
        },
        {
          "@id": "bemo:BEMO_2000377"
        },
        {
          "@id": "bemo:BEMO_2000378"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of false discovery rate control."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/370"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000363",
      "rdfs:label": {
        "@language": "en",
        "@value": "False Discovery Rate Control"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb377"
        },
        {
          "@id": "bemo:BEMO_1100014"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb377",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000363"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000419",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000419",
      "bemo:BEMO_3100022": 426,
      "bemo:BEMO_3100023": "f6803e55dc7d7550d62e5bed1f8773c7da7d0266b37145da5354a96ceaf769c2",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses negative-result reporting using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in negative-result reporting can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating negative-result reporting as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Study report / dataset / evidence package"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All biomedical study reports and data releases"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000419"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000411"
        },
        {
          "@id": "bemo:BEMO_2000420"
        },
        {
          "@id": "bemo:BEMO_2000427"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of negative-result reporting."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/426"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000419",
      "rdfs:label": {
        "@language": "en",
        "@value": "Negative-Result Reporting"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb428"
        },
        {
          "@id": "bemo:BEMO_1100016"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb428",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000419"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_0000106",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "An information content entity specifying how uncertainty is estimated, propagated, calibrated, and reported."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:0000106",
      "rdfs:label": {
        "@language": "en",
        "@value": "uncertainty specification"
      },
      "rdfs:subClassOf": {
        "@id": "obo:IAO_0000030"
      }
    },
    {
      "@id": "bemo:BEMO_2000400",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000400",
      "bemo:BEMO_3100022": 407,
      "bemo:BEMO_3100023": "80472d064c943a6566bee4bd605245ecac370ebde0eb5ae577d7687482d47cc8",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses multiverse analysis robustness using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in multiverse analysis robustness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating multiverse analysis robustness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All experimental, computational, clinical, and omics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0"
      },
      "bemo:BEMO_3200011": "https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000400"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000404"
        },
        {
          "@id": "bemo:BEMO_2000406"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Specialized / infrequent",
      "bemo:BEMO_3200020": "Developing",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of multiverse analysis robustness."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/407"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000400",
      "rdfs:label": {
        "@language": "en",
        "@value": "Multiverse Analysis Robustness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb410"
        },
        {
          "@id": "bemo:BEMO_1100015"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb410",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000400"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000082",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000082"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/89"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Tumor Purity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000132",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000132"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/139"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Prognostic Transportability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/114",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 114,
      "bemo:BEMO_3100023": "7a907a8dc4fe2c40df0aa3c333c85c8e7231c1e33d26321171335bcd3464b6a6",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized and observational etiologic studies, natural experiments, target-trial emulations\", \"Category\": \"Causal Inference\", \"Closely Related Metrics\": \"Causal Contrast Clarity; Instrument Validity; Negative-Control Validation\", \"Common Misinterpretations\": \"Treating target trial emulation fidelity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Target Trial Emulation Fidelity\", \"References or Origin\": \"https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of target trial emulation fidelity.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses target trial emulation fidelity using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in target trial emulation fidelity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 114"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/9",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 9,
      "bemo:BEMO_3100023": "6cbc5f525d668cebb0928b8428848a625103a7b6492d0a2a618adb116f200bd3",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Molecular, cellular, animal, translational, pharmacologic, and human studies\", \"Category\": \"Biological Plausibility and Mechanism\", \"Closely Related Metrics\": \"Mechanistic Support; Mechanistic Coverage\", \"Common Misinterpretations\": \"Treating biological plausibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Biological Plausibility\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"GRADE; FDA Biomarker; ClinGen; OHAT; OECD\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of biological plausibility.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses biological plausibility using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in biological plausibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 9"
    },
    {
      "@id": "bemo:BEMO_2000384",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000384",
      "bemo:BEMO_3100022": 391,
      "bemo:BEMO_3100023": "f98e41911ad517a10150d0d24373bec15a553a9812e119c2e6a10081e9a89aaf",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses sequence coverage using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in sequence coverage can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating sequence coverage as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAPE; HUPO PSI; Metabolomics Standards"
      },
      "bemo:BEMO_3200011": "https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000384"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000380"
        },
        {
          "@id": "bemo:BEMO_2000381"
        },
        {
          "@id": "bemo:BEMO_2000382"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The proportion and representativeness of the relevant sequence captured by the evidence or measurement process."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/391"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000384",
      "rdfs:label": {
        "@language": "en",
        "@value": "Sequence Coverage"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb396"
        },
        {
          "@id": "bemo:BEMO_1100014"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb396",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000384"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000478",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000478"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/485"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Follow-up Completeness"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/396",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 396,
      "bemo:BEMO_3100023": "45fcdc0cd9da1d73796f886d24683b4f40ead7f7a14a06e84d39631b66a910ad",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All experimental, computational, clinical, and omics studies\", \"Category\": \"Reproducibility and Replication\", \"Closely Related Metrics\": \"Direct Replication Success; Analytical Reproducibility; Computational Reproducibility\", \"Common Misinterpretations\": \"Treating conceptual replication success as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Conceptual Replication Success\", \"References or Origin\": \"https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines\", \"Related Frameworks\": \"PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of conceptual replication success.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses conceptual replication success using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in conceptual replication success can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 396"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000340",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000340"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/347"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Immunotoxicity Evidence Strength"
      }
    },
    {
      "@id": "bemo:BEMO_2000021",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000021",
      "bemo:BEMO_3100022": 28,
      "bemo:BEMO_3100023": "d6b2622e1418a4a4c75dd4e74edee6d3fe7ea5ecac7eb6c453c614421e29173a",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses phenotypic concordance using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in phenotypic concordance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating phenotypic concordance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Molecular, cellular, animal, translational, pharmacologic, and human studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; FDA Biomarker; ClinGen; OHAT; OECD"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000021"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000004"
        },
        {
          "@id": "bemo:BEMO_2000015"
        },
        {
          "@id": "bemo:BEMO_2000020"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree of agreement in phenotypic across measurements, studies, methods, populations, or biological levels."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/28"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000021",
      "rdfs:label": {
        "@language": "en",
        "@value": "Phenotypic Concordance"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb73"
        },
        {
          "@id": "bemo:BEMO_1100001"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb73",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000021"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000183",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000183",
      "bemo:BEMO_3100022": 190,
      "bemo:BEMO_3100023": "98f43a472c5bc9ced611ad7ff89ac485c18a5c20ba0a8428164700738b649f75",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses positive-control performance using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in positive-control performance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating positive-control performance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "In vitro, ex vivo, organoid, animal, and preclinical experiments"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ARRIVE 2.0; SYRCLE; OECD"
      },
      "bemo:BEMO_3200011": "https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000183"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000175"
        },
        {
          "@id": "bemo:BEMO_2000181"
        },
        {
          "@id": "bemo:BEMO_2000190"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of positive-control performance."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/190"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000183",
      "rdfs:label": {
        "@language": "en",
        "@value": "Positive-Control Performance"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb217"
        },
        {
          "@id": "bemo:BEMO_1100007"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb217",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000183"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/467",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 467,
      "bemo:BEMO_3100023": "a3eba05a4613d95dc796e3df689756346c4f78ac2fda1dcb4e8cf4b813a22638",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Statistical Power; Type II Error Risk; Multiplicity Control\", \"Common Misinterpretations\": \"Treating type i error control as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Type I Error Control\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of type i error control.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses type i error control using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in type i error control can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 467"
    },
    {
      "@id": "bemo:BEMO_2000325",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000325",
      "bemo:BEMO_3100022": 332,
      "bemo:BEMO_3100023": "cb110edeb57b36960477192ea5d1484823905d046fc0f22c33bc8eb340c3c4c3",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses practical identifiability using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in practical identifiability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating practical identifiability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Dataset / model / pathway / network / evidence body"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Integrated omics, networks, pathways, mechanistic and dynamic systems models"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "Gene Ontology; Reactome; UniProt; GA4GH"
      },
      "bemo:BEMO_3200011": "https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000325"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000306"
        },
        {
          "@id": "bemo:BEMO_2000327"
        },
        {
          "@id": "bemo:BEMO_2000328"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of practical identifiability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/332"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000325",
      "rdfs:label": {
        "@language": "en",
        "@value": "Practical Identifiability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb343"
        },
        {
          "@id": "bemo:BEMO_1100012"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb343",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000325"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000289",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000289",
      "bemo:BEMO_3100022": 296,
      "bemo:BEMO_3100023": "02b8d5d020f47fcd1190b0fa52a15a86a5dd04748bbf2908e8c4e87ccdb4670f",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses measurement uncertainty using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in measurement uncertainty can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating measurement uncertainty as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000289"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000276"
        },
        {
          "@id": "bemo:BEMO_2000278"
        },
        {
          "@id": "bemo:BEMO_2000290"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of measurement uncertainty."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/296"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000289",
      "rdfs:label": {
        "@language": "en",
        "@value": "Measurement Uncertainty"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb311"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb311",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000289"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000066",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000066"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/73"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Fixation Adequacy"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/153",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 153,
      "bemo:BEMO_3100023": "f74a279906eee7e4453803727494ade321b94fc1d6196fb1882daae7f1abcf75",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Systematic reviews, meta-analyses, evidence profiles, guidelines\", \"Category\": \"Evidence Certainty and Synthesis\", \"Closely Related Metrics\": \"Evidence Stability; Evidence Directness; Evidence Precision\", \"Common Misinterpretations\": \"Treating evidence consistency as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Evidence Consistency\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/\", \"Related Frameworks\": \"GRADE; PRISMA; AMSTAR 2; RoB\", \"Scientific Definition\": \"The degree of agreement in evidence across measurements, studies, methods, populations, or biological levels.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses evidence consistency using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in evidence consistency can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 153"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/208",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 208,
      "bemo:BEMO_3100023": "5c0db0a0257f7b171655d97624fdf4764d1fabad77716300abc92c2debe71f7d",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Clinical, epidemiologic, diagnostic, translational, and population studies\", \"Category\": \"External Validity and Applicability\", \"Closely Related Metrics\": \"Comparator Applicability; Spectrum Representativeness; Subgroup Consistency\", \"Common Misinterpretations\": \"Treating outcome applicability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Outcome Applicability\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/\", \"Related Frameworks\": \"GRADE; QUADAS-2; CONSORT; STROBE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of outcome applicability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses outcome applicability using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in outcome applicability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 208"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000432",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000432"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/439"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Bayes Factor Evidence"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/333",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 333,
      "bemo:BEMO_3100023": "9009911ac3f6266273d49aa664b528314dd25468ab2969a5c3dfb8593502a99c",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Integrated omics, networks, pathways, mechanistic and dynamic systems models\", \"Category\": \"Multi-omics and Systems Biology\", \"Closely Related Metrics\": \"Entity Resolution Accuracy; Ontology Annotation Completeness; Ontology Evidence-Code Strength\", \"Common Misinterpretations\": \"Treating relation evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Dataset / model / pathway / network / evidence body\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Relation Evidence Strength\", \"References or Origin\": \"https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/\", \"Related Frameworks\": \"Gene Ontology; Reactome; UniProt; GA4GH\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting relation evidence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses relation evidence strength using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in relation evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 333"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/254",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 254,
      "bemo:BEMO_3100023": "6b3ff41c46f655393bf02a8730b778b41b8fad3c6f62302d7543aef197484ea3",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies\", \"Category\": \"Genomics and Transcriptomics\", \"Closely Related Metrics\": \"Variant Call Quality; Allelic Balance; Strand Bias\", \"Common Misinterpretations\": \"Treating genotype quality as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Genotype Quality\", \"References or Origin\": \"https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/\", \"Related Frameworks\": \"MIAME; MINSEQE; STROBE-ME; GA4GH; HCA\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of genotype quality.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Read- and variant-level quality-control summaries; replicate concordance; orthogonal confirmation; benchmarking against reference materials.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses genotype quality using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in genotype quality can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 254"
    },
    {
      "@id": "bemo:BEMO_2000482",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000482",
      "bemo:BEMO_3100022": 489,
      "bemo:BEMO_3100023": "78e4475c3f570e4a3e966d2bc7b940517b5d7eaa514d888dc22a6ea5b68d38fb",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses period effect risk using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in period effect risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating period effect risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000482"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000468"
        },
        {
          "@id": "bemo:BEMO_2000469"
        },
        {
          "@id": "bemo:BEMO_2000476"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The probability or degree that period effect introduces systematic distortion into a biomedical estimate or conclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/489"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000482",
      "rdfs:label": {
        "@language": "en",
        "@value": "Period Effect Risk"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb483"
        },
        {
          "@id": "bemo:BEMO_1100018"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb483",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000482"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/437",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 437,
      "bemo:BEMO_3100023": "3aaeec4ac26a2a3b26b615c686a2f19768e2153bd9e1e676bdcd1f2ba2812fc8",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All biomedical study reports and data releases\", \"Category\": \"Research Transparency and Reporting Completeness\", \"Closely Related Metrics\": \"Deviations-from-Protocol Transparency\", \"Common Misinterpretations\": \"Treating reproducibility information completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Study report / dataset / evidence package\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Reproducibility Information Completeness\", \"References or Origin\": \"https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/\", \"Related Frameworks\": \"EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS\", \"Scientific Definition\": \"The extent to which all scientifically necessary components of reproducibility information are present, documented, and evaluable.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses reproducibility information completeness using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in reproducibility information completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 437"
    },
    {
      "@id": "bemo:BEMO_2000285",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000285",
      "bemo:BEMO_3100022": 292,
      "bemo:BEMO_3100023": "32751f0c3f93a66c901d3c5cea950ee45482dac2a524a6e4ed0ddc20000649d1",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses limit of detection using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in limit of detection can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Replicate dilution series; blank and spiked samples; reference materials; method-comparison studies; predefined CLSI/ISO acceptance criteria."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating limit of detection as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000285"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000271"
        },
        {
          "@id": "bemo:BEMO_2000286"
        },
        {
          "@id": "bemo:BEMO_2000287"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of limit of detection."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/292"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000285",
      "rdfs:label": {
        "@language": "en",
        "@value": "Limit of Detection"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb307"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb307",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000285"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000390",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000390"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/397"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Data Availability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/198",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 198,
      "bemo:BEMO_3100023": "e39c9004563f895f591d754f0c2c01d5cfe45a0e26d44584ecb91c07d72c494a",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Clinical, epidemiologic, diagnostic, translational, and population studies\", \"Category\": \"External Validity and Applicability\", \"Closely Related Metrics\": \"Disease-Severity Generalizability; Context Sensitivity; Ecological Validity\", \"Common Misinterpretations\": \"Treating care-pathway independence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Care-Pathway Independence\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/\", \"Related Frameworks\": \"GRADE; QUADAS-2; CONSORT; STROBE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of care-pathway independence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses care-pathway independence using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in care-pathway independence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 198"
    },
    {
      "@id": "bemo:BEMO_2000461",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000461",
      "bemo:BEMO_3100022": 468,
      "bemo:BEMO_3100023": "de4287424d92a6f5a119531d8abefacf3d79beff40059540425ff1afc5f1021d",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses type ii error risk using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in type ii error risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating type ii error risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000461"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000450"
        },
        {
          "@id": "bemo:BEMO_2000451"
        },
        {
          "@id": "bemo:BEMO_2000460"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The probability or degree that type ii error introduces systematic distortion into a biomedical estimate or conclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/468"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000461",
      "rdfs:label": {
        "@language": "en",
        "@value": "Type II Error Risk"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb464"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb464",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000461"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000047",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000047"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/54"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Minimal Clinically Important Difference Validity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/27",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 27,
      "bemo:BEMO_3100023": "e56c259480c9a3f5c7efe467a62a9721824469292b9aeb900d1804f2bbfb7983",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Molecular, cellular, animal, translational, pharmacologic, and human studies\", \"Category\": \"Biological Plausibility and Mechanism\", \"Closely Related Metrics\": \"Molecular-Phenotypic Concordance; Loss-of-Function Validation; Gain-of-Function Validation\", \"Common Misinterpretations\": \"Treating perturbational validation as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Perturbational Validation\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"GRADE; FDA Biomarker; ClinGen; OHAT; OECD\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of perturbational validation.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses perturbational validation using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in perturbational validation can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 27"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000423",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000423"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/430"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Prespecified Analysis Adherence"
      }
    },
    {
      "@id": "bemo:BEMO_2000150",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000150",
      "bemo:BEMO_3100022": 157,
      "bemo:BEMO_3100023": "fed12d9ff25f08fc6db399dc5bed2e8d719fc0db8bcefb33987a3ef3db40f55c",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses evidence precision using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in evidence precision can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating evidence precision as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Systematic reviews, meta-analyses, evidence profiles, guidelines"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; PRISMA; AMSTAR 2; RoB"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000150"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000142"
        },
        {
          "@id": "bemo:BEMO_2000145"
        },
        {
          "@id": "bemo:BEMO_2000148"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The closeness of repeated estimates or measurements and the narrowness of uncertainty around evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/157"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000150",
      "rdfs:label": {
        "@language": "en",
        "@value": "Evidence Precision"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb189"
        },
        {
          "@id": "bemo:BEMO_1100006"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb189",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000150"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000274",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000274",
      "bemo:BEMO_3100022": 281,
      "bemo:BEMO_3100023": "7d6efe540a48fdb6c1d86b381d867ad016fd03d3ba3039e34ba0dd8d59bcbf8d",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses calibration traceability using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in calibration traceability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating calibration traceability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000274"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000278"
        },
        {
          "@id": "bemo:BEMO_2000281"
        },
        {
          "@id": "bemo:BEMO_2000296"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of calibration traceability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/281"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000274",
      "rdfs:label": {
        "@language": "en",
        "@value": "Calibration Traceability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb296"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb296",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000274"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/279",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 279,
      "bemo:BEMO_3100023": "e4b1deae92fd2c549054f6f19f234dbf0b73ab8ff30ff5741db1c88b5618f6c3",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Accuracy; Trueness\", \"Common Misinterpretations\": \"Treating analytical validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Analytical Validity\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"The degree to which analytical supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses analytical validity using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in analytical validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 279"
    },
    {
      "@id": "bemo:BEMO_2000334",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000334",
      "bemo:BEMO_3100022": 341,
      "bemo:BEMO_3100023": "6d7bafb114f62ee059333139662f0dfa2a0fb0aaab829ac8fcdb03ed2fbd0708",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses dose proportionality using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in dose proportionality can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating dose proportionality as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "OECD; OHAT; FDA Biomarker; EMA E16"
      },
      "bemo:BEMO_3200011": "https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000334"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000331"
        },
        {
          "@id": "bemo:BEMO_2000342"
        },
        {
          "@id": "bemo:BEMO_2000356"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of dose proportionality."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/341"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000334",
      "rdfs:label": {
        "@language": "en",
        "@value": "Dose Proportionality"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb352"
        },
        {
          "@id": "bemo:BEMO_1100013"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb352",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000334"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_3100012",
      "@type": "owl:DatatypeProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Scientifically meaningful null value."
      },
      "oboInOwl:id": "BEMO:3100012",
      "rdfs:label": {
        "@language": "en",
        "@value": "null value"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000370",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000370"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/377"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Metabolite Annotation Level"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000094",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000094"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/101"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Effect-Modification Credibility"
      }
    },
    {
      "@id": "bemo:BEMO_3100024",
      "@type": "owl:DatatypeProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Source-provided scientific importance score."
      },
      "oboInOwl:id": "BEMO:3100024",
      "rdfs:label": {
        "@language": "en",
        "@value": "scientific importance score"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/321",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 321,
      "bemo:BEMO_3100023": "191acd0c1abb112365dc2e82b9a1c639642c0798eb52983d078ac92e3f0fbeec",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Integrated omics, networks, pathways, mechanistic and dynamic systems models\", \"Category\": \"Multi-omics and Systems Biology\", \"Closely Related Metrics\": \"Network Node Confidence; Pathway Enrichment Consistency; Pathway Topology Support\", \"Common Misinterpretations\": \"Treating module stability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Dataset / model / pathway / network / evidence body\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Module Stability\", \"References or Origin\": \"https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/\", \"Related Frameworks\": \"Gene Ontology; Reactome; UniProt; GA4GH\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of module stability.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses module stability using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in module stability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 321"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/268",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 268,
      "bemo:BEMO_3100023": "1ce87bfa0e14b3c49cdf26e92f3b39ba4ce32c6192d394a99b4f3b80c80031b2",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies\", \"Category\": \"Genomics and Transcriptomics\", \"Closely Related Metrics\": \"Single-Cell Viability; Cell-Type Annotation Confidence; Spatial Transcriptomic Registration Accuracy\", \"Common Misinterpretations\": \"Treating single-cell feature detection rate as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Single-Cell Feature Detection Rate\", \"References or Origin\": \"https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/\", \"Related Frameworks\": \"MIAME; MINSEQE; STROBE-ME; GA4GH; HCA\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of single-cell feature detection rate.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses single-cell feature detection rate using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in single-cell feature detection rate can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 268"
    },
    {
      "@id": "bemo:BEMO_2000061",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000061",
      "bemo:BEMO_3100022": 68,
      "bemo:BEMO_3100023": "de5efa73121b798bb0e1a53bddae9ef743d4a522e6df52007a5b7569bc63e020",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses cellularity adequacy using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in cellularity adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating cellularity adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All studies using human or animal biospecimens"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "BRISQ; ISO 15189; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000061"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000068"
        },
        {
          "@id": "bemo:BEMO_2000073"
        },
        {
          "@id": "bemo:BEMO_2000082"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which cellularity is sufficient and fit for the stated biomedical inference."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/68"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000061",
      "rdfs:label": {
        "@language": "en",
        "@value": "Cellularity Adequacy"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb107"
        },
        {
          "@id": "bemo:BEMO_1100003"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb107",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000061"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000138",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000138"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/145"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Verification Bias Risk"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/378",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 378,
      "bemo:BEMO_3100023": "dd08774f62d4c8036bc0f7c590a94eca58c7ca0613c38dec0e386cab59cc0dbd",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies\", \"Category\": \"Proteomics and Metabolomics\", \"Closely Related Metrics\": \"Proteoform Identification Confidence; Metabolite Annotation Level; Spectral Library Match Quality\", \"Common Misinterpretations\": \"Treating metabolite identification confidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Metabolite Identification Confidence\", \"References or Origin\": \"https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/\", \"Related Frameworks\": \"MIAPE; HUPO PSI; Metabolomics Standards\", \"Scientific Definition\": \"The justified degree of certainty assigned to metabolite identification given the quantity, quality, consistency, and limitations of supporting evidence.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Target-decoy analysis; spectral scoring; reference standards; replicate injections; retention-time and mass-error monitoring; orthogonal confirmation.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses metabolite identification confidence using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in metabolite identification confidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 378"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/484",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 484,
      "bemo:BEMO_3100023": "6d08552ad6c8b3c6d5a3c8ed35293fcfc624984197116fb158f6c3a04698789f",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies\", \"Category\": \"Study Design and Internal Validity\", \"Closely Related Metrics\": \"Adherence Integrity; Intervention Classification Validity; Comparator Validity\", \"Common Misinterpretations\": \"Treating exposure classification validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Exposure Classification Validity\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools\", \"Related Frameworks\": \"CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI\", \"Scientific Definition\": \"The degree to which exposure classification supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses exposure classification validity using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in exposure classification validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 484"
    },
    {
      "@id": "bemo:BEMO_2000408",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000408",
      "bemo:BEMO_3100022": 415,
      "bemo:BEMO_3100023": "a4617b71362b91773383e09e14a13eab2a1f342da234aa0f9bf7cc4400a6ff10",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses comparator description completeness using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in comparator description completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating comparator description completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Study report / dataset / evidence package"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All biomedical study reports and data releases"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000408"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000412"
        },
        {
          "@id": "bemo:BEMO_2000415"
        },
        {
          "@id": "bemo:BEMO_2000429"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which all scientifically necessary components of comparator description are present, documented, and evaluable."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/415"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000408",
      "rdfs:label": {
        "@language": "en",
        "@value": "Comparator Description Completeness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb417"
        },
        {
          "@id": "bemo:BEMO_1100016"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb417",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000408"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/84",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 84,
      "bemo:BEMO_3100023": "f776649240f851879898d488bb90516491936e0936f6f03ac5946be6c8b62a20",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All studies using human or animal biospecimens\", \"Category\": \"Biospecimen and Preanalytical Quality\", \"Closely Related Metrics\": \"DNA Integrity; Microbial Contamination; Chain-of-Custody Integrity\", \"Common Misinterpretations\": \"Treating protein integrity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Protein Integrity\", \"References or Origin\": \"https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"BRISQ; ISO 15189; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of protein integrity.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Target-decoy analysis; spectral scoring; reference standards; replicate injections; retention-time and mass-error monitoring; orthogonal confirmation.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses protein integrity using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in protein integrity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 84"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/181",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 181,
      "bemo:BEMO_3100023": "9718ea523adf00e3cd776b8e22423abc28cf080bd659786c7568ddd524ab9208",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"In vitro, ex vivo, organoid, animal, and preclinical experiments\", \"Category\": \"Experimental Biology and Animal Research\", \"Closely Related Metrics\": \"Attrition Accounting in Animal Studies; Experimental Batch Randomization; Positive-Control Performance\", \"Common Misinterpretations\": \"Treating exclusion-criteria prespecification as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Exclusion-Criteria Prespecification\", \"References or Origin\": \"https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"ARRIVE 2.0; SYRCLE; OECD\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of exclusion-criteria prespecification.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses exclusion-criteria prespecification using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in exclusion-criteria prespecification can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 181"
    },
    {
      "@id": "bemo:BEMO_2000446",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000446",
      "bemo:BEMO_3100022": 453,
      "bemo:BEMO_3100023": "47dddb5f2dde48130ebfa9464b01b7ed1efb5da34ac2d484caa4259055162e55",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses measurement error correction using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in measurement error correction can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating measurement error correction as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000446"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000433"
        },
        {
          "@id": "bemo:BEMO_2000437"
        },
        {
          "@id": "bemo:BEMO_2000455"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of measurement error correction."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/453"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000446",
      "rdfs:label": {
        "@language": "en",
        "@value": "Measurement Error Correction"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb450"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb450",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000446"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000194",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000194"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/201"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Demographic Generalizability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000286",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000003"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000012"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000013"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000020"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a validated analyte- and method-specific measurement procedure with calibration and quality control."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"unitRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "specimen_or_material; measurement_procedure; calibration_reference; quality_control_results; unit",
      "bemo:BEMO_3100007": "replicate_measurements; environmental_conditions; instrument_version",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Method- and analyte-specific physical units",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000286"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/293"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Limit of Quantification"
      }
    },
    {
      "@id": "bemo:BEMO_2000473",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000473",
      "bemo:BEMO_3100022": 480,
      "bemo:BEMO_3100023": "47dcb7d2162b3c8496d326c0cd9b9dfbef0e0b4032c2c7d93f31f67139c5990f",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses control group appropriateness using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in control group appropriateness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating control group appropriateness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000473"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000471"
        },
        {
          "@id": "bemo:BEMO_2000487"
        },
        {
          "@id": "bemo:BEMO_2000488"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which control group is sufficient and fit for the stated biomedical inference."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/480"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000473",
      "rdfs:label": {
        "@language": "en",
        "@value": "Control Group Appropriateness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb475"
        },
        {
          "@id": "bemo:BEMO_1100018"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb475",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000473"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/297",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 297,
      "bemo:BEMO_3100023": "8f2dfbddd616818e03a89990f48f31b1db69460f1919bb65cc71ee0d68b7b4f6",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Measurement Uncertainty; Commutability; Sample Stability\", \"Common Misinterpretations\": \"Treating method comparison agreement as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Method Comparison Agreement\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"The degree of agreement in method comparison across measurements, studies, methods, populations, or biological levels.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses method comparison agreement using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in method comparison agreement can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 297"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000032",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000032"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/39"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Biomarker Sensitivity to Change"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/452",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 452,
      "bemo:BEMO_3100023": "7942499ba472159741e9410722d92887d17131b3d661f12b98b8ec8f2d490791",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Nonlinearity Assessment; Overadjustment Bias Risk; Measurement Error Correction\", \"Common Misinterpretations\": \"Treating interaction assessment adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Interaction Assessment Adequacy\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"The extent to which interaction assessment is sufficient and fit for the stated biomedical inference.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses interaction assessment adequacy using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in interaction assessment adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 452"
    },
    {
      "@id": "bemo:BEMO_2000259",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000259",
      "bemo:BEMO_3100022": 266,
      "bemo:BEMO_3100023": "1685a23504d9a42b00cb2ea9bdca0c2daeec5f3be11cc0d479a9acb5349c658a",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses single-cell ambient rna burden using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in single-cell ambient rna burden can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating single-cell ambient rna burden as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAME; MINSEQE; STROBE-ME; GA4GH; HCA"
      },
      "bemo:BEMO_3200011": "https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000259"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000260"
        },
        {
          "@id": "bemo:BEMO_2000261"
        },
        {
          "@id": "bemo:BEMO_2000262"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of single-cell ambient rna burden."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/266"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000259",
      "rdfs:label": {
        "@language": "en",
        "@value": "Single-Cell Ambient RNA Burden"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb283"
        },
        {
          "@id": "bemo:BEMO_1100010"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb283",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000259"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000010",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000010",
      "bemo:BEMO_3100022": 17,
      "bemo:BEMO_3100023": "dc1b3b375698d0aec42693d5a0b2f87405e7e7bf90759105797ad714ab4e9ab2",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses mechanistic coherence using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in mechanistic coherence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating mechanistic coherence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Molecular, cellular, animal, translational, pharmacologic, and human studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; FDA Biomarker; ClinGen; OHAT; OECD"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000010"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000009"
        },
        {
          "@id": "bemo:BEMO_2000011"
        },
        {
          "@id": "bemo:BEMO_2000013"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of mechanistic coherence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/17"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000010",
      "rdfs:label": {
        "@language": "en",
        "@value": "Mechanistic Coherence"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb63"
        },
        {
          "@id": "bemo:BEMO_1100001"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb63",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000010"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000379",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000379"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/386"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Proteoform Identification Confidence"
      }
    },
    {
      "@id": "bemo:BEMO_2000321",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000321",
      "bemo:BEMO_3100022": 328,
      "bemo:BEMO_3100023": "9735c06335e80bafcbeea74ccb7b405e18e8684330b82448424f6e83ef3974ba",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses parameter sensitivity using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in parameter sensitivity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating parameter sensitivity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Dataset / model / pathway / network / evidence body"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Integrated omics, networks, pathways, mechanistic and dynamic systems models"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "Gene Ontology; Reactome; UniProt; GA4GH"
      },
      "bemo:BEMO_3200011": "https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000321"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000320"
        },
        {
          "@id": "bemo:BEMO_2000325"
        },
        {
          "@id": "bemo:BEMO_2000328"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of parameter sensitivity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/328"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000321",
      "rdfs:label": {
        "@language": "en",
        "@value": "Parameter Sensitivity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb339"
        },
        {
          "@id": "bemo:BEMO_1100012"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb339",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000321"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/80",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 80,
      "bemo:BEMO_3100023": "33466881e023e8dc75d5f189be9da266f95f3bf8283fa46f9f4cff10e5af6f95",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All studies using human or animal biospecimens\", \"Category\": \"Biospecimen and Preanalytical Quality\", \"Closely Related Metrics\": \"Cellularity Adequacy; Hemolysis Burden; Lipemia Burden\", \"Common Misinterpretations\": \"Treating necrosis burden as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Necrosis Burden\", \"References or Origin\": \"https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"BRISQ; ISO 15189; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of necrosis burden.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses necrosis burden using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in necrosis burden can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 80"
    },
    {
      "@id": "bemo:BEMO_1000002",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Metrics assessing internal validity, statistical inference, causal identification, bias, and study design."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:1000002",
      "rdfs:label": {
        "@language": "en",
        "@value": "Study Design, Statistical Validity, and Causal Inference metric"
      },
      "rdfs:subClassOf": {
        "@id": "bemo:BEMO_0000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/304",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 304,
      "bemo:BEMO_3100023": "289ee6101d32dc64bb4644380815480f0d1de4b3d0512c355bf6d1bb8e30c7f2",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Analytical Precision; Intermediate Precision; Reproducibility of Measurement\", \"Common Misinterpretations\": \"Treating repeatability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Repeatability\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"The degree to which repeatability yields concordant results under the specified repeated-analysis or repeated-measurement conditions.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses repeatability using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in repeatability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 304"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000064",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000064"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/71"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Collection Procedure Consistency"
      }
    },
    {
      "@id": "bemo:BEMO_3200006",
      "@type": "owl:AnnotationProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Preserves the source warnings about misinterpretation."
      },
      "oboInOwl:id": "BEMO:3200006",
      "rdfs:label": {
        "@language": "en",
        "@value": "common misinterpretations"
      }
    },
    {
      "@id": "bemo:BEMO_1100007",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Category of biomedical evidence metrics concerned with experimental biology and animal research."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:1100007",
      "rdfs:label": {
        "@language": "en",
        "@value": "Experimental Biology and Animal Research metric"
      },
      "rdfs:subClassOf": {
        "@id": "bemo:BEMO_1000006"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/480",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 480,
      "bemo:BEMO_3100023": "47dcb7d2162b3c8496d326c0cd9b9dfbef0e0b4032c2c7d93f31f67139c5990f",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies\", \"Category\": \"Study Design and Internal Validity\", \"Closely Related Metrics\": \"Comparator Validity; Temporal Precedence; Study Design Appropriateness\", \"Common Misinterpretations\": \"Treating control group appropriateness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Control Group Appropriateness\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools\", \"Related Frameworks\": \"CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI\", \"Scientific Definition\": \"The extent to which control group is sufficient and fit for the stated biomedical inference.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses control group appropriateness using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in control group appropriateness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 480"
    },
    {
      "@id": "https://w3id.org/bemo/alignment/PROV-O",
      "@type": "prov:Entity",
      "dcterms:source": {
        "@id": "http://www.w3.org/ns/prov-o"
      }
    },
    {
      "@id": "bemo:BEMO_2000053",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000053",
      "bemo:BEMO_3100022": 60,
      "bemo:BEMO_3100023": "a8e8ef21a701fbb547c028557e4678bc79ebeda610eb6926bf0061b6e9a016c4",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses response biomarker validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in response biomarker validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating response biomarker validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Biomarker development, qualification, endpoint and surrogate validation studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; BEST; EMA E16; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000053"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000045"
        },
        {
          "@id": "bemo:BEMO_2000055"
        },
        {
          "@id": "bemo:BEMO_2000056"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which response biomarker supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/60"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000053",
      "rdfs:label": {
        "@language": "en",
        "@value": "Response Biomarker Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb101"
        },
        {
          "@id": "bemo:BEMO_1100002"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb101",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000053"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/169",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 169,
      "bemo:BEMO_3100023": "ae14a6a3126f2ecd31144006a017263d5e10df0fcde0e6bd8cc0872e93853a7a",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Systematic reviews, meta-analyses, evidence profiles, guidelines\", \"Category\": \"Evidence Certainty and Synthesis\", \"Closely Related Metrics\": \"Missing Evidence Risk; Selective Nonreporting Risk; Small-Study Effects\", \"Common Misinterpretations\": \"Treating publication bias risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Publication Bias Risk\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/\", \"Related Frameworks\": \"GRADE; PRISMA; AMSTAR 2; RoB\", \"Scientific Definition\": \"The probability or degree that publication bias introduces systematic distortion into a biomedical estimate or conclusion.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Forest plots; heterogeneity statistics; tau-squared; prediction intervals; funnel plots; regression or selection models; sensitivity analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses publication bias risk using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in publication bias risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 169"
    },
    {
      "@id": "bemo:BEMO_2000439",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000439",
      "bemo:BEMO_3100022": 446,
      "bemo:BEMO_3100023": "e21896fd55cc8da1ecb273cc15de195832d87a4d4554d2b68b3a9ce060442d84",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses effect magnitude using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in effect magnitude can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating effect magnitude as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000439"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000435"
        },
        {
          "@id": "bemo:BEMO_2000441"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of effect magnitude."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/446"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000439",
      "rdfs:label": {
        "@language": "en",
        "@value": "Effect Magnitude"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb17"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb17",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000439"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_1100006",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Category of biomedical evidence metrics concerned with evidence certainty and synthesis."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:1100006",
      "rdfs:label": {
        "@language": "en",
        "@value": "Evidence Certainty and Synthesis metric"
      },
      "rdfs:subClassOf": {
        "@id": "bemo:BEMO_1000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000169",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000169"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/176"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Animal Model Predictive Validity"
      }
    },
    {
      "@id": "bemo:BEMO_2000459",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000459",
      "bemo:BEMO_3100022": 466,
      "bemo:BEMO_3100023": "b5866270dc0b1ae7d14dc9e42f0ff6a1d28896f404d73ddeb44c5f7fdaf6b51a",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses statistical power using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in statistical power can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating statistical power as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000459"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000435"
        },
        {
          "@id": "bemo:BEMO_2000460"
        },
        {
          "@id": "bemo:BEMO_2000461"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of statistical power."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/466"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000459",
      "rdfs:label": {
        "@language": "en",
        "@value": "Statistical Power"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb462"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb462",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000459"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/310",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 310,
      "bemo:BEMO_3100023": "89f675805a18a02e8214d03853d6a7cdcea2d29079ee839babae7605cea7a581",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Integrated omics, networks, pathways, mechanistic and dynamic systems models\", \"Category\": \"Multi-omics and Systems Biology\", \"Closely Related Metrics\": \"Cross-Omics Replication; Latent-Factor Stability; Network Reconstruction Robustness\", \"Common Misinterpretations\": \"Treating cross-layer directional concordance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Dataset / model / pathway / network / evidence body\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Cross-Layer Directional Concordance\", \"References or Origin\": \"https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/\", \"Related Frameworks\": \"Gene Ontology; Reactome; UniProt; GA4GH\", \"Scientific Definition\": \"The degree of agreement in cross-layer directional across measurements, studies, methods, populations, or biological levels.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses cross-layer directional concordance using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in cross-layer directional concordance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 310"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/267",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 267,
      "bemo:BEMO_3100023": "47e6d4bd3f64b35d8abb9925b05e112fbb1356d383dc641a47f78f8e9bbeb676",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies\", \"Category\": \"Genomics and Transcriptomics\", \"Closely Related Metrics\": \"Alternative Splicing Validation; Single-Cell Ambient RNA Burden; Single-Cell Viability\", \"Common Misinterpretations\": \"Treating single-cell doublet burden as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Single-Cell Doublet Burden\", \"References or Origin\": \"https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/\", \"Related Frameworks\": \"MIAME; MINSEQE; STROBE-ME; GA4GH; HCA\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of single-cell doublet burden.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses single-cell doublet burden using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in single-cell doublet burden can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 267"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000123",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000123"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/130"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Negative Predictive Value"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000362",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000362"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/369"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Extraction Recovery"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000187",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000187"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/194"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Species Appropriateness"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000104",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000104"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/111"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Residual Confounding Risk"
      }
    },
    {
      "@id": "bemo:BEMO_2000313",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000313",
      "bemo:BEMO_3100022": 320,
      "bemo:BEMO_3100023": "433f97851837c60d123f8a332258d7d5b3872aa7c5564c19691b4c4c00871a8b",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses model–experiment concordance using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in model–experiment concordance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating model–experiment concordance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Dataset / model / pathway / network / evidence body"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Integrated omics, networks, pathways, mechanistic and dynamic systems models"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "Gene Ontology; Reactome; UniProt; GA4GH"
      },
      "bemo:BEMO_3200011": "https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000313"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000319"
        },
        {
          "@id": "bemo:BEMO_2000320"
        },
        {
          "@id": "bemo:BEMO_2000321"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree of agreement in model–experiment across measurements, studies, methods, populations, or biological levels."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/320"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000313",
      "rdfs:label": {
        "@language": "en",
        "@value": "Model–Experiment Concordance"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb331"
        },
        {
          "@id": "bemo:BEMO_1100012"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb331",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000313"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/28",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 28,
      "bemo:BEMO_3100023": "d6b2622e1418a4a4c75dd4e74edee6d3fe7ea5ecac7eb6c453c614421e29173a",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Molecular, cellular, animal, translational, pharmacologic, and human studies\", \"Category\": \"Biological Plausibility and Mechanism\", \"Closely Related Metrics\": \"Cross-Species Biological Concordance; Molecular-Phenotypic Concordance; Perturbational Validation\", \"Common Misinterpretations\": \"Treating phenotypic concordance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Phenotypic Concordance\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"GRADE; FDA Biomarker; ClinGen; OHAT; OECD\", \"Scientific Definition\": \"The degree of agreement in phenotypic across measurements, studies, methods, populations, or biological levels.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses phenotypic concordance using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in phenotypic concordance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 28"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000127",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000005"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000009"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator; the null value is typically 1 where scientifically applicable"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator != 0\"],\"null_value\":1}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "confidence_level; stratum",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Ratio scale; null typically 1",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100012": "1",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Not generally required unless converted to a probability or score."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000127"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/134"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Positive Likelihood Ratio"
      }
    },
    {
      "@id": "bemo:BEMO_2000353",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000353",
      "bemo:BEMO_3100022": 360,
      "bemo:BEMO_3100023": "2957579a3d734fc808c8a89eb160fb182b5f5a0f68ba40c4eecc1921dea93153",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses selectivity profile using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in selectivity profile can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating selectivity profile as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "OECD; OHAT; FDA Biomarker; EMA E16"
      },
      "bemo:BEMO_3200011": "https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000353"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000336"
        },
        {
          "@id": "bemo:BEMO_2000349"
        },
        {
          "@id": "bemo:BEMO_2000350"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of selectivity profile."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/360"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000353",
      "rdfs:label": {
        "@language": "en",
        "@value": "Selectivity Profile"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb368"
        },
        {
          "@id": "bemo:BEMO_1100013"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb368",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000353"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000380",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000380"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/387"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Proteome Coverage"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000287",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000287"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/294"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Linearity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/236",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 236,
      "bemo:BEMO_3100023": "ae0b81578c2487ac58cc25c0925e5e5b5580990b17b1391fc512e266a26a2788",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mendelian disease, cancer genetics, association, segregation, and functional studies\", \"Category\": \"Genetics and Variant Evidence\", \"Closely Related Metrics\": \"Computational Variant Evidence; Variant Phase Evidence; Loss-of-Function Mechanism Validity\", \"Common Misinterpretations\": \"Treating phenotypic specificity for variant as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment.\", \"Metric\": \"Phenotypic Specificity for Variant\", \"References or Origin\": \"https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/\", \"Related Frameworks\": \"ClinGen; ACMG AMP; STREGA; Gene Ontology\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of phenotypic specificity for variant.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"ClinGen/ACMG evidence scoring; pedigree analysis; population databases; case-control data; functional assays; expert-panel review.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses phenotypic specificity for variant using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in phenotypic specificity for variant can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 236"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000048",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000048"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/55"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Monitoring Biomarker Validity"
      }
    },
    {
      "@id": "bemo:BEMO_2000328",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000328",
      "bemo:BEMO_3100022": 335,
      "bemo:BEMO_3100023": "36fbdf592582d2c048b53d43d95edfca8afe5d6c7c93d352f32f2a7d7644cfbe",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses structural identifiability using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in structural identifiability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating structural identifiability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Dataset / model / pathway / network / evidence body"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Integrated omics, networks, pathways, mechanistic and dynamic systems models"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "Gene Ontology; Reactome; UniProt; GA4GH"
      },
      "bemo:BEMO_3200011": "https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000328"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000306"
        },
        {
          "@id": "bemo:BEMO_2000321"
        },
        {
          "@id": "bemo:BEMO_2000325"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of structural identifiability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/335"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000328",
      "rdfs:label": {
        "@language": "en",
        "@value": "Structural Identifiability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb346"
        },
        {
          "@id": "bemo:BEMO_1100012"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb346",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000328"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000001",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000001"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/8"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Biological Gradient"
      }
    },
    {
      "@id": "bemo:BEMO_2000479",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000479",
      "bemo:BEMO_3100022": 486,
      "bemo:BEMO_3100023": "283a3544a9dd5cb1a16190c929c82c6db2608db0f4c24860780498cb89bc0ac5",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses intervention classification validity using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in intervention classification validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating intervention classification validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000479"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000471"
        },
        {
          "@id": "bemo:BEMO_2000473"
        },
        {
          "@id": "bemo:BEMO_2000477"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which intervention classification supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/486"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000479",
      "rdfs:label": {
        "@language": "en",
        "@value": "Intervention Classification Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb480"
        },
        {
          "@id": "bemo:BEMO_1100018"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb480",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000479"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000317",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000317"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/324"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Network Reconstruction Robustness"
      }
    },
    {
      "@id": "bemo:BEMO_3100019",
      "@type": "owl:DatatypeProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Policy governing thresholds."
      },
      "oboInOwl:id": "BEMO:3100019",
      "rdfs:label": {
        "@language": "en",
        "@value": "threshold policy"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000231",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000231"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/238"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for RNA Evidence Strength"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000388",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000388"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/395"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Computational Reproducibility"
      }
    },
    {
      "@id": "bemo:BEMO_2000044",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000044",
      "bemo:BEMO_3100022": 51,
      "bemo:BEMO_3100023": "f79c486fa1f56b17619593da318c44a3704cbd1294be41ae30a2b38ceb9410d1",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses endpoint validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in endpoint validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating endpoint validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Biomarker development, qualification, endpoint and surrogate validation studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; BEST; EMA E16; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000044"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000042"
        },
        {
          "@id": "bemo:BEMO_2000049"
        },
        {
          "@id": "bemo:BEMO_2000057"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which endpoint supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/51"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000044",
      "rdfs:label": {
        "@language": "en",
        "@value": "Endpoint Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb93"
        },
        {
          "@id": "bemo:BEMO_1100002"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb93",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000044"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/59",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 59,
      "bemo:BEMO_3100023": "2dd804ff14e01e089d83a5d2d6ef790d24cf90ca54d3426049116e4e7aeb095f",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Biomarker development, qualification, endpoint and surrogate validation studies\", \"Category\": \"Biomarker and Endpoint Validation\", \"Closely Related Metrics\": \"Predictive Biomarker Validity; Diagnostic Biomarker Validity; Pharmacodynamic Biomarker Validity\", \"Common Misinterpretations\": \"Treating prognostic biomarker validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Prognostic Biomarker Validity\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"FDA Biomarker; BEST; EMA E16; REMARK\", \"Scientific Definition\": \"The degree to which prognostic biomarker supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses prognostic biomarker validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in prognostic biomarker validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 59"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000234",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000234"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/241"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Variant Classification Stability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000473",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000473"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/480"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Control Group Appropriateness"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/184",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 184,
      "bemo:BEMO_3100023": "3f6791503c2895971802b5fb5573311999fc32cde51839dc771c56e4855ceb83",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"In vitro, ex vivo, organoid, animal, and preclinical experiments\", \"Category\": \"Experimental Biology and Animal Research\", \"Closely Related Metrics\": \"Age Appropriateness; Housing and Husbandry Control; Environmental Standardization\", \"Common Misinterpretations\": \"Treating genetic background control as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Genetic Background Control\", \"References or Origin\": \"https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"ARRIVE 2.0; SYRCLE; OECD\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of genetic background control.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses genetic background control using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in genetic background control can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 184"
    },
    {
      "@id": "bemo:BEMO_2000407",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000407",
      "bemo:BEMO_3100022": 414,
      "bemo:BEMO_3100023": "d85d4b116984de9e36c9410fc248aae4b536153c50f4651cf7e48c6b558b49eb",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses code-sharing transparency using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in code-sharing transparency can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating code-sharing transparency as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Study report / dataset / evidence package"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All biomedical study reports and data releases"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000407"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000410"
        },
        {
          "@id": "bemo:BEMO_2000416"
        },
        {
          "@id": "bemo:BEMO_2000417"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of code-sharing transparency."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/414"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000407",
      "rdfs:label": {
        "@language": "en",
        "@value": "Code-Sharing Transparency"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb416"
        },
        {
          "@id": "bemo:BEMO_1100016"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb416",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000407"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_0000404",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A controlled concept describing how greater or lower values should be interpreted."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:0000404",
      "rdfs:label": {
        "@language": "en",
        "@value": "directionality"
      },
      "rdfs:subClassOf": {
        "@id": "skos:Concept"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000098",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000098"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/105"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Instrument Validity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/477",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 477,
      "bemo:BEMO_3100023": "de36d6b209ddc70bf44fd968006b0ba61482bcc4bbe42db3c2a605301631de5e",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies\", \"Category\": \"Study Design and Internal Validity\", \"Closely Related Metrics\": \"Contamination Risk; Carryover Effect Risk; Period Effect Risk\", \"Common Misinterpretations\": \"Treating co-intervention bias risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Co-intervention Bias Risk\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools\", \"Related Frameworks\": \"CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI\", \"Scientific Definition\": \"The probability or degree that co-intervention bias introduces systematic distortion into a biomedical estimate or conclusion.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses co-intervention bias risk using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in co-intervention bias risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 477"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/306",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 306,
      "bemo:BEMO_3100023": "83e10528c5f3255388bb807d6bfc99c4e2c93d4f418421fcd184c242521982d5",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Intermediate Precision; Analytical Sensitivity; Analytical Specificity\", \"Common Misinterpretations\": \"Treating reproducibility of measurement as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Reproducibility of Measurement\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"The degree to which reproducibility of measurement yields concordant results under the specified repeated-analysis or repeated-measurement conditions.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses reproducibility of measurement using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in reproducibility of measurement can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 306"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/340",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 340,
      "bemo:BEMO_3100023": "f5636ed02b8746eb48d98671b027c695a8940399bff60ebeae8ca955d99bae6a",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies\", \"Category\": \"Pharmacology and Toxicology\", \"Closely Related Metrics\": \"Reproductive Toxicity Evidence Strength; Immunotoxicity Evidence Strength; Toxicokinetic Concordance\", \"Common Misinterpretations\": \"Treating developmental toxicity evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Developmental Toxicity Evidence Strength\", \"References or Origin\": \"https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline\", \"Related Frameworks\": \"OECD; OHAT; FDA Biomarker; EMA E16\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting developmental toxicity evidence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses developmental toxicity evidence strength using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in developmental toxicity evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 340"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/242",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 242,
      "bemo:BEMO_3100023": "ce239eedae0622eb1018ab2bfc52cd2d32ef0a5f6a874008c2d8838deb99bd4a",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mendelian disease, cancer genetics, association, segregation, and functional studies\", \"Category\": \"Genetics and Variant Evidence\", \"Closely Related Metrics\": \"Gene–Disease Validity; Population Frequency Compatibility; Segregation Evidence Strength\", \"Common Misinterpretations\": \"Treating variant pathogenicity evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Variant Pathogenicity Evidence Strength\", \"References or Origin\": \"https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/\", \"Related Frameworks\": \"ClinGen; ACMG AMP; STREGA; Gene Ontology\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting variant pathogenicity evidence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"ClinGen/ACMG evidence scoring; pedigree analysis; population databases; case-control data; functional assays; expert-panel review.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses variant pathogenicity evidence strength using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in variant pathogenicity evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 242"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000326",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000326"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/333"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Relation Evidence Strength"
      }
    },
    {
      "@id": "bemo:BEMO_2000368",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000368",
      "bemo:BEMO_3100022": 375,
      "bemo:BEMO_3100023": "ebb0e828e6a056d20bce6788aee10b743cfcc2fc175a82fd693585711880ff73",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses mass accuracy using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in mass accuracy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Target-decoy analysis; spectral scoring; reference standards; replicate injections; retention-time and mass-error monitoring; orthogonal confirmation."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating mass accuracy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAPE; HUPO PSI; Metabolomics Standards"
      },
      "bemo:BEMO_3200011": "https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000368"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000364"
        },
        {
          "@id": "bemo:BEMO_2000367"
        },
        {
          "@id": "bemo:BEMO_2000383"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The closeness of mass to the accepted reference or true value."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/375"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000368",
      "rdfs:label": {
        "@language": "en",
        "@value": "Mass Accuracy"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb382"
        },
        {
          "@id": "bemo:BEMO_1100014"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb382",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000368"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000283",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000283"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/290"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Interference Susceptibility"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000430",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000430"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/437"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Reproducibility Information Completeness"
      }
    },
    {
      "@id": "bemo:BEMO_2000219",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000219",
      "bemo:BEMO_3100022": 226,
      "bemo:BEMO_3100023": "6530e53b02059e4bfd6465ae64ac385198a560d8a80df4ba701894a8c5cb0975",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses founder-effect assessment using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in founder-effect assessment can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating founder-effect assessment as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mendelian disease, cancer genetics, association, segregation, and functional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ClinGen; ACMG AMP; STREGA; Gene Ontology"
      },
      "bemo:BEMO_3200011": "https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000219"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000218"
        },
        {
          "@id": "bemo:BEMO_2000224"
        },
        {
          "@id": "bemo:BEMO_2000228"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of founder-effect assessment."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/226"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000219",
      "rdfs:label": {
        "@language": "en",
        "@value": "Founder-Effect Assessment"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb248"
        },
        {
          "@id": "bemo:BEMO_1100009"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb248",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000219"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/119",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 119,
      "bemo:BEMO_3100023": "4a117ceb82993be69cf387d42f6626e25d4ff682e98eb458d01d55a60ca6f29d",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies\", \"Category\": \"Diagnostic and Prognostic Evidence\", \"Closely Related Metrics\": \"Calibration Slope; Observed-to-Expected Ratio; Prognostic Added Value\", \"Common Misinterpretations\": \"Treating calibration-in-the-large as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Calibration-in-the-Large\", \"References or Origin\": \"https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"QUADAS-2; STARD; TRIPOD; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of calibration-in-the-large.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses calibration-in-the-large using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in calibration-in-the-large can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 119"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000462",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000462"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/469"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Variance Estimation Validity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/494",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 494,
      "bemo:BEMO_3100023": "7f9fb8e0c1ccb555a18bd7b6b07b3173d661a6707fab17a21ee632e59503b393",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies\", \"Category\": \"Study Design and Internal Validity\", \"Closely Related Metrics\": \"Temporal Precedence; Protocol Fidelity; Outcome Ascertainment Validity\", \"Common Misinterpretations\": \"Treating study design appropriateness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Study Design Appropriateness\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools\", \"Related Frameworks\": \"CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI\", \"Scientific Definition\": \"The extent to which study design is sufficient and fit for the stated biomedical inference.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses study design appropriateness using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in study design appropriateness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 494"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000101",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000101"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/108"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for No-Interference Plausibility"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/481",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 481,
      "bemo:BEMO_3100023": "98c36b49fe475eec66359fae3b2440fc1429c378e2bbe5896e082ec203855535",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies\", \"Category\": \"Study Design and Internal Validity\", \"Closely Related Metrics\": \"Performance Bias Risk; Attrition Bias Risk; Selective Outcome Reporting Risk\", \"Common Misinterpretations\": \"Treating detection bias risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Detection Bias Risk\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools\", \"Related Frameworks\": \"CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI\", \"Scientific Definition\": \"The probability or degree that detection bias introduces systematic distortion into a biomedical estimate or conclusion.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses detection bias risk using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in detection bias risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 481"
    },
    {
      "@id": "bemo:BEMO_2000197",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000197",
      "bemo:BEMO_3100022": 204,
      "bemo:BEMO_3100023": "291600cbcf719af0c4e82629e00cccabf1b55b19eff672c1fb6c5c7fe2ec4338",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses external validity using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in external validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating external validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Clinical, epidemiologic, diagnostic, translational, and population studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; QUADAS-2; CONSORT; STROBE"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000197"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000203"
        },
        {
          "@id": "bemo:BEMO_2000205"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which external supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/204"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000197",
      "rdfs:label": {
        "@language": "en",
        "@value": "External Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb8"
        },
        {
          "@id": "bemo:BEMO_1100008"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb8",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000197"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000284",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000284"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/291"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Intermediate Precision"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/394",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 394,
      "bemo:BEMO_3100023": "196f2dc58cfb1ea70e003d9904020fcfd1f4feec7308ace2e85d573eb71d3b5e",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All experimental, computational, clinical, and omics studies\", \"Category\": \"Reproducibility and Replication\", \"Closely Related Metrics\": \"Material Availability; Data Availability; Random-Seed Stability\", \"Common Misinterpretations\": \"Treating code availability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Code Availability\", \"References or Origin\": \"https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines\", \"Related Frameworks\": \"PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of code availability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses code availability using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in code availability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 394"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/356",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 356,
      "bemo:BEMO_3100023": "2199b92ac6c23ce1866fa6fdae782c65a478ec51834e2f0193f79d608ea4c3e7",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies\", \"Category\": \"Pharmacology and Toxicology\", \"Closely Related Metrics\": \"Selectivity Profile; Efficacy Reproducibility; Therapeutic Window Evidence\", \"Common Misinterpretations\": \"Treating potency reproducibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Potency Reproducibility\", \"References or Origin\": \"https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline\", \"Related Frameworks\": \"OECD; OHAT; FDA Biomarker; EMA E16\", \"Scientific Definition\": \"The degree to which potency reproducibility yields concordant results under the specified repeated-analysis or repeated-measurement conditions.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses potency reproducibility using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in potency reproducibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 356"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/399",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 399,
      "bemo:BEMO_3100023": "e6b0ec1b803bb2c7cb8becab175dbb88ab91c9d8ccd3f713a814c836846ea547",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All experimental, computational, clinical, and omics studies\", \"Category\": \"Reproducibility and Replication\", \"Closely Related Metrics\": \"Independent Replication Strength; Conceptual Replication Success; Analytical Reproducibility\", \"Common Misinterpretations\": \"Treating direct replication success as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Direct Replication Success\", \"References or Origin\": \"https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines\", \"Related Frameworks\": \"PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of direct replication success.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses direct replication success using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in direct replication success can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 399"
    },
    {
      "@id": "bemo:BEMO_2000234",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000234",
      "bemo:BEMO_3100022": 241,
      "bemo:BEMO_3100023": "103d1dc365ad36d3caee0208333084352e814015d8cdbebbb9964106d3315f21",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses variant classification stability using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in variant classification stability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "ClinGen/ACMG evidence scoring; pedigree analysis; population databases; case-control data; functional assays; expert-panel review."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating variant classification stability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mendelian disease, cancer genetics, association, segregation, and functional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ClinGen; ACMG AMP; STREGA; Gene Ontology"
      },
      "bemo:BEMO_3200011": "https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000234"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000216"
        },
        {
          "@id": "bemo:BEMO_2000222"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of variant classification stability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/241"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000234",
      "rdfs:label": {
        "@language": "en",
        "@value": "Variant Classification Stability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb262"
        },
        {
          "@id": "bemo:BEMO_1100009"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb262",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000234"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/140",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 140,
      "bemo:BEMO_3100023": "74d83029c18dff3247c8fb9baae1d6aba52c9b7328d218dd0210458cbd5ad7d5",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies\", \"Category\": \"Diagnostic and Prognostic Evidence\", \"Closely Related Metrics\": \"Incremental Diagnostic Value; Prognostic Discrimination; Prognostic Calibration\", \"Common Misinterpretations\": \"Treating reclassification improvement as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Reclassification Improvement\", \"References or Origin\": \"https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"QUADAS-2; STARD; TRIPOD; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of reclassification improvement.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses reclassification improvement using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in reclassification improvement can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 140"
    },
    {
      "@id": "bemo:BEMO_2000033",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000033",
      "bemo:BEMO_3100022": 40,
      "bemo:BEMO_3100023": "d54499df144e3534026302c035690746b731c0abf25107f5fccdd8bada0bd79a",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses biomarker-outcome association strength using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in biomarker-outcome association strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating biomarker-outcome association strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Biomarker development, qualification, endpoint and surrogate validation studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; BEST; EMA E16; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000033"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000028"
        },
        {
          "@id": "bemo:BEMO_2000034"
        },
        {
          "@id": "bemo:BEMO_2000037"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting biomarker-outcome association."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/40"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000033",
      "rdfs:label": {
        "@language": "en",
        "@value": "Biomarker-Outcome Association Strength"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb21"
        },
        {
          "@id": "bemo:BEMO_1100002"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb21",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000033"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000213",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000213",
      "bemo:BEMO_3100022": 220,
      "bemo:BEMO_3100023": "e9e681d8a3c5b4ca82348a6cd8fe70f3f48bd8351d482c3aa492a6712873c3db",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses case-level evidence strength using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in case-level evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating case-level evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mendelian disease, cancer genetics, association, segregation, and functional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ClinGen; ACMG AMP; STREGA; Gene Ontology"
      },
      "bemo:BEMO_3200011": "https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000213"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000211"
        },
        {
          "@id": "bemo:BEMO_2000212"
        },
        {
          "@id": "bemo:BEMO_2000220"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting case-level evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/220"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000213",
      "rdfs:label": {
        "@language": "en",
        "@value": "Case-Level Evidence Strength"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb243"
        },
        {
          "@id": "bemo:BEMO_1100009"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb243",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000213"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000246",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000246"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/253"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Genome Coverage Uniformity"
      }
    },
    {
      "@id": "bemo:BEMO_2000045",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000045",
      "bemo:BEMO_3100022": 52,
      "bemo:BEMO_3100023": "4d46697f970727d741077ee1e1f9eeeaed4beee8d6ef96a339ca927181b91ef5",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses individual-level surrogacy using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in individual-level surrogacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating individual-level surrogacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Biomarker development, qualification, endpoint and surrogate validation studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; BEST; EMA E16; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000045"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000044"
        },
        {
          "@id": "bemo:BEMO_2000055"
        },
        {
          "@id": "bemo:BEMO_2000057"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of individual-level surrogacy."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/52"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000045",
      "rdfs:label": {
        "@language": "en",
        "@value": "Individual-Level Surrogacy"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb94"
        },
        {
          "@id": "bemo:BEMO_1100002"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb94",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000045"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/483",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 483,
      "bemo:BEMO_3100023": "8ac86a4a6b6a886dad127939918a466b8c70bd2b6b13b03a987aab048ac4c7c3",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies\", \"Category\": \"Study Design and Internal Validity\", \"Closely Related Metrics\": \"Cluster Recruitment Bias Risk; Adherence Integrity; Exposure Classification Validity\", \"Common Misinterpretations\": \"Treating early stopping bias risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Early Stopping Bias Risk\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools\", \"Related Frameworks\": \"CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI\", \"Scientific Definition\": \"The probability or degree that early stopping bias introduces systematic distortion into a biomedical estimate or conclusion.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses early stopping bias risk using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in early stopping bias risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 483"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000029",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000029"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/36"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Biomarker Qualification Strength"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000482",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000482"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/489"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Period Effect Risk"
      }
    },
    {
      "@id": "bemo:BEMO_2000395",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000395",
      "bemo:BEMO_3100022": 402,
      "bemo:BEMO_3100023": "b49eb32e7bf118727039f0240b17aee8970c665e4a359a2bcecc87341188ecf1",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses inferential reproducibility using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in inferential reproducibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating inferential reproducibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All experimental, computational, clinical, and omics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0"
      },
      "bemo:BEMO_3200011": "https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000395"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000391"
        },
        {
          "@id": "bemo:BEMO_2000403"
        },
        {
          "@id": "bemo:BEMO_2000405"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which inferential reproducibility yields concordant results under the specified repeated-analysis or repeated-measurement conditions."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/402"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000395",
      "rdfs:label": {
        "@language": "en",
        "@value": "Inferential Reproducibility"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb405"
        },
        {
          "@id": "bemo:BEMO_1100015"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb405",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000395"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/55",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 55,
      "bemo:BEMO_3100023": "cc605972d7119b4dabf5e0bc927d29fa05979e706703654bb3ea93c2ebe95461",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Biomarker development, qualification, endpoint and surrogate validation studies\", \"Category\": \"Biomarker and Endpoint Validation\", \"Closely Related Metrics\": \"Pharmacodynamic Biomarker Validity; Safety Biomarker Validity; Susceptibility/Risk Biomarker Validity\", \"Common Misinterpretations\": \"Treating monitoring biomarker validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Monitoring Biomarker Validity\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"FDA Biomarker; BEST; EMA E16; REMARK\", \"Scientific Definition\": \"The degree to which monitoring biomarker supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses monitoring biomarker validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in monitoring biomarker validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 55"
    },
    {
      "@id": "bemo:BEMO_3000013",
      "@type": "owl:ObjectProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Connects a metric to an applicability profile."
      },
      "oboInOwl:id": "BEMO:3000013",
      "rdfs:label": {
        "@language": "en",
        "@value": "has applicability profile"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/15",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 15,
      "bemo:BEMO_3100023": "7b09e166eefa32f832c89264de2b3521f93b540fbc674d78fc625fd792779d09",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Molecular, cellular, animal, translational, pharmacologic, and human studies\", \"Category\": \"Biological Plausibility and Mechanism\", \"Closely Related Metrics\": \"Perturbational Validation; Gain-of-Function Validation; Rescue Experiment Support\", \"Common Misinterpretations\": \"Treating loss-of-function validation as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Loss-of-Function Validation\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"GRADE; FDA Biomarker; ClinGen; OHAT; OECD\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of loss-of-function validation.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses loss-of-function validation using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in loss-of-function validation can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 15"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/10",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 10,
      "bemo:BEMO_3100023": "8fcb10135485d0dff26bef51519f2178a09a543c766f354a728ca79b2c39c582",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Molecular, cellular, animal, translational, pharmacologic, and human studies\", \"Category\": \"Biological Plausibility and Mechanism\", \"Closely Related Metrics\": \"Pathway-Level Support; Tissue Specificity; Spatial Biological Concordance\", \"Common Misinterpretations\": \"Treating cell-type specificity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment.\", \"Metric\": \"Cell-Type Specificity\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"GRADE; FDA Biomarker; ClinGen; OHAT; OECD\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of cell-type specificity.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses cell-type specificity using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in cell-type specificity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 10"
    },
    {
      "@id": "bemo:BEMO_2000251",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000251",
      "bemo:BEMO_3100022": 258,
      "bemo:BEMO_3100023": "518f55960ed771c22a0c382ff436c097ae34f4481b35b5a64e7f2cf8493778a4",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses normalization adequacy using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in normalization adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating normalization adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAME; MINSEQE; STROBE-ME; GA4GH; HCA"
      },
      "bemo:BEMO_3200011": "https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000251"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000238"
        },
        {
          "@id": "bemo:BEMO_2000244"
        },
        {
          "@id": "bemo:BEMO_2000265"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which normalization is sufficient and fit for the stated biomedical inference."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/258"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000251",
      "rdfs:label": {
        "@language": "en",
        "@value": "Normalization Adequacy"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb276"
        },
        {
          "@id": "bemo:BEMO_1100010"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb276",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000251"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000199",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000199",
      "bemo:BEMO_3100022": 206,
      "bemo:BEMO_3100023": "22cb03e816656f6f9ad7a2acb4c32a01ffbc6b40d04a48011cef0a52134d504e",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses geographic consistency using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in geographic consistency can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating geographic consistency as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Clinical, epidemiologic, diagnostic, translational, and population studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; QUADAS-2; CONSORT; STROBE"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000199"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000194"
        },
        {
          "@id": "bemo:BEMO_2000208"
        },
        {
          "@id": "bemo:BEMO_2000209"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree of agreement in geographic across measurements, studies, methods, populations, or biological levels."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/206"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000199",
      "rdfs:label": {
        "@language": "en",
        "@value": "Geographic Consistency"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb231"
        },
        {
          "@id": "bemo:BEMO_1100008"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb231",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000199"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000096",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000096"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/103"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Falsification Test Support"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000398",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000398"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/405"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Material Availability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/434",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 434,
      "bemo:BEMO_3100023": "b53b586f994fd48c27b9acc1c6fff59b966085610e593ec05c03735d90e329b2",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All biomedical study reports and data releases\", \"Category\": \"Research Transparency and Reporting Completeness\", \"Closely Related Metrics\": \"Processed-Data Availability; Negative-Result Reporting; Null-Result Interpretability\", \"Common Misinterpretations\": \"Treating quality-control reporting completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Study report / dataset / evidence package\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Quality-Control Reporting Completeness\", \"References or Origin\": \"https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/\", \"Related Frameworks\": \"EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS\", \"Scientific Definition\": \"The extent to which all scientifically necessary components of quality-control reporting are present, documented, and evaluable.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses quality-control reporting completeness using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in quality-control reporting completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 434"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000443",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000443"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/450"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Imputation Validity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/72",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 72,
      "bemo:BEMO_3100023": "494036e6478a34bfe608bc3b1267e04a777d16e96430109ab2ba9b01e99c6693",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All studies using human or animal biospecimens\", \"Category\": \"Biospecimen and Preanalytical Quality\", \"Closely Related Metrics\": \"RNA Integrity; Protein Integrity; Microbial Contamination\", \"Common Misinterpretations\": \"Treating dna integrity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"DNA Integrity\", \"References or Origin\": \"https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"BRISQ; ISO 15189; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of dna integrity.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses dna integrity using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in dna integrity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 72"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000060",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000060"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/67"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Biospecimen Provenance Completeness"
      }
    },
    {
      "@id": "bemo:BEMO_2000409",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000409",
      "bemo:BEMO_3100022": 416,
      "bemo:BEMO_3100023": "e951e1891736a22e6ef317b85f2f1f3032c69473b10d7ac72b1ed8342656df25",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses conflict-of-interest transparency using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in conflict-of-interest transparency can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating conflict-of-interest transparency as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Study report / dataset / evidence package"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All biomedical study reports and data releases"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000409"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000407"
        },
        {
          "@id": "bemo:BEMO_2000410"
        },
        {
          "@id": "bemo:BEMO_2000413"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of conflict-of-interest transparency."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/416"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000409",
      "rdfs:label": {
        "@language": "en",
        "@value": "Conflict-of-Interest Transparency"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb418"
        },
        {
          "@id": "bemo:BEMO_1100016"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb418",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000409"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000378",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000378"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/385"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Protein Inference Reliability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000155",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000155"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/162"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Evidence Sufficiency"
      }
    },
    {
      "@id": "bemo:BEMO_2000020",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000020",
      "bemo:BEMO_3100022": 27,
      "bemo:BEMO_3100023": "e56c259480c9a3f5c7efe467a62a9721824469292b9aeb900d1804f2bbfb7983",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses perturbational validation using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in perturbational validation can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating perturbational validation as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Molecular, cellular, animal, translational, pharmacologic, and human studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; FDA Biomarker; ClinGen; OHAT; OECD"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000020"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000006"
        },
        {
          "@id": "bemo:BEMO_2000008"
        },
        {
          "@id": "bemo:BEMO_2000015"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of perturbational validation."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/27"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000020",
      "rdfs:label": {
        "@language": "en",
        "@value": "Perturbational Validation"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb72"
        },
        {
          "@id": "bemo:BEMO_1100001"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb72",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000020"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000309",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000309"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/316"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Flux-Balance Consistency"
      }
    },
    {
      "@id": "bemo:BEMO_2000060",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000060",
      "bemo:BEMO_3100022": 67,
      "bemo:BEMO_3100023": "c859051c1fe5f3cb60cda0bb4dcf804459be135ee18bb1bb44d89345dea50253",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses biospecimen provenance completeness using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in biospecimen provenance completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating biospecimen provenance completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All studies using human or animal biospecimens"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "BRISQ; ISO 15189; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000060"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000059"
        },
        {
          "@id": "bemo:BEMO_2000064"
        },
        {
          "@id": "bemo:BEMO_2000083"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which all scientifically necessary components of biospecimen provenance are present, documented, and evaluable."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/67"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000060",
      "rdfs:label": {
        "@language": "en",
        "@value": "Biospecimen Provenance Completeness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb23"
        },
        {
          "@id": "bemo:BEMO_1100003"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb23",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000060"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000378",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000378",
      "bemo:BEMO_3100022": 385,
      "bemo:BEMO_3100023": "601ad0978c475da6065d2502b00169f5521ae97cb0543ad15ad88f49903cb27e",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses protein inference reliability using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in protein inference reliability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Target-decoy analysis; spectral scoring; reference standards; replicate injections; retention-time and mass-error monitoring; orthogonal confirmation."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating protein inference reliability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAPE; HUPO PSI; Metabolomics Standards"
      },
      "bemo:BEMO_3200011": "https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000378"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000375"
        },
        {
          "@id": "bemo:BEMO_2000380"
        },
        {
          "@id": "bemo:BEMO_2000384"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of protein inference reliability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/385"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000378",
      "rdfs:label": {
        "@language": "en",
        "@value": "Protein Inference Reliability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb390"
        },
        {
          "@id": "bemo:BEMO_1100014"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb390",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000378"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/85",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 85,
      "bemo:BEMO_3100023": "98ac509f170b3163d862e8e08cc16dad8b915df5508f4e7394a8627d881f7350",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All studies using human or animal biospecimens\", \"Category\": \"Biospecimen and Preanalytical Quality\", \"Closely Related Metrics\": \"Icterus Interference; DNA Integrity; Protein Integrity\", \"Common Misinterpretations\": \"Treating rna integrity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"RNA Integrity\", \"References or Origin\": \"https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"BRISQ; ISO 15189; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of rna integrity.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses rna integrity using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in rna integrity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 85"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/400",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 400,
      "bemo:BEMO_3100023": "6c9d1f649c85d73c0009300283cb79e817b0ca9b1d53444f1a4aa4b5a2e6d8ae",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All experimental, computational, clinical, and omics studies\", \"Category\": \"Reproducibility and Replication\", \"Closely Related Metrics\": \"Computational Reproducibility; Interlaboratory Reproducibility; Intralaboratory Repeatability\", \"Common Misinterpretations\": \"Treating experimental reproducibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Experimental Reproducibility\", \"References or Origin\": \"https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines\", \"Related Frameworks\": \"PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0\", \"Scientific Definition\": \"The degree to which experimental reproducibility yields concordant results under the specified repeated-analysis or repeated-measurement conditions.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses experimental reproducibility using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in experimental reproducibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 400"
    },
    {
      "@id": "bemo:BEMO_2000332",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000332",
      "bemo:BEMO_3100022": 339,
      "bemo:BEMO_3100023": "a171459b41fd9ad0436588a80669a48227118c77c3d87194654b56ab6dfa6ad7",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses carcinogenicity evidence strength using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in carcinogenicity evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating carcinogenicity evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "OECD; OHAT; FDA Biomarker; EMA E16"
      },
      "bemo:BEMO_3200011": "https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000332"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000333"
        },
        {
          "@id": "bemo:BEMO_2000338"
        },
        {
          "@id": "bemo:BEMO_2000351"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting carcinogenicity evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/339"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000332",
      "rdfs:label": {
        "@language": "en",
        "@value": "Carcinogenicity Evidence Strength"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb350"
        },
        {
          "@id": "bemo:BEMO_1100013"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb350",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000332"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/57",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 57,
      "bemo:BEMO_3100023": "4eb497c772907b7927e32ee929fba9a804b1c75888594041caa61dfab977440a",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Biomarker development, qualification, endpoint and surrogate validation studies\", \"Category\": \"Biomarker and Endpoint Validation\", \"Closely Related Metrics\": \"Diagnostic Biomarker Validity; Monitoring Biomarker Validity; Safety Biomarker Validity\", \"Common Misinterpretations\": \"Treating pharmacodynamic biomarker validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Pharmacodynamic Biomarker Validity\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"FDA Biomarker; BEST; EMA E16; REMARK\", \"Scientific Definition\": \"The degree to which pharmacodynamic biomarker supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses pharmacodynamic biomarker validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in pharmacodynamic biomarker validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 57"
    },
    {
      "@id": "bemo:BEMO_4000007",
      "@type": [
        "owl:NamedIndividual",
        "bemo:BEMO_0000401"
      ],
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Controlled BEMO ComputationMode value: ContextSpecificMetricComputation."
      },
      "oboInOwl:id": "BEMO:4000007",
      "rdfs:label": {
        "@language": "en",
        "@value": "Context Specific Metric Computation"
      },
      "skos:notation": "ContextSpecificMetricComputation"
    },
    {
      "@id": "bemo:BEMO_2000421",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000421",
      "bemo:BEMO_3100022": 428,
      "bemo:BEMO_3100023": "129e8fff9350e8d3fb88d0a300e3816f498afcc03cf17b3f6037da094441e4fe",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses outcome definition completeness using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in outcome definition completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating outcome definition completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Study report / dataset / evidence package"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All biomedical study reports and data releases"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000421"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000408"
        },
        {
          "@id": "bemo:BEMO_2000415"
        },
        {
          "@id": "bemo:BEMO_2000423"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which all scientifically necessary components of outcome definition are present, documented, and evaluable."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/428"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000421",
      "rdfs:label": {
        "@language": "en",
        "@value": "Outcome Definition Completeness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb430"
        },
        {
          "@id": "bemo:BEMO_1100016"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb430",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000421"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000011",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000011"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/18"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Mechanistic Completeness"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/69",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 69,
      "bemo:BEMO_3100023": "38ecb99023f4b12b1bfca7d66221917ae384546ef170c868cd32fb2eb70f3f40",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All studies using human or animal biospecimens\", \"Category\": \"Biospecimen and Preanalytical Quality\", \"Closely Related Metrics\": \"Microbial Contamination; Matched-Sample Integrity\", \"Common Misinterpretations\": \"Treating chain-of-custody integrity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Chain-of-Custody Integrity\", \"References or Origin\": \"https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"BRISQ; ISO 15189; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of chain-of-custody integrity.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses chain-of-custody integrity using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in chain-of-custody integrity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 69"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/357",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 357,
      "bemo:BEMO_3100023": "5025e34702ce03c8ed7e7aa3ed95dd9bde6bac1786183651ce608b34ffcc6a28",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies\", \"Category\": \"Pharmacology and Toxicology\", \"Closely Related Metrics\": \"Drug–Drug Interaction Evidence; Selectivity Profile; Potency Reproducibility\", \"Common Misinterpretations\": \"Treating receptor occupancy evidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Receptor Occupancy Evidence\", \"References or Origin\": \"https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline\", \"Related Frameworks\": \"OECD; OHAT; FDA Biomarker; EMA E16\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of receptor occupancy evidence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses receptor occupancy evidence using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in receptor occupancy evidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 357"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/93",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 93,
      "bemo:BEMO_3100023": "a6559bfe5ff78dd7455ed538b35cec6508c7c5507441bc614a71e2140188258e",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized and observational etiologic studies, natural experiments, target-trial emulations\", \"Category\": \"Causal Inference\", \"Closely Related Metrics\": \"Confounding Risk; Residual Confounding Risk\", \"Common Misinterpretations\": \"Treating causal identifiability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Causal Identifiability\", \"References or Origin\": \"https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of causal identifiability.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Directed acyclic graphs; design emulation; balance diagnostics; negative controls; quantitative bias analysis; sensitivity and falsification analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses causal identifiability using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in causal identifiability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 93"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000095",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000095"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/102"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Exchangeability Plausibility"
      }
    },
    {
      "@id": "bemo:BEMO_2000438",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000438",
      "bemo:BEMO_3100022": 445,
      "bemo:BEMO_3100023": "79608c041c0babc1613cca804b9e22a2fcbadbeabfda7d7b0bf2336528db7db1",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses distributional assumption adequacy using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in distributional assumption adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating distributional assumption adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000438"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000447"
        },
        {
          "@id": "bemo:BEMO_2000458"
        },
        {
          "@id": "bemo:BEMO_2000462"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which distributional assumption is sufficient and fit for the stated biomedical inference."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/445"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000438",
      "rdfs:label": {
        "@language": "en",
        "@value": "Distributional Assumption Adequacy"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb444"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb444",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000438"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/239",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 239,
      "bemo:BEMO_3100023": "4f9bdcfda63260ced3f40796d43228eea03ead68f517bc87939698d4f5d4faf2",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mendelian disease, cancer genetics, association, segregation, and functional studies\", \"Category\": \"Genetics and Variant Evidence\", \"Closely Related Metrics\": \"Population Frequency Compatibility; De Novo Evidence Strength; Allelic Evidence Strength\", \"Common Misinterpretations\": \"Treating segregation evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Segregation Evidence Strength\", \"References or Origin\": \"https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/\", \"Related Frameworks\": \"ClinGen; ACMG AMP; STREGA; Gene Ontology\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting segregation evidence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"ClinGen/ACMG evidence scoring; pedigree analysis; population databases; case-control data; functional assays; expert-panel review.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses segregation evidence strength using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in segregation evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 239"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000304",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Developing; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000304"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/311"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Cross-Omics Integration Coherence"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/132",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 132,
      "bemo:BEMO_3100023": "79f6b607e0d7504f46e1d3842fa8966ae929db7058236a6b4ed553277ad444b5",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies\", \"Category\": \"Diagnostic and Prognostic Evidence\", \"Closely Related Metrics\": \"Area Under the Receiver Operating Characteristic Curve; Threshold Validity; Reference Standard Validity\", \"Common Misinterpretations\": \"Treating partial area under the receiver operating characteristic curve as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Partial Area Under the Receiver Operating Characteristic Curve\", \"References or Origin\": \"https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"QUADAS-2; STARD; TRIPOD; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of partial area under the receiver operating characteristic curve.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses partial area under the receiver operating characteristic curve using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in partial area under the receiver operating characteristic curve can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 132"
    },
    {
      "@id": "bemo:BEMO_2000268",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000268",
      "bemo:BEMO_3100022": 275,
      "bemo:BEMO_3100023": "40562e2bdf0f0c373312aa0a75941fd6a83f056ba5201b300a46242b3f5457df",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses analytical measurement range using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in analytical measurement range can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating analytical measurement range as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000268"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000280"
        },
        {
          "@id": "bemo:BEMO_2000287"
        },
        {
          "@id": "bemo:BEMO_2000298"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of analytical measurement range."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/275"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000268",
      "rdfs:label": {
        "@language": "en",
        "@value": "Analytical Measurement Range"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb291"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb291",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000268"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/8",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 8,
      "bemo:BEMO_3100023": "6471dcf670c9dd05424f4606389decf6b51812d07c0a0680842d77bda957b0f3",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Molecular, cellular, animal, translational, pharmacologic, and human studies\", \"Category\": \"Biological Plausibility and Mechanism\", \"Closely Related Metrics\": \"Off-Target Liability Evidence; Homeostatic Compensation Assessment; Network Context Support\", \"Common Misinterpretations\": \"Treating biological gradient as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Biological Gradient\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"GRADE; FDA Biomarker; ClinGen; OHAT; OECD\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of biological gradient.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses biological gradient using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in biological gradient can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 8"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000078",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000078"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/85"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for RNA Integrity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/250",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 250,
      "bemo:BEMO_3100023": "91130249c6d3c5254de370a79251a5dce82ecc1afbe7b1276235f59ee93b7b5a",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies\", \"Category\": \"Genomics and Transcriptomics\", \"Closely Related Metrics\": \"Spatial Transcriptomic Registration Accuracy\", \"Common Misinterpretations\": \"Treating cross-platform genomic concordance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Cross-Platform Genomic Concordance\", \"References or Origin\": \"https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/\", \"Related Frameworks\": \"MIAME; MINSEQE; STROBE-ME; GA4GH; HCA\", \"Scientific Definition\": \"The degree of agreement in cross-platform genomic across measurements, studies, methods, populations, or biological levels.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses cross-platform genomic concordance using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in cross-platform genomic concordance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 250"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/110",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 110,
      "bemo:BEMO_3100023": "7ee1bd197cfd8211ed7ac785b0e49ec8e73324814e415213789e479477f73c74",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized and observational etiologic studies, natural experiments, target-trial emulations\", \"Category\": \"Causal Inference\", \"Closely Related Metrics\": \"Selection-on-Survival Bias Risk; E-value Strength; Assumption Sensitivity\", \"Common Misinterpretations\": \"Treating quantitative bias analysis robustness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Quantitative Bias Analysis Robustness\", \"References or Origin\": \"https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of quantitative bias analysis robustness.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses quantitative bias analysis robustness using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in quantitative bias analysis robustness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 110"
    },
    {
      "@id": "bemo:BEMO_2000168",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000168",
      "bemo:BEMO_3100022": 175,
      "bemo:BEMO_3100023": "1bc9d94635678f728d2a96fd7016f3d61e24c78d9e33c5093213c9d715511534",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses animal model face validity using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in animal model face validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating animal model face validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "In vitro, ex vivo, organoid, animal, and preclinical experiments"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ARRIVE 2.0; SYRCLE; OECD"
      },
      "bemo:BEMO_3200011": "https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000168"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000167"
        },
        {
          "@id": "bemo:BEMO_2000169"
        },
        {
          "@id": "bemo:BEMO_2000172"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which animal model face supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/175"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000168",
      "rdfs:label": {
        "@language": "en",
        "@value": "Animal Model Face Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb204"
        },
        {
          "@id": "bemo:BEMO_1100007"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb204",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000168"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/489",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 489,
      "bemo:BEMO_3100023": "78e4475c3f570e4a3e966d2bc7b940517b5d7eaa514d888dc22a6ea5b68d38fb",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies\", \"Category\": \"Study Design and Internal Validity\", \"Closely Related Metrics\": \"Carryover Effect Risk; Cluster Recruitment Bias Risk; Early Stopping Bias Risk\", \"Common Misinterpretations\": \"Treating period effect risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Period Effect Risk\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools\", \"Related Frameworks\": \"CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI\", \"Scientific Definition\": \"The probability or degree that period effect introduces systematic distortion into a biomedical estimate or conclusion.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses period effect risk using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in period effect risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 489"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000110",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000110"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/117"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Area Under the Receiver Operating Characteristic Curve"
      }
    },
    {
      "@id": "bemo:BEMO_2000179",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000179",
      "bemo:BEMO_3100022": 186,
      "bemo:BEMO_3100023": "efafe26c06dac15c0d485bfb264933c40fe9cf7ca97c5195ea92c9cfeb3f7a98",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses humane endpoint appropriateness using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in humane endpoint appropriateness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating humane endpoint appropriateness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "In vitro, ex vivo, organoid, animal, and preclinical experiments"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ARRIVE 2.0; SYRCLE; OECD"
      },
      "bemo:BEMO_3200011": "https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000179"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000170"
        },
        {
          "@id": "bemo:BEMO_2000174"
        },
        {
          "@id": "bemo:BEMO_2000180"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which humane endpoint is sufficient and fit for the stated biomedical inference."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/186"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000179",
      "rdfs:label": {
        "@language": "en",
        "@value": "Humane Endpoint Appropriateness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb213"
        },
        {
          "@id": "bemo:BEMO_1100007"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb213",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000179"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000077",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000077",
      "bemo:BEMO_3100022": 84,
      "bemo:BEMO_3100023": "f776649240f851879898d488bb90516491936e0936f6f03ac5946be6c8b62a20",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses protein integrity using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in protein integrity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Target-decoy analysis; spectral scoring; reference standards; replicate injections; retention-time and mass-error monitoring; orthogonal confirmation."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating protein integrity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All studies using human or animal biospecimens"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "BRISQ; ISO 15189; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000077"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000062"
        },
        {
          "@id": "bemo:BEMO_2000065"
        },
        {
          "@id": "bemo:BEMO_2000072"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of protein integrity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/84"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000077",
      "rdfs:label": {
        "@language": "en",
        "@value": "Protein Integrity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb122"
        },
        {
          "@id": "bemo:BEMO_1100003"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb122",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000077"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_3200008",
      "@type": "owl:AnnotationProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Preserves the source evidence-level scope."
      },
      "oboInOwl:id": "BEMO:3200008",
      "rdfs:label": {
        "@language": "en",
        "@value": "source evidence level"
      }
    },
    {
      "@id": "bemo:BEMO_3100017",
      "@type": "owl:DatatypeProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Acceptable uncertainty estimation method."
      },
      "oboInOwl:id": "BEMO:3100017",
      "rdfs:label": {
        "@language": "en",
        "@value": "uncertainty method"
      }
    },
    {
      "@id": "bemo:BEMO_2000474",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000474",
      "bemo:BEMO_3100022": 481,
      "bemo:BEMO_3100023": "98c36b49fe475eec66359fae3b2440fc1429c378e2bbe5896e082ec203855535",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses detection bias risk using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in detection bias risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating detection bias risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000474"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000465"
        },
        {
          "@id": "bemo:BEMO_2000481"
        },
        {
          "@id": "bemo:BEMO_2000486"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The probability or degree that detection bias introduces systematic distortion into a biomedical estimate or conclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/481"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000474",
      "rdfs:label": {
        "@language": "en",
        "@value": "Detection Bias Risk"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb476"
        },
        {
          "@id": "bemo:BEMO_1100018"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb476",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000474"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000081",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000081"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/88"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Transport Condition Integrity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000228",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000228"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/235"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Phenocopy Risk"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/150",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 150,
      "bemo:BEMO_3100023": "263bd485141b0cc75ee285fb1989c667b83eb378666886a960ed5bd2a610f232",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Systematic reviews, meta-analyses, evidence profiles, guidelines\", \"Category\": \"Evidence Certainty and Synthesis\", \"Closely Related Metrics\": \"Evidence Sufficiency; Evidence Coverage; Evidence Freshness\", \"Common Misinterpretations\": \"Treating evidence completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Evidence Completeness\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/\", \"Related Frameworks\": \"GRADE; PRISMA; AMSTAR 2; RoB\", \"Scientific Definition\": \"The extent to which all scientifically necessary components of evidence are present, documented, and evaluable.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses evidence completeness using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in evidence completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 150"
    },
    {
      "@id": "bemo:BEMO_0000300",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A process that applies a metric computation specification to validated inputs and produces a metric assessment."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:0000300",
      "rdfs:label": {
        "@language": "en",
        "@value": "metric computation process"
      },
      "rdfs:subClassOf": {
        "@id": "obo:BFO_0000015"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000305",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Developing; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000305"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/312"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Cross-Omics Replication"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/241",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 241,
      "bemo:BEMO_3100023": "103d1dc365ad36d3caee0208333084352e814015d8cdbebbb9964106d3315f21",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mendelian disease, cancer genetics, association, segregation, and functional studies\", \"Category\": \"Genetics and Variant Evidence\", \"Closely Related Metrics\": \"Genotype–Phenotype Concordance; Conflicting Interpretation Burden\", \"Common Misinterpretations\": \"Treating variant classification stability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Variant Classification Stability\", \"References or Origin\": \"https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/\", \"Related Frameworks\": \"ClinGen; ACMG AMP; STREGA; Gene Ontology\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of variant classification stability.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"ClinGen/ACMG evidence scoring; pedigree analysis; population databases; case-control data; functional assays; expert-panel review.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses variant classification stability using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in variant classification stability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 241"
    },
    {
      "@id": "bemo:BEMO_2000486",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000486",
      "bemo:BEMO_3100022": 493,
      "bemo:BEMO_3100023": "bcdaa5f06df0a5ab7941c490a740787093ffc20f433c48125d9c2e174850f7fd",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses selective outcome reporting risk using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in selective outcome reporting risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating selective outcome reporting risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000486"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000465"
        },
        {
          "@id": "bemo:BEMO_2000472"
        },
        {
          "@id": "bemo:BEMO_2000483"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The probability or degree that selective outcome reporting introduces systematic distortion into a biomedical estimate or conclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/493"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000486",
      "rdfs:label": {
        "@language": "en",
        "@value": "Selective Outcome Reporting Risk"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb486"
        },
        {
          "@id": "bemo:BEMO_1100018"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb486",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000486"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000251",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000251"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/258"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Normalization Adequacy"
      }
    },
    {
      "@id": "bemo:BEMO_2000041",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000041",
      "bemo:BEMO_3100022": 48,
      "bemo:BEMO_3100023": "c0e22c7d45b8b17a4c9f1de5c7c7bb4e085d98eb667da8d43e452ea31955900b",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses discriminant validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in discriminant validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating discriminant validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Biomarker development, qualification, endpoint and surrogate validation studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; BEST; EMA E16; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000041"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000035"
        },
        {
          "@id": "bemo:BEMO_2000038"
        },
        {
          "@id": "bemo:BEMO_2000039"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which discriminant supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/48"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000041",
      "rdfs:label": {
        "@language": "en",
        "@value": "Discriminant Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb90"
        },
        {
          "@id": "bemo:BEMO_1100002"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb90",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000041"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/125",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 125,
      "bemo:BEMO_3100023": "2805e0d0838d99254f4675a5517e72c35cb3e1cb875fbc214edb03376568c858",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies\", \"Category\": \"Diagnostic and Prognostic Evidence\", \"Closely Related Metrics\": \"Verification Bias Risk; Incorporation Bias Risk; Patient Flow Integrity\", \"Common Misinterpretations\": \"Treating differential verification bias risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Differential Verification Bias Risk\", \"References or Origin\": \"https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"QUADAS-2; STARD; TRIPOD; REMARK\", \"Scientific Definition\": \"The probability or degree that differential verification bias introduces systematic distortion into a biomedical estimate or conclusion.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses differential verification bias risk using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in differential verification bias risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 125"
    },
    {
      "@id": "bemo:BEMO_2000324",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000324",
      "bemo:BEMO_3100022": 331,
      "bemo:BEMO_3100023": "5cc466b3de703eb697570667c57a9230690c56d69b5cf6ec528e42740ec621e9",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses perturbation prediction accuracy using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in perturbation prediction accuracy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating perturbation prediction accuracy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Dataset / model / pathway / network / evidence body"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Integrated omics, networks, pathways, mechanistic and dynamic systems models"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "Gene Ontology; Reactome; UniProt; GA4GH"
      },
      "bemo:BEMO_3200011": "https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000324"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000307"
        },
        {
          "@id": "bemo:BEMO_2000309"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The closeness of perturbation prediction to the accepted reference or true value."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/331"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000324",
      "rdfs:label": {
        "@language": "en",
        "@value": "Perturbation Prediction Accuracy"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb342"
        },
        {
          "@id": "bemo:BEMO_1100012"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb342",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000324"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_0000100",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "An information content entity specifying inputs, outputs, formula status, uncertainty, thresholds, missing-data policy, and validation requirements for computing a metric."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:0000100",
      "rdfs:label": {
        "@language": "en",
        "@value": "metric computation specification"
      },
      "rdfs:subClassOf": {
        "@id": "obo:IAO_0000030"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/492",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 492,
      "bemo:BEMO_3100023": "8438f239c984919f366a44747e2e32efd683c0e45e3f7af6c269801f1d6694c8",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies\", \"Category\": \"Study Design and Internal Validity\", \"Closely Related Metrics\": \"Allocation Concealment; Baseline Comparability\", \"Common Misinterpretations\": \"Treating randomization integrity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Randomization Integrity\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools\", \"Related Frameworks\": \"CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of randomization integrity.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses randomization integrity using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in randomization integrity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 492"
    },
    {
      "@id": "bemo:BEMO_2000141",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000141",
      "bemo:BEMO_3100022": 148,
      "bemo:BEMO_3100023": "e87943e84aae44a1eeb6300f5a52416f0528fe0f3bf76f40f0a2a4486c87ea6a",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses cumulative evidence stability using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in cumulative evidence stability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating cumulative evidence stability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Systematic reviews, meta-analyses, evidence profiles, guidelines"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; PRISMA; AMSTAR 2; RoB"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000141"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000157"
        },
        {
          "@id": "bemo:BEMO_2000159"
        },
        {
          "@id": "bemo:BEMO_2000161"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of cumulative evidence stability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/148"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000141",
      "rdfs:label": {
        "@language": "en",
        "@value": "Cumulative Evidence Stability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb180"
        },
        {
          "@id": "bemo:BEMO_1100006"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb180",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000141"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/120",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 120,
      "bemo:BEMO_3100023": "01f4b65430acfaca391e550bb1550450d424a1dd47aebe4ed0f6dd9d60fe28ab",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies\", \"Category\": \"Diagnostic and Prognostic Evidence\", \"Closely Related Metrics\": \"Test-Timing Appropriateness; Incremental Diagnostic Value; Reclassification Improvement\", \"Common Misinterpretations\": \"Treating comparative test accuracy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Comparative Test Accuracy\", \"References or Origin\": \"https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"QUADAS-2; STARD; TRIPOD; REMARK\", \"Scientific Definition\": \"The closeness of comparative test to the accepted reference or true value.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses comparative test accuracy using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in comparative test accuracy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 120"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000452",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000452"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/459"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Noninferiority Margin Validity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/288",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 288,
      "bemo:BEMO_3100023": "3d6a1547d736b7a958bf1c94a2df8cb5599400f10305a91c657ae1dce184650b",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Carryover; Calibration Traceability; Reference Interval Validity\", \"Common Misinterpretations\": \"Treating hook effect risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Hook Effect Risk\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"The probability or degree that hook effect introduces systematic distortion into a biomedical estimate or conclusion.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses hook effect risk using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in hook effect risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 288"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000089",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000089"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/96"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Consistency Assumption Plausibility"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000224",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000224"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/231"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Locus Heterogeneity Assessment"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000261",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000261"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/268"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Single-Cell Feature Detection Rate"
      }
    },
    {
      "@id": "bemo:BEMO_2000335",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000335",
      "bemo:BEMO_3100022": 342,
      "bemo:BEMO_3100023": "3a82aa8a1751fa8372cd9735fd975781682a359be68aacfb1d0d78e896d96ce5",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses drug–drug interaction evidence using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in drug–drug interaction evidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating drug–drug interaction evidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "OECD; OHAT; FDA Biomarker; EMA E16"
      },
      "bemo:BEMO_3200011": "https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000335"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000342"
        },
        {
          "@id": "bemo:BEMO_2000350"
        },
        {
          "@id": "bemo:BEMO_2000353"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of drug–drug interaction evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/342"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000335",
      "rdfs:label": {
        "@language": "en",
        "@value": "Drug–Drug Interaction Evidence"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb353"
        },
        {
          "@id": "bemo:BEMO_1100013"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb353",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000335"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000270",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000270",
      "bemo:BEMO_3100022": 277,
      "bemo:BEMO_3100023": "193a9fb566dfa18750368d0657f7d1e8c3de7251eea014f0d99b1b3e73df3afa",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses analytical sensitivity using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in analytical sensitivity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating analytical sensitivity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000270"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000271"
        },
        {
          "@id": "bemo:BEMO_2000285"
        },
        {
          "@id": "bemo:BEMO_2000299"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of analytical sensitivity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/277"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000270",
      "rdfs:label": {
        "@language": "en",
        "@value": "Analytical Sensitivity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb293"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb293",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000270"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/465",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 465,
      "bemo:BEMO_3100023": "1193234e513641f836d7ad506af2e69fb2fcba17a604fff5710f7b53f487ad89",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Model Fit; Distributional Assumption Adequacy; Variance Estimation Validity\", \"Common Misinterpretations\": \"Treating residual diagnostics adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Residual Diagnostics Adequacy\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"The extent to which residual diagnostics is sufficient and fit for the stated biomedical inference.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses residual diagnostics adequacy using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in residual diagnostics adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 465"
    },
    {
      "@id": "bemo:BEMO_2000428",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000428",
      "bemo:BEMO_3100022": 435,
      "bemo:BEMO_3100023": "2fcf4f96e7ca202f61d3de161ead38ea506d30ac8f05b66ac8a84b27f3da645e",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses raw-data availability using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in raw-data availability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating raw-data availability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Study report / dataset / evidence package"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All biomedical study reports and data releases"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000428"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000417"
        },
        {
          "@id": "bemo:BEMO_2000424"
        },
        {
          "@id": "bemo:BEMO_2000427"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of raw-data availability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/435"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000428",
      "rdfs:label": {
        "@language": "en",
        "@value": "Raw-Data Availability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb435"
        },
        {
          "@id": "bemo:BEMO_1100016"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb435",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000428"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/442",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 442,
      "bemo:BEMO_3100023": "4b44e65362db0ef8f1ef0ae6eb87b631fd22642d5790f792ab6c3d6a9a693508",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Estimate Precision; Statistical Power; Type I Error Control\", \"Common Misinterpretations\": \"Treating confidence interval compatibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Confidence Interval Compatibility\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"The justified degree of certainty assigned to confidence interval compatibility given the quantity, quality, consistency, and limitations of supporting evidence.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses confidence interval compatibility using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in confidence interval compatibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 442"
    },
    {
      "@id": "bemo:BEMO_2000457",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000457",
      "bemo:BEMO_3100022": 464,
      "bemo:BEMO_3100023": "ced026349740f092de03ee4146894b4367dab3b43793f3aa048eac1fd782cbda",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses prior sensitivity using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in prior sensitivity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating prior sensitivity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000457"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000440"
        },
        {
          "@id": "bemo:BEMO_2000452"
        },
        {
          "@id": "bemo:BEMO_2000456"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of prior sensitivity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/464"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000457",
      "rdfs:label": {
        "@language": "en",
        "@value": "Prior Sensitivity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb460"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb460",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000457"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000385",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000385",
      "bemo:BEMO_3100022": 392,
      "bemo:BEMO_3100023": "5f1fa5732761f5ddf9eae216997fca90d2ec95264368ca476160849aac179e9a",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses spectral library match quality using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in spectral library match quality can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating spectral library match quality as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAPE; HUPO PSI; Metabolomics Standards"
      },
      "bemo:BEMO_3200011": "https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000385"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000362"
        },
        {
          "@id": "bemo:BEMO_2000365"
        },
        {
          "@id": "bemo:BEMO_2000370"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of spectral library match quality."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/392"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000385",
      "rdfs:label": {
        "@language": "en",
        "@value": "Spectral Library Match Quality"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb397"
        },
        {
          "@id": "bemo:BEMO_1100014"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb397",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000385"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000330",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000003"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000012"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000013"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000020"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a validated analyte- and method-specific measurement procedure with calibration and quality control."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"unitRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "specimen_or_material; measurement_procedure; calibration_reference; quality_control_results; unit",
      "bemo:BEMO_3100007": "replicate_measurements; environmental_conditions; instrument_version",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Method- and analyte-specific physical units",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000330"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/337"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Benchmark Dose Reliability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000219",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000219"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/226"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Founder-Effect Assessment"
      }
    },
    {
      "@id": "bemo:BEMO_3000015",
      "@type": "owl:ObjectProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Connects an ontology entity to its governance record."
      },
      "oboInOwl:id": "BEMO:3000015",
      "rdfs:label": {
        "@language": "en",
        "@value": "has governance record"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000210",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000210"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/217"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Transportability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000157",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000157"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/164"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Information Size Adequacy"
      }
    },
    {
      "@id": "bemo:BEMO_2000043",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000043",
      "bemo:BEMO_3100022": 50,
      "bemo:BEMO_3100023": "3cb1f45a15a5daa5f6b98c2d745a57440f42e5840e757c82a744e9f010f76df0",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses endpoint responsiveness using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in endpoint responsiveness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating endpoint responsiveness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Biomarker development, qualification, endpoint and surrogate validation studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; BEST; EMA E16; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000043"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000042"
        },
        {
          "@id": "bemo:BEMO_2000047"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of endpoint responsiveness."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/50"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000043",
      "rdfs:label": {
        "@language": "en",
        "@value": "Endpoint Responsiveness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb92"
        },
        {
          "@id": "bemo:BEMO_1100002"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb92",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000043"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/155",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 155,
      "bemo:BEMO_3100023": "880de5f192c9dc60c14576e428f1c46fbdcda3180afe950bcde297920e65c6df",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Systematic reviews, meta-analyses, evidence profiles, guidelines\", \"Category\": \"Evidence Certainty and Synthesis\", \"Closely Related Metrics\": \"Evidence Consistency; Evidence Precision; Evidence Coherence\", \"Common Misinterpretations\": \"Treating evidence directness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Evidence Directness\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/\", \"Related Frameworks\": \"GRADE; PRISMA; AMSTAR 2; RoB\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of evidence directness.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses evidence directness using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in evidence directness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 155"
    },
    {
      "@id": "bemo:BEMO_2000184",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000184",
      "bemo:BEMO_3100022": 191,
      "bemo:BEMO_3100023": "5cc94b6085b9c596d4f74c18712e9f8177db4335ab703b2218b9c3a63209c113",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses randomization in experimental allocation using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in randomization in experimental allocation can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating randomization in experimental allocation as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "In vitro, ex vivo, organoid, animal, and preclinical experiments"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ARRIVE 2.0; SYRCLE; OECD"
      },
      "bemo:BEMO_3200011": "https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000184"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000168"
        },
        {
          "@id": "bemo:BEMO_2000172"
        },
        {
          "@id": "bemo:BEMO_2000185"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of randomization in experimental allocation."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/191"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000184",
      "rdfs:label": {
        "@language": "en",
        "@value": "Randomization in Experimental Allocation"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb218"
        },
        {
          "@id": "bemo:BEMO_1100007"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb218",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000184"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/21",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 21,
      "bemo:BEMO_3100023": "d05eb179325de1077bb0eedc4d22a5f8c9cc2049d4ca5a5830b380984606cc90",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Molecular, cellular, animal, translational, pharmacologic, and human studies\", \"Category\": \"Biological Plausibility and Mechanism\", \"Closely Related Metrics\": \"Biological Plausibility; Mechanistic Coverage; Mechanistic Completeness\", \"Common Misinterpretations\": \"Treating mechanistic support as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Mechanistic Support\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"GRADE; FDA Biomarker; ClinGen; OHAT; OECD\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting mechanistic.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses mechanistic support using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in mechanistic support can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 21"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/107",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 107,
      "bemo:BEMO_3100023": "63bedc3fc09ef48160a8d522d76618e50e47197d3d502ae109f1015d0fbcb67e",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized and observational etiologic studies, natural experiments, target-trial emulations\", \"Category\": \"Causal Inference\", \"Closely Related Metrics\": \"Instrument Validity; Dose–Response Support; Dechallenge–Rechallenge Support\", \"Common Misinterpretations\": \"Treating negative-control validation as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Negative-Control Validation\", \"References or Origin\": \"https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of negative-control validation.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses negative-control validation using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in negative-control validation can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 107"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/170",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 170,
      "bemo:BEMO_3100023": "8c42609174eeba28064b2f75bd158a40f97b17f9cdaa32aed81219eddf87ef89",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Systematic reviews, meta-analyses, evidence profiles, guidelines\", \"Category\": \"Evidence Certainty and Synthesis\", \"Closely Related Metrics\": \"Publication Bias Risk; Small-Study Effects; Study Heterogeneity\", \"Common Misinterpretations\": \"Treating selective nonreporting risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Selective Nonreporting Risk\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/\", \"Related Frameworks\": \"GRADE; PRISMA; AMSTAR 2; RoB\", \"Scientific Definition\": \"The probability or degree that selective nonreporting introduces systematic distortion into a biomedical estimate or conclusion.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses selective nonreporting risk using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in selective nonreporting risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 170"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/193",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 193,
      "bemo:BEMO_3100023": "67d1bc84f2c2d0324ee734ed3d2df1c72cd4820b21290b5a8b136d75863a4866",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"In vitro, ex vivo, organoid, animal, and preclinical experiments\", \"Category\": \"Experimental Biology and Animal Research\", \"Closely Related Metrics\": \"Species Appropriateness; Age Appropriateness; Genetic Background Control\", \"Common Misinterpretations\": \"Treating sex as a biological variable adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Sex as a Biological Variable Adequacy\", \"References or Origin\": \"https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"ARRIVE 2.0; SYRCLE; OECD\", \"Scientific Definition\": \"The extent to which sex as a biological variable is sufficient and fit for the stated biomedical inference.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses sex as a biological variable adequacy using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in sex as a biological variable adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 193"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/148",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 148,
      "bemo:BEMO_3100023": "e87943e84aae44a1eeb6300f5a52416f0528fe0f3bf76f40f0a2a4486c87ea6a",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Systematic reviews, meta-analyses, evidence profiles, guidelines\", \"Category\": \"Evidence Certainty and Synthesis\", \"Closely Related Metrics\": \"Prediction Interval Adequacy; Information Size Adequacy; Multiplicity-Adjusted Credibility\", \"Common Misinterpretations\": \"Treating cumulative evidence stability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Cumulative Evidence Stability\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/\", \"Related Frameworks\": \"GRADE; PRISMA; AMSTAR 2; RoB\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of cumulative evidence stability.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses cumulative evidence stability using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in cumulative evidence stability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 148"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/389",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 389,
      "bemo:BEMO_3100023": "6e5af7c1fffa7603da0abd7518a670fd09cade5fe3e47c8417886f91e6b4e07a",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies\", \"Category\": \"Proteomics and Metabolomics\", \"Closely Related Metrics\": \"Sequence Coverage; Quantification Accuracy; Dynamic Range Coverage\", \"Common Misinterpretations\": \"Treating quantification precision as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Quantification Precision\", \"References or Origin\": \"https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/\", \"Related Frameworks\": \"MIAPE; HUPO PSI; Metabolomics Standards\", \"Scientific Definition\": \"The closeness of repeated estimates or measurements and the narrowness of uncertainty around quantification.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses quantification precision using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in quantification precision can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 389"
    },
    {
      "@id": "bemo:BEMO_2000245",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000245",
      "bemo:BEMO_3100022": 252,
      "bemo:BEMO_3100023": "c1d6b63aea87c65750f96b5e3a771c6866843a2e5ba7e8081dd07af03bc0e9c5",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses duplicate read burden using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in duplicate read burden can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Read- and variant-level quality-control summaries; replicate concordance; orthogonal confirmation; benchmarking against reference materials."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating duplicate read burden as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAME; MINSEQE; STROBE-ME; GA4GH; HCA"
      },
      "bemo:BEMO_3200011": "https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000245"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000242"
        },
        {
          "@id": "bemo:BEMO_2000249"
        },
        {
          "@id": "bemo:BEMO_2000253"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of duplicate read burden."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/252"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000245",
      "rdfs:label": {
        "@language": "en",
        "@value": "Duplicate Read Burden"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb271"
        },
        {
          "@id": "bemo:BEMO_1100010"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb271",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000245"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/249",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 249,
      "bemo:BEMO_3100023": "fc0cd98bc92235d469bf2bc025f0d327d8170dfb4df97b973710a8d887eff3f4",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies\", \"Category\": \"Genomics and Transcriptomics\", \"Closely Related Metrics\": \"Library Complexity; Sample Identity Concordance; Sex Concordance\", \"Common Misinterpretations\": \"Treating contamination burden as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Contamination Burden\", \"References or Origin\": \"https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/\", \"Related Frameworks\": \"MIAME; MINSEQE; STROBE-ME; GA4GH; HCA\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of contamination burden.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses contamination burden using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in contamination burden can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 249"
    },
    {
      "@id": "bemo:BEMO_2000309",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000309",
      "bemo:BEMO_3100022": 316,
      "bemo:BEMO_3100023": "f8d3b19efd68e0150e437c71bac90ab2bb80f33877b4a0e74bc52542a0fd3c26",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses flux-balance consistency using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in flux-balance consistency can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating flux-balance consistency as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Dataset / model / pathway / network / evidence body"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Integrated omics, networks, pathways, mechanistic and dynamic systems models"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "Gene Ontology; Reactome; UniProt; GA4GH"
      },
      "bemo:BEMO_3200011": "https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000309"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000307"
        },
        {
          "@id": "bemo:BEMO_2000324"
        },
        {
          "@id": "bemo:BEMO_2000327"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree of agreement in flux-balance across measurements, studies, methods, populations, or biological levels."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/316"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000309",
      "rdfs:label": {
        "@language": "en",
        "@value": "Flux-Balance Consistency"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb327"
        },
        {
          "@id": "bemo:BEMO_1100012"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb327",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000309"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000304",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000304",
      "bemo:BEMO_3100022": 311,
      "bemo:BEMO_3100023": "c10b406fc4ce6db5663280fc4b358cc062cc17f0ce7a593af68a762307815cdc",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses cross-omics integration coherence using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in cross-omics integration coherence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating cross-omics integration coherence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Dataset / model / pathway / network / evidence body"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Integrated omics, networks, pathways, mechanistic and dynamic systems models"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "Gene Ontology; Reactome; UniProt; GA4GH"
      },
      "bemo:BEMO_3200011": "https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000304"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000303"
        },
        {
          "@id": "bemo:BEMO_2000305"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Developing",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of cross-omics integration coherence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/311"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000304",
      "rdfs:label": {
        "@language": "en",
        "@value": "Cross-Omics Integration Coherence"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb12"
        },
        {
          "@id": "bemo:BEMO_1100012"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb12",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000304"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/141",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 141,
      "bemo:BEMO_3100023": "3bd12b9aed8e6e227ec8b1e5082fc9060b988babbc4204f8a360bb7503e6ad49",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies\", \"Category\": \"Diagnostic and Prognostic Evidence\", \"Closely Related Metrics\": \"Threshold Validity; Index-Test Blinding; Verification Bias Risk\", \"Common Misinterpretations\": \"Treating reference standard validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Reference Standard Validity\", \"References or Origin\": \"https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"QUADAS-2; STARD; TRIPOD; REMARK\", \"Scientific Definition\": \"The degree to which reference standard supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses reference standard validity using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in reference standard validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 141"
    },
    {
      "@id": "bemo:BEMO_2000323",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000323",
      "bemo:BEMO_3100022": 330,
      "bemo:BEMO_3100023": "f408d8b817c9e3179698dad395d8e94ea187b92ae192e0ab52e026106d82f40a",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses pathway topology support using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in pathway topology support can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating pathway topology support as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Dataset / model / pathway / network / evidence body"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Integrated omics, networks, pathways, mechanistic and dynamic systems models"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "Gene Ontology; Reactome; UniProt; GA4GH"
      },
      "bemo:BEMO_3200011": "https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000323"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000310"
        },
        {
          "@id": "bemo:BEMO_2000311"
        },
        {
          "@id": "bemo:BEMO_2000322"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting pathway topology."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/330"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000323",
      "rdfs:label": {
        "@language": "en",
        "@value": "Pathway Topology Support"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb341"
        },
        {
          "@id": "bemo:BEMO_1100012"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb341",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000323"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000012",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000012",
      "bemo:BEMO_3100022": 19,
      "bemo:BEMO_3100023": "8582aac321a237f1dd1db68f0893021d3bc987b71b373d1879cc2dfb098adbdb",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses mechanistic coverage using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in mechanistic coverage can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating mechanistic coverage as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Molecular, cellular, animal, translational, pharmacologic, and human studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; FDA Biomarker; ClinGen; OHAT; OECD"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000012"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000010"
        },
        {
          "@id": "bemo:BEMO_2000011"
        },
        {
          "@id": "bemo:BEMO_2000014"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The proportion and representativeness of the relevant mechanistic captured by the evidence or measurement process."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/19"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000012",
      "rdfs:label": {
        "@language": "en",
        "@value": "Mechanistic Coverage"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb65"
        },
        {
          "@id": "bemo:BEMO_1100001"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb65",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000012"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000476",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000476",
      "bemo:BEMO_3100022": 483,
      "bemo:BEMO_3100023": "8ac86a4a6b6a886dad127939918a466b8c70bd2b6b13b03a987aab048ac4c7c3",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses early stopping bias risk using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in early stopping bias risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating early stopping bias risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000476"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000463"
        },
        {
          "@id": "bemo:BEMO_2000469"
        },
        {
          "@id": "bemo:BEMO_2000477"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The probability or degree that early stopping bias introduces systematic distortion into a biomedical estimate or conclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/483"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000476",
      "rdfs:label": {
        "@language": "en",
        "@value": "Early Stopping Bias Risk"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb477"
        },
        {
          "@id": "bemo:BEMO_1100018"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb477",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000476"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000466",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000466"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/473"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Baseline Comparability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/266",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 266,
      "bemo:BEMO_3100023": "1685a23504d9a42b00cb2ea9bdca0c2daeec5f3be11cc0d479a9acb5349c658a",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies\", \"Category\": \"Genomics and Transcriptomics\", \"Closely Related Metrics\": \"Single-Cell Doublet Burden; Single-Cell Viability; Single-Cell Feature Detection Rate\", \"Common Misinterpretations\": \"Treating single-cell ambient rna burden as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Single-Cell Ambient RNA Burden\", \"References or Origin\": \"https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/\", \"Related Frameworks\": \"MIAME; MINSEQE; STROBE-ME; GA4GH; HCA\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of single-cell ambient rna burden.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses single-cell ambient rna burden using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in single-cell ambient rna burden can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 266"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/318",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 318,
      "bemo:BEMO_3100023": "50aaf6749314a5ad4694891f48d60c74feaa99da022b5cc91c17f4221f0696a2",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Integrated omics, networks, pathways, mechanistic and dynamic systems models\", \"Category\": \"Multi-omics and Systems Biology\", \"Closely Related Metrics\": \"Knowledge-Graph Evidence Completeness; Entity Resolution Accuracy; Relation Evidence Strength\", \"Common Misinterpretations\": \"Treating knowledge-graph provenance quality as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Dataset / model / pathway / network / evidence body\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Developing\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Knowledge-Graph Provenance Quality\", \"References or Origin\": \"https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/\", \"Related Frameworks\": \"Gene Ontology; Reactome; UniProt; GA4GH\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of knowledge-graph provenance quality.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses knowledge-graph provenance quality using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in knowledge-graph provenance quality can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 318"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/111",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 111,
      "bemo:BEMO_3100023": "fef3c7d8a6ff0d0d4088a08abb2cfe7420127e6170b4998b7b5ce06d44124e81",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized and observational etiologic studies, natural experiments, target-trial emulations\", \"Category\": \"Causal Inference\", \"Closely Related Metrics\": \"Confounding Risk; Unmeasured Confounding Sensitivity; Exchangeability Plausibility\", \"Common Misinterpretations\": \"Treating residual confounding risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Residual Confounding Risk\", \"References or Origin\": \"https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9\", \"Scientific Definition\": \"The probability or degree that residual confounding introduces systematic distortion into a biomedical estimate or conclusion.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Directed acyclic graphs; design emulation; balance diagnostics; negative controls; quantitative bias analysis; sensitivity and falsification analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses residual confounding risk using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in residual confounding risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 111"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000158",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000158"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/165"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Missing Evidence Risk"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000191",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000191"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/198"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Care-Pathway Independence"
      }
    },
    {
      "@id": "bemo:BEMO_2000427",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000427",
      "bemo:BEMO_3100022": 434,
      "bemo:BEMO_3100023": "b53b586f994fd48c27b9acc1c6fff59b966085610e593ec05c03735d90e329b2",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses quality-control reporting completeness using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in quality-control reporting completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating quality-control reporting completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Study report / dataset / evidence package"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All biomedical study reports and data releases"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000427"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000419"
        },
        {
          "@id": "bemo:BEMO_2000420"
        },
        {
          "@id": "bemo:BEMO_2000424"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which all scientifically necessary components of quality-control reporting are present, documented, and evaluable."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/434"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000427",
      "rdfs:label": {
        "@language": "en",
        "@value": "Quality-Control Reporting Completeness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb434"
        },
        {
          "@id": "bemo:BEMO_1100016"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb434",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000427"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000216",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000216",
      "bemo:BEMO_3100022": 223,
      "bemo:BEMO_3100023": "54567aec6ae0bbdadfae015005c07328ab45d161c0cc6d36f9e5198150b2b29e",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses conflicting interpretation burden using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in conflicting interpretation burden can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating conflicting interpretation burden as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mendelian disease, cancer genetics, association, segregation, and functional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ClinGen; ACMG AMP; STREGA; Gene Ontology"
      },
      "bemo:BEMO_3200011": "https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000216"
      },
      "bemo:BEMO_3200013": {
        "@id": "bemo:BEMO_2000234"
      },
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of conflicting interpretation burden."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/223"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000216",
      "rdfs:label": {
        "@language": "en",
        "@value": "Conflicting Interpretation Burden"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb35"
        },
        {
          "@id": "bemo:BEMO_1100009"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb35",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000216"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000196",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000196",
      "bemo:BEMO_3100022": 203,
      "bemo:BEMO_3100023": "04e73707dc619457f6718e0be03029ef6e99208f68cbcad30d9f5bb20b2cd94b",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses ecological validity using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in ecological validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating ecological validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Clinical, epidemiologic, diagnostic, translational, and population studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; QUADAS-2; CONSORT; STROBE"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000196"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000193"
        },
        {
          "@id": "bemo:BEMO_2000204"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which ecological supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/203"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000196",
      "rdfs:label": {
        "@language": "en",
        "@value": "Ecological Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb229"
        },
        {
          "@id": "bemo:BEMO_1100008"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb229",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000196"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_0000102",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "An information content entity specifying the datatype, scale, unit, range, and interpretation of a metric output."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:0000102",
      "rdfs:label": {
        "@language": "en",
        "@value": "metric output specification"
      },
      "rdfs:subClassOf": {
        "@id": "obo:IAO_0000030"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/247",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 247,
      "bemo:BEMO_3100023": "c69a25da4615faa5675944ca32d4c5ec30a0c44f5216034581329797d9a32abc",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies\", \"Category\": \"Genomics and Transcriptomics\", \"Closely Related Metrics\": \"Reference Bias; Hardy–Weinberg Equilibrium Compatibility; Batch-Effect Control\", \"Common Misinterpretations\": \"Treating call-rate completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Call-Rate Completeness\", \"References or Origin\": \"https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/\", \"Related Frameworks\": \"MIAME; MINSEQE; STROBE-ME; GA4GH; HCA\", \"Scientific Definition\": \"The extent to which all scientifically necessary components of call-rate are present, documented, and evaluable.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Read- and variant-level quality-control summaries; replicate concordance; orthogonal confirmation; benchmarking against reference materials.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses call-rate completeness using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in call-rate completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 247"
    },
    {
      "@id": "bemo:BEMO_2000375",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000375",
      "bemo:BEMO_3100022": 382,
      "bemo:BEMO_3100023": "69f7898b8265a7daaa45bd90d4d5387c92da6521721d3c4901a5c208a63f0169",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses peptide-spectrum match quality using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in peptide-spectrum match quality can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Target-decoy analysis; spectral scoring; reference standards; replicate injections; retention-time and mass-error monitoring; orthogonal confirmation."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating peptide-spectrum match quality as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAPE; HUPO PSI; Metabolomics Standards"
      },
      "bemo:BEMO_3200011": "https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000375"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000363"
        },
        {
          "@id": "bemo:BEMO_2000378"
        },
        {
          "@id": "bemo:BEMO_2000380"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of peptide-spectrum match quality."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/382"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000375",
      "rdfs:label": {
        "@language": "en",
        "@value": "Peptide-Spectrum Match Quality"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb388"
        },
        {
          "@id": "bemo:BEMO_1100014"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb388",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000375"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/315",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 315,
      "bemo:BEMO_3100023": "81ae3d3ac205c8d1258be22f4b5818a5c36df354b19605060eb458cfdfef682e",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Integrated omics, networks, pathways, mechanistic and dynamic systems models\", \"Category\": \"Multi-omics and Systems Biology\", \"Closely Related Metrics\": \"Knowledge-Graph Provenance Quality; Relation Evidence Strength; Ontology Annotation Completeness\", \"Common Misinterpretations\": \"Treating entity resolution accuracy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Dataset / model / pathway / network / evidence body\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Entity Resolution Accuracy\", \"References or Origin\": \"https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/\", \"Related Frameworks\": \"Gene Ontology; Reactome; UniProt; GA4GH\", \"Scientific Definition\": \"The closeness of entity resolution to the accepted reference or true value.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses entity resolution accuracy using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in entity resolution accuracy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 315"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/246",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 246,
      "bemo:BEMO_3100023": "0751d3491af658db1257b3b04a366a751c7fd0fdfb5e615ebbae3dab6970c7c9",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies\", \"Category\": \"Genomics and Transcriptomics\", \"Closely Related Metrics\": \"Hardy–Weinberg Equilibrium Compatibility; Population Stratification Control; Relatedness Control\", \"Common Misinterpretations\": \"Treating batch-effect control as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Batch-Effect Control\", \"References or Origin\": \"https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/\", \"Related Frameworks\": \"MIAME; MINSEQE; STROBE-ME; GA4GH; HCA\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of batch-effect control.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses batch-effect control using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in batch-effect control can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 246"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/20",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 20,
      "bemo:BEMO_3100023": "29074cf2dac765628d0a639b922f2e3313846aa414af9c4ef760ea93c86819ca",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Molecular, cellular, animal, translational, pharmacologic, and human studies\", \"Category\": \"Biological Plausibility and Mechanism\", \"Closely Related Metrics\": \"Mechanistic Coherence; Mechanistic Causality Strength; Pathway-Level Support\", \"Common Misinterpretations\": \"Treating mechanistic specificity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment.\", \"Metric\": \"Mechanistic Specificity\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"GRADE; FDA Biomarker; ClinGen; OHAT; OECD\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of mechanistic specificity.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses mechanistic specificity using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in mechanistic specificity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 20"
    },
    {
      "@id": "bemo:BEMO_2000441",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000441",
      "bemo:BEMO_3100022": 448,
      "bemo:BEMO_3100023": "9458d6e4371d11a80963339d3a9a6c5dcc187a36080cf18d964ecb5827c41820",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses estimate precision using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in estimate precision can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating estimate precision as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000441"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000435"
        },
        {
          "@id": "bemo:BEMO_2000439"
        },
        {
          "@id": "bemo:BEMO_2000459"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The closeness of repeated estimates or measurements and the narrowness of uncertainty around estimate."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/448"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000441",
      "rdfs:label": {
        "@language": "en",
        "@value": "Estimate Precision"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb51"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb51",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000441"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000063",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000063"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/70"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Cold Ischemia Control"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000449",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000449"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/456"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Model Fit"
      }
    },
    {
      "@id": "bemo:BEMO_3200019",
      "@type": "owl:AnnotationProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Source-provided frequency-of-use classification."
      },
      "oboInOwl:id": "BEMO:3200019",
      "rdfs:label": {
        "@language": "en",
        "@value": "frequency of use"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000446",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000446"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/453"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Measurement Error Correction"
      }
    },
    {
      "@id": "bemo:BEMO_3000014",
      "@type": "owl:ObjectProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Connects a metric or computation profile to a validation record."
      },
      "oboInOwl:id": "BEMO:3000014",
      "rdfs:label": {
        "@language": "en",
        "@value": "has validation record"
      }
    },
    {
      "@id": "bemo:BEMO_2000226",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000226",
      "bemo:BEMO_3100022": 233,
      "bemo:BEMO_3100023": "de2f4749e64a7014070a28c9c8587efaf4dbb9b3583c2ab6e78cd6826c00de34",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses null-variant quality using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in null-variant quality can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "ClinGen/ACMG evidence scoring; pedigree analysis; population databases; case-control data; functional assays; expert-panel review."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating null-variant quality as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mendelian disease, cancer genetics, association, segregation, and functional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ClinGen; ACMG AMP; STREGA; Gene Ontology"
      },
      "bemo:BEMO_3200011": "https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000226"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000223"
        },
        {
          "@id": "bemo:BEMO_2000231"
        },
        {
          "@id": "bemo:BEMO_2000233"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of null-variant quality."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/233"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000226",
      "rdfs:label": {
        "@language": "en",
        "@value": "Null-Variant Quality"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb254"
        },
        {
          "@id": "bemo:BEMO_1100009"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb254",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000226"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/66",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 66,
      "bemo:BEMO_3100023": "b89a21b15f8ca110af0a2e2a28ae4ce7939819f7d62769c459c1cd5dc9b712cc",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All studies using human or animal biospecimens\", \"Category\": \"Biospecimen and Preanalytical Quality\", \"Closely Related Metrics\": \"Biospecimen Provenance Completeness; Collection Procedure Consistency\", \"Common Misinterpretations\": \"Treating biospecimen integrity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Biospecimen Integrity\", \"References or Origin\": \"https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"BRISQ; ISO 15189; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of biospecimen integrity.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses biospecimen integrity using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in biospecimen integrity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 66"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000416",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000416"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/423"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Materials-and-Reagents Reporting Completeness"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000460",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000460"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/467"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Type I Error Control"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000019",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000019"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/26"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Pathway-Level Support"
      }
    },
    {
      "@id": "bemo:BEMO_4000027",
      "@type": [
        "owl:NamedIndividual",
        "bemo:BEMO_0000402"
      ],
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Controlled BEMO ApprovalStatus value: Draft."
      },
      "oboInOwl:id": "BEMO:4000027",
      "rdfs:label": {
        "@language": "en",
        "@value": "Draft"
      },
      "skos:notation": "Draft"
    },
    {
      "@id": "bemo:BEMO_2000346",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000346",
      "bemo:BEMO_3100022": 353,
      "bemo:BEMO_3100023": "99eef93672d2993b0ec131c09788c14463fd2a5166870e81b6b8d81c3637506b",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses pharmacodynamic adequacy using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in pharmacodynamic adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating pharmacodynamic adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "OECD; OHAT; FDA Biomarker; EMA E16"
      },
      "bemo:BEMO_3200011": "https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000346"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000331"
        },
        {
          "@id": "bemo:BEMO_2000334"
        },
        {
          "@id": "bemo:BEMO_2000347"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which pharmacodynamic is sufficient and fit for the stated biomedical inference."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/353"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000346",
      "rdfs:label": {
        "@language": "en",
        "@value": "Pharmacodynamic Adequacy"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb362"
        },
        {
          "@id": "bemo:BEMO_1100013"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb362",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000346"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/485",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 485,
      "bemo:BEMO_3100023": "a99fe581309ce29c4e888ffbd9a1cba6c99a6948f2a8e99e23714e0f40920b87",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies\", \"Category\": \"Study Design and Internal Validity\", \"Closely Related Metrics\": \"Outcome Ascertainment Validity; Differential Follow-up Risk\", \"Common Misinterpretations\": \"Treating follow-up completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Follow-up Completeness\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools\", \"Related Frameworks\": \"CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI\", \"Scientific Definition\": \"The extent to which all scientifically necessary components of follow-up are present, documented, and evaluable.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses follow-up completeness using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in follow-up completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 485"
    },
    {
      "@id": "bemo:BEMO_2000143",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000143",
      "bemo:BEMO_3100022": 150,
      "bemo:BEMO_3100023": "263bd485141b0cc75ee285fb1989c667b83eb378666886a960ed5bd2a610f232",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses evidence completeness using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in evidence completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating evidence completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Systematic reviews, meta-analyses, evidence profiles, guidelines"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; PRISMA; AMSTAR 2; RoB"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000143"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000147"
        },
        {
          "@id": "bemo:BEMO_2000149"
        },
        {
          "@id": "bemo:BEMO_2000155"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which all scientifically necessary components of evidence are present, documented, and evaluable."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/150"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000143",
      "rdfs:label": {
        "@language": "en",
        "@value": "Evidence Completeness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb182"
        },
        {
          "@id": "bemo:BEMO_1100006"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb182",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000143"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/287",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 287,
      "bemo:BEMO_3100023": "41309e5f36c397d08d76621c273137352b099c93484f2a2eca025bcf85ccffdc",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Reportable Range; Recovery; Dilution Integrity\", \"Common Misinterpretations\": \"Treating dynamic range as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Dynamic Range\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of dynamic range.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Method- and analyte-specific physical units\", \"What It Measures\": \"Assesses dynamic range using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in dynamic range can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 287"
    },
    {
      "@id": "https://w3id.org/bemo/alignment/OBI",
      "@type": "prov:Entity",
      "dcterms:source": {
        "@id": "obo:obi.owl"
      }
    },
    {
      "@id": "bemo:BEMO_2000405",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000405",
      "bemo:BEMO_3100022": 412,
      "bemo:BEMO_3100023": "60121a2998efa943018d3ff7dd4130d4332ee279da0e8111b650ea175e9dacce",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses result reproducibility using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in result reproducibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating result reproducibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All experimental, computational, clinical, and omics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0"
      },
      "bemo:BEMO_3200011": "https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000405"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000395"
        },
        {
          "@id": "bemo:BEMO_2000399"
        },
        {
          "@id": "bemo:BEMO_2000403"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which result reproducibility yields concordant results under the specified repeated-analysis or repeated-measurement conditions."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/412"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000405",
      "rdfs:label": {
        "@language": "en",
        "@value": "Result Reproducibility"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb415"
        },
        {
          "@id": "bemo:BEMO_1100015"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb415",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000405"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/479",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 479,
      "bemo:BEMO_3100023": "eed78db6e72161c41f0a51c8bc55e5d20b0d6675373ef1a7bf65b4c5b0dc75c0",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies\", \"Category\": \"Study Design and Internal Validity\", \"Closely Related Metrics\": \"Protocol Deviation Risk; Co-intervention Bias Risk; Carryover Effect Risk\", \"Common Misinterpretations\": \"Treating contamination risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Contamination Risk\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools\", \"Related Frameworks\": \"CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI\", \"Scientific Definition\": \"The probability or degree that contamination introduces systematic distortion into a biomedical estimate or conclusion.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses contamination risk using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in contamination risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 479"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/70",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 70,
      "bemo:BEMO_3100023": "450f9e94b009036abe7a13fe3055116e7c4959857a7291ed7e337a746d7bf722",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All studies using human or animal biospecimens\", \"Category\": \"Biospecimen and Preanalytical Quality\", \"Closely Related Metrics\": \"Warm Ischemia Control; Time-to-Fixation Adequacy; Fixation Adequacy\", \"Common Misinterpretations\": \"Treating cold ischemia control as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Cold Ischemia Control\", \"References or Origin\": \"https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"BRISQ; ISO 15189; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of cold ischemia control.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses cold ischemia control using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in cold ischemia control can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 70"
    },
    {
      "@id": "bemo:BEMO_4000005",
      "@type": [
        "owl:NamedIndividual",
        "bemo:BEMO_0000400"
      ],
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Controlled BEMO ScaleType value: RatioScale."
      },
      "oboInOwl:id": "BEMO:4000005",
      "rdfs:label": {
        "@language": "en",
        "@value": "Ratio Scale"
      },
      "skos:notation": "RatioScale"
    },
    {
      "@id": "bemo:BEMO_3100026",
      "@type": "owl:DatatypeProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Numeric metric assessment value."
      },
      "oboInOwl:id": "BEMO:3100026",
      "rdfs:label": {
        "@language": "en",
        "@value": "numeric metric value"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/298",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 298,
      "bemo:BEMO_3100023": "ae9e50b8f8857543ecb1eb315c23fc88dd3a028cfd40ee4377e1039431544ca0",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Instrument Drift; Site-to-Site Assay Portability; Batch-Effect Sensitivity\", \"Common Misinterpretations\": \"Treating operator variability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Operator Variability\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of operator variability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses operator variability using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in operator variability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 298"
    },
    {
      "@id": "bemo:BEMO_2000222",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000222",
      "bemo:BEMO_3100022": 229,
      "bemo:BEMO_3100023": "baeee8e900a9ffef8f3ddd054b3a12f2233d89fc626f852fd31efc4b84b81685",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses genotype–phenotype concordance using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in genotype–phenotype concordance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Read- and variant-level quality-control summaries; replicate concordance; orthogonal confirmation; benchmarking against reference materials."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating genotype–phenotype concordance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mendelian disease, cancer genetics, association, segregation, and functional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ClinGen; ACMG AMP; STREGA; Gene Ontology"
      },
      "bemo:BEMO_3200011": "https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000222"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000216"
        },
        {
          "@id": "bemo:BEMO_2000224"
        },
        {
          "@id": "bemo:BEMO_2000234"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree of agreement in genotype–phenotype across measurements, studies, methods, populations, or biological levels."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/229"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000222",
      "rdfs:label": {
        "@language": "en",
        "@value": "Genotype–Phenotype Concordance"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb250"
        },
        {
          "@id": "bemo:BEMO_1100009"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb250",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000222"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000241",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000241",
      "bemo:BEMO_3100022": 248,
      "bemo:BEMO_3100023": "f7aebc612affb172059739df32608fb7c4d69384f1ff8c565432595eea6b9937",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses cell-type annotation confidence using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in cell-type annotation confidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating cell-type annotation confidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAME; MINSEQE; STROBE-ME; GA4GH; HCA"
      },
      "bemo:BEMO_3200011": "https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000241"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000243"
        },
        {
          "@id": "bemo:BEMO_2000261"
        },
        {
          "@id": "bemo:BEMO_2000263"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The justified degree of certainty assigned to cell-type annotation given the quantity, quality, consistency, and limitations of supporting evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/248"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000241",
      "rdfs:label": {
        "@language": "en",
        "@value": "Cell-Type Annotation Confidence"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb268"
        },
        {
          "@id": "bemo:BEMO_1100010"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb268",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000241"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000308",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000308",
      "bemo:BEMO_3100022": 315,
      "bemo:BEMO_3100023": "81ae3d3ac205c8d1258be22f4b5818a5c36df354b19605060eb458cfdfef682e",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses entity resolution accuracy using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in entity resolution accuracy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating entity resolution accuracy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Dataset / model / pathway / network / evidence body"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Integrated omics, networks, pathways, mechanistic and dynamic systems models"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "Gene Ontology; Reactome; UniProt; GA4GH"
      },
      "bemo:BEMO_3200011": "https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000308"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000311"
        },
        {
          "@id": "bemo:BEMO_2000318"
        },
        {
          "@id": "bemo:BEMO_2000326"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The closeness of entity resolution to the accepted reference or true value."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/315"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000308",
      "rdfs:label": {
        "@language": "en",
        "@value": "Entity Resolution Accuracy"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb326"
        },
        {
          "@id": "bemo:BEMO_1100012"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb326",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000308"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000270",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000270"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/277"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Analytical Sensitivity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/115",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 115,
      "bemo:BEMO_3100023": "f46690f0cea7611ea5bb0e9a0e5c1b90d25ecad9c8f28f3083cc2a71b53ce7f0",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized and observational etiologic studies, natural experiments, target-trial emulations\", \"Category\": \"Causal Inference\", \"Closely Related Metrics\": \"Collider Bias Risk; Immortal-Time Bias Risk; Reverse-Causation Risk\", \"Common Misinterpretations\": \"Treating time-varying confounding control as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Time-Varying Confounding Control\", \"References or Origin\": \"https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of time-varying confounding control.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Directed acyclic graphs; design emulation; balance diagnostics; negative controls; quantitative bias analysis; sensitivity and falsification analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses time-varying confounding control using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in time-varying confounding control can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 115"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/392",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 392,
      "bemo:BEMO_3100023": "5f1fa5732761f5ddf9eae216997fca90d2ec95264368ca476160849aac179e9a",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies\", \"Category\": \"Proteomics and Metabolomics\", \"Closely Related Metrics\": \"Metabolite Annotation Level; Internal Standard Performance; Extraction Recovery\", \"Common Misinterpretations\": \"Treating spectral library match quality as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Spectral Library Match Quality\", \"References or Origin\": \"https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/\", \"Related Frameworks\": \"MIAPE; HUPO PSI; Metabolomics Standards\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of spectral library match quality.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses spectral library match quality using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in spectral library match quality can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 392"
    },
    {
      "@id": "bemo:BEMO_2000028",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000028",
      "bemo:BEMO_3100022": 35,
      "bemo:BEMO_3100023": "70bbbca5f05350dbfed193659c18ff0eef66a6552528618a931911c0bbfe7878",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses biomarker clinical relevance using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in biomarker clinical relevance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating biomarker clinical relevance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Biomarker development, qualification, endpoint and surrogate validation studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; BEST; EMA E16; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000028"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000029"
        },
        {
          "@id": "bemo:BEMO_2000033"
        },
        {
          "@id": "bemo:BEMO_2000037"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of biomarker clinical relevance."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/35"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000028",
      "rdfs:label": {
        "@language": "en",
        "@value": "Biomarker Clinical Relevance"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb79"
        },
        {
          "@id": "bemo:BEMO_1100002"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb79",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000028"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/470",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 470,
      "bemo:BEMO_3100023": "9a20a1494ccbc46d7bc0acd4d260241ebc29edd15b77d8ccc525c9f0dba8e8de",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies\", \"Category\": \"Study Design and Internal Validity\", \"Closely Related Metrics\": \"Early Stopping Bias Risk; Exposure Classification Validity; Intervention Classification Validity\", \"Common Misinterpretations\": \"Treating adherence integrity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Adherence Integrity\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools\", \"Related Frameworks\": \"CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of adherence integrity.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses adherence integrity using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in adherence integrity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 470"
    },
    {
      "@id": "bemo:BEMO_3100009",
      "@type": "owl:DatatypeProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Human-readable unit or scale."
      },
      "oboInOwl:id": "BEMO:3100009",
      "rdfs:label": {
        "@language": "en",
        "@value": "unit text"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000062",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000062"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/69"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Chain-of-Custody Integrity"
      }
    },
    {
      "@id": "bemo:BEMO_2000188",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000188",
      "bemo:BEMO_3100022": 195,
      "bemo:BEMO_3100023": "8d21017136fa388d87b531d9b552fc3f6787a0b2615866e0c0a1ca9ae2fb0bbf",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses technical artifact exclusion using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in technical artifact exclusion can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating technical artifact exclusion as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "In vitro, ex vivo, organoid, animal, and preclinical experiments"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ARRIVE 2.0; SYRCLE; OECD"
      },
      "bemo:BEMO_3200011": "https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000188"
      },
      "bemo:BEMO_3200013": {
        "@id": "bemo:BEMO_2000182"
      },
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of technical artifact exclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/195"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000188",
      "rdfs:label": {
        "@language": "en",
        "@value": "Technical Artifact Exclusion"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb32"
        },
        {
          "@id": "bemo:BEMO_1100007"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb32",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000188"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/152",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 152,
      "bemo:BEMO_3100023": "f207ed4da0508b76cb7e86f43fc62efc4861d327760c860608fc73ff3f4a6da8",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Systematic reviews, meta-analyses, evidence profiles, guidelines\", \"Category\": \"Evidence Certainty and Synthesis\", \"Closely Related Metrics\": \"Evidence Coherence; Evidence Sufficiency; Evidence Completeness\", \"Common Misinterpretations\": \"Treating evidence consensus strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Evidence Consensus Strength\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/\", \"Related Frameworks\": \"GRADE; PRISMA; AMSTAR 2; RoB\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting evidence consensus.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses evidence consensus strength using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in evidence consensus strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 152"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/230",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 230,
      "bemo:BEMO_3100023": "d2e72ca269dc077aef430f8efab1ad3e7adf8db5e6aa339468796f69dfaaee12",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mendelian disease, cancer genetics, association, segregation, and functional studies\", \"Category\": \"Genetics and Variant Evidence\", \"Closely Related Metrics\": \"Loss-of-Function Mechanism Validity; Null-Variant Quality; Splicing Evidence Strength\", \"Common Misinterpretations\": \"Treating hotspot/functional-domain evidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Hotspot/Functional-Domain Evidence\", \"References or Origin\": \"https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/\", \"Related Frameworks\": \"ClinGen; ACMG AMP; STREGA; Gene Ontology\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of hotspot/functional-domain evidence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses hotspot/functional-domain evidence using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in hotspot/functional-domain evidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 230"
    },
    {
      "@id": "bemo:BEMO_2000030",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000030",
      "bemo:BEMO_3100022": 37,
      "bemo:BEMO_3100023": "74c0c7f33ecc210cbe2fa1dd5ddc15c31273005f3e5caaa4afc370a3f6c94a4e",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses biomarker reliability using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in biomarker reliability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating biomarker reliability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Biomarker development, qualification, endpoint and surrogate validation studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; BEST; EMA E16; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000030"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000029"
        },
        {
          "@id": "bemo:BEMO_2000031"
        },
        {
          "@id": "bemo:BEMO_2000032"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of biomarker reliability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/37"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000030",
      "rdfs:label": {
        "@language": "en",
        "@value": "Biomarker Reliability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb81"
        },
        {
          "@id": "bemo:BEMO_1100002"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb81",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000030"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000176",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000176",
      "bemo:BEMO_3100022": 183,
      "bemo:BEMO_3100023": "3d08eaaab51eb4d1095b9fb5e884110ba36de86e61615acc1661c581f985a6b1",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses experimental unit validity using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in experimental unit validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating experimental unit validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "In vitro, ex vivo, organoid, animal, and preclinical experiments"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ARRIVE 2.0; SYRCLE; OECD"
      },
      "bemo:BEMO_3200011": "https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000176"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000171"
        },
        {
          "@id": "bemo:BEMO_2000189"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which experimental unit supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/183"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000176",
      "rdfs:label": {
        "@language": "en",
        "@value": "Experimental Unit Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb7"
        },
        {
          "@id": "bemo:BEMO_1100007"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb7",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000176"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000003",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000003",
      "bemo:BEMO_3100022": 10,
      "bemo:BEMO_3100023": "8fcb10135485d0dff26bef51519f2178a09a543c766f354a728ca79b2c39c582",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses cell-type specificity using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in cell-type specificity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating cell-type specificity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Molecular, cellular, animal, translational, pharmacologic, and human studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; FDA Biomarker; ClinGen; OHAT; OECD"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000003"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000019"
        },
        {
          "@id": "bemo:BEMO_2000023"
        },
        {
          "@id": "bemo:BEMO_2000027"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of cell-type specificity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/10"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000003",
      "rdfs:label": {
        "@language": "en",
        "@value": "Cell-Type Specificity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb56"
        },
        {
          "@id": "bemo:BEMO_1100001"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb56",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000003"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000036",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000036",
      "bemo:BEMO_3100022": 43,
      "bemo:BEMO_3100023": "1ceb580fd3a672a7c14d44163bda2886dd03d14b99ce004f1db40aa485bb3e1b",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses content validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in content validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating content validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Biomarker development, qualification, endpoint and surrogate validation studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; BEST; EMA E16; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000036"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000035"
        },
        {
          "@id": "bemo:BEMO_2000051"
        },
        {
          "@id": "bemo:BEMO_2000052"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which content supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/43"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000036",
      "rdfs:label": {
        "@language": "en",
        "@value": "Content Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb85"
        },
        {
          "@id": "bemo:BEMO_1100002"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb85",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000036"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/160",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 160,
      "bemo:BEMO_3100023": "1f9ca5bc5be56489e2caf9d2f3eaaf37b12ae4271716853fb373d2db6aa8d657",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Systematic reviews, meta-analyses, evidence profiles, guidelines\", \"Category\": \"Evidence Certainty and Synthesis\", \"Closely Related Metrics\": \"Evidence Confidence; Evidence Consistency; Evidence Directness\", \"Common Misinterpretations\": \"Treating evidence stability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Evidence Stability\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/\", \"Related Frameworks\": \"GRADE; PRISMA; AMSTAR 2; RoB\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of evidence stability.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses evidence stability using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in evidence stability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 160"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/282",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 282,
      "bemo:BEMO_3100023": "0e987b7e93f5f6b586140ce3b08eb3d87acd863bc4cb825ee0d1e4b7b1bb3994",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Cross-Reactivity; Hook Effect Risk; Calibration Traceability\", \"Common Misinterpretations\": \"Treating carryover as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Carryover\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of carryover.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Replicate dilution series; blank and spiked samples; reference materials; method-comparison studies; predefined CLSI/ISO acceptance criteria.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses carryover using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in carryover can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 282"
    },
    {
      "@id": "bemo:BEMO_4000024",
      "@type": [
        "owl:NamedIndividual",
        "bemo:BEMO_0000402"
      ],
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Controlled BEMO LifecycleStatus value: Stable."
      },
      "oboInOwl:id": "BEMO:4000024",
      "rdfs:label": {
        "@language": "en",
        "@value": "Stable"
      },
      "skos:notation": "Stable"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/260",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 260,
      "bemo:BEMO_3100023": "e9483af6db486496b6f4b0c18d333bb38a6c500a6b80dd23beefe82c05de4acc",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies\", \"Category\": \"Genomics and Transcriptomics\", \"Closely Related Metrics\": \"Mapping Quality; Duplicate Read Burden; Library Complexity\", \"Common Misinterpretations\": \"Treating read quality as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Read Quality\", \"References or Origin\": \"https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/\", \"Related Frameworks\": \"MIAME; MINSEQE; STROBE-ME; GA4GH; HCA\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of read quality.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Read- and variant-level quality-control summaries; replicate concordance; orthogonal confirmation; benchmarking against reference materials.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses read quality using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in read quality can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 260"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000439",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000439"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/446"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Effect Magnitude"
      }
    },
    {
      "@id": "bemo:BEMO_3200011",
      "@type": "owl:AnnotationProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Preserves the source reference list."
      },
      "oboInOwl:id": "BEMO:3200011",
      "rdfs:label": {
        "@language": "en",
        "@value": "source references"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000255",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000255"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/262"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Relatedness Control"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/421",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 421,
      "bemo:BEMO_3100023": "15ffc51fd66113f5e5c480a7127c592104dbff4a2e6faafcfafb509cd725ea07",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All biomedical study reports and data releases\", \"Category\": \"Research Transparency and Reporting Completeness\", \"Closely Related Metrics\": \"Participant Flow Completeness; Statistical Methods Reporting Completeness; Missing-Data Reporting Completeness\", \"Common Misinterpretations\": \"Treating harms reporting completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Study report / dataset / evidence package\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Harms Reporting Completeness\", \"References or Origin\": \"https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/\", \"Related Frameworks\": \"EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS\", \"Scientific Definition\": \"The extent to which all scientifically necessary components of harms reporting are present, documented, and evaluable.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses harms reporting completeness using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in harms reporting completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 421"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/63",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 63,
      "bemo:BEMO_3100023": "596927f557190db71a0b686158bde6134cafa9cdb9c1876784270d91a80452f5",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Biomarker development, qualification, endpoint and surrogate validation studies\", \"Category\": \"Biomarker and Endpoint Validation\", \"Closely Related Metrics\": \"Safety Biomarker Validity; Response Biomarker Validity; Surrogate Endpoint Validity\", \"Common Misinterpretations\": \"Treating susceptibility/risk biomarker validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Susceptibility/Risk Biomarker Validity\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"FDA Biomarker; BEST; EMA E16; REMARK\", \"Scientific Definition\": \"The probability or degree that susceptibility/risk biomarker validity introduces systematic distortion into a biomedical estimate or conclusion.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses susceptibility/risk biomarker validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in susceptibility/risk biomarker validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 63"
    },
    {
      "@id": "bemo:BEMO_2000210",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000210",
      "bemo:BEMO_3100022": 217,
      "bemo:BEMO_3100023": "ef0b46b07942a1780f9e2e890b09b7edc3579f016762848aa46c4d956da3075d",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses transportability using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in transportability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating transportability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Clinical, epidemiologic, diagnostic, translational, and population studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; QUADAS-2; CONSORT; STROBE"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000210"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000198"
        },
        {
          "@id": "bemo:BEMO_2000205"
        },
        {
          "@id": "bemo:BEMO_2000206"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of transportability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/217"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000210",
      "rdfs:label": {
        "@language": "en",
        "@value": "Transportability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb240"
        },
        {
          "@id": "bemo:BEMO_1100008"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb240",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000210"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000305",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000305",
      "bemo:BEMO_3100022": 312,
      "bemo:BEMO_3100023": "5b9be25d7af680eef194d1d2e393dbdeaaf607f62c516cb41c75f5dfd1ba50b9",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses cross-omics replication using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in cross-omics replication can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating cross-omics replication as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Dataset / model / pathway / network / evidence body"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Integrated omics, networks, pathways, mechanistic and dynamic systems models"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "Gene Ontology; Reactome; UniProt; GA4GH"
      },
      "bemo:BEMO_3200011": "https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000305"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000303"
        },
        {
          "@id": "bemo:BEMO_2000304"
        },
        {
          "@id": "bemo:BEMO_2000312"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Developing",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of cross-omics replication."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/312"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000305",
      "rdfs:label": {
        "@language": "en",
        "@value": "Cross-Omics Replication"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb41"
        },
        {
          "@id": "bemo:BEMO_1100012"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb41",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000305"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_1000003",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Metrics assessing analytical measurement performance, assay validity, biospecimen handling, and preanalytical quality."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:1000003",
      "rdfs:label": {
        "@language": "en",
        "@value": "Measurement, Assay, and Biospecimen Quality metric"
      },
      "rdfs:subClassOf": {
        "@id": "bemo:BEMO_0000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000372",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000372"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/379"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Missing-Value Burden"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/182",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 182,
      "bemo:BEMO_3100023": "1291027c6f53e5902a86a2cf22b3cca02564dbc940590bb8b8bcfd5004b998b7",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"In vitro, ex vivo, organoid, animal, and preclinical experiments\", \"Category\": \"Experimental Biology and Animal Research\", \"Closely Related Metrics\": \"Exclusion-Criteria Prespecification; Positive-Control Performance; Negative-Control Performance\", \"Common Misinterpretations\": \"Treating experimental batch randomization as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Experimental Batch Randomization\", \"References or Origin\": \"https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"ARRIVE 2.0; SYRCLE; OECD\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of experimental batch randomization.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses experimental batch randomization using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in experimental batch randomization can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 182"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000241",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000241"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/248"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Cell-Type Annotation Confidence"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000037",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000037"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/44"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Context-of-Use Validity"
      }
    },
    {
      "@id": "bemo:BEMO_2000460",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000460",
      "bemo:BEMO_3100022": 467,
      "bemo:BEMO_3100023": "a3eba05a4613d95dc796e3df689756346c4f78ac2fda1dcb4e8cf4b813a22638",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses type i error control using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in type i error control can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating type i error control as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000460"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000451"
        },
        {
          "@id": "bemo:BEMO_2000459"
        },
        {
          "@id": "bemo:BEMO_2000461"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of type i error control."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/467"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000460",
      "rdfs:label": {
        "@language": "en",
        "@value": "Type I Error Control"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb463"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb463",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000460"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_4000020",
      "@type": [
        "owl:NamedIndividual",
        "bemo:BEMO_0000403"
      ],
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Controlled BEMO FormulaStatus value: MethodSpecificProtocolRequired."
      },
      "oboInOwl:id": "BEMO:4000020",
      "rdfs:label": {
        "@language": "en",
        "@value": "Method Specific Protocol Required"
      },
      "skos:notation": "MethodSpecificProtocolRequired"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000203",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000203"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/210"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Population Representativeness"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000341",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000341"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/348"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Lowest-Observed-Adverse-Effect Level Robustness"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000166",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000166"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/173"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Age Appropriateness"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/221",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 221,
      "bemo:BEMO_3100023": "965b0273f9a305e64b50437dcad85ab39818fad51d561d0ac4da1daaf7d204f2",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mendelian disease, cancer genetics, association, segregation, and functional studies\", \"Category\": \"Genetics and Variant Evidence\", \"Closely Related Metrics\": \"RNA Evidence Strength; Penetrance Evidence; Expressivity Consistency\", \"Common Misinterpretations\": \"Treating co-segregation likelihood as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Co-segregation Likelihood\", \"References or Origin\": \"https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/\", \"Related Frameworks\": \"ClinGen; ACMG AMP; STREGA; Gene Ontology\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of co-segregation likelihood.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"ClinGen/ACMG evidence scoring; pedigree analysis; population databases; case-control data; functional assays; expert-panel review.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses co-segregation likelihood using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in co-segregation likelihood can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 221"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/363",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 363,
      "bemo:BEMO_3100023": "8bfcea065494f7118cb14f95a9459e3f35fa404437872877955c4fdff069147a",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies\", \"Category\": \"Pharmacology and Toxicology\", \"Closely Related Metrics\": \"Dose Proportionality; Metabolite Coverage; Drug–Drug Interaction Evidence\", \"Common Misinterpretations\": \"Treating time–concentration profile adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Time–Concentration Profile Adequacy\", \"References or Origin\": \"https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline\", \"Related Frameworks\": \"OECD; OHAT; FDA Biomarker; EMA E16\", \"Scientific Definition\": \"The extent to which time–concentration profile is sufficient and fit for the stated biomedical inference.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Method- and analyte-specific physical units\", \"What It Measures\": \"Assesses time–concentration profile adequacy using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in time–concentration profile adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 363"
    },
    {
      "@id": "bemo:BEMO_2000232",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000232",
      "bemo:BEMO_3100022": 239,
      "bemo:BEMO_3100023": "4f9bdcfda63260ced3f40796d43228eea03ead68f517bc87939698d4f5d4faf2",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses segregation evidence strength using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in segregation evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "ClinGen/ACMG evidence scoring; pedigree analysis; population databases; case-control data; functional assays; expert-panel review."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating segregation evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mendelian disease, cancer genetics, association, segregation, and functional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ClinGen; ACMG AMP; STREGA; Gene Ontology"
      },
      "bemo:BEMO_3200011": "https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000232"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000211"
        },
        {
          "@id": "bemo:BEMO_2000217"
        },
        {
          "@id": "bemo:BEMO_2000230"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting segregation evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/239"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000232",
      "rdfs:label": {
        "@language": "en",
        "@value": "Segregation Evidence Strength"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb260"
        },
        {
          "@id": "bemo:BEMO_1100009"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb260",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000232"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000148",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000148",
      "bemo:BEMO_3100022": 155,
      "bemo:BEMO_3100023": "880de5f192c9dc60c14576e428f1c46fbdcda3180afe950bcde297920e65c6df",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses evidence directness using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in evidence directness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating evidence directness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Systematic reviews, meta-analyses, evidence profiles, guidelines"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; PRISMA; AMSTAR 2; RoB"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000148"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000142"
        },
        {
          "@id": "bemo:BEMO_2000146"
        },
        {
          "@id": "bemo:BEMO_2000150"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of evidence directness."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/155"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000148",
      "rdfs:label": {
        "@language": "en",
        "@value": "Evidence Directness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb187"
        },
        {
          "@id": "bemo:BEMO_1100006"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb187",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000148"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000437",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000437",
      "bemo:BEMO_3100022": 444,
      "bemo:BEMO_3100023": "cf100cd63561a5d7a167b9d561a196b9309ca048456a8705766e76a54a524fce",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses discrimination of statistical predictions using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in discrimination of statistical predictions can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating discrimination of statistical predictions as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000437"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000433"
        },
        {
          "@id": "bemo:BEMO_2000434"
        },
        {
          "@id": "bemo:BEMO_2000436"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of discrimination of statistical predictions."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/444"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000437",
      "rdfs:label": {
        "@language": "en",
        "@value": "Discrimination of Statistical Predictions"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb443"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb443",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000437"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000343",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000343"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/350"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Mixture Interaction Assessment"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000090",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000090"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/97"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Correct Temporal Ordering"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000153",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000153"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/160"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Evidence Stability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000022",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000022"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/29"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Rescue Experiment Support"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/133",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 133,
      "bemo:BEMO_3100023": "67544e05c38d184f5e9fa9830136b1408e7835e115b1fa9c54147ad65e14b99c",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies\", \"Category\": \"Diagnostic and Prognostic Evidence\", \"Closely Related Metrics\": \"Incorporation Bias Risk; Test-Timing Appropriateness; Comparative Test Accuracy\", \"Common Misinterpretations\": \"Treating patient flow integrity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Patient Flow Integrity\", \"References or Origin\": \"https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"QUADAS-2; STARD; TRIPOD; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of patient flow integrity.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses patient flow integrity using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in patient flow integrity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 133"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/209",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 209,
      "bemo:BEMO_3100023": "9073b7f8b73fc788aa084d5c4ac174d69482c2a1439b22f86a39e465503328bc",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Clinical, epidemiologic, diagnostic, translational, and population studies\", \"Category\": \"External Validity and Applicability\", \"Closely Related Metrics\": \"Setting Applicability; Intervention Applicability; Comparator Applicability\", \"Common Misinterpretations\": \"Treating population applicability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Population Applicability\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/\", \"Related Frameworks\": \"GRADE; QUADAS-2; CONSORT; STROBE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of population applicability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses population applicability using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in population applicability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 209"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000459",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000459"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/466"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Statistical Power"
      }
    },
    {
      "@id": "bemo:BEMO_2000189",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000189",
      "bemo:BEMO_3100022": 196,
      "bemo:BEMO_3100023": "8f5bd5eed372632eafdff28f1c8035067d4634c207012fb089ff55a67d705176",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses technical replicate adequacy using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in technical replicate adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating technical replicate adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "In vitro, ex vivo, organoid, animal, and preclinical experiments"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ARRIVE 2.0; SYRCLE; OECD"
      },
      "bemo:BEMO_3200011": "https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000189"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000171"
        },
        {
          "@id": "bemo:BEMO_2000184"
        },
        {
          "@id": "bemo:BEMO_2000185"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which technical replicate is sufficient and fit for the stated biomedical inference."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/196"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000189",
      "rdfs:label": {
        "@language": "en",
        "@value": "Technical Replicate Adequacy"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb222"
        },
        {
          "@id": "bemo:BEMO_1100007"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb222",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000189"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000023",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000023",
      "bemo:BEMO_3100022": 30,
      "bemo:BEMO_3100023": "6c08ba26b1257f37b62212d7633a9e83166a0f74706ae3ffbb9de90cd98613f7",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses spatial biological concordance using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in spatial biological concordance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating spatial biological concordance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Molecular, cellular, animal, translational, pharmacologic, and human studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; FDA Biomarker; ClinGen; OHAT; OECD"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000023"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000004"
        },
        {
          "@id": "bemo:BEMO_2000026"
        },
        {
          "@id": "bemo:BEMO_2000027"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree of agreement in spatial biological across measurements, studies, methods, populations, or biological levels."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/30"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000023",
      "rdfs:label": {
        "@language": "en",
        "@value": "Spatial Biological Concordance"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb75"
        },
        {
          "@id": "bemo:BEMO_1100001"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb75",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000023"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000344",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000344",
      "bemo:BEMO_3100022": 351,
      "bemo:BEMO_3100023": "f5f71661574e809d9eb1b7625ffde603665b4c0d25ddbb968f6b8d1a88c38a42",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses no-observed-adverse-effect level robustness using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in no-observed-adverse-effect level robustness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating no-observed-adverse-effect level robustness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "OECD; OHAT; FDA Biomarker; EMA E16"
      },
      "bemo:BEMO_3200011": "https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000344"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000330"
        },
        {
          "@id": "bemo:BEMO_2000341"
        },
        {
          "@id": "bemo:BEMO_2000352"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of no-observed-adverse-effect level robustness."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/351"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000344",
      "rdfs:label": {
        "@language": "en",
        "@value": "No-Observed-Adverse-Effect Level Robustness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb360"
        },
        {
          "@id": "bemo:BEMO_1100013"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb360",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000344"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/201",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 201,
      "bemo:BEMO_3100023": "e22341c32d6f7aad19740ed4b08e7f5ffc168107f1e04a79ba4ec60f6b92c463",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Clinical, epidemiologic, diagnostic, translational, and population studies\", \"Category\": \"External Validity and Applicability\", \"Closely Related Metrics\": \"Temporal Generalizability; Disease-Severity Generalizability; Care-Pathway Independence\", \"Common Misinterpretations\": \"Treating demographic generalizability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Demographic Generalizability\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/\", \"Related Frameworks\": \"GRADE; QUADAS-2; CONSORT; STROBE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of demographic generalizability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses demographic generalizability using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in demographic generalizability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 201"
    },
    {
      "@id": "bemo:BEMO_2000442",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000442",
      "bemo:BEMO_3100022": 449,
      "bemo:BEMO_3100023": "045c39ed086cc31d598f1fe91547a90170ea8cc0b684f22d5338144e750a0843",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses fragility index using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in fragility index can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating fragility index as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000442"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000432"
        },
        {
          "@id": "bemo:BEMO_2000434"
        },
        {
          "@id": "bemo:BEMO_2000456"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of fragility index."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/449"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000442",
      "rdfs:label": {
        "@language": "en",
        "@value": "Fragility Index"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb446"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb446",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000442"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/128",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 128,
      "bemo:BEMO_3100023": "3bc623a30f8cb3956f6d71196888c1021137e72c87604513c9fc1e352f98bb4c",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies\", \"Category\": \"Diagnostic and Prognostic Evidence\", \"Closely Related Metrics\": \"Reference Standard Validity; Verification Bias Risk; Differential Verification Bias Risk\", \"Common Misinterpretations\": \"Treating index-test blinding as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Index-Test Blinding\", \"References or Origin\": \"https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"QUADAS-2; STARD; TRIPOD; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of index-test blinding.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses index-test blinding using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in index-test blinding can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 128"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/31",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 31,
      "bemo:BEMO_3100023": "07df8f6070c405006e36806e8ccb515126dc2c7269ea9cf3934662d28e9264c6",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Molecular, cellular, animal, translational, pharmacologic, and human studies\", \"Category\": \"Biological Plausibility and Mechanism\", \"Closely Related Metrics\": \"Network Context Support\", \"Common Misinterpretations\": \"Treating systems-level emergence support as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Systems-Level Emergence Support\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"GRADE; FDA Biomarker; ClinGen; OHAT; OECD\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting systems-level emergence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses systems-level emergence support using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in systems-level emergence support can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 31"
    },
    {
      "@id": "bemo:BEMO_2000175",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000175",
      "bemo:BEMO_3100022": 182,
      "bemo:BEMO_3100023": "1291027c6f53e5902a86a2cf22b3cca02564dbc940590bb8b8bcfd5004b998b7",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses experimental batch randomization using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in experimental batch randomization can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating experimental batch randomization as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "In vitro, ex vivo, organoid, animal, and preclinical experiments"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ARRIVE 2.0; SYRCLE; OECD"
      },
      "bemo:BEMO_3200011": "https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000175"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000174"
        },
        {
          "@id": "bemo:BEMO_2000181"
        },
        {
          "@id": "bemo:BEMO_2000183"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of experimental batch randomization."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/182"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000175",
      "rdfs:label": {
        "@language": "en",
        "@value": "Experimental Batch Randomization"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb210"
        },
        {
          "@id": "bemo:BEMO_1100007"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb210",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000175"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000274",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000274"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/281"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Calibration Traceability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/177",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 177,
      "bemo:BEMO_3100023": "bfb6735bf1e0494f94802ec087edc274ccdaea50558f3ea043f6f21ae9210505",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"In vitro, ex vivo, organoid, animal, and preclinical experiments\", \"Category\": \"Experimental Biology and Animal Research\", \"Closely Related Metrics\": \"Humane Endpoint Appropriateness; Exclusion-Criteria Prespecification; Experimental Batch Randomization\", \"Common Misinterpretations\": \"Treating attrition accounting in animal studies as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Attrition Accounting in Animal Studies\", \"References or Origin\": \"https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"ARRIVE 2.0; SYRCLE; OECD\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of attrition accounting in animal studies.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses attrition accounting in animal studies using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in attrition accounting in animal studies can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 177"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000136",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000136"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/143"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Threshold Validity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/176",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 176,
      "bemo:BEMO_3100023": "ae7f68af5b958c01b88066cf76664c77d333abaff4414b63760b817bf19359d0",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"In vitro, ex vivo, organoid, animal, and preclinical experiments\", \"Category\": \"Experimental Biology and Animal Research\", \"Closely Related Metrics\": \"Animal Model Construct Validity; Species Appropriateness; Sex as a Biological Variable Adequacy\", \"Common Misinterpretations\": \"Treating animal model predictive validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Animal Model Predictive Validity\", \"References or Origin\": \"https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"ARRIVE 2.0; SYRCLE; OECD\", \"Scientific Definition\": \"The degree to which animal model predictive supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses animal model predictive validity using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in animal model predictive validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 176"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000052",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000052"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/59"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Prognostic Biomarker Validity"
      }
    },
    {
      "@id": "bemo:BEMO_2000477",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000477",
      "bemo:BEMO_3100022": 484,
      "bemo:BEMO_3100023": "6d08552ad6c8b3c6d5a3c8ed35293fcfc624984197116fb158f6c3a04698789f",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses exposure classification validity using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in exposure classification validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating exposure classification validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000477"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000463"
        },
        {
          "@id": "bemo:BEMO_2000471"
        },
        {
          "@id": "bemo:BEMO_2000479"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which exposure classification supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/484"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000477",
      "rdfs:label": {
        "@language": "en",
        "@value": "Exposure Classification Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb478"
        },
        {
          "@id": "bemo:BEMO_1100018"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb478",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000477"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000291",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000291"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/298"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Operator Variability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/225",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 225,
      "bemo:BEMO_3100023": "d100842d4d2c367ecd1122df00784975aa0a773a92bbb5c68a8ff23fbbd4dfc4",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mendelian disease, cancer genetics, association, segregation, and functional studies\", \"Category\": \"Genetics and Variant Evidence\", \"Closely Related Metrics\": \"Penetrance Evidence; Founder-Effect Assessment; Phenocopy Risk\", \"Common Misinterpretations\": \"Treating expressivity consistency as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Expressivity Consistency\", \"References or Origin\": \"https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/\", \"Related Frameworks\": \"ClinGen; ACMG AMP; STREGA; Gene Ontology\", \"Scientific Definition\": \"The degree of agreement in expressivity across measurements, studies, methods, populations, or biological levels.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses expressivity consistency using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in expressivity consistency can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 225"
    },
    {
      "@id": "bemo:BEMO_2000205",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000205",
      "bemo:BEMO_3100022": 212,
      "bemo:BEMO_3100023": "39b818e971de479787fde11a4523a1b0d31f5dcbc88f645b968cff60fa6bf381",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses sampling frame adequacy using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in sampling frame adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating sampling frame adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Clinical, epidemiologic, diagnostic, translational, and population studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; QUADAS-2; CONSORT; STROBE"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000205"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000198"
        },
        {
          "@id": "bemo:BEMO_2000203"
        },
        {
          "@id": "bemo:BEMO_2000210"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which sampling frame is sufficient and fit for the stated biomedical inference."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/212"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000205",
      "rdfs:label": {
        "@language": "en",
        "@value": "Sampling Frame Adequacy"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb235"
        },
        {
          "@id": "bemo:BEMO_1100008"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb235",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000205"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000484",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000484"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/491"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Protocol Fidelity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/39",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 39,
      "bemo:BEMO_3100023": "80beed232e03f65da1843b394120d8baef7fb4428401374caac926260837e2b2",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Biomarker development, qualification, endpoint and surrogate validation studies\", \"Category\": \"Biomarker and Endpoint Validation\", \"Closely Related Metrics\": \"Biomarker Responsiveness; Known-Groups Validity; Convergent Validity\", \"Common Misinterpretations\": \"Treating biomarker sensitivity to change as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment.\", \"Metric\": \"Biomarker Sensitivity to Change\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"FDA Biomarker; BEST; EMA E16; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of biomarker sensitivity to change.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses biomarker sensitivity to change using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in biomarker sensitivity to change can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 39"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000213",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000213"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/220"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Case-Level Evidence Strength"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/124",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 124,
      "bemo:BEMO_3100023": "14be8f0b88f11902e6b1562a38b9cb710840858fc59f748048f96b74c8f6c2b2",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies\", \"Category\": \"Diagnostic and Prognostic Evidence\", \"Closely Related Metrics\": \"Diagnostic Sensitivity; Positive Predictive Value; Negative Predictive Value\", \"Common Misinterpretations\": \"Treating diagnostic specificity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment.\", \"Metric\": \"Diagnostic Specificity\", \"References or Origin\": \"https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"QUADAS-2; STARD; TRIPOD; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of diagnostic specificity.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Two-by-two tables; binomial confidence intervals; hierarchical diagnostic meta-analysis; threshold and prevalence analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses diagnostic specificity using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in diagnostic specificity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 124"
    },
    {
      "@id": "bemo:BEMO_1100016",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Category of biomedical evidence metrics concerned with research transparency and reporting completeness."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:1100016",
      "rdfs:label": {
        "@language": "en",
        "@value": "Research Transparency and Reporting Completeness metric"
      },
      "rdfs:subClassOf": {
        "@id": "bemo:BEMO_1000004"
      }
    },
    {
      "@id": "bemo:BEMO_2000123",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000123",
      "bemo:BEMO_3100022": 130,
      "bemo:BEMO_3100023": "9f42e5362ad2e55445a028ec6d3cc9c062886d8c9272f983b0c1acec345502f7",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses negative predictive value using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in negative predictive value can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Two-by-two tables; binomial confidence intervals; hierarchical diagnostic meta-analysis; threshold and prevalence analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating negative predictive value as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "QUADAS-2; STARD; TRIPOD; REMARK"
      },
      "bemo:BEMO_3200011": "https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000123"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000122"
        },
        {
          "@id": "bemo:BEMO_2000127"
        },
        {
          "@id": "bemo:BEMO_2000128"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of negative predictive value."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/130"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000123",
      "rdfs:label": {
        "@language": "en",
        "@value": "Negative Predictive Value"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb162"
        },
        {
          "@id": "bemo:BEMO_1100005"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb162",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000123"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000390",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000390",
      "bemo:BEMO_3100022": 397,
      "bemo:BEMO_3100023": "89d3d59a31fe591c17a3c61f83a55d18326e4b311b8033047e95bfb2a93715fa",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses data availability using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in data availability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating data availability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All experimental, computational, clinical, and omics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0"
      },
      "bemo:BEMO_3200011": "https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000390"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000387"
        },
        {
          "@id": "bemo:BEMO_2000402"
        },
        {
          "@id": "bemo:BEMO_2000404"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of data availability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/397"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000390",
      "rdfs:label": {
        "@language": "en",
        "@value": "Data Availability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb402"
        },
        {
          "@id": "bemo:BEMO_1100015"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb402",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000390"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000355",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000355",
      "bemo:BEMO_3100022": 362,
      "bemo:BEMO_3100023": "34f5d4730ddbb7e269fc6713d96c49c0fba2d2f738ddbfb47d339a6ed5f8cf6e",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses therapeutic window evidence using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in therapeutic window evidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating therapeutic window evidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "OECD; OHAT; FDA Biomarker; EMA E16"
      },
      "bemo:BEMO_3200011": "https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000355"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000336"
        },
        {
          "@id": "bemo:BEMO_2000344"
        },
        {
          "@id": "bemo:BEMO_2000352"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of therapeutic window evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/362"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000355",
      "rdfs:label": {
        "@language": "en",
        "@value": "Therapeutic Window Evidence"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb370"
        },
        {
          "@id": "bemo:BEMO_1100013"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb370",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000355"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000079",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000079",
      "bemo:BEMO_3100022": 86,
      "bemo:BEMO_3100023": "b39a92acfa55bd840331823c88476d9d65ca0179f68f0f37ed8d7677a63d2193",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses storage temperature control using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in storage temperature control can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating storage temperature control as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All studies using human or animal biospecimens"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "BRISQ; ISO 15189; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000079"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000067"
        },
        {
          "@id": "bemo:BEMO_2000075"
        },
        {
          "@id": "bemo:BEMO_2000081"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of storage temperature control."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/86"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000079",
      "rdfs:label": {
        "@language": "en",
        "@value": "Storage Temperature Control"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb124"
        },
        {
          "@id": "bemo:BEMO_1100003"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb124",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000079"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000165",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000165",
      "bemo:BEMO_3100022": 172,
      "bemo:BEMO_3100023": "93fce0e52f596e9f5e6b6636a82da697803846e686e6144faa894115a270196a",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses study heterogeneity using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in study heterogeneity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Forest plots; heterogeneity statistics; tau-squared; prediction intervals; funnel plots; regression or selection models; sensitivity analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating study heterogeneity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Systematic reviews, meta-analyses, evidence profiles, guidelines"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; PRISMA; AMSTAR 2; RoB"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000165"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000139"
        },
        {
          "@id": "bemo:BEMO_2000161"
        },
        {
          "@id": "bemo:BEMO_2000164"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of study heterogeneity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/172"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000165",
      "rdfs:label": {
        "@language": "en",
        "@value": "Study Heterogeneity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb201"
        },
        {
          "@id": "bemo:BEMO_1100006"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb201",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000165"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/142",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 142,
      "bemo:BEMO_3100023": "ffb2707e3bed89aca5f5c790dc5a9b0312e89c5a1dba27ebac908e4597a355bd",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies\", \"Category\": \"Diagnostic and Prognostic Evidence\", \"Closely Related Metrics\": \"Patient Flow Integrity; Comparative Test Accuracy; Incremental Diagnostic Value\", \"Common Misinterpretations\": \"Treating test-timing appropriateness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Test-Timing Appropriateness\", \"References or Origin\": \"https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"QUADAS-2; STARD; TRIPOD; REMARK\", \"Scientific Definition\": \"The extent to which test-timing is sufficient and fit for the stated biomedical inference.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses test-timing appropriateness using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in test-timing appropriateness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 142"
    },
    {
      "@id": "bemo:BEMO_2000434",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000434",
      "bemo:BEMO_3100022": 441,
      "bemo:BEMO_3100023": "7e04bf59de003d9389f3d5e5a39c09dbec7b25b54fdd665e24d339ccf148fb17",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses clinical relevance of effect using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in clinical relevance of effect can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating clinical relevance of effect as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000434"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000432"
        },
        {
          "@id": "bemo:BEMO_2000436"
        },
        {
          "@id": "bemo:BEMO_2000442"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of clinical relevance of effect."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/441"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000434",
      "rdfs:label": {
        "@language": "en",
        "@value": "Clinical Relevance of Effect"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb440"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb440",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000434"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/178",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 178,
      "bemo:BEMO_3100023": "74976e4cf57f53c444f4721c04fc26fb7298cad4ac743db45feeb9a0be34587a",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"In vitro, ex vivo, organoid, animal, and preclinical experiments\", \"Category\": \"Experimental Biology and Animal Research\", \"Closely Related Metrics\": \"Experimental Unit Validity; Technical Replicate Adequacy; Sample Size Justification\", \"Common Misinterpretations\": \"Treating biological replicate adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Biological Replicate Adequacy\", \"References or Origin\": \"https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"ARRIVE 2.0; SYRCLE; OECD\", \"Scientific Definition\": \"The extent to which biological replicate is sufficient and fit for the stated biomedical inference.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses biological replicate adequacy using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in biological replicate adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 178"
    },
    {
      "@id": "bemo:BEMO_2000042",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000042",
      "bemo:BEMO_3100022": 49,
      "bemo:BEMO_3100023": "e147bf4116de09d3c1bd6b5fb8081223589d31f54f697b6e869790830619757d",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses endpoint reliability using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in endpoint reliability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating endpoint reliability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Biomarker development, qualification, endpoint and surrogate validation studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; BEST; EMA E16; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000042"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000043"
        },
        {
          "@id": "bemo:BEMO_2000047"
        },
        {
          "@id": "bemo:BEMO_2000049"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of endpoint reliability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/49"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000042",
      "rdfs:label": {
        "@language": "en",
        "@value": "Endpoint Reliability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb91"
        },
        {
          "@id": "bemo:BEMO_1100002"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb91",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000042"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000177",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000177",
      "bemo:BEMO_3100022": 184,
      "bemo:BEMO_3100023": "3f6791503c2895971802b5fb5573311999fc32cde51839dc771c56e4855ceb83",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses genetic background control using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in genetic background control can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating genetic background control as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "In vitro, ex vivo, organoid, animal, and preclinical experiments"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ARRIVE 2.0; SYRCLE; OECD"
      },
      "bemo:BEMO_3200011": "https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000177"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000166"
        },
        {
          "@id": "bemo:BEMO_2000173"
        },
        {
          "@id": "bemo:BEMO_2000178"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of genetic background control."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/184"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000177",
      "rdfs:label": {
        "@language": "en",
        "@value": "Genetic Background Control"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb211"
        },
        {
          "@id": "bemo:BEMO_1100007"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb211",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000177"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/164",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 164,
      "bemo:BEMO_3100023": "1349313eaf86ad90454f8dbf26aa9cb5389132fc9ac2e44b703024851df5136c",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Systematic reviews, meta-analyses, evidence profiles, guidelines\", \"Category\": \"Evidence Certainty and Synthesis\", \"Closely Related Metrics\": \"Cumulative Evidence Stability; Multiplicity-Adjusted Credibility\", \"Common Misinterpretations\": \"Treating information size adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Information Size Adequacy\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/\", \"Related Frameworks\": \"GRADE; PRISMA; AMSTAR 2; RoB\", \"Scientific Definition\": \"The extent to which information size is sufficient and fit for the stated biomedical inference.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses information size adequacy using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in information size adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 164"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/316",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 316,
      "bemo:BEMO_3100023": "f8d3b19efd68e0150e437c71bac90ab2bb80f33877b4a0e74bc52542a0fd3c26",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Integrated omics, networks, pathways, mechanistic and dynamic systems models\", \"Category\": \"Multi-omics and Systems Biology\", \"Closely Related Metrics\": \"Steady-State Validity; Perturbation Prediction Accuracy; Emergent-Property Reproducibility\", \"Common Misinterpretations\": \"Treating flux-balance consistency as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Dataset / model / pathway / network / evidence body\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Flux-Balance Consistency\", \"References or Origin\": \"https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/\", \"Related Frameworks\": \"Gene Ontology; Reactome; UniProt; GA4GH\", \"Scientific Definition\": \"The degree of agreement in flux-balance across measurements, studies, methods, populations, or biological levels.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses flux-balance consistency using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in flux-balance consistency can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 316"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/323",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 323,
      "bemo:BEMO_3100023": "79eaf0a8e6c6fc3012d48e379c545c17d89aecf6de033d40ae6399ec89441a3b",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Integrated omics, networks, pathways, mechanistic and dynamic systems models\", \"Category\": \"Multi-omics and Systems Biology\", \"Closely Related Metrics\": \"Network Edge Confidence; Module Stability; Pathway Enrichment Consistency\", \"Common Misinterpretations\": \"Treating network node confidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Dataset / model / pathway / network / evidence body\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Network Node Confidence\", \"References or Origin\": \"https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/\", \"Related Frameworks\": \"Gene Ontology; Reactome; UniProt; GA4GH\", \"Scientific Definition\": \"The justified degree of certainty assigned to network node given the quantity, quality, consistency, and limitations of supporting evidence.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses network node confidence using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in network node confidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 323"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/459",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 459,
      "bemo:BEMO_3100023": "5c494db875d0f3ad6860a3bba83e6ac01d9f571b40aa89617a37a42c1c489cab",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Equivalence Margin Validity\", \"Common Misinterpretations\": \"Treating noninferiority margin validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Noninferiority Margin Validity\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"The degree to which noninferiority margin supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses noninferiority margin validity using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in noninferiority margin validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 459"
    },
    {
      "@id": "bemo:BEMO_2000465",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000465",
      "bemo:BEMO_3100022": 472,
      "bemo:BEMO_3100023": "0783cbbb1a7caf7ef448d6830ae564e73010beb87e2e08710ddb494b6b76ccb3",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses attrition bias risk using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in attrition bias risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating attrition bias risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000465"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000474"
        },
        {
          "@id": "bemo:BEMO_2000483"
        },
        {
          "@id": "bemo:BEMO_2000486"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The probability or degree that attrition bias introduces systematic distortion into a biomedical estimate or conclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/472"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000465",
      "rdfs:label": {
        "@language": "en",
        "@value": "Attrition Bias Risk"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb467"
        },
        {
          "@id": "bemo:BEMO_1100018"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb467",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000465"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/143",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 143,
      "bemo:BEMO_3100023": "c27bfe6217acf4b748aeb85aa4e9c4176c8256e12b7c61ff84a201b6fd374c82",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies\", \"Category\": \"Diagnostic and Prognostic Evidence\", \"Closely Related Metrics\": \"Partial Area Under the Receiver Operating Characteristic Curve; Reference Standard Validity; Index-Test Blinding\", \"Common Misinterpretations\": \"Treating threshold validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Threshold Validity\", \"References or Origin\": \"https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"QUADAS-2; STARD; TRIPOD; REMARK\", \"Scientific Definition\": \"The degree to which threshold supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses threshold validity using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in threshold validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 143"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000227",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000227"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/234"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Penetrance Evidence"
      }
    },
    {
      "@id": "bemo:BEMO_2000124",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000124",
      "bemo:BEMO_3100022": 131,
      "bemo:BEMO_3100023": "cdf33871a90f7426da799fbf8148672bff9e925c7981ff58372c39511bd4050e",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses observed-to-expected ratio using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in observed-to-expected ratio can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating observed-to-expected ratio as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "QUADAS-2; STARD; TRIPOD; REMARK"
      },
      "bemo:BEMO_3200011": "https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000124"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000112"
        },
        {
          "@id": "bemo:BEMO_2000129"
        },
        {
          "@id": "bemo:BEMO_2000132"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of observed-to-expected ratio."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/131"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000124",
      "rdfs:label": {
        "@language": "en",
        "@value": "Observed-to-Expected Ratio"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb163"
        },
        {
          "@id": "bemo:BEMO_1100005"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb163",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000124"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/192",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 192,
      "bemo:BEMO_3100023": "9c4289123cb7c0f9d87fa9453151e360a9b6781cd9fbb6f6b26a09f4543b0dab",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"In vitro, ex vivo, organoid, animal, and preclinical experiments\", \"Category\": \"Experimental Biology and Animal Research\", \"Closely Related Metrics\": \"Technical Replicate Adequacy; Randomization in Experimental Allocation; Blinding in Experimental Assessment\", \"Common Misinterpretations\": \"Treating sample size justification as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Sample Size Justification\", \"References or Origin\": \"https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"ARRIVE 2.0; SYRCLE; OECD\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of sample size justification.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses sample size justification using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in sample size justification can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 192"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/451",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 451,
      "bemo:BEMO_3100023": "0202d30b443e9ba2dd8ad4597c8e7b9fcc240af0f60b19db4a115b1d2866e858",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Outlier Influence Robustness; Nonlinearity Assessment; Interaction Assessment Adequacy\", \"Common Misinterpretations\": \"Treating influential observation sensitivity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment.\", \"Metric\": \"Influential Observation Sensitivity\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of influential observation sensitivity.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses influential observation sensitivity using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in influential observation sensitivity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 451"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000230",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000230"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/237"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Population Frequency Compatibility"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000353",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000353"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/360"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Selectivity Profile"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/289",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 289,
      "bemo:BEMO_3100023": "39eec82dab659b7826d3bea8f3227e8afeb55e0f15214b02955200cb8a59a8ba",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Reagent Lot Consistency; Operator Variability; Site-to-Site Assay Portability\", \"Common Misinterpretations\": \"Treating instrument drift as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Instrument Drift\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of instrument drift.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses instrument drift using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in instrument drift can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 289"
    },
    {
      "@id": "bemo:BEMO_2000398",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000398",
      "bemo:BEMO_3100022": 405,
      "bemo:BEMO_3100023": "ad24de4b8dd0c9ae8c1a3d7d5fcdd166b9bd923967cbf8032882e26fce35feb2",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses material availability using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in material availability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating material availability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All experimental, computational, clinical, and omics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0"
      },
      "bemo:BEMO_3200011": "https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000398"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000387"
        },
        {
          "@id": "bemo:BEMO_2000390"
        },
        {
          "@id": "bemo:BEMO_2000401"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of material availability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/405"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000398",
      "rdfs:label": {
        "@language": "en",
        "@value": "Material Availability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb408"
        },
        {
          "@id": "bemo:BEMO_1100015"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb408",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000398"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000470",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000470",
      "bemo:BEMO_3100022": 477,
      "bemo:BEMO_3100023": "de36d6b209ddc70bf44fd968006b0ba61482bcc4bbe42db3c2a605301631de5e",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses co-intervention bias risk using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in co-intervention bias risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating co-intervention bias risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000470"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000468"
        },
        {
          "@id": "bemo:BEMO_2000472"
        },
        {
          "@id": "bemo:BEMO_2000482"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The probability or degree that co-intervention bias introduces systematic distortion into a biomedical estimate or conclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/477"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000470",
      "rdfs:label": {
        "@language": "en",
        "@value": "Co-intervention Bias Risk"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb472"
        },
        {
          "@id": "bemo:BEMO_1100018"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb472",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000470"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/127",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 127,
      "bemo:BEMO_3100023": "8c0d8dc6983b3100a525f45a2c3c327af7d21cf2d155dc05a19b99e0d7f43578",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies\", \"Category\": \"Diagnostic and Prognostic Evidence\", \"Closely Related Metrics\": \"Comparative Test Accuracy; Reclassification Improvement; Prognostic Discrimination\", \"Common Misinterpretations\": \"Treating incremental diagnostic value as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Incremental Diagnostic Value\", \"References or Origin\": \"https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"QUADAS-2; STARD; TRIPOD; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of incremental diagnostic value.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses incremental diagnostic value using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in incremental diagnostic value can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 127"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/240",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 240,
      "bemo:BEMO_3100023": "50c6384810a1443b5a98f42466fb8ab2489b57dad29ed2dab35ef7acec1960d2",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mendelian disease, cancer genetics, association, segregation, and functional studies\", \"Category\": \"Genetics and Variant Evidence\", \"Closely Related Metrics\": \"Null-Variant Quality; RNA Evidence Strength; Co-segregation Likelihood\", \"Common Misinterpretations\": \"Treating splicing evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Splicing Evidence Strength\", \"References or Origin\": \"https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/\", \"Related Frameworks\": \"ClinGen; ACMG AMP; STREGA; Gene Ontology\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting splicing evidence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses splicing evidence strength using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in splicing evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 240"
    },
    {
      "@id": "bemo:BEMO_2000025",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000025",
      "bemo:BEMO_3100022": 32,
      "bemo:BEMO_3100023": "a51c69d24f2bf9ef711f1d3b54d2086032245754bf1992c1b5999a88e3ca185f",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses target engagement evidence using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in target engagement evidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating target engagement evidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Molecular, cellular, animal, translational, pharmacologic, and human studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; FDA Biomarker; ClinGen; OHAT; OECD"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000025"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000005"
        },
        {
          "@id": "bemo:BEMO_2000017"
        },
        {
          "@id": "bemo:BEMO_2000018"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of target engagement evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/32"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000025",
      "rdfs:label": {
        "@language": "en",
        "@value": "Target Engagement Evidence"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb76"
        },
        {
          "@id": "bemo:BEMO_1100001"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb76",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000025"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_3100020",
      "@type": "owl:DatatypeProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Quality-control requirements for computation."
      },
      "oboInOwl:id": "BEMO:3100020",
      "rdfs:label": {
        "@language": "en",
        "@value": "quality control requirements"
      }
    },
    {
      "@id": "bemo:BEMO_2000266",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000266",
      "bemo:BEMO_3100022": 273,
      "bemo:BEMO_3100023": "45320c5b96fc37b8148ee2721453c92e6bec79491a4ed2d2f6fedbc2cb99cb01",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses variant call quality using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in variant call quality can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "ClinGen/ACMG evidence scoring; pedigree analysis; population databases; case-control data; functional assays; expert-panel review."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating variant call quality as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAME; MINSEQE; STROBE-ME; GA4GH; HCA"
      },
      "bemo:BEMO_3200011": "https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000266"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000237"
        },
        {
          "@id": "bemo:BEMO_2000247"
        },
        {
          "@id": "bemo:BEMO_2000258"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of variant call quality."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/273"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000266",
      "rdfs:label": {
        "@language": "en",
        "@value": "Variant Call Quality"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb290"
        },
        {
          "@id": "bemo:BEMO_1100010"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb290",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000266"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_3200018",
      "@type": "owl:AnnotationProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Ontology-editor note."
      },
      "oboInOwl:id": "BEMO:3200018",
      "rdfs:label": {
        "@language": "en",
        "@value": "editor note"
      }
    },
    {
      "@id": "bemo:BEMO_2000115",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000115",
      "bemo:BEMO_3100022": 122,
      "bemo:BEMO_3100023": "a903f03627bce43e756f3c1d10c27c552a53bce0346a40196ea1cd72afe63de0",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses diagnostic odds ratio using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in diagnostic odds ratio can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Two-by-two tables; binomial confidence intervals; hierarchical diagnostic meta-analysis; threshold and prevalence analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating diagnostic odds ratio as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "QUADAS-2; STARD; TRIPOD; REMARK"
      },
      "bemo:BEMO_3200011": "https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000115"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000110"
        },
        {
          "@id": "bemo:BEMO_2000122"
        },
        {
          "@id": "bemo:BEMO_2000125"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of diagnostic odds ratio."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/122"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000115",
      "rdfs:label": {
        "@language": "en",
        "@value": "Diagnostic Odds Ratio"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb156"
        },
        {
          "@id": "bemo:BEMO_1100005"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb156",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000115"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/100",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 100,
      "bemo:BEMO_3100023": "8587ae49790e995db7d3bf84506f3bebdce4263532f6e5dcbd136229f5da442f",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized and observational etiologic studies, natural experiments, target-trial emulations\", \"Category\": \"Causal Inference\", \"Closely Related Metrics\": \"Quantitative Bias Analysis Robustness; Assumption Sensitivity; Falsification Test Support\", \"Common Misinterpretations\": \"Treating e-value strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Specialized / infrequent\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Developing\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"E-value Strength\", \"References or Origin\": \"https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting e-value.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ratio scale; null typically 1\", \"What It Measures\": \"Assesses e-value strength using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in e-value strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 100"
    },
    {
      "@id": "bemo:BEMO_2000072",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000072",
      "bemo:BEMO_3100022": 79,
      "bemo:BEMO_3100023": "a7e7bf9a47cefd808a5ba122413c735b8b095ffc84592451f9857f4fe080e389",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses microbial contamination using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in microbial contamination can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating microbial contamination as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All studies using human or animal biospecimens"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "BRISQ; ISO 15189; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000072"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000062"
        },
        {
          "@id": "bemo:BEMO_2000071"
        },
        {
          "@id": "bemo:BEMO_2000077"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of microbial contamination."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/79"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000072",
      "rdfs:label": {
        "@language": "en",
        "@value": "Microbial Contamination"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb117"
        },
        {
          "@id": "bemo:BEMO_1100003"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb117",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000072"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000399",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000399"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/406"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Method Reproducibility"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000030",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000030"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/37"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Biomarker Reliability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/78",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 78,
      "bemo:BEMO_3100023": "daf35eaf7e6632e499a494b9ba629171cde4aa96d4d637ad7669da2f69668fd5",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All studies using human or animal biospecimens\", \"Category\": \"Biospecimen and Preanalytical Quality\", \"Closely Related Metrics\": \"Chain-of-Custody Integrity\", \"Common Misinterpretations\": \"Treating matched-sample integrity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Matched-Sample Integrity\", \"References or Origin\": \"https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"BRISQ; ISO 15189; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of matched-sample integrity.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses matched-sample integrity using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in matched-sample integrity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 78"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/454",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 454,
      "bemo:BEMO_3100023": "399e0c1d410c7ca1c5cc767b5afb9291915d1ee3db3b4d7314b2092c6d4765e1",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Variance Estimation Validity; Missing-Data Sensitivity; Imputation Validity\", \"Common Misinterpretations\": \"Treating missing-data mechanism plausibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Missing-Data Mechanism Plausibility\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of missing-data mechanism plausibility.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses missing-data mechanism plausibility using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in missing-data mechanism plausibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 454"
    },
    {
      "@id": "bemo:BEMO_2000411",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000411",
      "bemo:BEMO_3100022": 418,
      "bemo:BEMO_3100023": "6d08df9b94938aa4356ba3bbe963ef6fed2e0e499e09e30936b635d55a24d3c8",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses deviations-from-protocol transparency using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in deviations-from-protocol transparency can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating deviations-from-protocol transparency as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Study report / dataset / evidence package"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All biomedical study reports and data releases"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000411"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000420"
        },
        {
          "@id": "bemo:BEMO_2000430"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of deviations-from-protocol transparency."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/418"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000411",
      "rdfs:label": {
        "@language": "en",
        "@value": "Deviations-from-Protocol Transparency"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb420"
        },
        {
          "@id": "bemo:BEMO_1100016"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb420",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000411"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000366",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000366",
      "bemo:BEMO_3100022": 373,
      "bemo:BEMO_3100023": "c108ebf1ca903ed7e96063f24ecaf39723dd5e925f97d641601f89fd859897b9",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses ion suppression assessment using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in ion suppression assessment can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating ion suppression assessment as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAPE; HUPO PSI; Metabolomics Standards"
      },
      "bemo:BEMO_3200011": "https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000366"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000368"
        },
        {
          "@id": "bemo:BEMO_2000372"
        },
        {
          "@id": "bemo:BEMO_2000383"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of ion suppression assessment."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/373"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000366",
      "rdfs:label": {
        "@language": "en",
        "@value": "Ion Suppression Assessment"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb380"
        },
        {
          "@id": "bemo:BEMO_1100014"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb380",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000366"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/18",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 18,
      "bemo:BEMO_3100023": "70dc43fe10f07fb6cf3546a825ad424f5db2e21cc1b19a9f92b47d758bf660bd",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Molecular, cellular, animal, translational, pharmacologic, and human studies\", \"Category\": \"Biological Plausibility and Mechanism\", \"Closely Related Metrics\": \"Mechanistic Coverage; Mechanistic Coherence; Mechanistic Specificity\", \"Common Misinterpretations\": \"Treating mechanistic completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Mechanistic Completeness\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"GRADE; FDA Biomarker; ClinGen; OHAT; OECD\", \"Scientific Definition\": \"The extent to which all scientifically necessary components of mechanistic are present, documented, and evaluable.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses mechanistic completeness using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in mechanistic completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 18"
    },
    {
      "@id": "bemo:BEMO_2000195",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000195",
      "bemo:BEMO_3100022": 202,
      "bemo:BEMO_3100023": "867ff07055e7596b98039def11c9ce9ca056af7a3a11134bb8f46a0bd5adc97a",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses disease-severity generalizability using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in disease-severity generalizability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating disease-severity generalizability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Clinical, epidemiologic, diagnostic, translational, and population studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; QUADAS-2; CONSORT; STROBE"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000195"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000191"
        },
        {
          "@id": "bemo:BEMO_2000193"
        },
        {
          "@id": "bemo:BEMO_2000194"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of disease-severity generalizability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/202"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000195",
      "rdfs:label": {
        "@language": "en",
        "@value": "Disease-Severity Generalizability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb228"
        },
        {
          "@id": "bemo:BEMO_1100008"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb228",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000195"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/126",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 126,
      "bemo:BEMO_3100023": "00ceeb2a9486ba76c68ad0f07ad3fe11fadf573e3b3b3fb37898281142b34a91",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies\", \"Category\": \"Diagnostic and Prognostic Evidence\", \"Closely Related Metrics\": \"Differential Verification Bias Risk; Patient Flow Integrity; Test-Timing Appropriateness\", \"Common Misinterpretations\": \"Treating incorporation bias risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Incorporation Bias Risk\", \"References or Origin\": \"https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"QUADAS-2; STARD; TRIPOD; REMARK\", \"Scientific Definition\": \"The probability or degree that incorporation bias introduces systematic distortion into a biomedical estimate or conclusion.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses incorporation bias risk using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in incorporation bias risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 126"
    },
    {
      "@id": "bemo:BEMO_2000450",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000450",
      "bemo:BEMO_3100022": 457,
      "bemo:BEMO_3100023": "c5d48404d8de034fc4aa45bb9f64638b1d861e61321423aa5f11d4f63cc6783b",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses model specification adequacy using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in model specification adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating model specification adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000450"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000449"
        },
        {
          "@id": "bemo:BEMO_2000451"
        },
        {
          "@id": "bemo:BEMO_2000458"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which model specification is sufficient and fit for the stated biomedical inference."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/457"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000450",
      "rdfs:label": {
        "@language": "en",
        "@value": "Model Specification Adequacy"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb454"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb454",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000450"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000110",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000110",
      "bemo:BEMO_3100022": 117,
      "bemo:BEMO_3100023": "5c4feaae4c2a565042108ac4cb807678f9be09f3e84e62f596afd3338e3ceec6",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses area under the receiver operating characteristic curve using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in area under the receiver operating characteristic curve can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating area under the receiver operating characteristic curve as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "QUADAS-2; STARD; TRIPOD; REMARK"
      },
      "bemo:BEMO_3200011": "https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000110"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000115"
        },
        {
          "@id": "bemo:BEMO_2000125"
        },
        {
          "@id": "bemo:BEMO_2000136"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of area under the receiver operating characteristic curve."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/117"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000110",
      "rdfs:label": {
        "@language": "en",
        "@value": "Area Under the Receiver Operating Characteristic Curve"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb152"
        },
        {
          "@id": "bemo:BEMO_1100005"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb152",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000110"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/313",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 313,
      "bemo:BEMO_3100023": "d58852cf510c70b8fcfa12f792791c36728adc16d59c5b9bb4b7a9b129c39f52",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Integrated omics, networks, pathways, mechanistic and dynamic systems models\", \"Category\": \"Multi-omics and Systems Biology\", \"Closely Related Metrics\": \"Practical Identifiability; Steady-State Validity; Flux-Balance Consistency\", \"Common Misinterpretations\": \"Treating dynamical stability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Dataset / model / pathway / network / evidence body\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Dynamical Stability\", \"References or Origin\": \"https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/\", \"Related Frameworks\": \"Gene Ontology; Reactome; UniProt; GA4GH\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of dynamical stability.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses dynamical stability using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in dynamical stability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 313"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/137",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 137,
      "bemo:BEMO_3100023": "bddeb4ff61529649f6f5d81ae9a9ab5588a6f6aed10ca70d0d400119d6c2e940",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies\", \"Category\": \"Diagnostic and Prognostic Evidence\", \"Closely Related Metrics\": \"Prognostic Discrimination; Calibration Slope; Calibration-in-the-Large\", \"Common Misinterpretations\": \"Treating prognostic calibration as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Prognostic Calibration\", \"References or Origin\": \"https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"QUADAS-2; STARD; TRIPOD; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of prognostic calibration.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses prognostic calibration using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in prognostic calibration can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 137"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000281",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000281"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/288"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Hook Effect Risk"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000163",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000163"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/170"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Selective Nonreporting Risk"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000440",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000440"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/447"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Equivalence Margin Validity"
      }
    },
    {
      "@id": "bemo:BEMO_2000293",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000293",
      "bemo:BEMO_3100022": 300,
      "bemo:BEMO_3100023": "b76350bac6098346689193598ba9a67fbdcf0cc16c9a9abb5e49d8238a97798b",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses preanalytical robustness using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in preanalytical robustness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating preanalytical robustness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000293"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000273"
        },
        {
          "@id": "bemo:BEMO_2000292"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of preanalytical robustness."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/300"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000293",
      "rdfs:label": {
        "@language": "en",
        "@value": "Preanalytical Robustness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb314"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb314",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000293"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_3100023",
      "@type": "owl:DatatypeProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "SHA-256 hash of the canonical source record."
      },
      "oboInOwl:id": "BEMO:3100023",
      "rdfs:label": {
        "@language": "en",
        "@value": "source record hash"
      },
      "rdfs:range": {
        "@id": "xsd:string"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/438",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 438,
      "bemo:BEMO_3100023": "d8af14618f3e80ecff3b617a35c54caa9b3c73184f234fcea88a9ee83c7090ff",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All biomedical study reports and data releases\", \"Category\": \"Research Transparency and Reporting Completeness\", \"Closely Related Metrics\": \"Harms Reporting Completeness; Missing-Data Reporting Completeness; Funding-Source Transparency\", \"Common Misinterpretations\": \"Treating statistical methods reporting completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Study report / dataset / evidence package\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Statistical Methods Reporting Completeness\", \"References or Origin\": \"https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/\", \"Related Frameworks\": \"EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS\", \"Scientific Definition\": \"The extent to which all scientifically necessary components of statistical methods reporting are present, documented, and evaluable.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses statistical methods reporting completeness using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in statistical methods reporting completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 438"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000199",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000199"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/206"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Geographic Consistency"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000328",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000328"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/335"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Structural Identifiability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000198",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000198"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/205"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Generalizability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000010",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000010"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/17"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Mechanistic Coherence"
      }
    },
    {
      "@id": "bemo:BEMO_2000377",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000377",
      "bemo:BEMO_3100022": 384,
      "bemo:BEMO_3100023": "86cf8ad175ebd274f625e908935f946750c2c41a33f40e7a8dc33224d8db7d28",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses protein identification confidence using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in protein identification confidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Target-decoy analysis; spectral scoring; reference standards; replicate injections; retention-time and mass-error monitoring; orthogonal confirmation."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating protein identification confidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAPE; HUPO PSI; Metabolomics Standards"
      },
      "bemo:BEMO_3200011": "https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000377"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000363"
        },
        {
          "@id": "bemo:BEMO_2000374"
        },
        {
          "@id": "bemo:BEMO_2000375"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The justified degree of certainty assigned to protein identification given the quantity, quality, consistency, and limitations of supporting evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/384"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000377",
      "rdfs:label": {
        "@language": "en",
        "@value": "Protein Identification Confidence"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb46"
        },
        {
          "@id": "bemo:BEMO_1100014"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb46",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000377"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000006",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000006",
      "bemo:BEMO_3100022": 13,
      "bemo:BEMO_3100023": "5c02cfac370a9d2c1514479546d6e291e60bffe1758412ceec02bbf8edaab2dc",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses gain-of-function validation using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in gain-of-function validation can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating gain-of-function validation as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Molecular, cellular, animal, translational, pharmacologic, and human studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; FDA Biomarker; ClinGen; OHAT; OECD"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000006"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000005"
        },
        {
          "@id": "bemo:BEMO_2000008"
        },
        {
          "@id": "bemo:BEMO_2000022"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of gain-of-function validation."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/13"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000006",
      "rdfs:label": {
        "@language": "en",
        "@value": "Gain-of-Function Validation"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb59"
        },
        {
          "@id": "bemo:BEMO_1100001"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb59",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000006"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000433",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000433"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/440"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Calibration of Statistical Predictions"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/62",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 62,
      "bemo:BEMO_3100023": "880b1c4a9fa2a25e2876679a2a7e759365591c8d0d0ae431e9a6e89a9d327bd9",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Biomarker development, qualification, endpoint and surrogate validation studies\", \"Category\": \"Biomarker and Endpoint Validation\", \"Closely Related Metrics\": \"Response Biomarker Validity; Individual-Level Surrogacy; Trial-Level Surrogacy\", \"Common Misinterpretations\": \"Treating surrogate endpoint validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Surrogate Endpoint Validity\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"FDA Biomarker; BEST; EMA E16; REMARK\", \"Scientific Definition\": \"The degree to which surrogate endpoint supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses surrogate endpoint validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in surrogate endpoint validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 62"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000033",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000033"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/40"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Biomarker-Outcome Association Strength"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000352",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000352"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/359"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Safety Margin Evidence"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000201",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000201"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/208"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Outcome Applicability"
      }
    },
    {
      "@id": "bemo:BEMO_2000223",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000223",
      "bemo:BEMO_3100022": 230,
      "bemo:BEMO_3100023": "d2e72ca269dc077aef430f8efab1ad3e7adf8db5e6aa339468796f69dfaaee12",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses hotspot/functional-domain evidence using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in hotspot/functional-domain evidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating hotspot/functional-domain evidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mendelian disease, cancer genetics, association, segregation, and functional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ClinGen; ACMG AMP; STREGA; Gene Ontology"
      },
      "bemo:BEMO_3200011": "https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000223"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000225"
        },
        {
          "@id": "bemo:BEMO_2000226"
        },
        {
          "@id": "bemo:BEMO_2000233"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of hotspot/functional-domain evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/230"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000223",
      "rdfs:label": {
        "@language": "en",
        "@value": "Hotspot/Functional-Domain Evidence"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb251"
        },
        {
          "@id": "bemo:BEMO_1100009"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb251",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000223"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_1100018",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Category of biomedical evidence metrics concerned with study design and internal validity."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:1100018",
      "rdfs:label": {
        "@language": "en",
        "@value": "Study Design and Internal Validity metric"
      },
      "rdfs:subClassOf": {
        "@id": "bemo:BEMO_1000002"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/104",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 104,
      "bemo:BEMO_3100023": "21a510319cb99a940f9fc99111522f80932b8a874f1ea984fb332f8f218483c8",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized and observational etiologic studies, natural experiments, target-trial emulations\", \"Category\": \"Causal Inference\", \"Closely Related Metrics\": \"Time-Varying Confounding Control; Reverse-Causation Risk; Selection-on-Survival Bias Risk\", \"Common Misinterpretations\": \"Treating immortal-time bias risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Immortal-Time Bias Risk\", \"References or Origin\": \"https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9\", \"Scientific Definition\": \"The probability or degree that immortal-time bias introduces systematic distortion into a biomedical estimate or conclusion.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses immortal-time bias risk using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in immortal-time bias risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 104"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/475",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 475,
      "bemo:BEMO_3100023": "6dbe1d75153c55efcce7da9af8dda3fe869c2f426eaaad651ee6f91b1670d205",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies\", \"Category\": \"Study Design and Internal Validity\", \"Closely Related Metrics\": \"Co-intervention Bias Risk; Period Effect Risk; Cluster Recruitment Bias Risk\", \"Common Misinterpretations\": \"Treating carryover effect risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Carryover Effect Risk\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools\", \"Related Frameworks\": \"CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI\", \"Scientific Definition\": \"The probability or degree that carryover effect introduces systematic distortion into a biomedical estimate or conclusion.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Replicate dilution series; blank and spiked samples; reference materials; method-comparison studies; predefined CLSI/ISO acceptance criteria.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses carryover effect risk using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in carryover effect risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 475"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/238",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 238,
      "bemo:BEMO_3100023": "8e776a34bb92ed3d093c7eb03481f1c61ce724a0995235355586c28e53418e35",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mendelian disease, cancer genetics, association, segregation, and functional studies\", \"Category\": \"Genetics and Variant Evidence\", \"Closely Related Metrics\": \"Splicing Evidence Strength; Co-segregation Likelihood; Penetrance Evidence\", \"Common Misinterpretations\": \"Treating rna evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"RNA Evidence Strength\", \"References or Origin\": \"https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/\", \"Related Frameworks\": \"ClinGen; ACMG AMP; STREGA; Gene Ontology\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting rna evidence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses rna evidence strength using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in rna evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 238"
    },
    {
      "@id": "bemo:BEMO_3000001",
      "@type": "owl:ObjectProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Connects a metric-bearing assessment or metric class restriction to its computation specification."
      },
      "oboInOwl:id": "BEMO:3000001",
      "rdfs:label": {
        "@language": "en",
        "@value": "has computation profile"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/149",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 149,
      "bemo:BEMO_3100023": "573628981de9da600edff4f13001018973ec4403d9ad58179a02f6958d0404dd",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Systematic reviews, meta-analyses, evidence profiles, guidelines\", \"Category\": \"Evidence Certainty and Synthesis\", \"Closely Related Metrics\": \"Evidence Precision; Evidence Consensus Strength; Evidence Sufficiency\", \"Common Misinterpretations\": \"Treating evidence coherence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Evidence Coherence\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/\", \"Related Frameworks\": \"GRADE; PRISMA; AMSTAR 2; RoB\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of evidence coherence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses evidence coherence using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in evidence coherence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 149"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000091",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000091"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/98"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Dechallenge–Rechallenge Support"
      }
    },
    {
      "@id": "bemo:BEMO_2000396",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000396",
      "bemo:BEMO_3100022": 403,
      "bemo:BEMO_3100023": "0977ae8d7278730723c8d024585a95d1125aa9fe6da897fe977a079b172ddb48",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses interlaboratory reproducibility using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in interlaboratory reproducibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating interlaboratory reproducibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All experimental, computational, clinical, and omics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0"
      },
      "bemo:BEMO_3200011": "https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000396"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000393"
        },
        {
          "@id": "bemo:BEMO_2000397"
        },
        {
          "@id": "bemo:BEMO_2000399"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which interlaboratory reproducibility yields concordant results under the specified repeated-analysis or repeated-measurement conditions."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/403"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000396",
      "rdfs:label": {
        "@language": "en",
        "@value": "Interlaboratory Reproducibility"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb406"
        },
        {
          "@id": "bemo:BEMO_1100015"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb406",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000396"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/175",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 175,
      "bemo:BEMO_3100023": "1bc9d94635678f728d2a96fd7016f3d61e24c78d9e33c5093213c9d715511534",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"In vitro, ex vivo, organoid, animal, and preclinical experiments\", \"Category\": \"Experimental Biology and Animal Research\", \"Closely Related Metrics\": \"Blinding in Experimental Assessment; Animal Model Construct Validity; Animal Model Predictive Validity\", \"Common Misinterpretations\": \"Treating animal model face validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Animal Model Face Validity\", \"References or Origin\": \"https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"ARRIVE 2.0; SYRCLE; OECD\", \"Scientific Definition\": \"The degree to which animal model face supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses animal model face validity using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in animal model face validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 175"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000245",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000245"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/252"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Duplicate Read Burden"
      }
    },
    {
      "@id": "bemo:BEMO_2000167",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000167",
      "bemo:BEMO_3100022": 174,
      "bemo:BEMO_3100023": "f8c928bcc279a4856d6377104c402fb4a00d102300c3c3fa14181f174b53f974",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses animal model construct validity using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in animal model construct validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating animal model construct validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "In vitro, ex vivo, organoid, animal, and preclinical experiments"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ARRIVE 2.0; SYRCLE; OECD"
      },
      "bemo:BEMO_3200011": "https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000167"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000168"
        },
        {
          "@id": "bemo:BEMO_2000169"
        },
        {
          "@id": "bemo:BEMO_2000187"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which animal model construct supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/174"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000167",
      "rdfs:label": {
        "@language": "en",
        "@value": "Animal Model Construct Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb203"
        },
        {
          "@id": "bemo:BEMO_1100007"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb203",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000167"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000127",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000127",
      "bemo:BEMO_3100022": 134,
      "bemo:BEMO_3100023": "65ab6bc3c7bfa89dbab942e4977888e1ec5d3ea554c360ceffa76f4daab1fd7e",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses positive likelihood ratio using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in positive likelihood ratio can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Two-by-two tables; binomial confidence intervals; hierarchical diagnostic meta-analysis; threshold and prevalence analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating positive likelihood ratio as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "QUADAS-2; STARD; TRIPOD; REMARK"
      },
      "bemo:BEMO_3200011": "https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000127"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000115"
        },
        {
          "@id": "bemo:BEMO_2000122"
        },
        {
          "@id": "bemo:BEMO_2000123"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of positive likelihood ratio."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/134"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000127",
      "rdfs:label": {
        "@language": "en",
        "@value": "Positive Likelihood Ratio"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb166"
        },
        {
          "@id": "bemo:BEMO_1100005"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb166",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000127"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000256",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000256"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/263"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Sample Identity Concordance"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000295",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000295"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/302"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Recovery"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000387",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000387"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/394"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Code Availability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/222",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 222,
      "bemo:BEMO_3100023": "1f84faa3d8c87f3b1ed44b62077d2c489782ab72b149d6009c127395a0070a10",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mendelian disease, cancer genetics, association, segregation, and functional studies\", \"Category\": \"Genetics and Variant Evidence\", \"Closely Related Metrics\": \"Functional Variant Evidence; Phenotypic Specificity for Variant; Variant Phase Evidence\", \"Common Misinterpretations\": \"Treating computational variant evidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Computational Variant Evidence\", \"References or Origin\": \"https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/\", \"Related Frameworks\": \"ClinGen; ACMG AMP; STREGA; Gene Ontology\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of computational variant evidence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"ClinGen/ACMG evidence scoring; pedigree analysis; population databases; case-control data; functional assays; expert-panel review.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses computational variant evidence using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in computational variant evidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 222"
    },
    {
      "@id": "bemo:BEMO_0000200",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A measurement datum or structured assessment produced by applying a biomedical evidence metric to a defined evidence object using a specified computation profile."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:0000200",
      "rdfs:label": {
        "@language": "en",
        "@value": "metric assessment"
      },
      "rdfs:subClassOf": {
        "@id": "obo:IAO_0000109"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/45",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 45,
      "bemo:BEMO_3100023": "4ad4866845885f677cad74042f65b0303f2d26597ea694b76dfed4bc71fedd68",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Biomarker development, qualification, endpoint and surrogate validation studies\", \"Category\": \"Biomarker and Endpoint Validation\", \"Closely Related Metrics\": \"Known-Groups Validity; Discriminant Validity; Criterion Validity\", \"Common Misinterpretations\": \"Treating convergent validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Convergent Validity\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"FDA Biomarker; BEST; EMA E16; REMARK\", \"Scientific Definition\": \"The degree to which convergent supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses convergent validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in convergent validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 45"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000368",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000368"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/375"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Mass Accuracy"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/398",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 398,
      "bemo:BEMO_3100023": "da25c768c2ee710f0cf6b50b686a1880c8166dd651b4f062c14e952fc1bdf622",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All experimental, computational, clinical, and omics studies\", \"Category\": \"Reproducibility and Replication\", \"Closely Related Metrics\": \"Reanalysis Concordance; Protocol Reproducibility; Material Availability\", \"Common Misinterpretations\": \"Treating data provenance completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Data Provenance Completeness\", \"References or Origin\": \"https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines\", \"Related Frameworks\": \"PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0\", \"Scientific Definition\": \"The extent to which all scientifically necessary components of data provenance are present, documented, and evaluable.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses data provenance completeness using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in data provenance completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 398"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000126",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000126"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/133"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Patient Flow Integrity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000042",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000042"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/49"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Endpoint Reliability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000310",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Developing; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000310"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/317"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Knowledge-Graph Evidence Completeness"
      }
    },
    {
      "@id": "bemo:BEMO_2000224",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000224",
      "bemo:BEMO_3100022": 231,
      "bemo:BEMO_3100023": "bd3af304ec15826df5f67db7f079c0ba66a1f5f5a3e852d600550186267f50cb",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses locus heterogeneity assessment using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in locus heterogeneity assessment can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Forest plots; heterogeneity statistics; tau-squared; prediction intervals; funnel plots; regression or selection models; sensitivity analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating locus heterogeneity assessment as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mendelian disease, cancer genetics, association, segregation, and functional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ClinGen; ACMG AMP; STREGA; Gene Ontology"
      },
      "bemo:BEMO_3200011": "https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000224"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000222"
        },
        {
          "@id": "bemo:BEMO_2000228"
        },
        {
          "@id": "bemo:BEMO_2000234"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of locus heterogeneity assessment."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/231"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000224",
      "rdfs:label": {
        "@language": "en",
        "@value": "Locus Heterogeneity Assessment"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb252"
        },
        {
          "@id": "bemo:BEMO_1100009"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb252",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000224"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000195",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000195"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/202"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Disease-Severity Generalizability"
      }
    },
    {
      "@id": "bemo:BEMO_2000052",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000052",
      "bemo:BEMO_3100022": 59,
      "bemo:BEMO_3100023": "2dd804ff14e01e089d83a5d2d6ef790d24cf90ca54d3426049116e4e7aeb095f",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses prognostic biomarker validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in prognostic biomarker validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating prognostic biomarker validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Biomarker development, qualification, endpoint and surrogate validation studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; BEST; EMA E16; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000052"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000040"
        },
        {
          "@id": "bemo:BEMO_2000050"
        },
        {
          "@id": "bemo:BEMO_2000051"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which prognostic biomarker supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/59"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000052",
      "rdfs:label": {
        "@language": "en",
        "@value": "Prognostic Biomarker Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb100"
        },
        {
          "@id": "bemo:BEMO_1100002"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb100",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000052"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/138",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 138,
      "bemo:BEMO_3100023": "b58deaf6b24f17f45025c2e10bd742dcb00a937cc0410366fbe092bfbfd13882",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies\", \"Category\": \"Diagnostic and Prognostic Evidence\", \"Closely Related Metrics\": \"Reclassification Improvement; Prognostic Calibration; Calibration Slope\", \"Common Misinterpretations\": \"Treating prognostic discrimination as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Prognostic Discrimination\", \"References or Origin\": \"https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"QUADAS-2; STARD; TRIPOD; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of prognostic discrimination.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses prognostic discrimination using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in prognostic discrimination can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 138"
    },
    {
      "@id": "bemo:BEMO_2000136",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000136",
      "bemo:BEMO_3100022": 143,
      "bemo:BEMO_3100023": "c27bfe6217acf4b748aeb85aa4e9c4176c8256e12b7c61ff84a201b6fd374c82",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses threshold validity using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in threshold validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating threshold validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "QUADAS-2; STARD; TRIPOD; REMARK"
      },
      "bemo:BEMO_3200011": "https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000136"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000121"
        },
        {
          "@id": "bemo:BEMO_2000125"
        },
        {
          "@id": "bemo:BEMO_2000134"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which threshold supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/143"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000136",
      "rdfs:label": {
        "@language": "en",
        "@value": "Threshold Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb175"
        },
        {
          "@id": "bemo:BEMO_1100005"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb175",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000136"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000321",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000321"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/328"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Parameter Sensitivity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/439",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 439,
      "bemo:BEMO_3100023": "ea8be0499c9c5441e47cac85f3e884bcc28099d593610c01dc6ad24ba5c3d0f3",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Fragility Index; Posterior Probability Strength; Prior Sensitivity\", \"Common Misinterpretations\": \"Treating bayes factor evidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Bayes Factor Evidence\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of bayes factor evidence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses bayes factor evidence using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in bayes factor evidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 439"
    },
    {
      "@id": "bemo:BEMO_2000412",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000412",
      "bemo:BEMO_3100022": 419,
      "bemo:BEMO_3100023": "02e23f40dd856c6f19f825d6191af4cb70f9ed2e604c47f5cbd7bf406e4d2381",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses eligibility criteria completeness using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in eligibility criteria completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating eligibility criteria completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Study report / dataset / evidence package"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All biomedical study reports and data releases"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000412"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000408"
        },
        {
          "@id": "bemo:BEMO_2000422"
        },
        {
          "@id": "bemo:BEMO_2000429"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which all scientifically necessary components of eligibility criteria are present, documented, and evaluable."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/419"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000412",
      "rdfs:label": {
        "@language": "en",
        "@value": "Eligibility Criteria Completeness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb421"
        },
        {
          "@id": "bemo:BEMO_1100016"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb421",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000412"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/423",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 423,
      "bemo:BEMO_3100023": "fc72795f141f7cb81bc8cc86190a0c7cf2a5f2f6065d3b22f9bc88dd2e13080e",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All biomedical study reports and data releases\", \"Category\": \"Research Transparency and Reporting Completeness\", \"Closely Related Metrics\": \"Code-Sharing Transparency; Metadata Completeness; Raw-Data Availability\", \"Common Misinterpretations\": \"Treating materials-and-reagents reporting completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Study report / dataset / evidence package\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Materials-and-Reagents Reporting Completeness\", \"References or Origin\": \"https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/\", \"Related Frameworks\": \"EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS\", \"Scientific Definition\": \"The extent to which all scientifically necessary components of materials-and-reagents reporting are present, documented, and evaluable.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses materials-and-reagents reporting completeness using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in materials-and-reagents reporting completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 423"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000389",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000389"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/396"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Conceptual Replication Success"
      }
    },
    {
      "@id": "bemo:BEMO_2000097",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000097",
      "bemo:BEMO_3100022": 104,
      "bemo:BEMO_3100023": "21a510319cb99a940f9fc99111522f80932b8a874f1ea984fb332f8f218483c8",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses immortal-time bias risk using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in immortal-time bias risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating immortal-time bias risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized and observational etiologic studies, natural experiments, target-trial emulations"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000097"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000105"
        },
        {
          "@id": "bemo:BEMO_2000106"
        },
        {
          "@id": "bemo:BEMO_2000108"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The probability or degree that immortal-time bias introduces systematic distortion into a biomedical estimate or conclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/104"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000097",
      "rdfs:label": {
        "@language": "en",
        "@value": "Immortal-Time Bias Risk"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb139"
        },
        {
          "@id": "bemo:BEMO_1100004"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb139",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000097"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000055",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000055",
      "bemo:BEMO_3100022": 62,
      "bemo:BEMO_3100023": "880b1c4a9fa2a25e2876679a2a7e759365591c8d0d0ae431e9a6e89a9d327bd9",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses surrogate endpoint validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in surrogate endpoint validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating surrogate endpoint validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Biomarker development, qualification, endpoint and surrogate validation studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; BEST; EMA E16; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000055"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000045"
        },
        {
          "@id": "bemo:BEMO_2000053"
        },
        {
          "@id": "bemo:BEMO_2000057"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which surrogate endpoint supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/62"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000055",
      "rdfs:label": {
        "@language": "en",
        "@value": "Surrogate Endpoint Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb103"
        },
        {
          "@id": "bemo:BEMO_1100002"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb103",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000055"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/334",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 334,
      "bemo:BEMO_3100023": "3a349724361b2712b35c94baaaa135ce8e313533d3edafc463242f1cddef411b",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Integrated omics, networks, pathways, mechanistic and dynamic systems models\", \"Category\": \"Multi-omics and Systems Biology\", \"Closely Related Metrics\": \"Dynamical Stability; Flux-Balance Consistency; Perturbation Prediction Accuracy\", \"Common Misinterpretations\": \"Treating steady-state validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Dataset / model / pathway / network / evidence body\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Steady-State Validity\", \"References or Origin\": \"https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/\", \"Related Frameworks\": \"Gene Ontology; Reactome; UniProt; GA4GH\", \"Scientific Definition\": \"The degree to which steady-state supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses steady-state validity using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in steady-state validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 334"
    },
    {
      "@id": "bemo:BEMO_2000140",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000140",
      "bemo:BEMO_3100022": 147,
      "bemo:BEMO_3100023": "d4c1d3bbceb7e86e058c678a7bbc386dd5980f93dcbc9a60ebc6c6d39231fcdb",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses counterevidence strength using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in counterevidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating counterevidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Systematic reviews, meta-analyses, evidence profiles, guidelines"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; PRISMA; AMSTAR 2; RoB"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000140"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000156"
        },
        {
          "@id": "bemo:BEMO_2000158"
        },
        {
          "@id": "bemo:BEMO_2000162"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting counterevidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/147"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000140",
      "rdfs:label": {
        "@language": "en",
        "@value": "Counterevidence Strength"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb179"
        },
        {
          "@id": "bemo:BEMO_1100006"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb179",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000140"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000456",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000456"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/463"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Posterior Probability Strength"
      }
    },
    {
      "@id": "bemo:BEMO_2000320",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000320",
      "bemo:BEMO_3100022": 327,
      "bemo:BEMO_3100023": "e1eaab072c302dca725ea1fb92e565c0aead2c5a6ddd49490dbfa43ad163dd03",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses parameter identifiability using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in parameter identifiability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating parameter identifiability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Dataset / model / pathway / network / evidence body"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Integrated omics, networks, pathways, mechanistic and dynamic systems models"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "Gene Ontology; Reactome; UniProt; GA4GH"
      },
      "bemo:BEMO_3200011": "https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000320"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000313"
        },
        {
          "@id": "bemo:BEMO_2000321"
        },
        {
          "@id": "bemo:BEMO_2000328"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of parameter identifiability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/327"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000320",
      "rdfs:label": {
        "@language": "en",
        "@value": "Parameter Identifiability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb338"
        },
        {
          "@id": "bemo:BEMO_1100012"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb338",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000320"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000396",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000396"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/403"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Interlaboratory Reproducibility"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000290",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000290"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/297"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Method Comparison Agreement"
      }
    },
    {
      "@id": "bemo:BEMO_2000180",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000180",
      "bemo:BEMO_3100022": 187,
      "bemo:BEMO_3100023": "f4ebc6af400b7084f27d64f43d25beed78acdab6caf4a03c3179cab231054034",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses intervention fidelity in animal studies using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in intervention fidelity in animal studies can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating intervention fidelity in animal studies as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "In vitro, ex vivo, organoid, animal, and preclinical experiments"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ARRIVE 2.0; SYRCLE; OECD"
      },
      "bemo:BEMO_3200011": "https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000180"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000170"
        },
        {
          "@id": "bemo:BEMO_2000173"
        },
        {
          "@id": "bemo:BEMO_2000179"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of intervention fidelity in animal studies."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/187"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000180",
      "rdfs:label": {
        "@language": "en",
        "@value": "Intervention Fidelity in Animal Studies"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb214"
        },
        {
          "@id": "bemo:BEMO_1100007"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb214",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000180"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000004",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000004"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/11"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Cross-Species Biological Concordance"
      }
    },
    {
      "@id": "bemo:BEMO_2000449",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000449",
      "bemo:BEMO_3100022": 456,
      "bemo:BEMO_3100023": "bf6f70bdb1883a9c1ba70dc7d37eb1885dd46ed70094a2b12bd2cc41e0f53bad",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses model fit using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in model fit can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating model fit as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000449"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000438"
        },
        {
          "@id": "bemo:BEMO_2000450"
        },
        {
          "@id": "bemo:BEMO_2000458"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of model fit."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/456"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000449",
      "rdfs:label": {
        "@language": "en",
        "@value": "Model Fit"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb453"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb453",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000449"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000194",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000194",
      "bemo:BEMO_3100022": 201,
      "bemo:BEMO_3100023": "e22341c32d6f7aad19740ed4b08e7f5ffc168107f1e04a79ba4ec60f6b92c463",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses demographic generalizability using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in demographic generalizability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating demographic generalizability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Clinical, epidemiologic, diagnostic, translational, and population studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; QUADAS-2; CONSORT; STROBE"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000194"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000191"
        },
        {
          "@id": "bemo:BEMO_2000195"
        },
        {
          "@id": "bemo:BEMO_2000209"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of demographic generalizability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/201"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000194",
      "rdfs:label": {
        "@language": "en",
        "@value": "Demographic Generalizability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb227"
        },
        {
          "@id": "bemo:BEMO_1100008"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb227",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000194"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000478",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000478",
      "bemo:BEMO_3100022": 485,
      "bemo:BEMO_3100023": "a99fe581309ce29c4e888ffbd9a1cba6c99a6948f2a8e99e23714e0f40920b87",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses follow-up completeness using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in follow-up completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating follow-up completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000478"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000475"
        },
        {
          "@id": "bemo:BEMO_2000480"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which all scientifically necessary components of follow-up are present, documented, and evaluable."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/485"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000478",
      "rdfs:label": {
        "@language": "en",
        "@value": "Follow-up Completeness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb479"
        },
        {
          "@id": "bemo:BEMO_1100018"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb479",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000478"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000222",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000222"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/229"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Genotype–Phenotype Concordance"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000384",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000384"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/391"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Sequence Coverage"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/290",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 290,
      "bemo:BEMO_3100023": "af7341a32f2656e5638dc5bce7ac126974e88c78554d2916a696247ebbe11d2b",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Matrix Effect; Cross-Reactivity; Carryover\", \"Common Misinterpretations\": \"Treating interference susceptibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Interference Susceptibility\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of interference susceptibility.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Replicate dilution series; blank and spiked samples; reference materials; method-comparison studies; predefined CLSI/ISO acceptance criteria.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses interference susceptibility using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in interference susceptibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 290"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000130",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000130"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/137"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Prognostic Calibration"
      }
    },
    {
      "@id": "bemo:BEMO_2000283",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000283",
      "bemo:BEMO_3100022": 290,
      "bemo:BEMO_3100023": "af7341a32f2656e5638dc5bce7ac126974e88c78554d2916a696247ebbe11d2b",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses interference susceptibility using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in interference susceptibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Replicate dilution series; blank and spiked samples; reference materials; method-comparison studies; predefined CLSI/ISO acceptance criteria."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating interference susceptibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000283"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000275"
        },
        {
          "@id": "bemo:BEMO_2000277"
        },
        {
          "@id": "bemo:BEMO_2000288"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of interference susceptibility."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/290"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000283",
      "rdfs:label": {
        "@language": "en",
        "@value": "Interference Susceptibility"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb305"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb305",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000283"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000009",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000009"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/16"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Mechanistic Causality Strength"
      }
    },
    {
      "@id": "bemo:BEMO_2000066",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000066",
      "bemo:BEMO_3100022": 73,
      "bemo:BEMO_3100023": "c08e61688a36fec680e9073fc8888dbfd98852919e3f7ccf7c3180ed49d1e921",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses fixation adequacy using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in fixation adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating fixation adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All studies using human or animal biospecimens"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "BRISQ; ISO 15189; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000066"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000075"
        },
        {
          "@id": "bemo:BEMO_2000079"
        },
        {
          "@id": "bemo:BEMO_2000080"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which fixation is sufficient and fit for the stated biomedical inference."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/73"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000066",
      "rdfs:label": {
        "@language": "en",
        "@value": "Fixation Adequacy"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb112"
        },
        {
          "@id": "bemo:BEMO_1100003"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb112",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000066"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/273",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 273,
      "bemo:BEMO_3100023": "45320c5b96fc37b8148ee2721453c92e6bec79491a4ed2d2f6fedbc2cb99cb01",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies\", \"Category\": \"Genomics and Transcriptomics\", \"Closely Related Metrics\": \"Sex Concordance; Genotype Quality; Allelic Balance\", \"Common Misinterpretations\": \"Treating variant call quality as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Variant Call Quality\", \"References or Origin\": \"https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/\", \"Related Frameworks\": \"MIAME; MINSEQE; STROBE-ME; GA4GH; HCA\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of variant call quality.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"ClinGen/ACMG evidence scoring; pedigree analysis; population databases; case-control data; functional assays; expert-panel review.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses variant call quality using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in variant call quality can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 273"
    },
    {
      "@id": "bemo:BEMO_2000204",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000204",
      "bemo:BEMO_3100022": 211,
      "bemo:BEMO_3100023": "2bcc973aa3f12efded260e2aef1541636262ee110856a34255ce0823d91dfb20",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses real-world evidence alignment using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in real-world evidence alignment can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating real-world evidence alignment as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Clinical, epidemiologic, diagnostic, translational, and population studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; QUADAS-2; CONSORT; STROBE"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000204"
      },
      "bemo:BEMO_3200013": {
        "@id": "bemo:BEMO_2000196"
      },
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of real-world evidence alignment."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/211"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000204",
      "rdfs:label": {
        "@language": "en",
        "@value": "Real-World Evidence Alignment"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb34"
        },
        {
          "@id": "bemo:BEMO_1100008"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb34",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000204"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000426",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000426"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/433"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Protocol Availability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000021",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000021"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/28"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Phenotypic Concordance"
      }
    },
    {
      "@id": "bemo:BEMO_3000008",
      "@type": "owl:ObjectProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Connects a computation specification to a computation-mode category."
      },
      "oboInOwl:id": "BEMO:3000008",
      "rdfs:label": {
        "@language": "en",
        "@value": "has computation mode"
      }
    },
    {
      "@id": "bemo:BEMO_2000246",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000246",
      "bemo:BEMO_3100022": 253,
      "bemo:BEMO_3100023": "c86e8ba8cbfb79ea4dbc1a9a4cd5da76837e35c7f45f5966b51b9734760bdf1f",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses genome coverage uniformity using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in genome coverage uniformity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating genome coverage uniformity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAME; MINSEQE; STROBE-ME; GA4GH; HCA"
      },
      "bemo:BEMO_3200011": "https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000246"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000250"
        },
        {
          "@id": "bemo:BEMO_2000253"
        },
        {
          "@id": "bemo:BEMO_2000257"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The proportion and representativeness of the relevant genome uniformity captured by the evidence or measurement process."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/253"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000246",
      "rdfs:label": {
        "@language": "en",
        "@value": "Genome Coverage Uniformity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb38"
        },
        {
          "@id": "bemo:BEMO_1100010"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb38",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000246"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/264",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 264,
      "bemo:BEMO_3100023": "719d5f0d3157f75114503dd8e8b0e75aa481929ab009d6c25b68024c7b5f71a0",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies\", \"Category\": \"Genomics and Transcriptomics\", \"Closely Related Metrics\": \"Genome Coverage Uniformity; Mapping Quality\", \"Common Misinterpretations\": \"Treating sequencing depth adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Sequencing Depth Adequacy\", \"References or Origin\": \"https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/\", \"Related Frameworks\": \"MIAME; MINSEQE; STROBE-ME; GA4GH; HCA\", \"Scientific Definition\": \"The extent to which sequencing depth is sufficient and fit for the stated biomedical inference.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Read- and variant-level quality-control summaries; replicate concordance; orthogonal confirmation; benchmarking against reference materials.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses sequencing depth adequacy using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in sequencing depth adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 264"
    },
    {
      "@id": "bemo:BEMO_2000037",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000037",
      "bemo:BEMO_3100022": 44,
      "bemo:BEMO_3100023": "170c4bee423f9901b11abd5c6c7203f1253da40dbd46a33c459bac07471058e8",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses context-of-use validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in context-of-use validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating context-of-use validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Biomarker development, qualification, endpoint and surrogate validation studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; BEST; EMA E16; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000037"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000028"
        },
        {
          "@id": "bemo:BEMO_2000029"
        },
        {
          "@id": "bemo:BEMO_2000030"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which context-of-use supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/44"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000037",
      "rdfs:label": {
        "@language": "en",
        "@value": "Context-of-Use Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb86"
        },
        {
          "@id": "bemo:BEMO_1100002"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb86",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000037"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000290",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000290",
      "bemo:BEMO_3100022": 297,
      "bemo:BEMO_3100023": "8f2dfbddd616818e03a89990f48f31b1db69460f1919bb65cc71ee0d68b7b4f6",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses method comparison agreement using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in method comparison agreement can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating method comparison agreement as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000290"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000276"
        },
        {
          "@id": "bemo:BEMO_2000289"
        },
        {
          "@id": "bemo:BEMO_2000300"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree of agreement in method comparison across measurements, studies, methods, populations, or biological levels."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/297"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000290",
      "rdfs:label": {
        "@language": "en",
        "@value": "Method Comparison Agreement"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb312"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb312",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000290"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000083",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000083",
      "bemo:BEMO_3100022": 90,
      "bemo:BEMO_3100023": "293c5ebda3d3695852f06644549a5b920266b83358bf49b383b5d90078fcdde6",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses warm ischemia control using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in warm ischemia control can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating warm ischemia control as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All studies using human or animal biospecimens"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "BRISQ; ISO 15189; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000083"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000063"
        },
        {
          "@id": "bemo:BEMO_2000064"
        },
        {
          "@id": "bemo:BEMO_2000080"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of warm ischemia control."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/90"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000083",
      "rdfs:label": {
        "@language": "en",
        "@value": "Warm Ischemia Control"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb128"
        },
        {
          "@id": "bemo:BEMO_1100003"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb128",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000083"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000173",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000173",
      "bemo:BEMO_3100022": 180,
      "bemo:BEMO_3100023": "432e96e9d5c02fcda1a353b0ddb2e18d1019ff594f33c248eedfbe337bf31fae",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses environmental standardization using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in environmental standardization can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating environmental standardization as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "In vitro, ex vivo, organoid, animal, and preclinical experiments"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ARRIVE 2.0; SYRCLE; OECD"
      },
      "bemo:BEMO_3200011": "https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000173"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000178"
        },
        {
          "@id": "bemo:BEMO_2000179"
        },
        {
          "@id": "bemo:BEMO_2000180"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of environmental standardization."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/180"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000173",
      "rdfs:label": {
        "@language": "en",
        "@value": "Environmental Standardization"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb208"
        },
        {
          "@id": "bemo:BEMO_1100007"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb208",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000173"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000099",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000099"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/106"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Mediation Evidence Strength"
      }
    },
    {
      "@id": "bemo:BEMO_4000009",
      "@type": [
        "owl:NamedIndividual",
        "bemo:BEMO_0000401"
      ],
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Controlled BEMO ComputationMode value: QuantitativeRatioComputation."
      },
      "oboInOwl:id": "BEMO:4000009",
      "rdfs:label": {
        "@language": "en",
        "@value": "Quantitative Ratio Computation"
      },
      "skos:notation": "QuantitativeRatioComputation"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/158",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 158,
      "bemo:BEMO_3100023": "f4e08b1965ce7d1832ff4c5191f1e7298781d9bec3cb9a96c09198d6faaa1339",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Systematic reviews, meta-analyses, evidence profiles, guidelines\", \"Category\": \"Evidence Certainty and Synthesis\", \"Closely Related Metrics\": \"Overall Evidence Certainty; Evidence Strength; Evidence Confidence\", \"Common Misinterpretations\": \"Treating evidence quality as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Evidence Quality\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/\", \"Related Frameworks\": \"GRADE; PRISMA; AMSTAR 2; RoB\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of evidence quality.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses evidence quality using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in evidence quality can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 158"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000383",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000383"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/390"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Retention-Time Stability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000050",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000050"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/57"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Pharmacodynamic Biomarker Validity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000453",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000453"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/460"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Nonlinearity Assessment"
      }
    },
    {
      "@id": "bemo:BEMO_2000475",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000475",
      "bemo:BEMO_3100022": 482,
      "bemo:BEMO_3100023": "ccfe7e445aeb97f5f6fbabfec00706b7cd315705f68e05e908e47860b40d8ad4",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses differential follow-up risk using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in differential follow-up risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating differential follow-up risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000475"
      },
      "bemo:BEMO_3200013": {
        "@id": "bemo:BEMO_2000478"
      },
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The probability or degree that differential follow-up introduces systematic distortion into a biomedical estimate or conclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/482"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000475",
      "rdfs:label": {
        "@language": "en",
        "@value": "Differential Follow-up Risk"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb54"
        },
        {
          "@id": "bemo:BEMO_1100018"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb54",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000475"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000455",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000455"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/462"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Overadjustment Bias Risk"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000059",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000059"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/66"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Biospecimen Integrity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000208",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000208"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/215"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Subgroup Consistency"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000146",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000146"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/153"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Evidence Consistency"
      }
    },
    {
      "@id": "bemo:BEMO_2000227",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000227",
      "bemo:BEMO_3100022": 234,
      "bemo:BEMO_3100023": "83c8ddff797d0831554af5cae66094d559ff9fcf3cefc498edc05f2c18b6ee97",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses penetrance evidence using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in penetrance evidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "ClinGen/ACMG evidence scoring; pedigree analysis; population databases; case-control data; functional assays; expert-panel review."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating penetrance evidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mendelian disease, cancer genetics, association, segregation, and functional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ClinGen; ACMG AMP; STREGA; Gene Ontology"
      },
      "bemo:BEMO_3200011": "https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000227"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000214"
        },
        {
          "@id": "bemo:BEMO_2000218"
        },
        {
          "@id": "bemo:BEMO_2000219"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of penetrance evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/234"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000227",
      "rdfs:label": {
        "@language": "en",
        "@value": "Penetrance Evidence"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb255"
        },
        {
          "@id": "bemo:BEMO_1100009"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb255",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000227"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000409",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000409"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/416"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Conflict-of-Interest Transparency"
      }
    },
    {
      "@id": "bemo:BEMO_2000310",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000310",
      "bemo:BEMO_3100022": 317,
      "bemo:BEMO_3100023": "082de1cac908d5d8b791ddee2974743d0e0eae71997e72080a5d978e931f8b6c",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses knowledge-graph evidence completeness using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in knowledge-graph evidence completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating knowledge-graph evidence completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Dataset / model / pathway / network / evidence body"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Integrated omics, networks, pathways, mechanistic and dynamic systems models"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "Gene Ontology; Reactome; UniProt; GA4GH"
      },
      "bemo:BEMO_3200011": "https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000310"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000308"
        },
        {
          "@id": "bemo:BEMO_2000311"
        },
        {
          "@id": "bemo:BEMO_2000323"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Developing",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which all scientifically necessary components of knowledge-graph evidence are present, documented, and evaluable."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/317"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000310",
      "rdfs:label": {
        "@language": "en",
        "@value": "Knowledge-Graph Evidence Completeness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb328"
        },
        {
          "@id": "bemo:BEMO_1100012"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb328",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000310"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/36",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 36,
      "bemo:BEMO_3100023": "35003a5d4be2844c7914597bb95d8d44ce388ce934a6b5067c8e498ac9e8de35",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Biomarker development, qualification, endpoint and surrogate validation studies\", \"Category\": \"Biomarker and Endpoint Validation\", \"Closely Related Metrics\": \"Context-of-Use Validity; Biomarker Reliability; Biomarker Responsiveness\", \"Common Misinterpretations\": \"Treating biomarker qualification strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Biomarker Qualification Strength\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"FDA Biomarker; BEST; EMA E16; REMARK\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting biomarker qualification.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses biomarker qualification strength using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in biomarker qualification strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 36"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/365",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 365,
      "bemo:BEMO_3100023": "05b74bda1c6ce0d8b99d4d0ffdc239f28a207c0631f25d1605f8d1438c74148a",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies\", \"Category\": \"Pharmacology and Toxicology\", \"Closely Related Metrics\": \"Benchmark Dose Reliability; Adverse Outcome Pathway Support; Organ-Specific Toxicity Evidence\", \"Common Misinterpretations\": \"Treating toxicological mode-of-action support as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Toxicological Mode-of-Action Support\", \"References or Origin\": \"https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline\", \"Related Frameworks\": \"OECD; OHAT; FDA Biomarker; EMA E16\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting toxicological mode-of-action.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses toxicological mode-of-action support using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in toxicological mode-of-action support can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 365"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000404",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000404"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/411"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Researcher-Degrees-of-Freedom Sensitivity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/159",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 159,
      "bemo:BEMO_3100023": "59315ce160586081fc3fd71f96646716829d26fde9e0a21aa0afec923b5083d6",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Systematic reviews, meta-analyses, evidence profiles, guidelines\", \"Category\": \"Evidence Certainty and Synthesis\", \"Closely Related Metrics\": \"Evidence Freshness; Evidence Triangulation Strength; Counterevidence Strength\", \"Common Misinterpretations\": \"Treating evidence robustness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Evidence Robustness\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/\", \"Related Frameworks\": \"GRADE; PRISMA; AMSTAR 2; RoB\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of evidence robustness.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses evidence robustness using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in evidence robustness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 159"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000197",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000197"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/204"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for External Validity"
      }
    },
    {
      "@id": "bemo:BEMO_2000236",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000236",
      "bemo:BEMO_3100022": 243,
      "bemo:BEMO_3100023": "e63350cbc225389693f86f1ceb6c24e47930b1a6b522574479bcaf1390376503",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses variant phase evidence using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in variant phase evidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "ClinGen/ACMG evidence scoring; pedigree analysis; population databases; case-control data; functional assays; expert-panel review."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating variant phase evidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mendelian disease, cancer genetics, association, segregation, and functional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ClinGen; ACMG AMP; STREGA; Gene Ontology"
      },
      "bemo:BEMO_3200011": "https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000236"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000223"
        },
        {
          "@id": "bemo:BEMO_2000225"
        },
        {
          "@id": "bemo:BEMO_2000229"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of variant phase evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/243"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000236",
      "rdfs:label": {
        "@language": "en",
        "@value": "Variant Phase Evidence"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb263"
        },
        {
          "@id": "bemo:BEMO_1100009"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb263",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000236"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000327",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000327"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/334"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Steady-State Validity"
      }
    },
    {
      "@id": "bemo:BEMO_2000229",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000229",
      "bemo:BEMO_3100022": 236,
      "bemo:BEMO_3100023": "ae0b81578c2487ac58cc25c0925e5e5b5580990b17b1391fc512e266a26a2788",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses phenotypic specificity for variant using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in phenotypic specificity for variant can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "ClinGen/ACMG evidence scoring; pedigree analysis; population databases; case-control data; functional assays; expert-panel review."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating phenotypic specificity for variant as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mendelian disease, cancer genetics, association, segregation, and functional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ClinGen; ACMG AMP; STREGA; Gene Ontology"
      },
      "bemo:BEMO_3200011": "https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000229"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000215"
        },
        {
          "@id": "bemo:BEMO_2000225"
        },
        {
          "@id": "bemo:BEMO_2000236"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of phenotypic specificity for variant."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/236"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000229",
      "rdfs:label": {
        "@language": "en",
        "@value": "Phenotypic Specificity for Variant"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb257"
        },
        {
          "@id": "bemo:BEMO_1100009"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb257",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000229"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/328",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 328,
      "bemo:BEMO_3100023": "9735c06335e80bafcbeea74ccb7b405e18e8684330b82448424f6e83ef3974ba",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Integrated omics, networks, pathways, mechanistic and dynamic systems models\", \"Category\": \"Multi-omics and Systems Biology\", \"Closely Related Metrics\": \"Parameter Identifiability; Structural Identifiability; Practical Identifiability\", \"Common Misinterpretations\": \"Treating parameter sensitivity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Dataset / model / pathway / network / evidence body\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment.\", \"Metric\": \"Parameter Sensitivity\", \"References or Origin\": \"https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/\", \"Related Frameworks\": \"Gene Ontology; Reactome; UniProt; GA4GH\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of parameter sensitivity.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses parameter sensitivity using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in parameter sensitivity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 328"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000077",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000077"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/84"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Protein Integrity"
      }
    },
    {
      "@id": "bemo:BEMO_2000130",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000130",
      "bemo:BEMO_3100022": 137,
      "bemo:BEMO_3100023": "bddeb4ff61529649f6f5d81ae9a9ab5588a6f6aed10ca70d0d400119d6c2e940",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses prognostic calibration using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in prognostic calibration can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating prognostic calibration as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "QUADAS-2; STARD; TRIPOD; REMARK"
      },
      "bemo:BEMO_3200011": "https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000130"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000111"
        },
        {
          "@id": "bemo:BEMO_2000112"
        },
        {
          "@id": "bemo:BEMO_2000131"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of prognostic calibration."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/137"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000130",
      "rdfs:label": {
        "@language": "en",
        "@value": "Prognostic Calibration"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb169"
        },
        {
          "@id": "bemo:BEMO_1100005"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb169",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000130"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000474",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000474"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/481"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Detection Bias Risk"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/210",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 210,
      "bemo:BEMO_3100023": "efa730876069251ed2dde336a59f381b8c109c4ee429da0b68bf8bae61b0ba48",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Clinical, epidemiologic, diagnostic, translational, and population studies\", \"Category\": \"External Validity and Applicability\", \"Closely Related Metrics\": \"External Validity; Sampling Frame Adequacy; Transportability\", \"Common Misinterpretations\": \"Treating population representativeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Population Representativeness\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/\", \"Related Frameworks\": \"GRADE; QUADAS-2; CONSORT; STROBE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of population representativeness.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses population representativeness using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in population representativeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 210"
    },
    {
      "@id": "bemo:BEMO_2000298",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000298",
      "bemo:BEMO_3100022": 305,
      "bemo:BEMO_3100023": "1958a10669f076f26b0e434840fd948f2a615d7e3a768038db89230b0e148857",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses reportable range using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in reportable range can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating reportable range as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000298"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000268"
        },
        {
          "@id": "bemo:BEMO_2000280"
        },
        {
          "@id": "bemo:BEMO_2000295"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of reportable range."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/305"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000298",
      "rdfs:label": {
        "@language": "en",
        "@value": "Reportable Range"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb319"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb319",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000298"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/374",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 374,
      "bemo:BEMO_3100023": "beec5d62727ea3baba10451d532801205b190af60b03027284c15989d51ba1e4",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies\", \"Category\": \"Proteomics and Metabolomics\", \"Closely Related Metrics\": \"Mass Accuracy; Fragmentation Spectrum Quality; Post-Translational Modification Localization Confidence\", \"Common Misinterpretations\": \"Treating isotope pattern fidelity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Isotope Pattern Fidelity\", \"References or Origin\": \"https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/\", \"Related Frameworks\": \"MIAPE; HUPO PSI; Metabolomics Standards\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of isotope pattern fidelity.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses isotope pattern fidelity using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in isotope pattern fidelity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 374"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000087",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000087"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/94"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Collider Bias Risk"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/180",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 180,
      "bemo:BEMO_3100023": "432e96e9d5c02fcda1a353b0ddb2e18d1019ff594f33c248eedfbe337bf31fae",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"In vitro, ex vivo, organoid, animal, and preclinical experiments\", \"Category\": \"Experimental Biology and Animal Research\", \"Closely Related Metrics\": \"Housing and Husbandry Control; Intervention Fidelity in Animal Studies; Humane Endpoint Appropriateness\", \"Common Misinterpretations\": \"Treating environmental standardization as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Environmental Standardization\", \"References or Origin\": \"https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"ARRIVE 2.0; SYRCLE; OECD\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of environmental standardization.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses environmental standardization using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in environmental standardization can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 180"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/487",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 487,
      "bemo:BEMO_3100023": "654f73aad6650cd58d63f5a49ae9e034bfcb22952cbf7a018f652c070e1ba6c1",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies\", \"Category\": \"Study Design and Internal Validity\", \"Closely Related Metrics\": \"Protocol Fidelity; Follow-up Completeness; Differential Follow-up Risk\", \"Common Misinterpretations\": \"Treating outcome ascertainment validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Outcome Ascertainment Validity\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools\", \"Related Frameworks\": \"CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI\", \"Scientific Definition\": \"The degree to which outcome ascertainment supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses outcome ascertainment validity using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in outcome ascertainment validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 487"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/373",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 373,
      "bemo:BEMO_3100023": "c108ebf1ca903ed7e96063f24ecaf39723dd5e925f97d641601f89fd859897b9",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies\", \"Category\": \"Proteomics and Metabolomics\", \"Closely Related Metrics\": \"Missing-Value Burden; Retention-Time Stability; Mass Accuracy\", \"Common Misinterpretations\": \"Treating ion suppression assessment as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Ion Suppression Assessment\", \"References or Origin\": \"https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/\", \"Related Frameworks\": \"MIAPE; HUPO PSI; Metabolomics Standards\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of ion suppression assessment.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses ion suppression assessment using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in ion suppression assessment can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 373"
    },
    {
      "@id": "bemo:BEMO_4000029",
      "@type": [
        "owl:NamedIndividual",
        "bemo:BEMO_0000402"
      ],
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Controlled BEMO ApprovalStatus value: Approved."
      },
      "oboInOwl:id": "BEMO:4000029",
      "rdfs:label": {
        "@language": "en",
        "@value": "Approved"
      },
      "skos:notation": "Approved"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/446",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 446,
      "bemo:BEMO_3100023": "e21896fd55cc8da1ecb273cc15de195832d87a4d4554d2b68b3a9ce060442d84",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Estimate Precision; Confidence Interval Compatibility\", \"Common Misinterpretations\": \"Treating effect magnitude as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Effect Magnitude\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of effect magnitude.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses effect magnitude using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in effect magnitude can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 446"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/257",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 257,
      "bemo:BEMO_3100023": "aef9eeffa971170a3db3642e806206bdf35806d1d8cc427e16ad9106f7e0207c",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies\", \"Category\": \"Genomics and Transcriptomics\", \"Closely Related Metrics\": \"Genome Coverage Uniformity; Read Quality; Duplicate Read Burden\", \"Common Misinterpretations\": \"Treating mapping quality as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Mapping Quality\", \"References or Origin\": \"https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/\", \"Related Frameworks\": \"MIAME; MINSEQE; STROBE-ME; GA4GH; HCA\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of mapping quality.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Read- and variant-level quality-control summaries; replicate concordance; orthogonal confirmation; benchmarking against reference materials.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses mapping quality using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in mapping quality can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 257"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/224",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 224,
      "bemo:BEMO_3100023": "e1a17a41d450c91691b405a890d0fa9af7ecd8fed12385f8124d85b912c16860",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mendelian disease, cancer genetics, association, segregation, and functional studies\", \"Category\": \"Genetics and Variant Evidence\", \"Closely Related Metrics\": \"Segregation Evidence Strength; Allelic Evidence Strength; Case-Level Evidence Strength\", \"Common Misinterpretations\": \"Treating de novo evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"De Novo Evidence Strength\", \"References or Origin\": \"https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/\", \"Related Frameworks\": \"ClinGen; ACMG AMP; STREGA; Gene Ontology\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting de novo evidence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"ClinGen/ACMG evidence scoring; pedigree analysis; population databases; case-control data; functional assays; expert-panel review.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses de novo evidence strength using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in de novo evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 224"
    },
    {
      "@id": "bemo:BEMO_0000203",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A defined collection of evidence records assembled to evaluate one or more biomedical claims."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:0000203",
      "rdfs:label": {
        "@language": "en",
        "@value": "body of evidence"
      },
      "rdfs:subClassOf": {
        "@id": "obo:IAO_0000030"
      }
    },
    {
      "@id": "bemo:BEMO_2000086",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000086",
      "bemo:BEMO_3100022": 93,
      "bemo:BEMO_3100023": "a6559bfe5ff78dd7455ed538b35cec6508c7c5507441bc614a71e2140188258e",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses causal identifiability using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in causal identifiability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Directed acyclic graphs; design emulation; balance diagnostics; negative controls; quantitative bias analysis; sensitivity and falsification analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating causal identifiability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized and observational etiologic studies, natural experiments, target-trial emulations"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000086"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000088"
        },
        {
          "@id": "bemo:BEMO_2000104"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of causal identifiability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/93"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000086",
      "rdfs:label": {
        "@language": "en",
        "@value": "Causal Identifiability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb4"
        },
        {
          "@id": "bemo:BEMO_1100004"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb4",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000086"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000319",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000319"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/326"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Ontology Evidence-Code Strength"
      }
    },
    {
      "@id": "bemo:BEMO_2000092",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000092",
      "bemo:BEMO_3100022": 99,
      "bemo:BEMO_3100023": "75f662d9e2ee059c317733c8704b2f0f1f234146f1b2920ed572ec892b5a2d41",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses dose–response support using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in dose–response support can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating dose–response support as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized and observational etiologic studies, natural experiments, target-trial emulations"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000092"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000091"
        },
        {
          "@id": "bemo:BEMO_2000099"
        },
        {
          "@id": "bemo:BEMO_2000100"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting dose–response."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/99"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000092",
      "rdfs:label": {
        "@language": "en",
        "@value": "Dose–Response Support"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb135"
        },
        {
          "@id": "bemo:BEMO_1100004"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb135",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000092"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000369",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000369"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/376"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Metabolic Feature Reproducibility"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000016",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000016"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/23"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Network Context Support"
      }
    },
    {
      "@id": "bemo:BEMO_2000149",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000149",
      "bemo:BEMO_3100022": 156,
      "bemo:BEMO_3100023": "2dc879dd1ad8ed3ebf228b83983e7de95e06b9c72131b584ccaa785f551eea2b",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses evidence freshness using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in evidence freshness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating evidence freshness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Systematic reviews, meta-analyses, evidence profiles, guidelines"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; PRISMA; AMSTAR 2; RoB"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000149"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000147"
        },
        {
          "@id": "bemo:BEMO_2000152"
        },
        {
          "@id": "bemo:BEMO_2000156"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of evidence freshness."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/156"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000149",
      "rdfs:label": {
        "@language": "en",
        "@value": "Evidence Freshness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb188"
        },
        {
          "@id": "bemo:BEMO_1100006"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb188",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000149"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_4000004",
      "@type": [
        "owl:NamedIndividual",
        "bemo:BEMO_0000400"
      ],
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Controlled BEMO ScaleType value: ProportionScale."
      },
      "oboInOwl:id": "BEMO:4000004",
      "rdfs:label": {
        "@language": "en",
        "@value": "Proportion Scale"
      },
      "skos:notation": "ProportionScale"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/406",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 406,
      "bemo:BEMO_3100023": "b36c4ba0356ae6813b5bb255ebc6934635b0cbf83c44326cfea7019592803c5e",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All experimental, computational, clinical, and omics studies\", \"Category\": \"Reproducibility and Replication\", \"Closely Related Metrics\": \"Intralaboratory Repeatability; Result Reproducibility; Inferential Reproducibility\", \"Common Misinterpretations\": \"Treating method reproducibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Method Reproducibility\", \"References or Origin\": \"https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines\", \"Related Frameworks\": \"PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0\", \"Scientific Definition\": \"The degree to which method reproducibility yields concordant results under the specified repeated-analysis or repeated-measurement conditions.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses method reproducibility using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in method reproducibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 406"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/151",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 151,
      "bemo:BEMO_3100023": "a6abc5b380d07d44d4ec1e48b63cf0e3bf7299ab7264d6edcc898627f3bd0952",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Systematic reviews, meta-analyses, evidence profiles, guidelines\", \"Category\": \"Evidence Certainty and Synthesis\", \"Closely Related Metrics\": \"Evidence Strength; Evidence Stability; Evidence Consistency\", \"Common Misinterpretations\": \"Treating evidence confidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Evidence Confidence\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/\", \"Related Frameworks\": \"GRADE; PRISMA; AMSTAR 2; RoB\", \"Scientific Definition\": \"The justified degree of certainty assigned to evidence given the quantity, quality, consistency, and limitations of supporting evidence.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses evidence confidence using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in evidence confidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 151"
    },
    {
      "@id": "bemo:BEMO_4000028",
      "@type": [
        "owl:NamedIndividual",
        "bemo:BEMO_0000402"
      ],
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Controlled BEMO ApprovalStatus value: UnderReview."
      },
      "oboInOwl:id": "BEMO:4000028",
      "rdfs:label": {
        "@language": "en",
        "@value": "Under Review"
      },
      "skos:notation": "UnderReview"
    },
    {
      "@id": "bemo:BEMO_2000317",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000317",
      "bemo:BEMO_3100022": 324,
      "bemo:BEMO_3100023": "0b4f2bdfa3ccc3b3abdb67b1f3be15b6d8479743942152580ad3f1929db67d5f",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses network reconstruction robustness using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in network reconstruction robustness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating network reconstruction robustness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Dataset / model / pathway / network / evidence body"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Integrated omics, networks, pathways, mechanistic and dynamic systems models"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "Gene Ontology; Reactome; UniProt; GA4GH"
      },
      "bemo:BEMO_3200011": "https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000317"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000312"
        },
        {
          "@id": "bemo:BEMO_2000315"
        },
        {
          "@id": "bemo:BEMO_2000316"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of network reconstruction robustness."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/324"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000317",
      "rdfs:label": {
        "@language": "en",
        "@value": "Network Reconstruction Robustness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb335"
        },
        {
          "@id": "bemo:BEMO_1100012"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb335",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000317"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000354",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000354",
      "bemo:BEMO_3100022": 361,
      "bemo:BEMO_3100023": "f3eb077ab3d21773df18d06eb29c8a11272ed7cbfe8f22da0ffedd8a171bc393",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses species extrapolation validity using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in species extrapolation validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating species extrapolation validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "OECD; OHAT; FDA Biomarker; EMA E16"
      },
      "bemo:BEMO_3200011": "https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000354"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000339"
        },
        {
          "@id": "bemo:BEMO_2000343"
        },
        {
          "@id": "bemo:BEMO_2000357"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which species extrapolation supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/361"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000354",
      "rdfs:label": {
        "@language": "en",
        "@value": "Species Extrapolation Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb369"
        },
        {
          "@id": "bemo:BEMO_1100013"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb369",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000354"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000299",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000299"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/306"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Reproducibility of Measurement"
      }
    },
    {
      "@id": "bemo:BEMO_2000027",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000027",
      "bemo:BEMO_3100022": 34,
      "bemo:BEMO_3100023": "e3cc6b49f3bcbfabd500e6222a7c3cc053aca55c824a6afddd04a9b448378651",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses tissue specificity using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in tissue specificity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating tissue specificity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Molecular, cellular, animal, translational, pharmacologic, and human studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; FDA Biomarker; ClinGen; OHAT; OECD"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000027"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000003"
        },
        {
          "@id": "bemo:BEMO_2000023"
        },
        {
          "@id": "bemo:BEMO_2000026"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of tissue specificity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/34"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000027",
      "rdfs:label": {
        "@language": "en",
        "@value": "Tissue Specificity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb78"
        },
        {
          "@id": "bemo:BEMO_1100001"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb78",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000027"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/17",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 17,
      "bemo:BEMO_3100023": "dc1b3b375698d0aec42693d5a0b2f87405e7e7bf90759105797ad714ab4e9ab2",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Molecular, cellular, animal, translational, pharmacologic, and human studies\", \"Category\": \"Biological Plausibility and Mechanism\", \"Closely Related Metrics\": \"Mechanistic Completeness; Mechanistic Specificity; Mechanistic Causality Strength\", \"Common Misinterpretations\": \"Treating mechanistic coherence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Mechanistic Coherence\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"GRADE; FDA Biomarker; ClinGen; OHAT; OECD\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of mechanistic coherence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses mechanistic coherence using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in mechanistic coherence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 17"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/305",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 305,
      "bemo:BEMO_3100023": "1958a10669f076f26b0e434840fd948f2a615d7e3a768038db89230b0e148857",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Analytical Measurement Range; Dynamic Range; Recovery\", \"Common Misinterpretations\": \"Treating reportable range as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Reportable Range\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of reportable range.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Method- and analyte-specific physical units\", \"What It Measures\": \"Assesses reportable range using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in reportable range can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 305"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/411",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 411,
      "bemo:BEMO_3100023": "c196ee0e5b3c49cffc78d559a15b400e1dec74f4854200e7fbd341eef60a59c4",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All experimental, computational, clinical, and omics studies\", \"Category\": \"Reproducibility and Replication\", \"Closely Related Metrics\": \"Random-Seed Stability; Multiverse Analysis Robustness; Specification-Curve Robustness\", \"Common Misinterpretations\": \"Treating researcher-degrees-of-freedom sensitivity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment.\", \"Metric\": \"Researcher-Degrees-of-Freedom Sensitivity\", \"References or Origin\": \"https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines\", \"Related Frameworks\": \"PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of researcher-degrees-of-freedom sensitivity.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses researcher-degrees-of-freedom sensitivity using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in researcher-degrees-of-freedom sensitivity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 411"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/463",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 463,
      "bemo:BEMO_3100023": "8a96194c8b8e65d04df266b282704e480656791b819df12c8c4924c984b02272",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Bayes Factor Evidence; Prior Sensitivity; Equivalence Margin Validity\", \"Common Misinterpretations\": \"Treating posterior probability strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Posterior Probability Strength\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting posterior probability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses posterior probability strength using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in posterior probability strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 463"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000168",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000168"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/175"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Animal Model Face Validity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000253",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000253"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/260"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Read Quality"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000162",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000162"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/169"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Publication Bias Risk"
      }
    },
    {
      "@id": "bemo:BEMO_2000022",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000022",
      "bemo:BEMO_3100022": 29,
      "bemo:BEMO_3100023": "9f3de30fb4252544b664477f26ad879c47cffd18e4a902652a07ca5b9fa59ec2",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses rescue experiment support using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in rescue experiment support can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating rescue experiment support as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Molecular, cellular, animal, translational, pharmacologic, and human studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; FDA Biomarker; ClinGen; OHAT; OECD"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000022"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000005"
        },
        {
          "@id": "bemo:BEMO_2000006"
        },
        {
          "@id": "bemo:BEMO_2000025"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting rescue experiment."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/29"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000022",
      "rdfs:label": {
        "@language": "en",
        "@value": "Rescue Experiment Support"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb74"
        },
        {
          "@id": "bemo:BEMO_1100001"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb74",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000022"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_3200015",
      "@type": "owl:AnnotationProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Name of the source worksheet."
      },
      "oboInOwl:id": "BEMO:3200015",
      "rdfs:label": {
        "@language": "en",
        "@value": "source sheet"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000300",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000300"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/307"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Sample Stability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/25",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 25,
      "bemo:BEMO_3100023": "5b75004715c78ae57eb0dfbf1a6fe3b6212289ca6b06f39e35b36270d16b13e5",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Molecular, cellular, animal, translational, pharmacologic, and human studies\", \"Category\": \"Biological Plausibility and Mechanism\", \"Closely Related Metrics\": \"Target Engagement Evidence; Off-Target Liability Evidence; Biological Gradient\", \"Common Misinterpretations\": \"Treating on-target specificity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment.\", \"Metric\": \"On-Target Specificity\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"GRADE; FDA Biomarker; ClinGen; OHAT; OECD\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of on-target specificity.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses on-target specificity using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in on-target specificity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 25"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000314",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000314"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/321"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Module Stability"
      }
    },
    {
      "@id": "bemo:BEMO_4000011",
      "@type": [
        "owl:NamedIndividual",
        "bemo:BEMO_0000401"
      ],
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Controlled BEMO ComputationMode value: RuleBasedRubricComputation."
      },
      "oboInOwl:id": "BEMO:4000011",
      "rdfs:label": {
        "@language": "en",
        "@value": "Rule Based Rubric Computation"
      },
      "skos:notation": "RuleBasedRubricComputation"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000159",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000159"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/166"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Multiplicity-Adjusted Credibility"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/98",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 98,
      "bemo:BEMO_3100023": "9e166f37b12b35c895b18fc7e56e04526e22004c0b70dee562c1cf80c5d17e69",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized and observational etiologic studies, natural experiments, target-trial emulations\", \"Category\": \"Causal Inference\", \"Closely Related Metrics\": \"Dose–Response Support; Mediation Evidence Strength; Effect-Modification Credibility\", \"Common Misinterpretations\": \"Treating dechallenge–rechallenge support as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Dechallenge–Rechallenge Support\", \"References or Origin\": \"https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting dechallenge–rechallenge.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses dechallenge–rechallenge support using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in dechallenge–rechallenge support can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 98"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000044",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000044"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/51"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Endpoint Validity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000407",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000407"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/414"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Code-Sharing Transparency"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/205",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 205,
      "bemo:BEMO_3100023": "27f8a61447192cbdeaaa7e84078183a3604b2e6ac6c0df13be6cfe9e4a09224a",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Clinical, epidemiologic, diagnostic, translational, and population studies\", \"Category\": \"External Validity and Applicability\", \"Closely Related Metrics\": \"Transportability; Setting Applicability; Population Applicability\", \"Common Misinterpretations\": \"Treating generalizability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Generalizability\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/\", \"Related Frameworks\": \"GRADE; QUADAS-2; CONSORT; STROBE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of generalizability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses generalizability using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in generalizability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 205"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/342",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 342,
      "bemo:BEMO_3100023": "3a82aa8a1751fa8372cd9735fd975781682a359be68aacfb1d0d78e896d96ce5",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies\", \"Category\": \"Pharmacology and Toxicology\", \"Closely Related Metrics\": \"Metabolite Coverage; Receptor Occupancy Evidence; Selectivity Profile\", \"Common Misinterpretations\": \"Treating drug–drug interaction evidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Drug–Drug Interaction Evidence\", \"References or Origin\": \"https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline\", \"Related Frameworks\": \"OECD; OHAT; FDA Biomarker; EMA E16\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of drug–drug interaction evidence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses drug–drug interaction evidence using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in drug–drug interaction evidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 342"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/428",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 428,
      "bemo:BEMO_3100023": "129e8fff9350e8d3fb88d0a300e3816f498afcc03cf17b3f6037da094441e4fe",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All biomedical study reports and data releases\", \"Category\": \"Research Transparency and Reporting Completeness\", \"Closely Related Metrics\": \"Prespecified Analysis Adherence; Intervention Description Completeness; Comparator Description Completeness\", \"Common Misinterpretations\": \"Treating outcome definition completeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Study report / dataset / evidence package\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Outcome Definition Completeness\", \"References or Origin\": \"https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/\", \"Related Frameworks\": \"EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS\", \"Scientific Definition\": \"The extent to which all scientifically necessary components of outcome definition are present, documented, and evaluable.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses outcome definition completeness using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in outcome definition completeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 428"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000364",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000364"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/371"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Fragmentation Spectrum Quality"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000250",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000250"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/257"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Mapping Quality"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000025",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000025"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/32"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Target Engagement Evidence"
      }
    },
    {
      "@id": "bemo:BEMO_3100029",
      "@type": "owl:DatatypeProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Identifier of the immutable evidence snapshot."
      },
      "oboInOwl:id": "BEMO:3100029",
      "rdfs:label": {
        "@language": "en",
        "@value": "evidence snapshot identifier"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/409",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 409,
      "bemo:BEMO_3100023": "c1a5a2e956afa3ff1606fb1893282ee7b8d5d3733fbd04798630fe0746f86074",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All experimental, computational, clinical, and omics studies\", \"Category\": \"Reproducibility and Replication\", \"Closely Related Metrics\": \"Data Availability; Researcher-Degrees-of-Freedom Sensitivity; Multiverse Analysis Robustness\", \"Common Misinterpretations\": \"Treating random-seed stability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Random-Seed Stability\", \"References or Origin\": \"https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines\", \"Related Frameworks\": \"PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of random-seed stability.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses random-seed stability using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in random-seed stability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 409"
    },
    {
      "@id": "bemo:BEMO_2000425",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000425",
      "bemo:BEMO_3100022": 432,
      "bemo:BEMO_3100023": "32ae2352b0f17339d30893a08c10c681c7fa3992e6b60a3343dae6e95aa8dda5",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses prospective registration using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in prospective registration can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating prospective registration as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Study report / dataset / evidence package"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All biomedical study reports and data releases"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000425"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000421"
        },
        {
          "@id": "bemo:BEMO_2000423"
        },
        {
          "@id": "bemo:BEMO_2000426"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of prospective registration."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/432"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000425",
      "rdfs:label": {
        "@language": "en",
        "@value": "Prospective Registration"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb49"
        },
        {
          "@id": "bemo:BEMO_1100016"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb49",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000425"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000128",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000128"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/135"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Positive Predictive Value"
      }
    },
    {
      "@id": "bemo:BEMO_3100015",
      "@type": "owl:DatatypeProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Required missing-data handling policy."
      },
      "oboInOwl:id": "BEMO:3100015",
      "rdfs:label": {
        "@language": "en",
        "@value": "missing data policy"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/308",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 308,
      "bemo:BEMO_3100023": "c0e7317023f6c1fc290d021e4b38163503a72ee411cc671fe6aae25ee84d1ee5",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Operator Variability; Batch-Effect Sensitivity; Preanalytical Robustness\", \"Common Misinterpretations\": \"Treating site-to-site assay portability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Site-to-Site Assay Portability\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of site-to-site assay portability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses site-to-site assay portability using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in site-to-site assay portability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 308"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000403",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000403"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/410"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Reanalysis Concordance"
      }
    },
    {
      "@id": "bemo:BEMO_3000019",
      "@type": "owl:ObjectProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Connects a metric profile or assessment to a benchmark or reference standard."
      },
      "oboInOwl:id": "BEMO:3000019",
      "rdfs:label": {
        "@language": "en",
        "@value": "validated against"
      }
    },
    {
      "@id": "bemo:BEMO_2000453",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000453",
      "bemo:BEMO_3100022": 460,
      "bemo:BEMO_3100023": "aec401720de6539460ff9d49f62284a772b28790802eda1b3dc7c5fc2d67af3f",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses nonlinearity assessment using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in nonlinearity assessment can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Replicate dilution series; blank and spiked samples; reference materials; method-comparison studies; predefined CLSI/ISO acceptance criteria."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating nonlinearity assessment as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000453"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000444"
        },
        {
          "@id": "bemo:BEMO_2000445"
        },
        {
          "@id": "bemo:BEMO_2000455"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of nonlinearity assessment."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/460"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000453",
      "rdfs:label": {
        "@language": "en",
        "@value": "Nonlinearity Assessment"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb456"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb456",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000453"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000331",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000331"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/338"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Bioavailability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/352",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 352,
      "bemo:BEMO_3100023": "277a918d22b52db9e79eabf5451f64320f342f326be1cc2382f16c69ec72f0a9",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies\", \"Category\": \"Pharmacology and Toxicology\", \"Closely Related Metrics\": \"Adverse Outcome Pathway Support; Genotoxicity Evidence Strength; Carcinogenicity Evidence Strength\", \"Common Misinterpretations\": \"Treating organ-specific toxicity evidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Organ-Specific Toxicity Evidence\", \"References or Origin\": \"https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline\", \"Related Frameworks\": \"OECD; OHAT; FDA Biomarker; EMA E16\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of organ-specific toxicity evidence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses organ-specific toxicity evidence using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in organ-specific toxicity evidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 352"
    },
    {
      "@id": "bemo:BEMO_2000254",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000254",
      "bemo:BEMO_3100022": 261,
      "bemo:BEMO_3100023": "7f170b7ac0b632bb15937074f6f54297bd1374274ba7dd6a71c308a1270c144b",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses reference bias using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in reference bias can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating reference bias as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAME; MINSEQE; STROBE-ME; GA4GH; HCA"
      },
      "bemo:BEMO_3200011": "https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000254"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000240"
        },
        {
          "@id": "bemo:BEMO_2000248"
        },
        {
          "@id": "bemo:BEMO_2000264"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of reference bias."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/261"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000254",
      "rdfs:label": {
        "@language": "en",
        "@value": "Reference Bias"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb279"
        },
        {
          "@id": "bemo:BEMO_1100010"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb279",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000254"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/116",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 116,
      "bemo:BEMO_3100023": "50677da95ed69c14f1f1ec5786cb5c4d590d6e339c1a13fdedfd18d811ffc8f4",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized and observational etiologic studies, natural experiments, target-trial emulations\", \"Category\": \"Causal Inference\", \"Closely Related Metrics\": \"Residual Confounding Risk; Exchangeability Plausibility; Positivity Adequacy\", \"Common Misinterpretations\": \"Treating unmeasured confounding sensitivity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment.\", \"Metric\": \"Unmeasured Confounding Sensitivity\", \"References or Origin\": \"https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of unmeasured confounding sensitivity.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Directed acyclic graphs; design emulation; balance diagnostics; negative controls; quantitative bias analysis; sensitivity and falsification analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses unmeasured confounding sensitivity using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in unmeasured confounding sensitivity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 116"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/295",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 295,
      "bemo:BEMO_3100023": "e901d4ca31939164c2ecbe0d0bed735b156c8e09a3c3f28444f5359947798b49",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Dilution Integrity; Interference Susceptibility; Cross-Reactivity\", \"Common Misinterpretations\": \"Treating matrix effect as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Matrix Effect\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of matrix effect.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Replicate dilution series; blank and spiked samples; reference materials; method-comparison studies; predefined CLSI/ISO acceptance criteria.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses matrix effect using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in matrix effect can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 295"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000268",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000003"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000012"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000013"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000020"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a validated analyte- and method-specific measurement procedure with calibration and quality control."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"unitRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "specimen_or_material; measurement_procedure; calibration_reference; quality_control_results; unit",
      "bemo:BEMO_3100007": "replicate_measurements; environmental_conditions; instrument_version",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Method- and analyte-specific physical units",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000268"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/275"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Analytical Measurement Range"
      }
    },
    {
      "@id": "bemo:BEMO_3100022",
      "@type": "owl:DatatypeProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "One-based row number in the source worksheet."
      },
      "oboInOwl:id": "BEMO:3100022",
      "rdfs:label": {
        "@language": "en",
        "@value": "source row"
      },
      "rdfs:range": {
        "@id": "xsd:integer"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/68",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 68,
      "bemo:BEMO_3100023": "de5efa73121b798bb0e1a53bddae9ef743d4a522e6df52007a5b7569bc63e020",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All studies using human or animal biospecimens\", \"Category\": \"Biospecimen and Preanalytical Quality\", \"Closely Related Metrics\": \"Tumor Purity; Necrosis Burden; Hemolysis Burden\", \"Common Misinterpretations\": \"Treating cellularity adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Cellularity Adequacy\", \"References or Origin\": \"https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"BRISQ; ISO 15189; REMARK\", \"Scientific Definition\": \"The extent to which cellularity is sufficient and fit for the stated biomedical inference.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses cellularity adequacy using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in cellularity adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 68"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000413",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000413"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/420"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Funding-Source Transparency"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/231",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 231,
      "bemo:BEMO_3100023": "bd3af304ec15826df5f67db7f079c0ba66a1f5f5a3e852d600550186267f50cb",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mendelian disease, cancer genetics, association, segregation, and functional studies\", \"Category\": \"Genetics and Variant Evidence\", \"Closely Related Metrics\": \"Phenocopy Risk; Genotype–Phenotype Concordance; Variant Classification Stability\", \"Common Misinterpretations\": \"Treating locus heterogeneity assessment as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Locus Heterogeneity Assessment\", \"References or Origin\": \"https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/\", \"Related Frameworks\": \"ClinGen; ACMG AMP; STREGA; Gene Ontology\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of locus heterogeneity assessment.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Forest plots; heterogeneity statistics; tau-squared; prediction intervals; funnel plots; regression or selection models; sensitivity analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses locus heterogeneity assessment using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in locus heterogeneity assessment can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 231"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/292",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 292,
      "bemo:BEMO_3100023": "32751f0c3f93a66c901d3c5cea950ee45482dac2a524a6e4ed0ddc20000649d1",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Analytical Specificity; Limit of Quantification; Linearity\", \"Common Misinterpretations\": \"Treating limit of detection as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Limit of Detection\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of limit of detection.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Replicate dilution series; blank and spiked samples; reference materials; method-comparison studies; predefined CLSI/ISO acceptance criteria.\", \"Units or Scale (if applicable)\": \"Method- and analyte-specific physical units\", \"What It Measures\": \"Assesses limit of detection using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in limit of detection can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 292"
    },
    {
      "@id": "bemo:BEMO_2000380",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000380",
      "bemo:BEMO_3100022": 387,
      "bemo:BEMO_3100023": "5fec1390446b523e8b6072b1babcb11902375d326650ad448b800e258e0a8401",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses proteome coverage using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in proteome coverage can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating proteome coverage as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAPE; HUPO PSI; Metabolomics Standards"
      },
      "bemo:BEMO_3200011": "https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000380"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000378"
        },
        {
          "@id": "bemo:BEMO_2000382"
        },
        {
          "@id": "bemo:BEMO_2000384"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The proportion and representativeness of the relevant proteome captured by the evidence or measurement process."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/387"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000380",
      "rdfs:label": {
        "@language": "en",
        "@value": "Proteome Coverage"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb392"
        },
        {
          "@id": "bemo:BEMO_1100014"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb392",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000380"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/408",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 408,
      "bemo:BEMO_3100023": "caa28491bc96ceb6cd2e1c6685b9eb89f21391a6d4502473143986af13cc088b",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All experimental, computational, clinical, and omics studies\", \"Category\": \"Reproducibility and Replication\", \"Closely Related Metrics\": \"Data Provenance Completeness; Material Availability; Code Availability\", \"Common Misinterpretations\": \"Treating protocol reproducibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Protocol Reproducibility\", \"References or Origin\": \"https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines\", \"Related Frameworks\": \"PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0\", \"Scientific Definition\": \"The degree to which protocol reproducibility yields concordant results under the specified repeated-analysis or repeated-measurement conditions.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses protocol reproducibility using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in protocol reproducibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 408"
    },
    {
      "@id": "bemo:BEMO_2000029",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000029",
      "bemo:BEMO_3100022": 36,
      "bemo:BEMO_3100023": "35003a5d4be2844c7914597bb95d8d44ce388ce934a6b5067c8e498ac9e8de35",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses biomarker qualification strength using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in biomarker qualification strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating biomarker qualification strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Biomarker development, qualification, endpoint and surrogate validation studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; BEST; EMA E16; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000029"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000030"
        },
        {
          "@id": "bemo:BEMO_2000031"
        },
        {
          "@id": "bemo:BEMO_2000037"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting biomarker qualification."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/36"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000029",
      "rdfs:label": {
        "@language": "en",
        "@value": "Biomarker Qualification Strength"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb80"
        },
        {
          "@id": "bemo:BEMO_1100002"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb80",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000029"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000400",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Developing; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000400"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/407"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Multiverse Analysis Robustness"
      }
    },
    {
      "@id": "bemo:BEMO_2000038",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000038",
      "bemo:BEMO_3100022": 45,
      "bemo:BEMO_3100023": "4ad4866845885f677cad74042f65b0303f2d26597ea694b76dfed4bc71fedd68",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses convergent validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in convergent validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating convergent validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Biomarker development, qualification, endpoint and surrogate validation studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; BEST; EMA E16; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000038"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000039"
        },
        {
          "@id": "bemo:BEMO_2000041"
        },
        {
          "@id": "bemo:BEMO_2000046"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which convergent supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/45"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000038",
      "rdfs:label": {
        "@language": "en",
        "@value": "Convergent Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb87"
        },
        {
          "@id": "bemo:BEMO_1100002"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb87",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000038"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000054",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000054"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/61"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Safety Biomarker Validity"
      }
    },
    {
      "@id": "bemo:BEMO_2000348",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000348",
      "bemo:BEMO_3100022": 355,
      "bemo:BEMO_3100023": "2cff4752043ea892788f37639d922b1a249d83c13dfedf581ad1a4ad12ab95b8",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses pharmacological target validity using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in pharmacological target validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating pharmacological target validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "OECD; OHAT; FDA Biomarker; EMA E16"
      },
      "bemo:BEMO_3200011": "https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000348"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000337"
        },
        {
          "@id": "bemo:BEMO_2000347"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which pharmacological target supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/355"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000348",
      "rdfs:label": {
        "@language": "en",
        "@value": "Pharmacological Target Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb13"
        },
        {
          "@id": "bemo:BEMO_1100013"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb13",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000348"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000057",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000057"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/64"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Trial-Level Surrogacy"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/462",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 462,
      "bemo:BEMO_3100023": "20f394b3ef37b7c0b5d8426ebcce5fe9f9ef841bbb2622101174fbb411ab7957",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Interaction Assessment Adequacy; Measurement Error Correction; Calibration of Statistical Predictions\", \"Common Misinterpretations\": \"Treating overadjustment bias risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Overadjustment Bias Risk\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"The probability or degree that overadjustment bias introduces systematic distortion into a biomedical estimate or conclusion.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses overadjustment bias risk using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in overadjustment bias risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 462"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000143",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000143"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/150"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Evidence Completeness"
      }
    },
    {
      "@id": "bemo:BEMO_1100010",
      "@type": "owl:Class",
      "bemo:BEMO_3200016": "Candidate",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Category of biomedical evidence metrics concerned with genomics and transcriptomics."
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:1100010",
      "rdfs:label": {
        "@language": "en",
        "@value": "Genomics and Transcriptomics metric"
      },
      "rdfs:subClassOf": {
        "@id": "bemo:BEMO_1000007"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/346",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 346,
      "bemo:BEMO_3100023": "32b4aadfeeab004a7a018b1fe09f04f0b2283eb92e7749123f8ac828db8cfce6",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies\", \"Category\": \"Pharmacology and Toxicology\", \"Closely Related Metrics\": \"Species Extrapolation Validity; Mixture Interaction Assessment\", \"Common Misinterpretations\": \"Treating human-relevance of toxicological evidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Human-Relevance of Toxicological Evidence\", \"References or Origin\": \"https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline\", \"Related Frameworks\": \"OECD; OHAT; FDA Biomarker; EMA E16\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of human-relevance of toxicological evidence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses human-relevance of toxicological evidence using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in human-relevance of toxicological evidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 346"
    },
    {
      "@id": "bemo:BEMO_2000484",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000484",
      "bemo:BEMO_3100022": 491,
      "bemo:BEMO_3100023": "ae404e8a9df9a665347ede4db7ae7370bdc6c77c15da3474e23c516ad81dd25e",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses protocol fidelity using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in protocol fidelity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating protocol fidelity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000484"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000478"
        },
        {
          "@id": "bemo:BEMO_2000480"
        },
        {
          "@id": "bemo:BEMO_2000487"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of protocol fidelity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/491"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000484",
      "rdfs:label": {
        "@language": "en",
        "@value": "Protocol Fidelity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb485"
        },
        {
          "@id": "bemo:BEMO_1100018"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb485",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000484"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/359",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 359,
      "bemo:BEMO_3100023": "51ce0324d6952becbbadfd71ba2913a1f56afbcc33aa0148093d10994d18697d",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies\", \"Category\": \"Pharmacology and Toxicology\", \"Closely Related Metrics\": \"Therapeutic Window Evidence; No-Observed-Adverse-Effect Level Robustness; Lowest-Observed-Adverse-Effect Level Robustness\", \"Common Misinterpretations\": \"Treating safety margin evidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Safety Margin Evidence\", \"References or Origin\": \"https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline\", \"Related Frameworks\": \"OECD; OHAT; FDA Biomarker; EMA E16\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of safety margin evidence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses safety margin evidence using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in safety margin evidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 359"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/33",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 33,
      "bemo:BEMO_3100023": "57d68c3c49543e85a4a6ee1a26a1705e9e0e05df169673d5a8f0a00632bfa39b",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Molecular, cellular, animal, translational, pharmacologic, and human studies\", \"Category\": \"Biological Plausibility and Mechanism\", \"Closely Related Metrics\": \"Spatial Biological Concordance; Cross-Species Biological Concordance; Phenotypic Concordance\", \"Common Misinterpretations\": \"Treating temporal biological concordance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Temporal Biological Concordance\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"GRADE; FDA Biomarker; ClinGen; OHAT; OECD\", \"Scientific Definition\": \"The degree of agreement in temporal biological across measurements, studies, methods, populations, or biological levels.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses temporal biological concordance using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in temporal biological concordance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 33"
    },
    {
      "@id": "bemo:BEMO_2000244",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000244",
      "bemo:BEMO_3100022": 251,
      "bemo:BEMO_3100023": "e70802b2991914211c0dcd91213c02319dd673fc93963b9e2064b8bca944c528",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses differential expression robustness using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in differential expression robustness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating differential expression robustness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAME; MINSEQE; STROBE-ME; GA4GH; HCA"
      },
      "bemo:BEMO_3200011": "https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000244"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000251"
        },
        {
          "@id": "bemo:BEMO_2000255"
        },
        {
          "@id": "bemo:BEMO_2000265"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of differential expression robustness."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/251"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000244",
      "rdfs:label": {
        "@language": "en",
        "@value": "Differential Expression Robustness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb270"
        },
        {
          "@id": "bemo:BEMO_1100010"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb270",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000244"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000102",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000102"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/109"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Positivity Adequacy"
      }
    },
    {
      "@id": "bemo:BEMO_2000347",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000347",
      "bemo:BEMO_3100022": 354,
      "bemo:BEMO_3100023": "2b02efdd0f6a774096cee910d90b575b8f28f136a8ee594876642fb213f66330",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses pharmacokinetic adequacy using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in pharmacokinetic adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating pharmacokinetic adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "OECD; OHAT; FDA Biomarker; EMA E16"
      },
      "bemo:BEMO_3200011": "https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000347"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000331"
        },
        {
          "@id": "bemo:BEMO_2000337"
        },
        {
          "@id": "bemo:BEMO_2000346"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which pharmacokinetic is sufficient and fit for the stated biomedical inference."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/354"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000347",
      "rdfs:label": {
        "@language": "en",
        "@value": "Pharmacokinetic Adequacy"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb363"
        },
        {
          "@id": "bemo:BEMO_1100013"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb363",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000347"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/52",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 52,
      "bemo:BEMO_3100023": "4d46697f970727d741077ee1e1f9eeeaed4beee8d6ef96a339ca927181b91ef5",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Biomarker development, qualification, endpoint and surrogate validation studies\", \"Category\": \"Biomarker and Endpoint Validation\", \"Closely Related Metrics\": \"Surrogate Endpoint Validity; Trial-Level Surrogacy; Endpoint Validity\", \"Common Misinterpretations\": \"Treating individual-level surrogacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Individual-Level Surrogacy\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"FDA Biomarker; BEST; EMA E16; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of individual-level surrogacy.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses individual-level surrogacy using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in individual-level surrogacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 52"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000278",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000278"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/285"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Cutoff Validity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/366",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 366,
      "bemo:BEMO_3100023": "447ad3207c1d5333015f6a5189727d810a3a517e4d6a4351f8dc28acbe93a5f0",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies\", \"Category\": \"Proteomics and Metabolomics\", \"Closely Related Metrics\": \"Pathway Enrichment Robustness\", \"Common Misinterpretations\": \"Treating cross-omics concordance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Developing\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Cross-Omics Concordance\", \"References or Origin\": \"https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/\", \"Related Frameworks\": \"MIAPE; HUPO PSI; Metabolomics Standards\", \"Scientific Definition\": \"The degree of agreement in cross-omics across measurements, studies, methods, populations, or biological levels.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses cross-omics concordance using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in cross-omics concordance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 366"
    },
    {
      "@id": "bemo:BEMO_2000122",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000122",
      "bemo:BEMO_3100022": 129,
      "bemo:BEMO_3100023": "6dc29889e79017542636c8b841aff4c0f5947b19dec51307e00a9c51cdc593cc",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses negative likelihood ratio using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in negative likelihood ratio can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Two-by-two tables; binomial confidence intervals; hierarchical diagnostic meta-analysis; threshold and prevalence analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating negative likelihood ratio as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "QUADAS-2; STARD; TRIPOD; REMARK"
      },
      "bemo:BEMO_3200011": "https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000122"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000110"
        },
        {
          "@id": "bemo:BEMO_2000115"
        },
        {
          "@id": "bemo:BEMO_2000127"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of negative likelihood ratio."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/129"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000122",
      "rdfs:label": {
        "@language": "en",
        "@value": "Negative Likelihood Ratio"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb161"
        },
        {
          "@id": "bemo:BEMO_1100005"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb161",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000122"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000288",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000288",
      "bemo:BEMO_3100022": 295,
      "bemo:BEMO_3100023": "e901d4ca31939164c2ecbe0d0bed735b156c8e09a3c3f28444f5359947798b49",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses matrix effect using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in matrix effect can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Replicate dilution series; blank and spiked samples; reference materials; method-comparison studies; predefined CLSI/ISO acceptance criteria."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating matrix effect as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000288"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000277"
        },
        {
          "@id": "bemo:BEMO_2000279"
        },
        {
          "@id": "bemo:BEMO_2000283"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of matrix effect."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/295"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000288",
      "rdfs:label": {
        "@language": "en",
        "@value": "Matrix Effect"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb310"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb310",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000288"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/60",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 60,
      "bemo:BEMO_3100023": "a8e8ef21a701fbb547c028557e4678bc79ebeda610eb6926bf0061b6e9a016c4",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Biomarker development, qualification, endpoint and surrogate validation studies\", \"Category\": \"Biomarker and Endpoint Validation\", \"Closely Related Metrics\": \"Susceptibility/Risk Biomarker Validity; Surrogate Endpoint Validity; Individual-Level Surrogacy\", \"Common Misinterpretations\": \"Treating response biomarker validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Response Biomarker Validity\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"FDA Biomarker; BEST; EMA E16; REMARK\", \"Scientific Definition\": \"The degree to which response biomarker supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses response biomarker validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in response biomarker validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 60"
    },
    {
      "@id": "bemo:BEMO_3000006",
      "@type": "owl:ObjectProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Connects a computation specification to its output specification."
      },
      "oboInOwl:id": "BEMO:3000006",
      "rdfs:label": {
        "@language": "en",
        "@value": "has output specification"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000415",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000415"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/422"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Intervention Description Completeness"
      }
    },
    {
      "@id": "bemo:BEMO_2000255",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000255",
      "bemo:BEMO_3100022": 262,
      "bemo:BEMO_3100023": "c66c714b8c2b1fb9da08eabc61ab1b346b5733232f7901baf90ed1206b3491ba",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses relatedness control using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in relatedness control can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating relatedness control as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAME; MINSEQE; STROBE-ME; GA4GH; HCA"
      },
      "bemo:BEMO_3200011": "https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000255"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000244"
        },
        {
          "@id": "bemo:BEMO_2000251"
        },
        {
          "@id": "bemo:BEMO_2000252"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of relatedness control."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/262"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000255",
      "rdfs:label": {
        "@language": "en",
        "@value": "Relatedness Control"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb280"
        },
        {
          "@id": "bemo:BEMO_1100010"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb280",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000255"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000145",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000145"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/152"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Evidence Consensus Strength"
      }
    },
    {
      "@id": "bemo:BEMO_2000016",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000016",
      "bemo:BEMO_3100022": 23,
      "bemo:BEMO_3100023": "d14cae7a1ae4e812a18da95395619423ade3837794dc32beea80cb11af0003f0",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses network context support using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in network context support can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating network context support as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Molecular, cellular, animal, translational, pharmacologic, and human studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; FDA Biomarker; ClinGen; OHAT; OECD"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000016"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000007"
        },
        {
          "@id": "bemo:BEMO_2000024"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting network context."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/23"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000016",
      "rdfs:label": {
        "@language": "en",
        "@value": "Network Context Support"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb68"
        },
        {
          "@id": "bemo:BEMO_1100001"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb68",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000016"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000005",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000005",
      "bemo:BEMO_3100022": 12,
      "bemo:BEMO_3100023": "cd57f610728234561644257a8387987f0aa8934688593c5fbd817b3779032054",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses epistasis support using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in epistasis support can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating epistasis support as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Molecular, cellular, animal, translational, pharmacologic, and human studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; FDA Biomarker; ClinGen; OHAT; OECD"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000005"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000018"
        },
        {
          "@id": "bemo:BEMO_2000022"
        },
        {
          "@id": "bemo:BEMO_2000025"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting epistasis."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/12"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000005",
      "rdfs:label": {
        "@language": "en",
        "@value": "Epistasis Support"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb58"
        },
        {
          "@id": "bemo:BEMO_1100001"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb58",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000005"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000172",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000172"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/179"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Blinding in Experimental Assessment"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000020",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000020"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/27"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Perturbational Validation"
      }
    },
    {
      "@id": "bemo:BEMO_2000420",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000420",
      "bemo:BEMO_3100022": 427,
      "bemo:BEMO_3100023": "0e7be34e4db71c86201d878decffa3c8da8ca62a1c8481dc3779d3c4caa454b1",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses null-result interpretability using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in null-result interpretability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating null-result interpretability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Study report / dataset / evidence package"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All biomedical study reports and data releases"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000420"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000411"
        },
        {
          "@id": "bemo:BEMO_2000419"
        },
        {
          "@id": "bemo:BEMO_2000430"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of null-result interpretability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/427"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000420",
      "rdfs:label": {
        "@language": "en",
        "@value": "Null-Result Interpretability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb429"
        },
        {
          "@id": "bemo:BEMO_1100016"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb429",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000420"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/87",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 87,
      "bemo:BEMO_3100023": "49559a7ae628351af963a27a55893cf501098be34876ce35bdc2d4969fd4f94b",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All studies using human or animal biospecimens\", \"Category\": \"Biospecimen and Preanalytical Quality\", \"Closely Related Metrics\": \"Cold Ischemia Control; Fixation Adequacy; Preservation Adequacy\", \"Common Misinterpretations\": \"Treating time-to-fixation adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Time-to-Fixation Adequacy\", \"References or Origin\": \"https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"BRISQ; ISO 15189; REMARK\", \"Scientific Definition\": \"The extent to which time-to-fixation is sufficient and fit for the stated biomedical inference.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses time-to-fixation adequacy using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in time-to-fixation adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 87"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/195",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 195,
      "bemo:BEMO_3100023": "8d21017136fa388d87b531d9b552fc3f6787a0b2615866e0c0a1ca9ae2fb0bbf",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"In vitro, ex vivo, organoid, animal, and preclinical experiments\", \"Category\": \"Experimental Biology and Animal Research\", \"Closely Related Metrics\": \"Orthogonal Validation\", \"Common Misinterpretations\": \"Treating technical artifact exclusion as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Technical Artifact Exclusion\", \"References or Origin\": \"https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"ARRIVE 2.0; SYRCLE; OECD\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of technical artifact exclusion.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses technical artifact exclusion using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in technical artifact exclusion can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 195"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/461",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 461,
      "bemo:BEMO_3100023": "3a52b33f3faa79b95100ff084b9c7ca54158523c656fcaf5c298f073960428c9",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Imputation Validity; Influential Observation Sensitivity; Nonlinearity Assessment\", \"Common Misinterpretations\": \"Treating outlier influence robustness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Outlier Influence Robustness\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of outlier influence robustness.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses outlier influence robustness using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in outlier influence robustness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 461"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/40",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 40,
      "bemo:BEMO_3100023": "d54499df144e3534026302c035690746b731c0abf25107f5fccdd8bada0bd79a",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Biomarker development, qualification, endpoint and surrogate validation studies\", \"Category\": \"Biomarker and Endpoint Validation\", \"Closely Related Metrics\": \"Clinical Validity; Biomarker Clinical Relevance; Context-of-Use Validity\", \"Common Misinterpretations\": \"Treating biomarker-outcome association strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Biomarker-Outcome Association Strength\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"FDA Biomarker; BEST; EMA E16; REMARK\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting biomarker-outcome association.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses biomarker-outcome association strength using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in biomarker-outcome association strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 40"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000036",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000036"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/43"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Content Validity"
      }
    },
    {
      "@id": "bemo:BEMO_2000212",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000212",
      "bemo:BEMO_3100022": 219,
      "bemo:BEMO_3100023": "a2868c878aff5e68e6f9aeb87fd5a98fd776f1ca106d2e9dbad34a8cc81ecfd8",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses case-control evidence strength using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in case-control evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating case-control evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mendelian disease, cancer genetics, association, segregation, and functional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ClinGen; ACMG AMP; STREGA; Gene Ontology"
      },
      "bemo:BEMO_3200011": "https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000212"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000213"
        },
        {
          "@id": "bemo:BEMO_2000215"
        },
        {
          "@id": "bemo:BEMO_2000220"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting case-control evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/219"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000212",
      "rdfs:label": {
        "@language": "en",
        "@value": "Case-Control Evidence Strength"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb242"
        },
        {
          "@id": "bemo:BEMO_1100009"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb242",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000212"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/19",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 19,
      "bemo:BEMO_3100023": "8582aac321a237f1dd1db68f0893021d3bc987b71b373d1879cc2dfb098adbdb",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Molecular, cellular, animal, translational, pharmacologic, and human studies\", \"Category\": \"Biological Plausibility and Mechanism\", \"Closely Related Metrics\": \"Mechanistic Support; Mechanistic Completeness; Mechanistic Coherence\", \"Common Misinterpretations\": \"Treating mechanistic coverage as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Mechanistic Coverage\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"GRADE; FDA Biomarker; ClinGen; OHAT; OECD\", \"Scientific Definition\": \"The proportion and representativeness of the relevant mechanistic captured by the evidence or measurement process.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses mechanistic coverage using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in mechanistic coverage can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 19"
    },
    {
      "@id": "bemo:BEMO_2000341",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000341",
      "bemo:BEMO_3100022": 348,
      "bemo:BEMO_3100023": "cd00c7765086fbbe65040e649de98f22bdf10298c91d8da0f6e7300a18f0ba9f",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses lowest-observed-adverse-effect level robustness using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in lowest-observed-adverse-effect level robustness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating lowest-observed-adverse-effect level robustness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "OECD; OHAT; FDA Biomarker; EMA E16"
      },
      "bemo:BEMO_3200011": "https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000341"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000330"
        },
        {
          "@id": "bemo:BEMO_2000344"
        },
        {
          "@id": "bemo:BEMO_2000358"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of lowest-observed-adverse-effect level robustness."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/348"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000341",
      "rdfs:label": {
        "@language": "en",
        "@value": "Lowest-Observed-Adverse-Effect Level Robustness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb358"
        },
        {
          "@id": "bemo:BEMO_1100013"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb358",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000341"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000049",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000049",
      "bemo:BEMO_3100022": 56,
      "bemo:BEMO_3100023": "1adca583ee04c245cdae3428bd050f3ed8796d29bf4b214b5880769da8977172",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses outcome relevance using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in outcome relevance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating outcome relevance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Biomarker development, qualification, endpoint and surrogate validation studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; BEST; EMA E16; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000049"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000042"
        },
        {
          "@id": "bemo:BEMO_2000043"
        },
        {
          "@id": "bemo:BEMO_2000044"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of outcome relevance."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/56"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000049",
      "rdfs:label": {
        "@language": "en",
        "@value": "Outcome Relevance"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb97"
        },
        {
          "@id": "bemo:BEMO_1100002"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb97",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000049"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000413",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000413",
      "bemo:BEMO_3100022": 420,
      "bemo:BEMO_3100023": "35377c10ba740cabcf147ce4b6ab00e3a9c4087ca2ca810c337f7fe08223e6f9",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses funding-source transparency using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in funding-source transparency can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating funding-source transparency as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Study report / dataset / evidence package"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All biomedical study reports and data releases"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000413"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000409"
        },
        {
          "@id": "bemo:BEMO_2000410"
        },
        {
          "@id": "bemo:BEMO_2000418"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of funding-source transparency."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/420"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000413",
      "rdfs:label": {
        "@language": "en",
        "@value": "Funding-Source Transparency"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb422"
        },
        {
          "@id": "bemo:BEMO_1100016"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb422",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000413"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/391",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 391,
      "bemo:BEMO_3100023": "f98e41911ad517a10150d0d24373bec15a553a9812e119c2e6a10081e9a89aaf",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies\", \"Category\": \"Proteomics and Metabolomics\", \"Closely Related Metrics\": \"Proteome Coverage; Quantification Precision; Quantification Accuracy\", \"Common Misinterpretations\": \"Treating sequence coverage as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Sequence Coverage\", \"References or Origin\": \"https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/\", \"Related Frameworks\": \"MIAPE; HUPO PSI; Metabolomics Standards\", \"Scientific Definition\": \"The proportion and representativeness of the relevant sequence captured by the evidence or measurement process.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses sequence coverage using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in sequence coverage can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 391"
    },
    {
      "@id": "bemo:BEMO_2000292",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000292",
      "bemo:BEMO_3100022": 299,
      "bemo:BEMO_3100023": "b1cf2cbf0a36602510f89d4d570874b9d2148d8bd132ef3b47e7be72655f9ff3",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses postanalytical integrity using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in postanalytical integrity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating postanalytical integrity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000292"
      },
      "bemo:BEMO_3200013": {
        "@id": "bemo:BEMO_2000293"
      },
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of postanalytical integrity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/299"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000292",
      "rdfs:label": {
        "@language": "en",
        "@value": "Postanalytical Integrity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb40"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb40",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000292"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000394",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000394"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/401"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Independent Replication Strength"
      }
    },
    {
      "@id": "bemo:BEMO_2000207",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000207",
      "bemo:BEMO_3100022": 214,
      "bemo:BEMO_3100023": "771c727a328004aa438f83d20410cd3600ce67ac5affa57fc6e9aaee55cb7ed9",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses spectrum representativeness using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in spectrum representativeness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Target-decoy analysis; spectral scoring; reference standards; replicate injections; retention-time and mass-error monitoring; orthogonal confirmation."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating spectrum representativeness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Clinical, epidemiologic, diagnostic, translational, and population studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; QUADAS-2; CONSORT; STROBE"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000207"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000199"
        },
        {
          "@id": "bemo:BEMO_2000201"
        },
        {
          "@id": "bemo:BEMO_2000208"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of spectrum representativeness."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/214"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000207",
      "rdfs:label": {
        "@language": "en",
        "@value": "Spectrum Representativeness"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb237"
        },
        {
          "@id": "bemo:BEMO_1100008"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb237",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000207"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/294",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 294,
      "bemo:BEMO_3100023": "511e3fb111714ad52a916859d22dfd9a9aa36539d615e5b295fdf52500ac32e5",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Limit of Quantification; Analytical Measurement Range; Reportable Range\", \"Common Misinterpretations\": \"Treating linearity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Linearity\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of linearity.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Replicate dilution series; blank and spiked samples; reference materials; method-comparison studies; predefined CLSI/ISO acceptance criteria.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses linearity using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in linearity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 294"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/445",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 445,
      "bemo:BEMO_3100023": "79608c041c0babc1613cca804b9e22a2fcbadbeabfda7d7b0bf2336528db7db1",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Residual Diagnostics Adequacy; Variance Estimation Validity; Missing-Data Mechanism Plausibility\", \"Common Misinterpretations\": \"Treating distributional assumption adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Distributional Assumption Adequacy\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"The extent to which distributional assumption is sufficient and fit for the stated biomedical inference.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses distributional assumption adequacy using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in distributional assumption adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 445"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000013",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000013"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/20"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Mechanistic Specificity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/223",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 223,
      "bemo:BEMO_3100023": "54567aec6ae0bbdadfae015005c07328ab45d161c0cc6d36f9e5198150b2b29e",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mendelian disease, cancer genetics, association, segregation, and functional studies\", \"Category\": \"Genetics and Variant Evidence\", \"Closely Related Metrics\": \"Variant Classification Stability\", \"Common Misinterpretations\": \"Treating conflicting interpretation burden as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Conflicting Interpretation Burden\", \"References or Origin\": \"https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/\", \"Related Frameworks\": \"ClinGen; ACMG AMP; STREGA; Gene Ontology\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of conflicting interpretation burden.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses conflicting interpretation burden using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in conflicting interpretation burden can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 223"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000385",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000385"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/392"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Spectral Library Match Quality"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/215",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 215,
      "bemo:BEMO_3100023": "26cabc1a909ce4ef7d5d54dc609f85f9fea3829985a8f8573b3da07a3e225f5b",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Clinical, epidemiologic, diagnostic, translational, and population studies\", \"Category\": \"External Validity and Applicability\", \"Closely Related Metrics\": \"Spectrum Representativeness; Geographic Consistency; Temporal Generalizability\", \"Common Misinterpretations\": \"Treating subgroup consistency as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Subgroup Consistency\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/\", \"Related Frameworks\": \"GRADE; QUADAS-2; CONSORT; STROBE\", \"Scientific Definition\": \"The degree of agreement in subgroup across measurements, studies, methods, populations, or biological levels.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses subgroup consistency using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in subgroup consistency can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 215"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/83",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 83,
      "bemo:BEMO_3100023": "575df935e8ca0edd1975c05772eaa99f38b63f196b0ee598cef40ebcb4554aaf",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All studies using human or animal biospecimens\", \"Category\": \"Biospecimen and Preanalytical Quality\", \"Closely Related Metrics\": \"Transport Condition Integrity; Anatomical Site Fidelity; Pathology Confirmation\", \"Common Misinterpretations\": \"Treating processing delay control as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Processing Delay Control\", \"References or Origin\": \"https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"BRISQ; ISO 15189; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of processing delay control.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses processing delay control using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in processing delay control can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 83"
    },
    {
      "@id": "bemo:BEMO_2000057",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000057",
      "bemo:BEMO_3100022": 64,
      "bemo:BEMO_3100023": "977d5f2b7e02b5e90f442ea4e8788e2fe539316cddda3ae61da29b0fa71c5325",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses trial-level surrogacy using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in trial-level surrogacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating trial-level surrogacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Biomarker development, qualification, endpoint and surrogate validation studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; BEST; EMA E16; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000057"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000044"
        },
        {
          "@id": "bemo:BEMO_2000045"
        },
        {
          "@id": "bemo:BEMO_2000049"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of trial-level surrogacy."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/64"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000057",
      "rdfs:label": {
        "@language": "en",
        "@value": "Trial-Level Surrogacy"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb105"
        },
        {
          "@id": "bemo:BEMO_1100002"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb105",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000057"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000211",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000211"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/218"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Allelic Evidence Strength"
      }
    },
    {
      "@id": "bemo:BEMO_2000228",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000228",
      "bemo:BEMO_3100022": 235,
      "bemo:BEMO_3100023": "eba377fe2c190b6390cd804f64874ad58540debe287184cfa259e70d97d1fcc8",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses phenocopy risk using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in phenocopy risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating phenocopy risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mendelian disease, cancer genetics, association, segregation, and functional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ClinGen; ACMG AMP; STREGA; Gene Ontology"
      },
      "bemo:BEMO_3200011": "https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000228"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000219"
        },
        {
          "@id": "bemo:BEMO_2000222"
        },
        {
          "@id": "bemo:BEMO_2000224"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The probability or degree that phenocopy introduces systematic distortion into a biomedical estimate or conclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/235"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000228",
      "rdfs:label": {
        "@language": "en",
        "@value": "Phenocopy Risk"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb256"
        },
        {
          "@id": "bemo:BEMO_1100009"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb256",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000228"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_3200001",
      "@type": "owl:AnnotationProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Preserves the exact scientific definition from the source catalog."
      },
      "oboInOwl:id": "BEMO:3200001",
      "rdfs:label": {
        "@language": "en",
        "@value": "source scientific definition"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/453",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 453,
      "bemo:BEMO_3100023": "47dddb5f2dde48130ebfa9464b01b7ed1efb5da34ac2d484caa4259055162e55",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Overadjustment Bias Risk; Calibration of Statistical Predictions; Discrimination of Statistical Predictions\", \"Common Misinterpretations\": \"Treating measurement error correction as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Measurement Error Correction\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of measurement error correction.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses measurement error correction using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in measurement error correction can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 453"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/156",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 156,
      "bemo:BEMO_3100023": "2dc879dd1ad8ed3ebf228b83983e7de95e06b9c72131b584ccaa785f551eea2b",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Systematic reviews, meta-analyses, evidence profiles, guidelines\", \"Category\": \"Evidence Certainty and Synthesis\", \"Closely Related Metrics\": \"Evidence Coverage; Evidence Robustness; Evidence Triangulation Strength\", \"Common Misinterpretations\": \"Treating evidence freshness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Evidence Freshness\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/\", \"Related Frameworks\": \"GRADE; PRISMA; AMSTAR 2; RoB\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of evidence freshness.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses evidence freshness using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in evidence freshness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 156"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000209",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000209"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/216"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Temporal Generalizability"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000477",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000477"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/484"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Exposure Classification Validity"
      }
    },
    {
      "@id": "bemo:BEMO_2000161",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000161",
      "bemo:BEMO_3100022": 168,
      "bemo:BEMO_3100023": "0acc1464b5d065a6f38744191dff4d933036cf918aeac3f16274b9cdb9dd1059",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses prediction interval adequacy using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in prediction interval adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating prediction interval adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Systematic reviews, meta-analyses, evidence profiles, guidelines"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; PRISMA; AMSTAR 2; RoB"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000161"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000139"
        },
        {
          "@id": "bemo:BEMO_2000141"
        },
        {
          "@id": "bemo:BEMO_2000157"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which prediction interval is sufficient and fit for the stated biomedical inference."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/168"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000161",
      "rdfs:label": {
        "@language": "en",
        "@value": "Prediction Interval Adequacy"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb197"
        },
        {
          "@id": "bemo:BEMO_1100006"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb197",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000161"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000093",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000093",
      "bemo:BEMO_3100022": 100,
      "bemo:BEMO_3100023": "8587ae49790e995db7d3bf84506f3bebdce4263532f6e5dcbd136229f5da442f",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses e-value strength using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in e-value strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating e-value strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized and observational etiologic studies, natural experiments, target-trial emulations"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000093"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000084"
        },
        {
          "@id": "bemo:BEMO_2000096"
        },
        {
          "@id": "bemo:BEMO_2000103"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Specialized / infrequent",
      "bemo:BEMO_3200020": "Developing",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting e-value."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/100"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000093",
      "rdfs:label": {
        "@language": "en",
        "@value": "E-value Strength"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb136"
        },
        {
          "@id": "bemo:BEMO_1100004"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb136",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000093"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000221",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000221"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/228"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Gene–Disease Validity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/335",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 335,
      "bemo:BEMO_3100023": "36fbdf592582d2c048b53d43d95edfca8afe5d6c7c93d352f32f2a7d7644cfbe",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Integrated omics, networks, pathways, mechanistic and dynamic systems models\", \"Category\": \"Multi-omics and Systems Biology\", \"Closely Related Metrics\": \"Parameter Sensitivity; Practical Identifiability; Dynamical Stability\", \"Common Misinterpretations\": \"Treating structural identifiability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Dataset / model / pathway / network / evidence body\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Structural Identifiability\", \"References or Origin\": \"https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/\", \"Related Frameworks\": \"Gene Ontology; Reactome; UniProt; GA4GH\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of structural identifiability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses structural identifiability using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in structural identifiability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 335"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000190",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000190"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/197"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Vehicle-Control Validity"
      }
    },
    {
      "@id": "bemo:BEMO_2000365",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000365",
      "bemo:BEMO_3100022": 372,
      "bemo:BEMO_3100023": "904dce77d19fcc637d6eae56d2d92b19b7052fd578de120e2a18bb08d00f2f54",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses internal standard performance using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in internal standard performance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating internal standard performance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAPE; HUPO PSI; Metabolomics Standards"
      },
      "bemo:BEMO_3200011": "https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000365"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000360"
        },
        {
          "@id": "bemo:BEMO_2000362"
        },
        {
          "@id": "bemo:BEMO_2000385"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of internal standard performance."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/372"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000365",
      "rdfs:label": {
        "@language": "en",
        "@value": "Internal Standard Performance"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb379"
        },
        {
          "@id": "bemo:BEMO_1100014"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb379",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000365"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000333",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000333"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/340"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Developmental Toxicity Evidence Strength"
      }
    },
    {
      "@id": "bemo:BEMO_2000096",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000096",
      "bemo:BEMO_3100022": 103,
      "bemo:BEMO_3100023": "280760fd65dbda26ef711b182bed36c1b7e3679af41be52e50dfca26f92b3400",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses falsification test support using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in falsification test support can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating falsification test support as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized and observational etiologic studies, natural experiments, target-trial emulations"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000096"
      },
      "bemo:BEMO_3200013": {
        "@id": "bemo:BEMO_2000084"
      },
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting falsification test."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/103"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000096",
      "rdfs:label": {
        "@language": "en",
        "@value": "Falsification Test Support"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb26"
        },
        {
          "@id": "bemo:BEMO_1100004"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb26",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000096"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_3100003",
      "@type": "owl:DatatypeProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Human-readable formula or protocol requirement."
      },
      "oboInOwl:id": "BEMO:3100003",
      "rdfs:label": {
        "@language": "en",
        "@value": "human-readable formula"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000080",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000080"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/87"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Time-to-Fixation Adequacy"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/353",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 353,
      "bemo:BEMO_3100023": "99eef93672d2993b0ec131c09788c14463fd2a5166870e81b6b8d81c3637506b",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies\", \"Category\": \"Pharmacology and Toxicology\", \"Closely Related Metrics\": \"Pharmacokinetic Adequacy; Bioavailability; Dose Proportionality\", \"Common Misinterpretations\": \"Treating pharmacodynamic adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Pharmacodynamic Adequacy\", \"References or Origin\": \"https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline\", \"Related Frameworks\": \"OECD; OHAT; FDA Biomarker; EMA E16\", \"Scientific Definition\": \"The extent to which pharmacodynamic is sufficient and fit for the stated biomedical inference.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses pharmacodynamic adequacy using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in pharmacodynamic adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 353"
    },
    {
      "@id": "bemo:BEMO_3200014",
      "@type": "owl:AnnotationProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Name of the source workbook."
      },
      "oboInOwl:id": "BEMO:3200014",
      "rdfs:label": {
        "@language": "en",
        "@value": "source workbook"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000018",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000018"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/25"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for On-Target Specificity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000226",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000226"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/233"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Null-Variant Quality"
      }
    },
    {
      "@id": "bemo:BEMO_2000145",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000145",
      "bemo:BEMO_3100022": 152,
      "bemo:BEMO_3100023": "f207ed4da0508b76cb7e86f43fc62efc4861d327760c860608fc73ff3f4a6da8",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses evidence consensus strength using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in evidence consensus strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating evidence consensus strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Systematic reviews, meta-analyses, evidence profiles, guidelines"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; PRISMA; AMSTAR 2; RoB"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000145"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000142"
        },
        {
          "@id": "bemo:BEMO_2000143"
        },
        {
          "@id": "bemo:BEMO_2000155"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting evidence consensus."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/152"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000145",
      "rdfs:label": {
        "@language": "en",
        "@value": "Evidence Consensus Strength"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb184"
        },
        {
          "@id": "bemo:BEMO_1100006"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb184",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000145"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000211",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000211",
      "bemo:BEMO_3100022": 218,
      "bemo:BEMO_3100023": "2dd4a685750034c6175101f0128d889784cf621fed0cf93a74098e6b4879332b",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses allelic evidence strength using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in allelic evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "ClinGen/ACMG evidence scoring; pedigree analysis; population databases; case-control data; functional assays; expert-panel review."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating allelic evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mendelian disease, cancer genetics, association, segregation, and functional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ClinGen; ACMG AMP; STREGA; Gene Ontology"
      },
      "bemo:BEMO_3200011": "https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000211"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000212"
        },
        {
          "@id": "bemo:BEMO_2000213"
        },
        {
          "@id": "bemo:BEMO_2000217"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting allelic evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/218"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000211",
      "rdfs:label": {
        "@language": "en",
        "@value": "Allelic Evidence Strength"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb241"
        },
        {
          "@id": "bemo:BEMO_1100009"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb241",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000211"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_3200007",
      "@type": "owl:AnnotationProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Preserves the source limitations."
      },
      "oboInOwl:id": "BEMO:3200007",
      "rdfs:label": {
        "@language": "en",
        "@value": "limitations"
      }
    },
    {
      "@id": "bemo:BEMO_2000426",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000426",
      "bemo:BEMO_3100022": 433,
      "bemo:BEMO_3100023": "6e6dfc0138818017108063ab02fea9da669c25ffc36ec988048eb058c538f84a",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses protocol availability using evidence appropriate to research transparency and reporting completeness, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in protocol availability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating protocol availability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Study report / dataset / evidence package"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All biomedical study reports and data releases"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "EQUATOR; PRISMA; CONSORT; STROBE; STARD; TRIPOD; CARE; CHEERS"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.care-statement.org/ | https://www.equator-network.org/reporting-guidelines/cheers/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000426"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000423"
        },
        {
          "@id": "bemo:BEMO_2000425"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of protocol availability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/433"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000426",
      "rdfs:label": {
        "@language": "en",
        "@value": "Protocol Availability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb16"
        },
        {
          "@id": "bemo:BEMO_1100016"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb16",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000426"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000115",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000005"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000009"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator; the null value is typically 1 where scientifically applicable"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator != 0\"],\"null_value\":1}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "confidence_level; stratum",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Ratio scale; null typically 1",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100012": "1",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Not generally required unless converted to a probability or score."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000115"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/122"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Diagnostic Odds Ratio"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/200",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 200,
      "bemo:BEMO_3100023": "84e49bfba34c254503c96b181528bf2beab33e58bfa3d6d711b6afaa740ea566",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Clinical, epidemiologic, diagnostic, translational, and population studies\", \"Category\": \"External Validity and Applicability\", \"Closely Related Metrics\": \"Care-Pathway Independence; Ecological Validity; Real-World Evidence Alignment\", \"Common Misinterpretations\": \"Treating context sensitivity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment.\", \"Metric\": \"Context Sensitivity\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/\", \"Related Frameworks\": \"GRADE; QUADAS-2; CONSORT; STROBE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of context sensitivity.\", \"Scientific Importance (1–10)\": \"9\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses context sensitivity using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in context sensitivity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 200"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000410",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000410"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/417"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Data-Sharing Transparency"
      }
    },
    {
      "@id": "bemo:BEMO_2000338",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000338",
      "bemo:BEMO_3100022": 345,
      "bemo:BEMO_3100023": "e40592e267890e51ad35407c7dc2af7775fdac9174afe2f08486d28a5e2901b8",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses genotoxicity evidence strength using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in genotoxicity evidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating genotoxicity evidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "OECD; OHAT; FDA Biomarker; EMA E16"
      },
      "bemo:BEMO_3200011": "https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000338"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000332"
        },
        {
          "@id": "bemo:BEMO_2000345"
        },
        {
          "@id": "bemo:BEMO_2000351"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting genotoxicity evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/345"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000338",
      "rdfs:label": {
        "@language": "en",
        "@value": "Genotoxicity Evidence Strength"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb355"
        },
        {
          "@id": "bemo:BEMO_1100013"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb355",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000338"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000046",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000046",
      "bemo:BEMO_3100022": 53,
      "bemo:BEMO_3100023": "8e195ef346deba393b7a3adaf4c77bfbd949dbf0f057cd9af26312568cb85421",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses known-groups validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in known-groups validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating known-groups validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Biomarker development, qualification, endpoint and surrogate validation studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; BEST; EMA E16; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000046"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000032"
        },
        {
          "@id": "bemo:BEMO_2000038"
        },
        {
          "@id": "bemo:BEMO_2000041"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which known-groups supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/53"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000046",
      "rdfs:label": {
        "@language": "en",
        "@value": "Known-Groups Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb95"
        },
        {
          "@id": "bemo:BEMO_1100002"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb95",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000046"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/229",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 229,
      "bemo:BEMO_3100023": "baeee8e900a9ffef8f3ddd054b3a12f2233d89fc626f852fd31efc4b84b81685",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mendelian disease, cancer genetics, association, segregation, and functional studies\", \"Category\": \"Genetics and Variant Evidence\", \"Closely Related Metrics\": \"Locus Heterogeneity Assessment; Variant Classification Stability; Conflicting Interpretation Burden\", \"Common Misinterpretations\": \"Treating genotype–phenotype concordance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Genotype–Phenotype Concordance\", \"References or Origin\": \"https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://pubmed.ncbi.nlm.nih.gov/25741868/ | https://www.equator-network.org/reporting-guidelines/strega/ | https://geneontology.org/docs/guide-go-evidence-codes/\", \"Related Frameworks\": \"ClinGen; ACMG AMP; STREGA; Gene Ontology\", \"Scientific Definition\": \"The degree of agreement in genotype–phenotype across measurements, studies, methods, populations, or biological levels.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Read- and variant-level quality-control summaries; replicate concordance; orthogonal confirmation; benchmarking against reference materials.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses genotype–phenotype concordance using evidence appropriate to genetics and variant evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in genotype–phenotype concordance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 229"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/276",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 276,
      "bemo:BEMO_3100023": "7c4987f5f8c3c9cca41bb28896f2392e5c664fc505d3f5db2c63ad7c10e1d04d",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Trueness; Repeatability; Intermediate Precision\", \"Common Misinterpretations\": \"Treating analytical precision as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Analytical Precision\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"The closeness of repeated estimates or measurements and the narrowness of uncertainty around analytical.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses analytical precision using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in analytical precision can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 276"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000429",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000429"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/436"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Recruitment Reporting Completeness"
      }
    },
    {
      "@id": "bemo:BEMO_2000067",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000067",
      "bemo:BEMO_3100022": 74,
      "bemo:BEMO_3100023": "40c5c886eacc67a9addeaa92c47d69bf9fbd4b1d2a0042a2efd3611fd5cebb4b",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses freeze–thaw burden using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in freeze–thaw burden can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating freeze–thaw burden as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All studies using human or animal biospecimens"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "BRISQ; ISO 15189; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000067"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000076"
        },
        {
          "@id": "bemo:BEMO_2000079"
        },
        {
          "@id": "bemo:BEMO_2000081"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of freeze–thaw burden."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/74"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000067",
      "rdfs:label": {
        "@language": "en",
        "@value": "Freeze–Thaw Burden"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb113"
        },
        {
          "@id": "bemo:BEMO_1100003"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb113",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000067"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000137",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000137"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/144"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Time-Dependent Discrimination"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/147",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 147,
      "bemo:BEMO_3100023": "d4c1d3bbceb7e86e058c678a7bbc386dd5980f93dcbc9a60ebc6c6d39231fcdb",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Systematic reviews, meta-analyses, evidence profiles, guidelines\", \"Category\": \"Evidence Certainty and Synthesis\", \"Closely Related Metrics\": \"Evidence Triangulation Strength; Missing Evidence Risk; Publication Bias Risk\", \"Common Misinterpretations\": \"Treating counterevidence strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Body of evidence / synthesis / outcome\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Counterevidence Strength\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/\", \"Related Frameworks\": \"GRADE; PRISMA; AMSTAR 2; RoB\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting counterevidence.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses counterevidence strength using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in counterevidence strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 147"
    },
    {
      "@id": "bemo:BEMO_3200009",
      "@type": "owl:AnnotationProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Preserves the source applicable study types."
      },
      "oboInOwl:id": "BEMO:3200009",
      "rdfs:label": {
        "@language": "en",
        "@value": "source study types"
      }
    },
    {
      "@id": "bemo:BEMO_2000352",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000352",
      "bemo:BEMO_3100022": 359,
      "bemo:BEMO_3100023": "51ce0324d6952becbbadfd71ba2913a1f56afbcc33aa0148093d10994d18697d",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses safety margin evidence using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in safety margin evidence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating safety margin evidence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "OECD; OHAT; FDA Biomarker; EMA E16"
      },
      "bemo:BEMO_3200011": "https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000352"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000341"
        },
        {
          "@id": "bemo:BEMO_2000344"
        },
        {
          "@id": "bemo:BEMO_2000355"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of safety margin evidence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/359"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000352",
      "rdfs:label": {
        "@language": "en",
        "@value": "Safety Margin Evidence"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb367"
        },
        {
          "@id": "bemo:BEMO_1100013"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb367",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000352"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/284",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 284,
      "bemo:BEMO_3100023": "1de0ffae2d83059ba1d111ea3bf309f20078d963ac7b7f912a42e8b4e10e5e32",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Interference Susceptibility; Carryover; Hook Effect Risk\", \"Common Misinterpretations\": \"Treating cross-reactivity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Cross-Reactivity\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of cross-reactivity.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses cross-reactivity using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in cross-reactivity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 284"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/16",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 16,
      "bemo:BEMO_3100023": "114851a566f6667271761fd50b701ab810f623c4ee0ecdabe88d5bbacc5941db",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Molecular, cellular, animal, translational, pharmacologic, and human studies\", \"Category\": \"Biological Plausibility and Mechanism\", \"Closely Related Metrics\": \"Mechanistic Specificity; Pathway-Level Support; Cell-Type Specificity\", \"Common Misinterpretations\": \"Treating mechanistic causality strength as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Mechanistic Causality Strength\", \"References or Origin\": \"https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"GRADE; FDA Biomarker; ClinGen; OHAT; OECD\", \"Scientific Definition\": \"The magnitude and credibility of independent evidence supporting mechanistic causality.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Directed acyclic graphs; design emulation; balance diagnostics; negative controls; quantitative bias analysis; sensitivity and falsification analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses mechanistic causality strength using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in mechanistic causality strength can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 16"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000164",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000164"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/171"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Small-Study Effects"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000244",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000244"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/251"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Differential Expression Robustness"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000046",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000046"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/53"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Known-Groups Validity"
      }
    },
    {
      "@id": "bemo:BEMO_3100002",
      "@type": "owl:DatatypeProperty",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Version of a computation profile."
      },
      "oboInOwl:id": "BEMO:3100002",
      "rdfs:label": {
        "@language": "en",
        "@value": "profile version"
      }
    },
    {
      "@id": "bemo:BEMO_2000132",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000132",
      "bemo:BEMO_3100022": 139,
      "bemo:BEMO_3100023": "c2720768cdf2be8ed6a3b935c205e9cb522ea1c958d036e680eee5e7cba4038e",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses prognostic transportability using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in prognostic transportability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating prognostic transportability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "QUADAS-2; STARD; TRIPOD; REMARK"
      },
      "bemo:BEMO_3200011": "https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000132"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000114"
        },
        {
          "@id": "bemo:BEMO_2000129"
        },
        {
          "@id": "bemo:BEMO_2000137"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of prognostic transportability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/139"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000132",
      "rdfs:label": {
        "@language": "en",
        "@value": "Prognostic Transportability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb171"
        },
        {
          "@id": "bemo:BEMO_1100005"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb171",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000132"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/300",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 300,
      "bemo:BEMO_3100023": "b76350bac6098346689193598ba9a67fbdcf0cc16c9a9abb5e49d8238a97798b",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies\", \"Category\": \"Measurement and Assay Analytical Validity\", \"Closely Related Metrics\": \"Batch-Effect Sensitivity; Postanalytical Integrity\", \"Common Misinterpretations\": \"Treating preanalytical robustness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Specimen / assay / run / laboratory / study\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds.\", \"Metric\": \"Preanalytical Robustness\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/\", \"Related Frameworks\": \"FDA Biomarker; CLSI; ISO 15189; MIQE\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of preanalytical robustness.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses preanalytical robustness using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in preanalytical robustness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 300"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/372",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 372,
      "bemo:BEMO_3100023": "904dce77d19fcc637d6eae56d2d92b19b7052fd578de120e2a18bb08d00f2f54",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies\", \"Category\": \"Proteomics and Metabolomics\", \"Closely Related Metrics\": \"Spectral Library Match Quality; Extraction Recovery; Derivatization Efficiency\", \"Common Misinterpretations\": \"Treating internal standard performance as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Internal Standard Performance\", \"References or Origin\": \"https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/\", \"Related Frameworks\": \"MIAPE; HUPO PSI; Metabolomics Standards\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of internal standard performance.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses internal standard performance using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in internal standard performance can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 372"
    },
    {
      "@id": "bemo:BEMO_2000071",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000071",
      "bemo:BEMO_3100022": 78,
      "bemo:BEMO_3100023": "daf35eaf7e6632e499a494b9ba629171cde4aa96d4d637ad7669da2f69668fd5",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses matched-sample integrity using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in matched-sample integrity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating matched-sample integrity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All studies using human or animal biospecimens"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "BRISQ; ISO 15189; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000071"
      },
      "bemo:BEMO_3200013": {
        "@id": "bemo:BEMO_2000062"
      },
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of matched-sample integrity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/78"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000071",
      "rdfs:label": {
        "@language": "en",
        "@value": "Matched-Sample Integrity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb24"
        },
        {
          "@id": "bemo:BEMO_1100003"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb24",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000071"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_4000013",
      "@type": [
        "owl:NamedIndividual",
        "bemo:BEMO_0000402"
      ],
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "Controlled BEMO ComputationReadinessStatus value: DomainProtocolRequired."
      },
      "oboInOwl:id": "BEMO:4000013",
      "rdfs:label": {
        "@language": "en",
        "@value": "Domain Protocol Required"
      },
      "skos:notation": "DomainProtocolRequired"
    },
    {
      "@id": "bemo:BEMO_2000111",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000111",
      "bemo:BEMO_3100022": 118,
      "bemo:BEMO_3100023": "44bfcfec74d2b98de3507998b5e63f6506912c93210fea4df7a678aed4417a75",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses calibration slope using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in calibration slope can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating calibration slope as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "QUADAS-2; STARD; TRIPOD; REMARK"
      },
      "bemo:BEMO_3200011": "https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000111"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000112"
        },
        {
          "@id": "bemo:BEMO_2000124"
        },
        {
          "@id": "bemo:BEMO_2000130"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of calibration slope."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/118"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000111",
      "rdfs:label": {
        "@language": "en",
        "@value": "Calibration Slope"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb153"
        },
        {
          "@id": "bemo:BEMO_1100005"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb153",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000111"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/54",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 54,
      "bemo:BEMO_3100023": "604e83a95f413c6c8ddc8abe7ad03f24c441ede8e65d506baef0410866c23fa7",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Biomarker development, qualification, endpoint and surrogate validation studies\", \"Category\": \"Biomarker and Endpoint Validation\", \"Closely Related Metrics\": \"Endpoint Responsiveness\", \"Common Misinterpretations\": \"Treating minimal clinically important difference validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Minimal Clinically Important Difference Validity\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"FDA Biomarker; BEST; EMA E16; REMARK\", \"Scientific Definition\": \"The degree to which minimal clinically important difference supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses minimal clinically important difference validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in minimal clinically important difference validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 54"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/397",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 397,
      "bemo:BEMO_3100023": "89d3d59a31fe591c17a3c61f83a55d18326e4b311b8033047e95bfb2a93715fa",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All experimental, computational, clinical, and omics studies\", \"Category\": \"Reproducibility and Replication\", \"Closely Related Metrics\": \"Code Availability; Random-Seed Stability; Researcher-Degrees-of-Freedom Sensitivity\", \"Common Misinterpretations\": \"Treating data availability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Data Availability\", \"References or Origin\": \"https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines\", \"Related Frameworks\": \"PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of data availability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses data availability using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in data availability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 397"
    },
    {
      "@id": "bemo:BEMO_2000182",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000182",
      "bemo:BEMO_3100022": 189,
      "bemo:BEMO_3100023": "86d52a57d493edc61e94352ed7d2d8f4feaaa492b37b0afb047315bb8706c00e",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses orthogonal validation using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in orthogonal validation can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating orthogonal validation as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "In vitro, ex vivo, organoid, animal, and preclinical experiments"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ARRIVE 2.0; SYRCLE; OECD"
      },
      "bemo:BEMO_3200011": "https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000182"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000188"
        },
        {
          "@id": "bemo:BEMO_2000190"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of orthogonal validation."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/189"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000182",
      "rdfs:label": {
        "@language": "en",
        "@value": "Orthogonal Validation"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb216"
        },
        {
          "@id": "bemo:BEMO_1100007"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb216",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000182"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000261",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000261",
      "bemo:BEMO_3100022": 268,
      "bemo:BEMO_3100023": "1ce87bfa0e14b3c49cdf26e92f3b39ba4ce32c6192d394a99b4f3b80c80031b2",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses single-cell feature detection rate using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in single-cell feature detection rate can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating single-cell feature detection rate as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAME; MINSEQE; STROBE-ME; GA4GH; HCA"
      },
      "bemo:BEMO_3200011": "https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000261"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000241"
        },
        {
          "@id": "bemo:BEMO_2000262"
        },
        {
          "@id": "bemo:BEMO_2000263"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of single-cell feature detection rate."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/268"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000261",
      "rdfs:label": {
        "@language": "en",
        "@value": "Single-Cell Feature Detection Rate"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb285"
        },
        {
          "@id": "bemo:BEMO_1100010"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb285",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000261"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000216",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000006"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000010"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000015"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000022"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned risk rubric or calibrated probability model defined for the metric and context."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_risk_category\",\"probability\",\"percentage\"]}",
      "bemo:BEMO_3100006": "risk_factors; assessment_context; rubric_or_model_version; evidence_records",
      "bemo:BEMO_3100007": "weights; thresholds; calibration_dataset",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal risk rating or quantitative percentage/probability; lower is generally better",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for probability outputs; rubric reliability required for ordinal outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000216"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/223"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Conflicting Interpretation Burden"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000351",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000351"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/358"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Reproductive Toxicity Evidence Strength"
      }
    },
    {
      "@id": "bemo:BEMO_2000257",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000257",
      "bemo:BEMO_3100022": 264,
      "bemo:BEMO_3100023": "719d5f0d3157f75114503dd8e8b0e75aa481929ab009d6c25b68024c7b5f71a0",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses sequencing depth adequacy using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in sequencing depth adequacy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Read- and variant-level quality-control summaries; replicate concordance; orthogonal confirmation; benchmarking against reference materials."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating sequencing depth adequacy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAME; MINSEQE; STROBE-ME; GA4GH; HCA"
      },
      "bemo:BEMO_3200011": "https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000257"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000246"
        },
        {
          "@id": "bemo:BEMO_2000250"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The extent to which sequencing depth is sufficient and fit for the stated biomedical inference."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/264"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000257",
      "rdfs:label": {
        "@language": "en",
        "@value": "Sequencing Depth Adequacy"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb10"
        },
        {
          "@id": "bemo:BEMO_1100010"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb10",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000257"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000191",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000191",
      "bemo:BEMO_3100022": 198,
      "bemo:BEMO_3100023": "e39c9004563f895f591d754f0c2c01d5cfe45a0e26d44584ecb91c07d72c494a",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses care-pathway independence using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in care-pathway independence can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating care-pathway independence as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Clinical, epidemiologic, diagnostic, translational, and population studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; QUADAS-2; CONSORT; STROBE"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000191"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000193"
        },
        {
          "@id": "bemo:BEMO_2000195"
        },
        {
          "@id": "bemo:BEMO_2000196"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of care-pathway independence."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/198"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000191",
      "rdfs:label": {
        "@language": "en",
        "@value": "Care-Pathway Independence"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb224"
        },
        {
          "@id": "bemo:BEMO_1100008"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb224",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000191"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/327",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 327,
      "bemo:BEMO_3100023": "e1eaab072c302dca725ea1fb92e565c0aead2c5a6ddd49490dbfa43ad163dd03",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Integrated omics, networks, pathways, mechanistic and dynamic systems models\", \"Category\": \"Multi-omics and Systems Biology\", \"Closely Related Metrics\": \"Model–Experiment Concordance; Parameter Sensitivity; Structural Identifiability\", \"Common Misinterpretations\": \"Treating parameter identifiability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Dataset / model / pathway / network / evidence body\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Parameter Identifiability\", \"References or Origin\": \"https://geneontology.org/docs/guide-go-evidence-codes/ | https://reactome.org/ | https://www.uniprot.org/help/evidences | https://www.ga4gh.org/\", \"Related Frameworks\": \"Gene Ontology; Reactome; UniProt; GA4GH\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of parameter identifiability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses parameter identifiability using evidence appropriate to multi-omics and systems biology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in parameter identifiability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 327"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000308",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000308"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/315"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Entity Resolution Accuracy"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/256",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 256,
      "bemo:BEMO_3100023": "fb650cc4b9fc46d550895b59d1656dada1a7ec625426686e0a708ba75b6fc5f0",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Whole-genome, exome, panel, bulk/single-cell/spatial transcriptomic studies\", \"Category\": \"Genomics and Transcriptomics\", \"Closely Related Metrics\": \"Duplicate Read Burden; Contamination Burden; Sample Identity Concordance\", \"Common Misinterpretations\": \"Treating library complexity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Library Complexity\", \"References or Origin\": \"https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.equator-network.org/reporting-guidelines/strobe-me/ | https://www.ga4gh.org/ | https://www.humancellatlas.org/\", \"Related Frameworks\": \"MIAME; MINSEQE; STROBE-ME; GA4GH; HCA\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of library complexity.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses library complexity using evidence appropriate to genomics and transcriptomics, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in library complexity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 256"
    },
    {
      "@id": "bemo:BEMO_2000485",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000485",
      "bemo:BEMO_3100022": 492,
      "bemo:BEMO_3100023": "8438f239c984919f366a44747e2e32efd683c0e45e3f7af6c269801f1d6694c8",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses randomization integrity using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in randomization integrity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating randomization integrity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000485"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000464"
        },
        {
          "@id": "bemo:BEMO_2000466"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of randomization integrity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/492"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000485",
      "rdfs:label": {
        "@language": "en",
        "@value": "Randomization Integrity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb18"
        },
        {
          "@id": "bemo:BEMO_1100018"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb18",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000485"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000001",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000001",
      "bemo:BEMO_3100022": 8,
      "bemo:BEMO_3100023": "6471dcf670c9dd05424f4606389decf6b51812d07c0a0680842d77bda957b0f3",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses biological gradient using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in biological gradient can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating biological gradient as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Molecular, cellular, animal, translational, pharmacologic, and human studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; FDA Biomarker; ClinGen; OHAT; OECD"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000001"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000007"
        },
        {
          "@id": "bemo:BEMO_2000016"
        },
        {
          "@id": "bemo:BEMO_2000017"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of biological gradient."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/8"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000001",
      "rdfs:label": {
        "@language": "en",
        "@value": "Biological Gradient"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb55"
        },
        {
          "@id": "bemo:BEMO_1100001"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb55",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000001"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000447",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000447"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/454"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Missing-Data Mechanism Plausibility"
      }
    },
    {
      "@id": "bemo:BEMO_2000101",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000101",
      "bemo:BEMO_3100022": 108,
      "bemo:BEMO_3100023": "8aa9a1ba76fa5fd8217fff1b4352656d262602a1040dc8618b138b2e37a93d9a",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses no-interference plausibility using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in no-interference plausibility can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Replicate dilution series; blank and spiked samples; reference materials; method-comparison studies; predefined CLSI/ISO acceptance criteria."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating no-interference plausibility as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized and observational etiologic studies, natural experiments, target-trial emulations"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000101"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000085"
        },
        {
          "@id": "bemo:BEMO_2000089"
        },
        {
          "@id": "bemo:BEMO_2000090"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of no-interference plausibility."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/108"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000101",
      "rdfs:label": {
        "@language": "en",
        "@value": "No-Interference Plausibility"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb143"
        },
        {
          "@id": "bemo:BEMO_1100004"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb143",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000101"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000014",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000014",
      "bemo:BEMO_3100022": 21,
      "bemo:BEMO_3100023": "d05eb179325de1077bb0eedc4d22a5f8c9cc2049d4ca5a5830b380984606cc90",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses mechanistic support using evidence appropriate to biological plausibility and mechanism, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in mechanistic support can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating mechanistic support as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Molecular, cellular, animal, translational, pharmacologic, and human studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; FDA Biomarker; ClinGen; OHAT; OECD"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.fda.gov/media/119271/download | https://clinicalgenome.org/curation-activities/gene-disease-validity/ | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000014"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000002"
        },
        {
          "@id": "bemo:BEMO_2000011"
        },
        {
          "@id": "bemo:BEMO_2000012"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The magnitude and credibility of independent evidence supporting mechanistic."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/21"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000014",
      "rdfs:label": {
        "@language": "en",
        "@value": "Mechanistic Support"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb19"
        },
        {
          "@id": "bemo:BEMO_1100001"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb19",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000014"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000267",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000267",
      "bemo:BEMO_3100022": 274,
      "bemo:BEMO_3100023": "35d988975cf78a06cb70788f89a4196551552de36a3cf47e57d2d96fc8cf41fd",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses accuracy using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in accuracy can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating accuracy as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000267"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000269"
        },
        {
          "@id": "bemo:BEMO_2000272"
        },
        {
          "@id": "bemo:BEMO_2000302"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The closeness of accuracy to the accepted reference or true value."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/274"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000267",
      "rdfs:label": {
        "@language": "en",
        "@value": "Accuracy"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb39"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb39",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000267"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000206",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000206",
      "bemo:BEMO_3100022": 213,
      "bemo:BEMO_3100023": "323f595d53815c626b380456c55c73f7ff5e2e10beb1e0ffc44edb8067c37e86",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses setting applicability using evidence appropriate to external validity and applicability, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in setting applicability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating setting applicability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Clinical, epidemiologic, diagnostic, translational, and population studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; QUADAS-2; CONSORT; STROBE"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000206"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000198"
        },
        {
          "@id": "bemo:BEMO_2000200"
        },
        {
          "@id": "bemo:BEMO_2000202"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of setting applicability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/213"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000206",
      "rdfs:label": {
        "@language": "en",
        "@value": "Setting Applicability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb236"
        },
        {
          "@id": "bemo:BEMO_1100008"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb236",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000206"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/42",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 42,
      "bemo:BEMO_3100023": "5bd558ed006f260bde44545e9ab38951fc6c2e450b4d3cb07f929d1fcb479f4e",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Biomarker development, qualification, endpoint and surrogate validation studies\", \"Category\": \"Biomarker and Endpoint Validation\", \"Closely Related Metrics\": \"Criterion Validity; Content Validity; Predictive Biomarker Validity\", \"Common Misinterpretations\": \"Treating construct validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Mature\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Construct Validity\", \"References or Origin\": \"https://www.fda.gov/media/119271/download | https://www.ncbi.nlm.nih.gov/books/NBK326791/ | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"FDA Biomarker; BEST; EMA E16; REMARK\", \"Scientific Definition\": \"The degree to which construct supports the intended scientific interpretation without material systematic error.\", \"Scientific Importance (1–10)\": \"10\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses construct validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in construct validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 42"
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000229",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000004"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000008"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000017"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000019"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "value = numerator / denominator, with denominator > 0"
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"divide\",\"arguments\":[\"numerator\",\"denominator\"],\"constraints\":[\"denominator > 0\"]}",
      "bemo:BEMO_3100006": "numerator; denominator; operational_definition; assessment_context",
      "bemo:BEMO_3100007": "weight; stratum; confidence_level",
      "bemo:BEMO_3100008": "xsd:decimal",
      "bemo:BEMO_3100009": "Proportion or percentage (0–1 or 0–100%)",
      "bemo:BEMO_3100010": {
        "@type": "xsd:decimal",
        "@value": "0.0"
      },
      "bemo:BEMO_3100011": {
        "@type": "xsd:decimal",
        "@value": "1.0"
      },
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; required when interpreted probabilistically."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000229"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/236"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Phenotypic Specificity for Variant"
      }
    },
    {
      "@id": "bemo:BEMO_2000162",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000162",
      "bemo:BEMO_3100022": 169,
      "bemo:BEMO_3100023": "ae14a6a3126f2ecd31144006a017263d5e10df0fcde0e6bd8cc0872e93853a7a",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses publication bias risk using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in publication bias risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Forest plots; heterogeneity statistics; tau-squared; prediction intervals; funnel plots; regression or selection models; sensitivity analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating publication bias risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Body of evidence / synthesis / outcome"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Systematic reviews, meta-analyses, evidence profiles, guidelines"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "GRADE; PRISMA; AMSTAR 2; RoB"
      },
      "bemo:BEMO_3200011": "https://www.gradeworkinggroup.org/ | https://www.prisma-statement.org/prisma-2020-checklist | https://www.bmj.com/content/358/bmj.j4008 | https://www.riskofbias.info/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000162"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000158"
        },
        {
          "@id": "bemo:BEMO_2000163"
        },
        {
          "@id": "bemo:BEMO_2000164"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The probability or degree that publication bias introduces systematic distortion into a biomedical estimate or conclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/169"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000162",
      "rdfs:label": {
        "@language": "en",
        "@value": "Publication Bias Risk"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb198"
        },
        {
          "@id": "bemo:BEMO_1100006"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb198",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000162"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000480",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000002"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000011"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000016"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned, prespecified domain rubric or validated normalized scoring model."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\",\"allowed_outputs\":[\"ordinal_category\",\"normalized_score\"]}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; rubric_version; operational_definition",
      "bemo:BEMO_3100007": "weights; thresholds; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:string_or_decimal",
      "bemo:BEMO_3100009": "Ordinal rubric, domain judgment, or normalized score",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": false,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "Required for normalized scores; inter-rater reliability required for human rubrics."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Mature; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000480"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/487"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Outcome Ascertainment Validity"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/338",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 338,
      "bemo:BEMO_3100023": "1dbec5a00f53d17cad5a3a88dd4dfde9ceab9bbbe33a898c76c7086698d1a0a2",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Pharmacology, pharmacokinetics, toxicology, safety and mode-of-action studies\", \"Category\": \"Pharmacology and Toxicology\", \"Closely Related Metrics\": \"Pharmacodynamic Adequacy; Dose Proportionality; Time–Concentration Profile Adequacy\", \"Common Misinterpretations\": \"Treating bioavailability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Required elements present; traceable provenance; unambiguous definitions; accessible underlying data/materials; documented deviations.\", \"Metric\": \"Bioavailability\", \"References or Origin\": \"https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm | https://ntp.niehs.nih.gov/whatwestudy/assessments/noncancer/handbook | https://www.fda.gov/media/119271/download | https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guideline\", \"Related Frameworks\": \"OECD; OHAT; FDA Biomarker; EMA E16\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of bioavailability.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Proportion or percentage (0–1 or 0–100%)\", \"What It Measures\": \"Assesses bioavailability using evidence appropriate to pharmacology and toxicology, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in bioavailability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 338"
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/173",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 173,
      "bemo:BEMO_3100023": "6f50922de3489bf44a56c621fcc8933973821a524b4c3ba13cb746276b4a9bea",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"In vitro, ex vivo, organoid, animal, and preclinical experiments\", \"Category\": \"Experimental Biology and Animal Research\", \"Closely Related Metrics\": \"Sex as a Biological Variable Adequacy; Genetic Background Control; Housing and Husbandry Control\", \"Common Misinterpretations\": \"Treating age appropriateness as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions.\", \"Metric\": \"Age Appropriateness\", \"References or Origin\": \"https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm\", \"Related Frameworks\": \"ARRIVE 2.0; SYRCLE; OECD\", \"Scientific Definition\": \"The extent to which age is sufficient and fit for the stated biomedical inference.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal rubric, domain judgment, or normalized score\", \"What It Measures\": \"Assesses age appropriateness using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in age appropriateness can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 173"
    },
    {
      "@id": "bemo:BEMO_2000448",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000448",
      "bemo:BEMO_3100022": 455,
      "bemo:BEMO_3100023": "6708217d617153345c000ff0b34cc96bd34facf9514e5d1a84b3e56623ffb545",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses missing-data sensitivity using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in missing-data sensitivity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating missing-data sensitivity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All quantitative biomedical studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; TRIPOD; REMARK; ICH E9"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000448"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000443"
        },
        {
          "@id": "bemo:BEMO_2000447"
        },
        {
          "@id": "bemo:BEMO_2000454"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of missing-data sensitivity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/455"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000448",
      "rdfs:label": {
        "@language": "en",
        "@value": "Missing-Data Sensitivity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb452"
        },
        {
          "@id": "bemo:BEMO_1100017"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb452",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000448"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000185",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000185",
      "bemo:BEMO_3100022": 192,
      "bemo:BEMO_3100023": "9c4289123cb7c0f9d87fa9453151e360a9b6781cd9fbb6f6b26a09f4543b0dab",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses sample size justification using evidence appropriate to experimental biology and animal research, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in sample size justification can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating sample size justification as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "In vitro, ex vivo, organoid, animal, and preclinical experiments"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "ARRIVE 2.0; SYRCLE; OECD"
      },
      "bemo:BEMO_3200011": "https://arriveguidelines.org/arrive-guidelines | https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-center-for-laboratory-animal-experimentation | https://www.oecd.org/chemicalsafety/testing/oecd-guidelines-testing-chemicals-related-documents.htm",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000185"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000172"
        },
        {
          "@id": "bemo:BEMO_2000184"
        },
        {
          "@id": "bemo:BEMO_2000189"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of sample size justification."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/192"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000185",
      "rdfs:label": {
        "@language": "en",
        "@value": "Sample Size Justification"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb219"
        },
        {
          "@id": "bemo:BEMO_1100007"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb219",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000185"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000401",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000401"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/408"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Protocol Reproducibility"
      }
    },
    {
      "@id": "bemo:BEMO_2000284",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000284",
      "bemo:BEMO_3100022": 291,
      "bemo:BEMO_3100023": "543dc6e95f52dce066f892ad8d141154500ea9d0cf35d11564c84cc551f70c3b",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses intermediate precision using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in intermediate precision can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating intermediate precision as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000284"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000270"
        },
        {
          "@id": "bemo:BEMO_2000297"
        },
        {
          "@id": "bemo:BEMO_2000299"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The closeness of repeated estimates or measurements and the narrowness of uncertainty around intermediate."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/291"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000284",
      "rdfs:label": {
        "@language": "en",
        "@value": "Intermediate Precision"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb306"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb306",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000284"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000134",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000134",
      "bemo:BEMO_3100022": 141,
      "bemo:BEMO_3100023": "3bd12b9aed8e6e227ec8b1e5082fc9060b988babbc4204f8a360bb7503e6ad49",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses reference standard validity using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in reference standard validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Clear intended use or estimand; accepted reference or criterion; prespecified acceptance thresholds; independent validation; performance across relevant conditions."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating reference standard validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "QUADAS-2; STARD; TRIPOD; REMARK"
      },
      "bemo:BEMO_3200011": "https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000134"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000121"
        },
        {
          "@id": "bemo:BEMO_2000136"
        },
        {
          "@id": "bemo:BEMO_2000138"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The degree to which reference standard supports the intended scientific interpretation without material systematic error."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/141"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000134",
      "rdfs:label": {
        "@language": "en",
        "@value": "Reference Standard Validity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb173"
        },
        {
          "@id": "bemo:BEMO_1100005"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb173",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000134"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/112",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 112,
      "bemo:BEMO_3100023": "17fc4b74f3434a4ae22f908b09530b9a1be33f82af499c89239235d78d7e1375",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Randomized and observational etiologic studies, natural experiments, target-trial emulations\", \"Category\": \"Causal Inference\", \"Closely Related Metrics\": \"Immortal-Time Bias Risk; Selection-on-Survival Bias Risk; Quantitative Bias Analysis Robustness\", \"Common Misinterpretations\": \"Treating reverse-causation risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Established within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.\", \"Metric\": \"Reverse-Causation Risk\", \"References or Origin\": \"https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.gradeworkinggroup.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"ROBINS-I; ROBINS-E; GRADE; STROBE; ICH E9\", \"Scientific Definition\": \"The probability or degree that reverse-causation introduces systematic distortion into a biomedical estimate or conclusion.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Ordinal risk rating or quantitative percentage/probability; lower is generally better\", \"What It Measures\": \"Assesses reverse-causation risk using evidence appropriate to causal inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in reverse-causation risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 112"
    },
    {
      "@id": "bemo:BEMO_2000068",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000068",
      "bemo:BEMO_3100022": 75,
      "bemo:BEMO_3100023": "1b0946c6b109834d9e6fa6dc5ae7dde1ce95bc65f999a58a3c5a88bc66c6a47c",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses hemolysis burden using evidence appropriate to biospecimen and preanalytical quality, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in hemolysis burden can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating hemolysis burden as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All studies using human or animal biospecimens"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "BRISQ; ISO 15189; REMARK"
      },
      "bemo:BEMO_3200011": "https://www.equator-network.org/reporting-guidelines/brisq/ | https://www.iso.org/standard/76677.html | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000068"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000069"
        },
        {
          "@id": "bemo:BEMO_2000070"
        },
        {
          "@id": "bemo:BEMO_2000073"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of hemolysis burden."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/75"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000068",
      "rdfs:label": {
        "@language": "en",
        "@value": "Hemolysis Burden"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb114"
        },
        {
          "@id": "bemo:BEMO_1100003"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb114",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000068"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/profile/BEMO_2000124",
      "@type": "bemo:BEMO_0000100",
      "bemo:BEMO_3000007": {
        "@id": "bemo:BEMO_4000001"
      },
      "bemo:BEMO_3000008": {
        "@id": "bemo:BEMO_4000007"
      },
      "bemo:BEMO_3000009": {
        "@id": "bemo:BEMO_4000014"
      },
      "bemo:BEMO_3000010": {
        "@id": "bemo:BEMO_4000018"
      },
      "bemo:BEMO_3000011": {
        "@id": "bemo:BEMO_4000021"
      },
      "bemo:BEMO_3100002": "0.1.0",
      "bemo:BEMO_3100003": {
        "@language": "en",
        "@value": "Apply a versioned metric-specific computation protocol consistent with the source definition, criteria, and methods."
      },
      "bemo:BEMO_3100004": "BEMO-Expression-JSON",
      "bemo:BEMO_3100005": "{\"language\":\"BEMO-Expression-JSON\",\"operator\":\"external_protocol\",\"protocolRef\":\"REQUIRED\"}",
      "bemo:BEMO_3100006": "evidence_records; assessment_context; operational_definition; computation_protocol_version",
      "bemo:BEMO_3100007": "weights; thresholds; reference_standard; expert_adjudication",
      "bemo:BEMO_3100008": "xsd:anySimpleType",
      "bemo:BEMO_3100009": "Metric-specific continuous, categorical, or ordinal scale",
      "bemo:BEMO_3100013": {
        "@language": "en",
        "@value": "Not specified in source; must be defined and versioned before composite use."
      },
      "bemo:BEMO_3100014": {
        "@language": "en",
        "@value": "None by default; any normalization must be justified, versioned, and validated."
      },
      "bemo:BEMO_3100015": {
        "@language": "en",
        "@value": "Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material."
      },
      "bemo:BEMO_3100016": true,
      "bemo:BEMO_3100017": {
        "@language": "en",
        "@value": "Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable."
      },
      "bemo:BEMO_3100018": true,
      "bemo:BEMO_3100019": {
        "@language": "en",
        "@value": "Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction."
      },
      "bemo:BEMO_3100020": {
        "@language": "en",
        "@value": "Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable."
      },
      "bemo:BEMO_3100021": {
        "@language": "en",
        "@value": "As applicable; mandatory for probabilistic or normalized outputs."
      },
      "bemo:BEMO_3100030": {
        "@language": "en",
        "@value": "Source maturity: Established; BEMO computation profile requires independent validation."
      },
      "dcterms:subject": {
        "@id": "bemo:BEMO_2000124"
      },
      "prov:wasDerivedFrom": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/131"
      },
      "rdfs:label": {
        "@language": "en",
        "@value": "Computation profile for Observed-to-Expected Ratio"
      }
    },
    {
      "@id": "bemo:BEMO_2000273",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000273",
      "bemo:BEMO_3100022": 280,
      "bemo:BEMO_3100023": "7222c30713cc035f86bae406549aaf0d4751a919d50ae68b917efd9629244d28",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses batch-effect sensitivity using evidence appropriate to measurement and assay analytical validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in batch-effect sensitivity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified threshold; valid reference standard; complete 2×2 classification; confidence intervals; spectrum and prevalence assessment."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating batch-effect sensitivity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Specimen / assay / run / laboratory / study"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Laboratory-developed tests, molecular assays, imaging, pathology, biomarker studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "FDA Biomarker; CLSI; ISO 15189; MIQE"
      },
      "bemo:BEMO_3200011": "https://www.fda.gov/media/119271/download | https://clsi.org/standards/products/method-evaluation/ | https://www.iso.org/standard/76677.html | https://pubmed.ncbi.nlm.nih.gov/19246619/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000273"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000292"
        },
        {
          "@id": "bemo:BEMO_2000293"
        },
        {
          "@id": "bemo:BEMO_2000301"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of batch-effect sensitivity."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/280"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000273",
      "rdfs:label": {
        "@language": "en",
        "@value": "Batch-Effect Sensitivity"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb295"
        },
        {
          "@id": "bemo:BEMO_1100011"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb295",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000273"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000382",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000382",
      "bemo:BEMO_3100022": 389,
      "bemo:BEMO_3100023": "6e5af7c1fffa7603da0abd7518a670fd09cade5fe3e47c8417886f91e6b4e07a",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses quantification precision using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in quantification precision can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating quantification precision as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAPE; HUPO PSI; Metabolomics Standards"
      },
      "bemo:BEMO_3200011": "https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000382"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000361"
        },
        {
          "@id": "bemo:BEMO_2000381"
        },
        {
          "@id": "bemo:BEMO_2000384"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The closeness of repeated estimates or measurements and the narrowness of uncertainty around quantification."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/389"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000382",
      "rdfs:label": {
        "@language": "en",
        "@value": "Quantification Precision"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb394"
        },
        {
          "@id": "bemo:BEMO_1100014"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb394",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000382"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "bemo:BEMO_2000389",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000389",
      "bemo:BEMO_3100022": 396,
      "bemo:BEMO_3100023": "45fcdc0cd9da1d73796f886d24683b4f40ead7f7a14a06e84d39631b66a910ad",
      "bemo:BEMO_3100024": 10,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses conceptual replication success using evidence appropriate to reproducibility and replication, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in conceptual replication success can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating conceptual replication success as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "All experimental, computational, clinical, and omics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "PRISMA; CONSORT; MIAME; MINSEQE; MIAPE; ARRIVE 2.0"
      },
      "bemo:BEMO_3200011": "https://www.prisma-statement.org/prisma-2020-checklist | https://www.consort-spirit.org/ | https://www.fged.org/projects/miame | https://www.fged.org/projects/minseqe/ | https://www.psidev.info/miape | https://arriveguidelines.org/arrive-guidelines",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000389"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000386"
        },
        {
          "@id": "bemo:BEMO_2000388"
        },
        {
          "@id": "bemo:BEMO_2000392"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Mature",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of conceptual replication success."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/396"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000389",
      "rdfs:label": {
        "@language": "en",
        "@value": "Conceptual Replication Success"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb401"
        },
        {
          "@id": "bemo:BEMO_1100015"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb401",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000389"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/444",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 444,
      "bemo:BEMO_3100023": "cf100cd63561a5d7a167b9d561a196b9309ca048456a8705766e76a54a524fce",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"All quantitative biomedical studies\", \"Category\": \"Statistical Validity and Inference\", \"Closely Related Metrics\": \"Calibration of Statistical Predictions; Decision-Curve Net Benefit; Clinical Relevance of Effect\", \"Common Misinterpretations\": \"Treating discrimination of statistical predictions as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Discrimination of Statistical Predictions\", \"References or Origin\": \"https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/ | https://database.ich.org/sites/default/files/E9_Guideline.pdf\", \"Related Frameworks\": \"CONSORT; STROBE; TRIPOD; REMARK; ICH E9\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of discrimination of statistical predictions.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses discrimination of statistical predictions using evidence appropriate to statistical validity and inference, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in discrimination of statistical predictions can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 444"
    },
    {
      "@id": "bemo:BEMO_2000468",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000468",
      "bemo:BEMO_3100022": 475,
      "bemo:BEMO_3100023": "6dbe1d75153c55efcce7da9af8dda3fe869c2f426eaaad651ee6f91b1670d205",
      "bemo:BEMO_3100024": 8,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses carryover effect risk using evidence appropriate to study design and internal validity, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in carryover effect risk can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Replicate dilution series; blank and spiked samples; reference materials; method-comparison studies; predefined CLSI/ISO acceptance criteria."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating carryover effect risk as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Randomized trials, nonrandomized intervention studies, cohort, case-control, cross-sectional studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "CONSORT; STROBE; RoB 2; ROBINS-I; ROBINS-E; NIH Quality Tools; JBI"
      },
      "bemo:BEMO_3200011": "https://www.consort-spirit.org/ | https://www.equator-network.org/reporting-guidelines/strobe/ | https://www.riskofbias.info/welcome/rob-2-0-tool | https://www.riskofbias.info/welcome/home/current-version-of-robins-i | https://www.riskofbias.info/welcome/robins-e-tool | https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools | https://jbi.global/critical-appraisal-tools",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000468"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000469"
        },
        {
          "@id": "bemo:BEMO_2000470"
        },
        {
          "@id": "bemo:BEMO_2000482"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Common",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "The probability or degree that carryover effect introduces systematic distortion into a biomedical estimate or conclusion."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/475"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000468",
      "rdfs:label": {
        "@language": "en",
        "@value": "Carryover Effect Risk"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb470"
        },
        {
          "@id": "bemo:BEMO_1100018"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb470",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000468"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    },
    {
      "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/144",
      "@type": "prov:Entity",
      "bemo:BEMO_3100022": 144,
      "bemo:BEMO_3100023": "5232bfe9f1dc1ddd88662ddb65a550d0d1fc5338bb4a530ed1072ed6078116bf",
      "dcterms:source": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "prov:value": "{\"Applicable Study Types\": \"Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies\", \"Category\": \"Diagnostic and Prognostic Evidence\", \"Closely Related Metrics\": \"Prognostic Transportability; Competing-Risk Model Validity\", \"Common Misinterpretations\": \"Treating time-dependent discrimination as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.\", \"Evidence Level Where Used\": \"Result / experiment / study / body of evidence, as applicable\", \"Frequency of Use\": \"Common within specialty\", \"Limitations\": \"Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.\", \"Maturity of Metric\": \"Established\", \"Measurement Criteria\": \"Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.\", \"Metric\": \"Time-Dependent Discrimination\", \"References or Origin\": \"https://pubmed.ncbi.nlm.nih.gov/22007046/ | https://www.equator-network.org/reporting-guidelines/stard/ | https://www.tripod-statement.org/ | https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/\", \"Related Frameworks\": \"QUADAS-2; STARD; TRIPOD; REMARK\", \"Scientific Definition\": \"A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of time-dependent discrimination.\", \"Scientific Importance (1–10)\": \"8\", \"Typical Methods of Assessment\": \"Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.\", \"Units or Scale (if applicable)\": \"Metric-specific continuous, categorical, or ordinal scale\", \"What It Measures\": \"Assesses time-dependent discrimination using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error.\", \"Why It Matters\": \"Material weakness in time-dependent discrimination can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.\"}",
      "rdfs:label": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 144"
    },
    {
      "@id": "bemo:BEMO_2000383",
      "@type": "owl:Class",
      "bemo:BEMO_3100001": "BEMO:2000383",
      "bemo:BEMO_3100022": 390,
      "bemo:BEMO_3100023": "7ed489b83705dc957b891fd6483e7b54ca4c70547f903f7dfa9e53d0ca59fa58",
      "bemo:BEMO_3100024": 9,
      "bemo:BEMO_3200002": {
        "@language": "en",
        "@value": "Assesses retention-time stability using evidence appropriate to proteomics and metabolomics, distinguishing random uncertainty from systematic error."
      },
      "bemo:BEMO_3200003": {
        "@language": "en",
        "@value": "Material weakness in retention-time stability can change the direction, magnitude, certainty, or biological interpretation of the research conclusion."
      },
      "bemo:BEMO_3200004": {
        "@language": "en",
        "@value": "Independent repeats; between-run/site/analyst variability; concordance of effect direction and magnitude; predefined reproducibility thresholds."
      },
      "bemo:BEMO_3200005": {
        "@language": "en",
        "@value": "Target-decoy analysis; spectral scoring; reference standards; replicate injections; retention-time and mass-error monitoring; orthogonal confirmation."
      },
      "bemo:BEMO_3200006": {
        "@language": "en",
        "@value": "Treating retention-time stability as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory."
      },
      "bemo:BEMO_3200007": {
        "@language": "en",
        "@value": "Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence."
      },
      "bemo:BEMO_3200008": {
        "@language": "en",
        "@value": "Result / experiment / study / body of evidence, as applicable"
      },
      "bemo:BEMO_3200009": {
        "@language": "en",
        "@value": "Mass spectrometry, affinity proteomics, metabolomics, lipidomics studies"
      },
      "bemo:BEMO_3200010": {
        "@language": "en",
        "@value": "MIAPE; HUPO PSI; Metabolomics Standards"
      },
      "bemo:BEMO_3200011": "https://www.psidev.info/miape | https://www.psidev.info/ | https://www.metabolomics-msi.org/",
      "bemo:BEMO_3200012": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000383"
      },
      "bemo:BEMO_3200013": [
        {
          "@id": "bemo:BEMO_2000366"
        },
        {
          "@id": "bemo:BEMO_2000367"
        },
        {
          "@id": "bemo:BEMO_2000368"
        }
      ],
      "bemo:BEMO_3200014": "Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx",
      "bemo:BEMO_3200015": "Biomedical Evidence Metrics",
      "bemo:BEMO_3200016": "Candidate",
      "bemo:BEMO_3200017": "Pending owner approval; CC BY 4.0 recommended for OBO compatibility.",
      "bemo:BEMO_3200018": {
        "@language": "en",
        "@value": "Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use."
      },
      "bemo:BEMO_3200019": "Established within specialty",
      "bemo:BEMO_3200020": "Established",
      "obo:IAO_0000115": {
        "@language": "en",
        "@value": "A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of retention-time stability."
      },
      "obo:IAO_0000119": {
        "@id": "https://w3id.org/bemo/source/pure_biomedical_evidence_research_metrics_part_2_3_xlsx/row/390"
      },
      "oboInOwl:hasOBONamespace": "bemo",
      "oboInOwl:id": "BEMO:2000383",
      "rdfs:label": {
        "@language": "en",
        "@value": "Retention-Time Stability"
      },
      "rdfs:subClassOf": [
        {
          "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb395"
        },
        {
          "@id": "bemo:BEMO_1100014"
        }
      ]
    },
    {
      "@id": "_:n3d8500c404224719bd9bf733a5ad4a7cb395",
      "@type": "owl:Restriction",
      "owl:hasValue": {
        "@id": "https://w3id.org/bemo/profile/BEMO_2000383"
      },
      "owl:onProperty": {
        "@id": "bemo:BEMO_3000001"
      }
    }
  ]
}